State of Israel | | | 7389 | | | Not applicable |
(State or other jurisdiction of incorporation or organization) | | | (Primary Standard Industrial Classification Code Number) | | | (I.R.S. Employer Identification Number) |
Jeffrey A. Brill Maxim O. Mayer-Cesiano Andrea L. Nicolás B. Chase Wink Skadden, Arps, Slate, Meagher & Flom LLP One Manhattan West New York, NY 10001 Tel: 212-735-3000 | | | Aaron M. Lampert Sharon Gazit Goldfarb Seligman & Co. 98 Yigal Alon Street Tel Aviv 6789141 Israel Tel: 972-3-608-9999 | | | Mark A. Brod Jonathan Corsico Simpson Thacher & Bartlett LLP 425 Lexington Avenue New York, NY 10017 Tel: 212-455-2000 | | | Ory Nacht Michal Herzfeld Herzog Fox & Neeman 6 Yitzhak Sadeh St. Herzog Tower Tel Aviv 6777506 Israel Tel: 972-3-692-2020 |
Title of Each Class of Securities to be Registered | | | Amount to be Registered(1)(2) | | | Proposed Maximum Offering Price per Security | | | Proposed Maximum Aggregate Offering Price | | | Amount of Registration Fee(3) |
Class A ordinary shares, no par value per share(4) | | | | | $(5) | | | $ (5) | | | $ | |
Warrants to purchase Class A ordinary shares, no par value per share(6) | | | | | $(7) | | | $(7) | | | $ | |
Class A ordinary shares, no par value per share, issuable upon exercise of the warrants(8) | | | | | $(9) | | | $(9) | | | $ | |
Total | | | | | $— | | | $ | | | $ |
(1) | All securities being registered will be issued by Pagaya Technologies Ltd. (“Pagaya”), a company organized under the laws of the State of Israel, in connection with the Merger Agreement described in this registration statement and the proxy statement/prospectus included herein, which provides for, among other things, Pagaya to acquire EJF Acquisition Corp. (“EJFA”), a Cayman Islands exempted company through the merger of Rigel Merger Sub Inc. (“Merger Sub”), a Cayman Islands exempted company and a direct, wholly-owned subsidiary of Pagaya, with and into EJFA, with EJFA surviving as a wholly-owned subsidiary of Pagaya (the “Merger”). Pursuant to the Merger Agreement, at the effective time of the Merger (the “Effective Time”), (i) each unit of EJFA issued in the initial public offering of EJFA (“EJFA Units”) and consisting of one Class A ordinary share of EJFA, par value $0.0001 per share (each, an “EJFA Class A Ordinary Share”) and one-third of one public warrant of EJFA entitling the holder to purchase one EJFA Class A Ordinary Share per warrant (each, an “EJFA Public Warrant”) will be automatically separated into one EJFA Class A Ordinary Share and one-third of one EJFA Public Warrant; provided that no fractional EJFA Public Warrants will be issued in connection with the EJFA Unit separation such that if a holder of EJFA Units would be entitled to receive a fractional EJFA Public Warrant upon the EJFA Unit separation, then the number of EJFA Public Warrants to be issued to such holder upon the EJFA Unit separation will be rounded down to the nearest whole number of EJFA Public Warrants, (ii) each Class B ordinary share of EJFA, par value $0.0001 per share (each, an “EJFA Class B Ordinary Share”, and, together with the EJFA Class A Ordinary Shares, the “EJFA Ordinary Shares”), issued and outstanding immediately prior to the Effective Time (other than all EJFA Ordinary Shares that are owned by EJFA, Merger Sub, Pagaya or any of their respective subsidiaries immediately prior to the Effective Time (collectively, the “Excluded Shares”)), will be converted into the right to receive one Class A ordinary share of Pagaya, no par value (each, a “Pagaya Class A Ordinary Share”), which will carry voting rights in the form of one vote per share of Pagaya, (iii) each EJFA Class A Ordinary Share issued and outstanding immediately prior to the Effective Time (after giving effect to the EJFA Shareholder Redemption (as defined in the accompanying proxy statement/prospectus) and other than Excluded Shares) will be converted into the right to receive one Pagaya Class A Ordinary Share, and (iv) each EJFA Public Warrant and each private placement warrant of EJFA entitling the holder to purchase one EJFA Class A Ordinary Share per warrant (each, an “EJFA Private Placement Warrant” and, together with the EJFA Public Warrants, the “EJFA Warrants”) outstanding immediately prior to the Effective Time will be converted into a warrant to purchase one Pagaya Class A Ordinary Share per warrant (each, a “Converted Pagaya Warrant”). Prior to the Effective Time, subject to receiving the requisite approval of the shareholders of Pagaya (the “Pagaya Shareholders”), Pagaya intends to (i) convert the then outstanding preferred shares of Pagaya into Pagaya Ordinary Shares (as defined below) in accordance with Pagaya’s organizational documents, and (ii) effect a stock split of the Pagaya Ordinary Shares into a number of Pagaya Ordinary Shares calculated in accordance with the terms of the Merger Agreement such that each Pagaya Ordinary Share will have a value of $10.00 per share (with the Founders (as defined in the accompanying proxy statement/prospectus), in their capacity as Pagaya Shareholders, receiving Class B ordinary shares of Pagaya, no par value (“Pagaya Class B Ordinary Shares”, and together with Pagaya Class A Ordinary Shares, “Pagaya Ordinary Shares”), which will carry voting rights in the form of 10 votes per share of Pagaya and the Pagaya Shareholders other than the Founders receiving Pagaya Class A Ordinary Shares) in accordance with Pagaya’s organizational documents (as discussed in more detail in the accompanying proxy statement/prospectus). |
(2) | Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, share dividends or similar transactions. |
(3) | Determined in accordance with Section 6(b) of the Securities Act at a rate equal to $92.70 per $1,000,000 of the proposed maximum aggregate offering price. |
(4) | Represents Pagaya Class A Ordinary Shares issuable to the shareholders of EJFA (the “EJFA Shareholders”) in exchange for outstanding EJFA Ordinary Shares upon the Merger. |
(5) | Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(f)(1) of the Securities Act, based on the average of the high ($ ) and low ($ )prices of the EJFA Class A Ordinary Shares on The Nasdaq Capital Market (“Nasdaq”) on , 2022. |
(6) | Represents Converted Pagaya Warrants, with each whole warrant entitling the holder to purchase one Pagaya Class A Ordinary Share, to be issued in exchange for EJFA Public Warrants upon the Merger. |
(7) | Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(f)(1) and 457(i) of the Securities Act, based on the average of the high ($ ) and low ($ ) prices of the EJFA Public Warrants on Nasdaq on , 2022 (such date being within five business days of the date that this registration statement was first filed with the SEC). |
(8) | Represents Pagaya Class A Ordinary Shares underlying Converted Pagaya Warrants, to be issued in exchange for EJFA Public Warrants upon the Merger, to be issued at an exercise price of $11.50 per share, at any time commencing 30 days after the closing of the Merger. |
(9) | No additional registration fee is payable pursuant to Rule 457(g). |
1. | Proposal No. 1—The Business Combination Proposal—to consider and vote upon a proposal to approve and adopt by ordinary resolution the Agreement and Plan of Merger (the “Merger Agreement”), dated as of September 15, 2021, by and among EJFA, Pagaya Technologies Ltd. (“Pagaya”), a company organized under the laws of the State of Israel, and Rigel Merger Sub Inc. (“Merger Sub”), a Cayman Islands exempted company and wholly-owned subsidiary of Pagaya, a copy of which is attached to the accompanying proxy statement/prospectus as Annex A, and the transactions contemplated therein (the “Transactions”), whereby, among other things, Merger Sub, will merge with and into EJFA (the “Merger”), with EJFA surviving the Merger and becoming a wholly-owned subsidiary of Pagaya (the “Business Combination Proposal”), which will become the parent/public company following the Merger; |
2. | Proposal No. 2—The Merger Proposal—to consider and vote upon a proposal to approve and authorize by special resolution the Merger and the Plan of Merger required by the Companies Act (as amended) of the Cayman Islands substantially in the form attached as Exhibit F to the Merger Agreement, a copy of which is attached as Annex A to the accompanying proxy statement/prospectus (the “Merger Proposal”); and |
3. | Proposal No. 3—The Adjournment Proposal—to consider and vote upon a proposal to approve by ordinary resolution, if necessary, the adjournment of the extraordinary general meeting to a later date or dates to ensure that any required supplement or amendment to the accompanying proxy statement/prospectus is provided to shareholders, to permit further solicitation and votes of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Business Combination Proposal and the Merger Proposal (the “Adjournment Proposal”, and, together with the Business Combination Proposal and the Merger Proposal, the “Proposals” and each, a “Proposal”), or to seek withdrawals of redemption requests from shareholders. |
| | By Order of the Board of Directors | |
| | Emanuel Friedman | |
| | Chairman of the Board of Directors |
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
SIGNATURES | | |
A | | | Agreement and Plan of Merger, dated as of September 15, 2021, by and among Pagaya Technologies Ltd., EJF Acquisition Corp. and Rigel Merger Sub Inc. |
B | | | Form of Memorandum of Association of EJF Acquisition Corp. |
C | | | Form of Amended and Restated Articles of Association of Pagaya Technologies Ltd. |
D | | | Subscription Agreement, dated as of September 15, 2021, by and between Pagaya Technologies Ltd. and EJF Debt Opportunities Master Fund, LP. |
E | | | Side Letter Agreement, dated as of September 15, 2021, by and among Pagaya Technologies Ltd., EJF Acquisition Corp. and Wilson Boulevard LLC |
F | | | Pagaya Voting Agreement, dated as of September 15, 2021, by and among EJF Acquisition Corp., Pagaya Technologies Ltd., and certain of Pagaya Technologies Ltd.’s shareholders |
G | | | EJFA Voting Agreement, dated as of September 15, 2021, by and between Pagaya Technologies Ltd. and Wilson Boulevard LLC |
H | | | Form of Amended and Restated Registration Rights Agreement |
I | | | Form of 2022 Incentive Equity Plan & Sub-Plan for Israeli Persons |
J | | | Opinion of Duff & Phelps |
• | an individual who is a citizen or resident of the United States; |
• | a corporation (including any entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States or any state thereof or the District of Columbia; |
• | an estate whose income is subject to U.S. federal income taxation regardless of its source; or |
• | a trust if (i) a court within the United States is able to exercise primary supervision over the trust’s administration and one or more U.S. persons have the authority to control all of the trust’s substantial decisions, or (ii) the trust has a valid election in effect under applicable Treasury Regulations to be treated as a U.S. person. |
Q: | Why am I receiving this proxy statement/prospectus? |
A: | EJFA and Pagaya have agreed to a merger and certain related transactions under the terms of the Merger Agreement that is described in this proxy statement/prospectus. A copy of the Merger Agreement is attached to this proxy statement/prospectus as Annex A and EJFA encourages the EJFA Shareholders to read the Merger Agreement in its entirety. EJFA Shareholders are being asked to consider and vote upon a proposal to approve and adopt the Merger Agreement and the Merger, with EJFA surviving the Merger as a wholly-owned subsidiary of Pagaya. See the section of this proxy statement/prospectus entitled “Proposal One—The Business Combination Proposal.” |
Q: | Are there any other matters being presented to EJFA Shareholders at the Special Meeting? |
A: | In addition to voting on the Business Combination Proposal, the EJFA Shareholders will vote on the following proposals: |
• | To approve and authorize the Merger. See the section of this proxy statement/prospectus entitled “Proposal Two—The Merger Proposal.” |
• | To consider and vote upon a proposal to adjourn the Special Meeting to a later date or dates, if necessary, if the parties are not able to consummate the Merger for any reason. See the section of this proxy statement/prospectus entitled “Proposal Three—The Adjournment Proposal.” |
Q: | Why is EJFA proposing the Merger? |
A: | EJFA was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. |
Q: | What will happen in the Merger? |
A: | At the Closing, Merger Sub will merge with and into EJFA, with EJFA surviving as a wholly-owned subsidiary of Pagaya. In addition, at the Effective Time, (i) each EJFA Unit will be automatically separated into one EJFA Class A Ordinary Share and one-third of one EJFA Public Warrant; provided that no fractional EJFA Public Warrants will be issued in connection with the EJFA Unit separation such that if a holder of EJFA Units would be entitled to receive a fractional EJFA Public Warrant upon the EJFA Unit separation, then the number of EJFA Public Warrants to be issued to such holder upon the EJFA Unit separation will be rounded down to the nearest whole number of EJFA Public Warrants., (ii) each EJFA Class B Ordinary Share issued and outstanding immediately prior to the Effective Time (other than Excluded Shares) will be converted into the right to receive one Pagaya Class A Ordinary Share, (iii) each EJFA Class A Ordinary Share issued and outstanding immediately prior to the Effective Time (after giving effect to the EJFA Shareholder Redemption and other than Excluded Shares) will be converted into the right to receive one Pagaya Class A Ordinary Share and (iv) each EJFA Warrant outstanding immediately prior to the Effective Time will be converted into one Pagaya Warrant, as described in more detail in the section of this proxy statement/prospectus entitled “Proposal One—The Business Combination Proposal.” |
Q: | What other transactions will happen in connection with the Merger? |
A: | Prior to the Effective Time, subject to receiving the Pagaya Shareholder Approval, Pagaya intends to (i) effect the Preferred Share Conversion, pursuant to which the then outstanding Pagaya Preferred Shares will convert into Pagaya Ordinary Shares in accordance with the Current Pagaya Articles, (ii) effect the Reclassification, pursuant to which Pagaya will reclassify (A) each Pagaya Ordinary Share that, immediately following the Preferred Share Conversion, is outstanding and held by any shareholder other than a Founder, as well as each Pagaya Ordinary Share underlying any Pagaya Options, into one Pagaya Class A Ordinary Share and (B) each Pagaya Ordinary Share that, immediately following the Preferred Share Conversion, is outstanding and held by a Founder, into one Pagaya Class B Ordinary Share, and (iii) effect the Stock Split, pursuant to which each Pagaya Ordinary Share will split into a number of Pagaya Ordinary Shares calculated in accordance with the terms of the Merger Agreement such that each Pagaya Ordinary Share will have a value of $10.00 per share immediately following such split, based on the Company Value. |
Q: | What is the PIPE Investment? |
A: | Concurrently with the execution of the Merger Agreement, Pagaya entered into the EJF Subscription Agreement with the EJF Investor, pursuant to which, on the terms and subject to the conditions set forth in the EJF Subscription Agreement, the EJF Investor has agreed to purchase, and Pagaya has agreed to sell to it, an aggregate of up to 20 million Pagaya Class A Ordinary Shares, for a purchase price of $10.00 per share and at an aggregate purchase price of up to $200 million. Subsequently, Pagaya also entered into additional subscription agreements with certain other investors, pursuant to which, on the terms and subject to the conditions set forth in such subscription agreements, such investors have agreed to purchase, and Pagaya has agreed to sell to them, 22.2 million Pagaya Class A Ordinary Shares at a purchase price of $10.00 per share, which shares reduced the foregoing commitment of the EJF Investor by 7.2 million shares. |
Q: | Did the EJFA Board obtain a third-party valuation or fairness opinion in determining whether or not to proceed with the Merger? |
A: | EJFA retained Duff & Phelps as its financial advisor in connection with the Merger. In connection with this engagement, the EJFA Board requested that Duff & Phelps evaluate the fairness, from a financial point of view, of the consideration to be paid to the EJFA Shareholders (excluding the Sponsor, EJFA, Pagaya and each of their respective wholly-owned subsidiaries, and any other Pagaya Voting Agreement Signatories (as defined in the Merger Agreement)(collectively, the “Excluded Shareholders”)). Duff & Phelps delivered a |
Q: | Do I have redemption rights? |
A: | Holders of EJFA Public Shares may seek to have all or a portion of such shares redeemed for cash, regardless of whether they vote for or against the Business Combination Proposal; provided that such redemption will be limited to an aggregate dollar amount that would allow EJFA to have net tangible assets in excess of $5,000,001. Any EJFA Public Shareholder holding EJFA Public Shares as of the Record Date may demand that EJFA redeem such shares into a full pro rata portion of the Trust Account (which was $ per share as of , 2022, the Record Date), calculated as of two Business Days prior to the anticipated consummation of the Merger. |
Q: | How do I exercise my redemption rights? |
A: | Holders of EJFA Public Shares as of the Record Date who wish to exercise their redemption rights are required to (i) submit their redemption request, which includes the name of the beneficial owner of the shares to be redeemed, in writing to Continental, EJFA’s transfer agent, and (ii) deliver their shares, either physically or electronically using DTC’s DWAC system, to Continental no later than 5:00 p.m. Eastern Time on (two Business Days prior to the Special Meeting). If a holder of EJFA Public Shares seeking redemption of EJFA Public Shares holds the shares in “street name,” meaning their EJFA Ordinary Shares are held of record by a broker, bank or other nominee, such EJFA Shareholder will have to coordinate with their broker, bank or other nominee to have the shares certificated or delivered electronically. Shares represented by certificates that have not been tendered (either physically or electronically) in accordance with these procedures will not be redeemed for cash. There is a nominal cost associated with this tendering process and the act of certificating the shares or delivering them through the DWAC system. If the Merger is not consummated this may result in an additional cost to shareholders for the return of their shares. |
Q: | If I am an EJFA Warrantholder, can I exercise redemption rights with respect to my EJFA Public Warrants? |
A: | No. The holders of EJFA Public Warrants have no redemption rights with respect to the EJFA Public Warrants. |
Q: | If I am an EJFA Unitholder, can I exercise redemption rights with respect to my EJFA Public Warrants? |
A: | No. Holders of outstanding EJFA Units must elect to separate the EJFA Units into the underlying EJFA Public Shares and EJFA Public Warrants prior to exercising redemption rights with respect to the EJFA Public Shares. If you hold your EJFA Units in an account at a brokerage firm, bank or other nominee, you must notify your broker or bank that you elect to separate the EJFA Units into the underlying EJFA Public Shares and EJFA Public Warrants, or if you hold EJFA Units registered in your own name, you must contact Continental, EJFA’s transfer agent, directly and instruct them to do so. If you fail to cause your EJFA Units to be separated and delivered to Continental by , New York City time, on , 2022, you will not be able to exercise your redemption rights with respect to your EJFA Public Shares. |
Q: | Do I have appraisal rights if I object to the Merger? |
A: | The Companies Act prescribes when EJFA Shareholder appraisal rights will be available and sets the limitations on such rights. Where such rights are available, EJFA Shareholders are entitled to receive fair value for their shares. However, regardless of whether such rights are or are not available, EJFA Shareholders are still entitled to exercise the rights of redemption, as set out in the section of this proxy statement/prospectus entitled “Special Meeting of EJFA Shareholders—Redemption Rights”, and the EJFA Board is of the view that the redemption proceeds payable to EJFA Shareholders who exercise such redemption rights represents the fair value of those shares. See the section of this proxy statement/prospectus entitled “Appraisal Rights.” |
Q: | What happens to the funds deposited in the Trust Account after consummation of the Merger? |
A: | A total of $287,500,000 of the net proceeds from the EJFA IPO and the concurrent private placement of EJFA Private Placement Warrants was placed in the Trust Account immediately following the EJFA IPO. If the Merger is consummated, the funds in the Trust Account will be used (i) to pay, on a pro rata basis, holders of EJFA Public Shares the redemption price for EJFA Public Shares redeemed by the EJFA Public Shareholders who properly exercised redemption rights, (ii) to pay fees and expenses incurred in connection with the transactions contemplated by the Merger Agreement (including aggregate fees of approximately $10.1 million to the underwriters of the EJFA IPO as deferred underwriting commissions) and (iii) to repay working capital loans made by the Sponsor, if any. As of the date of this proxy statement/prospectus, there are no outstanding working capital loans. Any funds remaining in the Trust Account after such payments will be released as directed by EJFA. |
Q: | What happens if a substantial number of EJFA Public Shareholders vote in favor of the Business Combination Proposal and exercise their redemption rights? |
A: | EJFA Public Shareholders may vote in favor of the Merger and still exercise their redemption rights, although they are not required to vote in any way to exercise such redemption rights. Accordingly, the Merger may be consummated even though the funds available from the Trust Account and the number of EJFA Public Shareholders are substantially reduced as a result of redemptions by EJFA Public Shareholders. |
Q: | What happens if the Merger is not consummated? |
A: | If EJFA does not consummate the Merger with Pagaya for whatever reason, EJFA would search for another target business with which to complete an initial business combination. If EJFA does not consummate the Merger with Pagaya or a business combination with another company by March 1, 2023 (or such later date as may be approved by EJFA Shareholders in an amendment to the EJFA Memorandum and Articles of Association), EJFA must redeem 100% of the outstanding EJFA Public Shares, at a per-share price, payable in cash, equal to an amount then held in the Trust Account (approximately $ as of , 2022), less up to $100,000 of interest to pay dissolution expenses, divided by the number of outstanding EJFA Public Shares. The Sponsor and certain directors and advisors of EJFA have waived their rights to liquidating distributions from the Trust Account with respect to their EJFA Class B Ordinary Shares in the event EJFA fails to complete a business combination by March 1, 2023 (or such later date as may be approved by EJFA Shareholders in an amendment to the EJFA Memorandum and Articles of Association), and, accordingly, their EJFA Class B Ordinary Shares will be worthless in such an event. Additionally, in the event of such liquidation, there will be no distribution with respect to the outstanding EJFA Warrants and the EJFA Warrants would expire worthless. |
Q: | How do the Sponsor and EJFA’s directors and officers intend to vote on the proposals? |
A: | The Sponsor beneficially owns and is entitled to vote an aggregate of approximately % of the outstanding EJFA Ordinary Shares. Pursuant to the EJFA Voting Agreement, the Sponsor and the directors and advisors and their permitted transferees of EJFA holding EJFA Class B Ordinary Shares have agreed to vote their EJFA Ordinary Shares in favor of the approval and adoption of the Merger Agreement and the transactions contemplated thereby, the approval and authorization of the Merger, if required, the approval of the adjournment of the EJFA Special Meeting, and any other matter reasonably necessary to the consummation of the transactions contemplated by the Merger Agreement and considered and voted upon by EJFA Shareholders. In addition to the EJFA Ordinary Shares held by the Sponsor and the directors and advisors of EJFA holding EJFA Class B Ordinary Shares and their permitted transferees, EJFA would need (i) shares, or approximately %, of the EJFA Public Shares outstanding as of the Record Date to be voted in favor of the Business Combination Proposal and the Adjournment Proposal in order for such proposals to be approved and (ii) shares, or approximately %, of the EJFA Public Shares outstanding as of the Record Date to be voted in favor of the Merger Proposal in order for such proposal to be approved. |
Q: | What interests do the Sponsor and the current officers and directors of EJFA have in the Merger? |
A: | In considering the recommendation of the EJFA Board to vote in favor of the Merger, EJFA Shareholders should be aware that, aside from their interests as shareholders, the Sponsor and certain of EJFA’s officers and directors have interests in the Merger that are different from, or in addition to, those of other shareholders generally. The EJFA Board was aware of and considered these interests, among other matters, in evaluating the Merger, in recommending to EJFA Shareholders that they approve the Merger and, where applicable, in agreeing to vote their shares in favor of the Merger. EJFA Shareholders should take these interests into account in deciding whether to approve the Merger. See the section of this proxy statement/prospectus entitled “Proposal One—The Business Combination Proposal—Interests of Certain Persons in the Business Combination.” |
• | If the Merger with Pagaya or another business combination is not consummated by March 1, 2023 (or such later date as may be approved by EJFA Shareholders in an amendment to the EJFA Memorandum and Articles of Association), EJFA will cease all operations except for the purpose of winding up, redeeming 100% of the outstanding EJFA Public Shares for cash and, subject to the approval of its remaining shareholders and the EJFA Board, dissolving and liquidating. On the other hand, if the Merger is consummated, each outstanding EJFA Ordinary Share will be converted into one Pagaya Class A Ordinary Share, subject to adjustment as described herein. |
• | If EJFA is unable to complete a business combination within the required time period, the Sponsor will be liable under certain circumstances described herein to ensure that the proceeds in the Trust Account are not reduced by the claims of target businesses or claims of vendors or other entities that are owed money by EJFA for services rendered or contracted for or products sold to EJFA. If EJFA consummates a business combination, on the other hand, EJFA will be liable for all such claims. |
• | The Sponsor and EJFA’s officers and directors and their affiliates are entitled to reimbursement of out-of-pocket expenses incurred by them in connection with certain activities on EJFA’s behalf, such as identifying and investigating possible business targets and business combinations. However, if EJFA fails to consummate a business combination within the required period, they will not have any claim against the Trust Account for reimbursement. Accordingly, EJFA may not be able to reimburse these expenses if the Merger or another business combination is not completed by March 1, 2023 (or such later date as may be approved by EJFA Shareholders in an amendment to the EJFA Memorandum and Articles of Association). As of the Record Date, the Sponsor and EJFA’s officers and directors and their affiliates had incurred approximately $ of unpaid reimbursable expenses. |
• | The Merger Agreement provides for the continued indemnification of EJFA’s current directors and officers and the continuation of directors and officers liability insurance covering EJFA’s current directors and officers. |
• | Subject to Pagaya’s consent in accordance with the Merger Agreement, the Sponsor and EJFA’s officers and directors (or their affiliates) may make loans from time to time to EJFA to fund certain capital requirements. Loans may be made after the date of this proxy statement/prospectus. If the Merger is not consummated, the loans will not be repaid and will be forgiven except to the extent there are funds available to EJFA outside of the Trust Account. |
• | Emanuel Friedman will be a member of the Pagaya Board following the Closing and, therefore, in the future, Mr. Friedman will receive any cash fees, stock options or stock awards that the Pagaya Board determines to pay to its non-executive directors. |
• | The EJF Investor will participate in the purchase of PIPE Shares from Pagaya at the Closing, and certain of EJFA’s directors and officers are affiliated with the EJF Investor. |
• | Duff & Phelps, a Kroll Business, rendered the Opinion (as defined below) to the EJFA Board, for which it will receive a fee from EJFA. A portion of such fee was payable upon delivery of the Opinion and a portion is payable upon and subject to the Closing. |
• | Pagaya, EJFA and the Sponsor entered into the Side Letter Agreement, which provides that, solely in the event the EJFA Transaction Costs exceed the Expenses Excess Amount, a number of EJFA Class B Ordinary Shares will be forfeited for no consideration and cancelled by EJFA and no longer outstanding, except that the Sponsor may pay, in whole or in part, the EJFA Transaction Costs in cash prior to the Effective Time without further liability to EJFA, in which case the Expenses Excess Amount will be reduced on a dollar-for-dollar basis by the amount so paid by the Sponsor. |
• | Given the difference in the purchase price the Sponsor paid for EJFA Class B Ordinary Shares ($0.003 per share) and EJFA Private Placement Warrants ($1.50 per Warrant) as compared to the purchase price of the EJFA Units sold in the EJFA IPO ($10.00 per EJFA Unit), the Sponsor may earn a positive return on its investment even if the EJFA Public Shareholders experience a negative rate of return following the consummation of the business combination. |
• | Certain directors and officers of EJFA, as well as certain partners and employees of EJF Capital, hold equity interests in the Sponsor, and thus have an interest in the business combination transaction that is not the same as the majority of EJFA Shareholders, who do not hold equity interests in the Sponsor. |
• | In connection with the consummation of the business combination, the Sponsor, EJFA, Pagaya and certain equityholders of Pagaya will enter into a new Registration Rights Agreement, which will, among other things, provide that the Sponsor and certain equity holders will have a demand right for Pagaya to conduct an underwritten offering of the Registrable Securities (as defined below), provided that the total offering price of all securities proposed to be sold in such offering exceeds $75 million in the aggregate and subject to certain limitations. |
• | Each of EJFA’s directors and officers presently has fiduciary or contractual obligations to other entities pursuant to which such officer or director is required to present a business combination opportunity to such entity. EJFA’s directors and officers also may have become aware of business combination opportunities which may have been appropriate for presentation to EJFA and the other entities to which they owe certain fiduciary or contractual duties. Accordingly, they may have had conflicts of interest in determining to which entity a particular business opportunity should have been presented. These conflicts may not have been resolved in EJFA’s favor and such potential business combination opportunities may have been presented to other entities prior to their presentation to EJFA. The EJFA Memorandum and Articles of Association provide that, to the maximum extent permitted by applicable law, EJFA renounces any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter (i) which may be a business combination opportunity for an entity related to a director or officer of EJFA, on the one hand, and EJFA, on the other, or (ii) the presentation of which would breach an existing legal obligation of a director or officer to another entity, and EJFA waives any claim or cause of action it may have in respect thereof. EJFA does not believe, however, that the fiduciary duties or contractual obligations of its officers or directors or waiver of corporate opportunity materially affected its search for an acquisition target nor will materially impact its ability to complete the proposed Merger. |
Q: | When do you expect the Merger to be completed? |
A: | It is currently anticipated that the Merger will be consummated in early 2022. The Closing is subject to the receipt of the requisite approval of the EJFA Shareholders described in this proxy statement/prospectus. The Closing is also subject to other customary closing conditions, including the receipt of the requisite approval by the Pagaya Shareholders. For a description of the conditions for the consummation of the Merger, see the section of this proxy statement/prospectus entitled “The Merger Agreement—Conditions to Closing.” |
Q: | Who will solicit and pay the cost of soliciting proxies? |
A: | EJFA has engaged a professional proxy solicitation firm, Morrow Sodali LLC (“Morrow Sodali”), to assist in soliciting proxies for the Special Meeting. EJFA has agreed to pay Morrow Sodali a fee of $35,000.00, plus disbursements. EJFA will reimburse Morrow Sodali for all other expenses associated with the Special Meeting (provided however, that (other than “broker bills”) any individual Morrow Sodali expense in excess of $8,500.00 must be approved by EJFA in advance) and will indemnify Morrow Sodali and its affiliates against certain claims, liabilities, losses, damages and expenses. EJFA will also reimburse banks, brokers and other nominees representing beneficial owners of EJFA Class A Ordinary Shares for their expenses in forwarding soliciting materials to beneficial owners of EJFA Class A Ordinary Shares and in obtaining voting instructions from those beneficial owners. EJFA’s management team may also solicit proxies by telephone, by facsimile, by mail, on the Internet or in person. They will not be paid any additional amounts for soliciting proxies. |
Q: | What do I need to do now? |
A: | EJFA urges you to carefully read and consider the information contained in this proxy statement/prospectus, including the annexes, and to consider how the Merger will affect you as an EJFA Shareholder and/or EJFA Warrantholder. EJFA Shareholders should then vote as soon as possible in accordance with the instructions provided in this proxy statement/prospectus and on the enclosed proxy card. |
Q: | When and where will the Special Meeting take place? |
A: | The Special Meeting will be held on , 2022 at Eastern Time at the offices of located at or at such other time, on such other date and at such other place to which the meeting may be adjourned or postponed, and is virtually accessible at . You may attend and vote at the Special Meeting webcast by visiting and entering the control number found on your proxy card, voting instruction form or notice you previously received. |
Q: | How can I vote my shares at the Special Meeting? |
A: | EJFA Ordinary Shares held directly in your name as the shareholder of record of such shares as of the close of business on , 2022, the Record Date, may be voted electronically at the Special Meeting. If you |
Q: | How can I vote my shares without attending the Special Meeting? |
A: | If you are a shareholder of record of EJFA Ordinary Shares as of the close of business on , 2022, the Record Date, you can vote by proxy by mail by following the instructions provided in the enclosed proxy card. Please note that if you hold such shares in “street name”, you should contact your broker, bank or other nominee to ensure that votes related to the shares you beneficially own are properly counted. In this regard, you must provide the broker, bank or other nominee with instructions on how to vote your shares, or otherwise follow the instructions provided by your bank, brokerage firm or other nominee. |
Q: | What happens if I sell my EJFA Ordinary Shares before the Special Meeting? |
A: | The Record Date for the Special Meeting is earlier than the date of the Special Meeting and earlier than the date the Merger is expected to be completed. If you transfer your EJFA Ordinary Shares after the applicable Record Date, but before the Special Meeting date, unless you grant a proxy to the transferee, you will retain your right to vote at the Special Meeting, but you will not be entitled to receive any portion of the Merger Consideration (as defined in the Merger Agreement) unless you hold EJFA Ordinary Shares immediately prior to the Effective Time. |
Q: | If my shares are held in “street name,” will my bank, broker or other nominee automatically vote my shares for me? |
A: | Your bank, broker or other nominee can vote your EJFA Ordinary Shares without receiving your instructions on “routine” proposals only. Your bank, broker or other nominee cannot vote your shares with respect to “non-routine” proposals unless you provide instructions on how to vote in accordance with the information and procedures provided to you by your broker, bank or other nominee. |
Q: | May I change my vote after I have mailed my signed proxy card? |
A: | Yes. If you are an EJFA Shareholder of record of EJFA Ordinary Shares as of the close of business on the Record Date, you can change or revoke your proxy before on in one of the following ways: |
• | submit a new proxy card bearing a later date; |
• | give written notice of your revocation to EJFA’s Corporate Secretary, which notice must be received by EJFA’s Corporate Secretary prior to the vote at the Special Meeting; or |
• | vote electronically at the Special Meeting by visiting and entering the control number found on your proxy card, voting instruction form or notice you previously received. Please note that your attendance at the Special Meeting will not alone serve to revoke your proxy. |
Q: | What constitutes a quorum for the Special Meeting? |
A: | A quorum is the minimum number of EJFA Ordinary Shares that must be present to hold a valid meeting. The presence, in person or by proxy, of a majority of the paid up voting share capital of EJFA entitled to vote at the Special Meeting constitutes a quorum at the Special Meeting. |
Q: | What shareholder vote thresholds are required for the approval of each proposal brought before the Special Meeting? |
A: | Vote thresholds are as follows: |
• | Business Combination Proposal — The approval of the Business Combination Proposal will require an ordinary resolution under Cayman Islands law, being the affirmative vote of the holders of a majority of EJFA Ordinary Shares who, being present and entitled to vote at the Special Meeting, vote at the Special Meeting. Abstentions and broker non-votes, while considered present for the purposes of establishing a quorum, will not count as votes cast at the Special Meeting, and otherwise will have no effect on a particular proposal. |
• | Merger Proposal — The authorization of the Plan of Merger will require a special resolution under Cayman Islands law, being the affirmative vote of the holders of at least two thirds of EJFA Ordinary Shares who, being present and entitled to vote at the Special Meeting, vote at the Special Meeting. Abstentions and broker non-votes, while considered present for the purposes of establishing a quorum, will not count as votes cast at the Special Meeting, and otherwise will have no effect on a particular proposal. |
• | Adjournment Proposal — The approval of the Adjournment Proposal will require an ordinary resolution under Cayman Islands law, being the affirmative vote of the holders of a majority of EJFA Ordinary Shares who, being present and entitled to vote at the Special Meeting, vote at the Special Meeting. Abstentions and broker non-votes, while considered present for the purposes of establishing a quorum, will not count as votes cast at the Special Meeting, and otherwise will have no effect on a particular proposal. |
Q: | Are the proposals conditioned on one another? |
A: | The Merger is conditioned on the approval of each of the proposals described in this proxy statement/prospectus (other than the Adjournment Proposal). The Business Combination Proposal and the Merger Proposal are cross-conditioned on the approval of each other, while the Adjournment Proposal is not conditioned on the approval of any other proposal. |
Q: | What will be the relative equity stakes of EJFA Shareholders, the Sponsor, the EJF Investor and existing Pagaya Shareholders in Pagaya upon consummation of the Merger? |
A: | Upon consummation of the Merger, Pagaya will become a new public company and EJFA will become a wholly-owned subsidiary of Pagaya. The former securityholders of EJFA will become securityholders of Pagaya. |
| | Pagaya Ordinary Shares (%) | |
EJFA Shareholders | | | % |
Sponsor | | | % |
Pagaya Shareholders | | | % |
EJF Investor | | | % |
Total | | | 100% |
Q: | What are the material differences in the rights of shareholders as a result of the dual class structure? |
A: | The Pagaya Class B Ordinary Shares will have 10 votes per share, while the Pagaya Class A Ordinary Shares will have one vote per share. |
(i) | (1) the earliest to occur of (a) such Founder’s employment or engagement as an officer of Pagaya being terminated not for Cause (as defined in the Pagaya A&R Articles), (b) such Founder’s resigning as an officer of Pagaya, (c) death or permanent disability of such Founder, except, in such event, such Founder’s Pagaya Class B Ordinary Shares shall be transferred automatically to the other Founders, pro rata to their holdings, if the other Founders continue to hold Pagaya Class B Ordinary Shares at such time, or (d) the appointment of a receiver, trustee or similar official in bankruptcy or similar proceeding with respect to a Founder or such Founder’s Pagaya Class B Ordinary Shares; and (2) such Founder no longer serves as a member of the Pagaya Board; |
(ii) | 90 days following the date on which such Founder first receives notice that his employment as an officer of Pagaya is terminated for Cause, except that if, prior to the expiration of such 90 day period, (a) the Pagaya Board repeals its determination that such Founder was terminated for Cause or determines that the Cause had been cured, then the provisions of clause (i) above shall apply, or (b) such Founder commences legal proceedings with the competent judicial forum to determine that such determination by the Pagaya Board of termination for Cause was improper or incorrect, then such Founder shall retain its Pagaya Class B Ordinary Shares until the earlier of (y) the issuance of a final unappealable judgment confirming the determination of the Pagaya Board, or a judgment which execution had not been stayed pending an appeal, and (z) the abandonment of such proceedings or their dismissal or denial by a ruling of the relevant judicial forum on any grounds, substantive or procedural, and regardless of whether or not the Pagaya Board’s determination regarding the termination for Cause is confirmed as part of such ruling, provided the basis for Cause shall be deemed to not be curable, and such conversion shall be effective immediately upon written notice by Pagaya to such Founder; or |
(iii) | the earlier to occur of (1) such time as the Founders and the Permitted Class B Owners first collectively hold less than 10% of the total issued and outstanding ordinary share capital of Pagaya, and (2) the fifteenth anniversary of the Closing Date. |
Q: | What happens if I fail to take any action with respect to the Special Meeting? |
A: | If you fail to take any action with respect to the Special Meeting and the Merger is approved by the EJFA Shareholders and consummated, you will become a shareholder or warrantholder of Pagaya as long as you hold EJFA Ordinary Shares, EJFA Public Warrants or EJFA Private Placement Warrants, as applicable, immediately prior to the Effective Time. |
Q: | What should I do with my share and/or warrant certificates? |
A: | EJFA Warrantholders and those EJFA Shareholders who do not elect to have their EJFA Ordinary Shares redeemed for a pro rata share of the Trust Account should wait for instructions from the EJFA Transfer Agent regarding what to do with their certificates. EJFA Shareholders who exercise their redemption rights must deliver their share certificates to EJFA’s Transfer Agent (either physically or electronically) no later than two Business Days prior to the Special Meeting as described above. |
Q: | What should I do if I receive more than one set of voting materials? |
A: | EJFA Shareholders may receive more than one set of voting materials, including multiple copies of this proxy statement/prospectus and multiple proxy cards or voting instruction cards. For example, if you hold your EJFA Ordinary Shares in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account in which you hold shares. If you are a holder of record and your shares are registered in more than one name, you will receive more than one proxy card. Please complete, sign, date and return each proxy card and voting instruction card that you receive in order to cast a vote with respect to all of your EJFA Ordinary Shares. |
Q: | What are the U.S. federal income tax consequences of the Merger to U.S. Holders of EJFA Ordinary Shares and/or EJFA Public Warrants? |
A: | As described in the section of this proxy statement/prospectus entitled “U.S. Federal Income Tax Considerations—Effects of the Merger—Characterization of the Merger as a reorganization under section 368(a) of the Code,” significant uncertainty exists as to the qualification of the Merger as a tax-free reorganization within the meaning of Section 368(a) of the Code to U.S. Holders of EJFA Ordinary Shares and EJFA Public Warrants. If, as of the Closing Date, any requirement for Section 368(a) of the Code is not met, then such U.S. Holder will recognize gain or loss in an amount equal to the difference, if any, between the fair market value (as of the Closing Date) of the securities received, over such U.S. Holder’s aggregate tax basis in the securities surrendered by such U.S. Holder in the Merger. Even if the requirements under Section 368(a) of the Code are satisfied, U.S. Holders may be required to recognize gain (but not loss) under the Passive Foreign Investment Company (“PFIC”) rules, as described in more detail below under “U.S. Federal Income Tax Considerations—Ownership and disposition of Pagaya securities—Passive foreign investment company considerations.” |
Q: | Under Israeli law, what are the material Israeli income tax consequences of the Merger for EJFA Shareholders? |
A: | The Merger is a taxable event in Israel. The EJFA Shareholders and holders of EJFA Warrants that are not residents of Israel should, under certain conditions, be exempt from Israeli tax while those that are Israeli residents may be taxed on any capital gains resulting from the exchange of their EJFA Class A Ordinary |
Q: | Under Israeli law, what are the material Israeli income tax consequences of the other transactions that will happen in connection with the Merger? |
A: | Each of the Preferred Share Conversion and Reclassification (including reclassifying Pagaya Ordinary Shares into Pagaya Class B Ordinary Shares) may be treated as a taxable event in Israel for some or all of the Pagaya Shareholders. Furthermore, the reclassification of the ordinary shares underlying the Pagaya Options into Pagaya Class A Ordinary Shares may cause the holders of such options to lose their eligibility for a reduced tax rate under the ITO and the Pagaya Share Plans with respect to such options. However, Pagaya has applied for a tax ruling from the ITA exempting the Pagaya Shareholders from such Israeli tax and preventing the option holders from losing their tax benefits. |
Q: | What are the U.S. federal income tax consequences of exercising my redemption rights? |
A: | The U.S. federal income tax consequences of exercising your redemption rights are complex and depend on your particular facts and circumstances. For a discussion of the U.S. federal income tax considerations of exercising your redemption rights, see the section of this proxy statement/prospectus entitled “U.S. Federal Income Tax Considerations—Exercise of redemption rights.” If you are a U.S. Holder of EJFA Ordinary Shares contemplating to exercise of your redemption rights, you are urged to consult your tax advisor to determine the tax consequences thereof. |
Q: | Who can help answer my questions? |
A: | If you have questions about the Merger or if you need additional copies of this proxy statement/prospectus or the enclosed proxy card, you should contact: |
• | Business Model. Pagaya is a financial technology company that the EJFA Board considered to be well-positioned to reshape the lending marketplace by using machine learning, big data analytics, and sophisticated AI-driven credit and analysis technology. |
• | Competitive Landscape. Pagaya is an early mover in using machine learning and other sophisticated data analysis techniques to assist its Partners in credit decisions and therefore enjoys a competitive advantage. Pagaya’s proprietary AI solutions and Partner relationships provide a strong differentiating factor from other competitors. |
• | Technology and AI. Pagaya’s business is driven by its proprietary AI and deep bench of data scientists. Pagaya has a highly accomplished technology and data team with a track record of innovation likely to further drive Pagaya’s success. |
• | Pagaya Management Team. Led by its Co-Founder and Chief Executive Officer Gal Krubiner, Co-Founder and Chief Technology Officer Avital Pardo, Co-Founder and Chief Revenue Officer Yahav Yulzari, and Chief Financial Officer Michael Kurlander, Pagaya has built a strong management team with extensive experience in the fintech space. |
• | Pagaya’s Business Performance. Pagaya has quickly achieved scale with its products and continues to demonstrate impressive growth. This is particularly impressive, given that Pagaya’s business was founded only four years ago. |
• | EJFA and Pagaya Combination Benefits. Pagaya’s potential public company status following the consummation of the Transactions, combined with the capital to be provided from the PIPE Investment, is expected to provide Pagaya with substantial support for further scaling its network. EJFA’s leadership in the finance space will help Pagaya further grow and identify attractive partnerships. |
• | Financial Performance and Valuation. EJFA has evaluated the performance of Pagaya and believes the valuation in the Transactions is attractive, including as the valuation is compared to competitor firms. |
• | Due Diligence. EJFA conducted due diligence examinations of Pagaya, including financial, accounting, tax, legal (including corporate governance, indebtedness, real property, intellectual property, executive compensation and labor, anti-trust/regulatory, litigation and asset management), industry, data science/artificial intelligence, management background and technical due diligence. |
• | Lock-Up. Following the Closing, all shares of the post-Closing combined company issued to the Pagaya Equity Holders (including those issued to the Founders) will be subject to a lock-up period of between 90 days and 12 months depending, among other things, upon whether the shares of the post-Closing combined entity trade for over $12.50 for any 20 trading days within a 30 consecutive trading day period on the principal securities exchange or securities market on which the Pagaya Class A Ordinary Shares are then traded or quoted for purchase and sale (anticipated to be Nasdaq). |
• | Fairness Opinion. The Opinion delivered by Duff & Phelps to the EJFA Board to the effect that, as of September 14, 2021 and based upon and subject to the assumptions made, scope of analysis considered, matters evaluated and other qualifications and limitations set forth therein, the Merger Consideration to be paid to the EJFA Shareholders (excluding the Excluded Shareholders) pursuant to the Transactions was fair, from a financial point of view, to such EJFA Shareholders. |
• | Other Alternatives. The EJFA Board believes, after a thorough review of other business combination opportunities reasonably available to EJFA, that the proposed Transactions represent the best potential business combination for EJFA that is currently available in the market. |
• | Lack of Operating History. Pagaya was founded only four years ago. Thus, although it has shown impressive performance over that period, Pagaya does not have a long and proven operating history. In particular, Pagaya has not operated its business during a credit downturn. |
• | Valuation Depends on Future Performance. The valuation of Pagaya agreed to in the Transactions depends in large part on Pagaya’s performance in calendar years 2021, 2022 and 2023. Although the EJFA Board believes that this valuation is fair, and received the Opinion from Duff & Phelps confirming, as of September 14, 2021 and based upon and subject to the assumptions made, scope of analysis considered, matters evaluated and other qualifications and limitations set forth therein, the same, there is risk that, if Pagaya does not perform as expected in 2021 and 2022, the valuation agreed to by the EJFA Board will be too high. |
• | Public Company Readiness. While EJFA believes Pagaya has a strong management team, the management team has limited experience managing a public company. Additionally, management and Pagaya’s infrastructure will need to mature quickly to support Pagaya as a public company. |
• | Execution of Growth Plan. Pagaya has a strong pipeline with large regional and money center banks, but slower sales conversion could delay the continued strong growth rate. |
• | Access to Funding. Pagaya has secured diversified funding access with multiple Financing Vehicles, but these sources need to expand materially in the future to allow Pagaya to execute on its aggressive growth strategy across asset classes and with larger partners. |
• | Consumer Credit and Macroeconomic Conditions. Consumer credit performance has received a boost in the last 18 months, with extended government support in the form of credits and unemployment payments, but performance in the coming years is dependent on a robust post-COVID-19 recovery. |
• | Limitations of Due Diligence. Although EJFA conducted due diligence on Pagaya, the scope of its review was limited by the time available, the materials provided by Pagaya and the inherent uncertainties in any due diligence process. Accordingly, there can be no assurance that EJFA discovered all material issues that may be present with regard to Pagaya’s business, or that factors outside of EJFA’s or Pagaya’s control will not later arise. |
• | Difficulty in Protecting, Maintaining and Enforcing Intellectual Property and other Proprietary Rights. Pagaya relies on AI and other proprietary data analysis techniques to assist its Partners in making credit decisions. This technology is core to Pagaya’s business. Pagaya may be unable to sufficiently, and it may be difficult and costly to, obtain, maintain, protect, or enforce its intellectual property and other proprietary rights effectively. As such, it is possible that competitors could develop similar or superior technology, or key personnel at Pagaya could leave the business and use their personal knowledge in a competitive fashion. |
• | Changes in Regulations. EJFA has conducted diligence into Pagaya’s operations based on the current regulatory landscape, but legislation and regulations that affect Pagaya’s core business may change. |
• | Closing Conditions. The fact that the completion of the Transactions is conditioned on the satisfaction of certain closing conditions that are not within EJFA’s control. |
• | Liquidation of EJFA. The risks and costs to EJFA if the Transactions are not completed, including the risk of diverting management focus and resources from other business combination opportunities. |
• | Litigation: The possibility of litigation challenging the business combination or that an adverse judgment granting permanent injunctive relief could indefinitely enjoin consummation of the Merger. |
• | Fees and Expenses: The fees and expenses associated with completing the business combination. |
• | Additional Risks and Uncertainties. EJFA also considered other risks of the type and nature described under the section of this proxy statement/prospectus entitled “Risk Factors.” |
• | If the Merger with Pagaya or another business combination is not consummated by March 1, 2023 (or such later date as may be approved by EJFA Shareholders in an amendment to the EJFA Memorandum and Articles of Association), EJFA will cease all operations except for the purpose of winding up, redeeming 100% of the outstanding EJFA Public Shares for cash and, subject to the approval of its remaining shareholders and the EJFA Board, dissolving and liquidating. On the other hand, if the Merger is consummated, each outstanding EJFA Ordinary Share will be converted into one Pagaya Class A Ordinary Share, subject to adjustment as described herein. |
• | If EJFA is unable to complete a business combination within the required time period, the Sponsor will be liable under certain circumstances described herein to ensure that the proceeds in the Trust Account are not reduced by the claims of target businesses or claims of vendors or other entities that are owed money by EJFA for services rendered or contracted for or products sold to EJFA. If EJFA consummates a business combination, on the other hand, EJFA will be liable for all such claims. |
• | The Sponsor and EJFA’s officers and directors and their affiliates are entitled to reimbursement of out-of-pocket expenses incurred by them in connection with certain activities on EJFA’s behalf, such as identifying and investigating possible business targets and business combinations. However, if EJFA fails to consummate a business combination within the required period, they will not have any claim against the Trust Account for reimbursement. Accordingly, EJFA may not be able to reimburse these expenses if the Merger or another business combination is not completed by March 1, 2023 (or such later date as may be approved by EJFA Shareholders in an amendment to the EJFA Memorandum and Articles of Association). As of the Record Date, the Sponsor and EJFA’s officers and directors and their affiliates had incurred approximately $ of unpaid reimbursable expenses. |
• | The Merger Agreement provides for the continued indemnification of EJFA’s current directors and officers and the continuation of directors and officers liability insurance covering EJFA’s current directors and officers. |
• | Subject to Pagaya’s consent in accordance with the Merger Agreement, the Sponsor and EJFA’s officers and directors (or their affiliates) may make loans from time to time to EJFA to fund certain capital requirements. Loans may be made after the date of this proxy statement/prospectus. If the Merger is not consummated, the loans will not be repaid and will be forgiven except to the extent there are funds available to EJFA outside of the Trust Account. |
• | Emanuel Friedman will be a member of the Pagaya Board following the Closing and, therefore, in the future Mr. Friedman will receive any cash fees, stock options or stock awards that the Pagaya Board determines to pay to its non-executive directors. |
• | The EJF Investor will participate in the purchase of PIPE Shares from Pagaya at the closing of the Transactions, and certain of EJFA’s directors and officers are affiliated with the EJF Investor. |
• | Duff & Phelps, a Kroll Business, rendered the Opinion to the EJFA Board, for which it will receive a fee from EJFA. A portion of such fee was payable upon delivery of the Opinion and a portion is payable upon and subject to the Closing. |
• | Pagaya, EJFA and the Sponsor entered into the Side Letter Agreement, which provides that, solely in the event the EJFA Transaction Costs exceed the Expenses Excess Amount, a number of EJFA Class B |
• | Given the difference in the purchase price the Sponsor paid for EJFA Class B Ordinary Shares ($0.003 per share) and EJFA Private Placement Warrants ($1.50 per Warrant) as compared to the purchase price of the EJFA Units sold in the EJFA IPO ($10.00 per EJFA Unit), the Sponsor may earn a positive return on its investment even if the EJFA Public Shareholders experience a negative rate of return following the consummation of the business combination. |
• | Certain directors and officers of EJFA, as well as certain partners and employees of EJF Capital, hold equity interests in the Sponsor, and thus have an interest in the business combination transaction that is not the same as the majority of EJFA Shareholders, who do not hold equity interests in the Sponsor. |
• | In connection with the consummation of the business combination, the Sponsor, EJFA, Pagaya and certain equityholders of Pagaya will enter into a new Registration Rights Agreement, which will, among other things, provide that the Sponsor and certain equity holders will have a demand right for Pagaya to conduct an underwritten offering of the Registrable Securities (as defined below), provided that the total offering price of all securities proposed to be sold in such offering exceeds $75 million in the aggregate and subject to certain limitations. |
• | Each of EJFA’s directors and officers presently has fiduciary or contractual obligations to other entities pursuant to which such officer or director is required to present a business combination opportunity to such entity. EJFA’s directors and officers also may have become aware of business combination opportunities which may have been appropriate for presentation to EJFA and the other entities to which they owe certain fiduciary or contractual duties. Accordingly, they may have had conflicts of interest in determining to which entity a particular business opportunity should have been presented. These conflicts may not have been resolved in EJFA’s favor and such potential business combination opportunities may have been presented to other entities prior to their presentation to EJFA. The EJFA Memorandum and Articles of Association provide that, to the maximum extent permitted by applicable law, EJFA renounces any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter (i) which may be a business combination opportunity for an entity related to a director or officer of EJFA, on the one hand, and EJFA, on the other, or (ii) the presentation of which would breach an existing legal obligation of a director or officer to another entity, and EJFA waives any claim or cause of action it may have in respect thereof. EJFA does not believe, however, that the fiduciary duties or contractual obligations of its officers or directors or waiver of corporate opportunity materially affected its search for an acquisition target nor will materially impact its ability to complete the proposed Merger. |
• | The exchange of shares held by Pagaya Shareholders will be accounted for as a recapitalization in accordance with U.S. GAAP. The Merger is not within the scope of ASC 805 since EJFA does not meet the definition of a business in accordance with ASC 805. Any difference between the fair value of Pagaya Ordinary Shares issued and the fair value of EJFA’s identifiable net assets will to be recorded as additional paid-in capital. For purposes of the unaudited pro forma condensed combined financial information, it is assumed that the fair value of each individual Pagaya Ordinary Share issued to EJFA Shareholders is equal to the fair value of each individual Pagaya Ordinary Share issued to pre-Closing Pagaya Shareholders resulting from the $8.5 billion enterprise value assigned to Pagaya in the Merger Agreement. |
• | The PIPE Investment will result in the issuance of Pagaya Class A Ordinary Shares, leading to an increase in Pagaya Ordinary Shares, par value and additional paid-in capital. |
Sources | | | | | Uses | | | ||
Trust Account(1) | | | $287.5 | | | Estimated fees, issuance and other expenses(3) | | | $90.0 |
PIPE Investment proceeds(2) | | | $350.0 | | | Net cash to Pagaya balance sheet | | | $547.5 |
Total sources: | | | $637.5 | | | Total uses: | | | $637.5 |
(1) | Cash available in the Trust Account excludes amounts in excess of $10.00 per share and estimated interest earned by the Closing Date and remaining operating cash, if any. In the case of maximum redemption, all funds in the Trust Account will be utilized to fund such redemption and there will be no remaining balance. |
(2) | Assumes the issuance of 35,000,000 shares of Pagaya Class A Ordinary Shares at $10 per share for aggregate gross proceeds of $350.0 million in connection with the PIPE Investment. |
(3) | Represents an estimate of Transaction expenses. Actual amount may vary and may include expenses unknown at this time. |
• | We are a rapidly growing company with a relatively limited operating history, which may result in increased risks, uncertainties, expenses and difficulties, and it may be difficult to evaluate our future prospects. |
• | Our revenue growth rate and financial performance in recent periods may not be indicative of future performance and such growth may slow over time. In addition, the historical returns attributable to the Financing Vehicles should not be indicative of the future results of the Financing Vehicles and poor performance of the Financing Vehicles would cause a decline in our revenue, income and cash flow. |
• | If we fail to effectively manage our growth, our business, financial condition, and results of operations could be adversely affected. |
• | Our business and the performance of Financing Vehicles may be adversely affected by economic conditions and other factors that we cannot control. These factors include interest rates, unemployment levels, conditions in the housing market, immigration policies, government shutdowns, trade wars and delays in tax refunds, as well as events such as natural disasters, acts of war, terrorism, catastrophes, and pandemics, including the ongoing COVID-19 pandemic. |
• | We are heavily dependent on our AI technology. If we are unable to continue to improve our AI technology or if our AI technology does not operate as we expect, contains errors or is otherwise ineffective, we could improperly evaluate products, not be able to process the volume we have historically, and our growth prospects, business, financial condition and results of operations could be adversely affected. |
• | We rely on our Partners to originate assets facilitated with the assistance of our AI technology. Currently, a limited number of Partners account for a substantial portion of the total number of financial products facilitated with the assistance of our AI technology and, ultimately, our revenue. |
• | If we are unable to both retain existing Partners and attract and onboard new Partners, our business, financial condition and results of operations could be adversely affected. |
• | Our ability to raise capital from Asset Investors is a vital component of the products we offer to Partners. If we are unable to raise capital from Asset Investors at competitive rates, it would materially reduce our revenue and cash flow and adversely affect our financial condition. |
• | The fees paid to us by Financing Vehicles comprise a key portion of our revenues, and a reduction in these revenues could have an adverse effect on our results of operations. |
• | If we are unable to develop and maintain a diverse and robust funding component of our network, our growth prospects, business, financial condition and results of operations could be adversely affected. In addition, certain Financing Vehicles have redemption features and a substantial withdrawal of capital by one or more Asset Investors may have an adverse effect on the Financing Vehicles’ performance. |
• | Our AI technology has not yet been extensively tested during different economic conditions, including down-cycles. We continue to build and refine our AI technology to offer new products and services as we expand into new markets, such as real estate and insurance, and if our AI technology does not perform as well in these new markets as it has in our existing business and we are unable to manage the related risks and effectively execute our growth strategy as we enter into these new lines of business, our growth prospects, business, financial condition and results of operations could be adversely affected. |
• | The industry in which we operate is highly competitive, and if we fail to compete effectively, we could experience price reductions, reduced margins or loss of revenues. |
• | A significant portion of our current revenues are derived from Financing Vehicles that acquire consumer credit assets and related products, and as a result, we are particularly susceptible to fluctuations in consumer credit activity and the capital markets. |
• | If we are unable to manage the risks associated with fraudulent activity, our brand and reputation, business, financial condition, and results of operations could be adversely affected and we could face material legal, regulatory and financial exposure (including fines and other penalties). |
• | We are subject to risks related to our dependency on our Founders, key personnel, employees and independent contractors, including highly-skilled technical experts, as well as attracting, retaining and developing human capital in a highly competitive market. |
• | We may need to raise additional funds in the future that may be unavailable on acceptable terms, or at all. As a result, we may be unable to meet our future capital requirements, which could limit our ability to grow and jeopardize our ability to continue our business. |
• | Our risk management policies and procedures, and those of our third-party vendors upon which we rely, may not be fully effective in identifying or mitigating risk exposure. |
• | We may be unable to sufficiently, and it may be difficult and costly to, obtain, maintain, protect, or enforce our intellectual property and other proprietary rights. |
• | Our proprietary AI technology relies in part on the use of our Partners’ borrower data and third-party data, and if we lose the ability to use such data, or if such data contains gaps or inaccuracies, our business could be adversely affected. |
• | Cyberattacks and security breaches of our technology, or those impacting our users or third parties, could adversely impact our brand and reputation and our business, operating results and financial condition. |
• | The dual class structure of Pagaya Ordinary Shares has the effect of concentrating voting power with certain shareholders—in particular, our Founders—which will effectively eliminate your ability to influence the outcome of many important determinations and transactions, including a change in control. |
• | Litigation, regulatory actions, consumer complaints and compliance issues could subject us to significant fines, penalties, judgments, remediation costs and/or requirements resulting in increased expenses. If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, and our ability to consummate the Merger and conduct business could be materially adversely affected. |
• | As the political and regulatory framework for AI technology and machine learning evolves, our business, financial condition and results of operations may be adversely affected. |
• | If obligations by one or more Partners that utilize our network were subject to successful challenge that the Partner was not the “true lender,” such obligations may be unenforceable, subject to rescission or otherwise impaired, we or other program participants may be subject to penalties, and/or our commercial relationships may suffer, each of which would adversely affect our business, financial condition and results of operations. |
• | If loans originated by our Partners were found to violate the laws of one or more states, whether at origination or after sale by our Partner, assets acquired, directly or indirectly, by Financing Vehicles may be unenforceable or otherwise impaired, we (or Financing Vehicles) may be subject to, among other things, fines and penalties, and/or our commercial relationships may suffer, each of which would adversely affect our business and results of operations. |
• | Conditions in Israel and relations between Israel and other countries could adversely affect our business. |
• | Our management team has limited experience managing a public company. |
• | The unaudited pro forma financial information included in the section of this proxy statement/prospectus entitled “Unaudited Pro Forma Condensed Combined Financial Information” may not be representative of our results if the Merger is completed. Additionally, the projections and forecasts presented in this proxy statement/prospectus may not be an indication of the actual results of the Transaction or Pagaya’s future results. |
| | Year Ended December 31, | | | Six Months Ended June 30, | |||||||
(In thousands, except share and per share data) | | | 2020 | | | 2019 | | | 2021 | | | 2020 |
| | (In thousands, except share and per share data) | ||||||||||
Revenue and Other Income | | | $99,010 | | | $36,141 | | | $183,268 | | | $26,257 |
Costs and Operating Expenses(1) | | | 77,757 | | | 40,045 | | | 201,696 | | | 23,568 |
Operating Income (Loss) | | | 21,253 | | | (3,904) | | | (18,428) | | | 2,689 |
Other expense, net | | | (55) | | | (124) | | | (18,771) | | | (51) |
Income (Loss) Before Income Taxes | | | 21,198 | | | (4,028) | | | (37,199) | | | 2,638 |
Income tax expense | | | 1,276 | | | 172 | | | 7,793 | | | 113 |
Net Income (Loss) and Comprehensive Income (Loss) | | | 19,922 | | | (4,200) | | | (44,992) | | | 2,525 |
Net Income and Comprehensive Income Attributable to Noncontrolling Interests | | | 5,452 | | | 1,420 | | | 7,546 | | | 2,353 |
Net Income (Loss) and Comprehensive Income (Loss) Attributable to Pagaya Technologies Ltd. shareholders | | | $14,470 | | | $(5,620) | | | $(52,538) | | | $172 |
Per share data: | | | | | | | | | ||||
Net Income (Loss) and Comprehensive Income (Loss) Attributable to Pagaya Technologies Ltd. Shareholders | | | $14,470 | | | $(5,620) | | | $(52,538) | | | $172 |
Less: Undistributed earnings allocated to participating securities | | | (9,558) | | | (2,748) | | | (8,559) | | | (1,903) |
Less: Deemed dividend distribution | | | — | | | — | | | (23,612) | | | — |
Net income (loss) attributable to Pagaya Technologies Ltd. ordinary shareholders—basic | | | $4,912 | | | $(8,368) | | | $(84,709) | | | $(1,731) |
Weighted average ordinary shares outstanding—basic | | | 1,022,959 | | | 1,017,033 | | | 1,036,688 | | | 1,026,122 |
Net income (loss) per share attributable to Pagaya Technologies Ltd. ordinary shareholders—basic | | | $4.80 | | | $(8.23) | | | $81.71 | | | $(1.69) |
Net income (loss) attributable to Pagaya Technologies Ltd. ordinary shareholders—diluted | | | $4,608 | | | $(8,580) | | | $(84,709) | | | $(1,731) |
Weighted average ordinary shares outstanding—diluted | | | 1,107,349 | | | 1,023,029 | | | 1,036,688 | | | 1,026,122 |
Net income (loss) per share attributable to Pagaya Technologies Ltd. ordinary shareholders—diluted | | | $4.16 | | | $(8.39) | | | $(81.71) | | | $(1.69) |
(1) | Amount includes share-based compensation expense as follows: |
| | Year Ended December 31, | | | Six Months Ended June 30, | |||||||
| | 2020 | | | 2019 | | | 2021 | | | 2020 | |
Research and Development | | | $89 | | | $37 | | | $25,074 | | | $30 |
Selling and Marketing | | | 4 | | | — | | | 16,779 | | | 1 |
General and Administrative | | | 63 | | | 37 | | | 17,264 | | | 19 |
Total share-based Compensation | | | $156 | | | $74 | | | $59,117 | | | $50 |
Consolidated Balance Sheet Data | | | As of December 31, | | | As of June 30, | ||||||
(in thousands) | | | 2020 | | | 2019 | | | 2021 | | | 2020 |
Total assets | | | $204,272 | | | $58,626 | | | $495,558 | | | $122,456 |
Total liabilities | | | 10,146 | | | 1,638 | | | 43,374 | | | 5,083 |
Redeemable convertible preferred shares | | | 105,981 | | | 43,613 | | | 278,608 | | | 91,759 |
Total Pagaya’s shareholders’ equity (deficit) | | | 3,200 | | | (11,426) | | | 30,665 | | | (11,204) |
Non-Controlling interests | | | 84,945 | | | 24,801 | | | 142,911 | | | 36,818 |
Total shareholders’ equity | | | 88,145 | | | 13,375 | | | 173,576 | | | 25,614 |
| | For the nine months ended September 30, 2021 | | | For the period from December 22, 2020 (inception) through December 31, 2020 | |
Statement of Operations: | | | | | ||
Net loss | | | $(5,028,520) | | | $(3,537) |
Weighted average ordinary shares subject to possible redemption outstanding, basic and diluted | | | 22,431,319 | | | — |
Basic and diluted net loss per ordinary share subject to possible redemption | | | $(0.17) | | | — |
Weighted average non-redeemable ordinary shares outstanding, basic and diluted | | | 6,981,456 | | | 6,250,000 |
Basic and diluted net loss per non-redeemable ordinary share | | | $(0.17) | | | $(0.00) |
| | As of September 30, 2021 | | | As of December 31, 2020 | |
Balance Sheet: | | | | | ||
Total assets | | | $288,553,896 | | | $276,751 |
Total liabilities | | | $36,724,020 | | | $255,288 |
Ordinary shares subject to possible redemption, 28,750,000 and no shares at redemption value as of September 30, 2021 and December 31, 2020, respectively | | | $287,500,000 | | | — |
Total shareholders’ equity | | | $(35,670,124) | | | $21,463 |
| | Pro Forma Combined (Assuming No Redemptions) | | | Pro Forma Combined (Assuming Maximum Redemptions) | |
Balance Sheet Data as of June 30, 2021 | | | | | ||
Total assets | | | $1,043,022 | | | $755,522 |
Total liabilities | | | $68,921 | | | $68,921 |
Total stockholders’ equity | | | $974,101 | | | $686,601 |
Selected Unaudited Pro Forma Condensed Combined Statement of Operations Data For the Six Months Ended June 30, 2021 | | | | | ||
Total revenue and other income | | | $183,268 | | | $183,268 |
Net loss | | | $(60,495) | | | $(60,495) |
Net loss attributable to Class A and Class B ordinary shareholders—basic and diluted | | | $(44,865) | | | $(44,865) |
Weighted-average Class A and Class B ordinary shares outstanding—basic and diluted | | | 965,522,006 | | | 936,772,006 |
Net loss per share attributable to Class A and Class B ordinary shareholders—basic and diluted | | | $(0.05) | | | $(0.05) |
For the Year Ended December 31, 2020 | | | | | ||
Total revenue and other income | | | $99,010 | | | $99,010 |
Net loss | | | $(82,789) | | | $(82,789) |
Net loss attributable to Class A and Class B ordinary shareholders—basic and diluted | | | $(88,241) | | | $(88,241) |
Weighted-average Class A and Class B ordinary shares outstanding—basic and diluted | | | 965,522,006 | | | 936,772,006 |
Net loss per share attributable to Class A and Class B ordinary shareholders—basic and diluted | | | $(0.09) | | | $(0.09) |
Trading Date | | | EJFA Units (EJFAU) | | | EJFA Public Shares (EJFA) | | | EJFA Public Warrants (EJFAW) |
September 14, 2021 | | | $9.85 | | | $9.69 | | | $0.61 |
January 20, 2022 | | | $10.27 | | | $9.88 | | | $1.21 |
| | | | | | Pagaya Equivalent Pro Forma Per Share Data(3) | | | | | ||||||||||||||
| | Pagaya (Historical) | | | EJFA (Historical) | | | Assuming No Redemptions | | | 50% Redemption Scenario | | | Assuming Maximum Redemptions | | | Assuming No Redemptions | | | 50% Redemption Scenario | | | Assuming Maximum Redemptions | |
As of and for the six months ended June 30, 2021(2) | | | | | | | | | | | | | | | | | ||||||||
Book value per share(1) | | | $29.58 | | | $(0.99) | | | $0.86 | | | | | $0.58 | | | $160.88 | | | | | $108.46 | ||
Net loss attributable to ordinary shareholders—basic and diluted | | | $(84,709) | | | | | | | | | | | | | | | |||||||
Weighted-average ordinary shares outstanding—basic and diluted | | | 1,036,688 | | | | | | | | | | | | | | | |||||||
Net loss per share attributable to ordinary shareholders—basic and diluted | | | $(81.71) | | | | | | | | | | | | | | | |||||||
Weighted-average non-redeemable ordinary shares outstanding—basic and diluted | | | | | 28,750,000 | | | | | | | | | | | | | |||||||
Basic and diluted net loss per non-redeemable ordinary share | | | | | $(0.34) | | | | | | | | | | | | | |||||||
Weighted average ordinary shares subject to possible redemption outstanding—basic and diluted | | | | | 7,187,500 | | | | | | | | | | | | | |||||||
Basic and diluted net loss per ordinary share subject to possible redemption | | | | | $(0.34) | | | | | | | | | | | | | |||||||
Net loss attributable to Class A and Class B ordinary shareholders—basic and diluted | | | | | | | $(44,865) | | | | | $(44,865) | | | | | | | ||||||
Weighted-average Class A and Class B ordinary shares outstanding—basic and diluted | | | | | | | 965,522,006 | | | | | 936,772,006 | | | | | | | ||||||
Net loss per share attributable to Class A and Class B ordinary shareholders—basic and diluted | | | | | | | $(0.05) | | | | | $(0.05) | | | $(8.68) | | | | | $(8.95) | ||||
As of and for the year ended December 31, 2020 | | | | | | | | | | | | | | | | | ||||||||
Net income attributable to ordinary shareholders—basic | | | $4,912 | | | | | | | | | | | | | | |
| | | | | | Pagaya Equivalent Pro Forma Per Share Data(3) | | | | | ||||||||||||||
| | Pagaya (Historical) | | | EJFA (Historical) | | | Assuming No Redemptions | | | 50% Redemption Scenario | | | Assuming Maximum Redemptions | | | Assuming No Redemptions | | | 50% Redemption Scenario | | | Assuming Maximum Redemptions | |
Weighted-average ordinary shares outstanding—basic | | | 1,022,959 | | | | | | | | | | | | | | | |||||||
Net income per share attributable to ordinary shareholders—basic | | | $4.80 | | | | | | | | | | | | | | | |||||||
Net income attributable to ordinary shareholders— diluted | | | $4,608 | | | | | | | | | | | | | | | |||||||
Weighted-average ordinary shares outstanding—diluted | | | 1,107,349 | | | | | | | | | | | | ||||||||||
Net income per share attributable to ordinary shareholders—diluted | | | $4.16 | | | | | | | | | | | | | | | |||||||
Basic and diluted weighted average Class B shares outstanding | | | | | 6,250,000 | | | | | | | | | | | | | |||||||
Basic and diluted net loss per share | | | | | $(0.00) | | | | | | | | | | | | | |||||||
Net loss attributable to Class A and Class B ordinary shareholders—basic and diluted | | | | | | | $(88,241) | | | | | $(88,241) | | | | | | | ||||||
Weighted-average Class A and Class B ordinary shares outstanding—basic and diluted | | | | | | | 965,522,006 | | | | | 936,772,006 | | | | | | | ||||||
Net loss per share attributable to Class A and Class B ordinary shareholders—basic and diluted | | | | | | | $(0.09) | | | | | $(0.09) | | | $(17.08) | | | | | $(17.60) |
(1) | Book value per share = Total equity divided by total ordinary shares outstanding on an as-converted basis. |
(2) | EJFA’s unaudited pro forma condensed combined statement of operations for the six months ended September 30, 2021 have been derived by subtracting its unaudited results of operations for the three months ended March 31, 2021 from its unaudited results of operations for the nine months ended September 30, 2021. See Note 3 in the section of this proxy statement/prospectus entitled “Unaudited Pro Forma Condensed Combined Financial Information.” |
(3) | The equivalent per share data for Pagaya is calculated by multiplying the combined pro forma per share data by the Per Share Merger Consideration set forth in the Merger Agreement. |
• | maintain and increase the volume of financial products facilitated with the assistance of our AI technology; |
• | enter into new and maintain existing relationships with Partners; |
• | maintain cost-effective access to capital and a diversified asset funding strategy; |
• | expand the use and applicability of our AI technology; |
• | improve the effectiveness and predictiveness of our AI technology; |
• | successfully build our brand and protect our reputation from negative publicity; |
• | successfully adjust our proprietary AI technology, products and services in a timely manner in response to changing macroeconomic conditions, including consumer credit performance and fluctuations in the credit markets; |
• | successfully compete with companies that are currently in, or may in the future enter, the business of providing technological services to enhance the access to credit for customers and funding services; |
• | enter into new markets and introduce new products and services; |
• | comply with and successfully adapt to complex and evolving legal and regulatory environments in our existing markets and ones we may enter in the future; |
• | effectively secure and maintain the confidentiality of the information received, accessed, stored, provided and used across our systems; |
• | successfully obtain and maintain funding and liquidity to support continued growth and general corporate purposes; |
• | attract, integrate and retain qualified employees and independent contractors; and |
• | effectively manage, scale and expand the capabilities of our teams, outsourcing relationships, third-party service providers, operating infrastructure and other business operations. |
• | Volatile economic and market conditions, which could cause Asset Investors to delay making new commitments to alternative Financing Vehicles or limit the ability of our existing Financing Vehicles to deploy capital; |
• | Competition may make fundraising and the deployment of capital more difficult, thereby limiting our ability to grow or maintain the assets of such Financing Vehicles; |
• | Changes in our strategy or the terms of our Network AI Fees; and |
• | Poor performance of one or more of the Financing Vehicles, either relative to market benchmarks or in absolute terms, or compared to our competitors, may cause Asset Investors to regard the Financing Vehicles less favorably than those of our competitors, thereby adversely affecting our ability to raise more capital for existing Financing Vehicles or new or successor Financing Vehicles. |
• | a number of our competitors in some of our businesses have greater financial, technical, marketing and other resources and more personnel than we do; |
• | some Financing Vehicles may not perform as well as competitors’ Financing Vehicles or other available investment products; |
• | several of our competitors have significant amounts of capital, and many of them have similar investment objectives to ours, which may create additional competition for investment opportunities and may reduce the size and duration of pricing inefficiencies that many alternative investment strategies seek to exploit; |
• | some of our competitors may be subject to less regulation and accordingly may have more flexibility to undertake and execute certain investments, including in certain industries or businesses, than we can and/or bear less compliance expense than we do; |
• | some of our competitors may have more flexibility than us in raising certain types of Financing Vehicles under the contracts or terms they have negotiated with their investors; and |
• | some of our competitors may have higher risk tolerances, different risk assessments or lower return thresholds, which could allow them to consider a wider variety of investments and to bid more aggressively than us for investments that we want to make. |
• | foreign, U.S. federal and state lending statutes and regulations that require certain parties, including our Partners, to hold licenses or other government approvals or filings in connection with specified activities, and impose requirements related to marketing and advertising, transaction disclosures and terms, fees and interest rates, usury, credit discrimination, credit reporting, servicemember relief, debt collection, repossession, unfair or deceptive business practices and consumer protection, as well as other state laws relating to privacy, information security, conduct in connection with data breaches and money transmission; |
• | the Equal Credit Opportunity Act and Regulation B promulgated thereunder, which prohibit creditors from discouraging or discriminating against credit applicants on the basis of race, color, sex, age, religion, national origin, marital status, the fact that all or part of the applicant’s income derives from any public assistance program or the fact that the applicant has in good faith exercised any right under the federal Consumer Credit Protection Act, and similar state and municipal fair lending laws; |
• | foreign, U.S. federal and state securities laws, including, among others, the Securities Act, the Exchange Act, the Investment Advisers Act, and the Investment Company Act rules and regulations adopted under those laws, and similar foreign, state laws and regulations which govern securities law, advisory services, Financing Vehicles or how we generate or purchase consumer credit assets, other loan product regulations, the Israeli Joint Investments in Trust Law, 5754-1994, the Israeli Securities Law, the Israeli Law for Regulation of Investment Advice, Investment Marketing and Portfolio Management, 5755-1995, the Israeli Law for Supervision of Financial Services (Regulated Financial Services), 5776-2016, the Israeli Banking (Licensing) Law, 5741-1981; |
• | foreign, U.S. federal and state laws and regulations addressing privacy, cybersecurity, data protection, and the receipt, storing, sharing, use, transfer, disclosure, protection, and processing of certain types of data, including, among others, Fair Credit Reporting Act (the “FCRA”), Gramm-Leach-Bliley Act (the “GLBA”), Children’s Online Privacy Protection Act, Personal Information Protection and Electronic Documents Act, Controlling the Assault of Non-Solicited Pornography and Marketing (the “CAN-SPAM”), Canada’s Anti-Spam Law, Telephone Consumer Protection Act (the “TCPA”), Federal Trade Commission Act (the “FTC Act”), California Consumer Privacy Act (the “CCPA”) and General Data Protection Regulation (the “GDPR”); |
• | the FCRA and Regulation V promulgated thereunder, which imposes certain obligations on users of consumer reports and those that furnish information to consumer reporting agencies, including obligations relating to obtaining or using consumer reports, taking adverse action on the basis of information from consumer reports, the accuracy and integrity of furnished information, addressing risks of identity theft and fraud and protecting the privacy and security of consumer reports and consumer report information and other related data use law and regulations; |
• | the GLBA and Regulation P promulgated thereunder, which includes limitations on financial institutions’ disclosure of nonpublic personal information about a consumer to nonaffiliated third parties, in certain circumstances requires financial institutions to limit the use and further disclosure of nonpublic personal information by nonaffiliated third parties to whom they disclose such information |
• | the U.S. credit risk retention rules promulgated under the Dodd-Frank Act, which require a securitizer of securitization vehicles to retain an economic interest in the credit risk of the assets collateralizing the securitization vehicles; |
• | the Truth in Lending Act and Regulation Z promulgated thereunder, and similar state laws, which require certain disclosures to borrowers regarding the terms and conditions of their consumer credit obligations, require creditors to comply with certain practice restrictions, limit the ability of a creditor to impose certain terms, impose disclosure requirements in connection with credit card applications and solicitations, and impose disclosure requirements in connection with credit advertising; |
• | Section 5 of the FTC Act, which prohibits unfair and deceptive acts or practices in or affecting commerce, and Section 1031 of the Dodd-Frank Act, which prohibits unfair, deceptive or abusive acts or practices in connection with any consumer financial product or service, and analogous state laws prohibiting unfair, deceptive, unconscionable, unlawful or abusive acts or practices; |
• | the Credit Practices Rule, which (i) prohibits creditors from using certain contract provisions that the Federal Trade Commission has found to be unfair to consumers; (ii) requires creditors to advise consumers who co-sign obligations about their potential liability if the primary obligor fails to pay; and (iii) prohibits certain late charges; |
• | the FDIC guidance related to model risk management and management of vendors and other bank specific requirements pursuant to the terms of service agreements with banks and the examination and enforcement authority of the FDIC under the Bank Service Company Act; |
• | U.S. federal and state regulation and licensing requirements related to the auto insurance and finance industries, including related to being a manager general agent; |
• | the U.S. Bankruptcy Code, which limits the extent to which creditors may seek to enforce debts against parties who have filed for bankruptcy protection; |
• | the Servicemembers Civil Relief Act, which allows military members to suspend or postpone certain civil obligations, requires creditors to reduce the interest rate to 6% on loans to military members under certain circumstances, and imposes restrictions on enforcement of loans to servicemembers, so that military members can devote full attention to military duties; |
• | the Military Lending Act, which requires those who lend to “covered borrowers,” including members of the military and their dependents, to only offer Military Annual Percentage Rates (“APRs”) (a specific measure of all-in-cost-of-credit) under 36%, prohibits arbitration clauses in loan agreements, and prohibits certain other loan agreement terms and lending practices in connection with loans to military servicemembers, among other requirements, and for which violations may result in penalties including voiding of a loan agreement; |
• | the Electronic Fund Transfer Act and Regulation E promulgated thereunder, which provide guidelines and restrictions on the electronic transfer of funds from consumers’ bank accounts, including a prohibition on a creditor requiring a consumer to repay a credit agreement in preauthorized (recurring) electronic fund transfers and disclosure and authorization requirements in connection with such transfers; |
• | the Electronic Signatures in Global and National Commerce Act and similar state laws, particularly the Uniform Electronic Transactions Act, which authorize the creation of legally binding and enforceable agreements utilizing electronic records and signatures and which require creditors and loan servicers to obtain a consumer’s consent to electronically receive disclosures required under federal and state laws and regulations; |
• | the Right to Financial Privacy Act and similar state laws enacted to provide the financial records of financial institution customers a reasonable amount of privacy from government scrutiny; |
• | the Bank Secrecy Act and the USA PATRIOT Act, which relate to compliance with anti-money laundering, borrower due diligence and record-keeping policies and procedures; |
• | the regulations promulgated by the Office of Foreign Assets Control (“OFAC”) under the U.S. Treasury Department related to the administration and enforcement of sanctions against foreign jurisdictions and persons that threaten U.S. foreign policy and national security goals, primarily to prevent targeted jurisdictions and persons from accessing the U.S. financial system; and |
• | other foreign, U.S., federal, state and local statutes, rules and regulations. |
• | Israeli corporate law regulates mergers and requires that a tender offer be effected when more than a specified percentage of shares in a company are purchased; |
• | Israeli corporate law requires special approvals for certain transactions involving directors, officers or significant shareholders and regulates other matters that may be relevant to these types of transactions; |
• | Israeli corporate law does not provide for shareholder action by written consent for public companies, thereby requiring all shareholder actions to be taken at a general meeting of shareholders; |
• | the dual class structure of Pagaya Ordinary Shares concentrates voting power with certain Pagaya Shareholders—in particular, our Founders; |
• | the Pagaya A&R Articles divide our directors into three classes, each of which is elected once every three years; |
• | the Pagaya A&R Articles generally require a vote of a majority of the voting power represented at a general meeting of the Pagaya Shareholders in person or by proxy and voting thereon, as one class (a “simple majority”), and the amendment of a limited number of provisions—such as the provision regarding the size of the Pagaya Board, the provision dividing our directors into three classes, the provision that sets forth the procedures and the requirements that must be met in order for a Pagaya Shareholder to require Pagaya to include a matter on the agenda for a general meeting of the Pagaya Shareholders and the provisions relating to the election and removal of members of the Pagaya Board and empowering the Pagaya Board to fill vacancies on the Pagaya Board—require a supermajority vote of the holders of 75% of the total voting power of Pagaya Shareholders if no Pagaya Class B Ordinary Shares remain outstanding (or a simple majority so long as Pagaya Class B Ordinary Shares remain outstanding); |
• | the Pagaya A&R Articles do not permit a director who is a member of one of the three staggered classes to be removed other than in the annual general meeting in which the term of such class expires, except in special circumstances of incapacity or ineligibility (and in the case of other directors, such as those appointed by the Pagaya Board to fill vacancies, do not permit a director to be removed by shareholders except by a vote of the holders of at least 75% of the total voting power of Pagaya Shareholders if no Pagaya Class B Ordinary Shares remain outstanding, or a simple majority so long as Pagaya Class B Ordinary Shares remain outstanding); and |
• | the Pagaya A&R Articles provide that director vacancies may be filled by the Pagaya Board. |
• | changes in the industries in which we and our Partners operate; |
• | developments involving our competitors; |
• | changes in laws and regulations affecting our business; |
• | variations in our operating performance and the performance of our competitors in general; |
• | actual or anticipated fluctuations in our quarterly or annual operating results; |
• | publication of research reports by securities analysts about us or our competitors or our industry; |
• | the public’s reaction to our press releases, our other public announcements and our filings with the SEC; |
• | actions by shareholders, including the sale by investors in the PIPE Investment of any of their Pagaya Ordinary Shares; |
• | additions and departures of key personnel; |
• | commencement of, or involvement in, litigation by or against Pagaya; |
• | changes in our capital structure, such as future issuances of equity securities or the incurrence of debt; |
• | the volume of Pagaya Class A Ordinary Shares available for public sale; and |
• | general economic and political conditions, such as interest rates, unemployment levels, conditions in the housing market, immigration policies, government shutdowns, trade wars and delays in tax refunds, as well as events such as natural disasters, acts of war, terrorism, catastrophes and pandemics. |
• | acts of war, sabotage, hostilities, civil unrest, protests, demonstrations, insurrections, riots, cyberattacks or terrorism, or any escalation or worsening of the foregoing, or changes in national, regional, state or local political or social conditions in countries in which, or in the proximate geographic region of which, Pagaya or EJFA, as applicable, operates; |
• | earthquakes, hurricanes, tornados, wildfires, or other natural disasters; |
• | epidemics, pandemics, including the COVID-19 pandemic, or other public health emergencies; |
• | changes directly attributable to the execution or performance of the Merger Agreement, the public announcement or pendency of the Transactions; |
• | changes in applicable legal requirements, changes of official guidance or official positions of general applicability, or changes in enforcement policies or official interpretations thereof or decisions of general applicability by any governmental entity; |
• | changes in U.S. GAAP, or any official interpretation of U.S. GAAP; |
• | general economic, regulatory, business or tax conditions; |
• | events, changes or conditions generally affecting participants in the industries and markets in which EJFA or Pagaya, as applicable, operates; |
• | failure to meet any projections, forecasts, guidance, estimates or financial or operating predictions of revenue, earnings, cash flow or cash position; or |
• | any actions required to be taken, or required not to be taken, pursuant to the terms of the Merger Agreement, taken with the prior written consent of the other party or taken by, or at the written request of, the other party. |
• | actual or anticipated fluctuations in Pagaya’s quarterly and annual financial results or the quarterly or annual financial results of companies perceived to be similar to Pagaya; |
• | changes in the market’s expectations about Pagaya’s operating results; |
• | success of competitors; |
• | Pagaya’s operating results failing to meet the expectation of securities analysts or investors in a particular period; |
• | changes in financial estimates and recommendations by securities analysts concerning Pagaya or the industries in which Pagaya operates in general; |
• | operating and share price performance of other companies that investors deem comparable to Pagaya; |
• | Pagaya’s ability to market new and enhanced products and services on a timely basis; |
• | changes in laws and regulations affecting Pagaya’s business; |
• | commencement of, or involvement in, litigation involving Pagaya; |
• | changes in Pagaya’s capital structure, such as future issuances of securities or the incurrence of additional debt; |
• | volume of Pagaya Ordinary Shares available for public sale; |
• | any major change in the Pagaya Board or management; |
• | sales of substantial amounts of Pagaya Class A Ordinary Shares by Pagaya’s directors, executive officers or significant shareholders or the perception that such sales could occur; |
• | general economic and political conditions such as recessions, interest rates, international currency fluctuations and acts of war or terrorism; and |
• | occurrence of natural disasters, pandemics or other unanticipated catastrophes. |
• | Approximately Pagaya Ordinary Shares are anticipated to be held by pre-Closing Pagaya Shareholders immediately after consummation of the Transactions. This represents approximately %, % or % of the number of Pagaya Ordinary Shares that will be outstanding following the consummation of the Transactions, assuming the no redemption scenario, the 50% redemption scenario and the maximum redemption scenario, respectively, and %, % or % of the total voting power of Pagaya Ordinary Shares that will be outstanding following the consummation of the Transactions, assuming the no redemption scenario, the 50% redemption scenario and the maximum redemption scenario, respectively. For additional information about the high vote Pagaya Class B Ordinary Shares that are expected to be held by the Founders after consummation of the Transactions, see “—Risks Related to Dual Class Structure”. |
• | Approximately Pagaya Ordinary Shares (including Pagaya Ordinary Shares issued upon the exercise of EJFA Private Placement Warrants and the conversion of ______ EJFA Class B Ordinary Shares) are anticipated to be held by the Sponsor immediately after consummation of the Transactions. This represents approximately %, % or % of the number of Pagaya Ordinary Shares that will be outstanding following the consummation of the Transactions, assuming the no redemption scenario, the 50% redemption scenario and the maximum redemption scenario, respectively, and %, % or % of the total voting power of Pagaya Ordinary Shares that will be outstanding following the consummation of the Transactions, assuming the no redemption scenario, the 50% redemption scenario and the maximum redemption scenario, respectively. |
• | Up to Pagaya Class A Ordinary Shares are anticipated to be issued to the PIPE Investors pursuant to the PIPE Investment, at a price of $10.00 per share. This represents approximately %, % or % of the number of shares of the Pagaya Ordinary Shares that will be outstanding following the consummation of the Transactions, assuming the no redemption scenario, the 50% redemption scenario and the maximum redemption scenario, respectively, and %, % or % of the total voting power of Pagaya Ordinary Shares that will be outstanding following the consummation of the Transactions, assuming the no redemption scenario, the 50% redemption scenario and the maximum redemption scenario, respectively. |
• | Approximately Pagaya Ordinary Shares (including Pagaya Ordinary Shares issued upon the exercise of EJFA Public Warrants) are anticipated to be held by the EJFA Public Shareholders immediately after consummation of the Transactions. This represents approximately %, % or % of the number of Pagaya Ordinary Shares that will be outstanding following the consummation of the Transactions, assuming the no redemption scenario, the 50% redemption scenario and the maximum redemption scenario, respectively, and %, % or % of the total voting power of Pagaya Ordinary Shares that will be outstanding following the consummation of the Transactions, assuming the no redemption scenario, the 50% redemption scenario and the maximum redemption scenario, respectively. |
• | your proportionate ownership interest in Pagaya will decrease; and/or |
• | the relative voting strength of each previously outstanding Pagaya Class A Ordinary Share will be diminished. |
• | a limited availability of market quotations for Pagaya’s securities; |
• | reduced liquidity for Pagaya’s securities; |
• | a determination that the Pagaya Class A Ordinary Shares are a “penny stock,” which will require brokers trading the Pagaya Class A Ordinary Shares to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for Pagaya Class A Ordinary Shares; |
• | a limited amount of news and analyst coverage; and/or |
• | a decreased ability to issue additional securities or obtain additional financing in the future. |
• | the risk that the Merger may not be completed in a timely manner or at all; |
• | the effect of the announcement or pendency of the Merger on Pagaya’s business; |
• | the failure to satisfy the conditions to the consummation of the Merger; |
• | the incurrence of significant costs in connection with and following the Merger; |
• | the inability to complete the Transactions; |
• | the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger Agreement; |
• | the amount of EJFA Shareholder redemption requests made by EJFA Public Shareholders; |
• | the effect of the announcement or pendency of the Merger on Pagaya’s business; |
• | risks that the Merger disrupts current plans and operations of Pagaya; |
• | potential litigation or conflicts relating to the Merger; |
• | the ability to implement business plans and other expectations after the consummation of the Merger; |
• | market interest rates; |
• | difficult market or political conditions in which Pagaya competes; |
• | the uncertain future prospects and rate of growth of Pagaya due to its relatively limited operating history; |
• | the ability of Pagaya to improve, operate and implement its AI technology, including as it expands into new businesses; |
• | competition in retaining and attracting and onboarding new Partners and raising capital from Asset Investors through Financing Vehicles given the current limited number of Partners that account for a substantial portion of the total number of the financial products facilitated with the assistance of Pagaya’s AI technology; |
• | potential difficulties in retaining Pagaya’s current management team and other key employees and independent contractors, including highly-skilled technical experts; |
• | Pagaya’s estimates of its future financial performance; |
• | changes in the political, legal and regulatory framework for AI technology and machine learning; |
• | the impact of health epidemics, including the ongoing COVID-19 pandemic; |
• | conditions related to Pagaya’s operations in Israel; |
• | risks related to data security and privacy; |
• | changes to accounting principles and guidelines; |
• | potential litigation relating to the Merger; |
• | following the Closing, the ability to maintain the listing of Pagaya’s securities on Nasdaq; |
• | the price of Pagaya’s securities may be volatile; |
• | unexpected costs or expenses; and |
• | the other matters described in the section titled “Risk Factors.” |
1 | From 2016 to 6/30/2021 |
2 | Application evaluation refers to applications that Partners choose to process with the assistance of the Pagaya network, as of Q2 2021 |
3 | Network Volume is defined as the gross dollar amount of assets that are originated by Partners with the assistance of Pagaya’s AI technology and are acquired by the Financing Vehicles |
1 | For Partners who have utilized our network for at least six months; Increase measured relative to Partner’s second month volume. |
2 | For Partners who have utilized our network for at least 12 months; Increase measured relative to Partner’s second month volume. |
1 | Estimated origination volumes based on Q4 2020 annualized originations in The TransUnion “Consumer Credit Origination, Balance and Delinquency Trends: Q4 2020” report. |
2 | Estimated origination volumes based on McKinsey & Company US Lending at the Point of Sale report. |
3 | Represents homeowners and auto insurance net written premiums in 2020, as per the Insurance Information Institute. |
4 | Estimated origination volumes based on Q4 2019 annualized originations in The TransUnion “Consumer Credit Origination, Balance and Delinquency Trends: Q4 2020” report. |
• | Larger datasets to train and inform our models |
• | Continuously improving AI technology |
• | Streamlined, tech-enabled access to multiple markets |
• | API-based integration and minimal latency for customers |
• | Light balance sheet and low-risk funding model |
• | Lean/nimble organization without the bureaucracy of large financial institutions |
• | Scaled data science network |
• | Deep Partner relationships with 100% historical retention |
• | foreign, U.S. federal and state lending statutes and regulations that require certain parties, including our Partners, to hold licenses or other government approvals or filings in connection with specified activities, and impose requirements related to marketing and advertising, transaction disclosures and terms, fees and interest rates, usury, credit discrimination, credit reporting, servicemember relief, debt collection, repossession, unfair or deceptive business practices and consumer protection, as well as other state laws relating to privacy, information security, conduct in connection with data breaches and money transmission; |
• | the Equal Credit Opportunity Act and Regulation B promulgated thereunder, which prohibit creditors from discouraging or discriminating against credit applicants on the basis of race, color, sex, age, religion, national origin, marital status, the fact that all or part of the applicant’s income derives from any public assistance program or the fact that the applicant has in good faith exercised any right under the federal Consumer Credit Protection Act, and similar state and municipal fair lending laws; |
• | foreign, U.S. federal and state securities laws, including, among others, the Securities Act, the Exchange Act, the Investment Advisers Act, and the Investment Company Act rules and regulations adopted under those laws, and similar foreign, state laws and regulations, which govern securities law, advisory services, Financing Vehicles or how we purchase consumer credit assets, the Israeli Joint Investment Law, the Israeli Securities Law and loan product regulations; |
• | foreign, U.S. federal and state laws and regulations addressing privacy, cybersecurity, data protection, and the receipt, storing, sharing, use, transfer, disclosure, protection, and processing of certain types of data, including, among others, FCRA, GLBA, Children’s Online Privacy Protection Act, Personal Information Protection and Electronic Documents Act, CAN-SPAM, Canada’s Anti-Spam Law, TCPA, FTC Act, California Consumer Privacy Act, or CCPA and GDPR; |
• | the Fair Credit Reporting Act and Regulation V promulgated thereunder, which imposes certain obligations on users of consumer reports and those that furnish information to consumer reporting agencies, including obligations relating to obtaining or using consumer reports, taking adverse action on |
• | the Gramm-Leach-Bliley Act and Regulation P promulgated thereunder, which includes limitations on financial institutions’ disclosure of nonpublic personal information about a consumer to nonaffiliated third parties, in certain circumstances requires financial institutions to limit the use and further disclosure of nonpublic personal information by nonaffiliated third parties to whom they disclose such information and requires financial institutions to disclose certain privacy notices and practices with respect to information sharing with affiliated and unaffiliated entities as well as to safeguard personal borrower information, and other privacy laws and regulations; |
• | the U.S. credit risk retention rules promulgated under the Dodd-Frank Act, which require a securitizer of securitization vehicles to retain an economic interest in the credit risk of the assets collateralizing the securitization vehicles; |
• | the Truth in Lending Act and Regulation Z promulgated thereunder, and similar state laws, which require certain disclosures to borrowers regarding the terms and conditions of their consumer credit obligations, require creditors to comply with certain practice restrictions, limit the ability of a creditor to impose certain terms, impose disclosure requirements in connection with credit card applications and solicitations, and impose disclosure requirements in connection with credit advertising; |
• | Section 5 of the Federal Trade Commission Act, which prohibits unfair and deceptive acts or practices in or affecting commerce, and Section 1031 of the Dodd-Frank Act, which prohibits unfair, deceptive or abusive acts or practices in connection with any consumer financial product or service, and analogous state laws prohibiting unfair, deceptive, unconscionable, unlawful or abusive acts or practices; |
• | the Credit Practices Rule, which (i) prohibits creditors from using certain contract provisions that the Federal Trade Commission has found to be unfair to consumers; (ii) requires creditors to advise consumers who co-sign obligations about their potential liability if the primary obligor fails to pay; and (iii) prohibits certain late charges; |
• | the FDIC guidance related to model risk management and management of vendors and other bank specific requirements pursuant to the terms of service agreements with banks and the examination and enforcement authority of the FDIC under the Bank Service Company Act; |
• | U.S. federal and state regulation and licensing requirements related to the auto insurance and finance industries, including related to being a manager general agent; |
• | the U.S. Bankruptcy Code, which limits the extent to which creditors may seek to enforce debts against parties who have filed for bankruptcy protection; |
• | the Servicemembers Civil Relief Act, which allows military members to suspend or postpone certain civil obligations, requires creditors to reduce the interest rate to 6% on loans to military members under certain circumstances, and imposes restrictions on enforcement of loans to servicemembers, so that military members can devote full attention to military duties; |
• | the Military Lending Act, which requires those who lend to “covered borrowers,” including members of the military and their dependents, to only offer Military APRs (a specific measure of all-in-cost-of-credit) under 36%, prohibits arbitration clauses in loan agreements, and prohibits certain other loan agreement terms and lending practices in connection with loans to military servicemembers, among other requirements, and for which violations may result in penalties including voiding of a loan agreement; |
• | the Electronic Fund Transfer Act and Regulation E promulgated thereunder, which provide guidelines and restrictions on the electronic transfer of funds from consumers’ bank accounts, including a prohibition on a creditor requiring a consumer to repay a credit agreement in preauthorized (recurring) electronic fund transfers and disclosure and authorization requirements in connection with such transfers; |
• | the Electronic Signatures in Global and National Commerce Act and similar state laws, particularly the Uniform Electronic Transactions Act, which authorize the creation of legally binding and enforceable agreements utilizing electronic records and signatures and which require creditors and loan servicers to obtain a consumer’s consent to electronically receive disclosures required under federal and state laws and regulations; |
• | the Right to Financial Privacy Act and similar state laws enacted to provide the financial records of financial institution customers a reasonable amount of privacy from government scrutiny; |
• | the Bank Secrecy Act and the USA PATRIOT Act, which relate to compliance with anti-money laundering, borrower due diligence and record-keeping policies and procedures; |
• | the regulations promulgated by the Office of Foreign Assets Control (“OFAC”) under the U.S. Treasury Department related to the administration and enforcement of sanctions against foreign jurisdictions and persons that threaten U.S. foreign policy and national security goals, primarily to prevent targeted jurisdictions and persons from accessing the U.S. financial system; and |
• | other foreign, U.S., federal, state and local statutes, rules and regulations. |
• | reviewed certain publicly available business and financial information relating to EJFA that Duff & Phelps deemed to be relevant; |
• | reviewed EJFA’s unaudited interim financial statements for March 31, 2021 included in EJFA’s Form 10-Q filed with the SEC on May 18, 2021 and EJFA’s unaudited interim financial statements for June 30, 2021 included in EJFA’s Form 10-Q filed with the SEC on August 16, 2021; |
• | reviewed consolidated audited financial statements for Pagaya for the years ended December 31, 2019 and December 31, 2020 with a Report of Independent Auditor to the Pagaya Shareholders, dated as of March 15, 2021; |
• | reviewed consolidated unaudited financial information for Pagaya for the quarters ended March 31, 2021 and June 30, 2021, which Pagaya’s management identified as being the most current financial statements available and on which Duff & Phelps was instructed to rely by the management of EJFA; |
• | reviewed capitalization information for Pagaya, prepared by Pagaya, pro forma for the Merger (including the Capital Restructuring) and the PIPE Investment, provided to Duff & Phelps by the management of EJFA and on which Duff & Phelps was instructed to rely by the management of EJFA, including the number of Pagaya Class A Ordinary Shares to be issued in the PIPE Investment and outstanding upon completion of the Capital Restructuring (including the Stock Split); |
• | reviewed other internal documents relating to the history, financial conditions and prospects, current and future operations, and probable future outlook of Pagaya, including financial projections for the years 2021 through 2025 prepared by Pagaya senior management (provided, that the 2024 and 2025 financial information that Duff & Phelps was provided was extrapolated based on 2022-2023 growth |
• | reviewed a letter dated September 14, 2021 from the management of EJFA and Pagaya which made certain representations as to historical financial statements, Financial Projections and the underlying assumptions thereof for EJFA and Pagaya; |
• | reviewed industry reports that Duff & Phelps deemed relevant; |
• | reviewed Pagaya’s company presentation dated August 2021; |
• | reviewed a draft of the Merger Agreement, dated September 13, 2021; |
• | discussed the information referred to above and the background and other elements of the proposed Merger with the management of EJFA and certain members of the EJFA Board (in their capacity as members of the EJFA Board); |
• | discussed with EJFA management the plans and intentions with respect to the management and operation of Pagaya and EJFA following the consummation of the Merger; |
• | discussed with EJFA management and certain members of the EJFA Board (in their capacity as members of the EJFA Board) their assessment of the strategic rationale for, and the potential benefits of, the Merger; |
• | participated in due diligence calls with EJFA management and Pagaya management discussing the operations of Pagaya including, but not limited to the Financial Projections; |
• | reviewed the historical trading price and trading volume of EJFA’s common shares, and the publicly traded securities of certain other companies that Duff & Phelps deemed relevant; |
• | performed certain valuation and comparative analyses using generally accepted valuation and analytical techniques, including a discounted cash flow analysis and an analysis of selected public companies that Duff & Phelps deemed relevant, as further described below in the section of this proxy statement/prospectus entitled “Fairness Opinion of Duff & Phelps”; and |
• | conducted such other analyses and considered such other factors as Duff & Phelps deemed appropriate. |
• | relied upon the accuracy, completeness, and fair presentation of all information, data, advice, opinions and representations obtained from public sources or provided to it from private sources, including EJFA and Pagaya and their respective management, including all financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by Duff & Phelps, and Duff & Phelps did not independently verify such information; |
• | relied upon the fact that the EJFA Board and EJFA have been advised by counsel as to all legal matters with respect to the proposed Merger, including whether all procedures required by law to be taken in connection with the proposed Merger have been duly, validly and timely taken; |
• | assumed that any estimates, evaluations, forecasts and projections, and other pro forma information, including the Financial Projections, furnished to Duff & Phelps were reasonably prepared and based upon the best currently available information and good faith judgment of the person(s) furnishing the same, and Duff & Phelps expressed no opinion with respect to such estimates, evaluations, forecasts and projections and other pro forma information or any underlying assumptions; |
• | assumed that information supplied by and representations made by EJFA and Pagaya management are substantially accurate regarding EJFA, Pagaya and the Merger; |
• | assumed that the representations and warranties made in the Merger Agreement are substantially accurate; |
• | assumed that the adjustments in Sections 3.4(a) and 3.4(b) of the Merger Agreement will not result in any material adjustment to the Merger Consideration; |
• | assumed that the final versions of all documents reviewed by Duff & Phelps in draft form conform in all material respects to the drafts reviewed; |
• | assumed that the Capital Restructuring and PIPE Investment will occur as contemplated by the draft documents reviewed by Duff & Phelps and as described by management of Pagaya and EJFA; |
• | assumed that there has been no material change in the assets, liabilities, financial condition, results of operations, business, or prospects of EJFA or Pagaya since the date of the most recent financial statements and other information made available to Duff & Phelps, and that there is no information or facts that would make the information reviewed by Duff & Phelps incomplete or misleading; |
• | assumed that all of the conditions required to implement the Merger will be satisfied and that the Merger will be completed in a timely manner in accordance with the Merger Agreement without any material amendments thereto or any material waivers of any terms or conditions thereof; and |
• | assumed that the consummation of the Merger will comply in all respects with all applicable foreign, federal, state and local statutes, rules and regulations and that all governmental, regulatory or other consents and approvals necessary for the consummation of the Merger will be obtained without any adverse effect, that would be material to Duff & Phelps’ analysis, on EJFA, Pagaya, or the contemplated benefits expected to be derived in the Merger. |
(i) | Selected Financial Technology Companies involving companies in the financial technology sector with similar projected 2021 revenue growth as Pagaya’s revenue growth in 2025 under the Financial Projections. Duff & Phelps used this group of six companies to select a range of 2021 revenue multiples to apply to Pagaya’s projected revenue in 2025. The resulting Terminal Values were used in Duff & Phelps’ DCF Analysis; and |
(ii) | Selected High Growth Consumer-Lending-Focused Financial Technology Platforms involving companies with similar operating businesses, end markets, revenue models and projected financial performance as Pagaya. Duff & Phelps used this group of eight publicly traded companies to select a range of 2022 revenue multiples to apply to Pagaya’s projected revenue in 2022. The resulting values were an indication of the current enterprise value of Pagaya. Duff & Phelps also used this group to test the implied enterprise value-to-revenue multiples of Pagaya’s projected revenue in 2021 and 2023 and the implied enterprise value-to-EBITDA multiples of Pagaya’s projected EBITDA in 2021, 2022 and 2023. |
| | ENTERPRISE VALUE AS MULTIPLE OF | ||||||||||
| | LTM Revenue | | | 2021 Revenue | | | 2022 Revenue | | | 2023 Revenue | |
BTRS Holdings Inc. | | | 11.51x | | | 11.01x | | | 9.44x | | | 7.59x |
Coupa Software Incorporated | | | 31.70x | | | 28.81x | | | 23.39x | | | 18.87x |
Alkami Technology, Inc. | | | 19.50x | | | 17.18x | | | 13.69x | | | 11.01x |
nCino, Inc. | | | 29.88x | | | 27.17x | | | 21.97x | | | 17.44x |
Q2 Holdings, Inc. | | | 11.47x | | | 10.42x | | | 8.71x | | | 7.26x |
PayPal Holdings, Inc. | | | 13.72x | | | 12.70x | | | 10.35x | | | 8.56x |
Mean | | | 19.63x | | | 17.88x | | | 14.59x | | | 11.79x |
Median | | | 16.61x | | | 14.94x | | | 12.02x | | | 9.79x |
| | ENTERPRISE VALUE AS MULTIPLE OF | ||||||||||
| | LTM Revenue | | | 2021 Revenue | | | 2022 Revenue | | | 2023 Revenue | |
Affirm Holdings, Inc. | | | 43.99x | | | 39.75x | | | 27.44x | | | 20.36x |
LendingClub Corporation | | | 8.40x | | | NM | | | NM | | | NM |
Open Lending Corporation | | | 30.49x | | | 24.41x | | | 18.55x | | | 15.25x |
Sezzle Inc. | | | 32.99x | | | 24.36x | | | 15.17x | | | 10.59x |
SoFi Technologies, Inc. | | | 18.69x | | | 15.64x | | | 10.31x | | | 7.26x |
Sunlight Financial Holdings Inc. | | | 12.78x | | | 10.92x | | | 8.37x | | | 6.67x |
Upstart Holdings, Inc. | | | 54.55x | | | 34.05x | | | 24.08x | | | 19.13x |
Zip Co Limited | | | 21.86x | | | 10.03x | | | 6.60x | | | 4.91x |
Mean | | | 27.97x | | | 22.74x | | | 15.79x | | | 12.03x |
Median | | | 26.17x | | | 24.36x | | | 15.17x | | | 10.59x |
| | REVENUE GROWTH | ||||||||||||||||
| | 2020 | | | YTD 2021(1) | | | 2021 | | | 2022 | | | 2023 | | | 2021- 2023 CAGR | |
BTRS Holdings Inc. | | | 12.6% | | | 29.0% | | | 18.5% | | | 16.6% | | | 24.5% | | | 13.2% |
Coupa Software Incorporated | | | 39.0% | | | 41.2% | | | 30.6% | | | 23.2% | | | 24.0% | | | 15.2% |
Alkami Technology, Inc. | | | 52.5% | | | 40.3% | | | 33.9% | | | 25.5% | | | 24.4% | | | 16.0% |
nCino, Inc. | | | 47.8% | | | 37.9% | | | 29.1% | | | 23.6% | | | 26.0% | | | 15.9% |
Q2 Holdings, Inc. | | | 27.7% | | | 26.4% | | | 23.8% | | | 19.5% | | | 20.0% | | | 12.8% |
PayPal Holdings, Inc. | | | 20.7% | | | 24.2% | | | 20.0% | | | 22.7% | | | 20.9% | | | 14.1% |
Mean | | | 33.4% | | | 33.2% | | | 26.0% | | | 21.9% | | | 23.3% | | | 14.5% |
Median | | | 33.3% | | | 33.4% | | | 26.4% | | | 23.0% | | | 24.2% | | | 14.6% |
| | EBITDA MARGIN | ||||||||||
| | 2020 | | | 2021 | | | 2022 | | | 2023 | |
BTRS Holdings Inc. | | | -4.8% | | | -14.3% | | | -10.0% | | | -2.2% |
Coupa Software Incorporated | | | -14.2% | | | -23.7% | | | -21.2% | | | -16.6% |
Alkami Technology, Inc. | | | -22.6% | | | -17.4% | | | -8.6% | | | -0.6% |
nCino, Inc. | | | -17.2% | | | -18.2% | | | -13.2% | | | -10.1% |
Q2 Holdings, Inc. | | | -8.3% | | | -5.7% | | | -4.5% | | | -3.0% |
PayPal Holdings, Inc. | | | 21.5% | | | 22.7% | | | 22.7% | | | 23.2% |
Mean | | | -7.6% | | | -9.4% | | | -5.8% | | | -1.5% |
Median | | | -11.3% | | | -15.9% | | | -9.3% | | | -2.6% |
(1) | YTD growth represents year-to-date June 30, 2021 compared to year-to-date June 30, 2020 |
| | REVENUE GROWTH | ||||||||||||||||
| | 2020 | | | YTD 2021(1) | | | 2021 | | | 2022 | | | 2023 | | | 2021- 2023 CAGR | |
Affirm Holdings, Inc. | | | 70.8% | | | 68.9% | | | 43.9% | | | 44.8% | | | 34.8% | | | 25.0% |
LendingClub Corporation | | | -55.8% | | | 22.2% | | | 141.1% | | | 40.8% | | | 22.3% | | | 19.9% |
Open Lending Corporation | | | 17.3% | | | 166.2% | | | 100.2% | | | 31.6% | | | 21.6% | | | 17.0% |
Sezzle Inc. | | | 272.1% | | | 159.2% | | | 111.6% | | | 60.6% | | | 43.2% | | | 32.0% |
SoFi Technologies, Inc. | | | 27.8% | | | 120.8% | | | 68.9% | | | 51.7% | | | 42.1% | | | 29.2% |
Sunlight Financial Holdings Inc. | | | 30.8% | | | 119.1% | | | 63.7% | | | 30.5% | | | 25.4% | | | 17.9% |
Upstart Holdings, Inc. | | | 26.6% | | | 265.9% | | | 213.5% | | | 41.4% | | | 25.9% | | | 21.2% |
Zip Co Limited | | | 91.0% | | | NM | | | 117.9% | | | 52.0% | | | 34.4% | | | 26.9% |
Mean | | | 60.1% | | | 131.8% | | | 107.6% | | | 44.2% | | | 31.2% | | | 23.6% |
Median | | | 29.3% | | | 120.8% | | | 105.9% | | | 43.1% | | | 30.1% | | | 23.1% |
| | EBITDA MARGIN | ||||||||||
| | 2020 | | | 2021 | | | 2022 | | | 2023 | |
Affirm Holdings, Inc. | | | -33.3% | | | -16.3% | | | -4.3% | | | -3.9% |
LendingClub Corporation | | | -27.8% | | | NM | | | NM | | | NM |
Open Lending Corporation | | | 61.2% | | | 68.1% | | | 68.1% | | | 67.4% |
Sezzle Inc. | | | -46.8% | | | -50.6% | | | -33.9% | | | -25.3% |
SoFi Technologies, Inc. | | | -25.7% | | | -14.5% | | | -2.8% | | | 5.2% |
Sunlight Financial Holdings Inc. | | | 34.3% | | | 40.7% | | | 47.9% | | | 51.8% |
Upstart Holdings, Inc. | | | 8.3% | | | 13.4% | | | 9.2% | | | 14.0% |
Zip Co Limited | | | -31.0% | | | -20.9% | | | -11.4% | | | -7.0% |
Mean | | | -7.6% | | | 2.8% | | | 10.4% | | | 14.6% |
Median | | | -26.7% | | | -14.5% | | | -2.8% | | | 5.2% |
(1) | YTD growth represents year-to-date June 30, 2021 compared to year-to-date June 30, 2020 |
• | you may send another proxy card to EJFA’s Corporate Secretary with a later date so that it is received prior to the vote at the Special Meeting; |
• | you may notify EJFA’s Corporate Secretary in writing, prior to the vote at the Special Meeting, that you have revoked your proxy; or |
• | you may attend the live webcast of the Special Meeting and vote electronically or revoke your proxy electronically, although your attendance alone will not revoke any proxy that you have previously given. |
• | If the Merger with Pagaya or another business combination is not consummated by March 1, 2023 (or such later date as may be approved by EJFA Shareholders in an amendment to the EJFA Memorandum and Articles of Association), EJFA will cease all operations except for the purpose of winding up, redeeming 100% of the outstanding EJFA Public Shares for cash and, subject to the approval of its remaining shareholders and the EJFA Board, dissolving and liquidating. On the other hand, if the Merger is consummated, each outstanding EJFA Ordinary Share will be converted into one Pagaya Class A Ordinary Share, subject to adjustment as described herein. |
• | If EJFA is unable to complete a business combination within the required time period, the Sponsor will be liable under certain circumstances described herein to ensure that the proceeds in the Trust Account are not reduced by the claims of target businesses or claims of vendors or other entities that are owed money by EJFA for services rendered or contracted for or products sold to EJFA. If EJFA consummates a business combination, on the other hand, EJFA will be liable for all such claims. |
• | The Sponsor and EJFA’s officers and directors and their affiliates are entitled to reimbursement of out-of-pocket expenses incurred by them in connection with certain activities on EJFA’s behalf, such as identifying and investigating possible business targets and business combinations. However, if EJFA fails to consummate a business combination within the required period, they will not have any claim against the Trust Account for reimbursement. Accordingly, EJFA may not be able to reimburse these expenses if the Merger or another business combination is not completed by March 1, 2023 (or such later date as may be approved by EJFA Shareholders in an amendment to the EJFA Memorandum and Articles of Association). As of the Record Date, the Sponsor and EJFA’s officers and directors and their affiliates had incurred approximately $ of unpaid reimbursable expenses. |
• | The Merger Agreement provides for the continued indemnification of EJFA’s current directors and officers and the continuation of directors and officers liability insurance covering EJFA’s current directors and officers. The Sponsor and the current officers and directors of EJFA do not have any employment or consulting agreements with Pagaya. |
• | Subject to Pagaya’s consent in accordance with the Merger Agreement, the Sponsor and EJFA’s officers and directors (or their affiliates) may make loans from time to time to EJFA to fund certain capital requirements. Loans may be made after the date of this proxy statement/prospectus. If the Merger is not consummated, the loans will not be repaid and will be forgiven except to the extent there are funds available to EJFA outside of the Trust Account. |
• | Emanuel Friedman will be a member of the Pagaya Board following the Closing and, therefore, in the future Mr. Friedman will receive any cash fees, stock options or stock awards that the Pagaya Board determines to pay to its non-executive directors. |
• | The EJF Investor will participate in the purchase of PIPE Shares from Pagaya at the closing of the Transactions, and certain of EJFA’s directors and officers are affiliated with the EJF Investor. |
• | Duff & Phelps, a Kroll Business, rendered the Opinion to the EJFA Board, for which it will receive a fee from EJFA. A portion of such fee was payable upon delivery of the Opinion and a portion is payable upon and subject to the Closing. |
• | Pagaya, EJFA and the Sponsor entered into the Side Letter Agreement, which provides that, solely in the event the EJFA Transaction Costs exceed the Expenses Excess Amount, a number of EJFA Class B Ordinary Shares will be forfeited for no Merger Consideration and cancelled by EJFA and no longer outstanding, except that the Sponsor may pay, in whole or in part, the EJFA Transaction Costs in cash prior to the Effective Time without further liability to EJFA, in which case the Expenses Excess Amount will be reduced on a dollar-for-dollar basis by the amount so paid by the Sponsor. |
• | Given the difference in the purchase price the Sponsor paid for EJFA Class B Ordinary Shares ($0.003 per share) and EJFA Private Placement Warrants ($1.50 per Warrant) as compared to the purchase price of the EJFA Units sold in the EJFA IPO ($10.00 per EJFA Unit), the Sponsor may earn a positive return on its investment even if the EJFA Public Shareholders experience a negative rate of return following the consummation of the business combination. |
• | Certain directors and officers of EJFA, as well as certain partners and employees of EJF Capital, hold equity interests in the Sponsor, and thus have an interest in the business combination transaction that is not the same as the majority of EJFA Shareholders, who do not hold equity interests in the Sponsor. |
• | In connection with the consummation of the business combination, the Sponsor, EJFA, Pagaya and certain equityholders of Pagaya will enter into a new Registration Rights Agreement, which will, among other things, provide that the Sponsor and certain equity holders will have a demand right for Pagaya to conduct an underwritten offering of the Registrable Securities, provided that the total offering price of all securities proposed to be sold in such offering exceeds $75 million in the aggregate and subject to certain limitations. |
• | Each of EJFA’s directors and officers presently has fiduciary or contractual obligations to other entities pursuant to which such officer or director is required to present a business combination opportunity to such entity. EJFA’s directors and officers also may have become aware of business combination opportunities which may have been appropriate for presentation to EJFA and the other entities to which they owe certain fiduciary or contractual duties. Accordingly, they may have had conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts may not have been resolved in EJFA’s favor and such potential business combination opportunities may have been presented to other entities prior to their presentation to EJFA. The EJFA Memorandum and Articles of Association provide that, to the maximum extent permitted by applicable law, EJFA renounces any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter (i) which may be a business combination opportunity for an entity related to a director or officer of EJFA, on the one hand, and EJFA, on the other, or (ii) the presentation of which would breach an existing legal obligation of a director or officer to another entity, and EJFA waives any claim or cause of action it may have in respect thereof. EJFA does not believe, however, that the fiduciary duties or contractual obligations of its officers or directors or waiver of corporate opportunity materially affected its search for an acquisition target nor will materially impact its ability to complete the proposed Merger. |
• | a fundamentally sound business that has a durable business model with the ability to successfully navigate an economic downturn, changes in the industry landscape, social sustainability trends and evolving regulatory environment, yet is not deeply distressed nor has a negative industry outlook; |
• | can benefit from the vast network, experience, reputation and guidance of the EJFA management team, advisors and board of directors as well as affiliation with, and endorsement of, EJFA; |
• | has a defensible market position and demonstrated differentiated competitive advantages with high barriers to entry against new competitors; |
• | has recurring, predictable revenues and a history of, or the near-term potential to, generate stable and sustainable free cash flow; |
• | exhibits unrecognized value, desirable returns on capital, and a need for capital to achieve the company’s growth strategy; |
• | has the potential for strong and continued growth both organically and through add-on acquisitions; |
• | is at an inflection point and would benefit from a catalyst such as incremental capital, innovation through new operational practices and application of innovative financial services technologies, product creation or additional management expertise; |
• | has publicly traded comparable companies that operate in a similar industry sector or that have similar operating metrics which may help establish that the valuation of our initial business combination is attractive relative to such public peers; and |
• | is positioned to be a publicly traded company and can benefit from being a publicly traded company, with access to broader and more efficient capital markets, to drive improved financial performance and achieve the company’s business strategy. |
• | Business Model. Pagaya is a financial technology company that the EJFA Board considered to be well-positioned to reshape the lending marketplace by using machine learning, big data analytics, and sophisticated AI-driven credit and analysis technology. |
• | Competitive Landscape. Pagaya is an early mover in using machine learning and other sophisticated data analysis techniques to assist their Partners in credit decisions and therefore enjoys a competitive advantage. Pagaya’s proprietary AI solutions and partner relationships provide a strong differentiating factor from other competitors. |
• | Technology and AI. Pagaya’s business is driven by its proprietary AI and deep bench of data scientists. Pagaya has a highly accomplished technology and data team with a track record of innovation likely to further drive Pagaya’s success. |
• | Pagaya Management Team. Led by its Co-Founder and Chief Executive Officer Gal Krubiner, Co-Founder and Chief Technology Officer Avital Pardo, Co-Founder and Chief Revenue Officer Yahav Yulzari, and Chief Financial Officer Michael Kurlander, Pagaya has built a strong management team with extensive experience in the fintech space. |
• | Pagaya’s Business Performance. Pagaya has quickly achieved scale with its network and continues to demonstrate impressive growth. This is particularly impressive, given that Pagaya’s business was founded only four years ago. |
• | EJFA and Pagaya Combination Benefits. Pagaya’s potential public company status following the consummation of the Transactions, combined with the capital to be provided from the PIPE Investment, is expected to provide Pagaya with substantial support for further scaling its network. EJFA’s leadership in the finance space will help Pagaya further grow and identify attractive partnerships. |
• | Financial Performance and Valuation. EJFA has evaluated the performance of Pagaya and believes the valuation in the Transactions is attractive, including as the valuation is compared to competitor firms. |
• | Due Diligence. EJFA conducted due diligence examinations of Pagaya, including financial, accounting, tax, legal (including corporate governance, indebtedness, real property, intellectual property, executive compensation and labor, anti-trust/regulatory, litigation and asset management), industry, data science/artificial intelligence, management background and technical due diligence. |
• | Lock-Up. Following the Closing, all shares of the post-Closing combined company issued to the Pagaya Equity Holders (including those issued to the Co-Founders of Pagaya) will be subject to a lock-up period of between 90 days and 12 months depending, among other things, upon whether the shares of the post-Closing combined entity trade for over $12.50 for any 20 trading days within a 30 consecutive trading day period on the principal securities exchange or securities market on which the Pagaya Class A Ordinary Shares are then traded or quoted for purchase and sale (anticipated to be Nasdaq). |
• | Fairness Opinion. The Opinion delivered by Duff & Phelps to the EJFA Board to the effect that, as of September 14, 2021 and based upon and subject to the assumptions made, scope of analysis considered, matters evaluated and other qualifications and limitations set forth therein, the Merger Consideration to be paid to the EJFA Shareholders (excluding the Excluded Shareholders) pursuant to the Transactions was fair, from a financial point of view, to such EJFA Shareholders. |
• | Other Alternatives. The EJFA Board believes, after a thorough review of other business combination opportunities reasonably available to EJFA, that the proposed Transactions represent the best potential business combination for EJFA that is currently available in the market. |
• | Lack of Operating History. Pagaya was founded only four years ago. Thus, although it has shown impressive performance over that period, Pagaya does not have a long and proven operating history. In particular, Pagaya has not operated its business during a credit downturn. |
• | Valuation Depends on Future Performance. The valuation of Pagaya agreed to in the Transactions depends in large part on Pagaya’s performance in calendar years 2021, 2022 and 2023. Although the EJFA Board believes that this valuation is fair, and received the Opinion from Duff & Phelps confirming, as of September 14, 2021 and based upon and subject to the assumptions made, scope of analysis considered, matters evaluated and other qualifications and limitations set forth therein, that from a financial point of view, the Merger Consideration to be paid to the EJFA Shareholders (excluding the Excluded Shareholders) in connection with the Merger is fair to such EJFA Shareholders, there is risk that, if Pagaya does not perform as expected in 2021 and 2022, the valuation agreed to by the EJFA Board will be too high. |
• | Public Company Readiness. While EJFA believes Pagaya has a strong management team, the management team has limited experience managing a public company. Additionally, Pagaya management and Pagaya’s infrastructure will need to mature quickly to support Pagaya as a public company. |
• | Execution of Growth Plan. Pagaya has a strong pipeline with large regional and money center banks, but slower sales conversion could delay the continued strong growth rate. |
• | Access to Funding. Pagaya has secured diversified funding access with multiple Financing Vehicles, but these sources need to expand materially in the future to allow Pagaya to execute on its aggressive growth strategy across asset classes and with larger partners. |
• | Consumer Credit and Macroeconomic Conditions. Consumer credit performance has received a boost in the last 18 months, with extended government support in the form of credits and unemployment payments, but performance in the coming years is dependent on a robust post-COVID-19 recovery. |
• | Limitations of Due Diligence. Although EJFA conducted due diligence on Pagaya, the scope of its review was limited by the time available, the materials provided by Pagaya and the inherent uncertainties in any due diligence process. Accordingly, there can be no assurance that EJFA discovered all material issues that may be present with regard to Pagaya’s business, or that factors outside of EJFA’s or Pagaya’s control will not later arise. |
• | Difficulty in Protecting, Maintaining and Enforcing Intellectual Property and other Proprietary Rights. Pagaya relies on AI and other proprietary data analysis techniques to assist its Partners in making credit decisions. This technology is core to Pagaya’s business. Pagaya may be unable to sufficiently, and it may be difficult and costly to, obtain, maintain, protect, or enforce its intellectual property and other proprietary rights effectively. As such, it is possible that competitors could develop similar or superior technology, or key personnel at Pagaya could leave the business and use their personal knowledge in a competitive fashion. |
• | Changes in Regulations. EJFA has conducted diligence into Pagaya’s operations based on the current regulatory landscape, but legislation and regulations that affect Pagaya’s core business may change. |
• | Closing Conditions. The fact that the completion of the Transactions is conditioned on the satisfaction of certain closing conditions that are not within EJFA’s control. |
• | Liquidation of EJFA. The risks and costs to EJFA if the Transactions are not completed, including the risk of diverting management focus and resources from other business combination opportunities. |
• | Litigation. The possibility of litigation challenging the business combination or that an adverse judgment granting permanent injunctive relief could indefinitely enjoin consummation of the Merger. |
• | Fees and Expenses. The fees and expenses associated with completing the business combination. |
• | Additional Risks and Uncertainties. EJFA also considered other risks of the type and nature described under the section of this proxy statement/prospectus entitled “Risk Factors.” |
• | Interests of Certain Persons. Some directors, officers and advisors of EJFA (and their permitted transferees) and the Sponsor may have interests in the Transactions, including via EJFA founder shares or anticipated membership on the Pagaya Board following the consummation of the Merger. See the sections titled “Proposal One—The Business Combination Proposal—Interests of Certain Persons in the Business Combination” and “Special Meeting of EJFA Shareholders—Interests of EJFA’s Officers and the EJFA Board in the Transactions.” The EJF Investor, an affiliate of EJFA, is providing a portion of the PIPE commitment. This investment may create an actual or perceived conflict of interest. See the section titled “Questions and Answers about the Transactions and the Special Meeting —Q: What is the PIPE Investment?” EJFA’s independent directors reviewed and considered these interests during the negotiation of the Transactions and in evaluating and unanimously approving, as members of the EJFA Board, the Merger Agreement and the transactions contemplated therein, including the Merger. The EJFA Board concluded that the potentially disparate interests would be mitigated because (i) these interests were disclosed in the prospectus for the EJFA IPO or included in this proxy statement/prospectus, (ii) these disparate interests would exist with respect to a business combination by EJFA with any other target business or businesses or (iii) a significant portion of the Merger Consideration issuable to EJFA’s directors and executive officers was structured to be realized based on future share performance; |
• | Business Combination Opportunities. Each of EJFA’s directors and officers presently has fiduciary or contractual obligations to other entities pursuant to which such officer or director is required to present a business combination opportunity to such entity. EJFA’s directors and officers also may have become aware of business combination opportunities which may have been appropriate for presentation to EJFA and the other entities to which they owe certain fiduciary or contractual duties. Accordingly, they may have had conflicts of interest in determining to which entity a particular business opportunity should have been presented. These conflicts may not have been resolved in EJFA’s favor and such potential business combination opportunities may have been presented to other entities prior to their presentation to EJFA. The EJFA Memorandum and Articles of Association provide that, to the maximum extent permitted by applicable law, EJFA renounces any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter (i) which may be a business combination opportunity for an entity related to a director or officer of EJFA, on the one hand, and EJFA, on the other, or (ii) the presentation of which would breach an existing legal obligation of a director or officer to another entity, and EJFA waives any claim or cause of action it may have in respect thereof. EJFA does not believe, however, that the fiduciary duties or contractual obligations of its officers or directors or waiver of corporate opportunity materially affected its search for an acquisition target nor will materially impact its ability to complete the proposed Merger; and |
• | Other Risks. Various other risks associated with Pagaya’s business and the Merger, as described in the section of this proxy statement/prospectus entitled “Risk Factors” appearing elsewhere in this proxy statement/prospectus. |
• | If the Merger with Pagaya or another business combination is not consummated by March 1, 2023 (or such later date as may be approved by EJFA Shareholders in an amendment to the EJFA Memorandum and Articles of Association), EJFA will cease all operations except for the purpose of winding up, redeeming 100% of the outstanding EJFA Public Shares for cash and, subject to the approval of its remaining shareholders and the EJFA Board, dissolving and liquidating. On the other hand, if the Merger is consummated, each outstanding EJFA Ordinary Share will be converted into one Pagaya Class A Ordinary Share, subject to adjustment as described herein. |
• | If EJFA is unable to complete a business combination within the required time period, the Sponsor will be liable under certain circumstances described herein to ensure that the proceeds in the Trust Account are not reduced by the claims of target businesses or claims of vendors or other entities that are owed money by EJFA for services rendered or contracted for or products sold to EJFA. If EJFA consummates a business combination, on the other hand, EJFA will be liable for all such claims. |
• | The Sponsor and EJFA’s officers and directors and their affiliates are entitled to reimbursement of out-of-pocket expenses incurred by them in connection with certain activities on EJFA’s behalf, such as identifying and investigating possible business targets and business combinations. However, if EJFA fails to consummate a business combination within the required period, they will not have any claim against the Trust Account for reimbursement. Accordingly, EJFA may not be able to reimburse these expenses if the Merger or another business combination is not completed by March 1, 2023 (or such later date as may be approved by EJFA Shareholders in an amendment to the EJFA Memorandum and Articles of Association). As of the Record Date, the Sponsor and EJFA’s officers and directors and their affiliates had incurred approximately $ of unpaid reimbursable expenses. |
• | The Merger Agreement provides for the continued indemnification of EJFA’s current directors and officers and the continuation of directors and officers liability insurance covering EJFA’s current directors and officers. |
• | Subject to Pagaya’s consent in accordance with the Merger Agreement, the Sponsor and EJFA’s officers and directors (or their affiliates) may make loans from time to time to EJFA to fund certain capital requirements. Loans may be made after the date of this proxy statement/prospectus. If the Merger is not consummated, the loans will not be repaid and will be forgiven except to the extent there are funds available to EJFA outside of the Trust Account. |
• | Emanuel Friedman will be a member of the Pagaya Board following the Closing and, therefore, in the future Mr. Friedman will receive any cash fees, stock options or stock awards that the Pagaya Board determines to pay to its non-executive directors. |
• | The EJF Investor will participate in the purchase of PIPE Shares from Pagaya at the closing of the Transactions, and certain of EJFA’s directors and officers are affiliated with the EJF Investor. |
• | Duff & Phelps, a Kroll Business, rendered the Opinion to the EJFA Board, for which it will receive a fee from EJFA. A portion of such fee was payable upon delivery of the Opinion and a portion is payable upon and subject to the Closing. |
• | Pagaya, EJFA and the Sponsor entered into the Side Letter Agreement, which provides that, solely in the event the EJFA Transaction Costs exceed the Expenses Excess Amount, a number of EJFA Class B Ordinary Shares will be forfeited for no Merger Consideration and cancelled by EJFA and no longer outstanding, except that the Sponsor may pay, in whole or in part, the EJFA Transaction Costs in cash prior to the Effective Time without further liability to EJFA, in which case the Expenses Excess Amount will be reduced on a dollar-for-dollar basis by the amount so paid by the Sponsor. |
• | Certain directors and officers of EJFA, as well as certain partners and employees of EJF Capital, hold equity interests in the Sponsor, and thus have an interest in the business combination transaction that is not the same as the majority of EJFA Shareholders, who do not hold equity interests in the Sponsor. |
• | In connection with the consummation of the business combination, the Sponsor, EJFA, Pagaya and certain equityholders of Pagaya will enter into a new Registration Rights Agreement, which will, among other things, provide that the Sponsor and certain equity holders will have a demand right for Pagaya to conduct an underwritten offering of the Registrable Securities, provided that the total offering price of all securities proposed to be sold in such offering exceeds $75 million in the aggregate and subject to certain limitations. |
• | Each of EJFA’s directors and officers presently has fiduciary or contractual obligations to other entities pursuant to which such officer or director is required to present a business combination opportunity to such entity. EJFA’s directors and officers also may have become aware of business combination opportunities which may have been appropriate for presentation to EJFA and the other entities to which they owe certain fiduciary or contractual duties. Accordingly, they may have had conflicts of interest in determining to which entity a particular business opportunity should have been presented. These conflicts may not have been resolved in EJFA’s favor and such potential business combination opportunities may have been presented to other entities prior to their presentation to EJFA. The EJFA Memorandum and Articles of Association provide that, to the maximum extent permitted by applicable law, EJFA renounces any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter (i) which may be a business combination opportunity for an entity related to a director or officer of EJFA, on the one hand, and EJFA, on the other, or (ii) the presentation of which would breach an existing legal obligation of a director or officer to another entity, and EJFA waives any claim or cause of action it may have in respect thereof. EJFA does not believe, however, that the fiduciary duties or contractual obligations of its officers or directors or waiver of corporate opportunity materially affected its search for an acquisition target nor will materially impact its ability to complete the proposed Merger. |
• | The exchange of shares held by Pagaya Shareholders will be accounted for as a recapitalization in accordance with U.S. GAAP. |
• | The Merger is not within the scope of ASC 805 since EJFA does not meet the definition of a business in accordance with ASC 805. Any difference between the fair value of Pagaya Ordinary Shares issued and the fair value of EJFA’s identifiable net assets will be recorded as additional paid-in capital. For purposes of the unaudited pro forma condensed combined financial information, it is assumed that the fair value of each individual Pagaya Ordinary Share issued to EJFA Shareholders is equal to the fair value of each individual Pagaya Ordinary Share issued to pre-Closing Pagaya Shareholders resulting from the $8.5 billion enterprise value assigned to Pagaya in the Merger Agreement. |
• | The PIPE Investment will result in the issuance of Pagaya Class A Ordinary Shares, leading to an increase in Pagaya Ordinary Shares, par value and additional paid-in capital. |
• | except for transactions solely among Pagaya and any of its subsidiaries, (i) declare, set aside or pay any dividends on or make any other distributions (whether in cash, shares, other equity securities or property) in respect of any share capital or other equity security of Pagaya or any of its subsidiaries (other than distributions made by any direct or indirect, wholly-owned subsidiaries of Pagaya to Pagaya or any of its other direct or indirect, wholly-owned subsidiaries) or (ii) grant, issue or sell, or authorize the grant, issuance or sale of, any share capital or equity security of Pagaya or any of its subsidiaries, other than grants to directors, officers, independent contractors and employees (including new hires) made subject to the terms of the Pagaya Share Plans; |
• | grant any cash bonus, cash change in control award, cash transaction bonus, or analogous cash payment to any of the Founders or their affiliates in excess of $20 million in the aggregate; |
• | amend its governing or organizational documents in any material respect other than to provide for grants of equity or equity-based compensation awards to directors, officers, independent contractors and employees made subject to the terms of the Pagaya Share Plans; |
• | create, incur, assume, guarantee or otherwise become liable for, any indebtedness for borrowed money incurred after the date of the Merger Agreement in excess of $500 million other than (i) indebtedness |
• | split, combine, subdivide, reclassify, redeem, purchase or otherwise acquire any shares of capital stock (or other equity interests) of Pagaya or any of its subsidiaries or any securities or obligations convertible (whether currently convertible or convertible only after the passage of time or the occurrence of certain events) into or exchangeable for any shares of capital stock (or other equity interests) of Pagaya or any of its subsidiaries, except for (i) acquisitions of any share capital of Pagaya in connection with the “net-settlement” exercise of Pagaya Options, (ii) the acquisition by Pagaya or any of its subsidiaries of any restricted shares (other than pursuant to the foregoing subsection (i)) of Pagaya or its subsidiaries in connection with the forfeiture or cancellation thereof, and (iii) transactions between Pagaya and any wholly-owned subsidiary of Pagaya or between wholly-owned subsidiaries of Pagaya; |
• | effect, authorize, recommend, propose or announce an intention to adopt a plan of complete or partial liquidation, dissolution or winding-up of Pagaya; |
• | (i) enter into or modify in any material respect any contract or other legally binding commitment between Pagaya or any of its subsidiaries, on the one hand, and a former, current or future direct or indirect equityholder, controlling persons, shareholders, optionholders, member, general or limited partner, affiliates, representative or a successor or assign of any such person, in each case of Pagaya or any of its subsidiaries, (each, a “Related Party”), on the other hand, other than such a contract or other legally binding commitment on arms-length terms or (ii) make any payment, distribution, loan or other transfer of value to any Related Party, other than (a) payments to employees in the ordinary course of business and (b) payments pursuant to the agreements set forth on the relevant section of the Pagaya Disclosure Letter; |
• | change (or request to change) any material method of accounting for tax purposes other than in the ordinary course of business; or |
• | agree in writing or otherwise agree, commit or resolve to take any of the actions prohibited by the foregoing restrictions. |
• | declare, set aside or pay dividends on or make any other distributions (whether in cash, shares, equity securities or property) in respect of any shares, warrant or other equity security or split, combine or reclassify any shares, warrant or other equity security, effect a recapitalization or issue or authorize the issuance of any other securities in respect of, in lieu of or in substitution for any shares or warrant, or effect any like change in capitalization; |
• | purchase, redeem or otherwise acquire, directly or indirectly, any equity securities of EJFA, Pagaya or any of the subsidiaries of Pagaya listed as such in the Pagaya Disclosure Letter; |
• | acquire or establish any subsidiary; |
• | grant, issue, deliver, sell, authorize, pledge or otherwise encumber, or agree to any of the foregoing with respect to, any shares or other equity securities or any securities convertible into or exchangeable for shares or other equity securities, or subscriptions, rights, warrants or options to acquire any shares of capital stock or other equity securities or any securities convertible into or exchangeable for shares of capital stock or other equity securities, or enter into other agreements or commitments of any character obligating it to issue any such or equity securities or convertible or exchangeable securities; |
• | enter into any agreement, understanding or arrangement with respect to the voting of equity securities of EJFA; |
• | amend its organizational or governing documents in any material respect; |
• | voluntarily sell, lease, license, sublicense, abandon, divest, transfer, cancel or permit to lapse or expire, dedicate to the public, or otherwise dispose of, or agree to do any of the foregoing, or otherwise dispose of material assets or properties of EJFA; |
• | (i) create, incur, assume, guarantee or otherwise become liable for, any indebtedness for borrowed money, other than intercompany debt and debt to effect any securitizations; (ii) issue or sell any debt securities or options, warrants, calls or other rights to acquire any debt securities, enter into any “keep well” or other agreement to maintain any financial statement condition; (iii) make a loan or advance to, or capital contribution or investment in, any person; (iv) issue any promissory notes to the Sponsor to the extent permitted by the Merger Agreement to meet the working capital needs of EJFA (such notes, “EJFA Working Capital Notes”); or (v) enter into any arrangement having the economic effect of any of the foregoing, in each case, except in the ordinary course of business; |
• | except as required by U.S. GAAP (or any interpretation thereof) or applicable legal requirements, make any change in accounting methods, principles or practices; |
• | except in the ordinary course of business, (i) make, change or revoke any material tax election; or (ii) change (or request to change) any material method of accounting for tax purposes; |
• | create any liens on any material property or material assets of EJFA; |
• | liquidate, dissolve, reorganize or otherwise wind up the business or operations of EJFA; |
• | enter into or amend any agreement with, or pay, distribute or advance any assets or property to, any of EJFA’s officers, directors, shareholders or other affiliates (other than EJFA’s subsidiaries), other than (i) payments or distributions relating to obligations in respect of arm’s-length commercial transactions or (ii) reimbursement for reasonable expenses; |
• | hire any employee, officer, consultant, freelancer, independent contractor or sub-contractor, or adopt or enter into any employee benefit or compensatory plan, policy, program, agreement, trust or arrangement, in each case, other than in the ordinary course of business; |
• | modify or amend the Trust Agreement, or enter into or amend any other agreement related to the Trust Account; |
• | incur (or otherwise take any action that would reasonably be expected to incur) EJFA Transaction Costs in excess of $45 million; provided, that EJFA will not be in breach of this clause to the extent the Sponsor performs its obligations under the Side Letter Agreement; |
• | other than in the ordinary course of business (i) pay or promise to pay, fund any new, enter into or make any grant of any severance, change in control, retention or termination payment to any director, officer other employee, consultant, freelancer, independent contractor or sub-contractor of EJFA, (ii) take any action to accelerate any material payments or benefits, or the funding of any material payments or benefits, payable or to become payable to any director, officer, other employee of EJFA, or (iii) take any action to materially increase any compensation or material benefits of any director, officer, other employee, consultant, freelancer, independent contractor or sub-contractor of EJFA; or |
• | agree in writing or otherwise agree, commit or resolve to take any of the actions prohibited by the foregoing restrictions. |
• | prior to the date on which this proxy statement/prospectus is declared effective by the SEC under the Securities Act (the “Proxy Statement/Prospectus Clearance Date”), setting the Record Date for determining the EJFA Shareholders entitled to attend the Special Meeting; |
• | timely commencing a “broker search” in accordance with Rule 14a-12 of the Exchange Act; |
• | promptly following the Proxy Statement/Prospectus Clearance Date, filing the definitive version of this proxy statement/prospectus with the SEC and causing this proxy statement/prospectus to be mailed to each EJFA Shareholder of record as of the Record Date; |
• | as promptly as practicable following the Proxy Statement/Prospectus Clearance Date, duly calling, giving notice of and holding the Special Meeting for the purpose of obtaining the EJFA Shareholder Approval, which meeting shall be held not more than 30 days after the Proxy Statement/Prospectus Clearance Date and in any event prior to the Outside Date; |
• | using commercially reasonable efforts to obtain the EJFA Shareholder Approval, including by soliciting proxies as promptly as practicable in accordance with applicable legal requirements for the purpose of seeking the EJFA Shareholder Approval; |
• | including in this proxy statement/prospectus the recommendation by the EJFA Board that the EJFA Shareholders vote to approve the Merger Agreement and the Transactions (including the Merger) and any other matters required by applicable legal requirements; |
• | obligating the EJFA Board (and any committees or subgroups of the EJFA Board) not to (i) change, withdraw, withhold, qualify or modify, or publicly propose to change, withdraw, withhold, qualify or modify, any previous recommendation of the Transactions or (ii) approve, recommend or declare advisable, or propose publicly to approve, recommend or declare advisable, any alternative acquisition proposal (in either case, a “Change in Recommendation”), except if, prior to receipt of the EJFA Shareholder Approval, the EJFA Board determines in good faith that it is required to do so in order to comply with fiduciary duties under applicable legal requirements of the Cayman Islands; |
• | not postponing or adjourning the Special Meeting except (i) after consultation with Pagaya, to ensure that any supplement or amendment to this proxy statement/prospectus that the EJFA Board has determined in good faith is required by applicable legal requirements is disclosed and promptly disseminated to the EJFA Shareholders prior to the Special Meeting to the extent required by applicable legal requirements; (ii) if, as of the time for which the Special Meeting is originally scheduled (as set forth in this proxy statement/prospectus), there are insufficient EJFA Ordinary Shares represented (either in person or by proxy) to constitute a quorum necessary to conduct the business to be conducted at the Special Meeting; (iii) to seek withdrawals of redemption requests from the EJFA Shareholders if EJFA or Pagaya reasonably expects that the Available Cash Condition (as defined below) would not be satisfied at the Closing; or (iv) in order to solicit additional proxies from the EJFA Shareholders for |
• | from the date of the Merger Agreement until the Closing, affording Pagaya and its financial advisors, accountants, counsel and other representatives reasonable access during EJFA’s normal business hours, upon reasonable notice, to the properties, books, records and personnel of EJFA, as Pagaya may reasonably request solely for purposes of facilitating the consummation of the Transactions provided that such access (i) will be subject to the confidentiality agreement between the parties, (ii) will be conducted in a manner not to materially interfere with the business or operations of EJFA, and (iii) may be limited to the extent EJFA reasonably determines, in light of COVID-19 and related measures, that such access could jeopardize the health and safety of any employee of EJFA or the Sponsor; |
• | from the date of the Merger Agreement, using its commercially reasonable efforts to ensure that EJFA remains listed as a public company on, and for EJFA Class A Ordinary Shares and EJFA Public Warrants (but, in the case of EJFA Public Warrants, only to the extent issued as of the date of the Merger Agreement) to be listed on, Nasdaq; |
• | prior to the Closing Date, cooperating with Pagaya and using commercially reasonable efforts to take such actions as are reasonably necessary or advisable to cause the EJFA Class A Ordinary Shares and EJFA Public Warrants to be delisted from Nasdaq and deregistered under the Exchange Act as soon as practicable following the Effective Time; |
• | reasonably cooperating in connection with Pagaya’s efforts to cause the Pagaya Class A Ordinary Shares and the Pagaya Warrants issuable in accordance with the Merger Agreement, including in the Merger, to be approved for listing on Nasdaq; |
• | from the date of the Merger Agreement through the Closing, using commercially reasonable efforts to keep current and timely file all reports required to be filed or furnished with the SEC and otherwise comply in all material respects with its reporting obligations under applicable legal requirements; |
• | (i) causing the documents, opinions and notices required to be delivered to Continental pursuant to the Trust Agreement to be so delivered, including providing Continental with the termination letter substantially in the applicable form attached to the Trust Agreement (the “Trust Termination Letter”); and (ii) making all appropriate arrangements to cause Continental to distribute the Trust Account as directed in the Trust Termination Letter, including all amounts payable: (A) to each EJFA Shareholder who properly elects to have such EJFA Shareholder’s EJFA Class A Ordinary Shares redeemed for cash in accordance with the provisions of EJFA’s governing and organizational documents; (B) to pay all EJFA Transaction Costs and (C) immediately thereafter, paying all remaining amounts then available in the Trust Account to EJFA in accordance with the Trust Agreement; |
• | purchasing a pre-paid “tail” or “runoff” directors’ and officers’ liability insurance policy in respect of acts or omissions occurring or alleged to have occurred at or prior to the Effective Time, including the transactions contemplated by the Merger Agreement, covering each person that is covered by EJFA’s directors’ and officers’ liability insurance policies in effect as of the date of the Merger Agreement on terms and conditions, including retentions and amounts, no less favorable in the aggregate than those of EJFA’s directors’ and officers’ liability insurance policies in effect on the date of the Merger Agreement for the six year period following the Closing; |
• | reasonably cooperating as necessary with Pagaya with respect to Pagaya’s filing any tax return or other document with respect to any Transfer Taxes (as defined below); |
• | on the Closing Date, providing Pagaya with a Foreign Investment in Real Property Tax Act certificate; |
• | prior to the Effective Time, the EJFA Board taking all reasonable steps as may be required or permitted to cause any disposition of the EJFA Ordinary Shares that occurs or is deemed to occur by reason of or pursuant to the Merger by each director and officer of EJFA who is or will be subject to the reporting requirements of Section 16(a) of the Exchange Act with respect to EJFA to be exempt under Rule 16b-3 promulgated under the Exchange Act, including by taking steps in accordance with the No-Action Letter, dated January 12, 1999, issued by the SEC regarding such matters; and |
• | at the Closing, repaying all amounts owed under the EJFA Working Capital Notes, if any |
• | Pagaya and/or its subsidiary Pagaya USHoldco, agreeing to, as promptly as reasonably practicable following the date of the Merger Agreement, send a notice to each Advisory Client (as defined in the Merger Agreement) informing such Advisory Client of the transactions contemplated by the Merger Agreement and use their respective commercially reasonable efforts to seek the consent of each such Advisory Client, in accordance with the requirements of its Advisory Contract (as defined in the Merger Agreement) and applicable law, to the “assignment” (as defined in the Investment Advisers Act) of such Advisory Contract resulting from the change in ownership of Pagaya USHoldco upon the consummation of the Transactions (it being understood that, except to the extent the applicable Advisory Contract or applicable law requires consent to such assignment to be obtained in writing, the implied or “negative” consent of the applicable Advisory Client to such assignment will be deemed sufficient); |
• | filing with the SEC (i) a registration statement on Form F-4 for the purpose of registering under the Securities Act the offer and sale of the Pagaya Class A Ordinary Shares to be issued as Merger Consideration and the Pagaya Warrants and (ii) this proxy statement/prospectus; |
• | as promptly as practicable following the Proxy Statement/Prospectus Clearance Date, duly calling, giving notice of and holding a special meeting of the Pagaya Shareholders (the “Pagaya Special Meeting”) for the purpose of obtaining the approval of the Pagaya Shareholder Matters, which meeting shall be held not more than 30 days after the Proxy Statement/Prospectus Clearance Date and in any event prior to the Outside Date; |
• | using commercially reasonable efforts to obtain the Pagaya Shareholder Approval, including by soliciting proxies as promptly as practicable in accordance with applicable legal requirements for the purpose of seeking the Pagaya Shareholder Approval; |
• | at the appropriate time prior to or during the Pagaya Special Meeting, the Pagaya Board recommending that the Pagaya Shareholders approve the Pagaya Shareholder Matters; |
• | obligating the Pagaya Board (and any committees or subgroups of the Pagaya Board) not to make a Change in Recommendation, except if, prior to receipt of the Pagaya Shareholder Approval, the Pagaya Board is required to do so by their fiduciary duties under Israeli Law; |
• | preparing and filing with the ITA an application to receive the Merger Consideration Tax Ruling (as defined in the Merger Agreement) and the Capital Restructuring Tax Ruling (as defined in the Merger Agreement) (the “Specified Tax Approvals”) as promptly as practicable (and in any event within 10 Business Days) following the date of the Merger Agreement; using commercially reasonable efforts to obtain the Specified Tax Approvals; not filing any Specified Filings (as defined below) without first consulting with EJFA’s Israeli counsel and granting it the opportunity to review, comment on and approve such filing; and keeping EJFA and its Israeli counsel reasonably updated of any discussions, meetings, significant conference calls, material correspondences and any exchange of drafts with the ITA relating to the Specified Filings or the Specified Tax Approvals; |
• | if either the Merger Consideration Tax Ruling or the Capital Restructuring Tax Ruling is obtained, promptly providing to EJFA a copy of such Merger Consideration Tax Ruling or the Capital Restructuring Tax Ruling, as applicable, including a copy of any executed consent letter delivered to the ITA in accordance with the provisions of such Merger Consideration Tax Ruling or the Capital Restructuring Tax Ruling, as applicable; |
• | affording EJFA and its financial advisors, accountants, counsel and other representatives reasonable access during Pagaya’s normal business hours, upon reasonable notice, to the properties, books, records and personnel of Pagaya and its direct and indirect subsidiaries, as EJFA may reasonably request solely for purposes of facilitating the consummation of the Transactions; |
• | using its commercially reasonable efforts to cause: (i) Pagaya’s initial listing application with Nasdaq in connection with the Transactions to have been approved; (ii) Pagaya to satisfy all applicable initial listing requirements of Nasdaq; and (iii) the Pagaya Class A Ordinary Shares and the Pagaya Warrants issuable in accordance with the Merger Agreement, including in the Merger, to be approved for listing on Nasdaq, subject to official notice of issuance, in each case, as promptly as reasonably practicable after the Proxy Statement/Prospectus Clearance Date, and in any event prior to the Effective Time; |
• | waiving any past, present or future right, title, interest or claim of any kind that Pagaya has or may have in the future in or to the Trust Account and agreeing not to seek recourse against the Trust Account or any funds distributed therefrom as a result of, or arising out of, the Merger Agreement and any negotiations, contracts or agreements with EJFA, other than (i) Pagaya’s right to pursue a claim against EJFA pursuant to the Merger Agreement for legal relief against assets of EJFA held outside the Trust Account or (ii) Pagaya’s future claims pursuant to the terms of the Merger Agreement for specific performance or other equitable relief in connection with the Transactions; |
• | providing rights to exculpation, indemnification and advancement of expenses now existing in favor of the current or former directors or officers of EJFA until the six-year anniversary of the Closing; |
• | agreeing to bear and pay any transfer, documentary, sales, use, stamp, registration, excise, recording, value added and other such similar taxes and fees (including any penalties and interest) that become payable in connection with or by reason of the execution of the Merger Agreement and the Transactions (collectively “Transfer Taxes”), and, unless otherwise required by applicable legal requirements, timely filing any tax return or other document with respect to such taxes or fees (and reasonably cooperating with EJFA with respect thereto as necessary); |
• | agreeing not to amend the EJF Subscription Agreement or waive any provision thereto in any manner that is material and adverse to EJFA without the prior written consent of EJFA; |
• | prior to the Closing Date, approving and adopting, subject to receipt of the Pagaya Shareholder Approval, the 2022 Plan substantially in the form attached to the Merger Agreement and, as soon as reasonably practicable following the Closing, filing an effective registration statement on Form S-8 (or other applicable form) with respect to the Pagaya Ordinary Shares issuable under the 2022 Plan; |
• | using commercially reasonable efforts to, as promptly as reasonably practicable, but in no event later than 90 days, following the date of the Merger Agreement in the case of the 2020 and 2019 financials, and in no event later than April 30, 2022 in the case of the 2021 financials (if 2021 financials will be required to be included in the registration statement) (in each case, the “PCAOB Deadline”), obtain from a “big four” accounting firm Public Company Accounting Oversight Board (the “PCAOB”) compliant audited financial statements for Pagaya’s fiscal years ending December 31, 2021 (if required to be included in this registration statement), December 31, 2020 and December 31, 2019 that satisfy SEC filing requirements for this registration statement (including this proxy statement/prospectus) and are prepared in accordance with U.S. GAAP (the “PCAOB Financials”), and agreeing that the auditor engaged to audit the PCAOB Financials is an independent registered public accounting firm with respect to Pagaya within the meaning of the Exchange Act and the applicable rules and regulations thereunder adopted by the SEC and the PCAOB; |
• | agreeing not to use the proceeds from the Transactions for the repurchase of Pagaya Ordinary Shares held by existing Pagaya Shareholders prior to the Effective Time or the payment of dividends to such Pagaya Shareholders, in each case if such repurchase of Pagaya Ordinary Shares or payment of dividends, as applicable, does not apply pro rata to all post-Closing Pagaya Shareholders, including the EJFA Shareholders; and |
• | prior to the Proxy Statement/Prospectus Clearance Date, providing Pagaya with a duly completed director questionnaire with respect to the Sponsor Director (as defined below) in form and substance reasonably acceptable to Pagaya along with a biography of the Sponsor Director suitable for inclusion in this proxy statement/prospectus. |
• | jointly preparing (i) a registration statement on Form F-4 for the purpose of registering under the Securities Act the offer and sale of the Pagaya Class A Ordinary Shares to be issued as Merger Consideration and the Pagaya Warrants and (ii) this proxy statement/prospectus; |
• | using commercially reasonable efforts to (i) cause this registration statement (including this proxy statement/prospectus), when filed, to comply in all material respects with all applicable legal requirements, (ii) respond as promptly as reasonably practicable to and resolve all comments received from the SEC or its staff concerning this registration statement (including this proxy statement/prospectus), (iii) have this registration statement declared effective under the Securities Act as promptly as practicable after the date on which this registration statement is initially filed with the SEC and (iv) keep this registration statement effective for so long as necessary to complete the Reclassification and the Merger; |
• | supplementing this registration statement if, at any time prior to the Special Meeting, any information relating to EJFA or Pagaya, or any of their respective affiliates, officers or directors, is discovered by EJFA or Pagaya which is required to be set forth in an amendment or supplement to this registration statement so that any of such documents would not include a misstatement of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the party that discovers such information will promptly inform the other parties and each of EJFA and Pagaya will cooperate reasonably in connection with preparing an appropriate amendment or supplement describing such information to be promptly filed with the SEC and, to the extent required by law, disseminating such information to the EJFA Shareholders; |
• | making all necessary filings with respect to the Transactions under the Securities Act, the Exchange Act and applicable “blue sky” laws, and using commercially reasonable efforts to promptly provide the other party with all information in its possession concerning the business, management, operations and financial condition of such party reasonably requested by the other party for inclusion in this registration statement; |
• | causing each party’s own officers and employees to be reasonably available, during such party’s normal business hours, to the other party and its counsel, auditors and other advisors in connection with the drafting of this registration statement and responding in a timely manner to comments on this registration statement from the SEC; |
• | using commercially reasonable efforts to (and EJFA will direct the Sponsor to use commercially reasonable efforts to) take, or cause to be taken, or to do or cause to be done, all actions and things necessary or advisable to consummate and make effective as promptly as practicable the Transactions; |
• | as promptly as practicable following the date of the Merger Agreement, making, and, if applicable, EJFA will direct the Sponsor to make, all filings, notices, waiver requests, applications and other submissions to any governmental entity (the “Required Regulatory Filings”) that are necessary or advisable in connection with all consents, approvals, orders, authorizations, clearances, licenses, waivers and exemptions that are necessary, proper or advisable to be obtained with respect to the Transactions (the “Required Regulatory Approvals”); |
• | promptly and in good faith responding to all information requested of them by any governmental entity in connection with such Required Regulatory Filings and otherwise reasonably cooperating in good faith with each other and such governmental entities in connection with the Required Regulatory Filings and obtaining the Required Regulatory Approvals; |
• | promptly furnishing (and EJFA will direct the Sponsor to promptly furnish) to the other party such information and assistance as the other may reasonably request in connection with its preparation of |
• | unless prohibited by any applicable legal requirement or governmental entity, promptly furnishing (and EJFA will direct the Sponsor to promptly furnish) to the other party, copies of any notices or substantive written communications received by such party or any of its affiliates from any governmental entity with respect to the Transactions, and each party will permit counsel to the other party an opportunity to review in advance, and each party will consider in good faith the views of such counsel in connection with, any proposed written communications by such party and/or its affiliates to any governmental entity concerning the Transactions; provided that none of the parties will enter into any binding agreement with any governmental entity with respect to the Transactions without the written consent of the other parties; |
• | to the extent not prohibited by any applicable legal requirement, agreeing to provide to the other party and its counsel (and, if applicable, EJFA to direct the Sponsor to provide to Pagaya and its counsel), the opportunity, on reasonable advance notice, to participate in any substantive meetings or discussions, either in person or by telephone, between such party and/or any of its affiliates (including, in the case of EJFA, the Sponsor), agents or advisors, on the one hand, and any governmental entity, on the other hand, concerning or in connection with the Transactions; |
• | agreeing not to (and EJFA will direct the Sponsor not to) willfully take any action that will have the effect of delaying, impairing or impeding in any material respect the receipt of any of the Required Regulatory Approvals; |
• | reasonably cooperating with each other with respect to obtaining the Specified Tax Approvals; cooperating with respect to all filings, notices, waiver requests, applications and other submissions to the ITA that are necessary or advisable in connection with the Specified Tax Approvals (the “Specified Filings”); and promptly furnishing (and EJFA will direct the Sponsor to promptly furnish) to the other party such information and assistance as such other party may reasonably request in connection with its preparation of any Specified Filings (including by providing any required information concerning the Sponsor); |
• | not (and EJFA will direct the Sponsor not to) willfully taking any action that will have the effect of delaying, impairing or impeding in any material respect the receipt of any of the Specified Tax Approvals; |
• | if the Capital Restructuring Tax Ruling is not timely obtained, cooperating in good faith to effectuate the alternative Capital Restructuring as set forth in the Pagaya Disclosure Letter; |
• | complying promptly with the notification and reporting requirements of the HSR Act, substantially complying with any Antitrust Information or Document Requests (as defined in the Merger Agreement), requesting early termination of any waiting period under the HSR Act (unless any announcement from the applicable governmental entities to the effect that early termination of any waiting period under the HSR Act is temporarily suspended remains in effect) and exercising commercially reasonable efforts to (i) obtain termination or expiration of the waiting period under the HSR Act (which waiting period expired on November 12, 2021) and (ii) prevent the entry, in any legal proceeding brought by an Antitrust Authority (as defined in the Merger Agreement) or any other person, of any order which would prohibit, make unlawful or delay the consummation of the Transactions; |
• | promptly after the execution of the Merger Agreement, issuing a mutually agreed upon joint press release announcing the execution of the Merger Agreement; |
• | keeping certain information confidential in accordance with the existing confidentiality agreement between Pagaya and EJFA; |
• | reasonably cooperating in good faith to create and implement a mutually agreed upon communications plan regarding the Transactions promptly following the date of the Merger Agreement, and agreeing not to make public announcements without the prior written consent of the other party, except (i) for |
• | using commercially reasonable efforts to take, or cause to be taken, all actions, and to do, or cause to be done, and to assist and cooperate with the other parties in doing, all things necessary, proper or advisable to consummate and make effective, in the most expeditious manner practicable, the Transactions, including using commercially reasonable efforts to: (i) cause the closing conditions set forth in the Merger Agreement to be satisfied prior to the Outside Date; (ii) defend any claim, legal complaint, action, suit, audit, non-routine regulatory examination, assessment, mediation or arbitration, or any proceeding or investigation (in each case, whether civil, criminal or administrative or at law or in equity) by or before any governmental entity or arbitral or mediation body, challenging the Merger Agreement or the consummation of the Transactions, including seeking to have any stay or temporary restraining order entered by any court or other governmental entity vacated or reversed; and (iii) execute and deliver any additional instruments reasonably necessary to consummate, and to fully carry out the purposes of, the Transactions; |
• | during the period from the date of the Merger Agreement and continuing until the earlier of the termination of the Merger Agreement pursuant to its terms or the Closing, agreeing not to, and agreeing to cause their respective subsidiaries not to, and agreeing to direct their representatives not to, directly or indirectly, other than as contemplated by the Merger Agreement: (i) solicit, initiate or knowingly encourage any inquiries or proposals by, or provide any non-public information to, any person (other than Pagaya, EJFA and their respective representatives) concerning any Alternative Acquisition Proposal (as defined in the Merger Agreement); (ii) enter into or continue any discussions, negotiations or transactions with or respond to any inquiries or proposals by any person (other than Pagaya, EJFA and their respective representatives) concerning any Alternative Acquisition Proposal; or (iii) enter into any agreement regarding any Alternative Acquisition Proposal; |
• | promptly notifying the other parties if a party or, to its knowledge, any of its representatives receives any inquiry, proposal, offer or submission with respect to an Alternative Acquisition Proposal (including the identity of the entity or person making such inquiry or submitting such proposal, offer or submission), after the execution and delivery of the Merger Agreement; |
• | (i) taking all action necessary so that the Pagaya Board immediately after the Effective Time will include (a) Emanuel Friedman (the “Sponsor Director”) and (b) a number of additional directors to be determined by Pagaya before the Closing in consultation with EJFA, consistent with applicable SEC and exchange rules and applicable legal requirements, and (ii) acknowledging and agreeing that the |
• | immediately prior to the Effective Time, entering into with Continental, as transfer agent, the Warrant Agreement. |
(i) | acts of war, sabotage, hostilities, civil unrest, protests, demonstrations, insurrections, riots, hostilities, cyberattacks or terrorism, or any escalation or worsening of the foregoing, or changes in national, regional, state or local political or social conditions in countries in which, or in the proximate geographic region of which, Pagaya or any of its subsidiaries operate; |
(ii) | earthquakes, hurricanes, tornados, wildfires, or other natural disasters; |
(iii) | epidemics, pandemics, including COVID-19 or any COVID-19 Measures, or other public health emergencies; |
(iv) | changes directly attributable to the execution of the Merger Agreement, the public announcement of the Transactions, the performance of the Merger Agreement or the pendency of the Transactions (including the impact thereof on relationships with customers, suppliers, employees, investors, licensors, licensees or other third-parties related thereto) (provided, that this clause (iv) will not apply to any representation or warranty to the extent such representation or warranty expressly addresses the consequences resulting from the execution and delivery of the Merger Agreement, the performance of a party’s obligations hereunder or the consummation of the transactions contemplated by the Merger Agreement); |
(v) | changes in applicable legal requirements, changes of official guidance or official positions of general applicability, or changes in enforcement policies or official interpretations thereof or decisions of general applicability, by any governmental entity after the date of the Merger Agreement; |
(vi) | changes in U.S. GAAP (or any official interpretation thereof) after the date of the Merger Agreement; |
(vii) | general economic, regulatory, business or tax conditions, including changes in the credit, debt, capital, currency, securities or financial markets (including changes in interest or exchange rates); |
(viii) | events, changes or conditions generally affecting participants in the industries and markets in which Pagaya or any of its subsidiaries operate; |
(ix) | any failure of Pagaya or any of its subsidiaries, taken as a whole, to meet any projections, forecasts, guidance, estimates or financial or operating predictions of revenue, earnings, cash flow or cash position (provided, that any Effect underlying such failure (except to the extent otherwise excluded by other clauses in this definition) will be taken into account in determining whether a Material Adverse Effect for Pagaya has occurred or would reasonably be expected to occur); and |
(x) | any actions (A) required to be taken, or required not to be taken, pursuant to the terms of the Merger Agreement, (B) taken with the prior written consent of EJFA or (C) taken by, or at the written request of, EJFA; |
(i) | acts of war, sabotage, hostilities, civil unrest, protests, demonstrations, insurrections, riots, hostilities, cyberattacks or terrorism, or any escalation or worsening of the foregoing, or changes in national, regional, state or local political or social conditions in countries in which, or in the proximate geographic region of which, EJFA operates; |
(ii) | earthquakes, hurricanes, tornados, wildfires, or other natural disasters; |
(iii) | epidemics, pandemics, including COVID-19 or any COVID-19 Measures, or other public health emergencies; |
(iv) | changes directly attributable to the execution of the Merger Agreement, the public announcement of the Transactions, the performance of the Merger Agreement or the pendency of the Transactions |
(v) | changes in applicable legal requirements, changes of official guidance or official positions of general applicability, or changes in enforcement policies or official interpretations thereof or decisions of general applicability, by any governmental entity after the date of the Merger Agreement; |
(vi) | changes in U.S. GAAP (or any official interpretation thereof) after the date of the Merger Agreement; |
(vii) | general economic, regulatory, business or tax conditions, including changes in the credit, debt, capital, currency, securities or financial markets (including changes in interest or exchange rates); |
(viii) | events, changes or conditions generally affecting participants in the industries and markets in which EJFA operates; |
(ix) | any failure of EJFA to meet any projections, forecasts, guidance, estimates or financial or operating predictions of revenue, earnings, cash flow or cash position (provided, that any Effect underlying such failure (except to the extent otherwise excluded by other clauses in this definition) shall be taken into account in determining whether a Material Adverse Effect for EJFA has occurred or would reasonably be expected to occur); and |
(x) | any actions (A) required to be taken, or required not to be taken, pursuant to the terms of the Merger Agreement, (B) taken with the prior written consent of Pagaya or (C) taken by, or at the written request of, Pagaya; |
• | receipt of the required approval by the EJFA Shareholders and the required approval by the Pagaya Shareholders; |
• | EJFA having at least $5,000,001 of net tangible assets after giving effect to the redemptions of EJFA Class A Ordinary Shares prior to the Closing pursuant to the EJFA Memorandum and Articles of Association upon the Closing; |
• | the absence of any injunction or other order of any governmental entity of competent jurisdiction prohibiting, enjoining or making illegal the consummation of the Transactions; |
• | effectiveness of this proxy statement/prospectus in accordance with the provisions of the Securities Act, the absence of any stop order or proceeding (or threatened proceeding by the SEC) seeking a stop order with respect to this proxy statement/prospectus; |
• | the approval for listing on Nasdaq (or any other public stock market or exchange in the United States as may be agreed by Pagaya and EJFA) of the Pagaya Ordinary Shares issuable as the Merger Consideration, as well as the Pagaya Warrants to be issued in connection with the Closing, subject only to notice of official issuance thereof; and |
• | expiration or termination of the waiting period or periods under the HSR Act applicable to the Transactions (which waiting period expired on November 12, 2021). |
• | the accuracy of the representations and warranties of EJFA (subject to certain materiality standards set forth in the Merger Agreement); |
• | material performance or compliance by EJFA with its pre-Closing agreements, obligations and covenants; |
• | the absence of a Material Adverse Effect for EJFA; |
• | EJFA’s delivery of a certificate, signed by an authorized executive officer of EJFA and dated as of the Closing Date, certifying that the conditions set forth in the three preceding bullet points have been satisfied; and |
• | the funds contained in the Trust Account (after giving effect to the EJFA Shareholder Redemption), together with the aggregate amount of proceeds from the purchase of Pagaya Ordinary Shares by the EJF Investor and any other PIPE investors executing a subscription agreement at or prior to the Closing, equaling or exceeding $200 million (the “Available Cash Condition”). |
• | the accuracy of the representations and warranties of Pagaya and Merger Sub (subject to certain materiality standards set forth in the Merger Agreement); |
• | material performance or compliance by each of Pagaya and Merger Sub with its pre-Closing agreements, obligations and covenants; |
• | the absence of a Material Adverse Effect for Pagaya; and |
• | Pagaya’s delivery of a certificate, signed by an authorized executive officer of Pagaya and dated as of the Closing Date, certifying that the conditions set forth in the three preceding bullet points have been satisfied. |
• | by mutual written consent of EJFA and Pagaya; |
• | by either EJFA or Pagaya, if the closing of the Transactions has not occurred by the Outside Date, except that the right to so terminate the Merger Agreement will not be available to any party whose action or failure to act has been a principal cause of or resulted in the failure of the Closing to occur on or before such date and such action or failure to act constitutes a material breach of the Merger Agreement; |
• | by either EJFA or Pagaya, if a governmental entity has issued any final non-appealable order or decree, or any applicable requirement of law is in effect, in any case having the effect of making the Transactions illegal or permanently prohibiting the Transactions, including the Merger; |
• | by Pagaya, if EJFA has breached any of its covenants or representations and warranties and has not cured such breach within the time periods provided for in the Merger Agreement; |
• | by EJFA, if Pagaya has breached any of its covenants or representations and warranties and has not cured such breach within the time periods provided for in the Merger Agreement; |
• | by either EJFA or Pagaya, if, at the Special Meeting (including any adjournments or postponements thereof), the Merger Agreement, the Merger, and the other EJFA Shareholder Proposals contemplated by the Merger Agreement are not duly adopted by the EJFA Shareholders by the requisite vote under applicable legal requirements and EJFA’s organizational documents; |
• | by either EJFA or Pagaya, if, at the Pagaya Special Meeting (including any adjournments thereof), the Merger Agreement, the Merger, and the other Pagaya Shareholder Matters contemplated by the Merger Agreement are not duly adopted by the Pagaya Shareholders by the requisite vote under applicable legal requirements and Pagaya’s organizational documents; and |
• | by EJFA, if Pagaya has not delivered to EJFA the PCAOB compliant audited financial statements of Pagaya by the relevant PCAOB Deadline. |
• | banks, insurance companies, and other financial institutions; |
• | tax-exempt entities or governmental organizations; |
• | tax-qualified retirement plans; |
• | regulated investment companies and real estate investment trusts; |
• | brokers, dealers, or traders in securities that elect to use a mark-to-market method of accounting; |
• | persons that elect to mark their securities to market; |
• | certain expatriates and former citizens or residents of the United States; |
• | persons that have a functional currency other than the U.S. Dollar; |
• | persons holding EJFA securities or Pagaya securities, as the case may be, as part of a hedging, integrated, straddle, conversion or constructive sale transaction for U.S. federal income tax purposes; |
• | persons subject to special tax accounting rules as a result of any item of gross income with respect to EJFA securities or Pagaya securities, as the case may be, being taken into account in an applicable financial statement; |
• | founders, sponsors, officers or directors of EJFA or holders of EJFA Private Placement Warrants; |
• | persons that actually or constructively own, directly or indirectly (or have at any time during the five-year period ending on the date of the Merger owned), 5% or more (by vote or value) of the outstanding EJFA securities or, after the Merger, actually or constructively, directly or indirectly, own 5% or more (by vote or value) of the Pagaya securities; |
• | “CFCs”; and |
• | “passive foreign investment companies.” |
• | an individual who is a citizen or resident of the United States; |
• | a corporation (including any entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States or any state thereof or the District of Columbia; |
• | an estate whose income is subject to U.S. federal income taxation regardless of its source; or |
• | a trust if (i) a court within the U.S. is able to exercise primary supervision over the trust’s administration and one or more U.S. persons have the authority to control all of the trust’s substantial decisions, or (ii) the trust has a valid election in effect under applicable Treasury Regulations to be treated as a U.S. person. |
• | any gain recognized by the U.S. Holder on the sale or other disposition of its Pagaya securities; and |
• | any “excess distribution” made to the U.S. Holder (generally, any distributions to such U.S. Holder during a taxable year of the U.S. Holder that are greater than 125% of the average annual distributions received by such U.S. Holder in respect of Pagaya securities during the three preceding taxable years of such U.S. Holder or, if shorter, such U.S. Holder’s holding period for such securities). |
• | the U.S. Holder’s gain or excess distribution will be allocated ratably over the U.S. Holder’s holding period for its securities; |
• | the amount of gain allocated to the U.S. Holder’s taxable year in which the U.S. Holder recognized the gain or received the excess distribution, or to the period in the U.S. Holder’s holding period before the first day of the first taxable year in which Pagaya is a PFIC, will be subject to tax as ordinary income; |
• | the amount of gain allocated to other taxable years (or portions thereof) of the U.S. Holder included in such U.S. Holder’s holding period will be subject to tax at the highest tax rate in effect for that year and applicable to the U.S. Holder; and |
• | an additional tax equal to the interest charge generally applicable to underpayments of tax will be imposed on the U.S. Holder in respect of the tax attributable to each such other taxable year of such U.S. Holder included in such U.S. Holder’s holding period. |
• | amortization of the cost of purchased patents, rights to use a patent, and know-how, which were purchased in good faith and are used for the development or advancement of the Industrial Enterprise, over an eight-year period, commencing on the year in which such rights were first exercised; |
• | under limited conditions, an election to file consolidated tax returns with controlled Israeli Industrial Companies; and |
• | expenses related to a public offering are deductible in equal amounts over three years commencing with the year of the offering. |
• | the expenditures are approved by the relevant Israeli government ministry, which depends on the field of research; |
• | the research and development must be for the promotion of the company; and |
• | the research and development is carried out by or on behalf of the company seeking such tax deduction. |
Name | | | Age | | | Title |
Emanuel J. Friedman | | | 75 | | | Chairman of the Board |
Neal Wilson | | | 55 | | | Vice Chairman, Director |
Kevin Stein | | | 60 | | | Chief Executive Officer, Director |
Thomas Mayrhofer | | | 49 | | | Chief Financial Officer |
Erika Gray | | | 34 | | | Chief Accounting Officer and Secretary |
Brian P. Brooks | | | 52 | | | Independent Director |
Joan C. Conley | | | 65 | | | Independent Director |
Campbell R. Dyer | | | 48 | | | Independent Director |
Robert Wolf | | | 59 | | | Independent Director |
• | assisting board oversight of (1) the integrity of EJFA’s financial statements, (2) EJFA’s compliance with legal and regulatory requirements, (3) EJFA’s independent registered public accounting firm’s qualifications and independence, and (4) the performance of EJFA’s internal audit function and independent auditors; the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by us; |
• | pre-approving all audit and non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; reviewing and discussing with the independent auditors all relationships the auditors have with us in order to evaluate their continued independence; |
• | setting clear policies for audit partner rotation in compliance with applicable laws and regulations; obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (1) the independent auditor’s internal quality-control procedures and (2) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues; |
• | meeting to review and discuss EJFA’s annual audited financial statements and quarterly financial statements with management and the independent auditor, including reviewing EJFA’s specific disclosures under “EJFA’s Management’s Discussion and Analysis of Financial Condition and Results of Operations”; reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated under the Exchange Act promulgated by the SEC prior to us entering into such transaction; and |
• | reviewing with management, the independent auditors, and EJFA’s legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding EJFA’s financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. |
• | reviewing and approving on an annual basis the corporate goals and objectives relevant to EJFA’s chief executive officer’s compensation, evaluating EJFA’s chief executive officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of EJFA’s chief executive officer’s based on such evaluation; |
• | reviewing and making recommendations to EJFA’s board of directors with respect to the compensation, and any incentive compensation and equity based plans that are subject to board approval of all of EJFA’s other officers; |
• | reviewing EJFA’s executive compensation policies and plans; |
• | implementing and administering EJFA’s incentive compensation equity-based remuneration plans; |
• | assisting management in complying with EJFA’s proxy statement and annual report disclosure requirements; |
• | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for EJFA’s officers and employees; |
• | producing a report on executive compensation to be included in EJFA’s annual proxy statement; and |
• | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
• | identifying, screening and reviewing individuals qualified to serve as directors, consistent with criteria approved by the board, and recommending to the board of directors candidates for nomination for appointment at the annual general meeting or to fill vacancies on the board of directors; |
• | developing and recommending to the board of directors and overseeing implementation of EJFA’s corporate governance guidelines; |
• | coordinating and overseeing the annual self-evaluation of the board of directors, its committees, individual directors and management in the governance of EJFA; and |
• | reviewing on a regular basis EJFA’s overall corporate governance and recommending improvements as and when necessary. |
| | As of January 20, 2022 | ||||||||||
| | No Redemption Scenario | | | 50% Redemption Scenario | | | Maximum Redemption Scenario | | |||
Unredeemed EJFA Public Shares | | | 28,750,000 | | | 14,375,000 | | | 0 | | ||
Trust Proceeds | | | $287,500,000 | | | $143,750,000 | | | $5,000,001 | | ||
Deferred Underwriting Fees | | | $10,062,500 | | | $10,062,500 | | | $10,062,500 | | ||
Effective Deferred Underwriting Fee (%) | | | 3.50% | | | 7.00% | | | 201.25% | |
| | Year ended December 31, | | | Six Months ended June 30, | ||||||||||
| | 2020 | | | 2019 | | | 2018 | | | 2021 | | | 2020 | |
| | (in millions) | |||||||||||||
Network Volume | | | $1,591 | | | $720 | | | $232 | | | $1,835 | | | $587 |
| | For the Year Ended December 31, | | | For the Six Months Ended June 30, | |||||||
| | 2020 | | | 2019 | | | 2021 | | | 2020 | |
| | (in thousands) | ||||||||||
Revenue | | | | | | | | | ||||
Revenue from fees | | | $91,740 | | | $32,313 | | | $173,455 | | | $22,975 |
Other Income | | | | | | | | | ||||
Interest income | | | 6,993 | | | 3,614 | | | 9,801 | | | 3,045 |
Investment income | | | 277 | | | 214 | | | 12 | | | 237 |
Total Revenue and Other Income | | | 99,010 | | | 36,141 | | | 183,268 | | | 26,257 |
Costs and Operating Expenses | | | | | | | | | ||||
Research and development(1) | | | 12,332 | | | 5,434 | | | 39,412 | | | 5,280 |
Sales and marketing(1) | | | 5,668 | | | 2,458 | | | 28,403 | | | 1,598 |
General and administrative(1) | | | 10,672 | | | 4,184 | | | 34,107 | | | 2,980 |
Production costs | | | 49,085 | | | 27,969 | | | 99,774 | | | 13,710 |
Total Costs and Operating Expenses | | | 77,757 | | | 40,045 | | | 201,696 | | | 23,568 |
Operating Income (Loss) | | | 21,253 | | | (3,904) | | | (18,428) | | | 2,689 |
Other expense, net | | | (55) | | | (124) | | | (18,771) | | | (51) |
Income (Loss) Before Income Taxes | | | 21,198 | | | (4,028) | | | (37,199) | | | 2,638 |
Income tax expense | | | 1,276 | | | 172 | | | 7,793 | | | 113 |
Net Income (Loss) and Comprehensive Income (Loss) | | | $19,922 | | | $(4,200) | | | $(44,992) | | | $2,525 |
Net Income and Comprehensive Income Attributable to Noncontrolling Interests | | | $5,452 | | | $1,420 | | | $7,546 | | | $2,353 |
Net Income (Loss) and Comprehensive Income (Loss) Attributable to Pagaya Technologies Ltd. shareholders | | | $14,470 | | | $(5,620) | | | $(52,538) | | | $172 |
(1) | The following table sets forth share-based compensation for the years indicated below: |
| | Year Ended December 31, | | | For the Six Months Ended June 30, | |||||||
| | 2020 | | | 2019 | | | 2021 | | | 2020 | |
| | (in thousands) | ||||||||||
Research and Development | | | $89 | | | $37 | | | $25,074 | | | $30 |
Selling and Marketing | | | 4 | | | — | | | 16,779 | | | 1 |
General and Administrative | | | 63 | | | 37 | | | 17,264 | | | $19 |
Total share-based Compensation in operating expenses | | | $156 | | | $74 | | | $59,117 | | | $50 |
| | Year Ended December 31, | | | | | ||||||
| | 2020 | | | 2019 | | | Change | | | % Change | |
| | (in thousands, except percentages) | ||||||||||
Revenue from fees | | | $91,740 | | | $32,313 | | | $59,427 | | | 184% |
Interest income | | | 6,993 | | | 3,614 | | | 3,379 | | | 93% |
Investment income | | | 277 | | | 214 | | | 63 | | | 29% |
Total Revenue and Other Income | | | $99,010 | | | $36,141 | | | $62,869 | | | 174% |
| | Year Ended December 31, | ||||
| | 2020 | | | 2019 | |
| | (in thousands) | ||||
Research and development | | | $12,332 | | | $5,434 |
Sales and marketing | | | 5,668 | | | 2,458 |
General and administrative | | | 10,672 | | | 4,184 |
Production costs | | | 49,085 | | | 27,969 |
Total Operating Expenses | | | $77,757 | | | $40,045 |
| | Year Ended December 31, | | | | | | | |||||||
| | 2020 | | | 2019 | | | Change | | | % Change | | |||
| | (in thousands, except percentages) | | ||||||||||||
Research and development | | | $12,332 | | | $5,434 | | | $6,898 | | | 127% | | ||
Percentage of total revenue and other income | | | 12% | | | 15% | | | | | |
| | Year Ended December 31, | | | | | ||||||
| | 2020 | | | 2019 | | | Change | | | % Change | |
| | (in thousands, except percentages) | ||||||||||
Sales and marketing | | | $5,668 | | | $2,458 | | | $3,210 | | | 131% |
Percentage of total revenue and other income | | | 6% | | | 7% | | | | |
| | Year Ended December 31, | | | | | | | |||||||
| | 2020 | | | 2019 | | | Change | | | % Change | | |||
| | (in thousands, except percentages) | | ||||||||||||
General and administrative | | | $10,672 | | | $4,184 | | | $6,488 | | | 155% | | ||
Percentage of total revenue and other income | | | 11% | | | 12% | | | | | |
| | Year Ended December 31, | | | | | ||||||
| | 2020 | | | 2019 | | | Change | | | % Change | |
| | (in thousands, except percentages) | ||||||||||
Production costs | | | $49,085 | | | $27,969 | | | $21,116 | | | 75% |
Percentage of total revenue and other income | | | 50% | | | 77% | | | | |
| | Year Ended December 31, | | | | | ||||||
| | 2020 | | | 2019 | | | Change | | | % Change | |
| | (in thousands, except percentages) | ||||||||||
Other expense, net | | | $(55) | | | $(124) | | | $69 | | | (56)% |
Percentage of total revenue and other income | | | (0.1)% | | | (0.3)% | | | | |
| | Fiscal Year Ended December 31, | | | | | | | |||||||
| | 2020 | | | 2019 | | | Change | | | % Change | | |||
| | (in thousands, except percentages) | | ||||||||||||
Income tax expense | | | $1,276 | | | $172 | | | $1,104 | | | 642% | | ||
Effective income tax rate | | | 6.0% | | | (4.3)% | | | | | |
| | Year Ended December 31, | | | | | ||||||
| | 2020 | | | 2019 | | | Change | | | % Change | |
| | (in thousands, except percentages) | ||||||||||
Net Income and Comprehensive Income Attributable to Noncontrolling Interests | | | $5,452 | | | $1,420 | | | $4,032 | | | 284% |
Percentage of total revenue and other income | | | 6% | | | 4% | | | | |
| | Six Months Ended June 30, | | | | | ||||||
| | 2021 | | | 2020 | | | Change | | | % Change | |
| | (in thousands, except percentages) | ||||||||||
Revenue from fees | | | $173,455 | | | $22,975 | | | $150,480 | | | 655% |
Interest income | | | 9,801 | | | 3,045 | | | 6,756 | | | 222% |
Investment income | | | 12 | | | 237 | | | (225) | | | (95)% |
Total revenue and other income | | | $183,268 | | | $26,257 | | | $157,011 | | | 598% |
| | Six Months Ended June 30, | ||||
| | 2021 | | | 2020 | |
| | (in thousands) | ||||
Research and development | | | $39,412 | | | $5,280 |
Sales and marketing | | | 28,403 | | | 1,598 |
General and administrative | | | 34,107 | | | 2,980 |
Production costs | | | 99,774 | | | 13,710 |
| | $201,696 | | | $23,568 |
| | Six Months Ended June 30, | | | | | ||||||
| | 2021 | | | 2020 | | | Change | | | % Change | |
| | (in thousands, except percentages) | ||||||||||
Research and development | | | $39,412 | | | $5,280 | | | $34,132 | | | 646% |
Percentage of total revenue and other income | | | 22% | | | 20% | | | | |
| | Six Months Ended June 30, | | | | | ||||||
| | 2021 | | | 2020 | | | Change | | | % Change | |
| | (in thousands, except percentages) | ||||||||||
Sales and Marketing | | | $28,403 | | | $1,598 | | | $26,805 | | | 1,677% |
Percentage of total revenue and other income | | | 15% | | | 6.1% | | | | |
| | Six Months Ended June 30, | | | | | | | |||||||
| | 2021 | | | 2020 | | | Change | | | % Change | | |||
| | (in thousands, except percentages) | | ||||||||||||
General and administrative | | | $34,107 | | | $2,980 | | | $31,127 | | | 1,045% | | ||
Percentage of total revenue and other income | | | 19% | | | 11% | | | | | |
| | Six Months Ended June 30, | | | | | ||||||
| | 2021 | | | 2020 | | | % Change | | | % Change | |
| | (in thousands, except percentages) | ||||||||||
Production costs | | | $99,774 | | | $13,710 | | | $86,064 | | | 628% |
Percentage of total revenue and other income | | | 54% | | | 52% | | | | |
| | Six Months Ended June 30, | | | | | ||||||
| | 2021 | | | 2020 | | | Change | | | % Change | |
| | (in thousands, except percentages) | ||||||||||
Other expense, net | | | $(18,771) | | | $(51) | | | $(18,720) | | | 36,706% |
Percentage of total revenue and other income | | | (10.2)% | | | (0.2)% | | | | |
| | Six Months Ended June 30, | | | | | ||||||
| | 2021 | | | 2020 | | | Change | | | % Change | |
| | (in thousands, except percentages) | ||||||||||
Income tax expense | | | $7,793 | | | $113 | | | $7,680 | | | 6,796% |
Effective income tax rate | | | (21.0)% | | | 4.3% | | | | |
| | Six Months Ended June 30, | | | | | ||||||
| | 2021 | | | 2020 | | | Change | | | % Change | |
| | (in thousands, except percentages) | ||||||||||
Net Income and Comprehensive Income Attributable to Noncontrolling Interests | | | $7,546 | | | $2,353 | | | $5,193 | | | 221% |
Percentage of total revenue and other income | | | 4.1% | | | 9.0% | | | | |
| | Year ended December 31, | | | Six Months Ended June 30, | |||||||
| | 2020 | | | 2019 | | | 2021 | | | 2020 | |
| | (in thousands) | ||||||||||
Adjusted EBITDA | | | $16,165 | | | $(5,232) | | | $33,671 | | | $467 |
| | Year ended December 31, | | | Six Months Ended June 30, | |||||||
| | 2020 | | | 2019 | | | 2021 | | | 2020 | |
| | (in thousands) | ||||||||||
Net (loss) income attributable to shareholders | | | $14,470 | | | $(5,620) | | | $(52,538) | | | $172 |
Adjusted to exclude the following: | | | | | | | | | ||||
Depreciation and amortization | | | 290 | | | 91 | | | 282 | | | 110 |
Share-based compensation | | | 156 | | | 74 | | | 59,117 | | | 50 |
Fair value adjustments to our warrant liability | | | 489 | | | (212) | | | 19,017 | | | (5) |
Interest expense | | | — | | | 263 | | | — | | | — |
Non-recurring expenses(1) | | | (516) | | | — | | | — | | | 27 |
Provision for income tax | | | 1,276 | | | 172 | | | 7,793 | | | 113 |
Adjusted EBITDA | | | $16,165 | | | $(5,232) | | | $33,671 | | | $467 |
1 | Non-recurring expenses include gain from the extinguishment of the Option and issuance costs of the Option and redeemable convertible preferred share warrants. |
| | Year Ended December 31, | | | Six Months Ended June 30, | |||||||
| | 2020 | | | 2019 | | | 2021 | | | 2020 | |
| | (in thousands) | ||||||||||
Net cash provided by (used in) operating activities | | | $4,257 | | | $(7,946) | | | $9,263 | | | $(3,679) |
Net cash used in investing activities | | | $(122,757) | | | $(36,239) | | | $(190,732) | | | $(15,647) |
Net cash provided by financing activities | | | $119,502 | | | $46,538 | | | $243,933 | | | $60,252 |
| | (in thousands) | |
2021 (the remainder of the year) | | | $1,949 |
2022 | | | 3,576 |
2023 | | | 2,999 |
2024 | | | 3,036 |
2025 | | | 2,057 |
Thereafter | | | 11,356 |
Total | | | $24,973 |
Financial Projections ($ amounts in millions) | | | 2021P | | | 2022P | | | 2023P |
Total Network Volume(1) | | | $4.4 | | | $7.6 | | | $12.7 |
Total Revenue | | | $407 | | | $679 | | | $1,086 |
Adjusted EBITDA(2) | | | 63 | | | 112 | | | 190 |
(1) | “Network Volume” means the gross dollar amount of assets that are originated by Partners with the assistance of Pagaya’s AI technology and are acquired by Financing Vehicles. |
(2) | “Adjusted EBITDA” means net income (loss) attributable to Pagaya’s Shareholders excluding share-based compensation expense, interest expense, depreciation expense, change in fair value of warrant liability, warrant expense, non-recurring expenses associated with this transaction, and provision for income taxes. Prior to the changes in the accounting policies of Pagaya (as further described in the section of this proxy statement/prospectus entitled “Fairness Opinion of Duff & Phelps”) and at the time the Financial Projections were provided by Pagaya and the Opinion was provided by Duff & Phelps, “Adjusted EBITDA” was referred to as “adjusted operating income.” |
• | projected revenue is based on a variety of operational assumptions including, among others, continued development of our technology adoption of additional solutions by our customers, timing for release of new solutions and assumptions about their expected adoption, the continued growth of our markets and |
• | other key assumptions impacting profitability projections including headcount, research and development costs, sales and marketing costs and excluding costs associated with public company operations and compliance. |
• | the accompanying notes to the unaudited pro forma condensed combined financial information; |
• | the historical audited consolidated financial statements of Pagaya as of and for the year ended December 31, 2020 and the historical unaudited condensed consolidated financial statements of Pagaya as of and for the six months ended June 30, 2021; |
• | the (a) historical audited financial statements of EJFA as of the year ended December 31, 2020 and for the period from December 22, 2020 (inception) through December 31, 2020, and (b) historical unaudited condensed financial statements of EJFA as of and for the six months ended September 30, 2021, which were derived from the accounting records used to prepare the historical unaudited condensed financial statements of EJFA as of and for the nine months ended September 30, 2021; |
• | other information relating to Pagaya and EJFA included in this proxy statement/prospectus, including the Merger Agreement and the description of certain terms thereof set forth under the section titled “Proposal One—The Business Combination Proposal”; and |
• | the sections titled “Pagaya’s Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “EJFA’s Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other financial information included elsewhere in this proxy statement/prospectus. |
• | Conversion of EJFA securities—At the Effective Time, |
• | each EJFA Class B Ordinary Share issued and outstanding will be converted into one Pagaya Class A Ordinary Share after giving effect to the Capital Restructuring, |
• | each EJFA Class A Ordinary Share of issued and outstanding will be converted into one Pagaya Class A Ordinary Share after giving effect to the Capital Restructuring and |
• | each EJFA Warrant issued and outstanding will automatically and irrevocably be assumed by Pagaya and converted into a corresponding Pagaya Warrant for Pagaya Class A Ordinary Shares. |
• | Preferred Share Conversion—Immediately prior to the Stock Split, each Pagaya Preferred Share will be converted into one Pagaya Class A Ordinary Share, with no par value, in accordance with the Current Pagaya Articles. |
• | Reclassification of Pagaya’s Ordinary Shares into Pagaya Class A Ordinary Shares and Pagaya Class B Ordinary Shares —immediately following the conversion of the Pagaya Preferred Shares but prior to the consummation of the PIPE Investment, Pagaya will convert each Pagaya Ordinary Share that is issued and outstanding immediately prior to the Effective Time (and any warrant, right or other security convertible into or exchangeable or exercisable therefor) into a number of Pagaya Ordinary Shares calculated in accordance with the terms of the Merger Agreement with the three Founders (in their capacity as shareholders of Pagaya), each receiving Class B ordinary shares of Pagaya (“Pagaya Class B Ordinary Shares”), which will carry voting rights in the form of 10 votes per share of Pagaya, and the other shareholders of Pagaya receiving Pagaya Class A Ordinary Shares, which will carry voting rights in the form of one vote per share of Pagaya, in accordance with Pagaya’s organizational documents. |
• | Stock Split—Immediately following the reclassification and prior to the consummation of the PIPE Investment, Pagaya will effect a share split to cause the value of the outstanding Pagaya Ordinary Shares immediately prior to the effective time to equal $10.00 per share. Each outstanding and unexercised options to purchase Pagaya ordinary shares (and any warrant, right or other security convertible into or exchangeable or exercisable therefor) issued, whether or not then vested or fully exercisable, will be adjusted by multiplying such number of Pagaya Ordinary Shares by a “split factor” that is equal to the result of (i) $8.5 billion divided by (ii) the total number of issued and outstanding Pagaya Ordinary Shares, plus the total number of Pagaya Ordinary Shares underlying any outstanding Pagaya options (and any warrant, right or other security convertible into or exchangeable or exercisable therefor) to acquire Pagaya Ordinary Shares, with the result of such calculation divided by (iii) $10.00, all as further described in and as calculated in accordance with the merger agreement. The exact Stock Split factor will not be known until on or about the closing of the Merger. However, for purposes hereof, the Stock Split factor is estimated to be equal to approximately 186.9 based on Pagaya’s capitalization table as of August 31, 2021. |
• | PIPE Investment – Prior to the effective date, Pagaya will consummate the PIPE Investment in accordance with the terms of the Subscription Agreements, pursuant to which the PIPE Investors will |
• | Side letter—EJFA and the Sponsor entered into the Side Letter Agreement, which provides that, solely in the event the EJFA Transaction Costs exceed $45 million (the amount of such excess, the “Expenses Excess Amount”), a number of EJFA Class B Ordinary Shares equal to the quotient of (i) the Expenses Excess Amount divided by (ii) $10.00 (subject to equitable adjustment) will be forfeited for no consideration and cancelled by EJFA and no longer outstanding, except that the Sponsor may pay, in whole or in part, the EJFA Transaction Costs in cash prior to the Effective Time without further liability to EJFA, in which case the Expenses Excess Amount will be reduced on a dollar-for-dollar basis by the amount so paid by the Sponsor. |
• | Pursuant to the terms of the Sponsor agreement, sponsor warrants will become exercisable at any time commencing 30 days after the consummation of the Business Combination and will expire five years after the consummation of the Business Combination or earlier upon redemption or liquidation, as described in this proxy statement/prospectus. |
• | The exchange of shares held by Pagaya Shareholders will be accounted for as a recapitalization in accordance with U.S. GAAP. |
• | The merger of EJFA with Merger Sub, which is not within the scope of ASC 805 (“Business Combinations”) since EJFA does not meet the definition of a business in accordance with ASC 805. Any difference between the fair value of Pagaya Ordinary Shares issued and the fair value of EJFA’s identifiable net assets will be recorded as additional paid-in capital. For purposes of the unaudited pro forma condensed combined financial information, it is assumed that the fair value of each individual Pagaya ordinary share issued to EJFA Shareholders is equal to the fair value of each individual Pagaya Ordinary Share issued to pre-Closing Pagaya Shareholders resulting from the $8.5 billion enterprise value assigned to Pagaya in the Merger Agreement. |
• | The PIPE Investment will result in the issuance of Pagaya Class A Ordinary Shares, leading to an increase in ordinary shares, par value and additional paid-in capital. |
• | Assuming No Redemptions: This scenario assumes that no EJFA Public Shareholders exercise redemption rights with respect to their EJFA Public Shares for a pro rata share of the funds in the Trust Account and there is no Expenses Excess Amount. |
• | Assuming Maximum Redemptions: This scenario assumes that EJFA Public Shareholders holding 28.8 million EJFA Public Shares will exercise their redemption rights for their pro rata share (approximately $10.00 per share) of the funds in the Trust Account. The Merger Agreement provides that the consummation of the Merger is conditioned on EJFA having funds at the closing of the Merger of at least $200.0 million. This scenario assumes that there is no Excess Expense Amount. |
| | Assuming no redemption | | | Assuming maximum redemption | |||||||
| | Shares | | | % | | | Shares | | | % | |
Existing Pagaya Shareholders(1) | | | 597,644,296 | | | 90% | | | 597,644,296 | | | 93% |
EJFA—Public Shareholders | | | 28,750,000 | | | 4% | | | — | | | 0% |
EJFA—Sponsor | | | 7,187,500 | | | 1% | | | 7,187,500 | | | 1% |
PIPE Investors | | | 35,000,000 | | | 5% | | | 35,000,000 | | | 6% |
Pro forma Ordinary Shares outstanding at June 30, 2021(2) | | | 668,581,796 | | | 100% | | | 639,831,796 | | | 100% |
(1) | Excludes approximately 264 million of Pagaya Options and Pagaya Warrants outstanding or reserved for future issuance that do not represent legally outstanding Pagaya Ordinary Shares at closing. It also excludes approximately 117 million Pagaya Ordinary Shares issuable upon vesting of certain Pagaya Warrants and options on restricted shares upon consummation of the transaction. |
(2) | Excludes EJFA Warrants as they are not exercisable until 30 days after the closing of the Merger. |
| | | | | | Assuming No Redemptions | | | Assuming Maximum Redemptions | |||||||||||||||
| | As of June 30, 2021 | | | As of September 30, 2021 | | | | | | | As of June 30, 2021 | | | | | | | As of June 30, 2021 | |||||
| | Pagaya (Historical) | | | EJFA (Historical) | | | Pro Forma Transaction Accounting Adjustments | | | | | Pro Forma Combined | | | Additional Pro Forma Transaction Accounting Adjustments | | | | | Pro Forma Combined | |||
Assets | | | | | | | | | | | | | | | | | ||||||||
Cash and cash equivalents | | | $42,504 | | | $443 | | | $546,485 | | | (A) | | | $589,432 | | | $(287,500) | | | (C) | | | $301,932 |
Restricted cash | | | 25,840 | | | — | | | — | | | | | 25,840 | | | — | | | | | 25,840 | ||
Short-term deposits | | | 149,514 | | | — | | | — | | | | | 149,514 | | | — | | | | | 149,514 | ||
Fee receivable | | | 34,661 | | | — | | | — | | | | | 34,661 | | | — | | | | | 34,661 | ||
Investments in loans and securities | | | 185,981 | | | — | | | — | | | | | 185,981 | | | — | | | | | 185,981 | ||
Equity method investments | | | 23,409 | | | — | | | — | | | | | 23,409 | | | — | | | | | 23,409 | ||
Cash and investments held in Trust Account | | | — | | | 287,574 | | | (287,574) | | | (B) | | | — | | | — | | | | | — | |
Property and equipment, net | | | 2,137 | | | — | | | — | | | | | 2,137 | | | — | | | | | 2,137 | ||
Deferred tax asset, net | | | 4,224 | | | — | | | — | | | | | 4,224 | | | — | | | | | 4,224 | ||
Prepaid expenses and other assets | | | 27,288 | | | 536 | | | — | | | | | 27,824 | | | — | | | | | 27,824 | ||
Total assets | | | $495,558 | | | $288,553 | | | $258,911 | | | | | $1,043,022 | | | $(287,500) | | | | | $755,522 | ||
Liabilities, Redeemable Convertible Preferred Shares And Shareholders’ Equity | | | | | | | | | | | | | | | | | ||||||||
Accounts payable | | | $3,495 | | | $— | | | $— | | | | | $3,495 | | | $— | | | | | $3,495 | ||
Accrued expenses and other liabilities | | | 5,581 | | | 792 | | | (792) | | | (G) | | | 5,581 | | | — | | | | | 5,581 | |
Redeemable convertible preferred shares warrant liability | | | 21,488 | | | — | | | — | | | | | 21,488 | | | — | | | | | 21,488 | ||
Due to related party | | | — | | | 322 | | | (322) | | | (G) | | | — | | | — | | | | | — | |
Income taxes payable | | | 12,810 | | | — | | | — | | | | | 12,810 | | | — | | | | | 12,810 | ||
Warrant liability | | | — | | | 25,547 | | | — | | | | | 25,547 | | | — | | | | | 25,547 | ||
Deferred underwriters’ discount | | | — | | | 10,062 | | | (10,062) | | | (D) | | | — | | | — | | | | | — | |
Total liabilities | | | $43,374 | | | $36,723 | | | $(11,176) | | | | | $68,921 | | | $— | | | | | $68,921 | ||
Commitments and contingencies | | | | | | | | | | | | | | | | | ||||||||
Ordinary shares subject to possible redemption, 28,750,000 shares as of September 30, 2021 | | | — | | | 287,500 | | | (287,500) | | | (I) | | | — | | | — | | | | | — | |
Redeemable convertible preferred shares, NIS 0.01 par value, 2,206,243 shares authorized at June 30, 2021; 2,154,949 shares issued and outstanding at June 30, 2021; liquidation preference of $389,107 at June 30, 2021 | | | 278,608 | | | — | | | (278,608) | | | (J) | | | — | | | — | | | | | — | |
Stockholders’ equity | | | | | | | | | | | | | | | | | ||||||||
Ordinary shares, NIS 0.01 par value; 8,258,757 shares authorized at June 30, 2021; 1,022,478 shares issued and outstanding at June 30, 2021 | | | 3 | | | — | | | (3) | | | (K) | | | — | | | — | | | | | — | |
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized | | | — | | | — | | | 48 | | | (K) | | | 48 | | | (3) | | | (C) | | | 45 |
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 7,187,500 shares issued and outstanding as of September 30, 2021 | | | — | | | 1 | | | 18 | | | (K) | | | 19 | | | — | | | | | 19 | |
Additional paid-in capital | | | 103,927 | | | — | | | 905,072 | | | (H) | | | 1,008,999 | | | (287,497) | | | (C) | | | 721,502 |
Accumulated deficit | | | (73,265) | | | (35,671) | | | (68,940) | | | (N) | | | (177,876) | | | — | | | | | (177,876) | |
Total shareholders’ equity | | | 30,665 | | | (35,670) | | | 836,195 | | | | | 831,190 | | | (287,500) | | | | | 543,690 | ||
Non-controlling interest | | | 142,911 | | | — | | | | | | | 142,911 | | | — | | | | | 142,911 | |||
Total shareholders’ equity | | | 173,576 | | | (35,670) | | | 836,195 | | | | | 974,101 | | | (287,500) | | | | | 686,601 | ||
Total Liabilities, Redeemable Convertible Preferred Shares And Shareholders’ Equity | | | $495,558 | | | $288,553 | | | $258,911 | | | | | $1,043,022 | | | $(287,500) | | | | | $755,522 |
| | | | | | Assuming No Redemptions and Maximum Redemptions | |||||||||
| | For the Year ended December 31, 2020 | | | Inception December 22 to December 31 2020 | | | | | | | For the Year ended December 31, 2020 | |||
| | Pagaya (Historical) | | | EJFA (Historical) | | | Pro Forma Transaction Accounting Adjustments | | | | | Pro Forma Combined | ||
Revenue | | | | | | | | | | | |||||
Revenue from fees | | | $91,740 | | | $— | | | $— | | | | | $91,740 | |
Other Income | | | | | | | | | | | |||||
Interest income | | | 6,993 | | | — | | | — | | | | | 6,993 | |
Investment income | | | 277 | | | — | | | — | | | | | 277 | |
Total Revenue and Other Income | | | 99,010 | | | — | | | — | | | | | 99,010 | |
Costs and Operating Expenses: | | | | | | | | | | | |||||
Formation and operating costs | | | — | | | 4 | | | — | | | | | 4 | |
Research and development | | | 12,332 | | | — | | | 51,790 | | | (CC) | | | 64,122 |
Sales and marketing | | | 5,668 | | | — | | | 35,176 | | | (CC) | | | 40,844 |
General and administrative | | | 10,672 | | | — | | | 29,747 | | | (CC) | | | 40,419 |
Production costs | | | 49,085 | | | — | | | — | | | | | 49,085 | |
Total Costs and Operating Expenses | | | 77,757 | | | 4 | | | 116,713 | | | | | 194,474 | |
Operating Income (Loss) | | | 21,253 | | | (4) | | | (116,713) | | | | | (95,464) | |
Other income (expense) | | | | | | | | | | | |||||
Other expense, net | | | (55) | | | — | | | — | | | | | (55) | |
Total other income (expense) | | | (55) | | | — | | | — | | | | | (55) | |
Income (Loss) Before Income Taxes | | | 21,198 | | | (4) | | | (116,713) | | | | | (95,519) | |
Income tax expense | | | 1,276 | | | — | | | (14,006) | | | (BB) | | | (12,730) |
Net Income (Loss) and Comprehensive Income (Loss) | | | $19,922 | | | $(4) | | | $(102,707) | | | | | $(82,789) | |
Net Income and Comprehensive Income attributable to Noncontrolling Interest | | | 5,452 | | | — | | | — | | | | | 5,452 | |
Net Income (Loss) and Comprehensive Income (Loss) attributable to Pagaya Technologies, Ltd. shareholders | | | $14,470 | | | $— | | | $— | | | | | $(88,241) |
| | | | | | Assuming No Redemptions | | | Assuming Maximum Redemptions | |||
Per share data: | | | | | | | | | ||||
Net income attributable to Pagaya Technologies Ltd. Ordinary shareholders—basic | | | $4,912 | | | | | | | |||
Weighted—average ordinary shares outstanding—basic | | | 1,022,959 | | | | | | | |||
Net income per share attributable to Pagaya Technologies Ltd. ordinary Shareholders—basic | | | $4.80 | | | | | | | |||
Net income attributable to Pagaya Technologies Ltd. Ordinary shareholders—diluted | | | $4,608 | | | | | | | |||
Weighted—average ordinary shares outstanding—diluted | | | 1,107,349 | | | | | | | |||
Net income per share attributable to Pagaya Technologies Ltd. Ordinary shareholders—diluted | | | $4.16 | | | | | | | |||
Basic and diluted weighted average Class B shares outstanding | | | | | 6,250,000 | | | | | |||
Basic and diluted net loss per share | | | | | $(0.00) | | | | | |||
Net loss attributable to Class A and Class B ordinary shareholders—basic and diluted | | | | | | | $(88,241) | | | $(88,241) | ||
Weighted—average Class A and Class B ordinary shares outstanding—basic and diluted | | | | | | | 965,522,006 | | | 936,772,006 | ||
Net loss per share attributable to Class A and Class B ordinary shareholders—basic and diluted | | | | | | | $(0.09) | | | $(0.09) |
| | | | | | Assuming No Redemptions and Maximum Redemptions | |||||||||
| | For the Six Months Ended June 30, 2021 | | | For the Six Months Ended September 30, 2021 (Refer to Tickmark DD) | | | | | | | For the Six Months Ended June 30, 2021 | |||
| | Pagaya (Historical) | | | EJFA (Historical) | | | Pro Forma Transaction Accounting Adjustments | | | | | Pro Forma Combined | ||
Revenue | | | | | | | | | | | |||||
Revenue from fees | | | $173,455 | | | $— | | | $— | | | | | $173,455 | |
Other income | | | | | | | | | | | |||||
Interest income | | | 9,801 | | | — | | | — | | | | | 9,801 | |
Investment income | | | 12 | | | — | | | — | | | | | 12 | |
Total Revenue and Other Income | | | 183,268 | | | — | | | — | | | | | 183,268 | |
Cost and Operating Expenses | | | | | | | | | | | |||||
Formation and operating costs | | | — | | | 1,402 | | | — | | | | | 1,402 | |
Research and development | | | 39,412 | | | — | | | 1,546 | | | (CC) | | | 40,958 |
Sales and marketing | | | 28,403 | | | — | | | 1,031 | | | (CC) | | | 29,434 |
General and administrative | | | 34,107 | | | — | | | 965 | | | (CC) | | | 35,072 |
Production costs | | | 99,774 | | | — | | | — | | | | | 99,774 | |
Total Costs and Operating Expenses | | | 201,696 | | | 1,402 | | | 3,542 | | | | | 206,640 | |
Operating income (loss) | | | (18,428) | | | (1,402) | | | (3,542) | | | | | (23,372) | |
Other Income (Loss) | | | | | | | | | | | |||||
Interest income on marketable securities held in trust | | | — | | | 63 | | | (63) | | | (AA) | | | — |
Change in fair value of warrant liability | | | — | | | (10,992) | | | — | | | | | (10,992) | |
Other expense, net | | | (18,771) | | | — | | | — | | | | | (18,771) | |
Loss Before Income Taxes | | | (37,199) | | | (12,331) | | | (3,605) | | | | | (53,135) | |
Income tax expense (benefit) | | | 7,793 | | | — | | | (433) | | | (BB) | | | 7,360 |
Net Loss and Comprehensive Loss | | | $(44,992) | | | $(12,331) | | | $(3,172) | | | | | $(60,495) | |
Net Income and Comprehensive Income Attributable to Noncontrolling Interests | | | 7,546 | | | — | | | — | | | | | 7,546 | |
Net Loss and Comprehensive Loss | | | $(52,538) | | | $(12,331) | | | $(3,172) | | | | | $(68,041) | |
Less: Undistributed earnings allocated to participating securities | | | (8,559) | | | | | | | | | ||||
Less: Deemed dividend distribution | | | (23,612) | | | | | | | | | ||||
Net Loss Attributable to Pagaya Technologies Ltd. Ordinary shareholders—basic and diluted | | | $(84,709) | | | | | | | | |
| | | | | | Assuming No Redemptions | | | Assuming Maximum Redemptions | |||
Per share data: | | | | | | | | | ||||
Net loss attributable to Pagaya Technologies Ltd. Ordinary shareholders—basic and diluted | | | $(84,709) | | | | | | | |||
Weighted-average ordinary shares outstanding—basic and diluted | | | 1,036,688 | | | | | | | |||
Net loss per share attributable to Pagaya Technologies Ltd. Ordinary shareholders—basic and diluted | | | $(81.71) | | | | | | | |||
Weighted average non-redeemable ordinary shares outstanding—basic and diluted | | | | | 28,750,000 | | | | | |||
Basic and diluted net income per non-redeemable ordinary share | | | | | $(0.34) | | | | | |||
Weighted average ordinary shares subject to possible redemption outstanding—basic and diluted | | | | | 7,187,500 | | | | | |||
Basic and diluted net income per ordinary share subject to possible redemption | | | | | $(0.34) | | | | | |||
Net loss attributable to Class A and Class B ordinary shareholders—basic and diluted | | | | | | | $(44,865) | | | $(44,865) | ||
Weighted-average Class A and Class B ordinary shares outstanding—basic and diluted | | | | | | | 965,522,006 | | | 936,772,006 | ||
Net loss per share attributable to Class A and Class B ordinary shareholders—basic and diluted | | | | | | | $(0.05) | | | $(0.05) |
• | the historical audited consolidated financial statements of Pagaya as of and for the year ended December 31, 2020 and the historical unaudited condensed consolidated financial statements of Pagaya as of and for the six months ended June 30, 2021; |
• | the (a) historical audited financial statements of the EJFA as of the year ended December 31, 2020 and for the period from December 22, 2020 (inception) through December 31, 2020, and (b) historical unaudited condensed financial statements of EJFA as of and for the six months ended September 30, 2021, which were derived from the accounting records used to prepare the historical unaudited condensed financial statements of EJFA as of and for the nine months ended September 30, 2021; |
• | other information relating to Pagaya and EJFA included in this proxy statement/prospectus, including the Merger Agreement and the description of certain terms thereof set forth under the section titled “Proposal One—The Business Combination Proposal”; and |
• | the sections titled “Pagaya’s Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “EJFA’s Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other financial information included elsewhere in this proxy statement/prospectus. |
| | Assuming no redemption | | | Assuming maximum redemption | |||||||
(in thousands, except for share amounts)(a) | | | Consideration | | | Shares Issued | | | Consideration | | | Shares Issued |
Share Consideration to EJFA Public Shareholders | | | $287,500 | | | 28,750,000 | | | $— | | | — |
PIPE Investment | | | $350,000 | | | 35,000,000 | | | $350,000 | | | 35,000,000 |
(a) | The value of ordinary shares is reflected at $10 per share. |
(A) | Represents transaction accounting pro forma adjustments to the cash balance to reflect in case of no redemption the following: |
| | (In thousands) | | | ||
Reclassification and liquidation of Investments held in Trust Account | | | $287,574 | | | (B) |
Payment of the estimated merger transaction cost | | | (79,913) | | | (E) |
Payment of deferred underwriters’ fee | | | (10,062) | | | (D) |
Payment of EJFA’s other accrued liabilities | | | (1,114) | | | (G) |
Proceeds from PIPE investment | | | 350,000 | | | (F) |
Total | | | $546,485 | | | (A) |
(B) | Reflects the liquidation and reclassification of $287.5 million of Investments held in the Trust Account to cash and cash equivalents account that becomes available upon the closing of the Merger, assuming no redemptions. |
(C) | Represents the maximum redemptions scenario in which 28.8 million shares of EJFA Class A redeemable shares are redeemed for $287.5 million in cash. The amount is allocated between EJFA Class A Ordinary Shares $3 thousand at par value of $0.0001 per share and additional paid-in capital $287.5 million at a redemption price of approximately $10.00 per share. |
(D) | Reflects the payment of $10.1 million of deferred underwriters’ fees incurred during EJFA’s IPO due upon the closing of the Merger. |
(E) | Reflects the total preliminary estimated advisory, legal, and accounting fees and other professional fees of approximately $80.0 million. Of this, $56.0 million costs are expected transaction costs in connection with the consummation of the Merger, PIPE Investment and the Transactions, and are deemed to be direct and incremental costs of the Merger, PIPE Investment and the Transactions, which have been recorded as a reduction to additional paid-in capital. The balance of $24.0 million was adjusted in accumulated deficit as such transaction costs are not directly related to the Merger, PIPE Investment and the Transactions. |
(F) | Reflects the proceeds of $350.0 million from the issuance and sale of 35.0 million shares of Pagaya Class A Ordinary Shares at $10.00 per share pursuant to the PIPE Investment. The PIPE placement fees have been included within the above estimated transaction costs and will be recorded as a reduction to additional paid-in capital. |
(G) | Reflects the settlement of EJFA’s historical liabilities that will be settled upon the closing of the Merger. |
(H) | Represents pro forma adjustments to additional paid-in capital to reflect in case of no redemption the following: |
| | (In thousands) | | | ||
Payment of the estimated merger transaction cost—capitalizable | | | $(56,000) | | | (E) |
Issuance of Class A Ordinary Share—PIPE Investment, net par value | | | 349,996 | | | (F) |
Reclassification of EJFA ordinary shares subject to redemption, net par value | | | 287,497 | | | (I) |
Conversion of Pagaya preferred shares to Pagaya Ordinary Shares | | | 278,586 | | | (J) |
Recapitalization of Class A and B Ordinary Shares as part of the merger | | | (34) | | | (K) |
Incremental share-based compensation upon consummation of the merger | | | 104,611 | | | (L) |
Elimination of EJFA’s accumulated deficit | | | (59,584) | | | (M) |
Total | | | $905,072 | | | (H) |
(I) | Reflects the reclassification of the EJFA Class A Ordinary Shares subject to possible redemption of $287.5 million to permanent equity allocated between the EJFA Class A Ordinary Shares at par value $3 thousand and additional paid-in capital $287.5 million, immediately prior to the closing of the Merger. |
(J) | Reflects the conversion of Pagaya redeemable convertible preferred shares of $278.6 million into Pagaya Ordinary Shares with $278.5 million recorded within additional paid-in capital and remaining $22 thousand recorded within ordinary shares, par value. |
(K) | Reflects the recapitalization entry whereby Pagaya Ordinary Shares converted into Pagaya Class A Ordinary Shares and Pagaya Class B Ordinary Shares, pursuant to the Merger terms, including reflection of the Stock-Split. The ordinary share par value increased as a result of the recapitalization and the offset has been recorded within additional paid-in capital. This adjustment also reflects par value of the Pagaya Class A Ordinary Shares and Pagaya Class B Ordinary Shares issued as part of the PIPE Investment and the Transactions. |
(L) | In March 2021, Pagaya granted 1.2 million options to purchase restricted shares (the “Awards”) at an exercise price of approximately $295 per share to certain employees. These Awards will vest upon the earlier of the following vesting conditions to occur of (i) a Transaction (defined as (a) a sale of all or substantially all assets or shares of Pagaya; or (b) a merger, consolidation, amalgamation or like transaction; or (c) a scheme of arrangement for the purpose of effecting such sale, merger, consolidation, amalgamation or other transaction) and (ii) a Public Event (defined as an IPO or a SPAC) (each, an “Qualifying Event”). The Qualifying Event, further, contains additional market-based vesting condition driven by the total value of Pagaya. |
• | Share Price: The grant date fair value of the Ordinary share. |
• | Expected volatility: The volatility was determined using the peer companies. |
• | Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of issuance for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the Awards. |
• | Expected term: The expected term assumes period until the closing of the Merger plus the 10 year term of the Awards. |
• | Expected dividend yield: The expected dividend yield is zero as Pagaya has never declared or paid cash dividends and has no current plans to do so during the expected term. |
(M) | Reflects elimination of EJFA’s accumulated deficit balance of $59.6 million which consists of a balance of $35.7 million and incremental non-capitalizable EJFA transaction cost of $23.9 million. |
(N) | Reflects the proforma adjustments to accumulated deficit/retained earnings— |
| | (In thousands) | | | ||
Incremental share-based compensation upon consummation of the merger | | | $(104,611) | | | (L) |
Payment of the estimated merger transaction cost—non-capitalizable | | | (23,913) | | | (M) |
Elimination of EJFA accumulated deficit | | | 59,584 | | | (M) |
Total | | | $(68,940) | | | (N) |
| | EJFA | |||||||
in thousands (except share and per share data) | | | For the Nine Months Ended September 30, 2021 | | | For the Three Months Ended March 31, 2021 | | | For the Six Months Ended September 30, 2021 |
Formation and operating Costs | | | $1,495 | | | $93 | | | $1,402 |
Loss from Operations | | | (1,495) | | | (93) | | | (1,402) |
Other income: | | | | | | | |||
Bank interest income | | | — | | | — | | | — |
Interest income on marketable securities held in trust | | | 74 | | | 11 | | | 63 |
Offering cost allocated to warrants | | | (862) | | | (862) | | | — |
Excess of Private Placement Warrants fair value over purchase price | | | (1,242) | | | (1,242) | | | — |
Change in fair value of warrant liability | | | (1,503) | | | 9,489 | | | (10,992) |
Total other income/(loss) | | | (3,533) | | | 7,396 | | | (10,929) |
Net income | | | (5,028) | | | 7,303 | | | (12,331) |
Weighted average non-redeemable common share outstanding, basic and diluted | | | 22,431,319 | | | 9,583,333 | | | 28,750,000 |
Basic and diluted net income per non-redeemable common stock | | | (0.17) | | | 0.44 | | | (0.34) |
Weighted average common shares subject to possible redemption outstanding, basic and diluted | | | 6,981,456 | | | 7,187,500 | | | 7,187,500 |
Basic and diluted net income per common share subject to possible redemption | | | (0.17) | | | 0.44 | | | (0.34) |
| | For the Six Months Ended June 30, 2021 | | | For the Year Ended December 31, 2020 | |||||||
(in thousands, except share and per share data) | | | Assuming No Redemptions | | | Assuming Maximum Redemptions | | | Assuming No Redemptions | | | Assuming Maximum Redemptions |
Pro forma net loss | | | (44,865) | | | (44,865) | | | (88,241) | | | (88,241) |
| | For the Six Months Ended June 30, 2021 | | | For the Year Ended December 31, 2020 | |||||||
(in thousands, except share and per share data) | | | Assuming No Redemptions | | | Assuming Maximum Redemptions | | | Assuming No Redemptions | | | Assuming Maximum Redemptions |
Weighted average shares outstanding of Class A and Class B Stock | | | 965,522,006 | | | 936,772,006 | | | 965,522,006 | | | 936,772,006 |
Net loss per Share of Class A and Class B—Basic and Diluted | | | $(0.05) | | | $(0.05) | | | $(0.09) | | | $(0.09) |
Weighted average shares outstanding—Basic and diluted | | | | | | | | | ||||
Pagaya Shareholders | | | 894,584,506 | | | 894,584,506 | | | 894,584,506 | | | 894,584,506 |
EJFA—Public Shareholders | | | 28,750,000 | | | — | | | 28,750,000 | | | — |
EJFA—Sponsor | | | 7,187,500 | | | 7,187,500 | | | 7,187,500 | | | 7,187,500 |
PIPE Investors | | | 35,000,000 | | | 35,000,000 | | | 35,000,000 | | | 35,000,000 |
Total | | | 965,522,006 | | | 936,772,006 | | | 965,522,006 | | | 936,772,006 |
Pagaya Share Options | | | 172,663,854 |
Pagaya Warrants | | | 35,086,765 |
EJFA Public and Private Placement Warrants | | | 14,750,000 |
• | at least a majority of the votes cast by all shareholders who are not controlling shareholders and do not have a personal interest in such matter, present and voting at such meeting (excluding abstentions), are in favor of the compensation package; or |
• | the total number of votes cast by non-controlling shareholders and shareholders who do not have a personal interest in such matter voting against the compensation package does not exceed 2% of the aggregate voting rights in the company. |
• | recommending to the board of directors with respect to the approval of the compensation policy for “office holders” (a term used under the Companies Law, which essentially means directors and executive officers) and, once every three years, regarding any extensions to a compensation policy that has been in effect for a period of more than three years; |
• | reviewing the implementation of the compensation policy and periodically recommending to the board of directors with respect to any amendments or updates of the compensation plan; |
• | resolving whether or not to approve arrangements with respect to the terms of office and employment of office holders; and |
• | exempting, under certain circumstances, from the requirement of approval by the general meeting of shareholders, transactions with the chief executive officer of Pagaya. |
• | at least a majority of the votes cast by all shareholders who are not controlling shareholders and do not have a personal interest in such matter, present and voting at such meeting (excluding abstentions) are in favor of the compensation package; or |
• | the total number of votes cast by non-controlling shareholders and shareholders who do not have a personal interest in such matter voting against the compensation package does not exceed 2% of the aggregate voting rights in the company. |
• | the education, skills, experience, expertise and accomplishments of the relevant office holder; |
• | the office holder’s position, responsibilities and prior compensation agreements with him or her; |
• | the ratio between the cost of the terms of employment of an office holder and the cost of the employment of other employees of the company, including employees employed through contractors who provide services to the company, in particular the ratio between such cost, on the one hand, and the average and median cost of employment of such other employees of the company and its contractors, on the other hand, as well as the impact of such disparities on the work relationships in the company; |
• | if the terms of employment include variable components — the possibility of reducing variable components at the discretion of the board of directors and the possibility of setting a limit on the value of non-cash variable equity-based components; and |
• | if the terms of employment include severance compensation — the term of employment or office of the office holder, the terms of his or her compensation during such period, the company’s performance during such period, his or her individual contribution to the achievement of the company goals and the maximization of its profits and the circumstances under which he or she is leaving the company. |
• | with regard to variable components of compensation: |
• | with the exception of office holders who report directly to the chief executive officer, provisions determining the variable components on the basis of long-term performance and on measurable criteria; however, the company may determine that an immaterial part of the variable components of the compensation package of an office holder shall be awarded based on non-measurable criteria, if such amount is not higher than three monthly salaries per annum, while taking into account such office holder’s contribution to the company; and |
• | the ratio between variable and fixed components, as well as the limit on the values of variable components at the time of their grant. |
• | a condition under which the office holder will return to the company, according to conditions to be set forth in the compensation policy, any amounts paid as part of his or her terms of employment, if such amounts were paid based on information later to be discovered to be wrong, and such information was restated in the company’s financial statements; |
• | the minimum holding or vesting period of variable equity-based components to be set in the terms of office or employment, as applicable, while taking into consideration long-term incentives; and |
• | a limit on retirement grants. |
Name | | | Age | | | Title |
Gal Krubiner | | | 33 | | | Chief Executive Officer, Co-Founder and Director |
Avital Pardo | | | 36 | | | Chief Technology Officer, Co-Founder and Director |
Yahav Yulzari | | | 36 | | | Chief Revenue Officer, Co-Founder and Director |
Michael Kurlander | | | 43 | | | Chief Financial Officer |
Richmond Glasgow | | | 35 | | | General Counsel and Chief Compliance Officer |
Avi Zeevi | | | 70 | | | Director |
Dan Petrozzo | | | 57 | | | Director |
Harvey Golub | | | 82 | | | Director |
Mircea Ungureanu | | | 44 | | | Director |
Amy Pressman | | | 58 | | | Director |
Emanuel J. Friedman | | | 75 | | | Director |
| | Authorized | | | Issued and Outstanding | |
Pagaya Class A Ordinary Shares(1) | | | | | ||
Pagaya Class B Ordinary Shares(2) | | | | |
(1) | Based on the current outstanding shares and assuming no options or warrants will be exercised at Closing, and based on the conversion ratio, excluding all 14,750,000 EJFA Warrants. |
(2) | Based on the Founders’ options. |
• | directly or indirectly, whether by amendment, or through merger, recapitalization, consolidation or otherwise, amend or repeal, or adopt any provision of the Pagaya A&R Articles inconsistent with, or otherwise alter, any provision of the Pagaya A&R Articles that modifies the voting, conversion or other rights, powers, preferences, privileges or restrictions of the Pagaya Class B Ordinary Shares; |
• | reclassify any outstanding Pagaya Class A Ordinary Shares into shares having the right to more than one vote for each share thereof, except as required by law; |
• | issue any Pagaya Class B Ordinary Shares (other than Pagaya Class B Ordinary Shares originally issued by Pagaya after the Closing Date pursuant to the exercise or conversion of options or warrants that, in each case, are outstanding as of the Closing Date); |
• | authorize, or issue any shares of, any class or series of the Pagaya’s share capital having the right to more than one vote for each share thereof; and |
• | modify the rights attached to the Pagaya Class B Ordinary Shares. |
1. | (1)(a) such Founder’s employment or engagement as an officer of Pagaya being terminated not for Cause (as defined in the Pagaya A&R Articles), (b) such Founder’s resigning as an officer of Pagaya, (c) death or Permanent Disability (as defined in the Pagaya A&R Articles) of such Founder; provided, however, in such event, such Founder’s Pagaya Class B Ordinary Shares shall be transferred automatically to the other Founders, pro rata to their holdings, if the other Founders continue to hold Pagaya Class B Ordinary Shares at such time, or (d) the appointment of a receiver, trustee or similar official in bankruptcy or similar proceeding with respect to a Founder or his Pagaya Class B Ordinary Shares; and (2) such Founder no longer serving as a member of the Pagaya Board; |
2. | 90 days following the date on which such Founder first receives notice that his employment as an officer of Pagaya is terminated for Cause (as defined in the Pagaya A&R Articles), subject to extensions or cancellation under specified circumstances; or |
3. | a transfer of such Pagaya Class B Ordinary Shares to any person or entity other than a Permitted Class B Owner. |
• | amendments to the articles of association; |
• | appointment, terms of service and termination of services of auditors; |
• | appointment of directors, including external directors (if applicable); |
• | approval of certain related party transactions; |
• | increases or reductions of authorized share capital; |
• | a merger; and |
• | the exercise of the board of director’s powers by a general meeting, if the board of directors is unable to exercise its powers and the exercise of any of its powers is required for proper management of the company. |
(i) | an extraordinary transaction with a controlling shareholder or in which the controlling shareholder has a personal interest; |
(ii) | the terms of employment or other engagement of a controlling shareholder of the company or a controlling shareholder’s relative (even if such terms are not extraordinary); and |
(iii) | certain compensation-related matters described above under “Director and Executive Compensation—Compensation Committee” and “Director and Executive Compensation—Compensation Policy under the Companies Law.” |
| | Pagaya | | | EJFA | |
Authorized and Outstanding Capital Share | | | Upon the Closing, Pagaya’s authorized capital shall include two classes of shares: Pagaya Class A Ordinary Shares, no par value, and Pagaya Class B Ordinary Shares, no par value. | | | EJFA’s authorized share capital is $55,500 divided into 500,000,000 EJFA Class A Ordinary Shares, 50,000,000 EJFA Class B Ordinary Shares and 5,000,000 preference shares of a par value of $0.0001 each. |
| | | | |||
Special Meetings of Shareholders | | | Pursuant to the Companies Law, the Pagaya Board may whenever it thinks fit convene a special general meeting, and, as provided in the Companies Law, it shall be obliged to do so upon (i) the demand of two directors or one quarter of the serving directors; (ii) the demand of one or more shareholders holding at least five percent of Pagaya’s issued and outstanding share capital and one percent or more of Pagaya voting rights; or (iii) the demand of one or more shareholders holding at least five percent of Pagaya’s voting rights. | | | The Companies Act does not have provisions governing the proceedings of shareholders meetings which are usually provided in the articles of association. The EJFA Memorandum and Articles of Association allow the directors to call general meetings and do not allow shareholders to call general meetings otherwise than in circumstances where there are no directors appointed. |
| | | | |||
Voting | | | Generally, holders of Pagaya Class A Ordinary Shares and Pagaya Class B Ordinary Shares vote together as one | | | Generally, the holders of EJFA Class A Ordinary Shares and EJFA Class B Ordinary Shares shall vote as |
| | Pagaya | | | EJFA | |
| | class on all matters (including the election of directors), provided that holders of Pagaya Class A Ordinary Shares will be entitled to cast one vote per Pagaya Class A Ordinary Share, while holders of Pagaya Class B Ordinary Shares will be entitled to cast 10 votes per Class B share. See “Description of Pagaya Securities—Pagaya Ordinary Shares—Pagaya Class B Ordinary Shares—Conversion“ and “Description of Pagaya Securities—Anti-Takeover Measures” for further information regarding the voting rights and limitations associated with the Pagaya Class B Ordinary Shares. | | | a single class. Each shareholder will be entitled to cast one vote per share. | |
| | | | |||
Action by Written Consent | | | The Companies Law prohibits shareholder action by written consent in public companies such as Pagaya. | | | The EJFA Memorandum and Articles of Association permit shareholders to approve resolutions by way of unanimous written resolution. |
| | | | |||
Quorum | | | The quorum required for Pagaya’s general meetings of shareholders consists of at least two shareholders present in person or by proxy who hold or represent at least 331⁄3% of the total outstanding voting power of Pagaya’s shares, except that if (i) any such general meeting was initiated by and convened pursuant to a resolution adopted by the board of directors and (ii) at the time of such general meeting Pagaya qualifies as a “foreign private issuer,” the requisite quorum will consist of two or more shareholders present in person or by proxy who hold or represent at least 25% of the total outstanding voting power of Pagaya’s shares. Notwithstanding the foregoing, a quorum for any general meeting shall also require the presence in person or by proxy of at least one shareholder holding Pagaya Class B Ordinary Shares if such shares are outstanding. The requisite quorum shall be present within half an hour of the time fixed for the commencement of the general meeting. A general meeting adjourned | | | One or more shareholders holding at least a majority of the paid up voting share capital of EJFA present in person or by proxy and entitled to vote at that meeting shall be a quorum for a general meeting of EJFA. If within half an hour from the time appointed for the meeting a quorum is not present, the meeting, if convened upon the requisition of shareholders, shall be dissolved. In any other case it shall stand adjourned to the same day in the next week, at the same time and place, and if at the adjourned meeting a quorum is not present within half an hour from the time appointed for the meeting the shareholder or shareholders present and entitled to vote shall form a quorum. |
| | Pagaya | | | EJFA | |
| | for lack of a quorum shall be adjourned either (i) to the same day in the next week, at the same time and place as the original meeting, (ii) to such day and at such time and place as indicated in the notice to the original meeting with regard to an adjourned meeting, or (iii) to such day and at such time and place as the chairperson of the original meeting shall determine. At the reconvened meeting, one or more shareholders present in person or by proxy and holding any number of shares shall constitute a quorum, unless a meeting was called pursuant to a request by the Pagaya Shareholders, in which case the quorum required is one or more shareholders, present in person or by proxy and holding the number of shares required to call the meeting. No business shall be transacted at any adjourned meeting except business which might lawfully have been transacted at the meeting as originally called. | | | ||
| | | | |||
Notice of Meetings | | | Pursuant to the Companies Law, Pagaya Shareholder meetings generally require prior notice of not less than 21 days and, for certain matters specified in the Companies Law, not less than 35 days. Pursuant to the Pagaya A&R Articles, Pagaya is not required to deliver or serve prior notice of general meetings of Pagaya Shareholders or of any adjournments thereof to any Pagaya Shareholder, and notice by Pagaya which is published on its website and on the SEC’s EDGAR database or similar publication via the internet shall be deemed to have been duly given on the date of such publication to all Pagaya Shareholders. | | | The EJFA Memorandum and Articles of Association provide that at least five clear days’ notice shall be given of any general meeting. Every notice shall specify the place, the day and the hour of the meeting and the general nature of the business to be conducted at the general meeting. |
| | | ||||
Advance Notice Provisions | | | Pursuant to the Companies Law, the holder(s) of at least one percent of Pagaya’s voting rights may propose any matter appropriate for deliberation at a Pagaya Shareholder meeting to be included on the agenda of a Pagaya Shareholder meeting, | | | Members seeking to bring business before the annual general meeting of EJFA or to nominate candidates for appointment as directors at the annual general meeting must (1) deliver notice to the principal executive officer of EJFA not less |
| | Pagaya | | | EJFA | |
| | including nomination of candidates for directors, generally by submitting a proposal within seven days of publicizing the convening of a Pagaya Shareholder meeting, or, if Pagaya publishes a preliminary notice at least 21 days prior to publicizing the convening of a Pagaya Shareholder meeting stating its intention to convene such meeting and the agenda thereof, within fourteen days of such preliminary notice. Any such proposal must further comply with the information requirements under applicable law and the Pagaya A&R Articles. | | | than 120 days and not more than 150 days prior to the date of EJFA’s annual general meeting or, if EJFA did not hold an annual general meeting during the previous year, or if the date of the current year’s annual general meeting has been changed by more than 30 days from the date of the previous year’s annual general meeting, then the deadline shall be set by the directors with such deadline being a reasonable time before EJFA begins to print and send its related proxy materials, (2) have continuously held Shares equal to at least $2,000 in market value, or 1% of EJFA’s shares entitled to be voted on the proposal at the meeting for at least one year by the date of such notice or deadline, and (3) continue to hold those shares through the date of the annual general meeting. | |
| | | | |||
Charter Amendments | | | According to the Pagaya A&R Articles, all Pagaya Shareholder resolutions, including amendments to the Pagaya A&R Articles, generally require a majority of the voting power represented at the meeting and voting thereon. In addition, if no Pagaya Class B Ordinary Shares remain outstanding, the affirmative vote of the holders of at least 75% of the voting power of the Pagaya Shareholders shall be required to amend or alter Article 26 (relating to shareholder proposals); Article 39 (relating to the number of directors); Article 40 (relating to the election and removal of directors); and Articles 42 and 43 (relating to board vacancies). | | | Pursuant to the Companies Act, the EJFA Memorandum and Articles of Association may only be amended by a special resolution of the shareholders. |
| | | | |||
Size of Board, Election of Directors | | | The Pagaya A&R Articles provide that the number of directors shall be not less than three nor more than ten, including any external directors, if any are elected. There are currently 8 directors serving on the Pagaya Board. | | | Pursuant to the EJFA Memorandum and Articles of Association, there shall be a board of directors consisting of not less than one person and the maximum number of directors is unlimited. The directors are divided into three (3) classes designated as Class I, Class II and Class III, respectively. The directors |
| | Pagaya | | | EJFA | |
| | Under the Pagaya A&R Articles, the Pagaya Board will be divided into three classes, each consisting, as nearly as possible, of one third of the total number of directors (other than external directors, if applicable), with staggered three-year terms. At each annual general meeting commencing with the annual general meeting to be held in 2023, the directors of only one class (in succession, beginning with the first class, and except for any external director who may be elected under the Companies Law, whose term is determined in accordance with the Companies Law, as discussed below) will be brought up for election or reelection, to serve until the third annual general meeting next succeeding his or her election or reelection (unless removed earlier due to circumstances or events prompting immediate removal under the Companies Law or the Pagaya A&R Articles), and until his or her respective successor shall have been elected and qualified. Under the Companies Law, a public company must have at least two external directors who meet certain independence and non-affiliation criteria. In addition, although not required by Israeli law, Pagaya may classify a director as an “independent director” pursuant to the Companies Law if he or she meets certain conditions provided in the Companies Law. Pursuant to regulations promulgated under the Companies Law, companies with shares traded on certain U.S. stock exchanges, including Nasdaq, may, subject to certain conditions (primarily that the company does not have a 50% controlling shareholder), “opt out” of the Companies Law requirement to appoint external directors. In accordance with these regulations, and having determined that its Founders, both individually and as a group, are not controlling shareholders, the Pagaya Board has | | | are assigned to each class in accordance with a resolution or resolutions adopted by the board of directors. Commencing at EJFA’s first annual general meeting, and at each annual general meeting thereafter, directors appointed to succeed those directors whose terms expire shall be appointed for a term of office to expire at the third succeeding annual general meeting after their appointment. Additional directors and any vacancies in the board of directors, including unfilled vacancies resulting from the removal of directors, may be filled by (i) prior to the closing of an initial business combination the passing of an ordinary resolution of the holders of the EJFA Class B Ordinary Shares (only), or (ii) following the closing of an initial business combination, an ordinary resolution (of all the Shareholders entitled to vote). In addition, directors may appoint any person to be a director, either to fill a vacancy or as an additional director; provided that the appointment does not cause the number of directors to exceed any number fixed as the maximum number of directors. All directors shall hold office until the expiration of their respective terms of office and until their successors shall have been appointed and qualified. A director appointed to fill a vacancy resulting from the death, resignation or removal of a director shall serve for the remainder of the full term of the director whose death, resignation or removal shall have created such vacancy and until his successor shall have been appointed and qualified. |
| | Pagaya | | | EJFA | |
| | elected to “opt out” of the Companies Law requirement to appoint external directors. | | | ||
| | | | |||
Removal of Directors | | | The Pagaya Shareholders may remove any director from office, and elect a new director instead, by a vote of: (i) so long as any Pagaya Class B Ordinary Shares remain outstanding, a majority of the total voting power of the Pagaya Shareholders, and (ii) if no Pagaya Class B Ordinary Shares remain outstanding, at least 75% of the total voting power of the Pagaya Shareholders, provided that no such resolution may shorten the term of an incumbent director who was elected under the staggered board composition. | | | Prior to the closing of a business combination, the EJFA Public Shareholders may by ordinary resolution of the holders of the EJFA Class B Ordinary Shares remove any Director. Following the closing of a business combination, the EJFA Public Shareholders may by ordinary resolution (of all of the shares in issue) appoint any person to be a director of EJFA or may by ordinary resolution (of all of the shares in issue) remove any director of EJFA. |
| | | | |||
Board Vacancies and Newly Created Directorships | | | The Pagaya A&R Articles provide that in the event that one or more vacancies are created on the Pagaya Board, however arising, including a situation in which the number of directors is less than the maximum number permitted, the continuing directors may continue to act in every matter and the board of directors may appoint directors to temporarily fill any such vacancy. In the event that the vacancy creates a situation where the number of directors is less than three, the continuing directors may only act (i) in an emergency, or (ii) to fill the office of a director which has become vacant, or (iii) in order to call a general meeting of the Pagaya Shareholders for the purpose of electing directors to fill any and all vacancies. Each director appointed as a result of a vacancy shall hold office for the remaining period of time during which the director whose service has ended would have held office. | | | Pursuant to the EJFA Memorandum and Articles of Association, the directors may appoint any person to be a director, either to fill a vacancy or as an additional director provided that the appointment does not cause the number of directors to exceed any number fixed by or in accordance with the Articles as the maximum number of directors. |
| | | | |||
Corporate Opportunity | | | Under the Companies Law, directors and officers of a company are bound by a fiduciary duty toward the company, and are obliged to act in | | | The EJFA Memorandum and Articles of Association provide that, to the fullest extent permitted by applicable law: (i) no individual serving as a |
| | Pagaya | | | EJFA | |
| | good faith and in the best interests of the company at all times. Such fiduciary duty requires, among other things, to (i) refrain from any activity competitive with the business of the company, (ii) refrain from exploiting any business opportunity of the company for personal gain or for the benefit of others, and (iii) disclose to the company any information pertinent to its affairs and which came into the possession of the director or officer in their capacity as such. | | | director or an officer shall have any duty, except to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same of similar business activities or lines of business as EJFA; and (ii) EJFA renounces any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for any director of officer, on the one hand, and EJFA, on the other. | |
| | | | |||
Exclusive Forum | | | The Pagaya A&R Articles provide that unless Pagaya consents in writing to the selection of an alternative forum, (i) the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act, and (ii) the competent courts in Tel Aviv, Israel shall be the exclusive forum for (a) any derivative action or proceeding brought on behalf of Pagaya, (b) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of Pagaya to Pagaya or its shareholders, or (c) any action asserting a claim arising pursuant to any provision of the Companies Law or the Israeli Securities Law. This exclusive forum provision is intended to apply to claims arising under Israeli law and would not apply to claims brought pursuant to the Securities Act or the Exchange Act, or any other claim for which U.S. federal courts would have exclusive jurisdiction. Such exclusive forum provision in the Pagaya A&R Articles will not relieve Pagaya of its duties to comply with U.S. federal securities laws and the rules and regulations thereunder, and Pagaya’s shareholders will not be deemed to have waived Pagaya’s compliance with these laws, rules and regulations. This exclusive forum provision may limit a shareholder’s | | | No equivalent provision. |
| | Pagaya | | | EJFA | |
| | ability to bring a claim in a judicial forum of its choosing for disputes with Pagaya or its directors, officers or other employees, which may discourage lawsuits against Pagaya, its directors, officers and employees. | | | ||
| | | | |||
Limitation of Liability | | | The Pagaya A&R Articles provide that Pagaya may, subject and pursuant to the provisions of the Companies Law or other applicable law, exempt Pagaya directors and officers, in advance, from and against all liability for damages due to any breach of such director’s or officer’s duty of care to Pagaya. The Companies Law prohibits a company from relieving its directors and officers in advance from liability for breach of the duty of care in respect of a dividend distribution, among other things. | | | The EJFA Memorandum and Articles of Association provide that no EJFA director or officer shall be liable: (a) for the acts, receipts, neglects, defaults or omissions of any other director or officer or agent of EJFA; or (b) for any loss on account of defect of title to any property of EJFA; or (c) on account of the insufficiency of any security in or upon which any money of EJFA shall be invested; or (d) for any loss incurred through any bank, broker or other similar person; or (e) for any loss occasioned by any negligence, default, breach of duty, breach of trust, error of judgement or oversight on such indemnified person’s part; or (f) for any liability, obligation or duty to EJFA that may arise as a consequence of such indemnified person becoming aware of any business opportunity and failing to present such business opportunity to EJFA; or (g) for any loss, damage or misfortune whatsoever which may happen in or arise from the execution or discharge of the duties, powers, authorities, or discretions of such indemnified person’s office or in relation thereto; unless the same shall happen through such indemnified person’s own actual fraud, willful default or willful neglect as determined by a court of competent jurisdiction. |
| | | | |||
Indemnification and Advancement | | | The Pagaya A&R Articles provide that Pagaya may, subject and pursuant to the provisions of the Companies Law, the Israeli Securities Law, and the Israeli Economic Competition Law, 5748-1988, or any other applicable law, indemnify (both retroactively and in advance) and insure a director or officer of Pagaya | | | Cayman Islands law does not limit the extent to which a company’s articles of association may provide for indemnification of directors and officers, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against the |
| | Pagaya | | | EJFA | |
| | for all liabilities and expenses incurred by him or her arising from or as a result of any act (or omission) carried out by him or her as a director or officer of Pagaya and which is indemnifiable or insurable pursuant to applicable law, to the fullest extent permitted by law. The Companies Law provides that undertakings to indemnify a director or officer for such liabilities in advance be limited to specified foreseeable events and to reasonable maximum amounts or criteria. | | | consequences of committing a crime, or against the indemnified person’s own actual fraud, willful default, or dishonesty. |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the closing price of the Pagaya Class A Ordinary Shares equals or exceeds $18.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like and for certain issuances of Pagaya Class A Ordinary Shares and equity-linked securities for capital raising purposes in connection with the Closing as described elsewhere in this proxy statement/prospectus) for any 20 trading days within a 30 trading day period ending three Business Days before Pagaya sends to the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | for cash at a price of at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table included in the Warrant Agreement, based on the redemption date and the “fair market value” of the Pagaya Class A Ordinary Shares as described in the Warrant Agreement; and |
• | if, and only if, the last reported sale price of the Pagaya Class A Ordinary Shares equals or exceeds $10.00 per share (subject to adjustment in compliance with the terms of the Warrant Agreement) for any 20 trading days within a 30 trading-day period ending on, and including, the third trading day prior to the date on which we send the notice of redemption to the warrant holders. |
• | each person known by Pagaya to beneficially own more than 5% of the outstanding shares of Pagaya, taking into account the Preferred Share Conversion; |
• | each of Pagaya’s current executive officers and directors; and |
• | all of Pagaya’s current executive officers and directors as a group. |
| | Ordinary Shares | |||||||||||||
Name and Address of Beneficial Owner(1) | | | Class A Ordinary Shares | | | Class A % | | | Class B Ordinary Shares | | | Class B % | | | % of Total Voting Power |
Five Percent Holders: | | | | | | | | | | | |||||
Viola Ventures(3) | | | 100,841,797 | | | 21.84% | | | — | | | — | | | 4.18% |
Oak HC/FT(4) | | | 65,676,146 | | | 14.22% | | | — | | | — | | | 2.72% |
Internet Fund VI Pte. Ltd(5) | | | 71,812,888 | | | 14.94% | | | — | | | — | | | 2.96% |
Saro, L.P.(6) | | | 38,688,084 | | | 8.36% | | | — | | | — | | | 1.60% |
Clal Insurance Company Ltd.(7) | | | 43,027,079 | | | 9.32% | | | — | | | — | | | 1.78% |
Gal Krubiner(8) | | | | | | | 129,614,526 | | | 49.19% | | | 27.39% | ||
Yahav Yulzari(9) | | | | | | | 129,614,526 | | | 49.19% | | | 27.39% | ||
Avital Pardo(10) | | | | | | | 174,299,584 | | | 58.80% | | | 33.01% | ||
Current Directors and Executive Officers of Pagaya: | | | | | | | | | | | |||||
Harvey Golub(11) | | | 2,808,267 | | | * | | | — | | | — | | | * |
Gal Krubiner(8) | | | — | | | — | | | 129,614,526 | | | 49.19% | | | 27.39% |
Yahav Yulzari(9) | | | — | | | — | | | 129,614,526 | | | 49.19% | | | 27.39% |
Daniel Petrozzo(12) ** | | | 2,468,935 | | | * | | | — | | | — | | | * |
Avital Pardo(10) | | | — | | | — | | | 174,299,584 | | | 58.80% | | | 33.01% |
Avi Zeevi(13) ** | | | 1,696,470 | | | * | | | — | | | — | | | * |
Mircea Vladimir Ungureanu(14) ** | | | 1,696,470 | | | * | | | — | | | — | | | * |
Michael Kurlander(15) | | | — | | | — | | | — | | | — | | | * |
Richmond Glasgow(16) | | | 476,297 | | | * | | | | | | | * | ||
All Directors and Executive Officers of Pagaya as a Group(9) | | | 9,146,439 | | | 1.94% | | | 433,528,636 | | | 100% | | | 82.63% |
1 | Note to Draft: Numbers to be updated in subsequent filing. |
(1) | Unless otherwise noted, the business address of each beneficial owner is c/o Pagaya Technologies Ltd., Azrieli Sarona Bldg, 54th floor, Derech Menachem Begin 121, Tel-Aviv, Israel 6701203. |
(2) | Prior to the Effective Time, all outstanding Pagaya Preferred Shares will automatically be converted into Pagaya Ordinary Shares in accordance with Pagaya’s organizational documents. |
(3) | Represents 42,870,680 Pagaya Ordinary Shares held by Viola Ventures IV(A), L.P.; 44,791,565 Pagaya Ordinary Shares held by Viola Ventures IV(B), L.P.; 2,468,001 Pagaya Ordinary Shares held by Viola Ventures IV Principals Fund, L.P.; 660,725 Pagaya Ordinary Shares held by Viola Ventures IV CEO Program, L.P.; 7,318,423 Pagaya Ordinary Shares held by Viola IV P, L.P.; and 2,732,403 Pagaya Ordinary Shares held by Viola Credit Five Fund, L.P. Investment and voting power of the shares is exercised by. The business address of each of the foregoing persons is Ackerstein Towers, Bldg. D, 12 Abba Eban Blvd., Herzliya 46120, Israel. |
(4) | Represents 65,676,146 Pagaya Ordinary Shares. Investment and voting power of the shares is exercised by . The business address of Oak HC/FT is Pickwick Plaza, Greenwich, Connecticut 06830, USA. |
(5) | This entity is also known as Tiger Global. Represents (i) 52,711,293 Pagaya Ordinary Shares, and (ii) warrants to acquire 19,101,596 Pagaya Ordinary Shares. Includes up to 19,101,596 shares subject to performance-based vesting. Investment and voting power of the shares is exercised by . The business address of Tiger Global is 8 Temasek Boulevard, #32-02 Suntec Tower Three Singapore 038988. |
(6) | Represents (i) 37,446,422 Pagaya Ordinary Shares, and (ii) warrants to acquire 1,241,662 Pagaya Ordinary Shares. Investment and voting power of the shares is exercised by . Includes up to 1,241,662 shares subject to performance-based vesting. The business address of Saro, LP is 810 7th Ave, 28th floor, New York, NY 10019, USA. |
(7) | Represents 43,027,079 Pagaya Ordinary Shares. Investment and voting power of the shares is exercised by . The business address of Clal Insurance Company Ltd is . |
(8) | Represents (i) 28,370,240 Pagaya Ordinary Shares, (ii) 32,699,892 Pagaya Ordinary Shares held in trust for Gal Krubiner by Hamilton Trust Company of South Dakota LLC, as Trustee of the Azure Sea Trust (in trust for Gal Krubiner), (iii) 65,922,423 options to acquire Pagaya Ordinary Shares that are exercisable within 60 days of November 15, 2021, and (iv) 2,621,971 vested options to acquire Pagaya Ordinary Shares. Includes up to 65,922,423 shares subject to performance-based vesting. |
(9) | Represents (i) 61,070,132 Pagaya Ordinary Shares, (ii) 65,922,423 options to acquire Pagaya Ordinary Shares that are exercisable within 60 days of November 15, 2021, and (iii) 2,621,971 vested options to acquire Pagaya Ordinary Shares. Includes up to 65,922,423 shares subject to performance-based vesting. |
(10) | Represents (i) 72,794,259 Pagaya Ordinary Shares, (ii) 98,883,354 options to acquire Pagaya Ordinary Shares that are exercisable within 60 days of November 15, 2021] and (iii) 2,621,971 vested options to acquire Pagaya Ordinary Shares. Includes up to 98,883,354 shares subject to performance-based vesting. |
(11) | Represents 2,808,267 options to acquire Pagaya Ordinary Shares that are exercisable within 60 days of November 15, 2021. Includes up to 2,035,802 shares subject to performance-based vesting and 772,465 vested option to acquire Pagaya Ordinary Shares. |
(12) | Represents (i) 772,465 Pagaya Ordinary Shares, and (ii) 1,696,470 options to acquire Pagaya Ordinary Shares that are exercisable within 60 days of November 15, 2021. Includes up to 1,696,470 shares subject to performance-based vesting. |
(13) | Represents 1,696,470 options to acquire Pagaya Ordinary Shares that are exercisable within 60 days of November 15, 2021. Includes up to 1,696,470 shares subject to performance-based vesting. |
(14) | Represents 1,696,470 options to acquire Pagaya Ordinary Shares that are exercisable within 60 days of November 15, 2021. Includes up to 1,696,470 shares subject to performance-based vesting. |
(15) | Allocated equity based compensation is not exercisable within 60 days of November 15, 2021. |
(16) | Represents 476,297 options to acquire Pagaya Ordinary Shares that are exercisable within 60 days of November 15, 2021. |
• | each person known by EJFA to be the beneficial owner of more than 5% of the outstanding EJFA Ordinary Shares; |
• | each of EJFA’s named executive officers and directors; and |
• | all of EJFA’s executive officers and directors as a group. |
Name and Address of Beneficial Owner(1) | | | Number of Ordinary Shares Beneficially Owned | | | Approximate Percentage of Outstanding Ordinary Shares |
Wilson Boulevard LLC (our sponsor)(2)(3) | | | 7,027,500 | | | 19.6% |
Emanuel J. Friedman | | | — | | | |
Neal Wilson | | | — | | |
Name and Address of Beneficial Owner(1) | | | Number of Ordinary Shares Beneficially Owned | | | Approximate Percentage of Outstanding Ordinary Shares |
Kevin Stein | | | — | | | |
Thomas Mayrhofer | | | — | | | |
Erika Gray | | | — | | | |
Brian P. Brooks(2) | | | 40,000 | | | * |
Joan C. Conley(2) | | | 40,000 | | | * |
Campbell R. Dyer(2) | | | 40,000 | | | * |
Robert Wolf(2) | | | 40,000 | | | * |
all officers and directors as a group (9 individuals)(2) | | | 160,000 | | | * |
Citadel Advisors LLC(4) | | | 2,217,631 | | | 7.7% |
* | Less than one percent. |
(1) | Unless otherwise noted, the business address of each of the following is 2107 Wilson Boulevard, Suite 410, Arlington, Virginia 22201. |
(2) | Interests shown consist solely of EJFA Class B Ordinary Shares. Such shares will automatically convert into Pagaya Class A Ordinary Shares concurrently with or immediately following the consummation of the Merger on a one-for-one basis, subject to adjustment, as described in the section of this proxy statement/prospectus entitled “Description of Pagaya Securities.” Interests shown do not include any indirect interests attributable to any of our officers or directors as a result of any economic interests in EJF Capital. After the consummation of the Merger, the Sponsor and its affiliates are also expected to own the EJFA Private Placement warrants to purchase an additional 5,166,667 Pagaya Class A Ordinary Shares. The preceding table does not reflect record or beneficial ownership of the EJFA Private Placement Warrants as those warrants are not exercisable within 60 days of the date of November 15, 2021. Such EJFA Private Placement Warrants will not be exercisable until the earlier of (a) the date that is 12 months following the Closing Date and (b) the date on which the VWAP equals or exceeds $12.50 for any 20 trading days within any 30 consecutive trading day period, except such restrictions will not be lifted pursuant to (b) above prior to the date that is 180 days following the Closing Date. Assuming the exercise of all of the warrants held by the Sponsor and its affiliates (and none of the EJFA Public Warrants) the Sponsor and its affiliates would be deemed to own Pagaya Class A Ordinary Shares, which constitutes % of the Pagaya Ordinary Shares outstanding as of assuming no redemptions by EJFA Public Shareholders, or % of the Pagaya Class A Ordinary Shares outstanding as of assuming maximum redemptions by EJFA Public Shareholders, in each case on a fully diluted basis. |
(3) | Wilson Boulevard LLC, the Sponsor, is the record holder of such shares. The managing member of the Sponsor is EJF Capital. EJF Capital may be deemed to have beneficial ownership of the shares. Certain of our officers and directors have invested in the LLC interests of the Sponsor. |
(4) | Based on information contained in a Schedule 13G filed on September 15, 2021 by Citadel Advisors LLC (“Citadel Advisors”), Citadel Advisors Holdings LP (“CAH”), Citadel GP LLC (“CGP”), Citadel Securities LLC (“Citadel Securities”), CALC IV LP (“CALC4”), Citadel Securities GP LLC (“CSGP”) and Mr. Kenneth Griffin (collectively, the “Reporting Persons”) with respect to the EJFA Class A Ordinary Shares owned by Citadel Multi-Strategy Equities Master Fund Ltd., a Cayman Islands company (“CM”), and Citadel Securities. The Reporting Persons reported that they beneficially owned an aggregate of 2,217,631 shares of EJFA Class A Ordinary Shares. Specifically, (i) Citadel Advisors beneficially owns 2,213,884 EJFA Class A Ordinary Shares, (ii) CAH beneficially owns 2,213,884 EJFA Class A Ordinary Shares, (iii) CGP beneficially owns 2,213,884 EJFA Class A Ordinary Shares, (iv) Citadel Securities beneficially owns 3,747 EJFA Class A Ordinary Shares, (v) CALC4 beneficially owns 3,747 EJFA Class A Ordinary Shares, (vi) CSGP beneficially owns 3,747 EJFA Class A Ordinary Shares and (vii) Mr. Griffin beneficially owns 2,217,631 EJFA Class A Ordinary Shares. Citadel Advisors is the portfolio manager for CM. CAH is the sole member of Citadel Advisors. CGP is the general partner of CAH. CALC4 is the non-member manager of Citadel Securities. CSGP is the general partner of CALC4. Mr. Griffin is the President and Chief Executive Officer of CGP, and owns a controlling interest in CGP and CSGP. The business address of the Reporting Persons is 131 S. Dearborn Street, 32nd Floor, Chicago, Illinois 60603. |
• | each person known by Pagaya who will beneficially own more than 5% of the outstanding shares of any class or series of Pagaya’s voting securities immediately after the consummation of the Merger; |
• | each person who will be an executive officer or director of Pagaya upon the consummation of the business combination; and |
• | all of Pagaya’s executive officers and directors as a group upon the consummation of the business combination. |
Beneficial Owner(1) | | | Post-Merger Assuming No Redemption(2) | | | Post-Merger Assuming Maximum Redemption | ||||||||||||||||||||||||
| | Pagaya Class A Ordinary Shares | | | Pagaya Class B Ordinary Shares | | | % of Total Voting Power | | | Pagaya Class A Ordinary Shares | | | Pagaya Class B Ordinary Shares | | | % of Total Voting Power | |||||||||||||
| | Number | | | % | | | Number | | | % | | | % | | | Number | | | % | | | Number | | | % | | | % | |
Five Percent or More Holders: | | | | | | | | | | | | | | | | | | | | | ||||||||||
Viola Ventures(3) | | | 100,841,797 | | | 21.84% | | | — | | | — | | | 4.18% | | | 100,841,797 | | | 23.29% | | | — | | | — | | | 4.23% |
Oak HC/FT(4) | | | 65,676,146 | | | 14.22% | | | — | | | — | | | 2.72% | | | 65,676,146 | | | 15.17% | | | — | | | — | | | 2.76% |
Internet Fund VI Pte. Ltd(5) | | | 71,812,888 | | | 14.94% | | | — | | | — | | | 2.96% | | | 71,812,888 | | | 15.89% | | | — | | | — | | | 2.99% |
Saro, L.P.(6) | | | 38,688,084 | | | 8.36% | | | — | | | — | | | 1.60% | | | 38,688,084 | | | 8.91% | | | — | | | — | | | 1.62% |
Clal Insurance Company Ltd.(7) | | | 43,027,079 | | | 9.32% | | | — | | | — | | | 1.78% | | | 43,027,079 | | | 9.94% | | | — | | | — | | | 1.81% |
Gal Krubiner(8) | | | — | | | — | | | 129,614,526 | | | 49.19% | | | 27.39% | | | — | | | — | | | 129,614,526 | | | 49.19% | | | 27.71% |
Yahav Yulzari(9) | | | — | | | — | | | 129,614,526 | | | 49.19% | | | 27.39% | | | — | | | — | | | 129,614,526 | | | 49.19% | | | 27.71% |
Avital Pardo(10) | | | — | | | — | | | 174,299,584 | | | 58.80% | | | 33.01% | | | — | | | — | | | 174,299,584 | | | 58.80% | | | 33.39% |
Post-Merger Directors and Officers of Pagaya: | | | | | | | | | | | | | | | | | | | | | ||||||||||
Harvey Golub(11) | | | 2,035,802 | | | * | | | — | | | — | | | * | | | 2,035,802 | | | * | | | — | | | — | | | * |
Gal Krubiner(8) | | | — | | | — | | | 129,614,526 | | | 49.19% | | | 27.39% | | | — | | | — | | | 129,614,526 | | | 49.19% | | | 27.71% |
Yahav Yulzari(9) | | | — | | | — | | | 129,614,526 | | | 49.19% | | | 37.39% | | | — | | | — | | | 129,614,526 | | | 49.19% | | | 27.71% |
Daniel Petrozzo(12) | | | 2,468,935 | | | * | | | — | | | — | | | * | | | 2,468,935 | | | * | | | — | | | — | | | * |
Avital Pardo(10) | | | — | | | — | | | 174,299,584 | | | 58.80% | | | 33.01% | | | — | | | — | | | 174,299,584 | | | 58.80% | | | 33.39% |
Avi Zeevi(13) | | | 1,696,470 | | | * | | | — | | | — | | | * | | | 1,696,470 | | | * | | | — | | | — | | | * |
Mircea Vladimir Ungureanu(14) | | | 1,696,470 | | | * | | | — | | | — | | | * | | | 1,696,470 | | | * | | | — | | | — | | | — |
Michael Kurlander(15) | | | — | | | * | | | — | | | — | | | * | | | 0 | | | * | | | — | | | — | | | * |
Richmond Glasgow(16) | | | 476,297 | | | * | | | — | | | — | | | * | | | 476,297 | | | * | | | — | | | — | | | * |
Emanuel J. Friedman | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — |
All Post-Merger Directors and Officers of Pagaya as a Group (10 Persons) | | | 8,373,974 | | | 1.78% | | | 433,528,636 | | | 100% | | | 82.63% | | | 8,373,974 | | | 1.90% | | | 433,528,636 | | | 100% | | | 83.53% |
(1) | Unless otherwise noted, the business address of each beneficial owner is c/o Pagaya Technologies Ltd., Azrieli Sarona Bldg, 54th floor, Derech Menachem Begin 121, Tel-Aviv, Israel 6701203. |
(2) | Prior to the Effective Time, all outstanding Pagaya Preferred Shares will automatically be converted into Pagaya Ordinary Shares in accordance with Pagaya’s organizational documents. |
(3) | Represents 42,870,680 Pagaya Ordinary Shares held by Viola Ventures IV(A), L.P.; 44,791,565 Pagaya Ordinary Shares held by Viola Ventures IV(B), L.P.; 2,468,001 Pagaya Ordinary Shares held by Viola Ventures IV Principals Fund, L.P.; 660,725 Pagaya Ordinary Shares held by Viola Ventures IV CEO Program, L.P.; 7,318,423 Pagaya Ordinary Shares held by Viola IV P, L.P.; and 2,732,403 Pagaya Ordinary Shares held by Viola Credit Five Fund, L.P. Investment and voting power of the shares is exercised by •. The business address of each of the foregoing persons is Ackerstein Towers, Bldg. D, 12 Abba Eban Blvd., Herzliya 46120, Israel. |
(4) | Represents 65,676,146 Pagaya Ordinary Shares. Investment and voting power of the shares is exercised by . The business address of Oak HC/FT is Pickwick Plaza, Greenwich, Connecticut 06830, USA. |
(5) | This entity is also known as Tiger Global. Represents (i) 52,711,293 Pagaya Ordinary Shares, and (ii) warrants to acquire 19,101,596 Pagaya Ordinary Shares. Includes up to 19,101,596 shares subject to performance-based vesting. Investment and voting power of the shares is exercised by. The business address of Tiger Global is 8 Temasek Boulevard, #32-02 Suntec Tower Three Singapore 038988. |
(6) | Represents (i) 37,446,422 Pagaya Ordinary Shares, and (ii) warrants to acquire 1,241,662 Pagaya Ordinary Shares. Investment and voting power of the shares is exercised by . Includes up to 1,241,662 shares subject to performance-based vesting. The business address of Saro, LP is 810 7th Ave, 28th floor, New York, NY 10019, USA. |
(7) | Represents 43,027,079 Pagaya Ordinary Shares. Investment and voting power of the shares is exercised by . The business address of Clal Insurance Company Ltd is . |
(8) | Represents (i) 28,370,240 Pagaya Ordinary Shares, (ii) 32,699,892 Pagaya Ordinary Shares held in trust for Gal Krubiner by Hamilton Trust Company of South Dakota LLC, as Trustee of the Azure Sea Trust (in trust for Gal Krubiner), (iii) 65,922,423 options to acquire Pagaya Ordinary Shares that are exercisable within 60 days of November 15, 2021, and (iv) 2,621,971 vested options to acquire Pagaya Ordinary Shares. Includes up to 65,922,423 shares subject to performance-based vesting. |
(9) | Represents (i) 61,070,132 Pagaya Ordinary Shares, (ii) 65,922,423 options to acquire Pagaya Ordinary Shares that are exercisable within 60 days of November 15, 2021, and (iii) 2,621,971 vested options to acquire Pagaya Ordinary Shares. Includes up to 65,922,423 shares subject to performance-based vesting. |
(10) | Represents (i) 72,794,259 Pagaya Ordinary Shares, (ii) 98,883,354 options to acquire Pagaya Ordinary Shares that are exercisable within 60 days of November 15, 2021] and (iii) 2,621,971 vested options to acquire Pagaya Ordinary Shares. Includes up to 98,883,354 shares subject to performance-based vesting. |
(11) | Represents 2,808,267 options to acquire Pagaya Ordinary Shares that are exercisable within 60 days of November 15, 2021. Includes up to 2,035,802 shares subject to performance-based vesting and 772,465 vested option to acquire Pagaya Ordinary Shares. |
(12) | Represents (i) 772,465 Pagaya Ordinary Shares, and (ii) 1,696,470 options to acquire Pagaya Ordinary Shares that are exercisable within 60 days of November 15, 2021. Includes up to 1,696,470 shares subject to performance-based vesting. |
(13) | Represents 1,696,470 options to acquire Pagaya Ordinary Shares that are exercisable within 60 days of November 15, 2021. Includes up to 1,696,470 shares subject to performance-based vesting. |
(14) | Represents 1,696,470 options to acquire Pagaya Ordinary Shares that are exercisable within 60 days of November 15, 2021. Includes up to 1,696,470 shares subject to performance-based vesting. |
(15) | Allocated equity based compensation is not exercisable within 60 days of November 15, 2021. |
(16) | Represents 476,297 options to acquire Pagaya Ordinary Shares that are exercisable within 60 days of November 15, 2021. |
| | Price Range of EJFA Units | | | Price Range of EJFA Class A Ordinary Shares | | | Price Range of EJFA Public Warrants | ||||||||||
| | Low | | | High | | | Low | | | High | | | Low | | | High | |
2022 | | | | | | | | | | | | | ||||||
Quarter ended March 31 (through January 20) | | | $10.20 | | | $11.25 | | | $9.85 | | | $10.00 | | | $1.00 | | | $1.445 |
2021 | | | | | | | | | | | | | ||||||
Quarter ended December 31 | | | $10.18 | | | $10.71 | | | $9.85 | | | $10.10 | | | $1.18 | | | $1.88 |
Quarter ended September 30 | | | $9.85 | | | $10.40 | | | $9.60 | | | $9.90 | | | $0.55 | | | $1.64 |
Quarter ended June 30 | | | $9.90 | | | $10.05 | | | $9.53 | | | $10.00 | | | $0.531 | | | $0.93 |
Quarter ended March 31 | | | $9.875 | | | $10.10 | | | $ | | | $ | | | $ | | | $ |
• | the judgment was rendered by a court which was, according to the laws of the state of the court, competent to render the judgment; |
• | the obligation imposed by the judgment is enforceable according to the rules relating to the enforceability of judgments in Israel and the substance of the judgment is not contrary to public policy; and |
• | the judgment is executory in the state in which it was given. |
• | the judgment was given in a state whose laws do not provide for the enforcement of judgments of Israeli courts (subject to exceptional cases); |
• | the enforcement of the judgment is likely to prejudice the sovereignty or security of the State of Israel; |
• | the judgment was obtained by fraud; |
• | the opportunity given to the defendant to bring its arguments and evidence before the court was not reasonable in the opinion of the Israeli court; |
• | the judgment was rendered by a court not competent to render it according to the laws of private international law as they apply in Israel; |
• | the judgment is contradictory to another judgment that was given in the same matter between the same parties and that is still valid; or |
• | at the time the action was brought in the foreign court, a lawsuit in the same matter and between the same parties was pending before a court or tribunal in Israel. |
| | Page | |
Unaudited Financial Statements of Pagaya Technologies Ltd. | | | |
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
Audited Financial Statements of Pagaya Technologies Ltd. | | | |
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
Unaudited Financial Statements of EJF Acquisition Corp. | | | |
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
Audited Financial Statements of EJF Acquisition Corp. | | | |
| | ||
| | ||
| | ||
| | ||
| | ||
| |
| | June 30, 2021 | | | December 31, 2020 | |
Assets | | | | | ||
Cash and cash equivalents | | | $42,504 | | | $5,066 |
Restricted cash | | | 25,840 | | | 814 |
Short-term deposits | | | 149,514 | | | 58,432 |
Fees receivable (including related party receivables of $34,661 and $23,985 as of June 30, 2021, and December 31, 2020, respectively) | | | 34,661 | | | 23,985 |
Investments in loans and securities | | | 185,981 | | | 109,262 |
Equity method investments | | | 23,409 | | | 1,351 |
Property and equipment, net | | | 2,137 | | | 1,534 |
Deferred tax assets, net | | | 4,224 | | | 2,303 |
Prepaid expenses and other assets (including related party receivables of $24,736 and $790 as of June 30, 2021, and December 31, 2020, respectively) | | | 27,288 | | | 1,525 |
Total Assets | | | $495,558 | | | $204,272 |
Liabilities, Redeemable Convertible Preferred Shares, and Shareholders’ Equity | | | | | ||
Liabilities: | | | | | ||
Accounts payable | | | $3,495 | | | $581 |
Accrued expenses and other liabilities (including related party payables of $818 and $291 as of June 30, 2021, and December 31, 2020, respectively) | | | 5,581 | | | 3,686 |
Redeemable convertible preferred shares warrant liability | | | 21,488 | | | 2,471 |
Income taxes payable | | | 12,810 | | | 3,408 |
Total liabilities | | | 43,374 | | | 10,146 |
Commitments and contingencies (Note 6) | | | | | ||
Redeemable convertible preferred shares, NIS 0.01 par value; 2,206,243 and 2,018,896 shares authorized at June 30, 2021, and December 31, 2020; 2,154,949 and 1,722,210 shares issued and outstanding at June 30, 2021, and December 31, 2020, respectively; liquidation preference of $389,107 and $118,342 at June 30, 2021, and December 31, 2020, respectively | | | 278,608 | | | 105,981 |
Shareholders’ equity: | | | | | ||
Ordinary shares, NIS 0.01 par value; 8,258,757 and 8,446,104 shares authorized at June 30, 2021, and December 31, 2020; 1,022,478 and 1,018,949 shares issued and outstanding at June 30, 2021, and December 31, 2020, respectively | | | 3 | | | 3 |
Additional paid-in capital | | | 103,927 | | | 312 |
Retained earnings (Accumulated deficit) | | | (73,265) | | | 2,885 |
Total Pagaya Technologies Ltd. shareholders’ equity | | | 30,665 | | | 3,200 |
Non-Controlling interests | | | 142,911 | | | 84,945 |
Total shareholders’ equity | | | 173,576 | | | 88,145 |
Total Liabilities, Redeemable Convertible Preferred Shares, and Shareholders’ Equity | | | $495,558 | | | $204,272 |
| | For the Six Months Ended June 30, | ||||
| | 2021 | | | 2020 | |
Revenue | | | | | ||
Revenue from fees (including related party revenues of $173,455 and $22,975 for the periods ended December 31, 2020 and 2019, respectively) | | | $173,455 | | | $22,975 |
Other Income | | | | | ||
Interest income | | | 9,801 | | | 3,045 |
Investment income | | | 12 | | | 237 |
Total Revenue and Other Income | | | 183,268 | | | 26,257 |
Costs and Operating Expenses | | | | | ||
Research and development | | | 39,412 | | | 5,280 |
Sales and marketing | | | 28,403 | | | 1,598 |
General and administrative | | | 34,107 | | | 2,980 |
Production costs | | | 99,774 | | | 13,710 |
Total Costs and Operating Expenses | | | 201,696 | | | 23,568 |
Operating Income (Loss) | | | (18,428) | | | 2,689 |
Other expense, net | | | (18,771) | | | (51) |
Income (Loss) Before Income Taxes | | | (37,199) | | | 2,638 |
Income tax expense | | | 7,793 | | | 113 |
Net Income (Loss) and Comprehensive Income (Loss) | | | $(44,992) | | | $2,525 |
Net Income and Comprehensive Income Attributable to Noncontrolling Interests | | | 7,546 | | | 2,353 |
Net Income (Loss) and Comprehensive Income (Loss) Attributable to Pagaya Technologies Ltd. shareholders | | | $(52,538) | | | $172 |
Per share data: | | | | | ||
Net income (Loss) attributable to Pagaya Technologies Ltd. ordinary shareholders—and diluted | | | $(52,538) | | | $172 |
Less: Undistributed earnings allocated to participating securities | | | (8,559) | | | (1,903) |
Less: Deemed dividend distribution | | | (23,612) | | | — |
Net loss attributable to Pagaya Technologies Ltd. Ordinary shareholders basic | | | $(84,709) | | | $(1,731) |
Weighted average ordinary shares outstanding—basic and diluted | | | 1,036,688 | | | 1,026,122 |
Net loss per share attributable to Pagaya Technologies Ltd. ordinary shareholders — basic and diluted | | | $(81.71) | | | $(1.69) |
| | Redeemable Convertible Preferred Shares | | | Ordinary shares | | | Additional Paid-In Capital | | | Retained Earnings (Accumulated Deficit) | | | Total Pagaya Technologies Ltd. Shareholders’ Equity (Deficit) | | | Non- Controlling interests | | | Total Shareholders’ Equity | |||||||
Six Months Ended June 30, 2021 | | | Shares | | | Amount | | | Shares | | | Amount | | ||||||||||||||
Balance as of December 31, 2020 | | | 1,722,210 | | | $105,981 | | | 1,018,949 | | | $3 | | | $312 | | | $2,885 | | | $3,200 | | | $84,945 | | | $88,145 |
Issuance of Series D convertible preferred share, net of issuance costs of $11 | | | 245,392 | | | 36,639 | | | — | | | — | | | — | | | — | | | — | | | — | | | — |
Issuance of Series E convertible preferred share, net of issuance costs of $202 | | | 187,347 | | | 135,988 | | | — | | | — | | | — | | | — | | | — | | | — | | | — |
Issuance of ordinary shares upon exercise of share options | | | — | | | — | | | 3,529 | | | — | | | 17 | | | — | | | 17 | | | — | | | 17 |
Share-based compensation | | | — | | | — | | | — | | | — | | | 59,117 | | | — | | | 59,117 | | | — | | | 59,117 |
Deemed Contribution (Note 9) | | | — | | | — | | | — | | | — | | | 23,612 | | | — | | | 23,612 | | | — | | | 23,612 |
Deemed dividend distribution (Note 9) | | | — | | | — | | | — | | | — | | | — | | | (23,612) | | | (23,612) | | | — | | | (23,612) |
Issuance of ordinary share warrants, net of issuance costs of $30 | | | — | | | — | | | — | | | — | | | 20,869 | | | — | | | 20,869 | | | — | | | 20,869 |
Contributions of interests in consolidated VIEs | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | 83,788 | | | 83,788 |
Return of capital to interests in consolidated VIEs | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (33,368) | | | (33,368) |
Net Income (loss) and Comprehensive Income (loss) | | | — | | | — | | | — | | | — | | | — | | | (52,538) | | | (52,538) | | | 7,546 | | | (44,992) |
Balance as of June 30, 2021 | | | 2,154,949 | | | $278,608 | | | 1,022,478 | | | $3 | | | $103,927 | | | ($73,265) | | | $30,665 | | | $142,911 | | | $173,576 |
| | Redeemable Convertible Preferred Shares | | | Ordinary shares | | | Additional Paid-In Capital | | | Retained Earnings | | | Total Pagaya Technologies Ltd. Shareholders’ Equity (Deficit) | | | Non- Controlling interests | | | Total Shareholders’ Equity | |||||||
Six Months Ended June 30, 2020 | | | Shares | | | Amount | | | Shares | | | Amount | | ||||||||||||||
Balance as of December 31, 2019 | | | 1,284,656 | | | $43,613 | | | 1,009,447 | | | $3 | | | $156 | | | ($11,585) | | | ($11,426) | | | $24,801 | | | $13,375 |
Issuance of Series D convertible preferred shares, net of issuance costs of $405 | | | 341,473 | | | 48,146 | | | — | | | — | | | — | | | — | | | — | | | — | | | — |
Issuance of ordinary shares upon exercise of share options | | | — | | | — | | | 4,104 | | | — | | | — | | | — | | | — | | | — | | | — |
Share-based compensation | | | — | | | — | | | — | | | — | | | 50 | | | — | | | 50 | | | — | | | 50 |
Contributions of interests in consolidated VIEs | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | 15,921 | | | 15,921 |
Return of capital to interests in consolidated VIEs | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (6,257) | | | (6,257) |
Net Income and Comprehensive Income | | | — | | | — | | | — | | | — | | | — | | | 172 | | | 172 | | | 2,353 | | | 2,525 |
Balance as of June 30, 2020 | | | 1,626,129 | | | $91,759 | | | 1,013,551 | | | $3 | | | $206 | | | ($11,413) | | | ($11,204) | | | $36,818 | | | $25,614 |
| | For the Six Months Ended June 30, | ||||
| | 2021 | | | 2020 | |
Cash Flows from Operating Activities | | | | | ||
Net Income (loss) | | | $(44,992) | | | $2,525 |
Adjustments to reconcile net income to net cash used in operating activities: | | | | | ||
Equity method income | | | (12) | | | (237) |
Depreciation and amortization | | | 282 | | | 110 |
Share-based compensation | | | 59,117 | | | 50 |
Remeasurement of redeemable convertible preferred share warrant liability | | | 19,017 | | | (5) |
Change in operating assets and liabilities: | | | | | ||
Fees receivable (including related party fees receivable of $(10,676) and $(7,545) for the periods ended June 30, 2021 and 2020, respectively) | | | (10,676) | | | (7,574) |
Deferred tax assets, net | | | (1,921) | | | — |
Prepaid expenses and other assets (including related party receivables of $(23,946) and $733 for the periods ended June 30, 2021 and 2020, respectively) | | | (25,763) | | | 444 |
Accounts payable | | | 2,914 | | | 380 |
Accrued expenses and other liabilities (including related party accrued expenses and other liabilities of $527 and $47 for the periods ended June 30, 2021 and 2020, respectively) | | | 1,895 | | | 498 |
Income tax accrual | | | 9,402 | | | 130 |
Net Cash provided by (Used in) Operating Activities | | | 9,263 | | | (3,679) |
Cash Flows from Investing Activities | | | | | ||
Additions to property, equipment and software | | | (885) | | | (466) |
Investment in loans and securities | | | (118,825) | | | (21,893) |
Amounts received from investments in loans and securities | | | 42,106 | | | 7,703 |
Investment in short-term deposits | | | (91,082) | | | (1,229) |
Amounts received from equity method investments | | | 954 | | | 238 |
Amounts paid to equity method investments | | | (23,000) | | | — |
Net Cash Used in Investing Activities | | | (190,732) | | | (15,647) |
Cash Flows from Financing Activities | | | | | ||
Proceeds received from noncontrolling interests | | | 83,788 | | | 15,921 |
Distribution made to noncontrolling interests | | | (33,368) | | | (6,257) |
Proceeds from issuance of redeemable convertible preferred shares, net | | | 193,496 | | | 50,588 |
Proceeds from exercise of share options | | | 17 | | | — |
Net Cash Provided by Financing Activities | | | 243,933 | | | 60,252 |
Net Increase in Cash, Cash Equivalents, and Restricted Cash | | | 62,464 | | | 40,926 |
Cash, cash equivalents, and restricted cash, beginning of period | | | 5,880 | | | 4,878 |
Cash, Cash Equivalents, and Restricted Cash, End of Period | | | $68,344 | | | $45,804 |
1. | BUSINESS DESCRIPTION |
2. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
| | June 30, 2021 | | | June 30, 2020 | |
Services transferred at a point in time | | | $153,819 | | | $14,264 |
Services transferred over time | | | 19,636 | | | 8,711 |
Total revenue from fees, net | | | $173,455 | | | $22,975 |
3. | BALANCE SHEET COMPONENTS |
| | June 30, 2021 | | | December 31, 2020 | |
Computer and software | | | $2,147 | | | $1,415 |
Equipment | | | 216 | | | 161 |
Leasehold improvements | | | 478 | | | 380 |
Property and equipment, gross | | | 2,841 | | | 1,956 |
Less accumulated depreciation and amortization | | | (704) | | | (422) |
Property and equipment, net | | | $2,137 | | | $1,534 |
| | June 30, 2021 | | | December 31, 2020 | |
Related party receivables | | | $24,736 | | | $790 |
Prepaid expenses | | | 913 | | | 410 |
Other assets | | | 1,639 | | | 325 |
Total Prepaid expenses and other assets | | | $27,288 | | | $1,525 |
| | June 30, 2021 | | | December 31, 2020 | |
Employee payables | | | $5,420 | | | $2,744 |
Other short-term liabilities | | | 161 | | | 942 |
Total accrued expenses and other liabilities | | | $5,581 | | | $3,686 |
4. | INVESTMENTS |
| | June 30, 2021 | ||||||||||
| | Amortized Cost | | | Gross Unrealized Gains | | | Gross Unrealized Losses | | | Fair Value | |
ABS - Consumer and Auto Loan | | | $185,608 | | | $7,664 | | | $— | | | $193,272 |
Other loans and receivables | | | 373 | | | — | | | — | | | 373 |
Total Investment Securities | | | $185,981 | | | $7,664 | | | $— | | | $193,645 |
| | December 31, 2020 | ||||||||||
| | Amortized Cost | | | Gross Unrealized Gains | | | Gross Unrealized Losses | | | Fair Value | |
ABS - Consumer and Auto Loan | | | $108,765 | | | $4,531 | | | $— | | | $113,296 |
Other loans and receivables | | | 497 | | | — | | | — | | | 497 |
Total Investment Securities | | | $109,262 | | | $4,531 | | | $— | | | $113,793 |
Equity Method Investments | | | Carrying Value as of June 30, 2021 | | | Carrying Value as of December 31, 2020 |
Investments | | | $23,409 | | | $1,351 |
Total Equity Method Investments | | | $23,409 | | | $1,351 |
5. | CONSOLIDATION AND VARIABLE INTEREST ENTITIES |
| | Carrying Amount | | | Net Assets | ||||
| | Assets | | | Liabilities | | |||
As of June 30, 2021 | | | $177,225 | | | $— | | | $177,225 |
As of December 31, 2020 | | | $106,339 | | | $— | | | $106,339 |
| | Carrying Amount | | | Maximum Exposure to Loss | | | VIE Assets | ||||
| | Assets | | | Liabilities | | ||||||
As of June 30, 2021 | | | $13,560 | | | $— | | | $13,560 | | | $553,420 |
As of December 31, 2020 | | | $3,524 | | | $— | | | $3,524 | | | $329,315 |
6. | COMMITMENTS AND CONTINGENCIES |
| | Minimum Rent Commitment | |
2021 (the remainder of the year) | | | $1,949 |
2022 | | | 3,576 |
2023 | | | 2,999 |
2024 | | | 3,036 |
2025 | | | 2,057 |
Thereafter | | | 11,356 |
Total | | | $24,973 |
7. | TRANSACTIONS WITH RELATED PARTIES |
8. | FAIR VALUE MEASUREMENT |
| | At June 30, 2021 | |||||||||||||
| | Carrying Value | | | Fair Value | ||||||||||
| | Level 1 | | | Level 2 | | | Level 3 | | | Total | ||||
Assets | | | | | | | | | | | |||||
Cash and cash equivalents | | | $68,344 | | | $68,334 | | | $— | | | $— | | | $68,344 |
Short-term deposits | | | 149,514 | | | 149,514 | | | — | | | — | | | 149,514 |
Investments in loans and securities | | | 185,981 | | | — | | | — | | | 193,645 | | | 193,645 |
Fees receivable | | | 34,661 | | | — | | | 34,661 | | | — | | | 34,661 |
Total | | | $438,500 | | | $217,858 | | | $34,661 | | | $193,645 | | | $446,164 |
| | At December 31, 2020 | |||||||||||||
| | Carrying Value | | | Fair Value | ||||||||||
| | Level 1 | | | Level 2 | | | Level 3 | | | Total | ||||
Assets | | | | | | | | | | | |||||
Cash and cash equivalents | | | $5,880 | | | $5,880 | | | $— | | | $— | | | $5,880 |
Short-term deposits | | | 58,432 | | | 58,432 | | | — | | | — | | | 58,432 |
Investments in loans and securities | | | 109,262 | | | — | | | — | | | 113,793 | | | 113,793 |
Fees receivable | | | 23,985 | | | — | | | 23,985 | | | — | | | 23,985 |
Total | | | $197,559 | | | $64,312 | | | $23,985 | | | $113,793 | | | $202,090 |
| | Warrant Liability | | | The Option | |
Opening balance, January 1, 2020 | | | $83 | | | $— |
Issuance of Series D warrants / the Option | | | 1,899 | | | 543 |
Chang in fair value | | | 489 | | | (543) |
Closing balance, December 31, 2020 | | | $2,471 | | | $— |
Change in fair value | | | 19,017 | | | — |
Closing balance, June 30, 2021 | | | $21,488 | | | $— |
9. | REDEEMABLE CONVERTIBLE PREFERRED SHARES AND REDEEMABLE CONVERTIBLE PREFERRED SHARES WARRANTS |
| | June 30, 2021 | |||||||||||||
| | Shares Authorized | | | Shares Issued and Outstanding | | | Issuance Price Per Share | | | Carrying Value | | | Aggregate Liquidation Preference | |
Series A | | | 370,370 | | | 370,370 | | | $3.38 | | | $1,243 | | | $1,775 |
Series A-1 | | | 179,398 | | | 172,857 | | | 18.90 | | | 3,254 | | | 4,338 |
Series B | | | 412,554 | | | 397,931 | | | 35.81 | | | 14,223 | | | 17,334 |
Series C | | | 343,498 | | | 343,498 | | | 72.57 | | | 24,893 | | | 29,096 |
Series D | | | 713,076 | | | 682,946 | | | 149.35 | | | 99,007 | | | 176,388 |
Series E | | | 187,347 | | | 187,347 | | | 838.49 | | | 135,988 | | | 160,176 |
| | 2,206,243 | | | 2,154,949 | | | | | $278,608 | | | $389,107 |
| | December 31, 2020 | |||||||||||||
| | Shares Authorized | | | Shares Issued and Outstanding | | | Issuance Price Per Share | | | Carrying Value | | | Aggregate Liquidation Preference | |
Series A | | | 370,370 | | | 370,370 | | | $3.38 | | | $1,243 | | | $1,717 |
Series A-1 | | | 179,398 | | | 172,857 | | | 18.90 | | | 3,254 | | | 4,195 |
Series B | | | 412,554 | | | 397,931 | | | 35.81 | | | 14,223 | | | 16,762 |
Series C | | | 343,498 | | | 343,498 | | | 72.57 | | | 24,893 | | | 28,136 |
Series D | | | 713,076 | | | 437,554 | | | 149.35 | | | 62,368 | | | 67,532 |
| | 2,018,896 | | | 1,772,210 | | | | | $105,981 | | | $118,342 |
(i) | in the event that the Preferred Majority consents in writing to such conversion; provided. However, with respect to the conversion of the Series E Preferred Shares, the consent or affirmative vote of the Series E Preferred Shares Majority shall also be required unless such conversion occurs in connection with a transaction pursuant to which the holders of Preferred E Shares receive consideration per Preferred E Share at least equal to the Preferred E Preference Amount; or |
(ii) | immediately prior to the closing of a Public Event, subject to the consummation of such Public Event. |
| | June 1, 2020 | |
Price of the Underlying Shares | | | $137.88 |
Exercise Price | | | $149.35 |
Expected Term | | | 0.38 |
Risk Free Rate | | | 0.10% |
Volatility | | | 16% |
Series B warrants: | | | June 30, 2021 | | | December 31, 2020 |
Probability of Occurrence of IPO | | | 40% | | | N/A |
Volatility | | | 44% | | | 44% |
Time to exit (years) | | | 1.25 | | | 1.5 |
Exercise Price | | | $27.36 | | | $27.36 |
Risk Free Rate | | | 0.12% | | | 0.12% |
Series D warrants: | | | June 30, 2021 | | | December 31, 2020 |
Probability of Occurrence of IPO | | | 40% | | | N/A |
Probability of achieving the vesting condition | | | 77% | | | 58% |
Volatility | | | 44% | | | 44% |
Time to exit (years) | | | 1.25 | | | 1.50 |
Exercise Price | | | $0.01 | | | $0.01 |
Risk Free Rate | | | 0.12% | | | 0.12% |
10. | ORDINARY SHARE AND ORDINARY SHARE WARRANTS |
| | June 30, 2021 | | | December 31, 2020 | |
Redeemable convertible preferred shares, all series | | | 2,154,949 | | | 1,722,210 |
Ordinary share options outstanding | | | 1,772,852 | | | 245,786 |
Warrants to purchase redeemable convertible preferred shares | | | 43,079 | | | 43,079 |
Warrants to purchase ordinary shares | | | 144,183 | | | — |
Shares available for future grant of equity awards | | | 241,347 | | | 114,197 |
Total shares of ordinary shares reserved | | | 4,356,410 | | | 2,125,272 |
11. | SHARE BASED COMPENSATION |
| | Options Available for Grant | | | Number of Options | | | Weighted- Average Exercise Price | | | Weighted- Average Remaining Contractual Term (Years) | | | Aggregate Intrinsic Value (000’s) | |
Balance, December 31, 2020 | | | 114,197 | | | 245,786 | | | $11.88 | | | 9.1 | | | $2,905 |
Authorized | | | 268,944 | | | | | | | | | ||||
Granted | | | (144,978) | | | 144,978 | | | 67.49 | | | — | | | — |
Exercised | | | — | | | (3,529) | | | 4.78 | | | — | | | — |
Forfeited, expired, or cancelled | | | 3,184 | | | (3,184) | | | 78.56 | | | — | | | — |
Balance, June 30, 2021 | | | 241,347 | | | 384,051 | | | $31.20 | | | 9.0 | | | $186,036 |
Vested and exercisable, June 30, 2021 | | | | | 94,088 | | | $6.75 | | | 8.1 | | | $47,939 |
| | June 30, 2021 | | | June 30, 2020 | |
Expected volatility | | | 44.90% | | | 48.65% |
Expected term (in years) | | | 5.0 – 6.3 | | | 5.7 – 6.1 |
Risk-free interest | | | 0.71%-1.12% | | | 0.42%-0.45% |
Dividend yield | | | — | | | — |
| | Options Available for Grant | | | Number of Options | | | Weighted- Average Exercise Price | | | Weighted- Average Remaining Contractual Term (Years) | | | Aggregate Intrinsic Value (000’s) | |
Balance, December 31, 2020 | | | — | | | — | | | $— | | | — | | | $— |
Authorized | | | 1,245,863 | | | | | | | | | ||||
Granted | | | (1,245,863) | | | 1,245,863 | | | 295.02 | | | — | | | — |
Exercised | | | — | | | — | | | — | | | — | | | — |
Forfeited, expired, or cancelled | | | — | | | | | — | | | — | | | — | |
Balance, June 30, 2021 | | | — | | | 1,245,863 | | | $295.02 | | | 9.7 | | | $275,649 |
Vested and exercisable, June 30, 2021 | | | | | — | | | $295.02 | | | 9.7 | | | $— |
| | June 30, 2021 | | | June 30, 2020 | |
Research and Development | | | $25,074 | | | $30 |
Selling and Marketing | | | 16,779 | | | 1 |
General and Administrative | | | 17,264 | | | 19 |
Total | | | $59,117 | | | $50 |
12. | INCOME TAXES |
13. | NET LOSS PER SHARE ATTRIBUTABLE TO ORDINARY SHAREHOLDERS |
| | June 30, 2021 | | | June 30, 2020 | |
Net loss per share – basic and diluted | | | | | ||
Numerator: | | | | | ||
Net income (loss) attributable to Pagaya Technologies Ltd. shareholders | | | $(52.538) | | | $172 |
Less: Undistributed earnings allocated to participating securities | | | (8,559) | | | (1,903) |
Less: Deemed dividend distribution | | | (23,612) | | | — |
Net loss attributable to attributable to Pagaya Technologies Ltd. ordinary shareholders, basic | | | (84,709) | | | (1,731) |
Denominator: | | | | | ||
Weighted average shares used in computing net loss per ordinary share, basic and diluted | | | 1,036,688 | | | 1,026,122 |
Net loss per share attributable to common shareholders, basic and diluted | | | $(81.71) | | | $(1.69) |
| | June 30, 2021 | | | June 30, 2020 | |
Share-based options | | | 358,644 | | | 87,089 |
Options to restricted shares | | | 1,245,683 | | | — |
Preferred share warrants | | | 43,079 | | | 43,079 |
Ordinary share warrants | | | 144,183 | | | — |
Redeemable convertible preferred shares | | | 2,154,949 | | | 1,626,129 |
Total net potential dilutive outstanding securities | | | 3,946,538 | | | 1,756,297 |
14. | SEGMENTS AND GEOGRAPHICAL INFORMATION |
| | June 30, 2021 | | | June 30, 2020 | |
United States | | | 153,508 | | | 17,780 |
Cayman Islands | | | 16,329 | | | 2,672 |
Israel | | | 3,618 | | | 2,523 |
Total Revenue | | | $173,455 | | | $22,975 |
| | June 30, 2021 | | | December 31, 2020 | |
Israel | | | $1,893 | | | $1,455 |
United States | | | 244 | | | 79 |
Total Long-Lived Assets, net | | | $2,137 | | | $1,534 |
15. | SUBSEQUENT EVENTS |
| | Kost Forer Gabbay & Kasierer 144 Menachem Begin Road, Building A, Tel-Aviv 6492102, Israel | | | Tel: +972-3-6232525 Fax: +972-3-5622555 ey.com |
| | December 31, | ||||
| | 2020 | | | 2019 | |
Assets | | | | | ||
Cash and cash equivalents | | | $5,066 | | | $4,828 |
Restricted cash | | | 814 | | | 50 |
Short-term deposits | | | 58,432 | | | 10,079 |
Fees receivable (including related party receivables of $23,985 and $4,265 as of December 31, 2020 and 2019, respectively) | | | 23,985 | | | 4,265 |
Investments in loans and securities | | | 109,262 | | | 35,605 |
Equity method investments | | | 1,351 | | | 1,404 |
Property and equipment, net | | | 1,534 | | | 727 |
Deferred tax assets, net | | | 2,303 | | | — |
Prepaid expenses and other assets (including related party receivables of $790 and $1,712 as of December 31, 2020 and 2019, respectively) | | | 1,525 | | | 1,668 |
Total Assets | | | $204,272 | | | $58,626 |
Liabilities: | | | | | ||
Accounts payable | | | $581 | | | $154 |
Accrued expenses and other liabilities (including related party payables of $291 and $159 as of December 31,2020 and 2019, respectively ) | | | 3,686 | | | 1,229 |
Redeemable convertible preferred shares warrant liability | | | 2,471 | | | 83 |
Income taxes payable | | | 3,408 | | | 172 |
Total liabilities | | | 10,146 | | | 1,638 |
Commitments and contingencies (Note 7) | | | | | ||
Redeemable convertible preferred shares, NIS 0.01 par value, 2,018,896 and 1,305,820 shares authorized at December 31, 2020 and 2019; 1,722,210 and 1,284,656 shares issued and outstanding at December 31, 2020 and 2019, respectively; liquidation preference of $118,342 and $47,478 at December 31, 2020 and 2019, respectively | | | 105,981 | | | 43,613 |
Shareholders’ equity (deficit): | | | | | ||
Ordinary shares, NIS 0.01 par value; 8,446,104 and 9,159,180 shares authorized at December 31, 2020 and 2019; 1,018,949 and 1,009,447 shares issued and outstanding at December 31, 2020 and 2019, respectively | | | 3 | | | 3 |
Additional paid in capital | | | 312 | | | 156 |
Retained earnings (Accumulated deficit) | | | 2,885 | | | (11,585) |
Total Pagaya Technologies Ltd. shareholders’ equity (deficit) | | | 3,200 | | | (11,426) |
Non-Controlling interests | | | 84,945 | | | 24,801 |
Total shareholders’ equity | | | 88,145 | | | 13,375 |
Total Liabilities, Redeemable Convertible Preferred Shares and Shareholders’ Equity | | | $204,272 | | | $58,626 |
| | For the Year Ended December 31, | ||||
| | 2020 | | | 2019 | |
Revenue | | | | | ||
Revenue from fees (including related party revenues of $91,740 and $32,313 for the years ended December 31, 2020 and 2019, respectively) | | | $91,740 | | | $32,313 |
Other Income | | | | | ||
Interest income | | | 6,993 | | | 3,614 |
Investment income | | | 277 | | | 214 |
Total Revenue and Other Income | | | 99,010 | | | 36,141 |
Costs and Operating Expenses | | | | | ||
Research and development | | | 12,332 | | | 5,434 |
Sales and marketing | | | 5,668 | | | 2,458 |
General and administrative | | | 10,672 | | | 4,184 |
Production costs | | | 49,085 | | | 27,969 |
Total Costs and Operating Expenses | | | 77,757 | | | 40,045 |
Operating Income (Loss) | | | 21,253 | | | (3,904) |
Other expense, net | | | (55) | | | (124) |
Income (Loss) Before Income Taxes | | | 21,198 | | | (4,028) |
Income tax expense | | | 1,276 | | | 172 |
Net Income (Loss) and Comprehensive Income (Loss) | | | 19,922 | | | (4,200) |
Net Income and Comprehensive Income Attributable to Noncontrolling Interests | | | 5,452 | | | 1,420 |
Net Income (Loss) and Comprehensive Income (Loss) Attributable to Pagaya Technologies Ltd. shareholders | | | $14,470 | | | $(5,620) |
Per share data: | | | | | ||
Net income (loss) attributable to Pagaya Technologies Ltd. ordinary shareholders | | | $14,470 | | | $(5,620) |
Less: Undistributed earnings allocated to participated securities | | | (9,558) | | | (2,748) |
Net income (loss) attributed to Pagaya Technologies Ltd. Ordinary shareholders – basic | | | $4,912 | | | $(8,368) |
Weighted average ordinary shares outstanding – basic | | | 1,022,959 | | | 1,017,033 |
Net income (loss) per share attributable to Pagaya Technologies Ltd. ordinary shareholders – basic | | | $4.80 | | | $(8.23) |
Net income (loss) attributable to Pagaya Technologies Ltd. ordinary shareholders – diluted | | | $4,608 | | | $(8,580) |
Weighted average ordinary shares outstanding – diluted | | | 1,107,349 | | | 1,023,029 |
Net income (loss) per share attributable to Pagaya Technologies Ltd. ordinary shareholders – diluted | | | $4.16 | | | $(8.39) |
| | Redeemable Convertible Preferred Shares | | | Ordinary shares | | | Additional Paid-In Capital | | | Retained Earnings (Accumulated Deficit) | | | Total Pagaya Technologies, Ltd. Shareholders’ Equity (Deficit) | | | Non Controlling interests | | | Total Shareholders’ Equity | |||||||
| | Shares | | | Amount | | | Shares | | | Amount | | |||||||||||||||
Balance – December 31, 2018 | | | 941,158 | | | $18,720 | | | 1,001,297 | | | $3 | | | $82 | | | $(5,965) | | | $(5,880) | | | $— | | | $(5,880) |
Issuance of Series C convertible preferred shares, net of issuance costs of $35 | | | 343,498 | | | 24,893 | | | — | | | — | | | — | | | — | | | — | | | — | | | $— |
Issuance of ordinary shares upon exercise of share options | | | — | | | — | | | 8,150 | | | — | | | — | | | — | | | — | | | — | | | $— |
Share-based compensation | | | — | | | — | | | — | | | — | | | 74 | | | — | | | 74 | | | — | | | $74 |
Contributions of interests in consolidated VIEs | | | | | | | | | | | | | | | | | 24,673 | | | $24,673 | |||||||
Return of capital to interests in consolidated VIEs | | | | | | | | | | | | | | | | | (1,292) | | | $(1,292) | |||||||
Net Loss and Comprehensive Loss | | | — | | | — | | | — | | | — | | | — | | | (5,620) | | | (5,620) | | | 1,420 | | | $(4,200) |
Balance – December 31, 2019 | | | 1,284,656 | | | $43,613 | | | 1,009,447 | | | $3 | | | $156 | | | $(11,585) | | | $(11,426) | | | $24,801 | | | $13,375 |
Issuance of Series D convertible preferred shares, net of issuance costs of $412 | | | 341,473 | | | 48,146 | | | — | | | — | | | — | | | — | | | — | | | — | | | $— |
Exercise of the Option, net of issuance cost of $128 | | | 96,081 | | | 14,222 | | | — | | | — | | | — | | | — | | | — | | | — | | | $— |
Issuance of ordinary shares upon exercise of share options | | | — | | | — | | | 9,502 | | | — | | | — | | | — | | | — | | | — | | | $— |
Share-based compensation | | | — | | | — | | | — | | | — | | | 156 | | | — | | | 156 | | | — | | | $156 |
Contributions of interests in consolidated VIEs | | | | | | | | | | | | | | | | | 74,560 | | | $74,560 | |||||||
Return of capital to interests in consolidated VIEs | | | — | | | — | | | | | | | | | | | | | (19,868) | | | $(19,868) | |||||
Net Income and Comprehensive Income | | | — | | | — | | | — | | | — | | | — | | | 14,470 | | | 14,470 | | | 5,452 | | | $19,922 |
Balance – December 31, 2020 | | | 1,722,210 | | | $105,981 | | | 1,018,949 | | | $3 | | | $312 | | | $2,885 | | | $3,200 | | | $84,945 | | | $88,145 |
| | Year Ended December 31, | ||||
| | 2020 | | | 2019 | |
Cash Flows from Operating Activities | | | | | ||
Net Income (Loss) | | | $19,922 | | | $(4,200) |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | | | | | ||
Equity method income | | | (277) | | | (214) |
Depreciation and amortization | | | 290 | | | 91 |
Share-based compensation | | | 156 | | | 74 |
Remeasurement of redeemable convertible preferred shares warrant liability | | | 489 | | | (212) |
Gain from the extinguishment of the Option | | | (543) | | | — |
Change in operating assets and liabilities: | | | | | ||
Fees receivable (including related party fees receivable of $(19,720) and $(3,783) for the years ended December 31, 2020 and 2019, respectively) | | | (19,720) | | | (3,783) |
Deferred tax assets, net | | | (2,303) | | | — |
Prepaid expenses and other assets (including related party receivables of $922 and $(904) for the years ended December 31, 2020 and 2019, respectively) | | | 123 | | | (799) |
Accounts payable | | | 427 | | | (40) |
Accrued expenses and other liabilities (including related accrued expenses of $132 and $95 for the years ended December 31, 2020 and 2019, respectively) | | | 2,457 | | | 965 |
Income tax accrual | | | 3,236 | | | 172 |
Net Cash Provided by (Used in) Operating Activities | | | 4,257 | | | (7,946) |
Cash Flows from Investing Activities | | | | | ||
Additions to property, equipment and software | | | (1,097) | | | (666) |
Investment in loans and securities | | | (102,665) | | | (38,401) |
Amounts received from investment in loans and securities | | | 29,008 | | | 2,796 |
Investment in short-term deposits | | | (48,353) | | | (67) |
Amounts received from equity method investments | | | 350 | | | 534 |
Amounts paid to equity method investments | | | — | | | (435) |
Net Cash Used in Investing Activities | | | (122,757) | | | (36,239) |
Cash Flows from Financing Activities | | | | | ||
Short term loans | | | — | | | (1,736) |
Proceeds received from noncontrolling interests | | | 74,560 | | | 24,673 |
Distribution made to noncontrolling interests | | | (19,868) | | | (1,292) |
Proceeds from issuance of redeemable convertible preferred shares, net | | | 64,810 | | | 24,893 |
Net Cash Provided by Financing Activities | | | 119,502 | | | 46,538 |
Net Increase in Cash, Cash Equivalents and Restricted Cash | | | 1,002 | | | 2,353 |
Cash, cash equivalents and restricted cash, beginning of year | | | 4,878 | | | 2,525 |
Cash, Cash Equivalents and Restricted Cash, End of Year | | | $5,880 | | | $4,878 |
Supplemental Disclosures of Cash Flow Information | | | | | ||
Cash paid for Interest | | | $— | | | $45 |
Cash paid for Taxes | | | 324 | | | 5 |
Supplemental disclosure of non-cash financing activity | | | | | ||
Issuance of redeemable convertible Series D preferred share warrants | | | $1,899 | | | $— |
Issuance of the Option | | | 543 | | | — |
1. | BUSINESS DESCRIPTION |
2. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
| | December 31, | ||||
| | 2020 | | | 2019 | |
Cash and cash equivalents | | | $5,066 | | | $4,828 |
Restricted cash | | | 814 | | | 50 |
Cash, cash equivalents and restricted cash | | | $5,880 | | | $4,878 |
Computer and software | | | 3 to 7 years |
Equipment | | | 3 to 7 years |
Leasehold improvements | | | Shorter of remaining lease term or estimated useful life (10 years) |
Internal-Use Software | | | 5 years |
1. | Identification of the contract with the customer: |
2. | Identification of the performance obligations in the contract: |
3. | Determination of the transaction price: |
4. | Allocation of the transaction price to the performance obligations in the contract: |
5. | Recognition of revenue when, or as, a performance obligation is satisfied: |
| | December 31, | ||||
| | 2020 | | | 2019 | |
Services transferred at a point in time | | | $75,180 | | | $27,969 |
Services transferred over time | | | 16,560 | | | 4,344 |
Total revenue from fees | | | $91,740 | | | $32,313 |
3. | BALANCE SHEET COMPONENTS |
| | December 31, | ||||
| | 2020 | | | 2019 | |
Computer and software | | | $1,415 | | | $444 |
Equipment | | | 161 | | | 117 |
Leasehold improvements | | | 380 | | | 298 |
Property and equipment, gross | | | 1,956 | | | 859 |
Less: accumulated depreciation and amortization | | | (422) | | | (132) |
Property and equipment, net | | | $1,534 | | | $727 |
| | December 31, | ||||
| | 2020 | | | 2019 | |
Employee payables | | | $2,744 | | | $860 |
Other short-term liabilities | | | 942 | | | 369 |
Total accrued expenses and other liabilities | | | $3,686 | | | $1,229 |
4. | INVESTMENTS |
| | December 31, 2020 | ||||||||||
| | Amortized Cost | | | Gross Unrealized Gains | | | Gross Unrealized Losses | | | Fair Value | |
ABS - Consumer and Auto Loan | | | $108,765 | | | 4,531 | | | $— | | | $113,296 |
Other loans and receivables | | | 497 | | | — | | | — | | | 497 |
Total Investment Securities | | | $109,262 | | | $4,531 | | | $— | | | $113,793 |
| | December 31, 2019 | ||||||||||
| | Amortized Cost | | | Gross Unrealized Gains | | | Gross Unrealized Losses | | | Fair Value | |
ABS - Consumer and Auto Loan | | | $35,243 | | | $— | | | $— | | | $35,243 |
Other loans and receivables | | | 362 | | | — | | | — | | | 362 |
Total Investment Securities | | | $35,605 | | | $— | | | $— | | | $35,605 |
Equity Method Investments | | | Carrying Value as of December 31, 2020 | | | Carrying Value as of December 31, 2019 |
Investments | | | 1,351 | | | 1,404 |
Total Equity Method Investments | | | $1,351 | | | $1,404 |
5. | CONSOLIDATION AND VARIABLE INTEREST ENTITIES |
| | Assets | | | Liabilities | | | Net Assets | |
As of December 31, 2020 | | | $106,339 | | | $— | | | $106,339 |
As of December 31, 2019 | | | $31,326 | | | $— | | | $31,326 |
| | Carrying Amount | | | Maximum Exposure to Loss | | | VIE Assets | ||||
| | Assets | | | Liabilities | | ||||||
As of December 31, 2020 | | | $3,524 | | | $— | | | $3,524 | | | $329,315 |
As of December 31, 2019 | | | $5,015 | | | $— | | | $5,015 | | | $464,840 |
6. | EMPLOYEE BENEFITS |
7. | COMMITMENTS AND CONTINGENCIES |
Year Ending December 31, | | | |
2021 | | | $2,412 |
2022 | | | 2,421 |
2023 | | | 2,322 |
2024 | | | 2,330 |
Total | | | $9,485 |
8. | TRANSACTIONS WITH RELATED PARTIES |
9. | FAIR VALUE MEASUREMENT |
| | At December 31, 2020 | |||||||||||||
| | | | Fair Value | |||||||||||
| | Carrying Value | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
Assets | | | | | | | | | | | |||||
Cash and cash equivalents | | | $5,880 | | | $5,880 | | | $— | | | $— | | | $5,880 |
Short-term deposits | | | 58,432 | | | 58,432 | | | — | | | — | | | 58,432 |
Investments in loans and securities | | | 109,262 | | | — | | | — | | | 113,793 | | | 113,793 |
Fees receivable | | | 23,985 | | | — | | | 23,985 | | | — | | | 23,985 |
Total | | | $197,559 | | | $64,312 | | | $23,985 | | | $113,793 | | | $202,090 |
| | At December 31, 2019 | |||||||||||||
| | | | Fair Value | |||||||||||
| | Carrying Value | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
Assets | | | | | | | | | | | |||||
Cash and cash equivalents | | | $4,878 | | | $4,878 | | | $— | | | $— | | | $4,878 |
Short-term deposits | | | 10,079 | | | 10,079 | | | — | | | — | | | 10,079 |
Investments in loans and securities | | | 35,605 | | | — | | | — | | | 35,605 | | | 35,605 |
Fees receivable | | | 4,265 | | | — | | | 4,265 | | | — | | | 4,265 |
Total | | | $54,827 | | | $14,957 | | | $4,265 | | | $35,605 | | | $54,827 |
| | Warrant Liability | | | The Option | |
Opening balance, January 1, 2019 | | | $295 | | | $— |
Modification of warrants | | | (229) | | | — |
Change in fair value | | | 17 | | | — |
Closing balance, December 31, 2019 | | | 83 | | | — |
Issuance of Series D warrants / the Option | | | 1,899 | | | 543 |
Change in fair value / extinguishment of the Option | | | 489 | | | (543) |
Closing balance, December 31, 2020 | | | $2,471 | | | $— |
10. | REDEEMABLE CONVERTIBLE PREFERRED SHARES AND REDEEMABLE CONVERTIBLE PREFERRED SHARES WARRANTS |
| | December 31, 2020 | |||||||||||||
| | Shares Authorized | | | Shares Issued and Outstanding | | | Issuance Price Per Share | | | Carrying Value | | | Aggregate Liquidation Preference | |
Series A | | | 370,370 | | | 370,370 | | | $3.38 | | | $1,243 | | | $1,717 |
Series A-1 | | | 179,398 | | | 172,857 | | | 18.90 | | | 3,254 | | | 4,195 |
Series B | | | 412,554 | | | 397,931 | | | 35.81 | | | 14,223 | | | 16,762 |
Series C | | | 343,498 | | | 343,498 | | | 72.57 | | | 24,893 | | | 28,136 |
Series D | | | 713,076 | | | 437,554 | | | 149.35 | | | 62,368 | | | 67,532 |
| | 2,018,896 | | | 1,722,210 | | | | | $105,981 | | | $118,342 |
| | December 31, 2019 | |||||||||||||
| | Shares Authorized | | | Shares Issued and Outstanding | | | Issuance Price Per Share | | | Carrying Value | | | Aggregate Liquidation Preference | |
Series A | | | 370,370 | | | 370,370 | | | $3.38 | | | $1,243 | | | $1,604 |
Series A-1 | | | 179,398 | | | 172,857 | | | 18.90 | | | 3,254 | | | 3,920 |
Series B | | | 412,554 | | | 397,931 | | | 35.81 | | | 14,223 | | | 15,663 |
Series C | | | 343,498 | | | 343,498 | | | 72.57 | | | 24,893 | | | 26,291 |
| | 1,305,820 | | | 1,284,656 | | | | | $43,613 | | | $47,478 |
(iii) | in the event that the Preferred Majority consents in writing to such conversion; provided, however, with respect to the conversion of the Series C Preferred Shares, the consent or affirmative vote of the Series C Preferred Majority shall also be required. With respect to the conversion of the Series D Preferred Shares, the consent or affirmative vote of the Series D Preferred Majority shall also be required; or |
(iv) | immediately prior to the closing of a Qualified IPO, subject to the consummation of such Qualified IPO. |
| | June 1, 2020 | |
Price of the Underlying Shares | | | $137.88 |
Exercise Price | | | $149.35 |
Expected Term | | | 0.38 |
Risk Free Rate | | | 0.10% |
Volatility | | | 16% |
| | June 1, 2020 | | | December 31, 2020 | |
Probability of achieving the vesting condition | | | 58% | | | 58% |
Volatility | | | 50% | | | 44% |
Time to exit (years) | | | 2.25 | | | 1.50 |
11. | ORDINARY SHARES |
| | December 31, | ||||
| | 2020 | | | 2019 | |
Redeemable convertible preferred shares, all series | | | 1,722,210 | | | 1,284,656 |
Ordinary share options outstanding | | | 245,786 | | | 90,587 |
Warrants to purchase redeemable convertible preferred share | | | 43,079 | | | 14,623 |
Shares available for future grant of equity awards | | | 114,197 | | | 11,077 |
Total ordinary share reserved | | | 2,125,272 | | | 1,400,943 |
12. | SHARE BASED COMPENSATION |
| | Options Available for Grant | | | Number of Options | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual Term (Years) | | | Aggregate Intrinsic Value (000’s) | |
Balance, December 31, 2018 | | | 39,457 | | | 70,357 | | | $9.725 | | | 9.2 | | | $131 |
Granted | | | (31,910) | | | 31,910 | | | 0.228 | | | | | ||
Exercised | | | — | | | (8,150) | | | 0.003 | | | | | ||
Forfeited, expired or cancelled | | | 3,530 | | | (3,530) | | | 0.003 | | | | | ||
Balance, December 31, 2019 | | | 11,077 | | | 90,587 | | | $7.630 | | | 8.8 | | | $277 |
Authorized | | | 267,821 | | | — | | | | | | | |||
Granted | | | (167,782) | | | 167,782 | | | $13.280 | | | | | ||
Exercised | | | — | | | (9,502) | | | 0.003 | | | | | ||
Forfeited, expired or cancelled | | | 3,081 | | | (3,081) | | | 0.003 | | | | | ||
Balance, December 31, 2020 | | | 114,197 | | | 245,786 | | | $11.880 | | | 9.1 | | | $2,905 |
Vested and exercisable, December 31, 2020 | | | | | 53,687 | | | $10.000 | | | 7.8 | | | $481 |
| | 2020 | | | 2019 | |
Expected volatility | | | 44.90% - 48.65% | | | 39.90% - 41.90% |
Expected term (in years) | | | 5.66 - 6.15 | | | 5.52 - 6.11 |
Risk free interest | | | 0.35% - 0.53% | | | 1.56% - 2.39% |
Dividend yield | | | — | | | — |
| | 2020 | | | 2019 | |
Research and Development | | | $89 | | | $37 |
Selling and Marketing | | | 4 | | | — |
General and Administrative | | | 63 | | | 37 |
Total | | | $156 | | | $74 |
13. | INCOME TAXES |
| | Year ended December 31, | ||||
| | 2020 | | | 2019 | |
Domestic (Israel) | | | $14,345 | | | $(5,246) |
Foreign | | | 6,853 | | | 1,218 |
Total income (loss) before income taxes | | | $21,198 | | | $(4,028) |
| | December 31, | ||||
| | 2020 | | | 2019 | |
Current: | | | | | ||
Domestic | | | $3,194 | | | $121 |
Foreign | | | 385 | | | 51 |
Total current | | | 3,579 | | | 172 |
Deferred: | | | | | ||
Domestic | | | (2,301) | | | — |
Foreign | | | (2) | | | — |
Total deferred | | | (2,303) | | | — |
Total income tax expense | | | $1,276 | | | $172 |
| | December 31, | ||||
| | 2020 | | | 2019 | |
Income (loss) before income taxes | | | $21,198 | | | $(4,028) |
Israel statutory income tax rate | | | 23% | | | 23% |
Theoretical income taxes at statutory rate | | | 4,876 | | | (926) |
Utilization of carry forward losses for which valuation allowance was provided | | | (1,577) | | | — |
Deferred taxes for which valuation allowance was provided | | | — | | | 1,168 |
Reduction in valuation allowance | | | (999) | | | — |
Uncertain tax positions | | | 43 | | | 121 |
Subsidiaries taxed at a different tax rate | | | (1,174) | | | (246) |
Permanent differences | | | 94 | | | 46 |
Other | | | 13 | | | 9 |
Income tax | | | $1,276 | | | $172 |
Effective tax rate | | | 6.0% | | | (4.3%) |
| | December 31, | ||||
| | 2020 | | | 2019 | |
Carryforward tax losses | | | $— | | | $1,541 |
Research and development cost | | | 2,126 | | | 920 |
Employee-related accruals | | | 163 | | | 42 |
Accrued expenses | | | 56 | | | 29 |
Credit carried forward | | | — | | | 23 |
Deferred tax assets before valuation allowance | | | 2,345 | | | 2,555 |
Valuation allowance | | | — | | | (2,541) |
Deferred tax assets | | | 2,345 | | | 14 |
Property and equipment | | | (26) | | | — |
Equity method investments | | | (16) | | | (14) |
Deferred tax liabilities | | | (42) | | | (14) |
Deferred tax assets, net | | | $2,303 | | | $— |
| | December 31, | ||||
| | 2020 | | | 2019 | |
Uncertain tax positions, beginning of the year | | | $121 | | | $— |
Increase in tax positions for prior years | | | 41 | | | 121 |
Increases related to current-year tax positions | | | 2 | | | — |
Uncertain tax positions, end of year | | | $164 | | | $121 |
14. | NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO ORDINARY SHAREHOLDERS |
| | December 31, | ||||
| | 2020 | | | 2019 | |
Basic net income (loss) per share | | | | | ||
Numerator: | | | | | ||
Net income (loss) attributable to Pagaya Technologies Ltd. ordinary shareholders | | | $14,470 | | | $(5,620) |
Less: Undistributed earnings allocated to participating securities | | | (9,558) | | | (2,748) |
Net income (loss) attributable to Pagaya Technologies Ltd. ordinary shareholders, basic | | | $4,912 | | | $(8,368) |
Denominator: | | | | | ||
Weighted average shares used in computing net income (loss) per ordinary share, basic | | | 1,022,959 | | | 1,017,033 |
Net income (loss) per share attributable to Pagaya Technologies Ltd. ordinary shareholders, basic | | | $4.80 | | | $(8.23) |
Dilutive net income (loss) per share | | | | | ||
Numerator: | | | | | ||
Net income (loss) attributable to Pagaya Technologies Ltd. ordinary shareholders, basic | | | $4,912 | | | $(8,368) |
Adjustment for undistributed earnings allocated to participating securities | | | 239 | | | — |
Adjustment for mark-to-market loss (gain) | | | (543) | | | (212) |
Net income (loss) attributable to Pagaya Technologies Ltd. ordinary shareholders, diluted | | | $4,608 | | | $(8,580) |
Denominator: | | | | | ||
Weighted average shares used in computing net income (loss) per ordinary share, basic | | | 1,022,959 | | | 1,017,033 |
Dilutive effect of firm commitment with founders | | | 1,624 | | | — |
Dilutive effect of stock options | | | 76,551 | | | — |
Dilutive effect of the Option | | | 6,215 | | | — |
Dilutive effect of Series B warrants | | | — | | | 5,996 |
Weighted average shares used in computing net income (loss) per ordinary share, diluted | | | 1,107,349 | | | 1,023,029 |
Net income (loss) per share attributable to Pagaya Technologies Ltd. ordinary shareholders, diluted | | | $4.16 | | | $(8.39) |
| | December 31, | ||||
| | 2020 | | | 2019 | |
Share options | | | — | | | 80,102 |
Preferred shares warrants | | | 43,079 | | | 14,623 |
Redeemable convertible preferred shares | | | 1,722,210 | | | 1,284,656 |
Net potential dilutive outstanding securities | | | 1,765,289 | | | 1,379,381 |
15. | SEGMENTS AND GEOGRAPHICAL INFORMATION |
| | 2020 | | | 2019 | |
United States | | | $68,526 | | | $23,565 |
Israel | | | 7,142 | | | 6,694 |
Cayman Islands | | | 16,072 | | | 2,054 |
| | $91,740 | | | $32,313 |
| | December 31, | ||||
| | 2020 | | | 2019 | |
Israel | | | $1,455 | | | $727 |
United States | | | 79 | | | — |
Total Long-Lived Assets, net | | | $1,534 | | | $727 |
16. | SUBSEQUENT EVENTS |
Item 1. | Financial Statements. (Unaudited) |
| | September 30, 2021 | | | December 31, 2020 | |
Assets | | | | | ||
Current Assets | | | | | ||
Cash on hand | | | $443,414 | | | $— |
Deferred offering costs | | | — | | | 276,751 |
Prepaid expenses | | | 393,344 | | | — |
Total current assets | | | 836,758 | | | 276,751 |
Prepaid expenses - Non-current | | | 142,931 | | | — |
Cash and Investments held in Trust Account | | | 287,574,207 | | | — |
Total assets | | | $288,553,896 | | | $276,751 |
Liabilities and Shareholders’ Equity | | | | | ||
Current liabilities: | | | | | ||
Accrued costs and expenses | | | $792,256 | | | $255,288 |
Due to related party | | | 322,000 | | | — |
Total current liabilities | | | 1,114,256 | | | 255,288 |
Warrant liability | | | 25,547,264 | | | — |
Deferred underwriters’ discount | | | 10,062,500 | | | — |
Total liabilities | | | 36,724,020 | | | 255,288 |
Commitments | | | | | ||
Ordinary shares subject to possible redemption, 28,750,000 and no shares at redemption value as of September 30, 2021 and December 31, 2020, respectively | | | 287,500,000 | | | — |
Shareholders’ Equity: | | | | | ||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding | | | — | | | — |
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; | | | — | | | — |
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 7,187,500 shares issued and outstanding as of September 30, 2021 and December 31, 2020 | | | 719 | | | 719 |
Additional paid-in capital | | | — | | | 24,281 |
Accumulated deficit | | | (35,670,843) | | | (3,537) |
Total shareholders’ equity | | | (35,670,124) | | | 21,463 |
Total Liabilities and Shareholders’ Equity | | | $288,553,896 | | | $276,751 |
| | For the three months ended September 30, 2021 | | | For the nine months ended September 30, 2021 | |
Formation and operating costs | | | $1,208,966 | | | $1,495,252 |
Loss from operations | | | (1,208,966) | | | (1,495,252) |
Other loss | | | | | ||
Bank interest income | | | 12 | | | 31 |
Interest income on marketable securities held in trust | | | 28,794 | | | 74,208 |
Offering cost allocated to warrants | | | — | | | (862,470) |
Excess of Private Placement Warrants fair value over purchase price | | | — | | | (1,242,401) |
Change in fair value of warrants liability | | | (12,400,851) | | | (1,502,636) |
Total other loss | | | (12,372,045) | | | (3,533,268) |
Net loss | | | $(13,581,011) | | | $(5,028,520) |
Weighted average ordinary shares subject to possible redemption outstanding, basic and diluted | | | 28,750,000 | | | 22,431,319 |
Basic and diluted net loss per ordinary share subject to possible redemption | | | $(0.38) | | | $(0.17) |
Weighted average non-redeemable ordinary shares outstanding, basic and diluted | | | 7,187,500 | | | 6,981,456 |
Basic and diluted net loss per non-redeemable ordinary share | | | $(0.38) | | | $(0.17) |
| | Class A Ordinary Shares | | | Class B Ordinary Shares | | | Additional Paid-in Capital | | | Accumulated Deficit | | | Total Shareholders’ Equity (Deficit) | |||||||
| | Shares | | | Amount | | | Shares | | | Amount | | |||||||||
Balance as of December 31, 2020 | | | — | | | $— | | | 7,187,500 | | | $719 | | | $24,281 | | | $(3,537) | | | $21,463 |
Subsequent remeasurement under ASC 480-10-S99 | | | — | | | — | | | — | | | — | | | (24,281) | | | (30,638,786) | | | (30,663,067) |
Net Income | | | — | | | — | | | — | | | — | | | — | | | 7,301,955 | | | 7,301,955 |
Balance as of March 31, 2021, as restated | | | — | | | $— | | | 7,187,500 | | | $719 | | | $— | | | $(23,340,368) | | | $(23,339,649) |
Net Income | | | — | | | — | | | — | | | — | | | — | | | 1,250,536 | | | 1,250,536 |
Balance as of June 30, 2021, as restated | | | — | | | $— | | | 7,187,500 | | | $719 | | | $— | | | $(22,089,832) | | | $(22,089,113) |
Net Loss | | | — | | | — | | | — | | | — | | | — | | | (13,581,011) | | | (13,581,011) |
Balance as of September 30, 2021 | | | — | | | $— | | | 7,187,500 | | | $719 | | | $— | | | $(35,670,843) | | | $(35,670,124) |
| | Nine Months Ended September 30, 2021 | |
Cash flows from operating activities: | | | |
Net loss | | | $(5,028,520) |
Adjustments to reconcile net loss to net cash used in operating activities: | | | |
Interest earned on cash and Investments held in Trust Account | | | (74,208) |
Offering costs allocated to warrants | | | 862,470 |
Excess of Private Placement Warrants fair value over purchase price | | | 1,242,401 |
Change in fair value of warrant liability | | | 1,502,636 |
Changes in current assets and liabilities: | | | |
Prepaid assets | | | (536,275) |
Accrued costs and expenses | | | 718,720 |
Due to related party | | | 322,000 |
Net cash used in operating activities | | | (990,776) |
Cash Flows from Investing Activities: | | | |
Investment held in Trust Account | | | (287,500,000) |
Net cash used in investing activities | | | (287,500,000) |
Cash flows from financing activities: | | | |
Proceeds from initial public offering, net of underwriters’ discount | | | 281,750,000 |
Proceeds from issuance of Private Placement Warrants | | | 7,750,000 |
Proceeds of Promissory Note - Related Party | | | 200,000 |
Payment of Promissory Note - Related Party | | | (200,000) |
Payments of offering costs | | | (565,810) |
Net cash provided by financing activities | | | 288,934,190 |
Net change in cash | | | 443,414 |
Cash, beginning of the period | | | — |
Cash, end of the period | | | $443,414 |
Supplemental disclosure of cash flow information: | | | |
Initial classification of warrant liability | | | $22,802,227 |
Initial classification of Class A ordinary shares subject to possible redemption | | | $287,500,000 |
Deferred underwriting commissions charged to additional paid in capital | | | $10,062,500 |
| | As Previously Reported | | | Adjustment | | | As Restated | |
Balance Sheet at March 1, 2021 | | | | | | | |||
Shares Subject to Redemption | | | 249,841,522 | | | 37,658,478 | | | 287,500,000 |
Class A Ordinary shares | | | 376 | | | (376) | | | — |
Additional Paid in Capital | | | 7,121,336 | | | (7,121,336) | | | — |
Accumulated Deficit | | | (2,122,421) | | | (30,536,765) | | | (32,659,186) |
Total Shareholders’ Equity | | | 5,000,010 | | | (37,658,477) | | | (32,658,467) |
Number of shares subject to redemption | | | 24,984,152 | | | 3,765,848 | | | 28,750,000 |
Balance Sheet at March 31, 2021 | | | | | | | |||
Shares Subject to Redemption | | | 259,160,350 | | | 28,339,650 | | | 287,500,000 |
Class A Ordinary shares | | | 283 | | | (283) | | | — |
Additional Paid in Capital | | | (2,299,419) | | | 2,299,419 | | | — |
(Accumulated Deficit) Retained Earnings | | | 7,298,418 | | | (30,638,786) | | | (23,340,368) |
Total Shareholders’ Equity | | | 5,000,001 | | | (28,339,650) | | | (23,339,649) |
Number of shares subject to redemption | | | 25,916,035 | | | 2,833,965 | | | 28,750,000 |
Balance Sheet at June 30, 2021 | | | | | | | |||
Shares Subject to Redemption | | | 260,410,881 | | | 27,089,119 | | | 287,500,000 |
Class A Ordinary shares | | | 270 | | | (270) | | | — |
Class B Ordinary shares | | | 719 | | | — | | | 719 |
Additional Paid in Capital | | | (3,549,937) | | | 3,549,937 | | | — |
(Accumulated Deficit) Retained Earnings | | | 8,548,954 | | | (30,638,786) | | | (22,089,832) |
Total Shareholders’ Equity | | | 5,000,006 | | | (27,089,119) | | | (22,089,113) |
Number of shares subject to redemption | | | 26,041,088 | | | 2,708,912 | | | 28,750,000 |
Statement of Operations for three months ended March 31, 2021 | | | | | | | |||
Basic and diluted weighted average shares outstanding, ordinary shares subject to redemption | | | 24,984,152 | | | (15,400,819) | | | 9,583,333 |
Basic and diluted weighted average shares outstanding, ordinary shares not subject to redemption | | | 8,442,783 | | | (1,255,283) | | | 7,187,500 |
EPS - Redeemable Shares | | | $— | | | $0.44 | | | $0.44 |
EPS - Non-Redeemable Shares | | | $0.86 | | | $(0.42) | | | $0.44 |
Statement of Operations for the three months ended June 30, 2021 | | | | | | | |||
Basic and diluted weighted average shares outstanding, ordinary shares subject to redemption | | | 25,916,035 | | | 2,833,965 | | | 28,750,000 |
Basic and diluted weighted average shares outstanding, ordinary shares not subject to redemption | | | 10,021,465 | | | (2,833,965) | | | 7,187,500 |
EPS - Redeemable Shares | | | $— | | | $0.03 | | | $0.03 |
EPS - Non-Redeemable Shares | | | $0.12 | | | $(0.09) | | | $0.03 |
Statement of Operations for the six months ended June 30, 2021 | | | | | | | |||
Basic and diluted weighted average shares outstanding, ordinary shares subject to redemption | | | 17,170,628 | | | 2,048,985 | | | 19,219,613 |
Basic and diluted weighted average shares outstanding, ordinary shares not subject to redemption | | | 9,236,485 | | | (2,048,985) | | | 7,187,500 |
EPS - Redeemable Shares | | | $— | | | $0.32 | | | $0.32 |
EPS - Non-Redeemable Shares | | | $0.92 | | | $(0.60) | | | $0.32 |
| | As Previously Reported | | | Adjustment | | | As Restated | |
Statement of Cash Flows for three months ended March 31, 2021 | | | | | | | |||
Initial value of shares subject to possible redemption | | | 249,841,522 | | | 37,658,478 | | | 287,500,000 |
Change in value of shares subject to possible redemption | | | 9,318,828 | | | (9,318,828) | | | — |
Statement of Cash Flows for six months ended June 30, 2021 | | | | | | | |||
Initial value of shares subject to possible redemption | | | 249,841,522 | | | 37,658,478 | | | 287,500,000 |
Change in value of shares subject to possible redemption | | | 10,569,359 | | | (10,569,359) | | | — |
Statement of Changes In Shareholders’ Equity (Deficit) for the three months ended June 30, 2021 | | | | | | | |||
Remeasurement of Class A ordinary shares subject to possible redemption | | | $1,250,518 | | | $1,250,518 | | | $— |
Statement of Changes in Stockholders’ (Deficit) Equity for the three months ended March 31, 2021 | | | | | | | |||
Sale of 28,750,000 Units on March 1, 2021 through IPO | | | $287,500,000 | | | $(287,500,000) | | | $— |
Sale of 5,166,667 Private Placement Warrants on March 1, 2021 to Sponsor | | | $7,750,000 | | | $(7,750,000) | | | $— |
Underwriters’ discount | | | $(5,750,000) | | | $5,750,000 | | | $— |
Deferred underwriters’ discount | | | $(10,062,500) | | | $10,062,500 | | | $— |
Offering costs charged to the shareholders’ equity | | | $(660,810) | | | $660,810 | | | $— |
Non-equity portion of offering costs charged to expense | | | $862,470 | | | $(862,470) | | | $— |
Initial classification of public warrant liability | | | $(15,052,227) | | | $15,052,227 | | | $ |
Initial classification of private warrant liability | | | $(7,750,000) | | | $7,750,000 | | | $ |
Class A ordinary shares subject to possible redemption | | | $(259,160,350) | | | $259,160,350 | | | $ |
Subsequent remeasurement under ASC 480-10-S99 against additional paid-in capital and accumulated deficit | | | $ | | | $(30,663,067) | | | $(30,663,067) |
| | For the Three Months Ended September 30, 2021 | | | For the Nine Months Ended September 30, 2021 | |||||||
| | Class A | | | Class B | | | Class A | | | Class B | |
Basic and diluted net loss per stock: | | | | | | | | | ||||
Numerator: | | | | | | | | | ||||
Allocation of net loss | | | $(10,864,809) | | | $(2,716,202) | | | $(3,834,944) | | | $(1,193,576) |
| | | | | | | | |||||
Denominator: | | | | | | | | | ||||
Weighted-average shares outstanding | | | 28,750,000 | | | 7,187,500 | | | 22,431,319 | | | 6,981,456 |
Basic and diluted net loss per share | | | $(0.38) | | | $(0.38) | | | $(0.17) | | | $(0.17) |
Level 1 — | Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. |
Level 2 — | Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. |
Level 3 — | Valuations based on inputs that are unobservable and significant to the overall fair value measurement. |
| | September 30, 2021 | | | Quoted Prices In Active Markets (Level 1) | | | Significant Other Observable Inputs (Level 2) | | | Significant Other Unobservable Inputs (Level 3) | |
Liabilities: | | | | | | | | | ||||
Warrant Liability – Public Warrants | | | $15,716,667 | | | $15,716,667 | | | $— | | | $— |
Warrant Liability – Private Warrants | | | 9,830,597 | | | — | | | — | | | 9,830,597 |
| | $25,547,264 | | | $15,716,667 | | | $— | | | $9,830,597 |
Gross proceeds from IPO | | | $287,500,000 |
Less: | | | |
Proceeds allocated to Public Warrants | | | (15,052,227) |
Ordinary share issuance costs | | | (15,610,840) |
Plus: | | | |
Accretion of carrying value to redemption value | | | 30,663,067 |
Contingently redeemable ordinary share | | | $287,500,000 |
| |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and |
• | if, and only if, the last reported sale price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on and including the third business days prior to the date the Company sends to the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant). |
• | in whole and not in part; |
• | for cash at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares, based on the redemption date and the “fair market value” of our Class A ordinary shares (as defined above); and |
• | if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described below). |
| | September 30, 2021 | |
Exercise price | | | $11.50 |
Share price | | | $9.83 |
Volatility | | | 26% |
Expected life of the options to convert | | | 5.00 |
Risk-free rate | | | 1.15% |
Dividend yield | | | 0.0% |
Assets | | | |
Deferred offering costs | | | $276,751 |
Total Assets | | | $276,751 |
Liabilities and Shareholder’s Equity | | | |
Current liabilities: | | | |
Accrued offering costs and expenses | | | $255,288 |
Total current liabilities | | | 255,288 |
Commitments and Contingencies | | | |
Shareholder’s Equity: | | | |
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding | | | — |
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; none issued and outstanding | | | — |
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 7,187,500 shares issued and outstanding(1) | | | 719 |
Additional paid-in capital | | | 24,281 |
Accumulated deficit | | | (3,537) |
Total shareholder’s equity | | | 21,463 |
Total Liabilities and Shareholder’s Equity | | | $276,751 |
(1) | This number includes up to 937,500 Class B ordinary shares subject to forfeiture depending on the extent to which the over-allotment option is exercised by the underwriters (see Note 5). |
Formation and operating costs | | | $3,537 |
Net loss | | | $(3,537) |
Basic and diluted weighted average Class B shares outstanding(1) | | | 6,250,000 |
Basic and diluted net loss per share | | | $(0.00) |
(1) | This number excludes an aggregate of up to 937,500 Class B ordinary shares subject to forfeiture depending on the extent to which the over-allotment option is exercised by the underwriters (see Note 5). |
| | Class B Ordinary Shares | | | Additional Paid-in Capital | | | Accumulated Deficit | | | Total Shareholder’s Equity | ||||
| | Shares(1) | | | Amount | | |||||||||
Balance as of December 22, 2020 (inception) | | | — | | | $— | | | $— | | | $— | | | $— |
Class B ordinary shares issued to Sponsor | | | 7,187,500 | | | 719 | | | 24,281 | | | — | | | 25,000 |
Net loss | | | — | | | — | | | — | | | (3,537) | | | (3,537) |
Balance as of December 31, 2020 | | | 7,187,500 | | | $719 | | | $24,281 | | | $(3,537) | | | $21,463 |
(1) | This number includes up to 937,500 Class B ordinary shares subject to forfeiture depending on the extent to which the over-allotment option is exercised by the underwriters (see Note 5). |
Cash Flows from Operating Activities: | | | |
Net loss | | | $(3,537) |
Changes in operating assets and liabilities: | | | |
Accrued offering costs and expenses | | | 3,537 |
Net cash used in operating activities | | | — |
Net change in cash | | | — |
Cash, December 22, 2020 (inception) | | | — |
Cash, end of the period | | | $— |
Supplemental disclosure of cash flow information: | | | |
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | | | $25,000 |
Deferred offering costs included in accrued expenses | | | $251,751 |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and |
• | if, and only if, the last reported sale price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on and including the third business days prior to the date the Company sends to the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant). |
• | in whole and not in part; |
• | for cash at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares, based on the redemption date and the “fair market value” of our Class A ordinary shares (as defined above); and |
• | if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described below). |
| | | | | | Page | |||
| | ||||||||
| | | | | | ||||
| | | | | | ||||
| | ||||||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | ||||||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | ||||||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | |
| | | | | | Page | |||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | ||||||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | ||||||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | ||||||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | |
| | | | | | Page | |||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | ||||||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | ||||||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | ||||||||
| | | | | | ||||
| | | | | | ||||
| | ||||||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | | ||||
| | | | | |
EXHIBITS | |||
| | ||
Exhibit A | | | SPAC Voting Agreement |
Exhibit B | | | Company Voting Agreement |
Exhibit C | | | Form of Incentive Equity Plan |
Exhibit D | | | Form of Registration Rights Agreement |
Exhibit E | | | Form of Amended and Restated Articles of Association |
Exhibit F | | | Form of Plan of Merger |
Exhibit G | | | Form of Memorandum of Association of the Surviving Company |
Exhibit H | | | Residency Notice |
| | if to SPAC, to: | |||||||
| | | | | | ||||
| | | | EJF Acquisition Corp. | |||||
| | | | 2107 Wilson Boulevard | |||||
| | | | Suite 410 | |||||
| | | | Arlington, VA 22201 | |||||
| | | | Attention: | | | Kevin Stein | ||
| | | | Email: | | | *@ejfcap.com | ||
| | ||||||||
| | with a copy to (which shall not constitute notice): | |||||||
| | | | | | ||||
| | | | Simpson Thacher & Bartlett LLP | |||||
| | | | 900 G Street, NW | |||||
| | | | Washington, D.C. 20001 | |||||
| | | | Attention: | | | Jonathan Corsico | ||
| | | | Email: | | | jonathan.corsico@stblaw.com | ||
| |||||||||
| | and | |||||||
| | ||||||||
| | | | Simpson Thacher & Bartlett LLP | |||||
| | | | 425 Lexington Avenue | |||||
| | | | New York, NY 10017 | |||||
| | | | Attention: | | | Mark Brod; Michael Wolfson | ||
| | | | Email: | | | mbrod@stblaw.com; mwolfson@stblaw.com | ||
| | ||||||||
| | and | |||||||
| | ||||||||
| | | | Herzog Fox & Neeman | |||||
| | | | Herzog Tower, 6 Yitzhak Sadeh Street | |||||
| | | | Tel Aviv 6777506, Israel | |||||
| | | | Attention: | | | Ory Nacht, Adv. | ||
| | | | Email: | | | nachto@herzoglaw.co.il | ||
| |
| | and | |||||||
| | ||||||||
| | | | Walkers | |||||
| | | | 190 Elgin Avenue | |||||
| | | | George Town, Grand Cayman | |||||
| | | | KY1-9001 | |||||
| | | | Cayman Islands | |||||
| | | | Attention: | | | Andrew Barker | ||
| | | | Email: | | | andrew.barker@walkersglobal.com | ||
| | ||||||||
| | if to the Company or Merger Sub to: | |||||||
| | ||||||||
| | | | Pagaya Technologies Ltd. | |||||
| | | | 90 Park Ave, | |||||
| | | | New York, NY 10016 | |||||
| | | | Attention: | | | Gal Krubiner | ||
| | | | | | Richmond Glasgow | |||
| | | | Email: | | | *@pagaya-inv.com | ||
| | | | | | *@pagaya.com | |||
| | ||||||||
| | with a copy to (which shall not constitute notice): | |||||||
| | ||||||||
| | | | Skadden, Arps, Slate, Meagher & Flom LLP | |||||
| | | | One Manhattan West | |||||
| | | | New York, NY 10001 | |||||
| | | | Attention: | | | Jeffrey A. Brill | ||
| | | | | | Maxim Mayer-Cesiano | |||
| | | | | | B. Chase Wink | |||
| | | | Email: | | | jeffrey.brill@skadden.com | ||
| | | | | | maxim.mayercesiano@skadden.com | |||
| | | | | | b.chase.wink@skadden.com | |||
| | ||||||||
| | | | Goldfarb Seligman & Co. | |||||
| | | | 98 Yigal Alon Street | |||||
| | | | Tel Aviv | |||||
| | | | 6789141 | |||||
| | | | Israel | |||||
| | | | Attention: | | | Aaron M. Lampert | ||
| | | | | | Sharon Gazit | |||
| | | | Email: | | | aaron.lampert@goldfarb.com | ||
| | | | | | sharon.gazit@goldfarb.com | |||
| | ||||||||
| | and | |||||||
| | ||||||||
| | | | Maples and Calder (Cayman) LLP | |||||
| | | | PO Box 309, Ugland House | |||||
| | | | Grand Cayman | |||||
| | | | KY1-1104 | |||||
| | | | Cayman Islands | |||||
| | | | Attention: | | | Suzanne Correy | ||
| | | | Email: | | | Suzanne.Correy@maples.com |
| | PAGAYA TECHNOLOGIES LTD. | |||||||
| | | | | | ||||
| | By: | | | /s/ Avi Zeevi | ||||
| | | | Name: | | | Avi Zeevi | ||
| | | | Title: | | | Chairman of the Board of Directors | ||
| | | | | | ||||
| | By: | | | /s/ Gal Krubiner | ||||
| | | | Name: | | | Gal Krubiner | ||
| | | | Title: | | | Chief Executive Officer | ||
| | | | | | ||||
| | RIGEL MERGER SUB INC. | |||||||
| | | | | |||||
| | By: | | | /s/ Gal Krubiner | ||||
| | | | Name: | | | Gal Krubiner | ||
| | | | Title: | | | Director |
| | EJF ACQUISITION CORP. | |||||||
| | ||||||||
| | By: | | | /s/ Kevin Stein | ||||
| | | | Name: | | | Kevin Stein | ||
| | | | Title: | | | Chief Executive Officer |
1 | The constituent companies (as defined in the Statute) to this Merger are the Surviving Company and the Merging Company. |
2 | The surviving company (as defined in the Statute) is the Surviving Company. |
3 | The registered office of the Surviving Company is Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands and the registered office of the Merging Company is c/o Maples Corporate Services Limited of PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands. |
4 | Immediately prior to the Effective Date (as defined below), the share capital of the Surviving Company will be US$55,500 divided into 500,000,000 Class A ordinary shares of a par value of US$0.0001 each, 50,000,000 Class B ordinary shares of a par value of US$0.0001 each and 5,000,000 preference shares of a par value of US$0.0001 each. |
5 | Immediately prior to the Effective Date (as defined below), the share capital of the Merging Company will be US$[50,000] divided into [50,000] shares of a par value of US$[1.00] each. |
6 | The date on which it is intended that the Merger is to take effect is the date that this Plan of Merger is registered by the Registrar in accordance with section 233(13) of the Statute (the “Effective Date”). |
7 | The terms and conditions of the Merger, including the manner and basis of converting shares in each constituent company into shares in the Surviving Company, are set out in the Merger Agreement in the form annexed at Annexure 1 hereto. |
8 | The rights and restrictions attaching to the shares in the Surviving Company are set out in the Amended and Restated Memorandum and Articles of Association of the Surviving Company in the form annexed at Annexure 2 hereto. |
9 | The Memorandum and Articles of Association of the Surviving Company shall be amended and restated by the deletion in their entirety and the substitution in their place of the Amended and Restated Memorandum and Articles of Association in the form annexed at Annexure 2 hereto on the Effective Date. |
10 | There are no amounts or benefits which are or shall be paid or payable to any director of either constituent company or the Surviving Company consequent upon the Merger. |
11 | The Merging Company has granted no fixed or floating security interests that are outstanding as at the date of this Plan of Merger. |
12 | The Surviving Company has granted no fixed or floating security interests that are outstanding as at the date of this Plan of Merger. |
13 | The names and addresses of each director of the surviving company (as defined in the Statute) are: |
14 | This Plan of Merger has been approved by the board of directors of each of the Surviving Company and the Merging Company pursuant to section 233(3) of the Statute. |
15 | This Plan of Merger has been authorised by the shareholders of each of the Surviving Company and the Merging Company pursuant to section 233(6) of the Statute by way of resolutions passed at an extraordinary general meeting of the Surviving Company and written resolutions of the sole shareholder of the Merging Company, as applicable. |
16 | At any time prior to the Effective Date, this Plan of Merger may be: |
(a) | change the Effective Date provided that such changed date shall not be a date later than the ninetieth day after the date of registration of this Plan of Merger with the Registrar of Companies; and |
(b) | effect any other changes to this Plan of Merger which the board of directors of both the Surviving Company and the Merging Company expressly authorise. |
17 | This Plan of Merger may be executed in counterparts. |
18 | This Plan of Merger shall be governed by and construed in accordance with the laws of the Cayman Islands. |
SIGNED by | | | ) | | | | | ||
Duly authorised for | | | ) | | | | | ||
and on behalf of | | | ) | | | Director | | | |
EJF Acquisition Corp. | | | ) | | | | | ||
| |||||||||
SIGNED by | | | ) | | | | | ||
Duly authorised for | | | ) | | | | | ||
and on behalf of | | | ) | | | Director | | | |
[Merger Sub] | | | ) | | | | |
1 | The name of the Company is EJF Acquisition Corp. |
2 | The Registered Office of the Company shall be at the offices of Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands, or at such other place within the Cayman Islands as the Directors may decide. |
3 | The objects for which the Company is established are unrestricted and the Company shall have full power and authority to carry out any object not prohibited by the laws of the Cayman Islands. |
4 | The liability of each Member is limited to the amount unpaid on such Member’s shares. |
5 | The share capital of the Company is US$55,500 divided into 500,000,000 Class A ordinary shares of a par value of US$0.0001 each, 50,000,000 Class B ordinary shares of a par value of US$0.0001 each and 5,000,000 preference shares of a par value of US$0.0001 each. |
6 | The Company has power to register by way of continuation as a body corporate limited by shares under the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands. |
7 | Capitalised terms that are not defined in this Memorandum of Association bear the respective meanings given to them in the Articles of Association of the Company. |
1 | Interpretation |
1.1 | In the Articles Table A in the First Schedule to the Statute does not apply and, unless there is something in the subject or context inconsistent therewith: |
“Articles” | | | means these articles of association of the Company. |
| | ||
“Auditor” | | | means the person for the time being performing the duties of auditor of the Company (if any). |
| | ||
“Company” | | | means the above named company. |
| | ||
“Directors” | | | means the directors for the time being of the Company. |
| | ||
“Dividend” | | | means any dividend (whether interim or final) resolved to be paid on Shares pursuant to the Articles. |
| | ||
“Electronic Record” | | | has the same meaning as in the Electronic Transactions Act. |
| | ||
“Electronic Transactions Act” | | | means the Electronic Transactions Act (As Revised) of the Cayman Islands. |
| | ||
“Member” | | | has the same meaning as in the Statute. |
| | ||
“Memorandum” | | | means the memorandum of association of the Company. |
| | ||
“Ordinary Resolution” | | | means a resolution passed by a simple majority of the Members as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting, and includes a unanimous written resolution. In computing the majority when a poll is demanded regard shall be had to the number of votes to which each Member is entitled by the Articles. |
| | ||
“Register of Members” | | | means the register of Members maintained in accordance with the Statute and includes (except where otherwise stated) any branch or duplicate register of Members. |
| | ||
“Registered Office” | | | means the registered office for the time being of the Company. |
| | ||
“Seal” | | | means the common seal of the Company and includes every duplicate seal. |
| | ||
“Share” | | | means a share of any class in the Company and includes a fraction of a share in the Company. |
| |
“Special Resolution” | | | has the same meaning as in the Statute, and includes a unanimous written resolution. |
| | ||
“Statute” | | | means the Companies Act (As Revised) of the Cayman Islands. |
| | ||
“Treasury Share” | | | means a Share held in the name of the Company as a treasury share in accordance with the Statute. |
1.2 | In the Articles: |
(a) | words importing the singular number include the plural number and vice versa; |
(b) | words importing the masculine gender include the feminine gender; |
(c) | words importing persons include corporations as well as any other legal or natural person; |
(d) | “written” and “in writing” include all modes of representing or reproducing words in visible form, including in the form of an Electronic Record; |
(e) | “shall” shall be construed as imperative and “may” shall be construed as permissive; |
(f) | references to provisions of any law or regulation shall be construed as references to those provisions as amended, modified, re-enacted or replaced; |
(g) | any phrase introduced by the terms “including”, “include”, “in particular” or any similar expression shall be construed as illustrative and shall not limit the sense of the words preceding those terms; |
(h) | the term “and/or” is used herein to mean both “and” as well as “or.” The use of “and/or” in certain contexts in no respects qualifies or modifies the use of the terms “and” or “or” in others. The term “or” shall not be interpreted to be exclusive and the term “and” shall not be interpreted to require the conjunctive (in each case, unless the context otherwise requires); |
(i) | headings are inserted for reference only and shall be ignored in construing the Articles; |
(j) | any requirements as to delivery under the Articles include delivery in the form of an Electronic Record; |
(k) | any requirements as to execution or signature under the Articles including the execution of the Articles themselves can be satisfied in the form of an electronic signature as defined in the Electronic Transactions Act; |
(l) | sections 8 and 19(3) of the Electronic Transactions Act shall not apply; |
(m) | the term “clear days” in relation to the period of a notice means that period excluding the day when the notice is received or deemed to be received and the day for which it is given or on which it is to take effect; and |
(n) | the term “holder” in relation to a Share means a person whose name is entered in the Register of Members as the holder of such Share. |
2 | Commencement of Business |
2.1 | The business of the Company may be commenced as soon after incorporation of the Company as the Directors shall see fit. |
2.2 | The Directors may pay, out of the capital or any other monies of the Company, all expenses incurred in or about the formation and establishment of the Company, including the expenses of registration. |
3 | Issue of Shares |
3.1 | Subject to the provisions, if any, in the Memorandum (and to any direction that may be given by the Company in general meeting) and without prejudice to any rights attached to any existing Shares, the Directors may allot, issue, grant options over or otherwise dispose of Shares (including fractions of a |
3.2 | The Company shall not issue Shares to bearer. |
4 | Register of Members |
4.1 | The Company shall maintain or cause to be maintained the Register of Members in accordance with the Statute. |
4.2 | The Directors may determine that the Company shall maintain one or more branch registers of Members in accordance with the Statute. The Directors may also determine which register of Members shall constitute the principal register and which shall constitute the branch register or registers, and to vary such determination from time to time. |
5 | Closing Register of Members or Fixing Record Date |
5.1 | For the purpose of determining Members entitled to notice of, or to vote at any meeting of Members or any adjournment thereof, or Members entitled to receive payment of any Dividend or other distribution, or in order to make a determination of Members for any other purpose, the Directors may provide that the Register of Members shall be closed for transfers for a stated period which shall not in any case exceed forty days. |
5.2 | In lieu of, or apart from, closing the Register of Members, the Directors may fix in advance or arrears a date as the record date for any such determination of Members entitled to notice of, or to vote at any meeting of the Members or any adjournment thereof, or for the purpose of determining the Members entitled to receive payment of any Dividend or other distribution, or in order to make a determination of Members for any other purpose. |
5.3 | If the Register of Members is not so closed and no record date is fixed for the determination of Members entitled to notice of, or to vote at, a meeting of Members or Members entitled to receive payment of a Dividend or other distribution, the date on which notice of the meeting is sent or the date on which the resolution of the Directors resolving to pay such Dividend or other distribution is passed, as the case may be, shall be the record date for such determination of Members. When a determination of Members entitled to vote at any meeting of Members has been made as provided in this Article, such determination shall apply to any adjournment thereof. |
6 | Certificates for Shares |
6.1 | A Member shall only be entitled to a share certificate if the Directors resolve that share certificates shall be issued. Share certificates representing Shares, if any, shall be in such form as the Directors may determine. Share certificates shall be signed by one or more Directors or other person authorised by the Directors. The Directors may authorise certificates to be issued with the authorised signature(s) affixed by mechanical process. All certificates for Shares shall be consecutively numbered or otherwise identified and shall specify the Shares to which they relate. All certificates surrendered to the Company for transfer shall be cancelled and subject to the Articles no new certificate shall be issued until the former certificate representing a like number of relevant Shares shall have been surrendered and cancelled. |
6.2 | The Company shall not be bound to issue more than one certificate for Shares held jointly by more than one person and delivery of a certificate to one joint holder shall be a sufficient delivery to all of them. |
6.3 | If a share certificate is defaced, worn out, lost or destroyed, it may be renewed on such terms (if any) as to evidence and indemnity and on the payment of such expenses reasonably incurred by the Company in investigating evidence, as the Directors may prescribe, and (in the case of defacement or wearing out) upon delivery of the old certificate. |
6.4 | Every share certificate sent in accordance with the Articles will be sent at the risk of the Member or other person entitled to the certificate. The Company will not be responsible for any share certificate lost or delayed in the course of delivery. |
7 | Transfer of Shares |
7.1 | Subject to Article 3.1, Shares are transferable subject to the approval of the Directors by resolution who may, in their absolute discretion, decline to register any transfer of Shares without giving any reason. If the Directors refuse to register a transfer they shall notify the transferee within two months of such refusal. |
7.2 | The instrument of transfer of any Share shall be in writing and shall be executed by or on behalf of the transferor (and if the Directors so require, signed by or on behalf of the transferee). The transferor shall be deemed to remain the holder of a Share until the name of the transferee is entered in the Register of Members. |
8 | Redemption, Repurchase and Surrender of Shares |
8.1 | Subject to the provisions of the Statute the Company may issue Shares that are to be redeemed or are liable to be redeemed at the option of the Member or the Company. The redemption of such Shares shall be effected in such manner and upon such other terms as the Company may, by Special Resolution, determine before the issue of the Shares. |
8.2 | Subject to the provisions of the Statute, the Company may purchase its own Shares (including any redeemable Shares) in such manner and on such other terms as the Directors may agree with the relevant Member. |
8.3 | The Company may make a payment in respect of the redemption or purchase of its own Shares in any manner permitted by the Statute, including out of capital. |
8.4 | The Directors may accept the surrender for no consideration of any fully paid Share. |
9 | Treasury Shares |
9.1 | The Directors may, prior to the purchase, redemption or surrender of any Share, determine that such Share shall be held as a Treasury Share. |
9.2 | The Directors may determine to cancel a Treasury Share or transfer a Treasury Share on such terms as they think proper (including, without limitation, for nil consideration). |
10 | Variation of Rights of Shares |
10.1 | If at any time the share capital of the Company is divided into different classes of Shares, all or any of the rights attached to any class (unless otherwise provided by the terms of issue of the Shares of that class) may, whether or not the Company is being wound up, be varied without the consent of the holders of the issued Shares of that class where such variation is considered by the Directors not to have a material adverse effect upon such rights; otherwise, any such variation shall be made only with the consent in writing of the holders of not less than two thirds of the issued Shares of that class, or with the approval of a resolution passed by a majority of not less than two thirds of the votes cast at a separate meeting of the holders of the Shares of that class. For the avoidance of doubt, the Directors reserve the right, notwithstanding that any such variation may not have a material adverse effect, to obtain consent from the holders of Shares of the relevant class. To any such meeting all the provisions of the Articles relating to general meetings shall apply mutatis mutandis, except that the necessary quorum shall be one person holding or representing by proxy at least one third of the issued Shares of the class and that any holder of Shares of the class present in person or by proxy may demand a poll. |
10.2 | For the purposes of a separate class meeting, the Directors may treat two or more or all the classes of Shares as forming one class of Shares if the Directors consider that such class of Shares would be affected in the same way by the proposals under consideration, but in any other case shall treat them as separate classes of Shares. |
10.3 | The rights conferred upon the holders of the Shares of any class issued with preferred or other rights shall not, unless otherwise expressly provided by the terms of issue of the Shares of that class, be deemed to be varied by the creation or issue of further Shares ranking pari passu therewith. |
11 | Commission on Sale of Shares |
12 | Non Recognition of Trusts |
13 | Lien on Shares |
13.1 | The Company shall have a first and paramount lien on all Shares (whether fully paid-up or not) registered in the name of a Member (whether solely or jointly with others) for all debts, liabilities or engagements to or with the Company (whether presently payable or not) by such Member or his estate, either alone or jointly with any other person, whether a Member or not, but the Directors may at any time declare any Share to be wholly or in part exempt from the provisions of this Article. The registration of a transfer of any such Share shall operate as a waiver of the Company’s lien thereon. The Company’s lien on a Share shall also extend to any amount payable in respect of that Share. |
13.2 | The Company may sell, in such manner as the Directors think fit, any Shares on which the Company has a lien, if a sum in respect of which the lien exists is presently payable, and is not paid within fourteen clear days after notice has been received or deemed to have been received by the holder of the Shares, or to the person entitled to it in consequence of the death or bankruptcy of the holder, demanding payment and stating that if the notice is not complied with the Shares may be sold. |
13.3 | To give effect to any such sale the Directors may authorise any person to execute an instrument of transfer of the Shares sold to, or in accordance with the directions of, the purchaser. The purchaser or his nominee shall be registered as the holder of the Shares comprised in any such transfer, and he shall not be bound to see to the application of the purchase money, nor shall his title to the Shares be affected by any irregularity or invalidity in the sale or the exercise of the Company’s power of sale under the Articles. |
13.4 | The net proceeds of such sale after payment of costs, shall be applied in payment of such part of the amount in respect of which the lien exists as is presently payable and any balance shall (subject to a like lien for sums not presently payable as existed upon the Shares before the sale) be paid to the person entitled to the Shares at the date of the sale. |
14 | Call on Shares |
14.1 | Subject to the terms of the allotment and issue of any Shares, the Directors may make calls upon the Members in respect of any monies unpaid on their Shares (whether in respect of par value or premium), and each Member shall (subject to receiving at least fourteen clear days’ notice specifying the time or times of payment) pay to the Company at the time or times so specified the amount called on the Shares. A call may be revoked or postponed, in whole or in part, as the Directors may determine. A call may be required to be paid by instalments. A person upon whom a call is made shall remain liable for calls made upon him notwithstanding the subsequent transfer of the Shares in respect of which the call was made. |
14.2 | A call shall be deemed to have been made at the time when the resolution of the Directors authorising such call was passed. |
14.3 | The joint holders of a Share shall be jointly and severally liable to pay all calls in respect thereof. |
14.4 | If a call remains unpaid after it has become due and payable, the person from whom it is due shall pay interest on the amount unpaid from the day it became due and payable until it is paid at such rate as the Directors may determine (and in addition all expenses that have been incurred by the Company by reason of such non-payment), but the Directors may waive payment of the interest or expenses wholly or in part. |
14.5 | An amount payable in respect of a Share on issue or allotment or at any fixed date, whether on account of the par value of the Share or premium or otherwise, shall be deemed to be a call and if it is not paid all the provisions of the Articles shall apply as if that amount had become due and payable by virtue of a call. |
14.6 | The Directors may issue Shares with different terms as to the amount and times of payment of calls, or the interest to be paid. |
14.7 | The Directors may, if they think fit, receive an amount from any Member willing to advance all or any part of the monies uncalled and unpaid upon any Shares held by him, and may (until the amount would otherwise become payable) pay interest at such rate as may be agreed upon between the Directors and the Member paying such amount in advance. |
14.8 | No such amount paid in advance of calls shall entitle the Member paying such amount to any portion of a Dividend or other distribution payable in respect of any period prior to the date upon which such amount would, but for such payment, become payable. |
15 | Forfeiture of Shares |
15.1 | If a call or instalment of a call remains unpaid after it has become due and payable the Directors may give to the person from whom it is due not less than fourteen clear days’ notice requiring payment of the amount unpaid together with any interest which may have accrued and any expenses incurred by the Company by reason of such non-payment. The notice shall specify where payment is to be made and shall state that if the notice is not complied with the Shares in respect of which the call was made will be liable to be forfeited. |
15.2 | If the notice is not complied with, any Share in respect of which it was given may, before the payment required by the notice has been made, be forfeited by a resolution of the Directors. Such forfeiture shall include all Dividends, other distributions or other monies payable in respect of the forfeited Share and not paid before the forfeiture. |
15.3 | A forfeited Share may be sold, re-allotted or otherwise disposed of on such terms and in such manner as the Directors think fit and at any time before a sale, re-allotment or disposition the forfeiture may be cancelled on such terms as the Directors think fit. Where for the purposes of its disposal a forfeited Share is to be transferred to any person the Directors may authorise some person to execute an instrument of transfer of the Share in favour of that person. |
15.4 | A person any of whose Shares have been forfeited shall cease to be a Member in respect of them and shall surrender to the Company for cancellation the certificate for the Shares forfeited and shall remain liable to pay to the Company all monies which at the date of forfeiture were payable by him to the Company in respect of those Shares together with interest at such rate as the Directors may determine, but his liability shall cease if and when the Company shall have received payment in full of all monies due and payable by him in respect of those Shares. |
15.5 | A certificate in writing under the hand of one Director or officer of the Company that a Share has been forfeited on a specified date shall be conclusive evidence of the facts stated in it as against all persons claiming to be entitled to the Share. The certificate shall (subject to the execution of an instrument of transfer) constitute a good title to the Share and the person to whom the Share is sold or otherwise disposed of shall not be bound to see to the application of the purchase money, if any, nor shall his title to the Share be affected by any irregularity or invalidity in the proceedings in reference to the forfeiture, sale or disposal of the Share. |
15.6 | The provisions of the Articles as to forfeiture shall apply in the case of non payment of any sum which, by the terms of issue of a Share, becomes payable at a fixed time, whether on account of the par value of the Share or by way of premium as if it had been payable by virtue of a call duly made and notified. |
16 | Transmission of Shares |
16.1 | If a Member dies the survivor or survivors (where he was a joint holder) or his legal personal representatives (where he was a sole holder), shall be the only persons recognised by the Company as having any title to his Shares. The estate of a deceased Member is not thereby released from any liability in respect of any Share, for which he was a joint or sole holder. |
16.2 | Any person becoming entitled to a Share in consequence of the death or bankruptcy or liquidation or dissolution of a Member (or in any other way than by transfer) may, upon such evidence being produced as may be required by the Directors, elect, by a notice in writing sent by him to the Company, either to become the holder of such Share or to have some person nominated by him registered as the holder of such Share. If he elects to have another person registered as the holder of such Share he shall sign an instrument of transfer of that Share to that person. The Directors shall, in either case, have the same right to decline or suspend registration as they would have had in the case of a transfer of the Share by the relevant Member before his death or bankruptcy or liquidation or dissolution, as the case may be. |
16.3 | A person becoming entitled to a Share by reason of the death or bankruptcy or liquidation or dissolution of a Member (or in any other case than by transfer) shall be entitled to the same Dividends, other distributions and other advantages to which he would be entitled if he were the holder of such Share. However, he shall not, before becoming a Member in respect of a Share, be entitled in respect of it to exercise any right conferred by membership in relation to general meetings of the Company and the Directors may at any time give notice requiring any such person to elect either to be registered himself or to have some person nominated by him be registered as the holder of the Share (but the Directors shall, in either case, have the same right to decline or suspend registration as they would have had in the case of a transfer of the Share by the relevant Member before his death or bankruptcy or liquidation or dissolution or any other case than by transfer, as the case may be). If the notice is not complied with within ninety days of being received or deemed to be received (as determined pursuant to the Articles) the Directors may thereafter withhold payment of all Dividends, other distributions, bonuses or other monies payable in respect of the Share until the requirements of the notice have been complied with. |
17 | Amendments of Memorandum and Articles of Association and Alteration of Capital |
17.1 | The Company may by Ordinary Resolution: |
(a) | increase its share capital by such sum as the Ordinary Resolution shall prescribe and with such rights, priorities and privileges annexed thereto, as the Company in general meeting may determine; |
(b) | consolidate and divide all or any of its share capital into Shares of larger amount than its existing Shares; |
(c) | convert all or any of its paid-up Shares into stock, and reconvert that stock into paid-up Shares of any denomination; |
(d) | by subdivision of its existing Shares or any of them divide the whole or any part of its share capital into Shares of smaller amount than is fixed by the Memorandum or into Shares without par value; and |
(e) | cancel any Shares that at the date of the passing of the Ordinary Resolution have not been taken or agreed to be taken by any person and diminish the amount of its share capital by the amount of the Shares so cancelled. |
17.2 | All new Shares created in accordance with the provisions of the preceding Article shall be subject to the same provisions of the Articles with reference to the payment of calls, liens, transfer, transmission, forfeiture and otherwise as the Shares in the original share capital. |
17.3 | Subject to the provisions of the Statute and the provisions of the Articles as regards the matters to be dealt with by Ordinary Resolution, the Company may by Special Resolution: |
(a) | change its name; |
(b) | alter or add to the Articles; |
(c) | alter or add to the Memorandum with respect to any objects, powers or other matters specified therein; and |
(d) | reduce its share capital or any capital redemption reserve fund. |
18 | Offices and Places of Business |
19 | General Meetings |
19.1 | All general meetings other than annual general meetings shall be called extraordinary general meetings. |
19.2 | The Company may, but shall not (unless required by the Statute) be obliged to, in each year hold a general meeting as its annual general meeting, and shall specify the meeting as such in the notices calling it. Any annual general meeting shall be held at such time and place as the Directors shall appoint and if no other time and place is prescribed by them, it shall be held at the Registered Office on the second Wednesday in December of each year at ten o’clock in the morning. At these meetings the report of the Directors (if any) shall be presented. |
19.3 | The Directors may call general meetings, and they shall on a Members’ requisition forthwith proceed to convene an extraordinary general meeting of the Company. |
19.4 | A Members’ requisition is a requisition of Members holding at the date of deposit of the requisition not less than ten per cent. in par value of the issued Shares which as at that date carry the right to vote at general meetings of the Company. |
19.5 | The Members’ requisition must state the objects of the meeting and must be signed by the requisitionists and deposited at the Registered Office, and may consist of several documents in like form each signed by one or more requisitionists. |
19.6 | If there are no Directors as at the date of the deposit of the Members’ requisition or if the Directors do not within twenty-one days from the date of the deposit of the Members’ requisition duly proceed to convene a general meeting to be held within a further twenty-one days, the requisitionists, or any of them representing more than one-half of the total voting rights of all of the requisitionists, may themselves convene a general meeting, but any meeting so convened shall be held no later than the day which falls three months after the expiration of the said twenty-one day period. |
19.7 | A general meeting convened as aforesaid by requisitionists shall be convened in the same manner as nearly as possible as that in which general meetings are to be convened by Directors. |
20 | Notice of General Meetings |
20.1 | At least five clear days’ notice shall be given of any general meeting. Every notice shall specify the place, the day and the hour of the meeting and the general nature of the business to be conducted at the general meeting and shall be given in the manner hereinafter mentioned or in such other manner if any as may be prescribed by the Company, provided that a general meeting of the Company shall, whether or not the notice specified in this Article has been given and whether or not the provisions of the Articles regarding general meetings have been complied with, be deemed to have been duly convened if it is so agreed: |
(a) | in the case of an annual general meeting, by all of the Members entitled to attend and vote thereat; and |
(b) | in the case of an extraordinary general meeting, by a majority in number of the Members having a right to attend and vote at the meeting, together holding not less than ninety five per cent. in par value of the Shares giving that right. |
20.2 | The accidental omission to give notice of a general meeting to, or the non receipt of notice of a general meeting by, any person entitled to receive such notice shall not invalidate the proceedings of that general meeting. |
21 | Proceedings at General Meetings |
21.1 | No business shall be transacted at any general meeting unless a quorum is present. Two Members being individuals present in person or by proxy or if a corporation or other non-natural person by its duly authorised representative or proxy shall be a quorum unless the Company has only one Member entitled to vote at such general meeting in which case the quorum shall be that one Member present in person or by proxy or (in the case of a corporation or other non-natural person) by its duly authorised representative or proxy. |
21.2 | A person may participate at a general meeting by conference telephone or other communications equipment by means of which all the persons participating in the meeting can communicate with each other. Participation by a person in a general meeting in this manner is treated as presence in person at that meeting. |
21.3 | A resolution (including a Special Resolution) in writing (in one or more counterparts) signed by or on behalf of all of the Members for the time being entitled to receive notice of and to attend and vote at general meetings (or, being corporations or other non-natural persons, signed by their duly authorised representatives) shall be as valid and effective as if the resolution had been passed at a general meeting of the Company duly convened and held. |
21.4 | If a quorum is not present within half an hour from the time appointed for the meeting to commence or if during such a meeting a quorum ceases to be present, the meeting, if convened upon a Members’ requisition, shall be dissolved and in any other case it shall stand adjourned to the same day in the next week at the same time and/or place or to such other day, time and/or place as the Directors may determine, and if at the adjourned meeting a quorum is not present within half an hour from the time appointed for the meeting to commence, the Members present shall be a quorum. |
21.5 | The Directors may, at any time prior to the time appointed for the meeting to commence, appoint any person to act as chairman of a general meeting of the Company or, if the Directors do not make any such appointment, the chairman, if any, of the board of Directors shall preside as chairman at such general meeting. If there is no such chairman, or if he shall not be present within fifteen minutes after the time appointed for the meeting to commence, or is unwilling to act, the Directors present shall elect one of their number to be chairman of the meeting. |
21.6 | If no Director is willing to act as chairman or if no Director is present within fifteen minutes after the time appointed for the meeting to commence, the Members present shall choose one of their number to be chairman of the meeting. |
21.7 | The chairman may, with the consent of a meeting at which a quorum is present (and shall if so directed by the meeting) adjourn the meeting from time to time and from place to place, but no business shall be transacted at any adjourned meeting other than the business left unfinished at the meeting from which the adjournment took place. |
21.8 | When a general meeting is adjourned for thirty days or more, notice of the adjourned meeting shall be given as in the case of an original meeting. Otherwise it shall not be necessary to give any such notice of an adjourned meeting. |
21.9 | A resolution put to the vote of the meeting shall be decided on a show of hands unless before, or on the declaration of the result of, the show of hands, the chairman demands a poll, or any other Member or Members collectively present in person or by proxy (or in the case of a corporation or other non-natural person, by its duly authorised representative or proxy) and holding at least ten per cent. in par value of the Shares giving a right to attend and vote at the meeting demand a poll. |
21.10 | Unless a poll is duly demanded and the demand is not withdrawn a declaration by the chairman that a resolution has been carried or carried unanimously, or by a particular majority, or lost or not carried by a particular majority, an entry to that effect in the minutes of the proceedings of the meeting shall be conclusive evidence of that fact without proof of the number or proportion of the votes recorded in favour of or against such resolution. |
21.11 | The demand for a poll may be withdrawn. |
21.12 | Except on a poll demanded on the election of a chairman or on a question of adjournment, a poll shall be taken as the chairman directs, and the result of the poll shall be deemed to be the resolution of the general meeting at which the poll was demanded. |
21.13 | A poll demanded on the election of a chairman or on a question of adjournment shall be taken forthwith. A poll demanded on any other question shall be taken at such date, time and place as the chairman of the general meeting directs, and any business other than that upon which a poll has been demanded or is contingent thereon may proceed pending the taking of the poll. |
21.14 | In the case of an equality of votes, whether on a show of hands or on a poll, the chairman shall be entitled to a second or casting vote. |
22 | Votes of Members |
22.1 | Subject to any rights or restrictions attached to any Shares, on a show of hands every Member who (being an individual) is present in person or by proxy or, if a corporation or other non-natural person is present by its duly authorised representative or by proxy, shall have one vote and on a poll every Member present in any such manner shall have one vote for every Share of which he is the holder. |
22.2 | In the case of joint holders the vote of the senior holder who tenders a vote, whether in person or by proxy (or, in the case of a corporation or other non-natural person, by its duly authorised representative or proxy), shall be accepted to the exclusion of the votes of the other joint holders, and seniority shall be determined by the order in which the names of the holders stand in the Register of Members. |
22.3 | A Member of unsound mind, or in respect of whom an order has been made by any court, having jurisdiction in lunacy, may vote, whether on a show of hands or on a poll, by his committee, receiver, curator bonis, or other person on such Member’s behalf appointed by that court, and any such committee, receiver, curator bonis or other person may vote by proxy. |
22.4 | No person shall be entitled to vote at any general meeting unless he is registered as a Member on the record date for such meeting nor unless all calls or other monies then payable by him in respect of Shares have been paid. |
22.5 | No objection shall be raised as to the qualification of any voter except at the general meeting or adjourned general meeting at which the vote objected to is given or tendered and every vote not disallowed at the meeting shall be valid. Any objection made in due time in accordance with this Article shall be referred to the chairman whose decision shall be final and conclusive. |
22.6 | On a poll or on a show of hands votes may be cast either personally or by proxy (or in the case of a corporation or other non-natural person by its duly authorised representative or proxy). A Member may appoint more than one proxy or the same proxy under one or more instruments to attend and vote at a meeting. Where a Member appoints more than one proxy the instrument of proxy shall state which proxy is entitled to vote on a show of hands and shall specify the number of Shares in respect of which each proxy is entitled to exercise the related votes. |
22.7 | On a poll, a Member holding more than one Share need not cast the votes in respect of his Shares in the same way on any resolution and therefore may vote a Share or some or all such Shares either for or against a resolution and/or abstain from voting a Share or some or all of the Shares and, subject to the terms of the instrument appointing him, a proxy appointed under one or more instruments may vote a Share or some or all of the Shares in respect of which he is appointed either for or against a resolution and/or abstain from voting a Share or some or all of the Shares in respect of which he is appointed. |
23 | Proxies |
23.1 | The instrument appointing a proxy shall be in writing and shall be executed under the hand of the appointor or of his attorney duly authorised in writing, or, if the appointor is a corporation or other non natural person, under the hand of its duly authorised representative. A proxy need not be a Member. |
23.2 | The Directors may, in the notice convening any meeting or adjourned meeting, or in an instrument of proxy sent out by the Company, specify the manner by which the instrument appointing a proxy shall be deposited and the place and the time (being not later than the time appointed for the commencement of the meeting or adjourned meeting to which the proxy relates) at which the instrument appointing a proxy shall be deposited. In the absence of any such direction from the Directors in the notice convening any meeting or adjourned meeting or in an instrument of proxy sent out by the Company, the instrument appointing a proxy shall be deposited physically at the Registered Office not less than 48 hours before the time appointed for the meeting or adjourned meeting to commence at which the person named in the instrument proposes to vote. |
23.3 | The chairman may in any event at his discretion declare that an instrument of proxy shall be deemed to have been duly deposited. An instrument of proxy that is not deposited in the manner permitted, or which has not been declared to have been duly deposited by the chairman, shall be invalid. |
23.4 | The instrument appointing a proxy may be in any usual or common form (or such other form as the Directors may approve) and may be expressed to be for a particular meeting or any adjournment thereof or generally until revoked. An instrument appointing a proxy shall be deemed to include the power to demand or join or concur in demanding a poll. |
23.5 | Votes given in accordance with the terms of an instrument of proxy shall be valid notwithstanding the previous death or insanity of the principal or revocation of the proxy or of the authority under which the proxy was executed, or the transfer of the Share in respect of which the proxy is given unless notice in writing of such death, insanity, revocation or transfer was received by the Company at the Registered Office before the commencement of the general meeting, or adjourned meeting at which it is sought to use the proxy. |
24 | Corporate Members |
25 | Shares that May Not be Voted |
26 | Directors |
27 | Powers of Directors |
27.1 | Subject to the provisions of the Statute, the Memorandum and the Articles and to any directions given by Special Resolution, the business of the Company shall be managed by the Directors who may exercise all the powers of the Company. No alteration of the Memorandum or Articles and no such direction shall invalidate any prior act of the Directors which would have been valid if that alteration had not been made or that direction had not been given. A duly convened meeting of Directors at which a quorum is present may exercise all powers exercisable by the Directors. |
27.2 | All cheques, promissory notes, drafts, bills of exchange and other negotiable or transferable instruments and all receipts for monies paid to the Company shall be signed, drawn, accepted, endorsed or otherwise executed as the case may be in such manner as the Directors shall determine by resolution. |
27.3 | The Directors on behalf of the Company may pay a gratuity or pension or allowance on retirement to any Director who has held any other salaried office or place of profit with the Company or to his widow or dependants and may make contributions to any fund and pay premiums for the purchase or provision of any such gratuity, pension or allowance. |
27.4 | The Directors may exercise all the powers of the Company to borrow money and to mortgage or charge its undertaking, property and assets (present and future) and uncalled capital or any part thereof and to issue debentures, debenture stock, mortgages, bonds and other such securities whether outright or as security for any debt, liability or obligation of the Company or of any third party. |
28 | Appointment and Removal of Directors |
28.1 | The Company may by Ordinary Resolution appoint any person to be a Director or may by Ordinary Resolution remove any Director. |
28.2 | The Directors may appoint any person to be a Director, either to fill a vacancy or as an additional Director provided that the appointment does not cause the number of Directors to exceed any number fixed by or in accordance with the Articles as the maximum number of Directors. |
29 | Vacation of Office of Director |
(a) | the Director gives notice in writing to the Company that he resigns the office of Director; or |
(b) | the Director absents himself (for the avoidance of doubt, without being represented by proxy or an alternate Director appointed by him) from three consecutive meetings of the board of Directors without special leave of absence from the Directors, and the Directors pass a resolution that he has by reason of such absence vacated office; or |
(c) | the Director dies, becomes bankrupt or makes any arrangement or composition with his creditors generally; or |
(d) | the Director is found to be or becomes of unsound mind; or |
(e) | all of the other Directors (being not less than two in number) determine that he should be removed as a Director, either by a resolution passed by all of the other Directors at a meeting of the Directors duly convened and held in accordance with the Articles or by a resolution in writing signed by all of the other Directors. |
30 | Proceedings of Directors |
30.1 | The quorum for the transaction of the business of the Directors may be fixed by the Directors, and unless so fixed shall be two if there are two or more Directors, and shall be one if there is only one Director. A person who holds office as an alternate Director shall, if his appointor is not present, be counted in the quorum. A Director who also acts as an alternate Director shall, if his appointor is not present, count twice towards the quorum. |
30.2 | Subject to the provisions of the Articles, the Directors may regulate their proceedings as they think fit. Questions arising at any meeting shall be decided by a majority of votes. In the case of an equality of votes, the chairman shall have a second or casting vote. A Director who is also an alternate Director shall be entitled in the absence of his appointor to a separate vote on behalf of his appointor in addition to his own vote. |
30.3 | A person may participate in a meeting of the Directors or any committee of Directors by conference telephone or other communications equipment by means of which all the persons participating in the meeting can communicate with each other at the same time. Participation by a person in a meeting in this manner is treated as presence in person at that meeting. Unless otherwise determined by the Directors the meeting shall be deemed to be held at the place where the chairman is located at the start of the meeting. |
30.4 | A resolution in writing (in one or more counterparts) signed by all the Directors or all the members of a committee of the Directors or, in the case of a resolution in writing relating to the removal of any Director or the vacation of office by any Director, all of the Directors other than the Director who is the subject of such resolution (an alternate Director being entitled to sign such a resolution on behalf of his appointor and if such alternate Director is also a Director, being entitled to sign such resolution both on behalf of his appointer and in his capacity as a Director) shall be as valid and effectual as if it had been passed at a meeting of the Directors, or committee of Directors as the case may be, duly convened and held. |
30.5 | A Director or alternate Director may, or other officer of the Company on the direction of a Director or alternate Director shall, call a meeting of the Directors by at least two days’ notice in writing to every Director and alternate Director which notice shall set forth the general nature of the business to be considered unless notice is waived by all the Directors (or their alternates) either at, before or after the meeting is held. To any such notice of a meeting of the Directors all the provisions of the Articles relating to the giving of notices by the Company to the Members shall apply mutatis mutandis. |
30.6 | The continuing Directors (or a sole continuing Director, as the case may be) may act notwithstanding any vacancy in their body, but if and so long as their number is reduced below the number fixed by or pursuant to the Articles as the necessary quorum of Directors the continuing Directors or Director may act for the purpose of increasing the number of Directors to be equal to such fixed number, or of summoning a general meeting of the Company, but for no other purpose. |
30.7 | The Directors may elect a chairman of their board and determine the period for which he is to hold office; but if no such chairman is elected, or if at any meeting the chairman is not present within five minutes after the time appointed for the meeting to commence, the Directors present may choose one of their number to be chairman of the meeting. |
30.8 | All acts done by any meeting of the Directors or of a committee of the Directors (including any person acting as an alternate Director) shall, notwithstanding that it is afterwards discovered that there was some defect in the appointment of any Director or alternate Director, and/or that they or any of them were disqualified, and/or had vacated their office and/or were not entitled to vote, be as valid as if every such person had been duly appointed and/or not disqualified to be a Director or alternate Director and/or had not vacated their office and/or had been entitled to vote, as the case may be. |
30.9 | A Director but not an alternate Director may be represented at any meetings of the board of Directors by a proxy appointed in writing by him. The proxy shall count towards the quorum and the vote of the proxy shall for all purposes be deemed to be that of the appointing Director. |
31 | Presumption of Assent |
32 | Directors’ Interests |
32.1 | A Director or alternate Director may hold any other office or place of profit under the Company (other than the office of Auditor) in conjunction with his office of Director for such period and on such terms as to remuneration and otherwise as the Directors may determine. |
32.2 | A Director or alternate Director may act by himself or by, through or on behalf of his firm in a professional capacity for the Company and he or his firm shall be entitled to remuneration for professional services as if he were not a Director or alternate Director. |
32.3 | A Director or alternate Director may be or become a director or other officer of or otherwise interested in any company promoted by the Company or in which the Company may be interested as a |
32.4 | No person shall be disqualified from the office of Director or alternate Director or prevented by such office from contracting with the Company, either as vendor, purchaser or otherwise, nor shall any such contract or any contract or transaction entered into by or on behalf of the Company in which any Director or alternate Director shall be in any way interested be or be liable to be avoided, nor shall any Director or alternate Director so contracting or being so interested be liable to account to the Company for any profit realised by or arising in connection with any such contract or transaction by reason of such Director or alternate Director holding office or of the fiduciary relationship thereby established. A Director (or his alternate Director in his absence) shall be at liberty to vote in respect of any contract or transaction in which he is interested provided that the nature of the interest of any Director or alternate Director in any such contract or transaction shall be disclosed by him at or prior to its consideration and any vote thereon. |
32.5 | A general notice that a Director or alternate Director is a shareholder, director, officer or employee of any specified firm or company and is to be regarded as interested in any transaction with such firm or company shall be sufficient disclosure for the purposes of voting on a resolution in respect of a contract or transaction in which he has an interest, and after such general notice it shall not be necessary to give special notice relating to any particular transaction. |
33 | Minutes |
34 | Delegation of Directors’ Powers |
34.1 | The Directors may delegate any of their powers, authorities and discretions, including the power to sub-delegate, to any committee consisting of one or more Directors. They may also delegate to any managing director or any Director holding any other executive office such of their powers, authorities and discretions as they consider desirable to be exercised by him provided that an alternate Director may not act as managing director and the appointment of a managing director shall be revoked forthwith if he ceases to be a Director. Any such delegation may be made subject to any conditions the Directors may impose and either collaterally with or to the exclusion of their own powers and any such delegation may be revoked or altered by the Directors. Subject to any such conditions, the proceedings of a committee of Directors shall be governed by the Articles regulating the proceedings of Directors, so far as they are capable of applying. |
34.2 | The Directors may establish any committees, local boards or agencies or appoint any person to be a manager or agent for managing the affairs of the Company and may appoint any person to be a member of such committees, local boards or agencies. Any such appointment may be made subject to any conditions the Directors may impose, and either collaterally with or to the exclusion of their own powers and any such appointment may be revoked or altered by the Directors. Subject to any such conditions, the proceedings of any such committee, local board or agency shall be governed by the Articles regulating the proceedings of Directors, so far as they are capable of applying. |
34.3 | The Directors may by power of attorney or otherwise appoint any person to be the agent of the Company on such conditions as the Directors may determine, provided that the delegation is not to the exclusion of their own powers and may be revoked by the Directors at any time. |
34.4 | The Directors may by power of attorney or otherwise appoint any company, firm, person or body of persons, whether nominated directly or indirectly by the Directors, to be the attorney or authorised signatory of the Company for such purpose and with such powers, authorities and discretions (not exceeding those vested in or exercisable by the Directors under the Articles) and for such period and subject to such conditions as they may think fit, and any such powers of attorney or other appointment |
34.5 | The Directors may appoint such officers of the Company (including, for the avoidance of doubt and without limitation, any secretary) as they consider necessary on such terms, at such remuneration and to perform such duties, and subject to such provisions as to disqualification and removal as the Directors may think fit. Unless otherwise specified in the terms of his appointment an officer of the Company may be removed by resolution of the Directors or Members. An officer of the Company may vacate his office at any time if he gives notice in writing to the Company that he resigns his office. |
35 | Alternate Directors |
35.1 | Any Director (but not an alternate Director) may by writing appoint any other Director, or any other person willing to act, to be an alternate Director and by writing may remove from office an alternate Director so appointed by him. |
35.2 | An alternate Director shall be entitled to receive notice of all meetings of Directors and of all meetings of committees of Directors of which his appointor is a member, to attend and vote at every such meeting at which the Director appointing him is not personally present, to sign any written resolution of the Directors, and generally to perform all the functions of his appointor as a Director in his absence. |
35.3 | An alternate Director shall cease to be an alternate Director if his appointor ceases to be a Director. |
35.4 | Any appointment or removal of an alternate Director shall be by notice to the Company signed by the Director making or revoking the appointment or in any other manner approved by the Directors. |
35.5 | Subject to the provisions of the Articles, an alternate Director shall be deemed for all purposes to be a Director and shall alone be responsible for his own acts and defaults and shall not be deemed to be the agent of the Director appointing him. |
36 | No Minimum Shareholding |
37 | Remuneration of Directors |
37.1 | The remuneration to be paid to the Directors, if any, shall be such remuneration as the Directors shall determine. The Directors shall also be entitled to be paid all travelling, hotel and other expenses properly incurred by them in connection with their attendance at meetings of Directors or committees of Directors, or general meetings of the Company, or separate meetings of the holders of any class of Shares or debentures of the Company, or otherwise in connection with the business of the Company or the discharge of their duties as a Director, or to receive a fixed allowance in respect thereof as may be determined by the Directors, or a combination partly of one such method and partly the other. |
37.2 | The Directors may by resolution approve additional remuneration to any Director for any services which in the opinion of the Directors go beyond his ordinary routine work as a Director. Any fees paid to a Director who is also counsel, attorney or solicitor to the Company, or otherwise serves it in a professional capacity shall be in addition to his remuneration as a Director. |
38 | Seal |
38.1 | The Company may, if the Directors so determine, have a Seal. The Seal shall only be used by the authority of the Directors or of a committee of the Directors authorised by the Directors. Every instrument to which the Seal has been affixed shall be signed by at least one person who shall be either a Director or some officer of the Company or other person appointed by the Directors for the purpose. |
38.2 | The Company may have for use in any place or places outside the Cayman Islands a duplicate Seal or Seals each of which shall be a facsimile of the common Seal of the Company and, if the Directors so determine, with the addition on its face of the name of every place where it is to be used. |
38.3 | A Director or officer, representative or attorney of the Company may without further authority of the Directors affix the Seal over his signature alone to any document of the Company required to be authenticated by him under seal or to be filed with the Registrar of Companies in the Cayman Islands or elsewhere wheresoever. |
39 | Dividends, Distributions and Reserve |
39.1 | Subject to the Statute and this Article and except as otherwise provided by the rights attached to any Shares, the Directors may resolve to pay Dividends and other distributions on Shares in issue and authorise payment of the Dividends or other distributions out of the funds of the Company lawfully available therefor. A Dividend shall be deemed to be an interim Dividend unless the terms of the resolution pursuant to which the Directors resolve to pay such Dividend specifically state that such Dividend shall be a final Dividend. No Dividend or other distribution shall be paid except out of the realised or unrealised profits of the Company, out of the share premium account or as otherwise permitted by law. |
39.2 | Except as otherwise provided by the rights attached to any Shares, all Dividends and other distributions shall be paid according to the par value of the Shares that a Member holds. If any Share is issued on terms providing that it shall rank for Dividend as from a particular date, that Share shall rank for Dividend accordingly. |
39.3 | The Directors may deduct from any Dividend or other distribution payable to any Member all sums of money (if any) then payable by him to the Company on account of calls or otherwise. |
39.4 | The Directors may resolve that any Dividend or other distribution be paid wholly or partly by the distribution of specific assets and in particular (but without limitation) by the distribution of shares, debentures, or securities of any other company or in any one or more of such ways and where any difficulty arises in regard to such distribution, the Directors may settle the same as they think expedient and in particular may issue fractional Shares and may fix the value for distribution of such specific assets or any part thereof and may determine that cash payments shall be made to any Members upon the basis of the value so fixed in order to adjust the rights of all Members and may vest any such specific assets in trustees in such manner as may seem expedient to the Directors. |
39.5 | Except as otherwise provided by the rights attached to any Shares, Dividends and other distributions may be paid in any currency. The Directors may determine the basis of conversion for any currency conversions that may be required and how any costs involved are to be met. |
39.6 | The Directors may, before resolving to pay any Dividend or other distribution, set aside such sums as they think proper as a reserve or reserves which shall, at the discretion of the Directors, be applicable for any purpose of the Company and pending such application may, at the discretion of the Directors, be employed in the business of the Company. |
39.7 | Any Dividend, other distribution, interest or other monies payable in cash in respect of Shares may be paid by wire transfer to the holder or by cheque or warrant sent through the post directed to the registered address of the holder or, in the case of joint holders, to the registered address of the holder who is first named on the Register of Members or to such person and to such address as such holder or joint holders may in writing direct. Every such cheque or warrant shall be made payable to the order of the person to whom it is sent. Any one of two or more joint holders may give effectual receipts for any Dividends, other distributions, bonuses, or other monies payable in respect of the Share held by them as joint holders. |
39.8 | No Dividend or other distribution shall bear interest against the Company. |
39.9 | Any Dividend or other distribution which cannot be paid to a Member and/or which remains unclaimed after six months from the date on which such Dividend or other distribution becomes payable may, in the discretion of the Directors, be paid into a separate account in the Company’s name, provided that the Company shall not be constituted as a trustee in respect of that account and the Dividend or other distribution shall remain as a debt due to the Member. Any Dividend or other distribution which remains unclaimed after a period of six years from the date on which such Dividend or other distribution becomes payable shall be forfeited and shall revert to the Company. |
40 | Capitalisation |
41 | Books of Account |
41.1 | The Directors shall cause proper books of account (including, where applicable, material underlying documentation including contracts and invoices) to be kept with respect to all sums of money received and expended by the Company and the matters in respect of which the receipt or expenditure takes place, all sales and purchases of goods by the Company and the assets and liabilities of the Company. Such books of account must be retained for a minimum period of five years from the date on which they are prepared. Proper books shall not be deemed to be kept if there are not kept such books of account as are necessary to give a true and fair view of the state of the Company’s affairs and to explain its transactions. |
41.2 | The Directors shall determine whether and to what extent and at what times and places and under what conditions or regulations the accounts and books of the Company or any of them shall be open to the inspection of Members not being Directors and no Member (not being a Director) shall have any right of inspecting any account or book or document of the Company except as conferred by Statute or authorised by the Directors or by the Company in general meeting. |
41.3 | The Directors may cause to be prepared and to be laid before the Company in general meeting profit and loss accounts, balance sheets, group accounts (if any) and such other reports and accounts as may be required by law. |
42 | Audit |
42.1 | The Directors may appoint an Auditor of the Company who shall hold office on such terms as the Directors determine. |
42.2 | Every Auditor of the Company shall have a right of access at all times to the books and accounts and vouchers of the Company and shall be entitled to require from the Directors and officers of the Company such information and explanation as may be necessary for the performance of the duties of the Auditor. |
42.3 | Auditors shall, if so required by the Directors, make a report on the accounts of the Company during their tenure of office at the next annual general meeting following their appointment in the case of a company which is registered with the Registrar of Companies as an ordinary company, and at the next extraordinary general meeting following their appointment in the case of a company which is registered with the Registrar of Companies as an exempted company, and at any other time during their term of office, upon request of the Directors or any general meeting of the Members. |
43 | Notices |
43.1 | Notices shall be in writing and may be given by the Company to any Member either personally or by sending it by courier, post, cable, telex, fax or e-mail to him or to his address as shown in the Register of Members (or where the notice is given by e-mail by sending it to the e-mail address provided by such Member). Any notice, if posted from one country to another, is to be sent by airmail. |
43.2 | Where a notice is sent by courier, service of the notice shall be deemed to be effected by delivery of the notice to a courier company, and shall be deemed to have been received on the third day (not including Saturdays or Sundays or public holidays) following the day on which the notice was delivered to the courier. Where a notice is sent by post, service of the notice shall be deemed to be effected by properly addressing, pre paying and posting a letter containing the notice, and shall be deemed to have been received on the fifth day (not including Saturdays or Sundays or public holidays in the Cayman Islands) following the day on which the notice was posted. Where a notice is sent by cable, telex or fax, service of the notice shall be deemed to be effected by properly addressing and sending such notice and shall be deemed to have been received on the same day that it was transmitted. Where a notice is given by e-mail service shall be deemed to be effected by transmitting the e-mail to the e-mail address provided by the intended recipient and shall be deemed to have been received on the same day that it was sent, and it shall not be necessary for the receipt of the e-mail to be acknowledged by the recipient. |
43.3 | A notice may be given by the Company to the person or persons which the Company has been advised are entitled to a Share or Shares in consequence of the death or bankruptcy of a Member in the same manner as other notices which are required to be given under the Articles and shall be addressed to them by name, or by the title of representatives of the deceased, or trustee of the bankrupt, or by any like description at the address supplied for that purpose by the persons claiming to be so entitled, or at the option of the Company by giving the notice in any manner in which the same might have been given if the death or bankruptcy had not occurred. |
43.4 | Notice of every general meeting shall be given in any manner authorised by the Articles to every holder of Shares carrying an entitlement to receive such notice on the record date for such meeting except that in the case of joint holders the notice shall be sufficient if given to the joint holder first named in the Register of Members and every person upon whom the ownership of a Share devolves by reason of his being a legal personal representative or a trustee in bankruptcy of a Member where the Member but for his death or bankruptcy would be entitled to receive notice of the meeting, and no other person shall be entitled to receive notices of general meetings. |
44 | Winding Up |
44.1 | If the Company shall be wound up the liquidator shall apply the assets of the Company in satisfaction of creditors’ claims in such manner and order as such liquidator thinks fit. Subject to the rights attaching to any Shares, in a winding up: |
(a) | if the assets available for distribution amongst the Members shall be insufficient to repay the whole of the Company’s issued share capital, such assets shall be distributed so that, as nearly as may be, the losses shall be borne by the Members in proportion to the par value of the Shares held by them; or |
(b) | if the assets available for distribution amongst the Members shall be more than sufficient to repay the whole of the Company’s issued share capital at the commencement of the winding up, the surplus shall be distributed amongst the Members in proportion to the par value of the Shares held by them at the commencement of the winding up subject to a deduction from those Shares in respect of which there are monies due, of all monies payable to the Company for unpaid calls or otherwise. |
44.2 | If the Company shall be wound up the liquidator may, subject to the rights attaching to any Shares and with the approval of a Special Resolution of the Company and any other approval required by the Statute, divide amongst the Members in kind the whole or any part of the assets of the Company (whether such assets shall consist of property of the same kind or not) and may for that purpose value any assets and determine how the division shall be carried out as between the Members or different classes of Members. The liquidator may, with the like approval, vest the whole or any part of such assets in trustees upon such trusts for the benefit of the Members as the liquidator, with the like approval, shall think fit, but so that no Member shall be compelled to accept any asset upon which there is a liability. |
45 | Indemnity and Insurance |
45.1 | Every Director and officer of the Company (which for the avoidance of doubt, shall not include auditors of the Company), together with every former Director and former officer of the Company (each an “Indemnified Person”) shall be indemnified out of the assets of the Company against any liability, action, proceeding, claim, demand, costs, damages or expenses, including legal expenses, whatsoever which they or any of them may incur as a result of any act or failure to act in carrying out their functions other than such liability (if any) that they may incur by reason of their own actual fraud or wilful default. No Indemnified Person shall be liable to the Company for any loss or damage incurred by the Company as a result (whether direct or indirect) of the carrying out of their functions unless that liability arises through the actual fraud or wilful default of such Indemnified Person. No person shall be found to have committed actual fraud or wilful default under this Article unless or until a court of competent jurisdiction shall have made a finding to that effect. |
45.2 | The Company shall advance to each Indemnified Person reasonable attorneys’ fees and other costs and expenses incurred in connection with the defence of any action, suit, proceeding or investigation involving such Indemnified Person for which indemnity will or could be sought. In connection with any advance of any expenses hereunder, the Indemnified Person shall execute an undertaking to repay the advanced amount to the Company if it shall be determined by final judgment or other final adjudication that such Indemnified Person was not entitled to indemnification pursuant to this Article. If it shall be determined by a final judgment or other final adjudication that such Indemnified Person was not entitled to indemnification with respect to such judgment, costs or expenses, then such party shall not be indemnified with respect to such judgment, costs or expenses and any advancement shall be returned to the Company (without interest) by the Indemnified Person. |
45.3 | The Directors, on behalf of the Company, may purchase and maintain insurance for the benefit of any Director or other officer of the Company against any liability which, by virtue of any rule of law, would otherwise attach to such person in respect of any negligence, default, breach of duty or breach of trust of which such person may be guilty in relation to the Company. |
46 | Financial Year |
47 | Transfer by Way of Continuation |
48 | Mergers and Consolidations |
1. | DEFINITIONS; INTERPRETATION. |
(a) | In these Articles, the following terms (whether or not capitalized) shall bear the meanings set forth opposite them, respectively, unless the subject or context requires otherwise. |
“Articles” | | | shall mean these Articles of Association, as amended from time to time. |
| | ||
“Board of Directors” | | | shall mean the Board of Directors of the Company. |
| | ||
“Chairperson” | | | shall mean the Chairperson of the Board of Directors, or the Chairperson of the General Meeting, as the context implies. |
| | ||
“Closing Date” | | | shall mean [•], 2021. |
| | ||
“Companies Law” | | | shall mean the Israeli Companies Law, 5759-1999 and the regulations promulgated thereunder. The Companies Law shall include reference to the Companies Ordinance (New Version), 5743-1983, of the State of Israel, to the extent in effect according to the provisions thereof. |
| | ||
“Company” | | | shall mean Pagaya Technologies Ltd. |
| | ||
“Director(s)” | | | shall mean the member(s) of the Board of Directors holding office at a given time. |
| | ||
“Economic Competition Law” | | | shall mean the Israeli Economic Competition Law, 5748-1988 and the regulations promulgated thereunder. |
| | ||
“External Director(s)” | | | shall have the meaning provided for such term in the Companies Law. |
| | ||
“General Meeting” | | | shall mean an Annual General Meeting or Special General Meeting of the Shareholders (each as defined in Article 24 of these Articles), as the case may be. |
| | ||
“Liquidation Event” | | | means a liquidation, merger, capital stock exchange, reorganization, sale of all or substantially all assets or other similar transaction involving the Company upon the consummation of which holders of Ordinary Shares would be entitled to exchange their Ordinary Shares for cash, securities or other property. |
| | ||
“NIS” | | | shall mean New Israeli Shekels. |
| | ||
“Office” | | | shall mean the registered office of the Company at a given time. |
| | ||
“Office Holder” | | | shall have the meaning provided for such term in the Companies Law. |
| | ||
“Securities Law” | | | shall mean the Israeli Securities Law, 5728-1968 and the regulations promulgated thereunder. |
| | ||
Shareholder(s)” | | | shall mean the shareholder(s) of the Company, at a given time. |
(b) | Unless the context shall otherwise require: words in the singular shall also include the plural, and vice versa; any pronoun shall include the corresponding masculine, feminine and neuter forms; the words “include”, “includes” and “including” shall be deemed to be followed by the phrase “without limitation”; the words “herein”, “hereof” and “hereunder” and words of similar import refer to these Articles in their entirety and not to any part hereof; all references herein to Articles or clauses shall be deemed references to Articles or clauses of these Articles; any references to any agreement or other instrument or law, statute or regulation are to it as amended, supplemented or restated, from time to time (and, in the case of any law, to any successor provisions or re-enactment or modification thereof being in force at the time); any reference to “law” shall include any law (‘din’) as defined in the Interpretation Law, 5741-1981 and any applicable supranational, national, federal, state, local, or foreign statute or law and shall be deemed also to refer to all rules and regulations promulgated thereunder; any reference to a “day” or a number of “days” (without any explicit reference otherwise, such as to business days) shall be interpreted as a reference to a calendar day or number of calendar days; any reference to a business day or business days shall mean each calendar day other than Saturday, Sunday, and any calendar day on which commercial banks in New York, New York or Tel Aviv, Israel are authorized or required by applicable law to close; reference to a month or year means according to the Gregorian calendar; any reference to a “person” shall mean any individual, partnership, corporation, limited liability company, association, estate, any political, governmental, regulatory or similar agency or body or other legal entity; and reference to “written” or “in writing” shall include written, printed, photocopied, typed, any electronic communication (including email, facsimile, signed electronically (in Adobe PDF, DocuSign or any other format)) or produced by any visible substitute for writing, or partly one and partly another, and signed shall be construed accordingly. |
(c) | The captions in these Articles are for convenience only and shall not be deemed a part hereof or affect the construction or interpretation of any provision hereof. |
(d) | The specific provisions of these Articles shall supersede the provisions of the Companies Law to the extent permitted thereunder. |
2. | The Company is a limited liability company and each Shareholder’s liability for the Company’s debts is therefore limited (in addition to any liabilities under any contract) to the payment of the full amount (par value (if any) and premium) such Shareholder was required to pay the Company for such Shareholder’s Shares (as defined below) and which amount has not yet been paid by such Shareholder. |
3. | OBJECTIVES. |
4. | DONATIONS. |
5. | AUTHORIZED SHARE CAPITAL. |
6. | INCREASE OF AUTHORIZED SHARE CAPITAL. |
(a) | The Company may, from time to time, by a Shareholders’ resolution, whether or not all of the shares then authorized have been issued, and whether or not all of the shares theretofore issued have been called up for payment, increase its authorized share capital by increasing the number of shares it is authorized to issue by such amount, and such additional shares shall confer such rights and preferences, and shall be subject to such restrictions, as such resolution shall provide. |
(b) | Except to the extent otherwise provided in such resolution, any new shares included in the authorized share capital increase as aforesaid shall be subject to all of the provisions of these Articles that are applicable to shares that are included in the existing share capital. |
7. | SPECIAL OR CLASS RIGHTS; MODIFICATION OF RIGHTS. |
(a) | Subject to Section 8(d) below, the Company may, from time to time, by a Shareholders’ resolution, provide for shares with such preferred or deferred rights or other special rights and/or such restrictions, whether in regard to dividends, voting, repayment of share capital or otherwise, as may be stipulated in such resolution. |
(b) | If at any time the share capital of the Company is divided into different classes of shares, the rights attached to any class, unless otherwise provided by these Articles, may be modified or cancelled by the Company by a resolution of the General Meeting of the holders of all shares as one class, without any required separate resolution of any class of shares; provided, however, that (i) any modification to the rights attached to the Class B Shares shall require approval of Shareholders holding 100% of the then issued Class B Shares, and (ii) as long as any Class B Shares remain outstanding, any modification to (or cancellation of) any rights of the Class A Shares that is not applied in the same manner to the Class B Shares shall require approval of a majority of the Class A Shares represented and voted, in person or by proxy, in a Class Meeting convened for such purpose. |
(c) | The provisions of these Articles relating to General Meetings shall apply, mutatis mutandis, to any separate General Meeting of the holders of the shares of a particular class (a “Class Meeting”), it being clarified that the requisite quorum at any such separate Class Meeting shall be two or more Shareholders present in person or by proxy and holding not less than thirty-three and one-third percent (331⁄3%) of the issued shares of such class, provided, however, that if such separate Class Meeting was initiated by and convened pursuant to a resolution adopted by the Board of Directors and at the time of such meeting the Company is a “foreign private issuer” under U.S. securities laws, the requisite quorum at any such separate Class Meeting shall be two or more Shareholders present in person or by proxy and holding not less than twenty five percent (25%) of the issued shares of such class; provided, however, that at all times the requisite quorum at any such separate Class Meeting of the Class B Shares shall be Shareholders present in person or by proxy and holding not less than a majority of the issued shares of such class. The above notwithstanding, any Shareholder in default of its payment obligation under Article 14 hereof shall not accounted as a Shareholder for purposes of this Article. The provisions of Article 28(c) shall apply to adjourned Class Meetings, mutatis mutandis. |
(d) | Unless otherwise provided by these Articles, an increase in the authorized share capital, the creation of a new class of shares, an increase in the authorized share capital of a class of shares, or the issuance of additional shares thereof out of the authorized and unissued share capital, shall not be deemed, for purposes of this Article 7, to modify or derogate or cancel the rights attached to previously issued shares of such class or of any other class; provided, however, that the creation of a new class of shares with more than one vote per share shall be considered a modification of the Class B Shares. |
8. | CLASS A SHARES AND CLASS B SHARES. |
(a) | From and after the effective time of these Articles, additional Class B Shares may be issued only to, and registered in the name of, (i) Gal Krubiner, Yahav Yulzari and Avital Pardo (each a “Founder” and, together, the “Founders”) and (ii) any Permitted Class B Owner (as defined below). |
(b) | Except as otherwise provided in these Articles or otherwise required by applicable law, each holder of Class A Shares shall be entitled to one (1) vote for each Class A Share held, and each holder of Class B Shares shall be entitled to ten (10) votes for each Class B Share held, in each case, as of the applicable record date set for the vote on any matter, whether the vote thereon is conducted by a show of hands, by written ballot, or by any other means. Notwithstanding anything herein to the contrary, in no event shall the aggregate voting power of a holder of Class B Shares exceed the maximum voting power permitted under applicable law without effecting a tender offer. |
(c) | Except as otherwise expressly provided in this Article 8, the Class A Shares and Class B Shares shall have the same rights and privileges and rank equally, share ratably and be identical in all respects as to all matters, including without limitation: |
(i) | Dividends and Distributions. Class A Shares and Class B Shares shall be treated equally and ratably, on a per share basis with respect to any dividend or distribution paid or distributed by the Company, unless different treatment of the shares of each such class is approved in separate Class Meetings of each of such classes, and in which a majority of the shares of each such class present and voting in such meeting affirmatively vote in favor of such treatment, provided, however, that in the event a distribution is paid in the form of shares or rights to acquire shares, the holders of Class A Shares shall receive Class A Shares (or rights to acquire such shares, as the case may be) while holders of Class B Shares shall receive Class B Shares (or rights to acquire such shares, as the case may be). |
(ii) | Subdivision and Combination. If the Company effects a split, reverse split, subdivision or combination of the outstanding Class A Shares or Class B Shares, the outstanding shares of the other class will be subject to the same split, reverse split, subdivision or combination in the same proportion and manner, unless different treatment is approved in separate Class Meetings of each of classes, and in which a majority of the shares of each such class present and voting in such meeting affirmatively vote in favor of such treatment. |
(iii) | Liquidation Event. Class A Shares and Class B Shares shall be treated equally, identically and ratably on a per share basis with respect to any consideration into which such Shares are converted or any consideration paid or otherwise distributed to shareholders of the Company in connection with a Liquidation Event, unless different treatment of the shares of each such class is approved in separate Class Meetings of each of such classes, and in which a majority of the shares of each such class present and voting in such meeting affirmatively vote in favor of such treatment. |
(d) | Each one Class B Share shall be convertible into one Class A Share at the option of the holder thereof, at any time, upon written notice to the Company and the Company’s transfer agent. |
(e) | All outstanding Class B Shares owned by a Founder and by any Permitted Class B Owners affiliated with such Founder shall automatically convert into an equal number of Class A Shares (without consideration and without need for further action by the Company or the relevant Founder or Permitted Class B Owner) on the date of the earliest to occur of (i), (ii) or (iii) below (the “Trigger Conditions”): |
(1) | the earliest to occur of (a) such Founder’s employment or engagement as an officer of the Company being terminated not for Cause (as defined below), (b) such Founder’s resigning as an officer of the Company, (c) death or Permanent Disability (as defined below) of such Founder; provided, however, in such event, such Founder’s Class B Shares shall be transferred |
(2) | such Founder no longer serves as a member of the Board of Directors; |
(ii) | ninety (90) days following the date on which such Founder first receives notice that his employment as an officer of the Company is terminated for Cause; provided, however, that if, prior to the expiration of such ninety-day period, (a) the Board of Directors repeals its determination that such Founder was terminated for Cause or determines that the Cause had been cured, then the provisions of clause (i) above shall apply, or (b) such Founder commences legal proceedings with the competent judicial forum to determine that such determination by the Board of Directors of termination for Cause was improper or incorrect, then such Founder shall retain its Class B Shares until the earlier of (y) the issuance of a final unappealable judgment confirming the determination of the Board of Directors, or a judgment which execution had not been stayed pending an appeal, and (z) the abandonment of such proceedings or their dismissal or denial by a ruling of the relevant judicial forum on any grounds, substantive or procedural, and regardless of whether or not the Board of Directors’ determination regarding the termination for Cause is confirmed as part of such ruling; provided, that notwithstanding anything to the contrary in this Article 8(e)(ii), in the case of clauses (1) – (3) of Article 8(n)(i) below, the basis for Cause shall be deemed to not be curable, and such redemption shall be effective immediately upon written notice by the Company to such Founder; |
(iii) | the earlier to occur of (1) such time as the Founders and the Permitted Class B Owners first collectively hold less than 10% of the total issued and outstanding ordinary share capital of the Company, and (2) the fifteenth (15th) anniversary of the Closing Date. |
(f) | In the event of voluntary conversion of Class B Shares to Class A Shares pursuant to Article 8(d), or automatic conversion pursuant to Article 8(e), all rights of the holder of such Class B Shares shall cease and such holder shall thereafter be treated for all purposes as having become the record holder of such number of Class A Shares into which such Class B Shares were convertible. The Class A Shares issuable upon conversion of the Class B Shares shall remain restricted shares, and all certificates or book-entries representing such shares shall bear a legend in customary form to that effect. Any proxy issued with respect to Class B Shares shall, unless otherwise stated in such proxy, continue to apply with respect to the Class A Shares into which the Class B shares have been converted. Class B Shares that are converted into Class A Shares as provided in this Article 8 shall not be reissued, and no further Class B Shares may be issued by the Company following the voluntary or automatic conversion of the last of the outstanding Class B Shares. |
(g) | The Company shall not, without the prior affirmative vote of 100% of the outstanding Class B Shares, voting as a separate class, in addition to any other vote required by applicable law or these Articles: |
(i) | directly or indirectly, whether by amendment, or through merger, recapitalization, consolidation or otherwise, amend or repeal, or adopt any provision of these Articles inconsistent with, or otherwise alter, any provision of these Articles that modifies the voting, conversion or other rights, powers, preferences, privileges or restrictions of the Class B Shares; |
(ii) | reclassify any outstanding Class A Shares into shares having the right to have more than one (1) vote for each share thereof, except as required by law; |
(iii) | issue any Class B Shares (other than Class B Shares originally issued by the Company after the Closing Date pursuant to the exercise or conversion of options or warrants that, in each case, are outstanding as of the Closing Date); or |
(iv) | authorize, or issue any shares of, any class or series of the Company’s share capital having the right to more than one (1) vote for each share thereof. |
(h) | Any Class B Shares that are Transferred (as defined below) to any person or entity other than a Permitted Class B Owner (a “Permitted Transfer”) shall automatically upon such Transfer convert into an equal number of Class A Shares (without consideration and without need for further action by the Company or the relevant Founder or Permitted Class B Owner). |
(i) | Any purported Transfer of Class B Shares in violation of this Article 8 shall be null and void. If, notwithstanding the limitations set out in this Article 8, a person shall voluntarily or involuntarily, purportedly become or attempt to become, the purported owner (the “Purported Owner”) of Class B Shares in violation of these limitations, then the Purported Owner shall not obtain any rights in and to such Class B Shares and the purported Transfer shall not be recognized by the Company’s transfer agent or recorded on the Company’s register of shareholders. |
(j) | Upon a determination by the Board of Directors that a person has attempted or is attempting to acquire Class B Shares, or has purportedly Transferred or acquired Class B Shares, in each case in violation of the limitations set out in this Article 8, the Board of Directors may take such action as it deems advisable to refuse to give effect to such attempted or purported transfer or acquisition on the books and records of the Company, including to institute proceedings to enjoin any such attempted or purported Transfer or acquisition, or reverse any entries or records reflecting such attempted or purported Transfer or acquisition. |
(k) | The Board of Directors shall have all powers necessary to implement the limitations set out in this Article 8, including the power to prohibit the Transfer of any Class B Shares in violation thereof. |
(l) | All certificates or book-entries representing Class B Shares shall bear a legend substantially in the following form (or in such other form as the Board of Directors may determine): |
(m) | Except for the special voting rights and protective provisions set forth herein, the Class B Shares shall bestow upon the holder(s) thereof the same rights, preferences and privileges as the Class A Shares, in accordance with Article 8(c) above. Similarly, and except for the automatic conversion provisions and the restrictions on transfer set out in this Article 8, the holders of Class B Shares shall be subject to the same prohibitions, limitations and obligations as those applicable to the holders of the Class A Shares. |
(n) | For purposes of this Article 8: |
(i) | Termination with Cause. A termination for “Cause” shall occur thirty (30) days after written notice by the Company to a Founder (based upon the unanimous decision of the Board of Directors, other than such Founder) of a termination for Cause if such Founder shall have failed to cure or remedy such matter, if curable, within such thirty (30) day period. In the event that the basis for Cause is not curable, then such thirty (30) day cure period shall not be required, and such termination shall be effective ten (10) days after the date the Company delivers notice of such termination for Cause. “Cause” shall mean the Company’s termination of a Founder’s employment with the Company or any of its subsidiaries as a result of: (1) fraud, embezzlement or |
(ii) | “Permanent Disability” shall mean a permanent and total disability such that a Founder is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which would reasonably be expected to result in death within twelve (12) months or which has lasted or would reasonably be expected to last for a continuous period of not less than twelve (12) months as determined by a licensed medical practitioner. |
(iii) | “Permitted Class B Owner” shall mean any person or entity that, through contract, proxy or operation of law, has irrevocably delegated the sole and exclusive right to vote the Class B Shares held by such person or entity to a Founder. A person or entity that is a Permitted Class B Owner shall cease to be a Permitted Class B Owner upon the occurrence of any action, event or other circumstance that (A) allows any person other than a Founder to vote the Class B Shares held by such first person or entity or (B) results in the Founder who holds such voting power becoming unable to exercise such voting power (for example, because of such Founder’s death or disability). |
(iv) | “Transfer” of a Class B Share shall mean, any sale, assignment, transfer, conveyance, hypothecation or other transfer or disposition, whether direct or indirect, of such share or any legal or beneficial interest in such share, whether or not for value and whether voluntary or involuntary or by operation of law (including by merger, consolidation or otherwise, and including by issuance or transfer of shares or interests of any Permitted Class B Owner which is a corporate entity), including a transfer of a Class B Share to a broker or other nominee (regardless of whether there is a corresponding change in beneficial ownership), or the transfer of, or entering into a binding agreement with respect to, Voting Control (as defined below) over such share by proxy or otherwise (other than proxy(ies), voting instruction(s) or voting agreement(s) solicited on behalf of the Board of Directors). Notwithstanding the foregoing, the pledge of Class B Shares by a shareholder that creates a mere security interest in such shares pursuant to a bona fide loan or indebtedness transaction for so long as such shareholder continues to exercise Voting Control over such pledged shares shall not constitute a Transfer within the meaning of this Article 8. A “Transfer” shall also be deemed to have occurred with respect to a Class B Share beneficially held by the transferor, if there occurs any act or circumstance that causes such transfer to not be a permitted hereunder. |
(v) | “Voting Control” shall mean, with respect to a Class B Share, the exclusive power to vote or direct the voting of such share by proxy, voting agreement or otherwise. |
9. | CONSOLIDATION, DIVISION, CANCELLATION AND REDUCTION OF SHARE CAPITAL.. |
(a) | The Company may, from time to time, by or pursuant to an authorization of a Shareholders’ resolution, and subject to applicable law: |
(i) | consolidate all or any part of its issued or unissued authorized share capital; |
(ii) | divide or sub-divide its shares (issued or unissued) or any of them and the resolution whereby any share is divided may determine that, as among the holders of the shares resulting from such subdivision, one or more of the shares may, in contrast to others, have any such preferred or deferred rights or rights of redemption or other special rights, or be subject to any such restrictions, as the Company may attach to unissued or new shares; |
(iii) | cancel any authorized shares which, at the date of the adoption of such resolution, have not been issued to any person nor has the Company made any commitment, including a conditional commitment, to issue such shares, and reduce the amount of its share capital by the amount of the shares so canceled; or |
(iv) | reduce its share capital in any manner. |
(b) | With respect to any consolidation of issued shares and with respect to any other action which may result in fractional shares, the Board of Directors may settle any difficulty which may arise with regard thereto, as it deems fit, and, in connection with any such consolidation or other action which could result in fractional shares, may, without limiting its aforesaid power: |
(i) | determine, as to the holder of shares so consolidated, which issued shares shall be consolidated; |
(ii) | issue, in contemplation of or subsequent to such consolidation or other action, shares sufficient to preclude or remove fractional share holdings; |
(iii) | redeem such shares or fractional shares sufficient to preclude or remove fractional share holdings; |
(iv) | round up, round down or round to the nearest whole number, any fractional shares resulting from the consolidation or from any other action which may result in fractional shares; or |
(v) | cause the transfer of fractional shares by certain Shareholders to other Shareholders so as to most expediently preclude or remove any fractional shareholdings, and cause the transferees of such fractional shares to pay the transferors thereof the fair value thereof, and the Board of Directors is hereby authorized to act in connection with such transfer, as agent for the transferors and transferees of any such fractional shares, with full power of substitution, for the purposes of implementing the provisions of this sub-Article 9(b)(v). |
(c) | If the Company in any manner subdivides, combines or reclassifies the outstanding shares of one class of Ordinary Shares, the outstanding shares of the other class of Ordinary Shares will be subdivided, combined or reclassified in the same manner; provided, however, that shares of one such class of Ordinary Shares may be subdivided, combined or reclassified in a different or disproportionate manner if such subdivision, combination or reclassification is approved in advance by the affirmative vote (or written consent) of the holders of a majority of the outstanding Class A Shares represented in person or by proxy and voted on such matter, and the holders of 100% of the outstanding Class B Shares, each voting separately as a class. |
10. | ISSUANCE OF SHARE CERTIFICATES, REPLACEMENT OF LOST CERTIFICATES. |
(a) | To the extent that the Board of Directors determines that all shares shall be certificated or, if the Board of Directors does not so determine, to the extent that any Shareholder requests a share certificate or the Company’s transfer agent so requires, share certificates shall be issued under the corporate seal of the Company or its written, typed or stamped name and shall bear the signature of one Director, the Company’s Chief Executive Officer, or any person or persons authorized therefor by the Board of Directors. Signatures may be affixed in any mechanical or electronic form, as the Board of Directors may prescribe. |
(b) | Subject to the provisions of Article 10(a), each Shareholder shall be entitled to one numbered certificate for all of the shares of any class registered in his, her or its name. Each certificate shall specify the |
(c) | A share certificate registered in the names of two or more persons shall be delivered to the person first named in the Register of Shareholders in respect of such co-ownership. |
(d) | A share certificate which has been defaced, lost or destroyed, may be replaced, and the Company shall issue a new certificate to replace such defaced, lost or destroyed certificate upon payment of such fee, and upon the furnishing of such evidence of ownership and such indemnity, as the Board of Directors in its discretion deems fit. |
11. | REGISTERED HOLDER. |
12. | ISSUANCE AND REPURCHASE OF SHARES. |
(a) | The unissued shares from time to time shall be under the control of the Board of Directors (and, to the extent permitted by law, any Committee (as defined below) thereof), which shall have the power to issue or otherwise dispose of shares and of securities convertible or exercisable into or other rights to acquire from the Company to such persons, on such terms and conditions (including, inter alia, price, with or without premium, discount or commission, and terms relating to calls set forth in Article 14(f) hereof), and at such times, as the Board of Directors (or the Committee, as the case may be) deems fit, and the power to give to any person the option to acquire from the Company any shares or securities convertible or exercisable into or other rights to acquire from the Company on such terms and conditions (including, price, with or without premium, discount or commission), during such time as the Board of Directors (or the Committee, as the case may be) deems fit; provided, however, that this Article 12(a) shall not apply to Class B Shares. |
(b) | Other than with respect to the Class B Shares (unless converted in accordance with Articles 8(d) or (e) above), the Company may at any time and from time to time, subject to the Companies Law, repurchase or finance the purchase of any shares or other securities issued by the Company, in such manner and under such terms as the Board of Directors shall determine, whether from any one or more Shareholders. Such purchase shall not be deemed as payment of dividends and as such, no Shareholder will have the right to require the Company to purchase his or her shares or offer to purchase shares from any other Shareholders. |
13. | PAYMENT IN INSTALLMENTS. |
14. | CALLS ON SHARES. |
(a) | The Board of Directors may, from time to time, as it, in its discretion, deems fit, make calls for payment upon Shareholders in respect of any sum (including premium) which has not been paid up in respect of shares held by such Shareholders and which is not, pursuant to the terms of issuance of such shares or otherwise, payable at a fixed time, and each Shareholder shall pay the amount of every call so made upon him or her (and of each installment thereof if the same is payable in installments), to the person(s) and at the time(s) and place(s) designated by the Board of Directors, as any such times may |
(b) | Notice of any call for payment by a Shareholder shall be given in writing to such Shareholder not less than fourteen (14) days prior to the time of payment fixed in such notice, and shall specify the time and place of payment, and the person to whom such payment is to be made. Prior to the time for any such payment fixed in a notice of a call given to a Shareholder, the Board of Directors may in its discretion, by notice in writing to such Shareholder, revoke such call in whole or in part, extend the time fixed for payment thereof, or designate a different place of payment or person to whom payment is to be made. In the event of a call payable in installments, only one notice thereof need be given. |
(c) | If pursuant to the terms of issuance of a share or otherwise, an amount is made payable at a fixed time, such amount shall be payable at such time as if it were payable by virtue of a call made by the Board of Directors and for which notice was given in accordance with paragraphs (a) and (b) of this Article 14, and the provision of these Articles with regard to calls (and the non-payment thereof) shall be applicable to such amount or such installment (and the non-payment thereof). |
(d) | Joint holders of a share shall be jointly and severally liable to pay all calls for payment in respect of such share and all interest payable thereon. |
(e) | Any amount called for payment which is not paid when due shall bear interest from the date fixed for payment until actual payment thereof, at such rate (not exceeding the then prevailing debitory rate charged by leading commercial banks in Israel), and payable at such time(s) as the Board of Directors may prescribe. |
(f) | Upon the issuance of shares, the Board of Directors may provide for differences among the holders of such shares as to the amounts and times for payment of calls for payment in respect of such shares. |
15. | PREPAYMENT. |
16. | FORFEITURE AND SURRENDER. |
(a) | If any Shareholder fails to pay an amount payable by virtue of a call, installment or interest thereon as provided for in accordance herewith, on or before the day fixed for payment of the same, the Board of Directors may at any time after the day fixed for such payment, so long as such amount (or any portion thereof) or interest thereon (or any portion thereof) remains unpaid, forfeit all or any of the shares in respect of which such payment was called for. All expenses incurred by the Company in attempting to collect any such amount or interest thereon, including attorneys’ fees and costs of legal proceedings, shall be added to, and shall, for all purposes (including the accrual of interest thereon) constitute a part of, the amount payable to the Company in respect of such call. |
(b) | Upon the adoption of a resolution as to the forfeiture of a Shareholder’s share, the Board of Directors shall cause notice thereof to be given to such Shareholder, which notice shall state that, in the event of the failure to pay the entire amount so payable by a date specified in the notice (which date shall be not less than fourteen (14) days after the date such notice is given and which may be extended by the Board of Directors), such shares shall be ipso facto forfeited, provided, however, that, prior to such date, the Board of Directors may cancel such resolution of forfeiture, but no such cancellation shall stop the Board of Directors from adopting a further resolution of forfeiture in respect of the non-payment of the same amount. |
(c) | Without derogating from Articles 52 and 56 hereof, whenever shares are forfeited as herein provided, all dividends, if any, theretofore declared in respect thereof and not actually paid shall be deemed to have been forfeited at the same time. |
(d) | The Company, by resolution of the Board of Directors, may accept the voluntary surrender of any share. |
(e) | Any share forfeited or surrendered as provided herein, shall become the property of the Company as a dormant share, and the same, subject to the provisions of these Articles, may be sold, re-issued or otherwise disposed of as the Board of Directors deems fit. |
(f) | Any person whose shares have been forfeited or surrendered shall cease to be a shareholder in respect of the forfeited or surrendered shares, but shall, notwithstanding, be liable to pay, and shall forthwith pay, to the Company, all calls, interest and expenses owing upon or in respect of such shares at the time of forfeiture or surrender, together with interest thereon from the time of forfeiture or surrender until actual payment, at the rate prescribed in Article 14(e) above, and the Board of Directors, in its discretion, may, but shall not be obligated to, enforce or collect the payment of such amounts, or any part thereof, as it shall deem fit. In the event of such forfeiture or surrender, the Company, by resolution of the Board of Directors, may accelerate the date(s) of payment of any or all amounts then owing to the Company by the person in question (but not yet due) in respect of all shares owned by such shareholder, solely or jointly with another. |
(g) | The Board of Directors may at any time, before any share so forfeited or surrendered shall have been sold, re-issued or otherwise disposed of, nullify the forfeiture or surrender on such conditions as it deems fit, but no such nullification shall stop the Board of Directors from re-exercising its powers of forfeiture pursuant to this Article 16. |
17. | LIEN. |
(a) | Except to the extent the same may be waived or subordinated in writing, the Company shall have a first and paramount lien upon all the shares registered in the name of each shareholder (without regard to any equitable or other claim or interest in such shares on the part of any other person), and upon the proceeds of the sale thereof, for his or her debts, liabilities and engagements to the Company arising from any amount payable by such shareholder in respect of any unpaid or partly paid share, whether or not such debt, liability or engagement has matured. Such lien shall extend to all dividends from time to time declared or paid in respect of such share. Unless otherwise provided, the registration by the Company of a transfer of shares shall be deemed to be a waiver on the part of the Company of the lien (if any) existing on such shares immediately prior to such transfer. |
(b) | The Board of Directors may cause the Company to sell a share subject to such a lien when the debt, liability or engagement giving rise to such lien has matured, in such manner as the Board of Directors deems fit, but no such sale shall be made unless such debt, liability or engagement has not been satisfied within fourteen (14) days after written notice of the intention to sell shall have been served on such shareholder, his or her executors or administrators. |
(c) | The net proceeds of any such sale, after payment of the costs and expenses thereof or ancillary thereto, shall be applied in or toward satisfaction of the debts, liabilities or engagements of such shareholder in respect of such share (whether or not the same have matured), and the remaining proceeds (if any) shall be paid to the shareholder, his or her executors, administrators or assigns. |
18. | SALE AFTER FORFEITURE OR SURRENDER OR FOR ENFORCEMENT OF LIEN. |
19. | REDEEMABLE SHARES. |
20. | REGISTRATION OF TRANSFER. |
21. | SUSPENSION OF REGISTRATION. |
22. | DECEDENTS’ SHARES. |
23. | RECEIVERS AND LIQUIDATORS. |
(a) | The Company may recognize any receiver, liquidator or similar official appointed to wind-up, dissolve or otherwise liquidate a corporate Shareholder, and a trustee, manager, receiver, liquidator or similar official appointed in bankruptcy or in connection with the reorganization of, or similar proceeding with respect to a Shareholder or its properties, as being entitled to the shares registered in the name of such Shareholder, except in the case of Class B Shares, which shall be dealt with in the manner set out in Article 8(e)(i)(1). |
(b) | Such receiver, liquidator or similar official appointed to wind-up, dissolve or otherwise liquidate a corporate Shareholder and such trustee, manager, receiver, liquidator or similar official appointed in bankruptcy or in connection with the reorganization of, or similar proceedings with respect to a Shareholder or its properties, upon producing such evidence as the Board of Directors (or an officer of the Company to be designated by the Chief Executive Officer) may deem sufficient as to his or her authority to act in such capacity or under this Article, shall with the consent of the Board of Directors or an officer of the Company to be designated by the Chief Executive Officer (which the Board of Directors or such officer may grant or refuse in its discretion), be registered as a Shareholder in respect of such shares, or may, subject to the regulations as to transfer herein contained, transfer such shares, in each case except for the Class B Shares, which shall be dealt with in the manner set out in Article 8(e)(i)(1). |
24. | GENERAL MEETINGS. |
(a) | An annual General Meeting (“Annual General Meeting”) shall be held every calendar year at such time and at such place, either within or outside of the State of Israel, as may be determined by the Board of Directors, and in compliance with any time limitations imposed by applicable law or stock exchange rules and regulations. |
(b) | All General Meetings other than Annual General Meetings shall be called “Special General Meetings”. The Board of Directors may, at its discretion, convene a Special General Meeting at such time and place, within or outside of the State of Israel, as may be determined by the Board of Directors. |
(c) | If so determined by the Board of Directors, an Annual General Meeting or a Special General Meeting may be held through the use of any means of communication approved by the Board of Directors, provided all of the participating Shareholders can hear each other simultaneously. A resolution approved by use of means of communications as aforesaid, shall be deemed to be a resolution lawfully adopted at such general meeting and a Shareholder shall be deemed present in person at such general meeting if attending such meeting through the means of communication used at such meeting. |
25. | RECORD DATE FOR GENERAL MEETING. |
26. | SHAREHOLDER PROPOSAL REQUEST. |
(a) | Any Shareholder or Shareholders holding at least the required percentage under the Companies Law of the voting rights of the Company which entitles such Shareholder(s) to require the Company to include a matter on the agenda of a General Meeting (the “Proposing Shareholder(s)”) may request, subject to the Companies Law, that the Board of Directors include a matter on the agenda of a General Meeting to be held in the future, provided that the Board of Directors determines that the matter is appropriate to be considered at a General Meeting (a “Proposal Request”). In order for the Board of Directors to consider a Proposal Request and whether to include the matter stated therein in the agenda of a General Meeting, notice of the Proposal Request must be timely delivered in accordance with applicable law and stock exchange rules and regulations, and the Proposal Request must comply with the requirements of these Articles (including this Article 26) and any applicable law and stock exchange rules and regulations. The Proposal Request must be in writing, signed by all of the Proposing Shareholder(s) making such request, delivered, either in person or by registered mail, postage prepaid, and addressed to the Secretary of the Company (the “Secretary”) or, in the absence thereof, to the Chief Executive Officer of the Company (the “Chief Executive Officer”)). To be considered timely, a Proposal Request must be received within the time periods prescribed by applicable law and any stock exchange rules and regulations. The announcement of an adjournment or postponement of a General Meeting shall not commence a new time period (or extend any time period) for the delivery of a Proposal Request as described above. In addition to any information required to be included in accordance with applicable law or any stock exchange rules and regulations, a Proposal Request must include the following: (i) the name, address, telephone number, fax number and email address of the Proposing Shareholder (or each Proposing Shareholder, as the case may be) and, if an entity, the name(s) of the person(s) that controls or manages such entity; (ii) the number of Shares held by the Proposing Shareholder(s), directly or indirectly (and, if any of such Shares are held indirectly, an explanation of how they are held and by whom), which shall be in such number no less than as is required to qualify as a Proposing Shareholder, accompanied by evidence satisfactory to the Company of the record holding of such Shares by the Proposing Shareholder(s) as of the date of the Proposal Request; (iii) the matter |
(b) | The information required pursuant to this Article shall be updated prior to the last date for submittal of Proposal Requests for the General Meeting in accordance with applicable law and stock exchange rules and regulations. |
(c) | The provisions of Articles 26(a) and 26(b) shall apply, mutatis mutandis, to any matter to be included on the agenda of a Special General Meeting which is convened pursuant to a request of a Shareholder duly delivered to the Company in accordance with the Companies Law. |
(d) | Notwithstanding anything to the contrary herein, this Article 26 may be amended, replaced or suspended only by a resolution adopted at a General Meeting by (i) so long as Class B Shares remain outstanding, a majority of the total voting power of the Shareholders and (ii) if no Class B Shares remain outstanding, a supermajority of at least seventy-five percent (75%) of the total voting power of the Shareholders. |
27. | NOTICE OF GENERAL MEETINGS; OMISSION TO GIVE NOTICE. |
(a) | The Company is not required to give notice of a General Meeting, subject to any mandatory provision of the Companies Law. |
(b) | The accidental omission to give notice of a General Meeting to any Shareholder, or the non-receipt of notice sent to such Shareholder, shall not invalidate the proceedings at such meeting or any resolution adopted thereat. |
(c) | No Shareholder present, in person or by proxy, at any time during a General Meeting shall be entitled to seek the cancellation or invalidation of any proceedings or resolutions adopted at such General Meeting on account of any defect in the notice of such meeting relating to the time or the place thereof, or any item acted upon at such meeting. |
(d) | In addition to any places at which the Company may make available for review by Shareholders the full text of the proposed resolutions to be adopted at a General Meeting, as required by the Companies Law, the Company may add additional places for Shareholders to review such proposed resolutions, including an internet site. |
28. | QUORUM. |
(a) | No business shall be transacted at a General Meeting, or at any adjournment thereof, unless the quorum required under these Articles for such General Meeting or such adjourned meeting, as the case may be, is present when the meeting proceeds to business. |
(b) | In the absence of contrary provisions in these Articles, the requisite quorum for any General Meeting shall be two or more Shareholders (not in default in payment of any sum referred to in Article 14 hereof) present in person or by proxy and holding shares conferring in the aggregate at least thirty-three and one-third percent (331⁄3%) of the voting power of the Company, provided, however, that with respect to any General Meeting that was initiated by and convened pursuant to a resolution adopted by the Board of Directors and at the time of such General Meeting the Company is a “foreign private issuer” under U.S. securities laws, the requisite quorum shall be two or more Shareholders (not in default in payment of any sum referred to in Article 14 hereof) present in person or by proxy and holding shares conferring in the aggregate at least twenty five percent (25%) of the voting power of the Company. For the purpose of determining the quorum present at a certain General Meeting, a proxy may be deemed to be two (2) or more Shareholders pursuant to the number of Shareholders represented by the proxy holder. Notwithstanding the foregoing, a quorum for any General Meeting shall also require the presence in person or by proxy of at least one Shareholder holding Class B Shares if such shares are outstanding. |
(c) | If within half an hour from the time appointed for the meeting a quorum is not present, then without any further notice the meeting shall be adjourned either (i) to the same day in the next week, at the same time and place, (ii) to such day and at such time and place as indicated in the notice of such meeting, or (iii) to such day and at such time and place as the Chairperson of the General Meeting shall determine (which may be earlier or later than the date pursuant to clause (i) above). No business shall be transacted at any adjourned meeting except business which might lawfully have been transacted at the meeting as originally called. At such adjourned meeting, if the original meeting was convened upon the request of a Shareholder in accordance with the Companies Law, one or more Shareholders, present in person or by proxy, and holding the number of shares required for making such request, shall constitute a quorum, but in any other case any Shareholder (not in default as aforesaid) present in person or by proxy, shall constitute a quorum. |
29. | CHAIRPERSON OF GENERAL MEETING. |
30. | ADOPTION OF RESOLUTIONS AT GENERAL MEETINGS. |
(a) | Except as required by the Companies Law or these Articles, including Article 40 below, a resolution of the Shareholders shall be adopted if approved by the holders of a simple majority of the voting power represented at the General Meeting in person or by proxy and voting thereon, as one class, and disregarding abstentions from the count of the voting power present and voting. Without limiting the generality of the foregoing, a resolution with respect to a matter or action for which the Companies Law prescribes a higher majority or pursuant to which a provision requiring a higher majority would have been deemed to have been incorporated into these Articles, but for which the Companies Law allows these Articles to provide otherwise (including, Sections 327 and 24 of the Companies Law), shall be adopted by a simple majority of the voting power represented at the General Meeting in person or by proxy and voting thereon, as one class, and disregarding abstentions from the count of the voting power present and voting. |
(b) | Every question submitted to a General Meeting shall be decided by a show of hands, but the Chairperson or other person chairing the General Meeting may determine that a resolution shall be decided by a written ballot. A written ballot may be implemented before the proposed resolution is voted upon or immediately after the declaration by the Chairperson of the results of the vote by a show of hands. If a vote by written ballot is taken after such declaration, the results of the vote by a show of hands shall be of no effect, and the proposed resolution shall be decided by such written ballot. |
(c) | A defect in convening or conducting a General Meeting other than with respect to the existence of a quorum, including a defect resulting from the non-fulfillment of any provision or condition set forth in the Companies Law or these Articles, including with regard to the manner of convening or conducting the General Meeting, shall not disqualify any resolution passed at the General Meeting and shall not affect the discussions or decisions which took place thereat. |
(d) | A declaration by the Chairperson or other person chairing the General Meeting that a resolution has been carried unanimously, or carried by a particular majority, or rejected, and an entry to that effect in the minute book of the Company, shall be prima facie evidence of the fact without proof of the number or proportion of the votes recorded in favor of or against such resolution. |
31. | POWER TO ADJOURN. |
32. | VOTING POWER. |
(a) | except as otherwise provided in these Articles or otherwise required by the Companies Law, and except in the event of a Class Meeting, any Shareholder holding both Class A Shares and Class B Shares may at all times vote both classes of shares on all matters (including the election of Directors); and |
(b) | each Shareholder of Class A Shares shall be entitled to one (1) vote for each Class A Share held as of the applicable record date on any matter whether the vote thereon is conducted by a show of hands, by |
33. | VOTING RIGHTS. |
(a) | No Shareholder shall be entitled to vote at any General Meeting (or be counted as a part of the quorum thereat), unless all calls then payable by him, her or its in respect of his or her shares in the Company have been paid. |
(b) | A company or other corporate body being a Shareholder may duly authorize any person to be its representative at any meeting of the Company or to execute or deliver a proxy on its behalf. Any person so authorized shall be entitled to exercise on behalf of such Shareholder all the power, which the Shareholder could have exercised if it were an individual. Upon the request of the Chairperson or other person chairing the General Meeting, written evidence of such authorization (in form reasonably acceptable to the Chairperson) shall be delivered to him or her. |
(c) | Any Shareholder entitled to vote may vote either in person or by proxy (who need not be a Shareholder), or, if the Shareholder is a company or other corporate body, by representative authorized pursuant to Article (b) above. |
(d) | If two (2) or more persons are registered as joint holders of any share, the vote of the senior who tenders a vote, in person or by proxy, shall be accepted to the exclusion of the vote(s) of the other joint holder(s). For the purpose of this Article 33(d), seniority shall be determined by the order of registration of the joint holders in the Register of Shareholders. |
(e) | If a Shareholder is a minor, under protection, bankrupt or legally incompetent, or in the case of a corporation, is in receivership or liquidation, it may, subject to all other provisions of these Articles and any documents or records required to be provided under these Articles, vote through his, her or its trustees, receiver, liquidator, natural guardian or another legal guardian, as the case may be, and the persons listed above may vote in person or by proxy. |
34. | INSTRUMENT OF APPOINTMENT. |
(a) | An instrument appointing a proxy shall be in writing and shall be substantially in the following form: |
“I | | | | | of | | | ||
| | (Name of Shareholder) | | | | | (Address of Shareholder) | ||
Being a shareholder of Pagaya Technologies Ltd. hereby appoints | |||||||||
| | | | of | | | |||
| | (Name of Proxy) | | | | | (Address of Proxy) | ||
as my proxy to vote for me and on my behalf at the General Meeting of the Company to be held on the day of , and at any adjournment(s) thereof. | |||||||||
| | | | | | ||||
Signed this day of , . | | | | | |||||
| | | | | | (Signature of Appointor)” |
(b) | Subject to the Companies Law, the original instrument appointing a proxy or a copy thereof certified by an attorney (and the power of attorney or other authority, if any, under which such instrument has been signed) shall be delivered to the Company (at its Office, at its principal place of business, or at the offices of its registrar or transfer agent, or at such place as notice of the meeting may specify) not less than forty eight (48) hours (or such shorter period as the notice shall specify) before the time fixed for such meeting. Notwithstanding the above, the Chairperson shall have the right to waive the time |
35. | EFFECT OF DEATH OF APPOINTOR OF TRANSFER OF SHARE AND OR REVOCATION OF APPOINTMENT. |
(a) | A vote cast in accordance with an instrument appointing a proxy shall be valid notwithstanding the prior death or bankruptcy of the appointing Shareholder (or of his or her attorney-in-fact, if any, who signed such instrument), or the transfer of the share in respect of which the vote is cast, unless written notice of such matters shall have been received by the Company or by the Chairperson of such meeting prior to such vote being cast. |
(b) | Subject to the Companies Law, an instrument appointing a proxy shall be deemed revoked (i) upon receipt by the Company or the Chairperson, subsequent to receipt by the Company of such instrument, of written notice signed by the person signing such instrument or by the Shareholder appointing such proxy canceling the appointment thereunder (or the authority pursuant to which such instrument was signed) or of an instrument appointing a different proxy (and such other documents, if any, required under Article 34(b) for such new appointment), provided such notice of cancellation or instrument appointing a different proxy were so received at the place and within the time for delivery of the instrument revoked thereby as referred to in Article 34(b) hereof, or (ii) if the appointing Shareholder is present in person at the meeting for which such instrument of proxy was delivered, upon receipt by the Chairperson of such meeting of written notice from such Shareholder of the revocation of such appointment, or if and when such Shareholder votes at such meeting. A vote cast in accordance with an instrument appointing a proxy shall be valid notwithstanding the revocation or purported cancellation of the appointment, or the presence in person or vote of the appointing Shareholder at a meeting for which it was rendered, unless such instrument of appointment was deemed revoked in accordance with the foregoing provisions of this Article 35(b) at or prior to the time such vote was cast. |
36. | POWERS OF THE BOARD OF DIRECTORS. |
(a) | The Board of Directors may exercise all such powers and do all such acts and things as the Board of Directors is authorized by law or as the Company is authorized to exercise and do and are not hereby or by law required to be exercised or done by the General Meeting or by a specific committee of the Board of Directors (where the establishment of such committee is mandatory under applicable law). The authority conferred on the Board of Directors by this Article 36 shall be subject to the provisions of the Companies Law, these Articles and any regulation or resolution consistent with these Articles adopted from time to time at a General Meeting, provided, however, that no such regulation or resolution shall invalidate any prior act done by or pursuant to a decision of the Board of Directors which would have been valid if such regulation or resolution had not been adopted. |
(b) | Without limiting the generality of the foregoing, the Board of Directors may, from time to time, set aside any amount(s) out of the profits of the Company as a reserve or reserves for any purpose(s) which the Board of Directors, in its discretion, shall deem fit, including capitalization and distribution of bonus shares, and may invest any sum so set aside in any manner and from time to time deal with and vary such investments and dispose of all or any part thereof, and employ any such reserve or any part thereof in the business of the Company without being bound to keep the same separate from other assets of the Company, and may subdivide or re-designate any reserve or cancel the same or apply the funds therein for another purpose, all as the Board of Directors may from time to time think fit. |
37. | EXERCISE OF POWERS OF THE BOARD OF DIRECTORS. |
(a) | A meeting of the Board of Directors at which a quorum is present in accordance with Article 46 shall be competent to exercise all the authorities, powers and discretion vested in or exercisable by the Board of Directors. |
(b) | Unless otherwise set forth herein, a resolution proposed at any meeting of the Board of Directors shall be deemed adopted if approved by a majority of the Directors present, entitled to vote and voting thereon when such resolution is put to a vote. |
(c) | The Board of Directors may adopt resolutions, without convening a meeting of the Board of Directors, in writing or in any other manner permitted by the Companies Law. |
38. | DELEGATION OF POWERS. |
(a) | The Board of Directors may, subject to the provisions of the Companies Law (or shall, where required by the Companies Law), delegate any or all of its powers to committees (in these Articles referred to as a “Committee of the Board of Directors” or “Committee”), each consisting of one or more persons who are Directors, and it may from time to time revoke such delegation or alter the composition of any such Committee, in each case subject to the provisions of the Companies Law. Any Committee so formed shall, in the exercise of the powers so delegated, conform to any regulations imposed on it by the Board of Directors, subject to applicable law or any stock exchange rules or regulations. No regulation imposed by the Board of Directors on any Committee and no resolution of the Board of Directors shall invalidate any prior act done or pursuant to a resolution by the Committee which would have been valid if such regulation or resolution of the Board of Directors had not been adopted. The meetings and proceedings of any such Committee of the Board of Directors shall, mutatis mutandis, be governed by the provisions herein contained for regulating the meetings of the Board of Directors, to the extent not superseded by any regulations adopted by the Board of Directors. Unless otherwise expressly prohibited by the Board of Directors, in delegating powers to a Committee of the Board of Directors, such Committee shall be empowered to further delegate such powers to a sub-committee of Directors or to an individual Director. |
(b) | The Board of Directors may from time to time appoint a Secretary, as well as officers, agents, employees and independent contractors, as the Board of Directors deems fit, and may terminate the service of any such person. The Board of Directors may, subject to the provisions of the Companies Law, determine the powers and duties, as well as the salaries and compensation, of all such persons. |
(c) | The Board of Directors may from time to time, by power of attorney or otherwise, appoint any person, company, firm or body of persons to be the attorney or attorneys of the Company at law or in fact for such purposes(s) and with such powers, authorities and discretions, and for such period and subject to such conditions, as it deems fit, and any such power of attorney or other appointment may contain such provisions for the protection and convenience of persons dealing with any such attorney as the Board of Directors deems fit, and may also authorize any such attorney to delegate all or any of the powers, authorities and discretions vested in him, her or it. |
39. | NUMBER OF DIRECTORS. |
(a) | The Board of Directors shall consist of such number of Directors (not less than three (3) nor more than ten (10), including the External Directors if any are required to be elected) as may be fixed from time to time by resolution of the General Meeting. |
(b) | Notwithstanding anything to the contrary herein, this Article 39 may be amended or replaced only by a resolution adopted at a General Meeting by (i) so long as Class B Shares remain outstanding, a majority of the total voting power of the Shareholders and (ii) if no Class B Shares remain outstanding, a supermajority of at least seventy-five percent (75%) of the total voting power of the Shareholders. |
40. | ELECTION AND REMOVAL OF DIRECTORS. |
(a) | The Directors, excluding the External Directors if any are required to be elected, shall be classified, with respect to the term for which they each severally hold office, into three classes, as nearly equal in number as practicable, hereby designated as Class I, Class II and Class III (each, a “Class”). The Board of Directors may assign members of the Board of Directors already in office to such classes at the time such classification becomes effective. |
(b) | At each Annual General Meeting, commencing with the Annual General Meeting to be held in the first calendar year following the year in which the Closing takes place, each Nominee or Alternate Nominee (each as defined below) elected to replace the Directors of a Class whose term shall have expired at such Annual General Meeting shall be elected to hold office until the third Annual General Meeting next succeeding his or her election and until his or her respective successor shall have been elected and qualified. Notwithstanding anything to the contrary, each Director shall serve until his or her successor is elected and qualified or until such earlier time as such Director’s office is vacated. |
(c) | If the number of Directors, excluding External Directors, if any are required to be elected, that comprises the Board of Directors is hereafter changed by the Board of Directors, any newly created directorships or decrease in directorships shall be so apportioned by the Board of Directors among the classes as to make all classes as nearly equal in number as is practicable, provided that no decrease in the number of Directors constituting the Board of Directors shall shorten the term of any incumbent Director. |
(d) | Prior to every General Meeting at which Directors are to be elected, and subject to clauses (a) and (h) of this Article, the Board of Directors (or a Committee thereof) shall select, by a resolution adopted by a majority of the Board of Directors (or such Committee), a number of persons to be proposed to the Shareholders for election as Directors at such General Meeting (the “Nominees”). |
(e) | Any Proposing Shareholder requesting to include on the agenda of a General Meeting a nomination of a person to be proposed to the Shareholders for election as Director (such person, an “Alternate Nominee”), may so request, provided that it complies with this Article 40(e), Article 26 and applicable law. A Proposal Request relating to an Alternate Nominee is deemed to be a matter that is appropriate to be considered only at an Annual General Meeting. In addition to any information required to be included in accordance with applicable law, such a Proposal Request shall include information required pursuant to Article 26, and shall also set forth: (i) the name, address, telephone number, fax number and email address of the Alternate Nominee and all citizenships and residencies of the Alternate Nominee; (ii) a description of all arrangements, relations or understandings during the past three (3) years, and any other material relationships, between the Proposing Shareholder(s) or any of its affiliates and each Alternate Nominee; (iii) a declaration signed by the Alternate Nominee that he or she consents to be named in the Company’s notices and proxy materials and on the Company’s proxy card relating to the General Meeting, if provided or published, and that he or she, if elected, consents to serve on the Board of Directors and to be named in the Company’s disclosures and filings; (iv) a declaration signed by each Alternate Nominee as required under the Companies Law and any other applicable law and stock exchange rules and regulations for the appointment of such an Alternate Nominee and an undertaking that all of the information that is required under law and stock exchange rules and regulations to be provided to the Company in connection with such an appointment has been provided (including, information in respect of the Alternate Nominee as would be provided in response to the applicable disclosure requirements under Form 20-F or any other applicable form prescribed by the U.S. Securities and Exchange Commission (the “SEC”)); (v) a declaration made by the Alternate Nominee of whether he or she meets the criteria for an independent director and, if applicable, External Director under any applicable law, regulation or stock exchange rules and regulations, and if not, then an explanation of why not; and (vi) any other information required at the time of submission of the Proposal Request by applicable law, regulations or stock exchange rules. In addition, the Proposing Shareholder(s) and each Alternate Nominee shall promptly provide any other information reasonably requested by the Company, including a duly completed director and officer questionnaire, in such form as may be provided by the Company, with respect to each Alternate Nominee. The Board of Directors may refuse to acknowledge the nomination of any person not made in compliance with the foregoing. The Company shall be entitled to publish any information provided by a Proposing Shareholder or Alternate Nominee pursuant to this Article 40(e) and Article 26, and the Proposing Shareholder and Alternate Nominee shall be responsible for the accuracy and completeness thereof. |
(f) | The Nominees or Alternate Nominees shall be elected by a resolution adopted at the General Meeting at which they are subject to election. |
(g) | Notwithstanding anything to the contrary herein, this Article 40 and Article 43(e) may be amended or replaced only by a resolution adopted at a General Meeting by (i) so long as any Class B Shares remain outstanding, a majority of the total voting power of the Shareholders and (ii) if no Class B Shares remain outstanding, a supermajority of at least seventy-five percent (75%) of the total voting power of the Shares, provided that no amendment or replacement of this Article 40 or Article 43(e) below shall shorten the term of any incumbent Director. |
(h) | Notwithstanding anything to the contrary in these Articles, the nomination, election, qualification, removal or dismissal of External Directors, if so elected, shall comply with the applicable provisions set forth in the Companies Law. |
41. | COMMENCEMENT OF DIRECTORSHIP. |
42. | CONTINUING DIRECTORS IN THE EVENT OF VACANCIES. |
43. | VACATION OF OFFICE. |
(a) | ipso facto, upon his or her death; |
(b) | if he or she is prevented by applicable law or any stock exchange rules or regulations from serving as a Director; |
(c) | if the Board of Directors determines that due to his or her mental or physical state he or she is unable to serve as a Director; |
(d) | if his or her directorship expires pursuant to these Articles and/or applicable law; |
(e) | by a resolution adopted at a General Meeting by (i) so long as any Class B Shares remain outstanding, a majority of the total voting power of the Shareholders and (ii) if no Class B Shares remain outstanding, a supermajority of at least seventy-five percent (75%) of the total voting power of the Shares (with such removal becoming effective on the date fixed in such resolution), provided that no such resolution shall shorten the term of an incumbent Director who was elected under the staggered board composition pursuant to Article 40; |
(f) | by his or her written resignation, such resignation becoming effective on the date fixed therein, or upon the delivery thereof to the Company, whichever is later; or |
(g) | with respect to an External Director, if so elected, and notwithstanding anything to the contrary herein, only pursuant to applicable law. |
44. | CONFLICT OF INTERESTS; APPROVAL OF RELATED PARTY TRANSACTIONS. |
(a) | Subject to the provisions of applicable law and these Articles, no Director shall be disqualified by virtue of his or her office from holding any office or place of profit in the Company or in any company in which the Company shall be a shareholder or otherwise interested, or from contracting with the Company as vendor, purchaser or otherwise, nor shall any such contract, or any contract or arrangement entered into by or on behalf of the Company in which any Director shall be in any way interested, be avoided, nor, other than as required under the Companies Law, shall any Director be liable to account to the Company for any profit arising from any such office or place of profit or realized by any such contract or arrangement by reason only of such Director’s holding that office or of the fiduciary relations thereby established, but the nature of his or her interest, as well as any material fact or document, must be disclosed by him or her at the meeting of the Board of Directors at which the contract or arrangement is first considered, if his or her interest then exists, or, in any other case, at no later than the first meeting of the Board of Directors after the acquisition of his or her interest. |
(b) | Subject to the Companies Law and these Articles, a transaction between the Company and an Office Holder, and a transaction between the Company and another entity in which an Office Holder has a personal interest, in each case, which is not an Extraordinary Transaction (as defined by the Companies Law), shall require only approval by the Board of Directors or a Committee of the Board of Directors. Such authorization, as well as the actual approval, may be for a particular transaction or more generally for specific type of transactions. |
45. | MEETINGS. |
(a) | The Board of Directors may meet and adjourn its meetings and otherwise regulate such meetings and proceedings as the Board of Directors deems fit. |
(b) | A meeting of the Board of Directors shall be convened by the Secretary (or, in the absence thereof, by the Chief Executive Officer) upon instruction of the Chairperson or upon a request of at least two (2)Directors which is submitted to the Chairperson or in any event that such meeting is required by the provisions of the Companies Law. In the event that the Chairperson does not instruct the Secretary (or, in the absence thereof, by the Chief Executive Officer) to convene a meeting upon a request of at least two (2) Directors within seven (7) days of such request, then such two Directors may convene a meeting of the Board of Directors. Any meeting of the Board of Directors shall be convened upon not less than two (2) days’ prior notice, unless such notice is waived in writing by all of the Directors as to a particular meeting or by their attendance at such meeting or unless the matters to be discussed at such meeting are of such urgency and importance that notice is reasonably determined by the Chairperson as ought to be waived or shortened under the circumstances. |
(c) | Notice of any such meeting shall be given in writing (including by email), unless the urgency of such meeting is reasonably determined by the Chairperson to require that notice be given orally, by telephone or by such other means of delivery as the Chairperson may deem appropriate under the circumstances. |
(d) | Notwithstanding anything to the contrary herein, failure to deliver notice to a Director of any such meeting in the manner required hereby may be waived by such Director, and a meeting shall be deemed to have been duly convened notwithstanding such defective notice if such failure or defect is waived prior to action being taken at such meeting, by all Directors entitled to participate at such meeting to whom notice was not duly given as aforesaid. Without derogating from the foregoing, no Director present at any time during a meeting of the Board of Directors shall be entitled to seek the cancellation or invalidation of any proceedings or resolutions adopted at such meeting on account of any defect in the notice of such meeting relating to the date, time or the place thereof or the convening of the meeting. |
46. | QUORUM. |
47. | CHAIRPERSON OF THE BOARD OF DIRECTORS. |
48. | VALIDITY OF ACTS DESPITE DEFECTS. |
49. | CHIEF EXECUTIVE OFFICER; OFFICERS WHO ARE FOUNDERS. |
(a) | The Board of Directors shall from time to time appoint one or more persons, whether or not Directors, as Chief Executive Officer who shall have the powers and authorities set forth in the Companies Law, and may confer upon such person(s), and from time to time modify or revoke, such titles and such duties and authorities of the Board of Directors as the Board of Directors may deem fit, subject to such limitations and restrictions as the Board of Directors may from time to time prescribe. Such appointment(s) may be either for a fixed term or without any limitation of time, and the Board of Directors may from time to time (subject to any additional approvals required under, and the provisions of, the Companies Law and of any contract between any such person and the Company) fix their salaries and compensation, remove or dismiss them from office and appoint another or others in his, her or their place or places. |
(b) | Until the third anniversary of the Closing Date, the termination of any of the Founders as an executive of the Company, whether or not for Cause, shall require the approval of a supermajority of at least seventy-five percent (75%) of the Directors then in office; thereafter, the termination of any of the Founders as an executive of the Company shall require a decision of the Board of Directors adopted in accordance with Article 37(b). |
50. | MINUTES. |
51. | DECLARATION OF DIVIDENDS. |
52. | AMOUNT PAYABLE BY WAY OF DIVIDENDS. |
53. | INTEREST. |
54. | PAYMENT IN SPECIE. |
55. | IMPLEMENTATION OF POWERS. |
56. | DEDUCTIONS FROM DIVIDENDS. |
57. | RETENTION OF DIVIDENDS. |
(a) | The Board of Directors may retain any dividend or other moneys payable or property distributable in respect of a share on which the Company has a lien, and may apply the same in or toward satisfaction of the debts, liabilities, or engagements in respect of which the lien exists. |
(b) | The Board of Directors may retain any dividend or other moneys payable or property distributable in respect of a share in respect of which any person is, under Articles 22 or 23, entitled to become a Shareholder, or which any person is, under said Articles, entitled to transfer, until such person shall become a Shareholder in respect of such share or shall transfer the same. |
58. | UNCLAIMED DIVIDENDS. |
59. | MECHANICS OF PAYMENT. |
60. | BOOKS OF ACCOUNT. |
61. | AUDITORS. |
62. | FISCAL YEAR. |
63. | SUPPLEMENTARY REGISTERS. |
64. | INSURANCE. |
(a) | a breach of duty of care to the Company or to any other person; |
(b) | a breach of his or her duty of loyalty to the Company, provided that the Office Holder acted in good faith and had reasonable grounds to assume that act that resulted in such breach would not prejudice the interests of the Company; |
(c) | a financial liability imposed on such Office Holder in favor of any other person; and |
(d) | any other event, occurrence, matters or circumstances under any law with respect to which the Company may, or will be able to, insure an Office Holder, and to the extent such law requires the inclusion of a provision permitting such insurance in these Articles, then such provision is deemed to be included and incorporated herein by reference (including in accordance with Section 56h(b)(1) of the Securities Law, if and to the extent applicable, and Section 50P of the Economic Competition Law). |
65. | INDEMNITY. |
(a) | Subject to the provisions of the Companies Law, the Company may retroactively indemnify an Office Holder to the maximum extent permitted under applicable law, including with respect to the following liabilities and expenses, provided that such liabilities or expenses were imposed on such Office Holder or incurred by such Office Holder due to an act performed by or an omission of the Office Holder in such Office Holder’s capacity as an Office Holder: |
(i) | a financial liability imposed on an Office Holder in favor of another person by any court judgment, including a judgment given as a result of a settlement or an arbitrator’s award which has been confirmed by a court; |
(ii) | reasonable litigation expenses, including reasonable legal fees, expended by the Office Holder as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding, or in connection with a financial sanction, provided that (1) no indictment (as defined in the Companies Law) was filed against such Office Holder as a result of such investigation or proceeding; and (2) no financial liability in lieu of a criminal proceeding (as defined in the Companies Law) was imposed upon him or her as a result of such investigation or proceeding or if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent; |
(iii) | reasonable litigation costs, including reasonable legal fees, expended by an Office Holder or which were imposed on an Office Holder by a court in proceedings filed against the Office Holder by the Company or in its name or by any other person or in a criminal charge in respect of which the Office Holder was acquitted or in a criminal charge in respect of which the Office Holder was convicted for an offence which did not require proof of criminal intent; and |
(iv) | any other event, occurrence, matter or circumstance under any law with respect to which the Company may, or will be able to, indemnify an Office Holder, and to the extent such law requires |
(b) | Subject to the provisions of the Companies Law and any other applicable law, the Company may undertake to indemnify an Office Holder, in advance, with respect to those liabilities and expenses described in the following Articles: |
(i) | Sub-Article 65(a)(i), provided that the undertaking to indemnify is limited to, and sets forth, (a) such events which the Directors shall deem to be foreseeable in light of the operations of the Company at the time that the undertaking to indemnify is made, and (b) such amounts or criteria which the Directors may, at the time of the giving of such undertaking to indemnify, deem to be reasonable under the circumstances; and |
(ii) | Sub-Articles 65(a)(ii), 65(a)(iii) and 65(a)(iv). |
66. | EXEMPTION. |
67. | GENERAL. |
(a) | Any amendment to the Companies Law or any other applicable law adversely affecting the right of any Office Holder to be indemnified, insured or exempt pursuant to Articles 64 to 66 and any amendments to Articles 64 to 66 shall be prospective in effect, and shall not affect the Company’s obligation or ability to indemnify, insure or exempt an Office Holder for any act or omission occurring prior to such amendment, unless otherwise provided by applicable law. |
(b) | The provisions of Articles 64 to 66: (i) shall apply to the maximum extent permitted by law (including, the Companies Law, the Securities Law and the Economic Competition Law); and (ii) are not intended, and shall not be interpreted so as to restrict the Company, in any manner, in respect of the procurement of insurance and/or in respect of indemnification (whether in advance or retroactively) and/or exemption, in favor of any person who is not an Office Holder, including any employee, agent, consultant or contractor of the Company who is not an Office Holder; and/or any Office Holder to the extent that such insurance and/or indemnification is not specifically prohibited under law. |
68. | LOCK-UP. |
(i) | with respect to the Company Equity Holders and their Permitted Transferees, the period beginning on the Closing Date and ending (A) with respect to 50% of the Ordinary Shares held by such Company Equity Holder on the Closing Date, on the earlier of (1) the date that is six (6) months following the Closing Date and (2) the date on which the VWAP equals or exceeds $12.50 for any twenty (20) Trading Days within any thirty (30) consecutive Trading Day period commencing on the Closing Date, and (B) with respect to the remaining 50% of the Ordinary Shares held by such Company Equity Holder on the Closing Date, on the earlier of (1) the date that is twelve (12) months following the Closing Date and (2) the date on which the VWAP equals or exceeds $12.50 for any twenty (20) Trading Days within any thirty (30) consecutive Trading Day period commencing on the Closing Date, and |
(ii) | with respect to SPAC Sponsor and its Permitted Transferees, the period beginning on the Closing Date and ending on the earlier of (A) the date that is twelve (12) months following the Closing Date and (B) the date on which the VWAP equals or exceeds $12.50 for any twenty (20) Trading Days within any thirty (30) consecutive Trading Day period; |
69. | PERMITTED TRANSFERS. |
(a) | Notwithstanding anything to the contrary set forth in these Articles, the lock-up restrictions set forth in Article 68 shall not apply to a Transfer of any or all of the Lock-Up Shares held by a Holder (i) to any Permitted Transferee of such Holder, (ii) by will or intestate succession upon the death of such Holder, (iii) by operation of law or pursuant to a court order or to a spouse upon divorce, as required by settlement, order or decree, or as required by a domestic relations settlement, order or decree; (iv) in connection with a Liquidation Event or (v) to any of the Founders or to entities directly or indirectly wholly owned by (or in the case of a trust solely for the benefit of) any of the Founders; provided, that in the case of clauses (i), (ii), (iii) or (v), the transferee shall receive and hold the Lock-Up Shares subject to the provisions of these Articles applicable to the transferring Holder, and there shall be no further Transfer of such Lock-Up Shares except in accordance with the terms of Article 68 and this Article 69. For the avoidance of doubt, the lock-up restrictions set forth in Article 68 shall not apply to the exercise of any options or warrants to purchase Ordinary Shares (which exercises may be effected on a cashless basis to the extent the instruments representing such options or warrants permit exercises on a cashless basis), but shall apply to the Ordinary Shares received upon such exercise. |
(b) | If any Transfer is made or attempted in violation of or contrary to the terms of these Articles (a “Prohibited Transfer”), such purported Prohibited Transfer shall be null and void ab initio, and the Company shall refuse to recognize any such purported transferee of the Lock-Up Shares as one of the Company’s equity holders for any purpose. In order to enforce this Article 69(b), the Company may impose stop-transfer instructions with respect to the Lock-Up Shares of a transferring Holder until the end of the Lock-Up Period, except in compliance with the restrictions set forth in these Articles. |
(c) | If, between the Closing Date and a Liquidation Event, the outstanding Ordinary Shares shall have been changed into a different number of shares or a different class, by reason of any stock dividend, subdivision, reclassification, recapitalization, split, combination or exchange of shares, or any similar transaction affecting the outstanding Ordinary Shares, then any number, value (including dollar value) or amount contained herein which is based upon the number of Ordinary Shares will be equitably adjusted for such dividend, subdivision, reclassification, recapitalization, split, combination or exchange of shares, or any similar transaction. Any adjustment under this Article 69(c) shall become effective at the date and time that such stock dividend, subdivision, reclassification, recapitalization, split, combination or exchange of shares, or any similar transaction became effective. For the avoidance of doubt, no change of units or shares pursuant to the transactions contemplated by the Merger Agreement shall constitute a stock dividend, subdivision, reclassification, recapitalization, split, combination or exchange of shares, or similar transaction requiring an equitable adjustment. |
(d) | The restrictions set forth in Article 68 and this Article 69 shall not limit the rights of a Holder to exercise such Holder’s rights as a shareholder of the Company during the Lock-Up Period, including the right to vote any Lock-Up Shares. |
70. | WINDING UP. |
71. | NOTICES. |
(a) | Any written notice or other document may be served by the Company upon any Shareholder either personally, by facsimile, email or other electronic transmission, or by sending it by prepaid mail (airmail if sent internationally) addressed to such Shareholder at his or her address as described in the Register of Shareholders or such other address as the Shareholder may have designated in writing for the receipt of notices and other documents. |
(b) | Any written notice or other document may be served by any Shareholder upon the Company by tendering the same in person to the Secretary or the Chief Executive Officer at the principal office of the Company, by facsimile transmission, email or other electronic transmission, or by sending it by prepaid registered mail (airmail if posted outside Israel) to the Company at its Office. |
(c) | Any such notice or other document shall be deemed to have been served: |
(i) | in the case of mailing, forty-eight (48) hours after it has been posted, or when actually received by the addressee if sooner than forty-eight hours after it has been posted, or |
(ii) | in the case of overnight air courier, on the next business day following the day sent, with receipt confirmed by the courier, or when actually received by the addressee if sooner than three business days after it has been sent; |
(iii) | in the case of personal delivery, when actually tendered in person, to such addressee; |
(iv) | in the case of facsimile, email or other electronic transmission, on the first business day (during normal business hours in place of addressee) on which the sender receives automatic electronic confirmation by the addressee’s facsimile machine that such notice was received by the addressee or delivery confirmation from the addressee’s email or other communication server. |
(d) | If a notice is, in fact, received by the addressee, it shall be deemed to have been duly served, when received, notwithstanding that it was defectively addressed or failed, in some other respect, to comply with the provisions of this Article 71. |
(e) | All notices to be given to the Shareholders shall, with respect to any share to which persons are jointly entitled, be given to whichever of such persons is named first in the Register of Shareholders, and any notice so given shall be sufficient notice to the holders of such share. |
(f) | Any Shareholder whose address is not described in the Register of Shareholders, and who shall not have designated in writing an address for the receipt of notices, shall not be entitled to receive any notice from the Company. |
(g) | Notwithstanding anything to the contrary contained herein, notice by the Company of a General Meeting, containing the information required by applicable law and these Articles to be set forth therein, which is published, within the time otherwise required for giving notice of such meeting, in either or several of the following manners (as applicable) shall be deemed to be notice of such meeting duly given, for the purposes of these Articles, to any Shareholder whose address as registered in the Register of Shareholders (or as designated in writing for the receipt of notices and other documents) is located either inside or outside the State of Israel: |
(i) | if the Company’s shares are then listed for trading on a national securities exchange in the United States or quoted in an over-the-counter market in the United States, publication of notice of a General Meeting pursuant to a report or a schedule filed with, or furnished to, the SEC pursuant to the Exchange Act; and/or |
(ii) | on the Company’s internet site. |
(h) | The mailing or publication date and the record date and/or date of the meeting (as applicable) shall be counted among the days comprising any notice period under the Companies Law and the regulations thereunder. |
(i) | To the extent permitted by the Companies Law or any regulations promulgated thereunder, the Company will not be required to deliver notices of General Meetings to Shareholders who are registered in the Company’s Register of Shareholders, and to whom the Company would otherwise have been required to deliver such notices if not for this Article 71(i). |
72. | AMENDMENT. |
73. | FORUM FOR ADJUDICATION OF DISPUTES. |
(a) | Unless the Company consents in writing to the selection of an alternative forum, with respect to any causes of action arising under the U.S. Securities Act of 1933, as amended, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the U.S. Securities Act of 1933, as amended; and (b) unless the Company consents in writing to the selection of an alternative forum, the competent courts in Tel Aviv, Israel shall be the exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Company to the Company or the Shareholders, or (iii) any action asserting a claim arising pursuant to any provision of these Articles, the Companies Law or the Securities Law. Any person or entity purchasing or otherwise acquiring or holding any interest in shares of the Company shall be deemed to have notice of and consented to these provisions. |
If to Pagaya, to: | ||||||
| | | | |||
| | Pagaya Technologies Ltd. 90 Park Ave, New York, NY 10016 Attention: | | | Gal Krubiner | |
| | | | Richmond Glasgow | ||
| | Email: | | | *@pagaya-inv.com | |
| | | | *@pagaya.com |
| | Skadden, Arps, Slate, Meagher & Flom LLP One Manhattan West New York, New York 10001 | ||||
| | Attention: | | | Andrea Nicolas | |
| | | | Jeffrey Brill | ||
| | | | Maxim Mayer-Cesiano | ||
| | | | B. Chase Wink | ||
| | Email: | | | andrea.nicolas@skadden.com | |
| | | | jeffrey.brill@skadden.com | ||
| | | | maxim.mayercesiano@skadden.com | ||
| | | | b.chase.wink@skadden.com |
and | | | ||||
| | Goldfarb Seligman & Co., Law Offices Ampa Tower, 98 Yigal Alon Street, Tel Aviv 6789141, Israel | ||||
| | Attention: | | | Sharon Gazit, Adv. | |
| | | | Aaron M. Lampert, Adv. | ||
| | Email: | | | sharon.gazit@goldfarb.com | |
| | | | aaron.lampert@goldfarb.com |
Name of Investor: EJF DEBT OPPORTUNITIES MASTER FUND, LP | | | State/Country of Formation or Domicile: Delaware | ||||||
| | | | | | ||||
By: EJF Opportunities FP, LLC | | | | | |||||
Its: General Partner | | | | | |||||
| | | | | | ||||
By: EJF Capital LLC | | | | | |||||
Its: Sole Member | | | | | |||||
| | | | | | ||||
By: | | | /s/ Neal J. Wilson | | | | | ||
Name: | | | Neal J. Wilson | | | | | ||
Title: | | | Co-Chief Executive Officer | | | | | ||
| | | | | | ||||
Name in which the Subscription Shares are to be registered (if different): | | | Date: September 15, 2021 | ||||||
| | | | | | ||||
Investor’s EIN: | | | | | |||||
| | | | | | ||||
Entity Type (e.g., corporation, partnership, trust, etc.): | | | Delaware limited liability company | ||||||
| | | | | | ||||
Business Address-Street: | | | Mailing Address-Street (if different): | ||||||
| | | | | | ||||
City, State, Zip: | | | City, State, Zip: | ||||||
| | | | | | ||||
Attn: | | | | | Attn: | | | ||
| | | | | | ||||
Telephone No.: | | | Telephone No.: | ||||||
Facsimile No.: | | | Facsimile No.: | ||||||
| | | | | | ||||
Number of Shares subscribed for: | | | | | |||||
| | | | | | ||||
Aggregate Subscription Amount: $200,000,000 | | | Price Per Share: $10.00 |
| | PAGAYA TECHNOLOGIES LTD. | |||||||
| | | | | | ||||
| | By: | | | /s/ Avi Zeevi | ||||
| | | | Name: | | | Avi Zeevi | ||
| | | | Title: | | | Chairman of the Board of Directors | ||
| | | | | | ||||
| | | | | | ||||
| | By: | | | /s/ Gal Krubiner | ||||
| | | | Name: | | | Gal Krubiner | ||
| | | | Title: | | | Chief Executive Officer |
A. | QUALIFIED INSTITUTIONAL BUYER STATUS |
☐ | We are a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act). |
☐ | We are an “institutional account” as defined by FINRA Rule 4512(c). |
B. | INSTITUTIONAL ACCREDITED INVESTOR STATUS |
1. | ☐ We are an institutional “accredited investor” (within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act), and have marked and initialed the appropriate box on the following page indicating the provision under which we qualify as an “accredited investor.” |
2. | ☐ We are not a natural person. |
3. | ☐ We are an “institutional account” as defined by FINRA Rule 4512(c). |
☐ | Any bank, registered broker or dealer, insurance company, registered investment company, business development company, or small business investment company; |
☐ | Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000; |
☐ | Any employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered investment advisor makes the investment decisions, or if the plan has total assets in excess of $5,000,000; |
☐ | Any organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, similar business trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000; or |
☐ | Any trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated person. |
C. | QUALIFIED ISRAELI INVESTOR STATUS (for Israeli investors only – please check the applicable box): |
1. | Are you an investor in one of the categories listed in the First Addendum to the Israeli Securities Law, 5728-1968 (the “Securities Law”), and listed below, such an investor being referred to in this Questionnaire as a “Qualified Israeli Investor”? |
2. | Please specify the category listed in the First Addendum to the Israeli Securities Law, to which you belong, by completing below. |
☐ | A joint investment fund or the manager of such a fund within the meaning of the Joint Investments in Trust Law, 5754-1994; |
☐ | A provident fund or the manager of such a fund within the meaning of the Control of Financial Services Law (Provident Funds), 5765-2005; |
☐ | An insurance company as defined in the Supervision of Insurance Business Law, 5741-1981; |
☐ | A banking corporation or a supporting corporation within the meaning of the Banking (Licensing) Law, 5741-1981, with the exception of a joint services company, purchasing for their own account or for the accounts of clients who are Qualified Israeli Investors or who are otherwise listed in Section 15A(b) of the Securities Law (collectively, “Exempt Investors”); |
☐ | A licensed portfolio manager within the meaning of the Regulation of Investment Advice, Investment Marketing and Investment Portfolio Management Law, 5755-1995 (“Investment Advice Law”), purchasing for its own account or for the accounts of clients who are Exempt Investors; |
☐ | A licensed investment advisor or a licensed investment marketer within the meaning of the Investment Advice Law, purchasing for its own account; |
☐ | A member of the Tel Aviv Stock Exchange, purchasing for its own account or for the accounts of clients who are Exempt Investors; |
☐ | An underwriter that satisfies the criteria prescribed in Section 56(c) of the Israeli Securities Law, 5728-1968, purchasing for its own account; |
☐ | A venture capital fund (defined for this purpose as an entity whose principal activity is investing in entities that are engaged primarily in research and development, or in the manufacture of innovative products and processes, with an unusually high investment risk); |
☐ | An entity that is wholly owned by Exempt Investors; |
☐ | An entity, except for an entity that was incorporated for the purpose of investing in securities in a specific offering, whose shareholders equity exceeds NIS 50 million; or |
☐ | An individual who fulfills at least one of the following criteria (note: you must provide confirmation from your certified public accountant regarding the criterion you satisfy): |
(a) | the aggregate value of Liquid Assets owned by such investor exceeds NIS 8,095,444; |
(b) | such investor’s annual income in each of the previous two years exceeds NIS 1,214,317, or the annual income of the Family Unit to which such investor belongs, for the same period, exceeds NIS 1,821,475; or |
(c) | the total value of such investor’s Liquid Assets exceeds NIS 5,059,652 and such investor’s annual income in each of the previous two years exceeds NIS 607,158, or the annual income of such investor’s Family Unit for the same period exceeds NIS 910,737; |
1. | Organizational documents (charters, articles of incorporation, etc.) of the Investor. |
2. | Names of ultimate beneficial owners holding 10% or more of the Investor’s beneficial ownership (“UBOs”). |
3. | Passport/national ID of natural person UBOs. |
| | if to the Sponsor, to: | |||||||
| | | | | |||||
| | | | Wilson Boulevard LLC | |||||
| | | | 2107 Wilson Boulevard, Suite 410 | |||||
| | | | Arlington, Virginia 22201 | |||||
| | | | Attention: | | | Kevin Stein | ||
| | | | Email: | | | kstein@ejfcap.com with a copy to (which shall not constitute notice): | ||
| | | | Simpson Thacher & Bartlett LLP | |||||
| | | | 900 G Street, NW | |||||
| | | | Washington, D.C. 20001 | |||||
| | | | Attention: | | | Jonathan Corsico | ||
| | | | Email: | | | jonathan.corsico@stblaw.com | ||
| | | | | |||||
| | and | |||||||
| | | | | |||||
| | | | Simpson Thacher & Bartlett LLP | |||||
| | | | 425 Lexington Avenue | |||||
| | | | New York, NY 10017 | |||||
| | | | Attention: | | | Mark Brod; Michael Wolfson | ||
| | | | Email: | | | mbrod@stblaw.com; mwolfson@stblaw.com | ||
| | | | | |||||
| | and | |||||||
| | | | | |||||
| | | | Herzog Fox & Neeman | |||||
| | | | Herzog Tower, 6 Yitzhak Sadeh Street | |||||
| | | | Tel Aviv 6777506, Israel | |||||
| | | | Attention: | | | Ory Nacht, Adv. | ||
| | | | Email: | | | nachto@herzoglaw.co.il | ||
| | | | | |||||
| | and | |||||||
| | | | | |||||
| | | | Walkers | |||||
| | | | 190 Elgin Avenue | |||||
| | | | George Town, Grand Cayman | |||||
| | | | Cayman Islands | |||||
| | | | Attention: | | | Andrew Barker | ||
| | | | Email: | | | andrew.barker@walkersglobal.com | ||
| | | | | |||||
| | if to the Company, to: | |||||||
| | | | | |||||
| | | | Pagaya Technologies Ltd. | |||||
| | | | 90 Park Ave, | |||||
| | | | New York, NY 10016 | |||||
| | | | Attention: | | | Gal Krubiner | ||
| | | | | | Richmond Glasgow | |||
| | | | Email: | | | gal@pagaya-inv.com | ||
| | | | | | richmond@pagaya.com | |||
| | | | |
| | with a copy to (which shall not constitute notice): | |||||||
| | | | | |||||
| | | | Skadden, Arps, Slate, Meagher & Flom LLP | |||||
| | | | One Manhattan West | |||||
| | | | New York, NY 10001 | |||||
| | | | Attention: | | | Jeffrey A. Brill | ||
| | | | | | Maxim Mayer-Cesiano | |||
| | | | | | B. Chase Wink | |||
| | | | Email: | | | jeffrey.brill@skadden.com | ||
| | | | | | maxim.mayercesiano@skadden.com | |||
| | | | | | b.chase.wink@skadden.com | |||
| | | | | |||||
| | | | Goldfarb Seligman & Co. | |||||
| | | | 98 Yigal Alon Street | |||||
| | | | Tel Aviv | |||||
| | | | 6789141 | |||||
| | | | Israel | |||||
| | | | Attention: | | | Aaron M. Lampert | ||
| | | | | | Sharon Gazit | |||
| | | | Email: | | | aaron.lampert@goldfarb.com | ||
| | | | | | sharon.gazit@goldfarb.com | |||
| | | | | |||||
| | and | |||||||
| | | | | |||||
| | | | Maples and Calder (Cayman) LLP | |||||
| | | | PO Box 309, Ugland House | |||||
| | | | Grand Cayman | |||||
| | | | KY1-1104 | |||||
| | | | Cayman Islands | |||||
| | | | | | ||||
| | | | Attention: | | | Suzanne Correy | ||
| | | | Email: | | | Suzanne.Correy@maples.com |
| | PAGAYA TECHNOLOGIES LTD. | |||||||
| | | | | |||||
| | By: | | | /s/ Avi Zeevi | ||||
| | | | Name: | | | Avi Zeevi | ||
| | | | Title: | | | Chairman of the Board of Directors | ||
| | | | | | ||||
| | By: | | | /s/ Gal Kribiner | ||||
| | | | Name: | | | Gal Krubiner | ||
| | | | Title: | | | Chief Executive Officer |
| | EJF ACQUISITION CORP. | |||||||
| | | | | |||||
| | By: | | | /s/ Kevin Stein | ||||
| | | | Name: | | | Kevin Stein | ||
| | | | Title: | | | Chief Executive Officer | ||
| | | | | |||||
| | WILSON BOULEVARD LLC | |||||||
| | | | | |||||
| | By: | | | /s/ Thomas Mayrhofer | ||||
| | | | Name: | | | Thomas Mayrhofer | ||
| | | | Title: | | | Authorized Signatory |
if to SPAC, prior to Closing, to: | ||||||
| | | | |||
| | EJF Acquisition Corp. | ||||
| | 2107 Wilson Boulevard, Suite 410 | ||||
| | Arlington, Virginia 22201 | ||||
| | Attention: | | | Kevin Stein | |
| | Email: | | | *@ejfcap.com | |
| | | | |||
with a copy to (which shall not constitute notice): | ||||||
| ||||||
| | Simpson, Thacher & Bartlett LLP | ||||
| | 900 G Street, NW | ||||
| | Washington, D.C. 20001 | ||||
| | Attention: | | | Jonathan Corsico | |
| | Email: | | | jonathan.corsico@stblaw.com | |
| ||||||
| | and | | |||
| ||||||
| | Simpson, Thacher & Bartlett LLP | ||||
| | 425 Lexington Avenue | ||||
| | New York, NY 10017 | ||||
| | Attention: | | | Mark Brod; Michael Wolfson | |
| | Email: | | | mbrod@stblaw.com; mwolfson@stblaw.com | |
| ||||||
| | and | | |||
| ||||||
| | Herzog Fox & Neeman | ||||
| | Herzog Tower, 6 Yitzhak Sadeh Street | ||||
| | Tel Aviv 6777506, Israel | ||||
| | Attention: | | | Ory Nacht, Adv. | |
| | Email: | | | nachto@herzoglaw.co.il | |
| ||||||
| | and | | |||
| ||||||
| | Walkers | ||||
| | 190 Elgin Avenue | ||||
| | George Town, Grand Cayman | ||||
| | KY1-9001 | ||||
| | Cayman Islands | ||||
| | Attention: | | | Andrew Barker | |
| | Email: | | | andrew.barker@walkersglobal.com | |
| ||||||
if to a Voting Party, to such person’s address of record as set forth on Annex A hereto, | ||||||
| | | |
with a copy to (which shall not constitute notice): | ||||||
| ||||||
| | Skadden, Arps, Slate Meagher & Flom LLP | ||||
| | One Manhattan West | ||||
| | New York, NY 10001 | ||||
| | Attention: | | | Jeffrey A. Brill | |
| | | | Maxim Mayer-Cesiano | ||
| | | | B. Chase Wink | ||
| | Email: | | | jeffrey.brill@skadden.com | |
| | | | maxim.mayercesiano@skadden.com | ||
| | | | b.chase.wink@skadden.com | ||
| ||||||
| | Goldfarb Seligman & Co. | ||||
| | 98 Yigal Alon Street | ||||
| | Tel Aviv | ||||
| | 6789141 | ||||
| | Israel | ||||
| | Attention: | | | Aaron M. Lampert | |
| | | | Sharon Gazit | ||
| | Email: | | | aaron.lampert@goldfarb.com | |
| | | | Sharon.gazit@goldfarb.com | ||
| ||||||
| | and | | | ||
| ||||||
| | Maples and Calder (Cayman) LLP | ||||
| | PO Box 309 | ||||
| | Ugland House | ||||
| | Grand Cayman, KY1-1104 | ||||
| | Cayman Islands | ||||
| | Attention: | | | Suzanne Correy | |
| | Email: | | | Suzanne.Correy@maples.com |
| | SPAC: | | | ||
| | | | |||
| | EJF ACQUISITION CORP. | ||||
| | | | |||
| | By: | | | ||
| | | | Name: Kevin Stein | ||
| | | | Title: Chief Executive Officer |
| | VOTING PARTY: | ||||
| | | | |||
| | By: | | | ||
| | | | Name: | ||
| | | | Title: | ||
| | | | |||
| | Address: | | | ||
| | | | |||
| | | |
| | if to Voting Party, to: | |||||||
| | | | | | ||||
| | | | Wilson Boulevard LLC | |||||
| | | | 2107 Wilson Boulevard, Suite 410 | |||||
| | | | Arlington, Virginia 22201 | |||||
| | | | Attention: | | | Kevin Stein | ||
| | | | Email: | | | *@ejfcap.com | ||
| | | | | | ||||
| | with a copy to (which shall not constitute notice): | |||||||
| | | | | | ||||
| | | | Simpson, Thacher & Bartlett LLP | |||||
| | | | 900 G Street, NW | |||||
| | | | Washington, D.C. 20001 | |||||
| | | | Attention: | | | Jonathan Corsico | ||
| | | | Email: | | | jonathan.corsico@stblaw.com | ||
| | | | | | ||||
| | | | and | | ||||
| | | | | | ||||
| | | | Simpson, Thacher & Bartlett LLP | |||||
| | | | 425 Lexington Avenue | |||||
| | | | New York, NY 10017 | |||||
| | | | Attention: | | | Mark Brod; Michael Wolfson | ||
| | | | Email: | | | mbrod@stblaw.com; mwolfson@stblaw.com | ||
| | | | | | ||||
| | | | and | | ||||
| | | | | | ||||
| | | | Herzog Fox & Neeman | |||||
| | | | Herzog Tower, 6 Yitzhak Sadeh Street | |||||
| | | | Tel Aviv 6777506, Israel | |||||
| | | | Attention: | | | Ory Nacht, Adv. | ||
| | | | Email: | | | nachto@herzoglaw.co.il | ||
| | | | | | ||||
| | | | and | | ||||
| | | | | | ||||
| | | | Walkers | |||||
| | | | 190 Elgin Avenue | |||||
| | | | George Town, Grand Cayman | |||||
| | | | KY1-9001 | |||||
| | | | Cayman Islands | |||||
| | | | Attention: | | | Andrew Barker | ||
| | | | Email: | | | andrew.barker@walkersglobal.com |
| | if to the Company, to: | |||||||
| | | | | | ||||
| | | | Pagaya Technologies Ltd. | |||||
| | | | 90 Park Ave | |||||
| | | | New York, NY 10016 | |||||
| | | | Attention: | | | Gal Krubiner | ||
| | | | | | Richmond Glasgow | |||
| | | | Email: | | | *@pagaya-inv.com | ||
| | | | | | *@pagaya.com | |||
| | | | | | ||||
| | with a copy to (which shall not constitute notice): | |||||||
| | | | | | ||||
| | | | Skadden, Arps, Slate Meagher & Flom LLP | |||||
| | | | One Manhattan West | |||||
| | | | New York, NY 10001 | |||||
| | | | Attention: | | | Jeffrey A. Brill | ||
| | | | | | Maxim Mayer-Cesiano | |||
| | | | | | B. Chase Wink | |||
| | | | Email: | | | jeffrey.brill@skadden.com | ||
| | | | | | maxim.mayercesiano@skadden.com | |||
| | | | | | b.chase.wink@skadden.com | |||
| | | | | | ||||
| | | | Goldfarb Seligman & Co. | |||||
| | | | 98 Yigal Alon Street | |||||
| | | | Tel Aviv | |||||
| | | | 6789141 | |||||
| | | | Israel | |||||
| | | | Attention: | | | Aaron M. Lampert | ||
| | | | | | Sharon Gazit | |||
| | | | Email: | | | aaron.lampert@goldfarb.com | ||
| | | | | | Sharon.gazit@goldfarb.com | |||
| | | | | | ||||
| | and | |||||||
| | | | | | ||||
| | | | Maples and Calder (Cayman) LLP | |||||
| | | | PO Box 309 | |||||
| | | | Ugland House | |||||
| | | | Grand Cayman, KY1-1104 | |||||
| | | | Cayman Islands | |||||
| | | | Attention: | | | Suzanne Correy | ||
| | | | Email: | | | Suzanne.Correy@maples.com |
| | VOTING PARTY: | ||||
| | | | |||
| | WILSON BOULEVARD LLC | ||||
| | | | |||
| | By: | | | ||
| | | | Name: | ||
| | | | Title: | ||
| | | | |||
| | Address: | | | ||
| | | |
| | COMPANY: | ||||
| | | | |||
| | PAYAGA TECHNOLOGIES LTD. | ||||
| | | | |||
| | By: | | | ||
| | | | Name: | ||
| | | | Title: |
| | PAGAYA TECHNOLOGIES LTD. | |||||||
| | | | | | ||||
| | By: | | | |||||
| | | | Name: | | | |||
| | | | Title: | | | |||
| | | | | | ||||
| | Shareholders: | | ||||||
| | | | | | ||||
| | ||||||||
| | | | Name: | | | |||
| | | | Address: | | | |||
| | ||||||||
| |
| | EJF ACQUISITION CORP. | |||||||
| | | | | | ||||
| | By: | | | |||||
| | Name: | | | |||||
| | Title: | | | |||||
| | Address: | | | |||||
| | ||||||||
| | ||||||||
| | | | | | ||||
| | WILSON BOULEVARD LLC | |||||||
| | | | | | ||||
| | By: | | | |||||
| | Name: | | | |||||
| | Title: | | | |||||
| | Address: | | | |||||
| | ||||||||
| |
| | [•] | |||||||
| | | | | | ||||
| | By: | | | |||||
| | Name: | | | |||||
| | Title: | | | |||||
| | | | | | ||||
| | Address: | | | |||||
| | ||||||||
| |
PAGAYA TECHNOLOGIES LTD. | | |||||
| | | | |||
By: | | | | |||
Name: | | | ||||
Title: | | |
1 | Note to Draft: To be 10% of the total outstanding number of Ordinary Shares as of immediately after Closing, post-conversion and post-money, calculated on a fully-diluted basis including all equity awards, warrants and other convertible securities outstanding as of such time. |
Confidential | | | September 14, 2021 |
1. | Immediately prior to the effective time of the Merger (as defined below), Pagaya shall undertake the Capital Restructuring, which shall involve the Stock Split, the Conversion, the Reclassification and the issuance of certain shares of capital stock of the company; |
2. | Upon Closing of the transactions contemplated by the Business Combination Agreement, an Affiliate of Wilson Boulevard LLC, will purchase Class A Company Ordinary Shares (as defined below) at a purchase price of $10.00 per share for aggregate gross proceeds of $200 million (as defined in the Business Combination Agreement, the “EJF Investment”); |
3. | Merger Sub will merge with and into EJFA, with EJFA being the surviving corporation (the “Merger”); |
4. | Each outstanding EJFA Class A Ordinary share, par value $0.0001 per share (“SPAC Class A Share”) and EJFA warrant to purchase SPAC Class A Shares (“Public Warrant”) comprising a SPAC Public Unit immediately prior to the Effective Time shall be automatically separated and the holder thereof shall be deemed to hold one (1) SPAC Class A Share and one-third (1/3) of one (1) Public Warrant (with no fractional Public Warrants, and such Public Warrants rounded down to the nearest whole number of Public Warrants); |
Duff & Phelps | | | T +1 312 697 4600 | | | www.duffandphelps.com |
167 N. Green Street | | | F +1 312 697 0112 | | | |
Floor 12 | | | | | ||
Chicago, IL 60607 | | | | |
5. | Each SPAC Class A Share and each outstanding EJFA Class B ordinary share, par value $0.0001 per share (“SPAC Class B Share”) held by the Holders (excluding, for the avoidance of doubt, any shares held by EJFA, Merger Sub or Pagaya, which shall be automatically cancelled for no Merger Consideration or other consideration), shall be converted into the right to receive one Class A ordinary share, without par value, of the Company (“Class A Company Ordinary Share”); and |
6. | Each EJFA warrant to purchase SPAC Class A Shares (“Public Warrant”) and each EJFA private placement warrant (“Private Placement Warrant”) that is outstanding and unexercised upon Closing will be converted into a warrant (a “Company Warrant”) to purchase an equivalent (to the number of SPAC Shares subject to such Public Warrant or Private Placement Warrant, as applicable) number of Class A Company Ordinary Shares, and all rights with respect to the shares underlying such Public Warrants and Private Placement Warrants shall thereupon be converted into rights with respect to the Company Warrants. |
1. | Reviewed the following documents: |
a. | Certain publicly available business and financial information relating to EJFA that we deemed to be relevant; |
b. | EJFA’s unaudited interim financial statements for March 31, 2021 included in EJFA’s Form 10-Q filed with the SEC on May 18, 2021 and EJFA’s unaudited interim financial statements for June 30, 2021 included in EJFA’s Form 10-Q filed with the SEC on August 16, 2021; |
c. | Consolidated audited financial statements for Pagaya for the years ended December 31, 2019 and December 31, 2020 with a Report of Independent Auditor to the Shareholders of Pagaya Technologies Ltd. date of March 15, 2021; |
d. | Consolidated unaudited financial information for the quarters ended March 31, 2021 and June 30, 2021, which Pagaya’s management identified as being the most current financial statements available and on which were instructed to rely by the management of EJFA; |
e. | Capitalization information for Pagaya, prepared by Pagaya, pro forma for the Initial Business Combination (including the Capital Restructuring) and the PIPE Investment, provided to us by management of EJFA and on which were instructed to rely by the management of EJFA, including the number of Class A Company Ordinary Shares to be issued in the PIPE Investment and outstanding upon completion of the Capital Restructuring (including the Stock Split); |
f. | Other internal documents relating to the history, financial conditions and prospects, current and future operations, and probable future outlook of Pagaya, including financial projections for the years 2021 through 2025, prepared by Pagaya senior management and provided to us by management of EJFA (the “Financial Projections”) and on which were instructed to rely by the management of EJFA; |
g. | A letter dated September 14, 2021 from the management of EJFA and Pagaya which made certain representations as to historical financial statements, Financial Projections and the underlying assumptions thereof for EJFA and Pagaya; |
h. | Industry reports that Duff & Phelps deemed relevant; |
i. | The Pagaya company presentation dated August 2021; and |
j. | A draft of the Business Combination Agreement, dated September 13, 2021; |
2. | Discussed the information referred to above and the background and other elements of the Initial Business Combination with the management of EJFA and certain members of the Board of Directors of EJFA (in their capacity as members of the Board of Directors); |
3. | Discussed with EJFA management the plans and intentions with respect to the management and operation of Pagaya and EJFA following the completion of the Initial Business Combination; |
4. | Discussed with EJFA management and certain members of the Board of Directors of EJFA (in their capacity as members of the Board of Directors) their assessment of the strategic rationale for, and the potential benefits of, the Initial Business Combination; |
5. | Participated in due diligence calls with EJFA management and Pagaya management discussing the operations of Pagaya including, but not limited to the Financial Projections; |
6. | Reviewed the historical trading price and trading volume of EJFA’s common stock and the publicly traded securities of certain other companies that Duff & Phelps deemed relevant; |
7. | Performed certain valuation and comparative analyses using generally accepted valuation and analytical techniques, including a discounted cash flow analysis and an analysis of selected public companies that Duff & Phelps deemed relevant; and |
8. | Conducted such other analyses and considered such other factors as Duff & Phelps deemed appropriate. |
1. | Relied upon the accuracy, completeness, and fair presentation of all information, data, advice, opinions and representations obtained from public sources or provided to it from private sources, including EJFA and Pagaya and their respective management, including all financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by us, and did not independently verify such information; |
2. | Relied upon the fact that the Board of Directors and EJFA have been advised by counsel as to all legal matters with respect to the Initial Business Combination, including whether all procedures required by law to be taken in connection with the Initial Business Combination have been duly, validly and timely taken; |
3. | Assumed that any estimates, evaluations, forecasts and projections and other pro forma information, including the Financial Projections, furnished to Duff & Phelps were reasonably prepared and based upon the best currently available information and good faith judgment of the person(s) furnishing the same, and Duff & Phelps expresses no opinion with respect to such estimates, evaluations, forecasts and projections and other pro forma information or any underlying assumptions; |
4. | Assumed that information supplied by and representations made by EJFA and Pagaya and their respective management are substantially accurate regarding EJFA, Pagaya and the Initial Business Combination; |
5. | Assumed that the representations and warranties made in the Business Combination Agreement are substantially accurate; |
6. | Assumed that the adjustments in Sections 3.4(a) and 3.4(b) of the Business Combination Agreement will not result in any material adjustment to the Consideration; |
7. | Assumed that the final versions of all documents reviewed by Duff & Phelps in draft form conform in all material respects to the drafts reviewed; |
8. | Assumed that the Capital Restructuring and PIPE Investment will occur as contemplated by the draft documents reviewed by Duff & Phelps and as described by management of Pagaya and EJFA; |
9. | Assumed that there has been no material change in the assets, liabilities, financial condition, results of operations, business, or prospects of EJFA or Pagaya since the date of the most recent financial statements and other information made available to Duff & Phelps, and that there is no information or facts that would make the information reviewed by Duff & Phelps incomplete or misleading; |
10. | Assumed that all of the conditions required to implement the Initial Business Combination will be satisfied and that the Initial Business Combination will be completed in a timely manner in accordance with the Business Combination Agreement without any material amendments thereto or any material waivers of any terms or conditions thereof; and |
11. | Assumed that the consummation of the Initial Business Combination will comply in all respects with all applicable foreign, federal, state and local statutes, rules and regulations and that all governmental, regulatory or other consents and approvals necessary for the consummation of the Initial Business Combination will be obtained without any adverse effect, that would be material to Duff & Phelps’ analysis, on EJFA, Pagaya, or the contemplated benefits expected to be derived in the Initial Business Combination. |
/s/ Duff & Phelps, A Kroll Business | | | |
Duff & Phelps, A Kroll Business | | | |
Kroll, LLC | | |
Item 20. | Indemnification of directors and officers |
• | monetary liability incurred by or imposed on the Office Holder in favor of another person pursuant to a court judgment, including pursuant to a settlement confirmed as judgment or arbitrator’s decision approved by a competent court. However, if an undertaking to indemnify an Office Holder with respect to such liability is provided in advance, then such an undertaking must be limited to events which, in the opinion of the board of directors, can be foreseen based on the company’s activities when the undertaking to indemnify is given, and to an amount or according to criteria determined by the board of directors as reasonable under the circumstances, and such undertaking shall detail the abovementioned foreseen events and amount or criteria; |
• | reasonable litigation expenses, including reasonable attorneys’ fees, which were incurred by the Office Holder as a result of an investigation or proceeding filed against the Office Holder by an authority authorized to conduct such investigation or proceeding, provided that such investigation or proceeding was either (i) concluded without the filing of an indictment against such Office Holder and without the imposition on the Office Holder of any monetary obligation in lieu of a criminal proceeding; (ii) concluded without the filing of an indictment against the Office Holder but with the imposition of a monetary obligation on the Office Holder in lieu of criminal proceedings for an offense that does not require proof of criminal intent; or (iii) in connection with a monetary sanction; |
• | a monetary liability imposed on the Office Holder in an Administrative Proceeding (as defined below) pursuant to Section 52(54)(a)(1)(a) of the Israeli Securities Law, in favor of all the parties injured by the Office Holder’s breach; |
• | reasonable litigation expenses, including reasonable attorneys’ fees, expended by the Office Holder with respect to an Administrative Proceeding under the Israeli Securities Law; |
• | reasonable litigation expenses, including reasonable attorneys’ fees, incurred by the Office Holder or which were imposed on the Office Holder by a court (i) in a proceeding instituted against the Office Holder by the company, on its behalf, or by a third-party, (ii) in connection with criminal indictment of which the Office Holder was acquitted, or (iii) in connection with a criminal indictment which the Office Holder was convicted of an offense that does not require proof of criminal intent; |
• | financial liability imposed on the Office Holder in an Administrative Proceeding, on behalf of all the parties injured by the Office Holder’s breach; |
• | reasonable litigation expenses, including reasonable attorneys’ fees, incurred by an Office Holder in connection with a proceeding under the Law for Increased Enforcement of Labor Laws, 5772-2011 and the regulations promulgated thereunder, or the Law for Encouragement of Research, Development and Technological Innovation in the Industry, 5744-1984 and all the regulations promulgated under it; |
• | reasonable litigation expenses, including reasonable attorneys’ fees, incurred by an Office Holder in connection with a proceeding conducted with respect to the Office Holder under the Economic Competition Law; and |
• | any other obligation or expense in respect of which it is permitted or will be permitted under applicable law to indemnify an Office Holder, including, without limitation, matters referenced in Section 56H(b)(1) of the Israeli Securities Law. |
• | a breach of the duty of loyalty to the company, provided that the Office Holder acted in good faith and had a reasonable basis to believe that the act would not harm the company; |
• | a breach of duty of care to the company or to a third-party; |
• | a monetary liability imposed on the Office Holder in favor of a third-party; |
• | a monetary liability imposed on the Office Holder in favor of an injured party in certain Administrative Proceedings under the Israeli Securities Law, including reasonable attorneys’ fees and other litigation expenses; |
• | expenses incurred by the Office Holder in connection with an Administrative Proceeding, including reasonable attorneys’ fees and other litigation expenses; and |
• | expenses incurred by the Office Holder in proceedings under or in connection with the Economic Competition Law, including reasonable attorneys’ fees and other litigation expenses. |
• | a breach of the duty of loyalty, except for indemnification and insurance for a breach of the duty of loyalty to the company to the extent that the Office Holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company; |
• | a breach of duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the Office Holder; |
• | an act or omission committed with intent to derive illegal personal benefit; or |
• | a fine or forfeit levied against the Office Holder. |
Item 21. | Exhibits and financial statements schedules |
Exhibit Number | | | Description |
2.1† | | | Agreement and Plan of Merger, dated as of September 15, 2021, by and among Pagaya Technologies Ltd., EJF Acquisition Corp. and Rigel Merger Sub Inc. (included as Annex A to the proxy statement/prospectus). |
3.1 | | | Amended and Restated Articles of Association of Pagaya Technologies Ltd. (as currently in effect). |
3.2 | | | Form of Amended and Restated Articles of Association of Pagaya Technologies Ltd. (to be effective upon consummation of the Merger) (included as Annex C to the proxy statement/prospectus). |
3.3 | | | Amended and Restated Memorandum and Articles of EJF Acquisition Corp. (incorporated by reference to Exhibit 3.1 of EJF Acquisition Corp.’s Current Report on Form 8-K filed with the SEC on February 24, 2021). |
4.1 | | | Specimen Unit Certificate of EJF Acquisition Corp. (incorporated by reference to Exhibit 4.1 of EJF Acquisition Corp.’s Amendment No. 3 to Form S-1 filed with the SEC on February 18, 2021). |
4.2 | | | Specimen Class A Common Stock Certificate of EJF Acquisition Corp. (incorporated by reference to Exhibit 4.2 of EJF Acquisition Corp.’s Amendment No. 3 to Form S-1 filed with the SEC on February 18, 2021). |
4.3 | | | Specimen Warrant Certificate of EJF Acquisition Corp. (incorporated by reference to Exhibit 4.3 of EJF Acquisition Corp.’s Amendment No. 3 to Form S-1 filed with the SEC on February 18, 2021). |
4.4 | | | Warrant Agreement, dated as of February 24, 2021, between Continental Stock Transfer & Trust Company and EJF Acquisition Corp. (incorporated by reference to Exhibit 4.1 of EJF Acquisition Corp.’s Current Report on Form 8-K filed with the SEC on February 24, 2021). |
4.5** | | | Specimen Common Share Certificate of Pagaya Technologies Ltd. |
4.6** | | | Specimen Warrant Certificate of Pagaya Technologies Ltd. |
4.7** | | | Form of Assignment, Assumption and Amendment Agreement, by and among Pagaya Technologies Ltd., EJF Acquisition Corp. and Continental Stock Transfer & Trust Company. |
4.8 | | | Registration and Shareholder Rights Agreement, by and among EJF Acquisition Corp., Wilson Boulevard LLC and certain security holders (incorporated by reference to Exhibit 10.3 of EJF Acquisition Corp. Current Report on Form 8-K filed with the SEC on March 1, 2021). |
4.9 | | | Form of Registration Rights Agreement (to be effective upon consummation of the Merger) (included as Annex H to the proxy statement/prospectus). |
5.1** | | | Opinion of Goldfarb Seligman & Co. as to the validity of Pagaya Ordinary Shares to be issued. |
5.2** | | | Opinion of Skadden, Arps, Slate, Meagher & Flom LLP as to the validity of the Pagaya Warrants to be issued. |
10.1 | | | Investment Management Trust Agreement, dated as of February 24, 2021, by and between Continental Stock & Trust Company and EJF Acquisition Corp. (incorporated by reference to Exhibit 10.2 of EJF Acquisition Corp.’s Current Report on Form 8-K filed with the SEC on February 24, 2021). |
Exhibit Number | | | Description |
10.2 | | | Administrative Services Agreement, dated as of February 24, 2021, by and between EJF Acquisition Corp. and Wilson Boulevard LLC (incorporated by reference to Exhibit 10.5 of EJF Acquisition Corp’s Current Report on Form 8-K filed with the SEC on February 24, 2021). |
10.3 | | | Letter Agreement, dated as of February 24, 2021, by and among EJF Acquisition Corp., Wilson Boulevard LLC and each of EJF Acquisition Corp.’s officers and directors (incorporated by reference to Exhibit 10.4 of EJF Acquisition Corp.’s Current Report on Form 8-K filed with the SEC on February 24, 2021). |
10.4†† | | | EJFA Voting Agreement, dated as of September 15, 2021, by and between Pagaya Technologies Ltd. and Wilson Boulevard LLC (included as Annex G to the proxy statement/prospectus). |
10.5†† | | | Pagaya Voting Agreement, dated as of September 15, 2021, by and among EJF Acquisition Corp., Pagaya Technologies Ltd., and certain of Pagaya Technologies Ltd.’s shareholders (included as Annex F to the proxy statement/prospectus). |
10.6 | | | Side Letter Agreement, dated as of September 15, 2021, by and between Pagaya Technologies Ltd., EJF Acquisition Corp. and Wilson Boulevard LLC (included as Annex E to the proxy statement/prospectus). |
10.7†† | | | Subscription Agreement, dated as of September 15, 2021, by and between Pagaya Technologies Ltd. and EJFA Debt Opportunities Master Fund, LP (included as Annex D to the proxy statement/prospectus). |
10.8 | | | Form of Subscription Agreement. |
10.9††† | | | Pagaya Technologies Ltd.’s 2016 Equity Incentive Plan |
10.10††† | | | Pagaya Technologies Ltd. 2016 Equity Incentive Plan Stock Option Sub-Plan for United States Persons |
10.11††† | | | Pagaya Technologies Ltd.’s 2021 Equity Incentive Plan |
10.12††† | | | Pagaya Technologies Ltd. 2021 Equity Incentive Plan Stock Option Sub-Plan for United States Persons |
10.13††† | | | Form of Pagaya Technologies Ltd.’s 2022 Share Incentive Plan (included as Annex I to the proxy statement/prospectus). |
10.14** | | | Form of Director Indemnification Agreement. |
10.15 | | | Credit Agreement, dated as of December 23, 2021, by and among Pagaya Technologies Ltd., the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent. |
21.1 | | | List of subsidiaries of Pagaya Technologies Ltd. |
23.1** | | | Consent of Ernst & Young Global Limited, independent registered accounting firm for Pagaya Technologies Ltd. |
23.2** | | | Consent of Marcum LLP, independent registered accounting firm for EJF Acquisition Corp. |
23.3** | | | Consent of Goldfarb Seligman & Co. (included in Exhibit 5.1). |
23.4** | | | Consent of Duff & Phelps, financial advisor to EJF Acquisition Corp. |
24.1** | | | Power of Attorney (included on signature page to the initial filing of the Registration Statement). |
99.1** | | | Form of Proxy Card for Special Meeting. |
99.2** | | | Consent of Gal Krubiner to be named as a director. |
99.3** | | | Consent of Avital Pardo to be named as a director. |
99.4** | | | Consent of Yahav Yulzari to be named as a director. |
Exhibit Number | | | Description |
99.5** | | | Consent of Emanuel Friedman to be named as a director. |
99.6** | | | Consent of Avi Zeevi to be named as a director. |
99.7** | | | Consent of Dan Petrozzo to be named as a director. |
99.8** | | | Consent of Harvey Golub to be named as a director. |
99.9** | | | Consent of Mircea Ungureanu to be named as a director. |
99.10** | | | Consent of Amy Pressman to be named as a director. |
* | Previously filed. |
** | To be filed by amendment. |
† | Schedules and certain portions of the exhibits omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplementally a copy of such schedules, or any section thereof, to the SEC upon request. |
†† | Certain portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The Company agrees to furnish supplementally an unredacted copy of the exhibit to the SEC upon its request. |
††† | Indicates a management contract or compensatory plan. |
Item 22. | Undertakings |
• | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |
• | To include any prospectus required by Section 10(a)(3) of the Securities Act; |
• | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement; |
• | To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; |
• | That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment will be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time will be deemed to be the initial bona fide offering thereof; |
• | To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering; and |
• | To file a post-effective amendment to the registration statement to include any financial statements required by Item 8.A of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Securities Act need not be furnished; provided that the registrant includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (1)(d) and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements. |
• | Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; |
• | Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; |
• | The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and |
• | Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |
| | PAGAYA TECHNOLOGIES LTD. | ||||
| | | | |||
| | By: | | | ||
| | | | Name: | ||
| | | | Title: | ||
| | | | |||
| | By: | | | ||
| | | | Name: | ||
| | | | Title: |
NAME | | | POSITION | | | DATE |
| | | | |||
| | Chief Executive Officer and Board Member (Principal Executive Officer) | | | ||
Gal Krubiner | | | ||||
| | | | |||
| | Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | | | ||
Michael Kurlander | | | ||||
| | | | |||
| | Chairman | | | ||
Avi Zeevi | | | ||||
| | | | |||
| | Board Member | | | ||
Amy Estey Hald | | | ||||
| | | | |||
| | Board Member | | | ||
Harvey Golub | | | ||||
| | | | |||
| | Chief Technology Officer and Board Member | | | ||
Avital Pardo | | | ||||
| | | | |||
| | Board Member | | | ||
Dan Petrozzo | | | ||||
| | | | |||
| | Board Member | | | ||
Mircea Ungureanu | | | ||||
| | | | |||
| | Chief Revenue Officer and Board Member | | | ||
Yahav Yulzari | | |
| | Pagaya US Holding Company LLC | ||||
| | | | |||
| | By: | | | ||
| | | | Name: | ||
| | | | Title: |
Exhibit 3.1
The Companies Law, 5759-1999
A Company Limited By Shares
Amended And Restated Articles Of Association
of
PAGAYA TECHNOLOGIES LTD.
Dated March 17, 2021
PRELIMINARY
1. | Company’s Objectives. |
1.1 | The Company is a private company. |
1.2 | The objects for which the Company is founded are to engage in any business, commercial, industrial or other activity of any kind, which is not legally prohibited or restricted by law. |
1.3 | The Company may contribute reasonable amounts for any suitable purpose or categories of purpose even if such contributions do not fall within business considerations of the Company. The Board may determine the amounts of the contributions, the purpose or category of purposes for which the contribution is to be made, and the identity of the recipients of any contribution. |
2. | Interpretation |
2.1 | In these Articles, unless the context otherwise requires: |
Affiliate | means an entity or person, which, directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with such transferor-shareholder. For the purpose of these Articles, “Control” shall mean the holding of more than 50% of the equity or voting rights, voting control, or power to influence in an entity or the right to appoint a majority of its board of directors or other equivalent body, whether directly or indirectly through voting agreements or otherwise. The term “Controlled” shall have a correlative meaning. |
Articles or the | |
Articles | |
of Associations | means these Amended and Restated Articles of Association of the Company, as they may be amended and replaced from time to time. |
Board or the | |
Board | |
of Directors | means the Board of Directors of the Company elected or properly appointed in accordance with the provisions of these Articles of Association; any committee of the Board of Directors to the extent that any of the authorities of the Board of Directors are delegated to it. |
Business Day | means a day on which commercial banks in Israel are required to be open for business. |
Clal | means Clal Insurance Company Ltd. (Nostro) (in Hebrew: כ׌׌ חברה ׌בי×~וח בע”מ (עבור × ×•×¡×~רו)), Clal Insurance Company Ltd. (for the benefit of participating insurance policies under its management)(in Hebrew: כ׌׌ חברה ׌בי×~וח בע”מ (עבור פו׌יסות משתתפות ×‘× ×™×”×•×Œ×”)), Clal Pension and Provident Funds Ltd. (for the benefit of provident funds and pension funds under its management) (in Hebrew: כ׌׌ ×¤× ×¡×™×” וגמ׌ בע”מ (עבור קופות גמ׌ ×•×§×¨× ×•×ª ×¤× ×¡×™×” ×‘× ×™×”×•×Œ×”)), “Atudot” – Pension Fund for Employees and Independents Ltd. (for the benefit of pension funds under its management)(in Hebrew:“עתודות” - קרן ×¤× ×¡×™×” ×Œ×©×›×™×¨×™× ×•×¢×¦×ž××™×™× ×‘×¢”מ (עבור ×§×¨× ×•×ª ×¤× ×¡×™×” ×‘× ×™×”×•×Œ×”) |
Clal Insurance Company Ltd. (for the benefit of participating insurance policies under its management), Clal Pension and Provident Funds Ltd. (for the benefit of provident funds and pension funds under its management) and “Atudot” — Pension Fund for Employees and Independents Ltd. (for the benefit of pension funds under its management) shall be referred to herein collectively as the “Clal Pension Funds”. | |
Companies Law | means the Companies Law, 5759-1999 or any law, which may replace or amend it, as shall be in force from time to time. |
Companies | |
Ordinance | means those sections of the Companies Ordinance [New Version] 5743 — 1983 that remain in force after the date of the coming into force of the Companies Law, as the same shall be amended from time to time thereafter, or any other law which shall replace those sections after the date of entry into force of the Companies Law. |
Company | means Pagaya Technologies Ltd. |
Coral Blue | means Coral Blue Investment Pte. Ltd. |
Deemed | |
Liquidation | means (i) a merger, consolidation, recapitalization or similar event of the Company with or into another corporation in a single transaction or a series of transactions as a result of which the Shareholders of the Company immediately prior to such transaction do not own in such capacity a majority of the voting securities of the surviving entity or the parent of the surviving entity, (ii) a sale or grant of an exclusive, perpetual, worldwide license (other than the license in the ordinary course of business, which does not amount to a de facto sale of all or substantially all of the Company) or other disposition of all or substantially all of the intellectual property rights of the Company, or all or substantially all of the Company’s assets, in each case, other than to a wholly-owned subsidiary of the Company, (iii) a sale of all or substantially all of the Shares of the Company or the sale of all or substantially all of the shares of one or more subsidiaries of the Company that own(s) all or substantially all of the aggregate assets of the Company and its subsidiaries taken as a whole, other than to a wholly-owned subsidiary of the Company, or (iv) any transaction or series of related transactions as a result of which at least 50% of the Shares of the Company are transferred to any third party; in all cases, other than the issuance of Shares of the Company solely for financing purposes. |
Director or | |
Directors | means a member or members of the Board of Directors who are elected or appointed in accordance with the provisions of these Articles of Association, including an Alternate Director serving in such capacity at the relevant time. |
Founders | Gal Krubiner, Avital Pardo and Yahav Yulzari. |
GF | Means Saro, L.P., Jim Brown and Golub Investments, LP. |
GF shall have the right to assign and allocate any of its rights under these Articles to any of the above-mentioned member(s) of GF and shall not be required to do so on a proportionate basis; provided that the member(s) of GF holding the majority of the issued and outstanding share capital of the Company shall be deemed as a representative(s) of all the GF members for the purpose of administering or exercising any specific right under these Articles and any notice provided by such representative(s) shall be binding upon all the members of GF. |
GIC Entities | means Coral Blue and Radiance. |
IPO | means the consummation of the initial underwritten public offering or a direct listing of the Company’s securities pursuant to an effective registration statement under the U.S. Securities Act of 1933, as amended, or under any other applicable securities law that results in a class of the Company’s equity securities being listed on a United States national securities exchange. |
Minimum | |
Share | |
Threshold | means 3.0% of the Company’s issued and outstanding share capital on an as converted basis (except that as to GF and the New Investors Group, it shall be understood to mean 2.5% of the Company’s issued and outstanding share capital on an as converted basis), excluding (both in the numerator and the denominator) (i) any shares issued by the Company which are Excluded Securities, (ii) any Additional Shares issued by the Company which do not result in an adjustment under Article 7.2.5 and (iii) any other shares issued or sold by the Company where the Preferred Shareholders do not have a right to purchase their pro-rata share of such shares. |
New Investors | |
Group | Viola 4 P, Limited Partnership, Poalim Ventures Ltd., SCB 10X Company Limited and Aflac Ventures LLC. |
All Shares held by any Shareholder of the New Investors Group shall be aggregated together for the purpose of determining the availability of rights under articles 12, 25, 26 and 44.7 for such Shareholders, including rights which are conditioned on the relevant Shareholder holding Shares representing a minimum percentage, etc. | |
For the avoidance of doubt, no Shareholder of the New Investors Group shall be obligated in any manner to vote together with any other member of the New Investors Group, nor act in any manner as a group except as specifically set forth hereunder. | |
New Securities | means shares of the Company, whether now authorized or not, and rights, options or warrants to purchase shares, and securities of any type whatsoever that are convertible into shares of the Company; provided, however, that the term “New Securities” does not include: (i) Ordinary Shares issued or reserved for issuance upon exercise of options granted under a plan or other arrangements approved by the Company’s Board of Directors and granted to officers, directors, employees or consultants of the Company or a subsidiary; (ii) issuances of securities pro-rata to all shareholders, as bonus shares or upon share splits, share dividends, reclassification and similar recapitalization events; (iii) securities issued upon the conversion of the Preferred Shares; (iv) securities issued in a Public Event; (v) (A) shares or securities issued to Viola Credit Five Fund, Limited Partnership pursuant to that certain warrant issued and delivered by the Company on November 20, 2017, as amended on March 4, 2019, (B) up to 3,348 Preferred D Shares issued to Coral Blue (or an affiliate thereof) pursuant to that certain warrant issued and delivered by the Company on June 1, 2020, (C) up to 23,434 Preferred D Shares issued to Radiance (or an affiliate thereof) pursuant to that certain warrant issued and delivered by the Company on June 1, 2020, and (D) up to 3,348 Preferred D Shares, which may be issued in two parts to Aflac Ventures LLC (or an affiliate thereof) pursuant to that certain warrant issued and delivered by the Company on June 1, 2020, and in accordance with the adjustment mechanism thereunder; (vi) those certain warrants issued pursuant to the Preferred E Share Purchase Agreement and any underlying shares issuable upon exercise thereof; and (vii) any shares or securities issued to a Strategic Party and exempt from the definition “New Securities” by a resolution adopted by the Preferred Majority, provided however that no member of the Preferred Majority consenting in writing to the exclusion of an issuance from the definition of “New Securities” (the “Waiving Shareholders”) shall, directly or indirectly (including through any person controlled by the Waiving Shareholders or any Permitted Transferee thereof), participate in the offering of those certain New Securities which were so excluded (provided, for the sake of clarification, that nothing herein shall be deemed as preventing the Waiving Shareholders from participating in an offering of securities in connection with a financing round in the framework of which such exclusion from the definition of “New Securities” is made, but provided further that all the Shareholders entitled to participate in the offering under Article 12 hereto shall have the opportunity to participate in the offering of securities as part of the financing round that were not so excluded by the Waiving Shareholders on a pro rata basis among them in accordance with the provisions of Article 12, mutatis mutandis) (such excluded securities in subsections (i) through (vi), the “Excluded Securities”). |
It is clarified that the limitations on the ability of the Preferred Majority to exclude issuances of securities from the definition of “New Securities” provided for in subsection (vi) above do not apply to an investment by any entities belonging to the Viola Group, other than entities investing under the “Carmel” name or the “Viola Ventures” or the “Viola 4 P, Limited Partnership”, name, regardless of whether such entities change their names in the future. | |
Oak | means HC/FT Partners II, L.P. |
Office | means the registered office of the Company for the time being. |
Ordinary | |
Shareholder | means a holder of Ordinary Shares. |
Ordinary | |
Shares | means Ordinary Shares of the Company, nominal value NIS 0.01 each. |
Ordinary | |
Issue Price | means for the Preferred A Shares - US$ 3.3750, for the Preferred A-1 Shares - US$ 18.90, for the Preferred B Shares - US$ 35.810163, for the Preferred C Shares - US$ 72.5727, for the Preferred D Shares - US $149.3534, and for the Preferred E Shares – US $ 838.49, in each case as adjusted for any share splits, share combinations, distributions of bonus shares and other recapitalization events in accordance with Article 7.2. |
Permitted | |
Transferee | means as defined in Article 25.2 below. |
Preferred A | |
Shares | means Series A Preferred Shares of the Company, nominal value NIS 0.01 each. |
Preferred A-1 | |
Shares | means Series A Preferred Shares of the Company, nominal value NIS 0.01 each. |
Preferred B | |
Shares | means Series B Preferred Shares of the Company, nominal value NIS 0.01 each. |
Preferred C | |
Shares | means Series C Preferred Shares of the Company, nominal value NIS 0.01 each. |
Preferred D | |
Shares | means Series D Preferred Shares of the Company, nominal value NIS 0.01 each. |
Preferred E | |
Shares | means Series E Preferred Shares of the Company, nominal value NIS 0.01 each. |
Preferred | |
Shares | means the Preferred A Shares, the Preferred A-1 Shares, the Preferred B Shares, the Preferred C Shares, the Preferred D Shares, and the Preferred E Shares, as applicable. |
Preferred | |
Director(s) | means as defined in Article 44.1.4 below. |
Preferred | |
Majority | means the holders of a majority of the then outstanding Preferred Shares, voting together as a single class on an as converted basis. |
Preferred C | |
Majority | means the holders of a majority of the issued and outstanding Preferred C Shares, voting together as a single class (on an as converted basis). |
Preferred D | |
Majority | means the holders of a majority of the issued and outstanding Preferred D Shares, voting together as a single class (on an as converted basis). |
Preferred E | |
Majority | means the holders of a majority of the issued and outstanding Preferred E Shares, voting together as a single class (on an as converted basis). |
Preferred | |
Shareholder | means a holder of Preferred Shares. |
Public Event | means either an IPO or the completion of a SPAC Transaction. |
Radiance | means Radiance Star Pte. Ltd. |
Register | means the register of Shareholders to be kept in accordance with the Companies Law, or, if the Company shall have any additional register(s) outside of Israel, any such additional register(s) as the case may be. |
SCB | means The Siam Commercial Bank Public Company Limited and / or SCB 10X Company Limited. |
Series E | |
Closing | means the Closing under the Series E Preferred Share Purchase Agreement |
Series E Preferred | |
Share Purchase | |
Agreement | means the Series E Preferred Share Purchase Agreement, by and among the Company and Tiger Global Private Investment Partners XIV, L.P. (or one or more affiliates thereof) (“Tiger”) and other purchasers, dated March 17, 2021. |
Shares | shall have the meaning set forth in Article 5. |
Shareholder | means any person that owns Shares, at any given time. |
Shareholder | |
Resolution | means a resolution adopted by holders of majority of the voting power of the Company represented, personally or by proxy, and voting with respect thereto (excluding abstentions), unless a different majority is required in respect to such matter pursuant to the Companies Law or these Articles at the time the resolution is voted on, in which case a “Shareholder Resolution” shall mean a resolution adopted by such required majority. |
SPAC | means a newly formed special purpose acquisition entity, which (i) has been formed with the purpose of raising capital, (ii) has completed an initial public offering resulting in the equity interests of such entity being listed on a United States national securities exchange, and (iii) does not conduct any material business or maintain any material assets other than cash. |
SPAC Transaction | means an acquisition, merger or other business combination pursuant between the Company and a SPAC (or a subsidiary thereof), provided that (i) the transaction shall result in a class of equity securities of the surviving parent entity being listed on a United States national securities exchange, and (ii) the Company or its shareholders shall receive a majority of the voting stock of the combined company as a result of the transaction consummated in connection therewith. |
Strategic | |
Investor | means an entity or person that, as determined by the Board in its reasonable good faith opinion, has or could have a substantial interest, or a potential substantial interest, in the business of the Company. |
Viola | |
Ventures | means Viola Ventures, IV (A) L.P., Viola Ventures, IV (B) L.P., Viola Ventures IV CEO Program, L.P. and/or Viola Ventures IV Principals Fund, L.P. |
2.2 | Subject to the provisions of this Article, in these Articles, unless the context otherwise requires, expressions used herein which are defined in the Companies Law, or any modification thereof in force at the date at which these Articles become binding upon the Company, shall have the meaning so defined. |
2.3 | In these Articles, words importing the singular shall include the plural and vice versa, and words importing the masculine gender shall include the feminine and words importing persons shall include bodies corporate. |
2.4 | Any Article in these Articles which provides for an arrangement which differs in whole or in part from any provision in the Companies Law or the Companies Ordinance, as the case may be, which can be stipulated against, amended or added to, in whole or with regard to specific matters or within specific limitations, in accordance with any law, shall be considered a stipulation against the provision of the Companies Law or Companies Ordinance, as the case may be, even if the actual stipulation is not specified in the said Article, and even if it is expressly stated in the Article (in whatever form) that the effectiveness of the Article is subject to the provisions of any law. |
2.5 | In the event of a contradiction between any Article and the provisions of any law that may not be stipulated against, amended or added to, the provisions of the said law shall prevail, provided that nothing thereby shall nullify or impair the effectiveness of these Articles in general or any other Article therein. |
2.6 | In the event that a Hebrew version of these Articles is filed with any regulatory or governmental agency, including the Israeli Registrar of Companies, then whether or not such Hebrew version contains signatures of Shareholders, such Hebrew version shall be considered solely a convenience translation and shall have no binding effect, as between the Shareholders of the Company and with respect to any third party. The English version shall be the only binding version of these Articles, and in the event of any contradiction or inconsistency between the meaning of the English version and the meaning of the Hebrew version of these Articles, the Hebrew version shall be disregarded, shall have no binding effect and shall have no impact on the interpretation of these Articles or any provision hereof. |
LIMITATION OF LIABILITY; PRIVATE COMPANY
3. | The Company is a private company limited by shares and therefore the liability of the Shareholders of the Company for the indebtedness of the Company shall be limited as follows: |
3.1 | Each Shareholder’s obligations to the Company’s obligations shall be limited to the payment of the nominal value of the shares held by such Shareholder, subject to the provisions of the Companies Law. |
3.2 | If at any time the Company shall issue shares with no nominal value, the liability of the Shareholders shall be limited to payment of the amount that the Shareholders should have paid to the Company in the respect of each share according to the conditions of issuance. |
4. | The Company is a private company, and: |
4.1 | The number of Shareholders of the Company (exclusive of persons who are in the employment of the Company and of persons who have been formerly in the employment of the Company and were, while in such employment, and have continued after such employment to be, Shareholders of the Company) is not to exceed fifty (50), but where two (2) or more persons hold one (1) or more share(s) in the Company jointly, they shall, for the purposes of this Article, be treated as a single Shareholder; |
4.2 | The right to transfer shares shall be restricted as hereinafter provided. |
4.3 | Any offer to the public to subscribe for any shares or debentures of the Company is prohibited. |
SHARE CAPITAL
5. | Authorized Share Capital. |
The share capital of the Company is 104,650 New Israeli Shekels (“NIS”), divided into an aggregate of 10,465,000 Shares designated as follows:
(i) | 8,258,757 Ordinary Shares; |
(ii) | 370,370 Preferred A Shares; |
(iii) | 179,398 Preferred A-1 Shares; |
(iv) | 412,554 Preferred B Shares; |
(v) | 343,498 Preferred C Shares; |
(vi) | 713,076 Preferred D Shares; |
(vii) | 187,347 Preferred E Shares. |
The Ordinary Shares, the Preferred A Shares, the Preferred A-1 Shares, the Preferred B Shares the Preferred C Shares, the Preferred D Shares, and the Preferred E Shares shall be collectively referred to as the “Shares.” The powers, preferences, rights, restrictions and other matters relating to the Shares of the Company are as set forth in these Articles.
The Preferred A Shares, the Preferred A-1 Shares, the Preferred B Shares, the Preferred C Shares, the Preferred D Shares and the Preferred E Shares, unless specifically set forth in these Articles, shall (i) have all of the same rights and privileges and (ii) vote together as one class on all matters that may require the approval of a class of shareholders of the Company.
6. | Ordinary Shares. |
Subject to any provisions in these Articles conferring special preferences and rights, Ordinary Shares in respect of which all calls have been fully paid, shall confer on their holders the right to receive notices of, and to attend and to vote at, general meetings of the Company, the right to receive dividends and to participate in the distribution of the surplus assets of the Company upon its winding-up and certain other rights all as are specified in these Articles.
7. | Preferred Shares. |
The Preferred Shares shall confer upon the holders thereof all of the rights accruing to holders of Ordinary Shares and, in addition, shall confer the following rights and any other special rights contained in these Articles:
7.1 | Voting Rights. |
Subject to Article 41 and any other provision hereof conferring special rights as to voting, or restricting the right to vote, each holder of Preferred Share shall have one vote for each Ordinary Share which the Preferred Shares held by such holder of record could be converted into pursuant to Article 7.2 hereof, in every resolution, regardless to whether the vote thereon is conducted by a show of hands, by written consent in lieu of a meeting, or by any other mean, on all matters entitled to be voted on by the Shareholders of the Company or by the holders of Preferred Shares voting together as a single class on an as converted basis (except as otherwise expressly provided herein or as required by law).
7.2 | Conversion. |
7.2.1 | Right to Convert. Each Preferred Share shall be convertible, at the option of the holder thereof, at any time after the date of issuance of such share, and without the payment of additional consideration by the holder thereof, into such number of fully paid and non-assessable Ordinary Shares as is determined by dividing the applicable Original Issue Price of such share by the Conversion Price (as defined below) of such share, in effect at the time of conversion. The initial Conversion Price of a Preferred Share shall be the applicable Original Issue Price thereof; provided, however, that each such Conversion Price shall be subject to adjustment as set forth in this Article 7.2 below (the “Conversion Price”). |
7.2.2 | Automatic Conversion. Each Preferred Share shall automatically be converted into Ordinary Shares as provided in sub-Article 7.2.3, upon the earlier of: (i) in the event that the Preferred Majority consents in writing to such conversion, provided, however, with respect to the conversion of the Preferred E Shares, the consent or affirmative vote of the Preferred E Majority shall be required unless such conversion occurs in connection with a transaction pursuant to which the holders of Preferred E Shares receive consideration per Preferred E Share at least equal to the Preferred E Preference Amount; or (ii) mandatorily immediately prior to the closing of a Public Event, subject to the consummation of such Public Event. |
7.2.3 | Mechanism of Conversion |
(i) | A conversion of Preferred Shares pursuant to the election of the holder thereof, shall be made by the surrender of the applicable certificate or certificates for such Preferred Shares, at the principal office of the Company, together with written notice of the election to convert all or any number of the Preferred Shares represented by such certificate or certificates and, if applicable, any event on which such conversion is contingent. Such conversion shall be deemed to have been made immediately prior to the close of business on the date of such surrender of the certificate representing the Preferred Shares to be converted, and the person(s) entitled to receive the Ordinary Shares into which the Preferred Shares are convertible shall be treated for all purposes as the record holder(s) of such Ordinary Shares as of such date. |
(ii) | If the conversion is in connection with a Public Event, the conversion will occur upon the closing of the sale of securities pursuant to the IPO or the closing of the SPAC Transaction, as applicable. |
(iii) | If the conversion is an automatic conversion, then the conversion shall be deemed to have taken place automatically regardless of whether the certificates representing such Shares have been tendered to the Company, but from and after such conversion any such certificates not tendered to the Company shall be deemed to evidence solely the Ordinary Shares received upon such conversion and the right to receive a certificate for such Ordinary Shares. |
(iv) | The Company shall, as soon as practicable after the conversion and tender of the certificates for the Preferred Shares converted, issue and deliver to the holder(s) of such Preferred Shares, a certificate or certificates for the number of Ordinary Shares into which such Preferred Shares are then convertible. |
(v) | To the extent required, each conversion shall be made by converting or reclassifying the applicable Preferred Share into one fully paid and non-assessable Ordinary Share and the Company shall, at such time, issue to the holder thereof, for no additional charge (a portion of the premium paid for such Preferred Share being attributed as payment on account of the nominal value of such additional Ordinary Shares), such additional number of fully paid and non-assessable Ordinary Shares as is required so that the total number of Ordinary Shares so issued together with the one Ordinary Share into which the Preferred Share was converted or reclassified will equal such number of Ordinary Shares into which such Preferred Share is then convertible. |
7.2.4 | Adjustment of Conversion Price for Certain Splits, Dividends and Combinations. |
The applicable Conversion Price of each of the Preferred Shares shall be proportionately adjusted as set forth below:
(i) | Adjustments for Splits and Combinations. |
If the Company shall subdivide its Ordinary Shares, the applicable Conversion Price shall be proportionately decreased, so that the number of Ordinary Shares into which the Preferred Shares are convertible shall be increased in proportion to such increase in the aggregate number of Ordinary Shares. If the Company shall combine its Ordinary Shares, the applicable Conversion Price shall be proportionately increased, so that the number of Ordinary Shares into which the Preferred Shares are convertible shall be decreased in proportion to such decrease in the aggregate number of Ordinary Shares. Any adjustment under this subsection shall become effective as of the earlier of (i) the date such subdivision or combination becomes effective; or (ii) if the Company shall fix a record date for the purpose of so subdividing or combining, such record date.
(ii) | Recapitalizations. |
If at any time or from time to time the Ordinary Shares shall be changed into the same or a different number of shares of any other class or series of shares of the Company, whether by capital reorganization, reclassification or otherwise (other than a subdivision or combination of shares provided for elsewhere in this Article 7.2 or a merger or other reorganization referred to in Article 7.3 to the extent that such event is deemed to be a Deemed Liquidation), provision shall be made, concurrently with the effectiveness of such reorganization or reclassification, so that the holders of Preferred Shares shall thereafter be entitled to receive, upon conversion of their Preferred Shares and in lieu of the Ordinary Shares into which such Preferred Shares are convertible, such number of other class or series of shares of the Company, which a holder of such number of Ordinary Shares deliverable upon conversion immediately prior to such change would have been entitled to receive upon such change. In any such case, appropriate adjustment shall be made in the application of the provisions of this Article 7.2 with respect to the rights of the Preferred Shareholders and of the Preferred Shares after the recapitalization, to the end that the provisions of this Article 7.2 (including adjustment, if necessary, of the Conversion Price then in effect and the number of shares into which the Preferred Shares are convertible) shall be applicable after that event in a manner as nearly equivalent as may be practicable to the manner in which they were applied prior to such event.
(iii) | Adjustment for Certain Dividends and Distributions. If at any time or from time to time the Company shall make or issue, or fix a record date for the determination of holders of Ordinary Shares entitled to receive, a dividend or other distribution payable on the Ordinary Shares in additional Ordinary Shares, then and in each such event the Conversion Price in effect immediately before such event shall be decreased as of the time of such issuance or, in the event such a record date shall have been fixed, as of the close of business on such record date, by multiplying the Conversion Price then in effect by a fraction: |
(a) | the numerator of which shall be the total number of Ordinary Shares issued and outstanding immediately prior to the time of such issuance or the close of business on such record date; and |
(b) | the denominator of which shall be the total number of Ordinary Shares issued and outstanding immediately prior to the time of such issuance or the close of business on such record date plus the number of Ordinary Shares issuable in payment of such dividend or distribution. |
(c) | Notwithstanding the foregoing (a) if such record date shall have been fixed and such dividend is not fully paid or if such distribution is not fully made on the date fixed therefor, the Conversion Price shall be recomputed accordingly as of the close of business on such record date and thereafter the Conversion Price shall be adjusted pursuant to this subsection as of the time of actual payment of such dividends or distributions; and (b) that no such adjustment shall be made if the holders of the Preferred Shares simultaneously receive a dividend or other distribution of Ordinary Shares in a number equal to the number of Ordinary Shares as they would have received if all outstanding Preferred Shares had been converted into Ordinary Shares on the date of such event. |
(iv) | Adjustments for Other Dividends and Distributions. If at any time or from time to time the Company shall make or issue, or fix a record date for the determination of holders of Ordinary Shares entitled to receive, a dividend or other distribution payable in securities of the Company (other than a distribution of Ordinary Shares in respect of outstanding Ordinary Shares) or in other property and the provisions of Article 7.3 do not apply to such dividend or distribution, then and in each such event the holders of Preferred Shares shall receive, simultaneously with the distribution to the holders of Ordinary Shares, a dividend or other distribution of such securities or other property in an amount equal to the amount of such securities or other property as they would have received if all outstanding Preferred Shares had been converted into Ordinary Shares on the date of such event. |
7.2.5 | Adjustments to Conversion Price for Dilutive Issues. |
(i) | Special Definitions. For purposes of this sub-Article 7.2.5, the following definitions shall apply: |
(a) | “Options” shall mean rights, options or warrants to subscribe for, purchase or otherwise acquire either Ordinary Shares or Convertible Securities (as defined below). |
(b) | “Convertible Securities” shall mean any evidence of indebtedness, shares or other securities directly or indirectly convertible into or exchangeable for Ordinary Shares or Preferred Shares (not including Options). |
(c) | “Additional Shares” shall mean all Ordinary Shares issued (or, pursuant to Article 7.2.5(iv), deemed to be issued) by the Company after the Series E Closing (the “Series E Original Issue Date”) with the exception of the Excluded Securities. |
(ii) | Adjustment for the Conversion Price of Preferred Shares. |
If prior to the closing of a Public Event, the Company shall issue Additional Shares (including Additional Shares deemed to be issued pursuant to Article 7.2.5(iv)) without consideration or for a consideration per share less than the applicable Conversion Price of the Preferred Shares, in effect on the date of and immediately prior to such issuance, then in such event the applicable Conversion Price of the Preferred Shares shall be reduced, concurrent with such issuance, to a price equal to a fraction: (A) the numerator of which is the sum of: (1) the total number of Ordinary Shares outstanding, immediately prior to the issuance of such Additional Shares multiplied by the applicable Conversion Price of the Preferred Shares, in effect immediately prior to the issuance of such Additional Shares, plus (2) the total amount of the consideration received by the Company for such Additional Shares in such dilutive event, and (B) the denominator of which is the sum of: (1) the total number of Ordinary Shares outstanding immediately prior to the issuance of such Additional Shares, plus (2) the number of such Additional Shares issued in such dilutive event. For the purpose of the above calculation, the number of Ordinary Shares outstanding immediately prior to such issue of the Additional Shares shall be calculated on a fully diluted basis, treating for this purpose as issued and outstanding all Ordinary Shares issuable upon exercise of Options outstanding immediately prior to such issue or upon conversion or exchange of Convertible Securities (including the Preferred Shares) outstanding (assuming exercise of any outstanding Options therefor) immediately prior to such issue.
The formula can be expressed algebraically as follows:
P1 | = | (PxN) +C |
N+n |
where:
P = Conversion Price of the Preferred Shares immediately prior to the dilutive issuance.
P1 = New Conversion Price of the Preferred Shares after the dilutive issuance.
N = Total number of Ordinary Shares outstanding immediately prior to the dilutive issuance of Additional Shares (treating for this purpose as outstanding all Ordinary Shares issuable upon exercise of Options outstanding immediately prior to such issue or upon conversion or exchange of Convertible Securities (including the Preferred Shares) outstanding (assuming exercise of any outstanding Options therefor) immediately prior to such issue).
n = Number of Additional Shares issued in the dilutive issuance.
C = Total amount of consideration received by the Company for the
Additional Shares issued in the dilutive issuance.
(iii) | No Adjustment of Conversion Price. No adjustments of any Conversion Price shall be made in an amount less than one cent per share. |
(iv) | Deemed Issue of Additional Shares. In the event the Company at any time or from time to time after the Series E Closing Date shall issue any Option or Convertible Securities (excluding Options or Convertible Securities which are themselves Excluded Securities), which are themselves Additional Shares, or shall fix a record date for the determination of holders of any class of securities then entitled to receive any such Options or Convertible Securities, then the maximum number of shares (as set forth in the instrument relating thereto without regard to any provisions contained therein for a subsequent adjustment of such number (including provisions designed to protect against dilution) of Ordinary Shares issuable upon the exercise of such Options or, in the case of Convertible Securities and Options for Convertible Securities, the conversion or exchange of such Convertible Securities, shall be deemed to be Additional Shares issued as of the time of such issue or, in case such a record date shall have been fixed, as of the close of business on such record date, provided that in any such case in which Additional Shares are deemed to be issued: |
(a) | no further adjustment in the applicable Conversion Price shall be made upon the subsequent issue of Convertible Securities or shares of Ordinary Shares upon the exercise of such Options or conversion or exchange of such Convertible Securities, in each case, pursuant to their respective terms; |
(b) | if such Options or Convertible Securities by their terms (but excluding automatic adjustments to such terms pursuant to anti-dilution or similar provisions of such Options or Convertible Securities), provide, with the passage of time or otherwise, for any increase or decrease in the consideration payable to the Company, or decrease or increase in the number of Ordinary Shares issuable, upon the exercise, conversion or exchange thereof, the applicable Conversion Price computed upon the original issue thereof (or upon the occurrence of a record date with respect thereto), and any subsequent adjustments based thereon, shall, upon any such increase or decrease becoming effective, be recomputed to such Conversion Price as would have obtained had such increase or decrease been in effect upon the original date of issuance of such Options or Convertible Securities; |
(c) | upon the expiration of any such Options or any rights of conversion or exchange under such Convertible Securities which shall not have been exercised, the applicable Conversion Price computed upon the original issue thereof (or upon the occurrence of a record date with respect thereto), and any subsequent adjustments based thereon, shall, upon such expiration, be recomputed as if: |
(1) | in the case of Convertible Securities or Options for Ordinary Shares, the only Additional Shares issued were Ordinary Shares, if any, actually issued upon the exercise of such Options or the conversion or exchange of such Convertible Securities and the consideration received therefor was the consideration actually received by the Company for the issue of all such Options, whether or not exercised, plus the consideration actually received by the Company upon such exercise, or for the issue of all such Convertible Securities which were actually converted or exchanged, plus the additional consideration, if any, actually received by the Company upon such conversion or exchange; and |
(2) | in the case of Options for Convertible Securities, only the Convertible Securities, if any, actually issued upon the exercise thereof were issued at the time of issue of such Options, and the consideration received by the Company for the Additional Shares deemed to have been then issued was the consideration actually received by the Company for the issue of all such Options, whether or not exercised, plus the consideration deemed to have been received by the Company upon the issue of the Convertible Securities with respect to which such Options were actually exercised; |
(d) | [Reserved]. |
(e) | no readjustment pursuant to clauses (b) or (c) above shall have the effect of increasing the Conversion Price to an amount which exceeds the lower of (i) the applicable Conversion Price in effect immediately prior to the original adjustment made as a result of the issuance of such Options or Convertible Securities, or (ii) the applicable Conversion Price that would have resulted from other issuances of Additional Shares (other than deemed issuances of Additional Shares as a result of the issuance of such Option or Convertible Security) between the original adjustment date and such readjustment date. |
(v) | Determination of Consideration. For purposes of this Article 7.2, the consideration received by the Company for the issue of any Additional Shares shall be computed as follows: |
(a) | Cash and Property. Such consideration shall: |
(1) | insofar as it consists of cash, be computed at the aggregate amount of cash received by the Company excluding amounts paid or payable for accrued interest; |
(2) | insofar as it consists of property other than cash, be computed at the fair market value thereof at the time of such issue, as determined in good faith by the Board of Directors; and |
(3) | in the event Additional Shares are issued together with other shares or securities or other assets of the Company for consideration which covers both, be the proportion of such consideration so received, computed as provided in clauses (1) and (2) above, as determined in good faith by the Board of Directors. |
(b) | Options and Convertible Securities. The consideration per share received by the Company for Additional Shares deemed to have been issued pursuant to Article 7.2.5(iv), relating to Options and Convertible Securities, shall be determined by dividing (x) the total amount, if any, received or receivable by the Company as consideration for the issue of such Options or Convertible Securities, plus the minimum aggregate amount of additional consideration (in each case as set forth in the instrument relating thereto, without regard to any provision contained therein for any subsequent adjustment of such consideration) payable to the Company upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities, by (y) the maximum number of Ordinary Shares (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities, as determined in Article 7.2.5(iv) hereof. |
7.2.6 | Multiple Closing Dates. In the event the Company issues Additional Shares at more than one closing, as a part of one transaction or a series of related transactions, resulting in an adjustment to the Conversion Price pursuant to the terms of Article 7.2.5, then, upon the final such issuance, the Conversion Price shall be readjusted to give effect to all such issuances as if they occurred on the first closing (and without giving effect to any additional adjustments as a result of any such subsequent issuances within such period). |
7.2.7 | No Fractional Shares and Certificates as to Adjustments. |
(i) | No fractional shares shall be issued upon conversion of the Preferred Shares, and the number of Ordinary Shares to be issued shall be rounded up or down to the nearest whole share. All Ordinary Shares (including fractions thereof) issuable upon conversion of more than one Preferred Share by a holder thereof shall be aggregated for purposes of determining whether the conversion would result in the issuance of any fractional share. |
(ii) | Upon the occurrence of each adjustment or readjustment of the Conversion Price of Preferred Shares pursuant to this Article 7.2, the Company, at its expense, shall promptly compute such adjustment or readjustment in accordance with the terms hereof and prepare and furnish to each holder of Preferred Shares a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Company shall, upon the written request at any time of any holder of Preferred Shares furnish or cause to be furnished to such holder a like certificate setting forth (a) such adjustment or readjustment, (b) the Conversion Price of the Preferred Shares at the time in effect, and (c) the number of Ordinary Shares and the amount, if any, of other property which at the time would be received upon the conversion of a Preferred Share held by such holder. |
7.2.8 | Notices of Record Date. In the event of any taking by the Company of a record date for the purpose of determining the holders of any class of securities who are entitled to receive any dividend (including a cash dividend) or other distribution, any right to subscribe for, purchase or otherwise acquire any shares of any class or any other securities or property, or to receive any other right, the Company shall mail to each Preferred Shareholder, at least ten (10) days prior to the record date specified therein, a notice specifying the record date for the purpose of such dividend, distribution or right, and the amount and character of such dividend, distribution or right. |
7.2.9 | Reservation of Shares Issuable Upon Conversion. The Company shall at all times keep available out of its authorized but unissued Ordinary Shares, for the purpose of effecting the conversion of the Preferred Shares, such number of its Ordinary Shares as shall from time to time be sufficient to effect the conversion of all issued Preferred Shares according to the then applicable Conversion Price; and if at any time the number of authorized but unissued Ordinary Shares shall not be sufficient to effect the conversion of all then issued Preferred Shares, then the Company will take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued Ordinary Shares to such number of shares as shall be sufficient for such purposes. Without derogating from the aforesaid, in the event that in the opinion of the Company’s legal counsel, any conversion of Preferred Shares shall require additional Shareholders’ resolutions or consents, each Shareholder shall execute any such document and/or resolutions reasonably necessary to effectuate such conversion. |
7.2.10 | Conversion Effected by Reclassification. If applicable, conversion of the Preferred Shares may be effected by way of reclassification of the Preferred Shares into Ordinary Shares or issuance of additional Ordinary Shares, as shall be required by the conversion at the then existing conversion rate determined pursuant to Article 7.2.1. To the extent that any corporate action shall be required to effect the above, all Shareholders shall provide their affirmative vote to any such corporate action and execute any such document and/or resolutions reasonably necessary to effectuate the same. |
7.2.11 | Waiver. The anti-dilution rights provided to the Preferred Shares under this Article 7.2 shall not be waived without the prior written consent of the Preferred Majority, provided, however, that such waiver shall not apply to the Preferred E Shares, unless it includes the prior written consent of the Preferred E Majority. |
7.3 | Distribution Preference. |
In the event of (i) any dissolution, liquidation, bankruptcy or winding-up of the Company, or (ii) any distribution of cash or in kind to Shareholders of the Company (including dividends) (but excluding bonus shares distributed pro-rata to all shareholders), or (iii) a Deemed Liquidation of the Company (provided that with respect to the event described in subsection (iv) of the definition of “Deemed Liquidation”, the provisions of this Article 7.3 shall only apply to the Preferred Shares sold as part of such transaction) (each of (i), (ii) and (iii), a “Distribution Event”), then all dividends, assets or proceeds legally available for distribution to the Shareholders in such event (the “Distributable Proceeds”) shall be distributed among the Shareholders according to the following order of preference.
7.3.1 | Distribution Waterfall. |
(i) | First, each holder of Preferred E Shares shall be entitled to receive, on a pari passu basis with the other holders of Preferred E Shares, in respect of each Preferred E Share held by it, an amount per share equal to the higher of (A) its Original Issue Price (after adjustment pursuant to Article 7.2), plus cumulative interest at a rate of 7% per annum accruing from the applicable issue date of each such Preferred Share, compounded annually, plus an amount equal to all declared but unpaid dividends on each such Preferred E Share, less the amount of distributions, including any dividends, actually received in a prior Distribution Event which were paid on account of each such Preferred E Share (such amount, the “Preferred E Preference Amount”), prior and in preference to all other holders of shares of the Company; OR (B) the pro rata portion of the Distributable Proceeds such holder of Preferred E Shares would have received had all Preferred Shares which would have received a greater portion of the Distributable Proceeds on an as-converted basis been converted into Ordinary Shares pursuant to Article 7.2 immediately prior to such Distribution Event (for the avoidance of doubt, such calculation of the pro-rata amount shall be made with respect to the Distributable Proceeds after deducting the Preferred Preference Amount (as defined below), if any, previously distributed in accordance with this Article 7.3, if any, and shall exclude any Preferred Shares that received their Preferred Preference Amount) (such amount, the “Pro-Rata Amount”). If upon the occurrence of such Distribution Event, the Distributable Proceeds shall be insufficient to permit the full payment of the Preferred E Preference Amount, then the Distributable Proceeds shall be distributed ratably among all the holders of Preferred E Shares only, and in proportion to the preferential amounts such Shareholders would otherwise be entitled to receive as specified above. |
(ii) | Second, each holder of Preferred D Shares shall be entitled to receive, on a pari passu basis with the other holders of Preferred D Shares, in respect of each Preferred D Share held by it, an amount per share equal to the higher of (A) its Original Issue Price (after adjustment pursuant to Article 7.2), plus cumulative interest at a rate of 7% per annum accruing from the applicable issue date of each such Preferred Share, compounded annually, plus an amount equal to all declared but unpaid dividends on each such Preferred D Share, less the amount of distributions, including any dividends, actually received in a prior Distribution Event which were paid on account of each such Preferred D Share (such amount, the “Preferred D Preference Amount”), prior and in preference to all other holders of shares of the Company; OR (B) the portion of the Distributable Proceeds applicable Pro-Rata Amount of the holders of the Preferred D Shares. If upon the occurrence of such Distribution Event, the Distributable Proceeds, if any, remaining available for distribution following payment of the Preferred E Preference Amount shall be insufficient to permit the full payment of the Preferred D Preference Amount, then the Distributable Proceeds shall be distributed ratably among all the holders of Preferred D Shares only, and in proportion to the preferential amounts such Shareholders would otherwise be entitled to receive as specified above. |
(iii) | Third, each holder of Preferred C Shares shall be entitled to receive, on a pari passu basis with the other holders of Preferred C Shares, in respect of each Preferred C Share held by it, an amount per share equal to the higher of (A) its Original Issue Price (after adjustment pursuant to Article 7.2), plus cumulative interest at a rate of 7% per annum accruing from the applicable issue date of each such Preferred Share, compounded annually, plus an amount equal to all declared but unpaid dividends on each such Preferred C Share, less the amount of distributions, including any dividends, actually received in a prior Distribution Event which were paid on account of each such Preferred C Share (such amount, the “Preferred C Preference Amount”), prior and in preference to all other holders of shares of the Company; OR (B) the applicable Pro-Rata Amount of the holders of the Preferred C Shares. If upon the occurrence of such Distribution Event, the balance of the Distributable Proceeds, if any, remaining available for distribution following payment of the Preferred D Preference Amount, shall be insufficient to permit the full payment of the Preferred C Preference Amount, then the Distributable Proceeds shall be distributed ratably among all the holders of Preferred C Shares only, and in proportion to the preferential amounts such Shareholders would otherwise be entitled to receive as specified above. |
(iv) | Fourth, each holder of Preferred B Shares shall be entitled to receive, on a pari passu basis with the other holders of Preferred B Shares, in respect of each Preferred B Share held by it, an amount per share equal to the higher of (A) its Original Issue Price (after adjustment pursuant to Article 7.2), plus cumulative interest at a rate of 7% per annum accruing from the applicable issue date of each such Preferred Share, compounded annually, plus an amount equal to all declared but unpaid dividends on each such Preferred B Share, less the amount of distributions, including any dividends, actually received in a prior Distribution Event which were paid on account of each such Preferred B Share (such amount, the “Preferred B Preference Amount”), prior and in preference to all other holders of shares of the Company; OR (B) the applicable Pro-Rata Amount of the holders of the Preferred B Shares. If upon the occurrence of such Distribution Event, the balance of the Distributable Proceeds, if any, remaining available for distribution following payment of the Preferred D Preference Amount and the Preferred C Preference Amount, shall be insufficient to permit the full payment of the Preferred B Preference Amount, then the Distributable Proceeds shall be distributed ratably among all the holders of Preferred B Shares only, and in proportion to the preferential amounts such Shareholders would otherwise be entitled to receive as specified above. |
(v) | Fifth, each holder of Preferred A Shares and Preferred A-1 Shares (together, the “Remaining Preferred Shares”) shall be entitled to receive, on a pari passu basis with the other holders of the Remaining Preferred Shares, in respect of each Remaining Preferred Share held by it, an amount per share equal to the higher of (A) its Original Issue Price (after adjustment pursuant to Article 7.2), plus cumulative interest at a rate of 7% per annum accruing from the applicable issue date of each such Remaining Preferred Share, compounded annually, plus an amount equal to all declared but unpaid dividends on each such Remaining Preferred Share, less the amount of distributions, including any dividends, actually received in a prior Distribution Event which were paid on account of each such Remaining Preferred Share (such amount, the “Remaining Preferred Shares Preference Amount” and together with the “Preferred E Preference Amount, ” “Preferred D Preference Amount”, the “Preferred C Preference Amount” and “Preferred B Preference Amount”, the “Preferred Preference Amount”), prior and in preference to all holders of Ordinary Shares of the Company; OR (B) the applicable Pro-Rata Amount of the holders of the Remaining Preferred Shares. If upon the occurrence of such Distribution Event, the balance of the Distributable Proceeds, if any, remaining available for distribution following payment of the Preferred E Preference Amount, Preferred D Preference Amount, the Preferred C Preference Amount and the Preferred B Preference Amount, shall be insufficient to permit the full payment of the Remaining Preferred Shares Preference Amount, then the remaining Distributable Proceeds shall be distributed ratably among all the holders of the Remaining Preferred Shares only, and in proportion to the preferential amounts such Shareholders would otherwise be entitled to receive as specified above. |
(vi) | Sixth, following payment to the holders of the Preferred Shares their Preferred Preference Amount or their Pro-Rata Amount, in full, as applicable, according to this Article 7.3 above, the remaining Distributable Proceeds available for distribution (if at all) shall be distributed among the holders of Ordinary Shares (excluding, for greater certainty, any Ordinary Shares issued upon the conversion of Preferred Shares who received their Preferred Preference Amount or the Pro-Rata Amount, as applicable, pursuant to Articles 7.3.1(i), 7.3.1(ii), and 7.3.1(iii) and 7.3.1(iv) above) on a pro rata basis in proportion to the number of Ordinary Shares held by the respective holders thereof. |
7.3.2 | Whenever the distribution provided for in this Sub-article shall be payable in securities or property other than cash, the value of such distribution shall be the fair market value of such securities or property as determined in such Distribution Event, and if not so determined, as determined in good faith by the Board (or by the liquidator in the case of winding up). |
7.3.3 | In the event of any taking by the Company of a record of the holders of any class of securities for the purpose of determining the holders thereof who are entitled to receive any dividend (including a cash dividend) or other distribution, any right to subscribe for, purchase or otherwise acquire any Shares of any class or any other securities or property, or to receive any other right, the Company shall mail to each Preferred Shareholder and/or Ordinary Shareholder, respectively, at least ten (10) days prior to the date specified therein, a notice specifying the date on which any such record is to be taken for the purpose of such dividend, distribution or right, and the amount and character of such dividend, distribution or right. |
8. | Special Rights; Modification of Rights |
Subject to the provisions of these Articles, including, without limitation, Article 41, and subject further to the Companies Law, the Company may issue shares with such preferred or deferred rights or issue from its unissued capital, if such exists, redeemable preferred shares, shares with limited or special rights, limited or preferred rights to dividends or limited or preferred voting or other rights as the Company may decide from time to time.
8.1 | Subject to any other special majority requirement in these Articles, including, without limitation, pursuant to Article 41, if at any time the share capital is divided into different classes of shares, the Company may modify, convert, broaden, add or otherwise alter the rights, privileges, advantages, restrictions and provisions related at that time to the shares of any class by a resolution passed at a general meeting of the holders of all the Shares as one class notwithstanding the provisions of Section 20(c) of the Companies Law, and subject to any other special majority or consent requirement in these Articles, including, without limitation, pursuant to Article 41, the holders of the Ordinary Shares, the Preferred Shares and any other class of preferred shares, shall not be entitled to any class vote, except with respect to direct and adverse changes of the rights attached to such shares under the Articles (provided that for the purpose of any such class vote, the Preferred A Shares and the Preferred A-1 Shares shall be treated and vote together as one class). It is hereby clarified that any resolution explicitly required to be adopted pursuant to these Articles by the consent of a separate class of shares, whether by way of a separate general meeting of such class or by way of written consent, shall be given by the holders of shares of such class entitled to vote or give consent thereon and no holder of shares of a certain class shall be banned from voting or consenting by virtue of being a holder of more than one class or series of shares of the Company, irrespective of any conflicting interests that may exist between such different classes of shares. A Shareholder shall not be required to refrain from participating in the discussion, voting and/or consenting on any resolution concerning an amendment to any class or series of shares held by such Shareholder, due to the fact that such Shareholder may benefit in one way or another from the outcome of such resolution. |
8.2 | The provisions of these Articles relating to general meetings and to the convening thereof and to notices in respect thereof and to resolutions to be passed thereat shall, mutatis mutandis, apply to every separate general meeting as mentioned above. |
8.3 | Unless otherwise provided by these Articles, including, without limitation, Article 41, (a) the enlargement or increase of the authorized or issued share capital of an existing class of shares, or the issuance of additional shares thereof, (b) the creation of any new class of shares (including a new class of shares which confer one or more rights, preferences or privileges which are superior to any right, power, preference or privilege of one or more other existing classes or series of shares of the Company or pari passu with such other classes), or the issuance of shares thereof, and (c) a waiver or a change, in whole or in part, to a right, preference or privilege of a class of shares (such as liquidation rights, anti-dilution rights, registration rights, pre-emptive rights, etc., whether set forth in these Articles or in any agreement), whether applied on a one-time or permanent basis and whether applied in connection with a current or a future event, which waiver or change is applied in the same manner to all classes of shares to which such waiver or change is or may be applicable, regardless of whether the economic effect of such change affects classes of shares differently ; shall not be deemed to be a direct and adverse change to the rights, preferences or privileges attached to any one (1) class or series of shares. Furthermore, any waiver or change to the rights attached to a class of shares shall not be deemed to be a direct change to the rights attached to any other class of shares. The aforementioned shall not derogate from Article 41 to the extent applicable. |
8.4 | All Shares held by two or more Shareholders who are Affiliates of one another shall be aggregated together for the purpose of determining the availability of any rights under these Articles for such Shareholders, including rights which are conditioned on the relevant Shareholder holding Shares representing a minimum percentage, etc. |
9. | Alteration of Share Capital. |
9.1 | Subject to any other special majority requirement in these Articles, including, without limitation, pursuant to Article 41 and any other provision hereof conferring special rights as to voting, or restricting the right to vote, the Company may from time to time, by a Shareholders Resolution, whether or not all the shares authorized have been issued, and whether or not the whole of the Shares then issued has been called up for payment, increase its share capital by the creation of new Shares, and such increase shall be in such amount and shall be divided into Shares of such nominal amounts, and be issued subject to such restrictions and terms and with such rights and preferences, as the resolution creating the same shall provide, and in particular the Shares may be issued with preferential or deferred rights as to dividends or the distribution of assets and with special, limited or no voting rights. |
9.2 | Unless otherwise provided in the resolution authorizing the increase of share capital, the new Shares shall be subject to the same provisions applicable to the Shares of the original capital with regard to the payment of calls, lien, forfeiture, transfer, transmission and otherwise. |
10. | Consolidation; Subdivision; Cancellation and Reduction of Share Capital. |
10.1 | Subject to any other special majority requirement in these Articles, including, without limitation, pursuant to Article 41 below, the Company may, by a Shareholders Resolution and in accordance with and subject to the Companies Law: |
10.1.1 | Consolidate its share capital or any portion thereof and divide it into Shares of larger nominal value than its existing Shares; |
10.1.2 | Divide its existing Shares or any portion thereof by subdivision into Shares of smaller nominal value; |
10.1.3 | Cancel any unissued Shares provided there is no obligation of the Company, including a contingent obligation, to issue the Shares, and reduce in such manner its share capital by the amount of the Shares which were cancelled; |
10.1.4 | Reduce its share capital in any manner permitted by law and subject to any condition required by law; |
10.1.5 | Convert part of its issued and paid-up Shares into deferred shares. |
10.2 | With respect to any consolidation of issued Shares into Shares of larger nominal value, and with respect to any other action which may result in fractional shares, the Board of Directors may settle any difficulty which may arise with regard thereto, as it deems fit, including, inter alia, resort to one or more of the following actions, subject to applicable law: |
10.2.1 | Determine, as to the holder of Shares so consolidated, which issued Shares shall be consolidated into each Share of larger nominal value; |
10.2.2 | Allot, in contemplation of or subsequent to such consolidation or other action, such Shares or fractional shares sufficient to preclude or remove fractional share holdings; |
10.2.3 | Redeem in the case of redeemable Shares, and subject to applicable law, such Shares or fractional Shares sufficient to preclude or remove fractional share holdings; and |
10.2.4 | Cause the transfer of fractional Shares by certain Shareholders of the Company to other Shareholders thereof so as to most expediently preclude or remove any fractional shareholdings, and cause the transferees to pay the transferors the fair value of fractional Shares so transferred, and the Board of Directors is hereby authorized to act as agent for the transferors and transferees with power of substitution for purposes of implementing the provisions of this Article. |
SHARES
11. | Allotment of Shares. |
Subject to and in addition to any other special majority requirement in these Articles, including, without limitation, pursuant to Article 41, to the extent applicable, the Shares other than the issued and outstanding Shares, shall be under the control of the Board of Directors who may issue or allot them or give any person the option to acquire them or otherwise dispose of them for cash or other consideration to such persons, on such terms and conditions, and either at a premium or at par, or, subject to the provisions of the Companies Law, at a discount and at such times as the Board of Directors may deem fit, and with full authority to serve on any person a call on any Shares either at par or at a premium, or, subject as aforesaid, at a discount, during such time and for such consideration as the Board of Directors may deem fit.
12. | Pre-Emptive Rights. |
12.1 | Prior to the consummation of a Public Event, if the Company proposes to issue or sell any New Securities, the Company shall grant, prior to such issuance, to each Preferred Shareholder and to each Founder, each holding at least the Minimum Share Threshold (each, an “Entitled Holder”) the right to purchase its pro-rata share of the New Securities. An “Entitled Holder’s pro-rata share”, for purposes of this Article, is the ratio of the number of Ordinary Shares held by such Entitled Holder immediately prior to the issuance of the New Securities (on an as converted basis) in relation to the total number of all Ordinary Shares issued and outstanding (on an as converted basis) and held by all the Entitled Holders immediately prior to the issuance of New Securities. Each Entitled Holder shall also have a right of over-allotment (the “Overallotment Right”) such that if any other Entitled Holder declines or fails to exercise its right hereunder to purchase its pro-rata share of the New Securities, each other Entitled Holder exercising its preemptive right hereunder in full, may purchase such declining Entitled Holder’s portion, on a pro-rata basis to those Entitled Holders exercising their right of over-allotment and shall indicate its intention in its notice to the Company referred to below. |
12.2 | In the event the Company proposes to issue New Securities, it shall give each Entitled Holder written notice of its intention, describing the type of New Securities, their price and the general terms upon which the Company proposes to issue the same (the “Offer”). Each Entitled Holder shall have fourteen (14) days after such notice is mailed or delivered to elect to purchase its pro rata share of such New Securities and any additional Shares as may be available for overallotment, upon the terms and conditions specified in the notice, by giving binding written notice to the Company and stating therein the maximum amount of New Securities elected to be purchased (the “Subscription Notice”). |
12.3 | An Entitled Holder who shall not have given a Subscription Notice within the said fourteen (14)-day period shall be conclusively deemed to have rejected the Offer to him/it. A qualified or conditional acceptance of an Offer shall be conclusively deemed a rejection thereof. |
12.4 | In the event the Entitled Holders fail to exercise fully the preemptive right within the said fourteen (14) days period, the Company shall have ninety (90) days thereafter to sell to any third party, the remainder of the New Securities with respect to which the Entitled Holders’ preemptive right was not exercised, at a price and upon terms no more favorable to the purchasers thereof than specified in the Company’s notice to the Entitled Holders. In the event the Company has not sold the New Securities within the ninety (90) days period, the Company shall not issue or sell any New Securities without first complying with the provisions of this Article 12. |
12.5 | The preemptive rights under this Article 12 may be assigned by each Entitled Holder to its applicable Permitted Transferees. The preemptive rights under this Article 12 may be assigned by each Founder to his Permitted Transferee; provided that such Permitted Transferee shall execute, upon exercise of such preemptive rights, an irrevocable proxy in a form approved by the Board with respect to the securities purchased upon such exercise, granting such Founder full and complete irrevocable authority to vote all such securities until an IPO. |
12.6 | The provisions of Section 290 of the Companies Law shall not apply to the Company. |
12.7 | The Overallotment Right may be waived by a resolution of the Shareholders of the Company holding the majority of the issued and outstanding share capital of the Company, which majority includes the Preferred Majority, provided, however that the Shareholders consenting in writing to the waiver of the Overallotment Right shall not participate, directly or indirectly (including through any person controlled by the waiving Shareholders or any Permitted Transferee thereof), in an offering of that portion of New Securities, in connection with which it consented to such waiver of the Overallotment Right, above its pro-rata share (in accordance with Article 12.1 above). It is clarified that the limitations on the ability to waive the Overallotment Right provided for in this Article 12.7 do not apply to an investment by any entities belonging to the Viola Group, other than any entities investing under the “Carmel” name or the “Viola Ventures” or the “Viola 4 P, Limited Partnership,” name, regardless of whether such entities change their names in the future. |
12.8 | Notwithstanding the foregoing, if the implementation of the provisions of this Article 12 may, in the opinion of the Company’s counsel, constitute an offer to the public under applicable laws which is subject to prospectus requirements, then the preemptive right pursuant to this Articles 12 shall be in effect only in respect of such number of offerees which shall not require the preparation of a prospectus (in accordance with applicable law), and the offerees for such purpose shall be: (i) the type of offerees the offering to which is exempted from such prospectus requirements, and (ii) such Entitled Holders who are entitled to purchase the largest pro rata portion among all those Entitled Holders eligible to participate in the offer under this Article 12, not including and in addition to the offerees under clause (i), the offering to which is exempted from such prospectus requirements. |
12.9 | The Company acknowledges that under applicable Israeli law or regulation relating to the regulation of Israeli provident funds and pension funds (as may be amended, the “Regulations”) (a) the aggregate holdings of all the Clal Pension Funds in the Company may not exceed twenty percent (20%) of the issued and outstanding share capital of the Company, and the aggregate holdings of all Israeli provident funds in the Company may not exceed, in the aggregate, fifty percent (50%) of issued and outstanding share capital of the Company, without the loss of tax exempt status (the aforesaid 20% and/or 50% limitations, the “Tax Holding Limitations”), and (b) the aggregate holdings of the Clal Pension Funds in the Company may not exceed forty-nine percent (49%) of the issued and outstanding share capital of the Company without a breach of regulatory requirements (such 49% limitation, the “Regulatory Holding Limitation”). Therefore, for so long as and to the extent that: (i) the Regulations prohibit any deviation above the Tax Holding Limitations, and absent an appropriate tax ruling, or (ii) the Regulations prohibit any deviation above the Regulatory Holding Limitation, then each of the cases in (i) and (ii), the Company (a) shall promptly notify the Clal Pension Funds in writing regarding any expected deviation above the Tax Holding Limitations and the Regulatory Holding Limitation, other than any such deviation as a result of any actions of Clal Pension Funds, (b) shall not consummate any transaction in which the Company shall repurchase or redeem its own shares, without providing the Clal Pension Funds with a prior written notice of at least 30 days; and (c) the Board of Directors shall not unreasonably withhold its consent to any such transfer of shares of the Clal Pension Funds’ holdings in the Company to the extent necessary for the Clal Pension Funds to be in compliance with the Regulations and register such transfer of shares, all subject to the provisions of these Articles, including Article 24. |
12.10 | The Company acknowledges that under applicable law or regulation, the aggregate combined holdings of SCB in the Company may not exceed ten percent (10%) of the issued and outstanding share capital of the Company without a breach of such regulatory requirements (such 10% limitation, the “SCB Holding Limitation”). Therefore, for so long as and to the extent that the applicable regularity regulations prohibit any deviation above the SCB Holding Limitation, the Company (a) shall promptly notify SCB in writing regarding any expected deviation above the SCB Holding Limitation, other than any such deviation resulting from any actions of SCB, (b) shall not consummate any transaction in which the Company shall repurchase or redeem its own shares, without providing SCB with a prior written notice of at least 30 days; and (c) the Board of Directors shall not unreasonably withhold its consent to any such transfer of shares of SCB’s holdings in the Company to the extent necessary for SCB to be in compliance with the applicable regulations and register such transfer of shares, all subject to the provisions of these Articles, including Article 24. |
13. | Payment of Installments. |
If by the conditions of allotment of any Share, the whole or any part of the price thereof shall be payable by installments, every such installment shall, when due, be paid to the Company by the registered holder of the Share for the time being or from time to time or by his administrators.
14. | Registered Holder. |
Save as herein otherwise provided, the Company shall be entitled to treat the registered holder of any Share as the absolute owner thereof, and, accordingly, shall not, except as ordered by a court of competent jurisdiction, or as by statute required, be bound to recognize any equitable or other claim to or interest in such Share on the part of any other person and the Company shall not be bound by or required to recognize any equitable, contingent, future or partial interest in any Shares or any right whatsoever in respect of any Shares other than an absolute right to the entirety thereof in the registered holder.
15. | Share Certificates. |
15.1 | The certificates of title to Shares (“Share Certificates”) shall be issued under the seal or the rubber stamp of the Company and shall bear the signatures of one Director, or such other person or persons as are authorized by the Board of Directors. |
15.2 | Every Shareholder shall be entitled to one Share Certificate for all the Shares registered in his name, and if the Board of Directors so approves (upon payment of the amount which may from time to time be fixed by the Board of Directors), to several Share Certificates each for one or more such Shares. |
A Share Certificate of Shares registered in the names of two or more persons shall be delivered to the person first named on the Register in respect of such co-ownership.
15.3 | If a Share Certificate is defaced, lost or destroyed, it may be renewed on payment of such fee, if any, and on such terms as to evidence and indemnity, as the Board of Directors thinks fit. |
16. | Calls on Shares. |
16.1 | The Board of Directors may from time to time make such calls as it deems fit upon the Shareholders in respect of all moneys unpaid (according to their terms of issuance or agreement with the Company) on the Shares held by them respectively, and by the conditions of allotment thereof not made payable at fixed times, and each Shareholder shall pay the amount of every call so made on him to the persons and at the time and place appointed by the Board of Directors. A call may be made payable by installments, and shall be deemed to have been made when the resolution of the Board of Directors authorizing such call was passed. |
16.2 | No less than fourteen (14) days’ notice of any call shall be given in writing, specifying the time and place of payment, and to whom such call shall be paid, provided that before the time for payment of such call the Board of Directors may, by notice in writing to the Shareholders, revoke the same or extend the time for payment thereof. |
16.3 | The joint holders of a Share shall be jointly and severally liable to pay all calls in respect thereof. |
16.4 | If by the terms of issue of any Share or otherwise any amount is made payable at any fixed time or by installments at fixed times, whether on account of the nominal value of the Share or by the way of premium, every such amount or installment shall be payable as if it were a call duly made by the Board of Directors of which due notice had been given, and all the provisions herein contained in respect of such calls shall apply to such amount or to such installment. |
16.5 | If the amount of any call or installment is not paid on or before the due date for payment thereof, then the person who is for the time being the owner of the Share on which the call was made or the installment became due, shall pay interest on the said amount at the maximum rate permissible under law for the time being, or at such lesser rate as may be fixed by the Board of Directors from time to time, as from the date of payment until the same is actually paid. The Board of Directors shall, however, be at liberty to waive the payment of interest, wholly or in part. No Shareholder shall be entitled to receive any dividend or to exercise any privileges as a Shareholder until he shall have paid all calls for the time being due and payable on every share held by him whether alone or jointly with any other person together with interest and expenses (if any). |
17. | Prepayment. |
If the Board of Directors deems fit, it may receive from any Shareholder willing to advance the same, any amounts due on account of all or any of his shares which have not yet been called or in respect of which the date of payment has not yet fallen due, and, unless otherwise agreed with such Shareholder, the Board of Directors may pay him interest on all or any of the amounts so advanced, up to the date when same would, if not paid in advance, have fallen due, at such rate of interest as may be agreed upon between the Board of Directors and such Shareholder, and the Board of Directors may at any time repay any amount so advanced by giving such Shareholder a seven days’ prior notice in writing.
18. | Forfeiture of Shares. |
18.1 | If any Shareholder fails to pay any call or installment on or before the day appointed for payment of the same, the Board of Directors may at any time thereafter, subject to the provisions of Section 181 of the Companies Law, as long as the said call or installment remains unpaid, resolve to forfeit all or any of the Shares in respect to which the call had been made, in the event the Shareholder does not pay the same, as provided below, together with any interest that may have accrued and all expenses that may have been incurred by reason of attempting to collect any such non-payment. |
18.2 | Notice of any such resolution shall be served on the Shareholder. The notice shall name a day (being not less than fourteen (14) days from the date of the notice and which may be extended by the Board of Directors) and a place or places on and at which such call or installment and such interest and expenses as aforesaid are to be paid. The notice shall also state that in the event of non-payment at or before the time and at the place appointed, the Shares in respect of which the call was made or installment is payable will be ipso facto forfeited, save Shares that have been fully paid for. |
18.3 | Any forfeiture as aforesaid shall include all dividends declared in respect of the forfeited Shares and not actually paid before the forfeiture. |
18.4 | Any Share so forfeited shall be the property of the Company, subject to Section 308 of the Companies Law, and the Board of Directors may, subject to the provisions hereof, sell, re-allot and otherwise dispose of the same as it may deem fit. |
18.5 | The Board of Directors may at any time, before any Share so forfeited shall have been sold, re-allotted or otherwise disposed of, annul the forfeiture on such conditions as it deems fit. No such annulment shall stop the Board of Directors from re-exercising its powers of forfeiture pursuant to these Articles. |
18.6 | Any Shareholder whose Shares have been forfeited shall cease to be a Shareholder in respect of the forfeited Shares, but shall, notwithstanding, be liable to pay, and shall forthwith pay, to the Company, all calls, installments, interest and expenses owing upon or in respect of such Shares at the time of forfeiture, together with interest thereon from the time of forfeiture, until payment, at the maximum rate of interest permissible under law for the time being, and the Board of Directors may enforce the payment of such moneys, or any part thereof, if it so thinks fit, but shall not be under any obligation to do so. |
18.7 | The provisions of these Articles relating to forfeiture shall apply to any case of nonpayment of a known sum which, according to the terms of issue or allotment of the Share, is payable at any fixed time, whether on account of the nominal value of the Share or by way of premium, as if such a sum were payable under a call duly made, notified and delivered. |
19. | Lien. |
19.1 | Except to the extent that the same may be waived or subordinated in writing, the Company shall have a first and paramount lien upon all the Shares registered in the name of each Shareholder (without regard to any equitable or other claim or interest in such Shares on the part of any other person), and upon the proceeds of the sale thereof, for his debts, liabilities and obligations to the Company arising from any amount payable by such Shareholder in respect of any unpaid or partly paid Share. Such lien shall extend to all dividends from time to time declared or paid in respect of such Share. Unless otherwise decided, the registration by the Company of a transfer of Shares shall be deemed to be a waiver on the part of the Company of the lien (if any) on such Shares, immediately prior to such transfer. |
19.2 | For the purpose of enforcing such lien, the Board of Directors may sell the Shares subject thereto in such manner as it deems fit; but no sale shall be made until the period for the fulfillment or discharge of the debts, liabilities and engagements as aforesaid shall have arrived, and until notice in writing of the Company’s intention to sell shall have been served on such Shareholder, his executors or administrators, and the payment, fulfillment or discharge of such debts, liabilities or engagements is not made during the seven days after such notice. |
19.3 | The net proceeds of any such sale, after payment of the costs thereof, shall be applied in or towards satisfaction of the debts, liabilities or engagements of such Shareholder (including debts, liabilities and engagements which have not yet fallen due for payment or satisfaction) and the remainder (if any) shall be paid to the Shareholder, his executors, administrators or assigns. |
20. | Sale after Forfeiture or for Enforcement of Lien. |
Upon any sale after forfeiture or for enforcing a lien in exercise of the powers hereinbefore given, the Board of Directors may appoint some person to execute an instrument of transfer of the Shares sold and cause the purchaser’s name to be entered in the Register in respect of the Shares sold, and the purchaser shall not be bound to see to the regularity of the proceedings, or to the application of the purchase money, and after his name has been entered in the Register in respect of such Shares, the validity of the sale shall not be impeached by any person, and the remedy of any person aggrieved by the sale, if grounds for any remedy exist in accordance with law, shall be in damages only and against the Company exclusively.
21. | Redeemable Shares. |
The Company may, subject to the provisions of the Companies Law, issue redeemable Shares and redeem them.
22. | Purchase of the Company’s Shares. |
The Company may, subject to and in accordance with the provisions of the Companies Law and these Articles, purchase or undertake to purchase, or provide finance and/or assistance or undertake to provide finance and/or assistance, directly or indirectly, with respect to the purchase of, its Shares or securities which may be converted into Shares of the Company or which confer rights upon the holders thereof to purchase Shares of the Company.
23. | Borrowing Powers. |
Subject to the provisions of these Articles, the Board of Directors may from time to time, at its discretion, borrow or secure the payment of any sum or sums of money for the purposes of the Company. The Directors may raise or secure the repayment of such sum or sums in such manner, at such times and upon such terms and conditions in all respects as they think fit, and in particular, by the issue of bonds, perpetual or redeemable debentures, debenture stock, or any mortgages, charges, or other securities on the undertaking of the whole or any part of the property of the Company, both present and future, including its uncalled capital for the time being and its called but unpaid capital.
TRANSFER AND TRANSMISSION OF SHARES.
24. | Effectiveness and Registration. |
24.1 | Any transfer of Shares of the Company, except for Permitted Transfers (other than to a Permitted Transferee who is a Forbidden Transferee (as defined below), will be subject to the approval of the Board of Directors, which shall not be unreasonably withheld and shall be provided in reasonable promptness, provided the transfer is made in accordance with the provisions of Articles 24 to 25. In addition, the Company shall be entitled to reject a transfer of Shares if the transfer is (i) to a person who has been convicted of a criminal offense involving moral turpitude or who is a competitor of the Company, or (ii) to an entity controlled or managed by a person described in clause (i) (persons described in clauses (i) and (ii) are referred to herein as a “Forbidden Transferee”). |
24.2 | No transfer of Shares shall be approved or registered unless a proper instrument of transfer has been submitted to the Company (or its transfer agent) together with the Share Certificate for the transferred Shares (if such has been issued) and with any other evidence the Board of Directors may require in order to prove to its satisfaction the rights of the transferor in the transferred Shares. Subject to the transfer limitations set forth in these Articles, a Shareholder shall not make any transfer of the Shares, unless (i) such transfer is in compliance with these Articles, as shall be amended from time to time and any other agreement governing the subject matter and to which the transferring Shareholder is subject, as shall be from time to time; and (ii) such transferee undertook in advance in writing to be bound by and to be subject to the terms and conditions of the Articles of Association as shall be amended from time to time and any other agreement governing the subject matter and to which the transferring Shareholder is subject, as shall be from time to time, as if it was an original party thereunder. |
24.3 | The instrument of transfer shall be signed by the transferor and the transferee, shall be duly stamped, if required by law, and the transferor shall be considered the owner of the Shares until the transferee is registered in the Register in respect of the Shares transferred to him. The instrument of transfer of any Share shall be in writing in the following form or as near thereto as possible, or in a usual or accepted form that shall be approved by the Board of Directors: |
“I ___________ of ____________ (the “Transferor”) in consideration of the sum of _____________ paid to me by _____ of _______ (the “Transferee”) hereby transfer to the Transferee shares of NIS 0.01 each, denoted by numbers __________ to _________ (both inclusive) of PAGAYA TECHNOLOGIES LTD., to be held by the Transferee, the executors and administrators of his estate, his custodian and his legal personal representative, under the same conditions under which I myself held them immediately prior to signing this instrument of transfer, and I, the Transferee, hereby agree to accept the above mentioned Shares in accordance with the above mentioned conditions.
IN WITNESS THEREOF we hereby affix our signatures this ______ day of ______ 20_.
The Transferor | The Transferee” |
24.4 | The Board of Directors may suspend the registration of transfers during the fourteen (14) days immediately preceding the ordinary general meeting in each year. |
24.5 | Instruments of transfer that are registered shall remain in the Company’s possession; however, instruments of transfer which the Board of Directors refuses to register in accordance with this Article, shall be returned, on demand, to whomever delivered them along with the Share Certificate (if delivered). |
24.6 | The executors and administrators of a deceased sole holder of a Share, or, if there are no executors or administrators, the persons beneficially entitled as heirs of a deceased sole holder, shall be the only persons recognized by the Company as having any title to the Share. In case of a Share registered in the names of two or more holders, the Company shall recognize the survivor or survivors as the only persons having any title to or benefit in the Share. Nothing herein contained shall release the estate of a deceased joint holder from any liability in respect of any Share jointly held by him. |
24.7 | Any person becoming entitled to a Share in consequence of the death of any person, upon producing evidence of the grant of probate or letters of administration or declaration of succession or such other evidence as the Board of Directors may deem sufficient that he sustains the character in respect of which he proposes to act under this Article or of his title, shall be registered as a Shareholder in respect of such shares, or may, subject to the regulations as to transfer herein contained, transfer such Shares. |
24.8 | The Company may recognize the receiver or liquidator of any Shareholder in winding-up or dissolution, or the trustee in bankruptcy or any official receiver of a bankrupt Shareholder as being entitled to the Shares registered in the name of such Shareholder. |
24.9 | The receiver or liquidator of a Shareholder in winding-up or dissolution, or the trustee in bankruptcy, or any official receiver of any bankrupt Shareholder, upon producing such evidence as the Board of Directors may deem sufficient that he sustains the character in respect of which he proposes to act under this Article or of his title, may, with the consent of the Board of Directors (which the Board of Directors may refuse to grant without giving any reason for its refusal), be registered as a Shareholder in respect of such Shares, or may, subject to the regulations as to transfer herein contained, transfer such Shares. |
24.10 | A person upon whom the ownership of a Share devolves by transmission shall be entitled to receive, and may give a discharge for any dividends or other monies payable in respect of the Share but he shall not be entitled in respect of it to receive notices, or to attend or vote at meetings of the Company, or, save as otherwise provided herein, to exercise any of the rights or privileges of a Shareholder unless and until he shall be registered in the Register. |
25. | Right of First Refusal. |
Dispositions, including Dispositions by the Founders, shall be subject to the Right of First Refusal set forth in this Article 25.
25.1 | The term “Disposition” shall mean any sale, assignment, transfer, pledge, charge or other encumbrance or other dispositions; provided, however, that, a Founder may pledge up to fifty percent of his Shares for purposes of securing personal indebtedness in the form of mortgages, margin loans, or securities lending arrangements; provided that in any event such Shares are not voted by lender and lender shall not have recourse to dispose of the Shares on a default without such pledge being deemed a “Disposition.” |
25.2 | The term “Permitted Transferee” means (A) with respect to a Shareholder: (i) any member of such Shareholder’s immediate family (i.e., parents, spouse, siblings and children) (“Family Members”) and with respect to any Founder any transfer shall be limited to 50% of such Founder’s holdings as of the Series D Closing; (ii) a trustee whose sole beneficiaries are such Shareholder or his Family Members; (iii) any entity wholly owned by such Shareholder; (iv) a trustee by will or operation of law; and (v) a vehicle created for tax planning or trust and estate purposes the beneficiary of which is or the Controlling party of which is the Shareholder, (B) in addition, as to each Investor (i) limited or general partnerships (and the general or limited partners thereof) managed directly or indirectly by the same management company or the same managing general partner or any entity which Controls, is Controlled by, or is under common Control with the Investor; limited or general partnerships (and the general or limited partners thereof) managed directly or indirectly by an Affiliate of the management company or the managing general partner of the general or limited partnership in question (e.g. managed by general partners which are under similar Control as the general partner of such Investor); and (ii) transferees that become transferees either (x) in a Disposition of the entire shareholdings of the Investor in the Company which are part of a Disposition of a significant portion of portfolio of investments, (y) a Disposition in connection with the dissolution of the Investor, or (z) a Disposition resulting from a regulatory or tax constraint applicable to the Investor or any of the partners in the Investor, in all cases, other than pursuant to subsection (B)(ii) above, the transfer to the Permitted Transferee shall be possible, only provided that (i) such Permitted Transferee shall remain within the definition of Permitted Transferee, and that the transferor undertakes to reacquire the transferred securities in the event that such Permitted Transferee ceases to be deemed a Permitted Transferee of such transferor; and (ii) a Permitted Transferee of a transferee who received its/his shares from the transferor in a Permitted Transfer (the “Original Transferor”) shall only be deemed a Permitted Transferee under this definition, to the extent that he/it is a Permitted Transferee of the Original Transferor; (C) in addition, as to Clal, (x) reputable transferees which are not competitors of the Company, that become transferees of Clal in a Disposition of the entire interest in a pension and/or provident fund (the “Fund”) managed by Clal Insurance Company Ltd. and/or its Affiliates, which interest includes all the investments of the Fund, including the shareholdings in the Company; (D) in addition, as to Viola 4 P, Limited Partnership, the general or limited partners of Viola 4 P, Limited Partnership and their Affiliates.; (E) in addition, as to [Tiger], the general or limited partners of [Tiger] and their Affiliates. |
25.3 | The term “Permitted Transfer” means a transfer to a Permitted Transferee; subject to any terms and conditions contained in these Articles and any ancillary agreement with respect to the transferred securities to which the transferor or the transferee is a party and; provided that a transfer of any share pursuant to this Article 25.3 shall only be treated as a Permitted Transfer if the transferee agrees in writing to be bound by the terms and conditions of these Articles and any ancillary agreement with respect to the transferred securities to which the transferor or the transferee is a party; and provided further that any transfer by a Founder to a Permitted Transferee shall be effected only if such Permitted Transferee executes, upon such transfer and as a condition thereto, an irrevocable proxy in a form approved by the Board with respect to the transferred securities granting the Founder full and complete irrevocable authority to vote all the securities so transferred until a Public Event. |
25.4 | Except for Permitted Transfers in accordance with Article 25.3, if at any time prior to a Public Event, a Shareholder (in these Articles 25 and 26, the “Selling Shareholder”) desires to effect a Disposition of any or all of his or its Shares (the “Offered Shares”), such Selling Shareholder shall first give written notice to the Company, which shall promptly thereafter deliver such notice (“Notice of Sale”) to each Entitled Holder (each, an “Offeree”). |
25.4.1 | The Notice of Sale shall state the following: the number of Offered Shares; that the Offered Shares will, upon the Disposition, be free of all liens, charges and encumbrances, that a bona fide offer has been received from a third party and such third party’s name; and the price, terms of payment and conditions for the purchase of the Offered Shares together with any term sheet or other written offer provided by such third party. |
25.4.2 | For a period of 14 days from delivery of the Notice of Sale, each Offeree may elect to purchase all or any part of its pro rata share of the Offered Shares and shall also have a right of over-allotment such that if any Offeree declines or fails to exercise its right hereunder to purchase its pro-rata share of the Offered Shares, each other Offeree exercising its right of first refusal hereunder may purchase such declining Offeree’s portion, on a pro-rata basis to those Offerees exercising their right of over-allotment (based on each purchaser’s pro-rata share). |
25.4.3 | An Offeree’s “pro-rata share”, for purposes of this Article 25.4, is the ratio of the number of Ordinary Shares held by such Offeree immediately prior to the Disposition of the Offered Shares (on an as converted basis) in relation to the total number of all Ordinary Shares issued and outstanding immediately prior to the Disposition of the Offered Shares (on an as converted basis) held by all the Offerees (excluding the Selling Shareholder). |
25.4.4 | The right of first refusal under this Article 25.4 shall be exercised by an Offeree by delivery of a binding notice to the Selling Shareholder with a copy to the Company within 14 days from delivery of the Notice of Sale, stating its election to purchase all or a portion of its pro rata share of such Offered Shares, and to the extent applicable, any additional Shares as may be available for over-allotment, and stating therein the maximum amount of Offered Shares elected to be purchased. If the Offeree(s) expressed their wish to purchase all but not less than all of the Offered Shares (the “Buying Shareholders”), then they shall acquire all such Offered Shares, in proportion to their respective pro rata shares, provided that no Buying Shareholder shall be entitled or required to acquire under the provisions of this Article 25.4 more than the number of Offered Shares initially accepted by such Buying Shareholder, and upon the allocation to it of the full number of Shares so accepted, such Buying Shareholder shall be disregarded in any subsequent computations and allocations hereunder with respect to such Disposition. Any Shares remaining after the computation of such respective entitlements shall be re-allocated among the Buying Shareholders (other than those to be disregarded as aforesaid), in the same manner, until one hundred percent (100%) of the Offered Shares have been allocated as aforesaid. The purchase of the Offered Shares shall be on the same terms and conditions as stated in the Notice of Sale. |
25.4.5 | If the Offerees did not exercise their right of first refusal or elected to purchase in the aggregate less than all of the Offered Shares, then the Selling Shareholder shall be free, within 90 days of the date of expiration of the Option, to sell all the Offered Shares to the prospective buyer set forth in the Notice of Sale at the price and on the terms contained in the Notice of Sale. If such sale is not consummated within such 90-day period, the Selling Shareholder shall not sell or transfer the Offered Shares, or any other Shares acquired before or after the date hereof, without again complying with the provisions of this Article 25.4. |
25.5 | In the event that there is a situation in which fractional Shares will need to be transferred, the number of Shares will be rounded to the nearest whole number so that only full Shares will be transferred. |
25.6 | The provisions of Article 25 shall not apply to a Disposition effected pursuant to Article 27 below (Bring Along) or to Shares sold by Co Sale Holders pursuant to Article 26 or to a Deemed Liquidation. In addition, the provisions of Article 25 shall not apply to a Disposition of Preferred Shares by any Preferred Shareholder. |
25.7 | The provisions of Article 25 shall be of no further force and effect immediately prior to and conditioned upon the consummation of a Public Event. |
25.8 | An Offeree may freely assign its rights under this Article 25 to a Permitted Transferee. |
25.9 | Notwithstanding the foregoing, if the implementation of the provisions of Article 25.4 may constitute an offer to the public under applicable laws which is subject to prospectus requirements, then the right of first refusal pursuant to Article 25.4 shall be in effect only in respect of such number of offerees which shall not require the preparation of a prospectus (in accordance with applicable law), and the offerees for such purpose shall be: (i) the type of offerees the offering to which is exempted from such prospectus requirements, and (ii) such Offerees who are entitled to purchase the largest pro rata portion among all those Offerees eligible to participate in the offer under Article 25.4, not including and in addition to the offerees under clause (i), the offering to which is exempted from such prospectus requirements. |
26. | Co-Sale Rights. |
26.1 | If, at any time prior to the consummation of a Public Event, any Founder and/or their respective Permitted Transferees desires to effect a Disposition of the Offered Shares, except for a Permitted Transfer according to Article 25.3 above, then the provisions of this Article 26 shall apply and each holder of Preferred Shares that holds at least the Minimum Share Threshold (in this Article 26, a “Co Sale Holder”) shall have the right to participate on a pro rata basis in the proposed Disposition, all as set forth below. |
26.2 | The Co Sale Holder’s right to participate shall be exercisable by a written notice to the Company and the Selling Shareholder within 14 days after receipt of the Notice of Sale (as mentioned in sub-article 25.4 above), in which each Co Sale Holder wishing to participate in such sale or transfer (the “Participating Shareholder”) shall notify the Selling Shareholder of the number of Shares such Co Sale Holder wishes to sell in such sale or transfer, on the same terms and conditions as the Selling Shareholder, provided, however, that such number shall not exceed such Participating Shareholder’s pro rata portion out of the Offered Shares. For the purpose of this Article 26, the term “Participating Shareholder’s pro rata portion” shall mean the number of shares owned at such time by the Co Sale Holder (on an as converted basis), in proportion to the respective number of Shares owned at such time by the Selling Shareholder and all the Co Sale Holders (on an as converted basis) wishing to participate in such sale or transfer. If such option is exercised by the Participating Shareholders, the Selling Shareholder shall not proceed with such sale unless such Participating Shareholders are given the right to participate and if the purchaser in such transaction does not agree to purchase the additional Shares offered for sale by the Participating Shareholders, the number of Offered Shares that the Selling Shareholder may sell in such sale or transfer shall be correspondingly reduced. |
26.3 | In the event that no participation notices have been delivered within the aforesaid 14-day period, or if some participation notices have been delivered within the aforesaid 14-day period, the Selling Shareholder may, within ninety (90) days after the expiration of the aforesaid 14-day period, transfer the Offered Shares identified in the Notice of Sale (together with the Participating Shareholders, if any, who elected to exercise their co-sale right within the aforesaid 14-day period), at a price and on the terms that are not more favorable to the purchaser(s) thereof than those stated in the Notice of Sale. If such transfer is not consummated within such ninety (90) days period, the Selling Shareholder shall not transfer any of the Offered Shares without complying again with all of the provisions of this Article 26. |
26.4 | In the event that a fractional Share will need to be transferred, the number of Shares will be rounded to the nearest whole number so that only full Shares are transferred. |
26.5 | The provisions of this Article 26 shall be of no further force and effect immediately prior to and conditioned upon the consummation of a Public Event. |
26.6 | The provisions of Article 26 shall not apply to (i) a Disposition effected pursuant to Article 27 below (Bring Along) or (ii) a Deemed Liquidation. |
26.7 | A Co Sale Holder may freely assign its rights under this Article 26 to a Permitted Transferee. |
27. | Bring Along. |
27.1 | Notwithstanding Article 26 above and without limitation of any provision of applicable law, but subject in any event to Article 7.3 (Distribution Preference), this Article 27, and 41 (Negative Covenants), in the event that prior to a Public Event, a majority of the issued and outstanding share capital of the Company on an as converted basis, including the Preferred Majority (collectively, the “Proposing Shareholders”), shall have approved and accepted a transaction or series of related transactions with any person or persons regarding a sale, whether through a purchase, merger or otherwise, of all the Company’s issued and outstanding share capital, or a sale of all or substantially all of the Company’s assets (the “Transaction”), then: |
27.1.1 | at every meeting of the Shareholders of the Company called with respect to any of the following, and at every adjournment or postponement thereof, and on every action or approval by written consent of the Shareholders of the Company with respect to any of the following, the other Shareholders (such other Shareholders, collectively, the “Remaining Holders”) shall vote all Shares of the Company that such Remaining Holders then hold or for which such Remaining Holders otherwise then have voting power: (A) in favor of approval of the Transaction and any matter that could reasonably be expected to facilitate the Transaction, and (B) against any proposal for any recapitalization, merger, sale of assets or other business combination (other than the Transaction) between the Company and any person or entity other than the party or parties to the Transaction or any other action or agreement that would result in a breach of any covenant, representation or warranty or any other obligation or agreement of the Company under the definitive agreement(s) related to the Transaction or which could result in any of the conditions to the Company’s obligations under such agreement(s) not being fulfilled, in each case unless otherwise determined by the Proposing Shareholders. |
27.1.2 | If the Transaction is structured as a sale of Shares, each Remaining Holder shall agree to sell all of the Shares and rights to acquire Shares of the Company held by such Remaining Holder on the terms and conditions approved by the Proposing Shareholders. |
27.1.3 | Each Remaining Holder shall take all necessary actions in connection with the consummation of the Transaction as requested by the Company or the Proposing Shareholders and shall, if requested by the Proposing Shareholders, execute and deliver any agreements and instruments prepared in connection with such Transaction which agreements are executed by the Proposing Shareholders and approved by the Board, provided that each Shareholder’s liability (other than in the case of fraud by such Shareholder) is up to the proceeds it receives from the Transaction, and provided that any liability, and escrow and holdback of proceeds of a Transaction is allocated on a pro-rata basis among all Shareholders (pro-rata on the basis of the total proceeds to be actually distributed thereto to each Shareholder, taking into consideration any liquidation preferences provided as part of such distribution). |
27.1.4 | In the event that a Remaining Holder fails to surrender its certificate in connection with the consummation of a Transaction, such certificate shall be deemed cancelled and the Company shall be authorized to issue a new certificate in the name of the Remaining Holder and the Board of Directors shall be authorized to establish an escrow account, for the benefit of such Remaining Holder into which the consideration for such securities represented by such cancelled certificate shall be deposited and to appoint a trustee to administer such account. |
27.1.5 | Each Remaining Holder hereby grants to such person as may be designated by the Board an irrevocable proxy, coupled with an interest, upon (and only upon) a failure or a refusal by any such Remaining Holder to vote its Shares or act in accordance with its contractual obligations herewith, to so vote such Shares or make other actions to effect the foregoing obligations of the Remaining Holders herein. The Company and all of its shareholders, each agree and acknowledge that: (i) monetary damages would not adequately compensate an injured party for the breach of this Article 27 by any party; (ii) this Article 27 shall be specifically enforceable; and (iii) any breach or threatened breach of this Article 27 shall be the proper subject of a temporary or permanent injunction or restraining order. |
27.2 | The majority set forth in Article 27.1 is hereby determined also for the purposes of Sections 341 of the Companies Law, and the procedure set forth in Section 341 of the Companies Law regarding the forced sale by Shareholders which do not participate in the Transaction shall apply. Notwithstanding Section 341 of the Companies Law to the contrary: (i), the price and other terms and conditions of a Transaction shall be considered to apply equally as to all Shareholders, if the application of such price and all such other terms and conditions to the respective Shares of the Company held by each Shareholder is made based upon and in accordance with the respective rights, preferences and privileges applicable to such Shares under these Articles (e.g., if each such Share receives the respective portion of the proceeds of such proposed Transaction as determined pursuant to the provisions of Article 7.3 above); and (ii) any bonus, retention payment, monetary incentive, management compensation and/or any similar payment or arrangement, payable or offered in connection with the Transaction by either the Company or by the purchaser in the Transaction to any Shareholder of the Company in his/her capacity as an employee or service provider of the Company and separately from any payment or distribution to which such Shareholder is entitled by virtue of his ownership of Shares in the Company, shall not be deemed contrary to the provisions of Section 341 of the Companies Law and Shareholders not receiving any such separate payment shall not be deemed, for purposes of Section 341 of the Companies Law, to be treated unequally compared to any Shareholders receiving such payment; provided, however, that any such bonus, retention payment, monetary incentive, management compensation and/or similar payment or arrangement is approved in advance by the Preferred Majority. |
27.3 | For the removal of doubt, any proceeds payable to the Shareholders hereunder shall be distributed in accordance with the provisions relating to `Distribution Preference’ as set forth in the Article 7.3 above, and each of the Shareholders will receive the consideration per Share in the same form and amount for each Share held thereby, and, except for with respect to sub section (ii) in Article 27.2 above, if any Shareholders are given an option as to the form and amount of consideration to be received, all Shareholders will be given the same option. |
27.4 | Limitations on Indemnification, etc. Notwithstanding the provisions set forth in this Article 27, the obligations of a Shareholder to take any action whatsoever under this Article 27, including without prejudice to the generality of the foregoing (i) voting all shares held by it in favor of the Transaction; (ii) selling or transferring all of its shares in the Company pursuant to such Transaction; and (iii) the timely delivery of documents and instruments as may be required elsewhere in this Article 27, shall be subject to the satisfaction of each of the following conditions: |
27.4.1 | Limitations on Representations, Warranties and Indemnities. The only representations, warranties or indemnities that a Shareholder shall be required to make in connection with a Transaction are representations, warranties or indemnities with respect to its ownership of shares and securities and ability to convey title free and clear of liens, encumbrances and third party rights, or adverse claims; its corporate power and authority and consents; enforceability and binding effect on such Shareholder; no finders’ fee agreed to by such Shareholder; non contravention and no breach by such Shareholder; representations relating to securities law matters pertaining to such Shareholder; absence of legal proceedings involving such Shareholder that may affect the consummation of the Transaction; and accuracy of tax information applicable to such Shareholder, and indemnities related to the Company’s representations, warranties and covenants in the Transaction, as set forth below (the “Required Obligations”). The Required Obligations shall be in the same form for all Shareholders of the Company and shall be given by Shareholder on a several but not joint basis only (other than as set forth below). Notwithstanding any other provisions of this clause, the maximum aggregate liability of a Shareholder shall be limited to the amount of consideration actually received by such Shareholder or payable to such Shareholder or placed in escrow or otherwise held for such Shareholder, as applicable, except with respect to claims related to fraud of such Shareholder, the liability for which need not be limited as to such Shareholder. The liability of a Shareholder with respect to any representation, warranty, indemnity or covenant made by the Company in connection with a Transaction shall be several and not joint with any other person (except to the extent that funds may be paid out of an escrow established or deducted from any amount to be paid by buyer (such as holdback and earn-outs) to cover breach of representations, warranties and covenants of the Company and the Required Obligations) and such liability shall be limited to a pro rata share of an escrow account, a holdback amount or a similar mechanism. |
27.4.2 | Other Agreements. No Shareholder shall be required to amend, extend or terminate any commercial contract or other commercial relationship with the Company, the purchaser or its respective affiliates or subsidiaries (with the exception of (i) the termination of any agreement between the Shareholder and the Company related to the purchase or holding shares of the Company, and (ii) termination under the terms of the applicable agreement). |
27.4.3 | Covenants. No Shareholder shall be required to agree to any covenants other than reasonable covenants regarding confidentiality, no solicitation, and publicity and in relation to actions necessary to transfer its Shares to the buyer in the Transaction. |
28. | Other Subject Securities |
The Company shall not issue any securities, or any other right to subscribe for, or convert to, securities (including options or Shares issued or granted under option or share incentive plan approved by the Board), or effect any transfer of securities by any Shareholder until it has satisfactory evidence that such subscriber or transferee (to the extent such subscriber or transferee is not a Shareholder prior to the issuance or transfer) shall be bound by, and be subject to, the provisions of these Articles, including without limitation, Articles 25, 26 and 27 hereof.
RECORD DATE FOR NOTICE OF GENERAL MEETING
29. | Notwithstanding any other provision of these Articles to the contrary, and subject to applicable law, the Board of Directors may fix a date, not exceeding sixty (60) days prior to the date of any general meeting, as the date as of which Shareholders entitled to notice of and to vote at such meeting shall be determined, and all persons who were registered in the Register as holders of voting Shares on such date and no others shall be entitled to notice of and to vote at such meeting. A determination of Shareholders of record entitled to notice of and to vote at any meeting shall apply to any adjournment of such meeting, provided, however, that the Board may fix a new record date for the adjourned meeting. |
GENERAL MEETINGS
30. | Annual General Meeting. |
Annual general meetings shall be held at least once in every calendar year, but not later than fifteen (15) months after the last preceding annual general meeting, at such time and place as the Board of Directors may determine. All general meetings other than Annual General Meetings of the Company shall be called “Extraordinary General Meetings”.
31. | Extraordinary General Meetings. |
The Board of Directors may whenever it thinks fit convene an Extraordinary General Meeting, and shall be obliged to do so upon a request in writing as provided in the Companies Law.
32. | Notice. |
32.1 | Unless a longer period is prescribed by applicable law, at least a seven (7) day prior notice, specifying the place, the day and the hour of the meeting and the general nature of every matter on the agenda, shall be given to all Shareholders entitled to receive notices by notice sent by mail, fax, e-mail or otherwise served as hereinafter provided. Notwithstanding the foregoing, if all Shareholders entitled to receive notices of general meetings so agree, a general meeting may be held if less than seven (7) days’ notice or the period otherwise required by law, as the case may be, is given and generally in such manner as such Shareholders may approve. |
32.2 | The accidental omission to give notice of a meeting to any Shareholder, or the non-receipt of notice sent to such Shareholder, shall not invalidate the proceedings at such meeting. |
PROCEEDINGS AT GENERAL MEETINGS
33. | Quorum. |
33.1 | Subject to Article 41, no business shall be transacted at a general meeting unless the requisite quorum is present at the commencement of the business, and no resolution shall be passed unless the requisite quorum is present when the resolution is voted upon. Unless otherwise provided in these Articles, one or more Shareholders, present in person or by proxy, holding or representing Shares conferring in the aggregate at least the majority of the voting rights of the Company (on as converted basis), including the Preferred Majority, shall constitute a quorum. |
33.2 | Shareholders entitled to be present and vote at a general meeting may participate in a general meeting by means of conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other and such participation in a meeting shall constitute attendance in person at the meeting. |
33.3 | Subject to Article 41, if a meeting is called and no quorum is present, within half an hour from the time appointed for the meeting, it shall stand adjourned to the same day in the following week, at the same time and place or such other time and place as set forth in the notice of such a meeting. At an adjourned General (or Extraordinary) Meeting any number of Shareholders present in person or by proxy holding or representing Shares conferring in the aggregate at least 33% of the voting rights of the Company shall constitute a quorum. At an adjourned General Meeting the only business to be considered shall be those matters which might have been lawfully considered at the General Meeting originally called if a requisite quorum had been present, and the only resolutions to be adopted are such types of resolutions which could have been adopted at the General Meeting originally called. If such quorum is not present the adjourned meeting shall be cancelled. |
35. | Chairman. |
35.1 | The Chairman of the Board of Directors will serve as the Chairman of the general meetings of the Company. If the Board of Directors has no Chairman or if he is not present 15 minutes from the time stated for the commencement of the meeting, those present may choose from amongst them a person to chair the meeting. |
35.2 | The Chairman of any general meeting of the Company shall not be entitled to a second or casting vote. |
36. | Adoption of Resolutions at General Meetings. |
36.1 | Unless otherwise prescribed by applicable law or by these Articles, including, without limitation, Article 41, a resolution of the Shareholders will be deemed adopted if approved by a simple majority of the voting rights of the Company represented personally or by proxy and voting thereon at a meeting at which a quorum is present (excluding abstentions). |
36.2 | Every question submitted to a general meeting shall be decided by a show of hands, but if a written ballot is demanded by a Shareholder, present in person or by proxy and entitled to vote at the meeting, the same shall be decided by a written ballot. A written ballot may be demanded before the proposed resolution is voted upon or immediately after the declaration by the Chairman of the results of the vote by a show of hands. If a written ballot is demanded after such declaration, the results of the vote by a show of hands shall be of no effect, and the proposed resolution shall be decided by a written ballot. If a written ballot is demanded as aforesaid, it shall be taken in such manner and at such time and place as the Chairman of the meeting directs, and either at once or after an interval or adjournment, or otherwise, and the result of the written ballot shall be deemed to be the resolution of the meeting at which the written ballot was demanded. The demand for a written ballot may be withdrawn at any time before the written ballot is taken. The demand for a written ballot shall not prevent the continuance of a meeting for the transaction of any business other than the question on which the written ballot has been demanded. A written ballot demanded on the election of a Chairman and on a question of an adjournment of a meeting shall be taken forthwith. |
36.3 | A declaration by the Chairman of the meeting that a resolution has been carried unanimously, or carried by a particular majority, or rejected, and an entry to that effect in the book of proceedings of the Company, shall be conclusive evidence of the fact without proof of the number or proportion of the votes recorded in favor of or against such resolution. |
37. | Power to Adjourn. |
The Chairman of a general meeting at which a quorum is present may, with the consent of the holders of a majority of the voting rights of the Company represented, personally or by proxy, at the meeting and voting on the question of adjournment, adjourn the same from time to time and from place to place and the Chairman shall do so if so directed by the meeting; but no business shall be transacted at any adjourned meeting other than the business left unfinished at the meeting from which the adjournment took place. A notice of the adjournment and of the matters to be included on the agenda of the adjourned meeting shall be given to all Shareholders.
38. | Resolutions in Writing. |
A resolution in writing signed by all Shareholders then entitled to vote at general meetings or to which all such Shareholders have given their written consent (including, but not limited to, by letter, facsimile, e-mail or otherwise) shall be deemed to have been adopted as if it were adopted at a general meeting of the Company duly convened and held. Any such resolution may consist of several documents in like form and signed or consented to as aforesaid, by one or more Shareholders.
39. | Votes of Shareholders. |
39.1 | Subject to any special conditions, rights or restrictions to voting rights set forth in the terms of issue of any Shares or attached at the time to any class of Shares, including, without limitation, Article 41, every Shareholder present in person or by proxy, whether in a vote by a show of hands or by written ballot, shall have one vote for each Ordinary Share held by him of record and in the case of a Preferred Shareholder, one vote for each Ordinary Share into which the Preferred Shares held by him of record could be converted. |
39.2 | A company or other corporate body being a Shareholder of the Company may duly authorize any person it deems fit to be its representative at any meeting of the Company or to execute or deliver a proxy on its behalf, as provided for below. Any person so authorized shall be entitled to exercise on behalf of the corporation which he represents all the powers which the corporation could have exercised if it were an individual Shareholder. Upon the request of the Chairman of the meeting, written evidence of such authorization (in form reasonably acceptable to the Chairman) shall be delivered to him. |
39.3 | In case of joint holders, the vote of the senior who tenders a vote, whether in person or by proxy, shall be accepted to the exclusion of the votes of the other joint holders; and for this purpose seniority shall be determined by the order in which the names stand in the Register. |
39.4 | Shareholders may vote either personally or by proxy, or, if the Shareholder is a company or other corporate body, by a representative pursuant to Article 38.2 or by a duly authorized proxy, as prescribed hereinafter. |
39.5 | No Shareholder (or proxy or representative of a Shareholder) shall be entitled to vote at a general meeting unless all calls or other sums presently payable by him in respect of his Shares in the Company have been paid. |
40. | Class Meetings. |
The provisions of these Articles relating to General Meetings shall apply, mutatis mutandis, to any separate General Meeting of the holders of the Shares of a particular class, provided however, that the requisite quorum at such separate General Meeting shall be Shareholder(s) present in person or proxy holding Shares conferring in the aggregate a majority of the voting power of the Shares of such class, on an as converted basis.
41. | Proxy. |
41.1 | Any instrument appointing a proxy or representative shall be in writing under the hand of the appointer or of his attorney duly authorized in writing, or, if such appointer is a corporation, under its common seal if any, or under the hand of some officer duly authorized in that behalf. |
41.2 | Every instrument of proxy, whether for a specified meeting or otherwise shall, as nearly as circumstances will admit, be substantially in the following form: |
“I ________________ of _______________ being a Shareholder of PAGAYA TECHNOLOGIES LTD. (the “Company”) hereby appoint __________of __________ or, failing him, ________________ of __________ as my proxy to vote for me and on my behalf at the Annual or Extraordinary or Adjourned (as the case may be) General Meeting of the Company, to be held on the day __________ of and at any adjournment thereof.
IN WITNESS WHEREOF, I affix my signature this _____ day of _______ 2_____.”
A vote given in accordance with the terms of an instrument of appointment of attorney or proxy shall be valid notwithstanding the previous death of the principal, or revocation of the appointment, or transfer of the Share in respect of which the vote is given, unless notice in writing of the death, revocation or transfer shall have been received at the Office or by the Chairman of the meeting before the vote is given.
42. | Negative Covenants. |
42.1 | Until the consummation of a Public Event, the Company shall not, whether by action or through resolution of the Company’s general meeting, take any action set forth below, without first obtaining the consent (by vote or written consent) of the Preferred Majority: |
42.1.1 | amend the Articles of Association or take other action which would have the effect of amending or adversely affecting the rights, preferences or privileges of the Preferred Shares; |
42.1.2 | authorize or issue (including by way of merger, reclassification, recapitalization or any other way) any share capital, or other rights or securities convertible into or exchangeable for share capital or any equivalent rights under benefit plans, with rights equal to or superior to the rights of the Preferred Shares; |
42.1.3 | effect a Deemed Liquidation; |
42.1.4 | increase the number of the Company’s Directors above eight (8) or change the composition of the Board of Directors; |
42.1.5 | other than in compliance with the Companies Laws, effect or undertake to effect any interested party transaction with any shareholder, director or officer having a value of more than $120,000; |
42.1.6 | effect a liquidation, bankruptcy, dissolution or winding up of the Company; |
42.1.7 | transfer all or substantially all of the assets of the Company (including through the grant of an exclusive, perpetual, worldwide license (other than the license in the ordinary course of business, which does not amount to a de facto sale of all or substantially all of the Company)) from one or more wholly-owned subsidiaries of the Company that own(s) all or substantially all the aggregate assets of the Company and its subsidiaries taken as a whole, other than to a wholly-owned subsidiary of the Company; |
42.1.8 | effect any transaction or series of related transactions as a result of which more than 50% of the shares of one or more subsidiaries of the Company that own(s) all or substantially all of the aggregate assets of the Company and its subsidiaries taken as a whole, are transferred to any third party, other than (i) the issuance of such shares solely for financing purposes and/or (ii) a transaction following which the Shareholders of the Company immediately prior to such transaction continue to own, directly or indirectly, the majority of the voting securities of such subsidiaries; |
42.1.9 | redeem or repurchase, subject to applicable law, any shares of Preferred Shares, or Ordinary Shares (other than pursuant to employee or consulting agreements giving the right to repurchase shares upon termination of services at no greater than the original cost thereof); or |
42.1.10 | change the principal business of the Company from Data driven investment and investment management. |
42.2 | Notwithstanding anything to the contrary herein, any amendment to, or waiver of, rights granted specifically by name in these Articles to a certain Shareholder shall require the prior written consent of such Shareholder. Any right granted to a specified majority of holders of a specified class of Shares may not be amended or terminated or the observance of any specific term of these Articles granted to such specified majority may not be waived, without the written consent of such specified majority of holders of such class of Shares. Any amendment of this Article 41 shall require the consent of the Preferred Majority |
42.3 | Notwithstanding anything to the contrary herein, (i) amending or waiving the liquidation preference of the Preferred C Shares under Article 7.3.1; (ii) amending or removing this Article 41.3, but solely with respect the requirement to obtain the consent of the Preferred C Majority as provided therein, and (iii) the issuance of any additional Preferred C Shares; shall, in each case, require the prior written consent of the Series C Majority. |
42.4 | Notwithstanding anything to the contrary herein, (i) amending or waiving the definitions of “New Securities” or “Additional Securities”, the provisions of Article 7.2.2 and 7.2.5, the liquidation preference of the Preferred D Shares under Article 7.3.1; (ii) amending or removing this Article 41.4, but solely with respect the requirement to obtain the consent of the Preferred D Majority as provided therein, and (iii) that issuance of any additional Preferred D Shares (or any options or rights to purchase such shares) after the closing of the Series D Preferred Share Purchase Agreement and if applicable, the Additional Closing thereunder, shall, in each case, require the prior written consent of the Series D Majority. |
BOARD OF DIRECTORS
43. | Powers of the Board of Directors. |
43.1 | In addition to all powers and authorities of the Board of Directors as specified in the Companies Law, the determination of the Company’s policy, and the supervision of the General Manager and the Company’s officers shall be vested in the Board of Directors. In addition, the Board of Directors may exercise all such powers and do all such acts and things as the Company is, by these Articles or under the law, authorized to exercise and do, and are not hereby or by statute directed or required to be exercised or done by the Company in a general meeting, but subject, nevertheless, to the provisions of the Companies Law, and to these Articles and any regulations or resolution not being inconsistent with these Articles made from time to time by the Company in a general meeting; provided that no such regulation or resolution shall invalidate any prior act done by or pursuant to the directions of the Board of Directors which would have been valid if such regulation or resolution had not been made. |
43.2 | Without prejudice to any of the general powers granted to the Board of Directors in accordance with above Article and any other powers granted to it under these Articles, and without restricting or reducing in any way any of the above-mentioned powers, it is hereby explicitly declared that the Board of Directors shall have the following powers: |
43.2.1 | To appoint a person or persons (whether they be incorporated or not) to receive and hold in trust for the Company any property whatsoever that belongs to the Company or that the Company has an interest in, or for any other purpose and to execute and perform all actions, deeds and necessary activities with relation to any such trust, and to see to the remuneration of any such trustee(s). |
43.2.2 | To initiate, manage, defend, compromise or discontinue any and all legal proceedings on behalf of or against the Company or its officials or that pertain in any way to its affairs, and to compromise and extend the period for payment or discharge of any debt due or suits or claims by or against the Company. |
43.2.3 | To refer any suit or claim by or against the Company to arbitration. |
43.2.4 | To determine, from time to time, those authorized to sign in the Company’s name on bills of exchange, promissory notes, receipts, certificates of receipt, endorsements, checks, certificates of dividend, releases, contracts and other documents of any kind whatsoever. |
43.2.5 | In general and subject to the provisions of the Companies Law and these Articles, to delegate to any person, firm, company or variable group of people, the powers, authority and discretion vested in the Board of Directors. |
44. | Delegation of Powers. |
44.1 | To the extent provided under Sections 112 and 288 of the Companies Law, the Board of Directors may for any particular matter delegate any or all of its powers to committees consisting of three or more Directors as the Board of Directors may deem fit, each including at least one Preferred Director (a “Committee”), and it may from time to time revoke such delegation. The Board may not delegate authorities to committees without approval of at least one Preferred Director. Unless otherwise expressly provided by the Board of Directors in delegating powers to a Committee of the Board of Directors, such Committee shall not be empowered to further delegate powers. |
44.2 | Any Committee so formed shall, in the exercise of the powers so delegated, conform to any regulations that may be imposed on it by the Board of Directors. |
44.3 | The meetings and proceedings of any such Committee, shall be governed by the provisions herein contained for regulating the meetings of the Board of Directors, so far as the same are applicable thereto, and so far as not superseded by any regulations made by the Board of Directors under this Article. |
44.4 | The Board of Directors may appoint a Secretary to the Company, and may appoint officers, personnel, agents and servants, for fixed, provisional or special duties, as the Board of Directors may from time to time deem fit, and may from time to time, in their absolute discretion, suspend the service of any one or more of such persons. The Board of Directors may determine the powers and duties, as well as the salaries, of such persons and may demand security in such cases and in such amounts as it deems fit. |
45. | Composition. |
45.1 | The Board of the Company shall consist of a total of up to eight (8) members as follows: |
45.1.1 | A majority among the Founders (i.e., 2 of the 3 Founders) shall be entitled to appoint three (3) Directors (each such appointed Director, an “Ordinary Director” and collectively, the “Ordinary Directors”); |
45.1.2 | Oak may appoint one (1) Director (the “Oak Director”) for as long as Oak holds at least the Minimum Share Threshold; |
45.1.3 | Saro, L.P. may appoint one (1) Director (the “GF Director”) for as long as GF holds at least the Minimum Share Threshold; |
45.1.4 | Viola Ventures may appoint one (1) Director (the “Viola Ventures Director”) for as long as Viola Ventures holds at least the Minimum Share Threshold; |
45.1.5 | The GIC Entities may jointly appoint one (1) Director (the “GIC Director”, and together with the Oak Director, the GF Director and the Viola Ventures Director the “Preferred Directors”) for as long as the GIC Entities collectively hold at least the Minimum Share Threshold; |
45.1.6 | [RESERVED] |
45.1.7 | The Ordinary Directors, the Oak Director, the GF Director, the Viola Ventures Director and the GIC Director in office may, by a majority vote among them, appoint one (1) Director who shall have expertise and extensive knowledge in the Company’s field of business. |
45.2 | The Viola Ventures Director, the GF Director, the GIC Director and the Oak Director shall be entitled to membership in all committees of the Board. |
45.3 | [RESERVED] |
45.4 | For the avoidance of doubt, any representative serving as a director on the Board of Directors pursuant to the provisions of Article 44.1 may be designated and/or removed only by a written notice delivered to the Company (which will contain the identity of the representative director) by the party or parties authorized to make such designation, without the need for any further action including but not limited to a resolution at a General Meeting. Notwithstanding the provisions of Sections 59 and 230(a) of the Companies Law, the General Meeting of the Company shall not be entitled to appoint or remove from his office any director of the Company. |
45.5 | Any vacancy in a directorship shall be filled only by a person nominated by those who are entitled to appoint the director whose seat is vacant. |
45.6 | Notwithstanding anything to the contrary in these articles, the Company reserves the right to exclude the GIC Director from any information delivered to the Board or portion thereof and not to disclose to the GIC Director certain information, relating to proprietary commercial information of a competitor of the GIC Entities, which the Board determines in good faith, after consultation with the Company’s legal counsel, is reasonably deemed to create, or exacerbate, a conflict of interest. Prior to such determination of the Board, the Company will provide the GIC Director a high-level description of the subject matter that is the basis for the exclusion, at a level of detail that does not itself create or exacerbate a conflict of interest. This provision shall terminate upon termination of the commercial relationship between the GIC Entities and the Company. |
45.7 | Each of (i) Clal, (ii) SCB, (iii) New Investors Group, by the vote of a majority in interest of its members, based on their pro-rata holdings in the Company, (iv) the GIC Entities to the extent they are no longer entitled to appoint the GIC Director, (v) Oak, to the extent it is no longer entitled to appoint the Oak Director, and (vi) Saro, L.P., to the extent it is no longer entitled to appoint the GF Director, each, for as long as it holds at least 1% of the Company’s issued share capital on an as converted basis, other than SCB, that will have such right for as long as it holds at least 0.7% of the Company’s issued share capital on an as converted basis, shall have the right to appoint, remove and replace one (1) observer to the Board (each, an “Observer”) who shall be entitled to attend in a non-voting observer capacity all meetings of the Board to receive notice of such meetings and to receive any and all documentations and communications provided to the members of the Board of Directors (including for the avoidance of doubt, suggested written resolutions), as and when provided to the Board, provided that such Observer executes confidentiality undertakings in a form reasonably satisfactory to the Company, provided, however, that the Company reserves the right to exclude the Observer from any Board meeting or portion thereof, and deny the Observer access to any material given to Board members, if the Board determines that such exclusion is reasonably necessary (i) to preserve attorney-client privilege, or (ii) to avoid a conflict of interest for or with the Company. |
45.8 | Article 44.1.2 may not be amended without the prior written consent of Oak; Article 44.1.3 may not be amended without the prior written consent of Saro, L.P.; Article 44.1.4 may not be amended without the prior written consent of Viola Ventures; Article 44.1.5 may not be amended without the prior written consent of the GIC Entities; Article 44.1.1 may not be amended without the prior written consent of the majority of the Founders (i.e., 2 of the 3 Founders); Article 44.7 may not be amended without the prior written consent of Clal (with respect to Clal), SCB (with respect to SCB), Saro, L.P. (with respect to Saro, L.P.), Viola Ventures (with respect to Viola Ventures), the GIC Entities (with respect to the GIC Entities) , Oak (with respect to Oak) and New Investors Group (with respect to New Investors Group). This Article 44.8 may not be amended without the prior written consent of Clal (with respect to Clal), SCB (with respect to SCB), Saro, L.P. (with respect to Saro, L.P.), Viola Ventures (with respect to Viola Ventures), the GIC Entities (with respect to the GIC Entities), Oak (with respect to Oak), and New Investors Group (with respect to New Investors Group). |
46. | Alternate Directors. |
46.1 | Subject to the provisions of the Companies Law, a Director shall have the right, by written notice to the Company, to appoint a person as a substitute to act in his place, to remove the substitute and appoint another in his place and to appoint a substitute in place of a substitute whose office was vacated for any reason whatsoever (each such substitute, an “Alternate Director”). A person who is not qualified to be appointed as a Director, may not be appointed as an Alternate Director. |
46.2 | Any notice given to the Company as aforesaid shall become effective on the date fixed therein, upon delivery to the Company. Unless the appointing Director limits the time or scope of the appointment, the appointment is effective for all purposes until the appointing Director ceases to be a Director or terminates the appointment. |
46.3 | An Alternate Director shall have, subject to any instructions or limitations contained in the instrument appointing him, all the authority and powers held by the Director for whom he acts as substitute, provided, however, that he may not in turn appoint a substitute for himself (unless the instrument appointing him otherwise expressly provides), and provided further that a substitute shall have no standing at any meeting of the Board of Directors or any committee thereof at which the Director appointing him is personally present or at which the Director appointing him is not entitled to participate in accordance with applicable law. |
46.4 | The office of an Alternate Director shall ipso facto be vacated if he is removed by the Director appointing him, or if the office of the Director for whom he acts as substitute is vacated for any reason whatsoever, or if one of the circumstances described in Article 45 should befall the substitute. |
46.5 | An Alternate Director shall alone be responsible for his actions and omissions, and shall not be deemed an agent of the Director(s) who appointed him. |
46.6 | Every substitute shall be entitled to receive, so long as he serves as a substitute, notice of meetings of the Board of Directors and of any relevant committees. |
47. | Vacation of Office. |
The office of a Director shall ipso facto be vacated upon the occurrence of any of the following events:
47.1 | Upon his death, or, if the Director is a company—upon its winding-up; |
47.2 | Should he be declared to be of unsound mind; |
47.3 | Should he become bankrupt; |
47.4 | Should he resign his office by notice in writing to the Company; |
47.5 | He is removed from office by written notice to the Company pursuant to Article 44 above; |
47.6 | He is convicted of an offense as described in Article 232 of the Companies Law; |
47.7 | He is removed by a court of law in accordance with Article 233 of the Companies Law. |
48. | Qualification of Directors. |
48.1 | Subject to applicable law, a Director who has ceased to hold office shall be eligible for re-election or re-appointment. |
48.2 | A Director shall not be required to hold qualification shares. |
49. | Conflict of Interest; Approval of Related Party Transactions. |
49.1 | Subject to the provisions of the Companies Law and these Articles, the Company may enter into any contract or otherwise transact any business with any Director, or other Office Holder (as defined in the Companies Law) in which contract or business such Director or other Office Holder has a personal interest, directly or indirectly; and may enter into any contract or otherwise transact any business with any third party in which contract or business a Director or other Office Holder has a personal interest, directly or indirectly. |
49.2 | Unless and to the extent provided otherwise in the Companies Law, a Director or other Office Holder, shall not participate in deliberations concerning, nor vote upon a resolution approving, a transaction with the Company in which he has a personal interest. |
50. | Remuneration of Directors. |
50.1 | A Director may be paid remuneration by the Company for his services as a Director to the extent such remuneration is approved by a Shareholders Resolution and pursuant to the Companies Law. |
50.2 | Directors and Alternate Directors may be entitled to reimbursement from the Company for all reasonable travel, board and lodging expenses incurred in connection with performance of their duties as members of the Board of Directors of the Company (provided that the Company did not reimburse the Director for all such expenses in his capacity as an employee of the Company). |
PROCEEDINGS OF THE BOARD OF DIRECTORS
51. | Meetings of the Board of Directors. |
51.1 | The Board of Directors shall convene its meetings, and may adjourn and otherwise regulate the proceedings of such meetings, as the Board of Directors thinks fit. |
51.2 | In addition, the Chairman of the Board of Directors or any Director may, at any time, convene a meeting of the Board of Directors. |
51.3 | Notice of a meeting of the Board of Directors may be sent to all Directors at their registered addresses, by facsimile, e-mail or other reliable written form/method of transmission at least three Business Days prior to the meeting unless such notice is waived in writing by all of the Directors as to a particular meeting |
51.4 | Subject to all of the other provisions of these Articles concerning meetings of the Board of Directors, Directors will be entitled to participate by way of video or audio conference, so long as each participating Director can hear, and be heard by, each other participating, and the Company will cooperate, as may reasonably be required, in providing video or audio conferencing capabilities to effectuate such. |
51.5 | The Board of Directors may operate and adopt resolutions in writing, including by facsimile, e-mail or other electronic means, or by telephone or any other means of communication. |
52. | Quorum. |
52.1 | The quorum for a meeting of the Board and/or for any matter to be brought before the Board shall be constituted by the presence (in person, via telephone conference call, or by proxy) of a majority of the Directors then in office and entitled to participate and vote with respect thereto, which majority must include at least three (3) of the Oak Director, the GF Director, the Viola Ventures Director and the GIC Director. If a meeting is called and no quorum is present, within half an hour from the time appointed for the meeting, it shall stand adjourned to the second Business Day after the day it was originally called for, at the same time and place or such time and place as the Directors may determine. The quorum at any adjourned meeting thereof shall be constituted by the presence of the Directors holding the majority of the voting power of the Directors then in office, provided that all Directors have been served with a notice of such meeting pursuant to Articles 50.3. At an adjourned meeting of the Board the only matters to be considered shall be those matters which might have been lawfully considered at the meeting of the Board originally called if a requisite quorum had been present, and the only resolutions to be adopted are such types of resolutions which could have been adopted at the meeting of the Board originally called. |
52.2 | Unless and to the extent provided otherwise in the Companies Law, a Director who is an interested party in any transaction shall be counted for purposes of a quorum despite his interest but shall not be entitled to vote on or participate in the discussions with management in regard to such matter, unless otherwise permitted under the Companies Law. |
53. | Exercise of Powers. |
53.1 | Subject to Article 41, a meeting of the Board of Directors at which a quorum is present shall be competent to exercise all the authorities, powers and discretion’s for the time being vested in or exercisable by the Board of Directors. |
53.2 | Subject to Article 41, all resolutions of the Board will be adopted by a simple majority of the voting power of the Directors present and voting (with the Directors participating by video or audio conference, if any, being deemed present and entitled to vote) at a meeting of the Board. |
54. | Chairman of the Board of Directors. |
54.1 | The Board of Directors may elect one of its directors to be the Chairman of the Board of Directors, remove such Chairman from office and appoint another in its place. The Chairman of the Board shall take the chair at every meeting of the Board of Directors, but if there is no such Chairman, or if at any meeting he is not present within fifteen (15) minutes of the time appointed for the meeting, or if he is unwilling to take the chair, the Directors present shall choose one of their number to be the Chairman of such meeting. |
54.2 | Unless provided explicitly in these Articles, the office of the Chairman of a meeting of the Board of Directors, whether he be the Chairman of the Board of Directors or any other member of the Board of Directors, by itself, shall not entitle the holder thereof to any extra or casting vote. |
55. | Validity of Act Despite Defects. |
Subject to the provisions of the Companies Law, all acts performed bona fide at or in accordance with any meeting of the Board of Directors, or of a Committee of the Board of Directors, or by any person acting as a Director or substitute for a Director, shall, notwithstanding that it may afterwards be discovered that there was some defect in the appointment of such Directors or members of a Committee of the Board of Directors or person acting as aforesaid or any of them, or that they or any of them were disqualified, be as valid as if every such person had been duly appointed and was qualified to be a Director, substitute or a member of such a Committee, as the case may be.
GENERAL MANAGER
56. | Subject to Article 41, the Board of Directors may from time to time appoint, remove and determine the terms of employment of one or more persons (whether a Director or not) to be General Manager(s), Chief Executive Officer(s) and/or President(s) (or any similar function with a different title) of the Company, either for a fixed term or without any limitation as to the period for which he is or they are to hold office, and may from time to time modify or revoke such titles or (subject to any provisions of any contract between him or them and the Company) remove or dismiss him or them from office and appoint another or others in his or their place or places; provided, however, that under no circumstance shall a Founder that is an executive officer of the Company be removed unless such removal has been approved by a vote of both: (1) the other two Founders; and (2) a majority of the Board of Directors; provided, however, that a Founder that is an executive officer may be removed by a vote of a majority of the Board of Directors for cause, which term shall be understood based on the definition for such term contained in any of the employment agreements then in effect with a Founder. |
57. | The remuneration of a General Manager, Chief Executive Officer and/or President shall from time to time (subject to any contract between him and the Company and subject to the provisions of the Companies Law) be fixed by the Board of Directors, and may be in the form of a fixed salary or commission on dividend, profits or turnover of the Company, or of any other company the Company has an interest in, or by participation in profits or in one or more of these forms. |
58. | Subject to the provisions of the Companies Law and these Articles (including Article 41), the Board of Directors may from time to time entrust to and confer upon a General Manager, Chief Executive Officer and/or President for the time being such of the powers exercisable under these Articles by the Board of Directors as it may think fit, and may confer such powers for such time, and to be exercised for such objects and purposes, and upon such terms and conditions, and with such restrictions, as it thinks expedient; and it may confer such powers, either collaterally with, or to the exclusion of, and in substitution for, all or any of the powers of the Board of Directors in that behalf; and may from time to time revoke, withdraw, alter, or vary all or any of such powers. |
REGISTER OF SHAREHOLDERS
59. | The Company shall keep the Register and record in it the following information: |
59.1 | The names and addresses of the Shareholders and a list of the shares held by each one, designating each share by its number, and the amount paid or the amount to be considered as paid on the shares of each Shareholder; |
59.2 | The day each person was registered in the Register as a Shareholder; |
59.3 | The day each person ceased to be a Shareholder; |
59.4 | The amounts called, if any, that are due on the Shares of each Shareholder; and |
59.5 | Any other information required or permitted by the Companies Law or these Articles to be recorded in the Register. |
60. | The Register shall be kept at the head office, and aside from the times the Register is closed in accordance with the provisions of the Companies Law or these Articles, they shall be open to the inspection of any Shareholder free of charge, and of any other person at a fee the Company shall determine for each matter, during regular business hours. |
61. | The Register shall be closed for a period of fourteen (14) days immediately prior to an annual general meeting and during other periods, if any, that the Board of Directors shall determine from time to time, on the condition that the Register shall not be closed for a period exceeding 30 days during any one year; and on the additional condition that the Register shall not be closed unless a notice has been published in accordance with the provisions of the Companies Law, if required. |
MINUTES AND THE SEAL
62. | The Board of Directors shall cause minutes to be duly recorded regarding: the names of the Directors present at each meeting of the Board of Directors and of any committee of the Board of Directors; the names of the Shareholders present at each general meeting, and the proceedings and resolutions of general meetings and of meetings of the Board of Directors and Committees of the Board of Directors. Any minutes as aforesaid of a meeting of the Board of Directors, of a meeting of a Committee of the Board of Directors or of a general meeting of the Company, if purporting to be signed by the Chairman of such meeting or by the Chairman of the next succeeding meeting, shall be accepted as prima facie evidence of the matters therein recorded. |
63. | The Company may have one or more rubber stamps, for affixing on documents, and the Board of Directors shall provide for the safe custody of any such rubber stamp. |
64. | Subject to Article 41, the Board of Directors shall be entitled to authorize any person or persons (even if he or they are not Directors(s) of the Company) to act and sign on behalf of the Company, and the acts and signatures of such person or persons on behalf of the Company shall bind the Company insofar as such person or persons acted and signed within his or their powers aforesaid. |
65. | The Board of Directors may provide for a seal. If the Board of Directors so provides, it shall also provide for the safe custody thereof; such seal shall not be used except by the authority of the Board of Directors. |
DIVIDENDS AND RESERVE FUND
66. | Articles 66 to 78 below shall be subject to, and shall not derogate from, Article 7 and Article 41, to the extent applicable. |
67. | The Board of Directors may, from time to time, set aside, out of the profits of the Company, such sums as it thinks proper, as a reserve fund to meet contingencies, or for equalizing dividends, or for special dividends, or for repairing, improving and maintaining any of the property of the Company, and for such other purposes as the Board of Directors shall in its absolute discretion think conducive to the interests of the Company, and may invest the sums so set aside in such investments as it may think fit, and from time to time deal with and vary such investments, and dispose of all or any part thereof for the benefit of the Company, and may divide the reserve fund into such special funds as it thinks fit, and employ the reserve fund or any part thereof in the business of the Company, and that without being bound to keep the same separate from the other assets of the Company. The Board of Directors may also, without placing the same to reserve, carry forward any profits, which it deems prudent not to divide. |
68. | Subject to the rights of holders of Shares with limited or preferred rights as to dividends, and subject to the provisions of these Articles as to the reserve fund, all the dividends shall be paid to the Shareholders in proportion to the amount paid up or credited as paid up on account of the nominal value of the Shares held by them respectively and in respect of which such dividend is being paid, without regard to any premium paid in excess of the nominal value, if any, but if any Share is issued on terms providing that it shall rank for dividend from a particular date, such Share will rank for dividend accordingly. |
69. | Subject to the provisions of the Companies Law, the Board of Directors may from time to time declare such dividends as may appear to the Board of Directors to be justified by the profits of the Company and cause the Company to pay such dividends. The Board of Directors shall have the full authority to determine the time for payment of such dividends, and the record date for determining the Shareholders entitled thereto, provided such date is not prior to the date of the resolution to distribute the dividend and no Shareholder who shall be registered in the Register with respect to any Shares after the record date so determined shall be entitled to a share in any such dividend with respect to such Shares. |
70. | No dividend shall be paid other than out of the profits of the Company, as defined in the Companies Law, and no interest shall be paid by the Company on dividends. |
71. | A dividend may be paid, wholly or partly, by the distribution of specific assets, and, in particular, by distribution of paid-up Shares, debentures or debenture stock of any other company, or in any one or more such ways. |
72. | The Board of Directors may resolve that: any moneys, investments, or other assets forming part of the undivided profits of the Company standing to the credit of the reserve fund, or to the credit of any reserve fund for the redemption of capital, or to the credit of a reserve fund for the revaluation of real estate or other assets of the Company or any other reserve fund or investment funds or assets in the hands of the Company and available for dividends, or representing premiums received on the issue of Shares and standing to the credit of the Share premium account, be capitalized and distributed among such of the Shareholders as would be entitled to receive the same if distributed by the way of dividend and in the same proportion on the basis that they become entitled thereto as capital; and that all or any part of such capitalized fund be applied on behalf of such Shareholders in paying up in full, either at par or at such premiums as the resolution may provide, any unissued Shares or debentures or debenture stock of the Company which shall be distributed accordingly or in or towards the payment, in full or in part, of the uncalled liability on any issued Shares or debentures or debenture stock; and that such distribution or payment shall be accepted by such Shareholders in full satisfaction of their share and interest in the said capitalized sum. |
73. | For the purpose of giving effect to any resolution under the two (2) last preceding Articles, the Board of Directors may settle any difficulty which may arise in regard to the distribution as it thinks expedient, and, in particular, without derogating from the generality of the foregoing, may issue fractional certificates or make payment in lieu of fractional Shares in an amount determined by the Board, and may fix the value for distribution of any specific assets, and may determine that cash payments shall be made to any Shareholders upon the basis of the value so fixed, or that fractions of less than NIS 0.01 (one New Agora) in value may be disregarded in order to adjust the rights of all parties, and may vest any such cash, Shares, debentures, debenture stock or specific assets in trustees for the persons entitled to the dividend or capitalized fund against such securities as may seem expedient to the Board of Directors. Where requisite, a proper contract shall be filed in accordance with the Companies Law, and the Board of Directors may appoint any person to sign such contract on behalf of such persons entitled to the dividend or capitalized fund, and such appointment shall be effective. |
74. | The Board of Directors may deduct from any dividend, bonus or other amount to be paid in respect of shares held by any Shareholder, whether alone or together with another Shareholder, any sum or sums due from him and payable by him alone or together with any other person to the Company on account of calls or the like. |
75. | The Board of Directors may retain any dividend or other monies payable or property distributable in respect of a Share on which the Company has a lien, and may apply the same in or towards satisfaction of the debts, liabilities, or engagements in respect of which the lien exists. |
76. | The Board of Directors may, when paying any dividend, resolve to retain any dividend, or other monies payable or property distributable, for distribution with respect to a Share in respect of which any person is under these Articles entitled to become a Shareholder, or which any person is under these Articles entitled to transfer, until such person shall become a Shareholder in respect of such Share or shall transfer the same. |
77. | All unclaimed dividends or other monies payable in respect of a Share may be invested or otherwise made use of by the Board of Directors for the benefit of the Company until claimed. The payment by the Directors of any unclaimed dividend or such other monies into a separate account shall not constitute the Company a trustee in respect thereof. The principal (and only the principal) of an unclaimed dividend or such other moneys shall be, if claimed, paid to a person entitled thereto. |
78. | Any dividend or other monies payable in cash in respect of a Share may be paid by check or warrant sent through the post to, or left at, the registered address of the person entitled thereto or by transfer to a bank account specified by such person (or, if two or more persons are registered as joint holders of such share to the one whose name appears first in the Register), or to such person and at such address as the person entitled thereto may by writing direct. Every such check or warrant shall be made payable to the order of the person to whom it is sent, or to such person as the person entitled thereto as aforesaid may direct, and payment of the check or warrant by the banker upon whom it is drawn shall be a good discharge to the Company. |
79. | If several persons are registered as joint holders of any Share, any one of them may give effectual receipts for any dividend payable or property distributable, on the Share. |
BOOKS OF ACCOUNT
80. | The Board of Directors shall cause accurate books of account to be kept in accordance with the provisions of the Companies Law and any other applicable law. The books of account shall be kept at the Office or at any other place or places as the Board of Directors may deem fit, and they shall always be open to inspection by Directors. No Shareholder not being a Director shall have the right to inspect any account or book or document of the Company except as conferred by law or authorized by the Board of Directors or by the Company in a general meeting. |
ACCOUNTS AND AUDIT
81. | Once at least in every year the accounts of the Company shall be examined and the correctness of the profit and loss account and balance sheet ascertained by a duly qualified auditor. |
82. | The appointment, authorities, rights, salaries and duties of the auditor or auditors shall be regulated by the law in force for the time being and by the provisions of these Articles, provided, however, that in exercising its authority to fix the remuneration of the auditor(s), the Shareholders in a general meeting may, by a Shareholder Resolution, act (and in the absence of any action in connection therewith shall be deemed to have so acted), to authorize the Board of Directors to fix such remuneration subject to such criteria or standards, if any, as may be provided in such resolution, and if no such criteria or standards are so provided, such remuneration shall be fixed in an amount commensurate with the volume and nature of the services rendered by such auditor(s). |
NOTICES
83. | Any notice or other document may be served by the Company upon any Shareholder either personally or by sending it by prepaid mail (air mail if sent to a place outside Israel), fax or e-mail addressed to such Shareholder at his address as described in the Register or such other address (if any) as he may have designated in writing for the receipt of notices and other documents. Any notice or other document may be served by any Shareholder upon the Company by tendering the same in person to the General Manager of the Company at the Office or by sending it by prepaid registered mail (air mail if posted outside Israel) to the Company at the Office. Any such notice or other document shall be deemed to have been served on two (2) Business Days after it has been posted (seven (7) Business Days if sent to a place, or posted at a place, outside Israel), or when actually received by the addressee if sooner than two (2) Business Days or seven (7) Business Days, as the case may be, after it has been posted, or when actually tendered in person, to such Shareholder (or to the General Manager), provided, however, that notice may be sent by e-mail, facsimile or other customary method, and such notice shall be deemed to have been given the first Business Day after such e-mail, facsimile or other customary method has been sent (and sender has received electronic confirmation of receipt by the recipient) or when actually received by such Shareholder (or by the Company), whichever is earlier. If a notice is in fact, received by the addressee, it shall be deemed to have been duly served, when received, notwithstanding that it was defectively addressed or failed in some other respect, to comply with the provisions of this Article. |
84. | A notice may be given by the Company to the joint holders of a Share by giving notice to the joint holder named first in the Register in respect of the Share. |
85. | Any Shareholder whose address is not described in the Register, and who shall not have designated in writing an address for the receipt of notices, shall not be entitled to receive any notice from the Company. |
86. | The Company may declare that any document(s) will be delivered or be available for review at the Office or any other place designated by the Board of Directors. |
87. | Whenever it is required to give prior notice a specified number of days in advance or where a notice is valid for a specified period, the day immediately following service of the notice shall be included in such count or period. Where notice is given by more than one method, it will be deemed served on the earliest of such dates. |
88. | Subject to applicable law, any Shareholder, Director or any other person entitled to receive notice in accordance with these Articles or law, may waive notice, in advance or retroactively, in a particular case or type of cases or generally, and if so, notice will be deemed as having been duly served, and all proceedings or actions for which the notice was required will be deemed valid. |
89. | Any person entitled to a Share by operation of law or by transfer, transmission or otherwise, will be bound by any notice served with respect to such Shares prior to his being registered in the Register as owner of the Shares. |
90. | Notwithstanding anything to the contrary contained herein, the Company may give notice to any Shareholder whose address as registered in the Register is within the State of Israel, by publishing such notice in two daily newspapers in the State of Israel, and the date of such publication shall be deemed the date on which such notice has been served to such Shareholders. |
WINDING-UP
91. | If the Company shall be wound up, then, subject to applicable law and the rights of holders of Shares with limited or preferred rights, including, without limitation, Article 7.3.1, the assets of the Company available for distribution among the Shareholders shall be distributed to them in proportion to the amount paid up or credited as paid up on account of the nominal value of the Shares held by them respectively and in respect of which such distribution is being made, without regard to any premium paid in excess of the nominal value, if any. |
INSURANCE. INDEMNITY AND RELEASE
92. | Subject to the provisions of the Companies Law, including the receipt of all approvals as required therein or under any applicable law, the Company shall indemnify any Office Holder (as such term is defined in the Companies Law) to the fullest extent permitted by the Companies Law. |
93. | Without prejudice to the foregoing, subject to the provisions of the Companies Law including the receipt of all approvals as required therein or under any applicable law, the Company may resolve retroactively to indemnify an Office Holder with respect to the following liabilities and expenses, provided, however, that such liabilities or expenses were incurred by such Office Holder in such Office Holder’s capacity as an Office Holder of the Company: |
93.1 | monetary liability imposed on an Office Holder, or incurred by the Office Holder, in favor of another person pursuant to a judgment, including a judgment imposed on such Office Holder in a compromise or in an arbitration decision that was approved by a court of law. |
93.2 | reasonable legal expenses, including attorney’s fees, which the Office Holder incurred due to an investigation or a proceeding instituted against the Office Holder by an authority competent to administrate such an investigation or proceeding, and that was “finalized without the filing of an indictment” (as defined in Section 260(a)(1A) of the Companies Law) and “without any financial obligation imposed in lieu of criminal proceedings” (as defined in Section 260(a)(1A) of the Companies Law), or that was finalized without the filing of an indictment against the Office Holder but with financial obligation imposed on the Office Holder in lieu of criminal proceedings of an offense that does not require proof of criminal intent, or in connection with a monetary sanction. |
93.3 | reasonable legal expenses, including attorney’s fees, which the Office Holder incurred or with which the Office Holder was charged by a court of law, in a proceeding brought against the Office Holder, by the Company or by another on behalf of the Company, or in a criminal prosecution in which the Office Holder was acquitted, or in a criminal prosecution in which the Office Holder was convicted of an offense that does not require proof of criminal intent. |
93.4 | any other circumstances arising under the law in respect of which the Company may indemnify an Office Holder of the Company, and to the extent such law requires the inclusion of a provision permitting such indemnity in these Articles, then such provision is deemed to be included and incorporated herein by reference (including, without limitation, in accordance with Section 56h(b)(1) of the Securities Law (as defined below), if applicable, and 50P(b)(2) of the Israeli Restrictive Trade Practices Law, 5758-1988. |
93.5 | a payment which the Office Holder is obligated to make to an injured party as set forth in Section 52(54)(a)(1)(a) of the Israeli Securities Law, 1968, as amended (the “Securities Law”), if applicable, and expenses that he incurred in connection with a proceeding under Chapters H’3, H’4 or 1’1 of the Securities Law, if applicable, including reasonable legal expenses, which term includes attorney fees. |
94. | Subject to the provisions of the Companies Law including the receipt of all approvals as required therein or under any applicable law, the Company may undertake in advance to indemnify the Company’s Office Holders (i) for those liabilities and expenses described in Sub-Article 92.1, provided that the undertaking is limited to events that in the opinion of the Board of Directors are foreseeable in view of the Company’s activity at the time of the undertaking and limited in an amount or standard which the Board of Directors determines is reasonable under the circumstances, and (ii) for those liabilities and expenses described in Sub-Articles 92.2, through 92.5. |
95. | The Company shall, subject and pursuant to the provisions of the Companies Law, enter into contracts to insure the liability of Office Holders of the Company for any liabilities incurred by them arising from or as a result of any act (or omission) carried out by them as Office Holders of the Company and for which the Company may insure office holders pursuant to the Companies Law, to the maximum extent permitted by law, including in respect of one of the following: |
(a) | a breach of duty of care to the Company or to any other person; |
(b) | a breach of his fiduciary duty to the Company, provided that the Office Holder acted in good faith and had reasonable grounds to assume that act that resulted in such breach would not prejudice the interests of the Company; |
(c) | a financial liability imposed on such Office Holder in favor of any other person; |
(d) | payments to an injured party imposed on the Office Holder pursuant to Section 52ND(a)(1)(a) of the Securities Law; and |
(e) | any other event, occurrence, matters or circumstances under any law with respect to which the Company may, or will be able to, insure an Office Holder, and to the extent such law requires the inclusion of a provision permitting such insurance in these Articles, then such provision is deemed to be included and incorporated herein by reference (including, without limitation, in accordance with 56h(b)(1) of the Securities Law, if and to the extent applicable, and Section 50P of the Israeli Restrictive Trade Practices Law, 5758-1988). |
96. | The Company shall, to the maximum extent permitted by law, exempt and release an Office Holder of the Company, including in advance, from and against all or part of his or her liability for monetary or other damages due to, arising or resulting from, a breach of his or her duty of care to the Company. The Directors of the Company are released and exempt from all liability as aforesaid to the maximum extent permitted by law with respect to any such breach, which has been or may be committed. |
97. | The provisions of Articles 91 through 95 above (a) shall apply to the maximum extent permitted by law (including the Companies Law, the Securities Law and the Israeli Restrictive Trade Practices Law, 57581988); and (b) are not intended, and shall not be interpreted, to restrict the Company in any manner in 61 respect of the procurement of insurance and/or in respect of indemnification (whether in advance or retroactively) and/or exemption (i) in connection with any person who is not an Office Holder including, without limitation, any employee, agent, consultant or contractor of the Company who is not an Office Holder, and/or (ii) in connection with any Office Holder to the extent that such insurance and/or indemnification is not specifically prohibited under law. |
98. | In any case where insurance of liability of an Office Holder of the Company or indemnification of such Office Holder is prohibited by any applicable law, the Company shall not insure the liability of such Office Holder of the Company, nor shall it indemnify such Office Holder. |
99. | Any amendment to the Companies Law and/or the Securities Law or any other applicable law adversely affecting the right of any Office Holder to be indemnified, insured or exempt pursuant to Articles 91 through 95 and any amendments to Articles 91 through 95 shall be prospective in effect, and shall not affect the Company’s obligation or ability to indemnify, insure or exempt an Office Holder for any act or omission occurring prior to such amendment, unless otherwise provided by applicable law. |
EXCLUDED OPPORTUNITIES
100. | The Company renounces any interest or expectancy of the Company in, or in being offered an opportunity to participate in, or in being informed about, an Excluded Opportunity. An “Excluded Opportunity” is any matter, transaction or interest that is presented to, or acquired, created or developed by, or which otherwise comes into the possession of, (i) any director of the Company who is not an employee of the Company or any of its subsidiaries, or (ii) any holder of Preferred Shares or any Affiliate, partner, member, director, shareholder, employee, agent or other related person of any such holder, other than someone who is an employee of the Company or any of its subsidiaries (collectively, “Covered Persons”), unless such matter, transaction or interest is presented to, or acquired, created or developed by, or otherwise comes into the possession of, a Covered Person solely in such Covered Person’s capacity as a Director or shareholder of the Company. For avoidance of doubt, a Founder shall not be deemed a Covered Person (and therefore the renouncement of the Company in this Article 99 shall not apply to him); provided, however, that the same shall not, by and of itself, impose on such Founder any obligations beyond the requirements of any applicable law or agreement with such Founders. |
MARKET STAND-OFF
101. | Each Shareholder hereby agrees that it will enter into a lock-up agreement as required in connection with an IPO or a SPAC Transaction as part of a Public Event pursuant to which the Shareholder shall agree, as the case may be, during the period commencing on the date of the final prospectus relating to the Company’s IPO in the case of an IPO or commencing on the date of the consummation of the initial business combination in the case of a SPAC Transaction (such date, the “Stand-Off Effective Date”), not to lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right, or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any Ordinary Shares or any securities convertible into or exercisable or exchangeable (directly or indirectly) for Ordinary Shares held immediately prior to the Stand-Off Effective Date or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of such securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Ordinary Shares or other securities, in cash, or otherwise for a period not to exceed 180 days in the case of an IPO and for such reasonable period as negotiated in good faith by the Board of Directors in the case of a SPAC Transaction. |
It shall be understood that in the case of an IPO, the foregoing provisions shall be subject to customary carveouts, and shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, or the transfer of any shares to any trust for the direct or indirect benefit of the Shareholder or the immediate family of the Shareholder, provided that the trustee of the trust agrees to be bound in writing by the restrictions set forth herein, and provided further that any such transfer shall not involve a disposition for value, and shall be applicable to the Shareholders only if all officers and directors are subject to the same restrictions and the Company uses commercially reasonable efforts to obtain a similar agreement from all shareholders individually owning more than one percent (1%) of the Company’s outstanding Ordinary Shares (after giving effect to conversion into Ordinary Shares of all outstanding Preferred Shares). The underwriters in connection with such registration are intended third party beneficiaries of this provision and shall have the right, power, and authority to enforce the provisions hereof as though they were a party hereto. Each Shareholder further agrees to execute such agreements as may be reasonably requested by the underwriters in connection with such registration that are consistent with this provision or that are necessary to give further effect thereto. Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters shall apply pro rata to all Shareholders subject to such agreements, based on the number of shares subject to such agreements. Notwithstanding anything herein to the contrary, this provision shall not apply to any equity securities purchased by a Shareholder in the Company’s IPO.
* * * * * *
67
Pagaya Technologies Ltd.
90 Park Ave,
New York, NY 10016
|
|
Attention:
|
Gal Krubiner
Richmond Glasgow
|
Email:
|
gal@pagaya-inv.com
richmond@pagaya.com
|
Skadden, Arps, Slate, Meagher & Flom LLP
One Manhattan West New York, New York 10001 |
|
Attention:
|
Andrea Nicolas
Jeffrey Brill Maxim Mayer-Cesiano B. Chase Wink
|
Email:
|
andrea.nicolas@skadden.com
jeffrey.brill@skadden.com maxim.mayercesiano@skadden.com b.chase.wink@skadden.com
|
Goldfarb Seligman & Co., Law Offices
Ampa Tower, 98 Yigal Alon Street,
Tel Aviv 6789141, Israel
|
|
Attention:
|
Sharon Gazit, Adv.
Aaron M. Lampert, Adv.
|
Email:
|
sharon.gazit@goldfarb.com
aaron.lampert@goldfarb.com
|
Name of Investor:
|
State/Country of Formation or Domicile:
|
||||
By:
|
|||||
Name:
|
|||||
Title:
|
|||||
Name in which the Subscription Shares are to be registered (if different):
|
Date: ________, 2021
|
||||
Investor’s EIN:
|
|||||
Entity Type (e.g., corporation, partnership, trust, etc.):
|
|||||
Business Address-Street:
|
Mailing Address-Street (if different):
|
||||
City, State, Zip:
|
City, State, Zip:
|
||||
Attn:
|
Attn:
|
||||
Telephone No.:
|
Telephone No.:
|
||||
Facsimile No.:
|
Facsimile No.:
|
||||
Number of Shares subscribed for:
|
|||||
Aggregate Subscription Amount: $[●]
|
Price Per Share: $10.00
|
|
PAGAYA TECHNOLOGIES LTD.
|
||
|
|
||
|
By:
|
||
|
Name:
|
||
|
Title:
|
|
By:
|
||
|
Name:
|
||
|
Title:
|
A. |
QUALIFIED INSTITUTIONAL BUYER STATUS
(Please check the applicable subparagraphs): |
☐ |
We are a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act).
|
☐ |
We are an “institutional account” as defined by FINRA Rule 4512(c).
|
B. |
INSTITUTIONAL ACCREDITED INVESTOR STATUS
(Please check the applicable subparagraphs): |
1. | ☐ | We are an institutional “accredited investor” (within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act), and have marked and initialed the appropriate box on the following page indicating the provision under which we qualify as an “accredited investor.” |
2. | ☐ | We are not a natural person. |
3. | ☐ | We are an “institutional account” as defined by FINRA Rule 4512(c). |
☐ |
Any bank, registered broker or dealer, insurance company, registered investment company, business development company, or small business investment company;
|
☐ |
Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions for the benefit of its employees, if such plan has total assets in excess of
$5,000,000;
|
☐ |
Any employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered investment advisor makes the investment decisions, or if the plan has total assets in
excess of $5,000,000;
|
☐ |
Any organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, similar business trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of
$5,000,000;
|
☐ |
Any trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated person;
|
☐ |
Any revocable trust where all of the grantors are “accredited investors”; or
|
☐ |
Any entity in which all of the equity owners are “accredited investors”.
|
C. |
QUALIFIED ISRAELI INVESTOR STATUS (for Israeli investors only – please check the applicable box):
|
1. |
Are you an investor in one of the categories listed in the First Addendum to the Israeli Securities Law, 5728-1968 (the “Securities Law”), and listed below, such an investor being referred to in
this Questionnaire as a “Qualified Israeli Investor”?
|
☐ Yes |
☐ No
|
2. |
Please specify the category listed in the First Addendum to the Israeli Securities Law, to which you belong, by completing below.
|
☐ |
A joint investment fund or the manager of such a fund within the meaning of the Joint Investments in Trust Law, 5754-1994;
|
☐ |
A provident fund or the manager of such a fund within the meaning of the Control of Financial Services Law (Provident Funds), 5765-2005;
|
☐ |
An insurance company as defined in the Supervision of Insurance Business Law, 5741-1981;
|
☐ |
A banking corporation or a supporting corporation within the meaning of the Banking (Licensing) Law, 5741-1981, with the exception of a joint services company, purchasing for their own account or for the accounts of clients who are
Qualified Israeli Investors or who are otherwise listed in Section 15A(b) of the Securities Law (collectively, “Exempt Investors”);
|
☐ |
A licensed portfolio manager within the meaning of the Regulation of Investment Advice, Investment Marketing and Investment Portfolio Management Law, 5755-1995 (“Investment Advice Law”), purchasing
for its own account or for the accounts of clients who are Exempt Investors;
|
☐ |
A licensed investment advisor or a licensed investment marketer within the meaning of the Investment Advice Law, purchasing for its own account;
|
☐ |
A member of the Tel Aviv Stock Exchange, purchasing for its own account or for the accounts of clients who are Exempt Investors;
|
☐ |
An underwriter that satisfies the criteria prescribed in Section 56(c) of the Israeli Securities Law, 5728-1968, purchasing for its own account;
|
☐ |
A venture capital fund (defined for this purpose as an entity whose principal activity is investing in entities that are engaged primarily in research and development, or in the manufacture of innovative products and processes, with an
unusually high investment risk);
|
☐ |
An entity that is wholly owned by Exempt Investors;
|
☐ |
An entity, except for an entity that was incorporated for the purpose of investing in securities in a specific offering, whose shareholders equity exceeds NIS 50 million; or
|
☐ |
An individual who fulfills at least one of the following criteria (note: you must provide confirmation from your certified public accountant regarding the criterion you satisfy):
|
(a) |
the aggregate value of Liquid Assets owned by such investor exceeds NIS 8,095,444;
|
(b) |
such investor’s annual income in each of the previous two years exceeds NIS 1,214,317, or the annual income of the Family Unit to which such investor belongs, for the same period, exceeds NIS 1,821,475; or
|
(c) |
the total value of such investor’s Liquid Assets exceeds NIS 5,059,652 and such investor’s annual income in each of the previous two years exceeds NIS 607,158, or the annual income of such investor’s Family Unit for the same period
exceeds NIS 910,737;
|
1. |
Organizational documents (charters, articles of incorporation, etc.) of the Investor or the certificate of an authorized officer with material excerpts of same as agreed by the Company.
|
2. |
Names of ultimate beneficial owners holding 10% or more of the Investor’s beneficial ownership (“UBOs”), if applicable to the Investor.
|
3. |
Passport/national ID of natural person UBOs, if applicable to the Investor.
|
Name
|
Title
|
Signature
|
Gal Krubiner
|
CEO
|
|
Avital Pardo
|
CTO
|
|
Yahav Yulzari
|
CRO
|
|
Michael Kurlander
|
CFO
|
|
Richmond Glasgow
|
GC
|
Exhibit 10.9
PAGAYA TECHNOLOGIES LTD.
2016 EQUITY INCENTIVE PLAN
1. | Purposes of the Plan |
The purposes of this Equity Incentive Plan are to attract and retain the best available personnel, to provide additional incentive to Employees, Directors and Consultants and to promote the success of the business of the Company and its Subsidiaries. Awards granted under this Plan may be 102 Options, 3(i) Options, Awards of Restricted Stock, Awards of Restricted Stock Units, Incentive Stock Options, Nonstatutory Stock Options or any combination of the foregoing, as determined by the Administrator at the time of grant.
2. | Definitions |
As used herein, the following definitions shall apply:
2.1. | “Affiliate” means any “employing company” within the meaning of Section 102(a) of the Ordinance. |
2.2. | “Administrator” means the Board or any of its Committees as shall be administrating the Plan in accordance with Section 4 hereof. |
2.3. | “Applicable Laws” means the requirements relating to the administration of stock option plans under Israeli and U.S. state corporate laws, Israeli and U.S. federal and state securities laws, the Code, the Ordinance, any stock exchange or quotation system on which the Shares are listed or quoted and the applicable laws of any other country or jurisdiction that may apply to Awards which are granted under the Plan. |
2.4. | “Articles” means the Articles of Association of the Company, as amended or restated from time to time. |
2.5. | “Award” means any 102 Options, 3(i) Options, awards of Restricted Stock, awards of Restricted Stock Units, Incentive Stock Options, Nonstatutory Stock Options or any combination of the foregoing, which are granted under the Plan. |
2.6. | “Award Agreement” means, with respect to each Award, the applicable signed written agreement between the Company and the Participant setting forth the terms and conditions of an individual Award granted under the plan. |
2.7. | “Board” means the Board of Directors of the Company. |
2.8. | “Code” means the Internal Revenue Code of 1986, as amended from time to time. |
2.9. | “Cause” shall have the meaning ascribed to it in the applicable employment or consulting agreement of Participant. In the absence of such definition, “Cause” shall mean any of the following: (i) the Participant’s theft, dishonesty, or falsification of any Company documents or records; (ii) the Participant’s improper use or disclosure of the Company’s confidential or proprietary information; (iii) any action by the Participant which has a detrimental effect on the Company’s reputation or business; (iv) the Participant’s failure or inability to perform any reasonable assigned duties after written notice from the Company of, and a reasonable opportunity to cure, such failure or inability; (v) any material breach of the Participant of any employment agreement between the Participant and the Company, which breach is not cured within thirty (30) days pursuant to the terms of such agreement; or (vi) the Participant’s conviction (including any plea of guilty) of any criminal act which impairs the Participant’s ability to perform his or her duties with the Company. For purposes of the definition of Cause, with respect to a Participant employed by or providing services to a Parent or Subsidiary of the Company, the term “Company” shall also include the Parent or Subsidiary employing or engaging the services of the Participant. |
2.10. | “Committee” means a committee of Directors appointed by the Board in accordance with Section 4 hereof. |
2.11. | “Company” means Pagaya Technologies Ltd., an Israeli company. |
2.12. | “Consultant” means any person who is engaged by the Company or any Parent or Subsidiary to render consulting or advisory services to such entity, including any employees of such person and including a non-Employee Director of the Company or any Parent or Subsidiary thereof. A Participant shall not cease to be a Consultant in case of any temporary interruption in such person’s availability to provide services to the Company, its Parent, any Subsidiary, or any successor, which has been authorized in writing by the engaging company (or by the Parent or Subsidiary) prior to its commencement. |
2.13. | “Controlling Shareholder” shall have the meaning ascribed to it in Section 32(i) of the Ordinance. |
2.14. | “Director” means a member of the Board of Directors of the Company or any Parent or Subsidiary. |
2.15. | “Eligible Recipient” means an Employee or Consultant. |
2.16. | “Employee” means any person, including Officers and Directors, employed by the Company, or any Parent or Subsidiary of the Company, with or without payment. Subject to the provisions of any Applicable Law, a Participant shall not cease to be an Employee in the case of (i) any leave of absence approved by the Company (or by the Parent or Subsidiary that employs the person) or (ii) transfers between locations of the Company (or the Parent or Subsidiary that employs the person) or between the Company, its Parent, any Subsidiary, or any successor. |
2.17. | “Exchange Act” means the Securities Exchange Act of 1934, as amended. |
2.18. | “Employing Company” shall have the meaning ascribed to it in Section 102(a) of the Ordinance. |
2.19. | “Exercise Price” means the per share price at which a holder of an Award may purchase Shares issuable upon exercise of the Award. |
2.20. | “Fair Market Value” means, as of any date, the value of Shares determined as follows: |
(i) | If the Shares are listed on any established stock exchange or a national market system, including without limitation the Nasdaq National Market or The Nasdaq SmallCap Market of The Nasdaq Stock Market, its Fair Market Value shall be the closing sales price for such shares (or the closing bid, if no sales were reported) as quoted on such exchange or system for the last market trading day prior to the time of determination, as reported in The Wall Street Journal or such other source as the Administrator deems reliable (if the Shares are listed or quoted on more than one established stock exchange or national market system, the Administrator shall determine the appropriate exchange or system); |
(ii) | If the Shares are regularly quoted by a recognized securities dealer but selling prices are not reported, its Fair Market Value shall be the mean between the high bid and low asked prices for the Shares on the last market trading day prior to the day of determination; or |
(iii) | In the absence of an established market for the Shares, the Fair Market Value thereof shall be determined in good faith by the Administrator. |
2.21. | “Incentive Stock Option” means an Option intended to qualify as an incentive stock option within the meaning of Section 422 of the Code. |
2.22. | “IPO” means the consummation of the initial public offering of the Company’s Ordinary Shares. |
2.23. | “Israeli Employee” means a person who is a resident of the state of Israel or who is deemed to be a resident of the state of Israel for tax purposes, and who is an Employee or an Office Holder (“Nose Missra”) of the Company, or any Parent or Subsidiary of the Company, in each case excluding a person who is a Controlling Shareholder prior to the issuance of the relevant Award or as a result thereof. |
2.24. | “Israeli Non-Employee” means a person who is a resident of the state of Israel or who is deemed to be a resident of the state of Israel for tax purposes, and who is (i) a Consultant, who is not an Employee, or (ii) a Controlling shareholder (whether or not an employee of the Company or any Parent or Subsidiary thereof) prior to the issuance of the relevant Option or as a result thereof. |
2.25. | “ITA” means the Israeli Income Tax Authorities. |
2.26. | “Nonstatutory Stock Option” means an Option not intended to qualify as an Incentive Stock Option. |
2.27. | “Officer” or “Office Holder” shall have the meaning ascribed to it in the Israeli Companies Law, 5759-1999, as amended from time to time. |
2.28. | “Non-Trustee 102 Option” means an Option granted to an Employee pursuant to Section 102(c) of the Ordinance, which is not required to be held in trust by a Trustee. |
2.29. | “Option” means a stock option granted pursuant to the Plan (including 102 Options, 3(i) Options, Incentive Stock Options and Nonstatutory Stock Options). |
2.30. | “Option Exchange Program” means a program whereby outstanding Options are exchanged for Options with a lower Exercise Price. |
2.31. | “Ordinance” means the Israeli Income Tax Ordinance (New Version), 1961, as amended, the rules promulgated thereunder, or any law or regulations which shall replace the Ordinance or Sections 3(i) or 102 promulgated thereunder. |
2.32. | “Parent” means a company, whether now or hereafter existing, to which the Company is a Subsidiary. |
2.33. | “Participant” means any Eligible Recipient selected by the Administrator, pursuant to the Administrator’s authority in Section 4 below, to receive grants of Options, Restricted Stock, Restricted Stock Units or any combination of the foregoing. |
2.34. | “Plan” means this 2016 Equity Incentive Plan. |
2.35. | “Restricted Stock” means Shares subject to certain restrictions granted pursuant to Section 18 below. |
2.36. | “Restricted Stock Unit” means a right granted under and subject to restrictions pursuant to Section 19 below. |
2.37. | “Share” means an Ordinary Share of the Company, having a nominal value of NIS 0. 01, as may be adjusted in accordance with Section 21 below. |
2.38. | “Section 102” means section 102 of the Ordinance and any regulations, rules, orders or procedures promulgated thereunder as now in effect or as amended or replaced from time to time. |
2.39. | “Subsidiary” means any company, whether now or hereafter existing, other than the first company, in an unbroken chain of companies, if each of the companies (other than the last company) in the unbroken chain, owns shares possessing more than fifty percent (50%) of the total combined voting power of all classes of shares in one of the other companies in such chain. |
2.40. | “Successor Company” means a successor corporation in a Transaction or any parent or Affiliate thereof, as determined by the Administrator in its discretion. |
2.41. | “Transaction” means: (i) a sale of all or substantially all of the assets of the Company, or a sale (including an exchange) of all or substantially all of the shares of the Company, to any person, or a purchase by a shareholder of the Company or by an Affiliate of such shareholder, of all or substantially all the shares of the Company held by all or substantially all other shareholders or by other shareholders who are not Affiliated with such acquiring party; (ii) a merger (including, a reverse merger and a reverse triangular merger), consolidation, amalgamation or like transaction of the Company with or into another corporation; (iii) a scheme of arrangement for the purpose of effecting such sale, merger, consolidation, amalgamation or other transaction; or (iv) such other transaction or set of circumstances that is determined by the Administrator, in its discretion, to be a Transaction subject to the provisions of Section 21.4 below; excluding (a) any of the above transactions in clauses (i) through (iv) with a wholly-owned subsidiary (directly or indirectly) of the Company for the purpose of reincorporating the Company in another jurisdiction, (b) any of the above transactions in clauses (i) through (iii) if the Administrator determines that such transaction should be excluded from the definition hereof and the applicability of Section 21.4 below, (c) any of the above transactions in clauses (i) through (iv) in which shareholders of the Company prior to the transaction will maintain more than fifty percent (50%) of the voting power of the resulting or surviving entity after the transaction (provided, however, that shares of the resulting or surviving entity held by shareholders of the Company acquired by means other than the exchange or conversion of the shares of the Company shall not be used in determining if the shareholders of the Company own more than fifty percent (50%) of the voting power of the resulting or surviving entity (or its parent), but shall be used for determining the total outstanding voting power of the resulting or surviving entity); (d) any of the above transactions in clauses (i) through (iv) in connection with an issuance of securities by the Company as part of a transaction financing. |
2.42. | “Trustee” means any person or entity appointed by the Company, any of its Parents or any of its Subsidiaries, as applicable, and approved by the ITA, to serve as a trustee, all in accordance with the provisions of Section 102(a) of the Ordinance. |
2.43. | “Trustee 102 Option” means an Option granted pursuant to the rules set in Section 102(b) of the Ordinance and held in trust by a Trustee for the benefit of the Participant. |
2.44. | “102 Option” means an Option granted under the rules of Section 102 of the Ordinance, as amended, or any law or regulations, which shall replace Section 102. |
2.45. | “102 Capital Gain Options (102 CGO)” means a Trustee 102 Option elected and designated by the Employing Company to qualify for capital gain tax treatment in accordance with the provisions of Section 102(b)(2) of the Ordinance. |
2.46. | “102 Ordinary Income Option (102 OIO)” means a Trustee 102 Option elected and designated by the Employing Company to qualify for ordinary income tax treatment in accordance with the provisions of Section 102(b)(1) of the Ordinance. |
2.47. | “3(i) Option” means an Option granted under the rules of Section 3(i) of the Ordinance, as amended, or any law or regulations, which shall replace Section 3(i). |
3. | Shares Subject to the Plan |
Subject to the provisions of Section 21 of the Plan, the aggregate number of Shares reserved and available for grant of Awards under the Plan is 111,111 or such other number of Shares as the Board shall determine from time to time. The Shares may be authorized but unissued, or reacquired Shares. Such Shares may consist, in whole or in part, of authorized and unissued shares or treasury shares.
If and to the extent that an Option expires, terminates or is canceled or forfeited for any reason without having been exercised in full, the Shares associated with that portion of that Option which was not exercised will again become available for grant under the Plan. Similarly, if and to the extent an Award of Restricted Stock or Restricted Stock Units is canceled or forfeited for any reason, the Shares subject to that Award will again become available for grant under the Plan. Shares withheld in settlement of a tax withholding obligation associated with an Award, or in satisfaction of the Exercise Price payable upon exercise of an Award, will again become available for grant under the Plan. If any Award or portion thereof is settled for cash, the Shares attributable for such cash settlement will again become available for grant.
4. | Administration of the Plan |
4.1. | Administrator. The Plan shall be administered by the Board or a Committee appointed by the Board, which Committee shall be constituted to comply with Applicable Laws. Notwithstanding the above, the Board shall automatically have residual authority if no Committee shall be constituted or if such Committee shall cease to operate for any reason. |
4.2. | Powers of the Administrator. Subject to the provisions of the Plan and, in the case of a Committee, the specific duties delegated by the Board to such Committee, and subject to the approval of any relevant authorities and compliance with all Applicable Laws, the Administrator shall have the full power and authority at its sole discretion, from time to time and at any time: |
(i) | To determine whether and to what extent Awards are to be granted hereunder to Participants; |
(ii) | To determine and/or amend the Exercise Price of the Awards; |
(iii) | To determine and/or amend the vesting schedule of the Awards; |
(iv) | To determine and/or amend the terms of payment for the Shares; |
(v) | To select the Eligible Recipients to whom Awards may from time to time be granted hereunder; |
(vi) | To determine the number of Shares to be covered by each Award granted hereunder; |
(vii) | To approve forms of agreement for use under the Plan; |
(viii) | To determine the terms and conditions of any Award granted hereunder. Such terms and conditions shall include, but shall not be limited to, the Exercise Price, the time or times and the extent to which the Awards may be exercised (which may be based on performance criteria), any vesting acceleration (whether or not in connection with a Transaction) or waiver of forfeiture restrictions, and any restriction or limitation regarding any Award or the Shares relating thereto, based in each case on such factors as the Administrator, at its sole discretion, shall determine; |
(ix) | To determine the Fair Market Value of the shares covered by each Award; |
(x) | To make an election as to the type of 102 Option; |
(xi) | To establish, add, cancel, amend or otherwise alter any restrictions, terms or conditions of any Award or Shares subject to any Award (including, without limitation, change the vesting terms, or accelerate the vesting periods, or add acceleration provisions with respect to, any Award granted hereunder); |
(xii) | To prescribe, amend and rescind rules and regulations relating to the Plan, including rules and regulations relating to sub-plans established for the purpose of qualifying for preferred tax treatment under foreign tax laws; |
(xiii) | To authorize conversion or substitution under the Plan of any or all Awards and to cancel or suspend Awards, as necessary, provided the material interests of the Participants are not harmed; |
(xiv) | To construe and interpret the terms of the Plan and Awards granted pursuant to the Plan; |
(xv) | To alter, revise or otherwise adjust the terms of the Plan and the Award Agreement, as may be required pursuant to any applicable laws of local or foreign jurisdictions; |
All the abovementioned powers and actions may be taken by the Administrator at the date of grant of the Award and/or at any time thereafter.
4.3. | In the event of a tie vote with respect to any matter brought before the Administrator, such matter shall be presented to the Board and the decision of the Board shall be final with respect to such matter. |
4.4. | Neither the Trustee nor any member of the Board or the Committee shall be liable to the Company or to any Participant, for any action or determination taken or made in good faith as a Committee member in the course of administrating the Plan. Each member of the Board or the Committee shall be indemnified and held harmless by the Company or by any Participant against any cost or expense (including counsel fees) reasonably incurred by him, or any liability (including any sum paid in settlement of a claim with the approval of the Company) arising out of any act or omission to act in connection with the Plan unless arising out of such member’s own fraud or bad faith, all to the extent permitted by applicable law. Such indemnification shall be in addition to any rights of indemnification the member may have as a director or otherwise under the Company’s charter documents, any agreement, any vote of shareholders or disinterested directors, insurance policy or otherwise. |
4.5. | Effect of Administrator’s Decision. All decisions, determinations and interpretations of the Administrator shall be final and binding on all Participants. |
5. | Term of Plan |
5.1. | The Plan shall become effective upon its adoption by the Board. It shall continue in effect for a term of ten (10) years unless sooner terminated under Section 23 below. |
5.2. | Termination of the Plan shall not affect the Administrator’s ability to exercise the powers granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination. |
6. | Eligibility |
Awards may be granted to Participants and to persons to whom offers of employment or engagement as Employees or Consultants have been extended.
7. | Options to Non Israeli Participants |
7.1. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, Nonstatutory Stock Options may be granted to non-Israeli Employees and non-Israeli Consultants and Incentive Stock Options may be granted only to non-Israeli Employees. |
7.2. | Each Option granted to non Israeli Participants shall be designated in the Award Agreement as either an Incentive Stock Option or a Nonstatutory Stock Option, unless the Administrator determines otherwise at any time and subject to Applicable Laws. However, notwithstanding such designation, to the extent that the aggregate Fair Market Value of the Shares with respect to which Incentive Stock Options are exercisable for the first time by the Participant during any calendar year (under all plans of the Company and any Parent or Subsidiary) exceeds $100,000, then unless the Administrator determines otherwise at any time and subject to the requirements of any applicable law, such options shall be treated as Nonstatutory Stock Options. For purposes of this Section, Incentive Stock Options shall be taken into account in the order in which they were granted. The Fair Market Value of the Shares shall be determined as of the time the option with respect to such Shares is granted. |
8. | Options to Israeli Participants |
8.1. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, Israeli Employees may be granted only 102 Options and Israeli Non-Employees may be granted only 3(i) Options. In each case, such options shall be subject to the terms and conditions of the Ordinance. |
8.2. | The Employing Company may designate 102 Options granted to Israeli Employees pursuant to Section 102 as Non-Trustee 102 Options or as Trustee 102 Options. |
9. | Trustee 102 Options |
9.1. | Options granted pursuant to this Section 9 are intended to constitute Trustee 102 Options and are subject to the provisions of Section 102 and the general terms and conditions specified in the Plan, except for such provisions of the Plan applying to options under a different tax law or regulation. |
9.2. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, Trustee 102 Options may be granted only to Israeli Employees. |
9.3. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, Trustee 102 Options shall be classified as either 102 CGO or 102 OIO, subject to the terms and conditions of Section 102 and the provisions of the Plan. |
9.4. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, no Trustee 102 Options may be granted under this Plan, unless the Employing Company’s election of the type of Trustee 102 Options granted to Israeli Employees, 102 CGO or 102 OIO (the “Election”), is appropriately filed with the ITA. |
9.5. | After making an Election, unless the Administrator determines otherwise at any time and subject to Applicable Laws, the Company may grant only the type of Trustee 102 Options it has elected (i.e. 102 CGO or 102 OIO), and the Election shall apply to all grants to Participants of Trustee 102 Options until such Election is changed pursuant to the provisions of Section 102(g) of the Ordinance. Unless the Administrator determines otherwise at any time and subject to Applicable Laws, the Employing Company may change such Election only after the passage of at least one year following the end of the year during which the applicable Employing Company first granted Trustee 102 Options in accordance with the previous Election. |
9.6. | For the avoidance of doubt, such Election shall not prevent the Company from granting Non-Trustee 102 Options or 3(i) Options simultaneously with the grant of Trustee 102 Options. |
9.7. | The grant of Trustee 102 Options shall be conditioned upon the approval (or the deemed approval pursuant to the provisions of section 102(a) of the Ordinance) of the Plan and the Trustee by the ITA. |
9.8. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, Trustee 102 Options may be granted only after the passage of thirty (30) days (or a shorter period as and if approved by the ITA) following the delivery by the appropriate Employing Company to the ITA of a request for approval of the Plan and the Trustee according to Section 102, as mentioned in section 9.4 above. |
9.9. | Notwithstanding the foregoing paragraph, if within ninety (90) days of delivery of the abovementioned request, the appropriate ITA officer notifies the Employing Company of his or her decision not to approve the Plan or the Trustee, the Options that were intended to be granted as a Trustee 102 Options shall be deemed to be Non-Trustee 102 Options, unless otherwise determined by the ITA officer. |
9.10. | Anything herein to the contrary notwithstanding, all Trustee 102 Options granted under this Plan shall be granted or issued to a Trustee. The Trustee shall hold each such Trustee 102 Option, all Shares issued upon exercise thereof, and all other securities received following any exercise or realization of rights, including bonus shares, in trust for the benefit of the Participant in respect of whom such Option was granted. All certificates representing Options or Shares issued to the Trustee under the Plan shall be deposited with the Trustee, and shall be held by the Trustee until such time that such Options or Shares are released from the trust. |
9.11. | With respect to 102 CGO and 102 OIO, the Options or Shares issued upon the exercise thereof and all rights related to them, including bonus shares, will be held by the Trustee for such period of time as required under Section 102 (currently, at least 24 months (in case of a 102 CGO) and 12 months (in case of a 102 OIO), from the date on which such Option was issued and deposited with the Trustee) or a shorter period as approved by the ITA (hereinafter, the “Holding Period”), under the terms set forth in Section 102. |
9.12. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, in accordance with Section 102, the Participant shall not sell, cause the release from trust, or otherwise dispose of, any Trustee 102 Option, any Share issued upon the exercise thereof, or any rights related to them, including bonus shares, until the end of the applicable Holding Period. Notwithstanding the foregoing but without derogating from the provisions of the Plan and the terms and conditions set forth in the Award Agreement, if any such sale, release, or disposition occurs during the Holding Period, then the provision of Section 102, relating to non-compliance with the Holding Period, will apply and all sanctions under Section 102 shall be borne by the Participant. |
9.13. | Anything herein to the contrary notwithstanding, the Trustee shall not release any Options which were not already exercised into Shares by the Participant, nor release any Shares issued upon exercise of the Trustee 102 Options or rights related thereto, including bonus shares, prior to the full payment of the Exercise Price and Participant’s tax liability arising from the Trustee 102 Options which were granted to him or her. |
9.14. | In the event that a stock split shall be effected or bonus shares shall be issued on account of the Shares which have been issued for the Participant’s benefit, such new split or bonus shares shall be transferred by the Company to the Trustee to hold for such Participant’s benefit. |
9.15. | The validity of any order given to the Trustee by a Participant shall be subject to the approval of the Company. The Company shall render its decision regarding orders given by any Participant to the Trustee within a reasonable period of time. The Company shall not be required to approve any order which is incomplete, is not in accordance with the provisions of this Plan and the relevant Award Agreement or which the Company believes should not be executed for any reasonable reason. The Company shall notify the Participant of the reason for not approving his/her order. Approval by the Company of any order given to the Trustee by a Participant shall not constitute proof of the Company’s recognition of any right of such Participant. |
9.16. | Without derogating from the aforementioned, the Administrator shall have the authority to determine the specific procedures and conditions of the trusteeship with the Trustee in a separate agreement between the Company and the Trustee. |
9.17. | In the event that the requirements for the Trustee 102 Options are not met, then the Trustee 102 Options shall be regarded as Non-Trustee 102 Options. |
9.18. | Upon receipt of a Trustee 102 Option, the Participant will sign an Award Agreement under which such Participant will agree to be subject to the trust agreement between the Company and/or its Subsidiaries and the Trustee, stating, inter alia, that the Trustee will be released from any liability in respect of any action or decision duly taken and executed in good faith in relation to this Appendix, or any Trustee 102 Option or Share issued to him or her thereunder. |
10. | Fair Market Value For Israeli Tax Purposes |
Without derogating from Section 2.20 and solely for the purpose of determining the tax liability pursuant to Section 102(b)(3) of the Ordinance, if at the date of grant of a 102 CGO the Company’s shares are listed on any established stock exchange or a national market system, or if the Company’s shares are registered for trading within ninety (90) days following the date of grant of the 102 CGO, the fair market value of the Shares at the date of grant shall be determined in accordance with the average value of the Company’s shares on the thirty (30) trading days preceding the date of grant or on the thirty (30) trading days following the date of registration for trading, as applicable, unless the Administrator determines otherwise at any time and subject to Applicable Laws.
11. | Integration of Section 102 and Tax Assessing Officer’s Permit |
Unless the Administrator determines otherwise at any time and subject to Applicable Laws, with respect to Trustee 102 Options, the provisions of the Plan and the Award Agreement shall be subject to the provisions of Section 102 and the Tax Assessing Officer’s permit (to the extent that such permit is issued) (the “Permit”), and said provisions and Permit shall be deemed an integral part of the Plan and the Award Agreement.
12. | Non-Trustee 102 Options |
12.1. | Options granted pursuant to this Section 12 are intended to constitute Non-Trustee 102 Options and are subject to the provisions of Section 102 and the general terms and conditions specified in the Plan, except for such provisions of the Plan applying to Options granted under a different tax law or regulations. |
12.2. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, Non-Trustee 102 Options may be granted only to Israeli Employees. |
12.3. | Non-Trustee 102 Options shall be granted pursuant to the Plan may be issued directly to the Israeli Employee or to a trustee appointed by the Administrator in his\its sole discretion. In the event that the Administrator determines that Non-Trustee 102 Options, and Shares issued upon the exercise thereof, shall be deposited with a trustee, the provisions of Sections 9.10, 9.13, and 9.17 hereof shall apply, mutatis mutandis. |
12.4. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, in the event that an Israeli Employee who was granted a Non-Trustee 102 Option is an employee of the Company, or any Parent or Subsidiary thereof, such employee will be obligated to provide his employer, upon the termination of his employment for any reason, with a security or guarantee to cover any future tax obligation resulting from the grant, exercise or disposition of the Option or the Shares issuable upon the exercise thereof, in the form satisfactory to such employer in the latter’s sole discretion. |
13. | 3(i) Options |
13.1. | Options granted pursuant to this Section 13 are intended to constitute 3(i) Options and are subject to the provisions of Section 3(i) of the Ordinance and the general terms and conditions specified in the Plan, except for provisions of the Plan applying to Options granted under a different tax law or regulations. |
13.2. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, 3(i) Options may be granted only to Israeli or foreigners Non-Employees. |
13.3. | 3(i) Options that shall be granted pursuant to the Plan may be issued directly to the Israeli and foreigners Non-Employee or to a trustee appointed by the Administrator in his\its sole discretion. In the event that the Administrator determines that 3(i) Options, and Shares issued upon the exercise thereof, shall be deposited with a trustee, the provisions of Sections 9.10, 9.13, and 9.17 hereof shall apply, mutatis mutandis. |
14. | General Provisions |
14.1. | Term of Option. The expiration date of the term of each Option shall be stated in the Award Agreement (the “Expiration Date”); provided, however, that in no event the term of any Option shall be more than ten (10) years from the date of grant thereof. Each unexercised Option shall automatically expire and shall no longer be exercisable immediately upon the earlier of: (i) the Expiration Date of such Option (as set forth in the applicable Award Agreement), or (ii) at the time at which such Option otherwise expires pursuant to the terms of the Plan. |
14.2. | Option Exercise Price and Consideration |
(i) | The per share Exercise Price for the Shares to be issued upon exercise of an Option shall be such price as is determined by the Administrator at any time at its sole and absolute discretion, subject to any Applicable Laws. |
(ii) | The consideration to be paid for the Shares to be issued upon exercise of an Option, including the method of payment, shall be determined by the Administrator at the time of grant and/or at any time thereafter, subject to any Applicable Law. Such consideration may consist of (1) cash; (2) check; (3) previously acquired Shares based on the Fair Market Value of the Shares on the date the Option is exercised; (4) a cashless exercise method, whereby the Option’s Exercise Price will not be due in cash and where the number of Shares issued upon such exercise will be equal to: (A) the product of (i) the number of Shares as to which the Option is then being exercised, and (ii) the excess, if any, of (a) the then current Fair Market Value per Share over (b) the Option Exercise Price, divided by (B) the then current Fair Market Value per Share; (5) any combination of the foregoing methods of payment; or (6) any other method as shall be determined by the Administrator at its sole discretion. |
14.3. | Manner of Exercising the Option |
(i) | Procedure for Exercise; Rights as a Shareholder. Any Option granted hereunder shall be exercisable according to the terms hereof, at such times and under such conditions as determined by the Administrator and set forth in the Award Agreement and in accordance with the requirements of Section 102 of the Ordinance, if applicable. |
(ii) | In the event of any conflict between the terms and conditions of an Award Agreement and the terms hereof, the terms hereof shall control, unless explicitly provided otherwise in the Award Agreement. |
(iii) | Unless the Administrator provides otherwise at any time, vesting of Options granted hereunder shall be ceased during any unpaid leave of absence. |
(iv) | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, an Option shall be deemed exercised when the Company receives: (i) written notice of exercise (in accordance with the Award Agreement) from the person entitled to exercise the Option and (ii) full payment for the Shares with respect to which the Option is exercised. Full payment may consist of any consideration and method of payment authorized by the Administrator and permitted by the Award Agreement and the Plan. Unless the Administrator determines otherwise at any time and subject to Applicable Laws, Shares issued upon exercise of an Option (excluding Shares underlying a 102 Option, which Shares shall be issued in the name of the Trustee) shall be issued in the name of the Participant or, if requested by the Participant, in the name of the Participant and his or her spouse. |
(v) | Until the applicable Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a shareholder shall exist with respect to such Shares, notwithstanding the exercise of the Option, nor shall the Participants be deemed to be a class of shareholders or creditors of the Company for the purpose of the operation of sections 350 and 351 of the Israeli Companies Law, 5759-1999 or any successor to such sections. |
(vi) | The Company shall issue (or cause to be issued) such Shares promptly after the Option is exercised. No adjustment will be made for a dividend or other right, including without limitation, in connection with rights offering, for which the record date is prior to the date the Shares are issued, except as provided in Section 21 hereof. |
(vii) | Exercise of an Option in any manner shall result in a decrease in the number of Shares thereafter available, both for purposes of the Plan and for sale under the Option, by the number of Shares as to which the Option is exercised. |
(viii) | An Option may not be exercised for fractional shares. |
(ix) | Until the consummation of an IPO, and unless explicitly provided otherwise in the Award Agreement, any Shares acquired upon the exercise of Options shall be voted by an irrevocable proxy, substantially in the form attached hereto as Schedule A (or any other form approved by the Board) (the “Proxy”), according to which, the Participant irrevocably appoints the chairman of the Board, or any other person designated for such purpose by the Board, as his/her proxy with respect to the Shares acquired upon the exercise of Options (the “Proxy Holder”). The Proxy will be signed and delivered to the Company by the Participant concurrently with the execution of the Participant’s Award Agreement. |
(x) | The Proxy Holder shall be indemnified and held harmless by the Company against any cost or expense (including counsel fees) reasonably incurred by him/her, or any liability (including any sum paid in settlement of a claim with the approval of the Company) arising out of any act or omission to act in connection with the voting of such Proxy, unless arising out of such Proxy Holder’s own fraud or willful misconduct, to the extent permitted by Applicable Law. Such indemnification shall be in addition to any rights of indemnification the Proxy Holder may have (if any) as a director or otherwise under the Articles, any agreement, any vote of shareholders or disinterested directors, insurance policy or otherwise. Without derogating from the above, with respect to 102 Options, such shares shall be voted in accordance with the provisions of Section 102 and any rules, regulations or orders promulgated thereunder. |
15. | Non-Transferability of Options |
15.1. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, Options may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime of the Participant, only by the Participant. |
15.2. | Without derogating from the foregoing and unless the Administrator determines otherwise at any time and subject to Applicable Laws, for as long as Options or Shares purchased upon the exercise thereof are held by the Trustee on behalf of the Participant, all rights of the Participant with respect to such Options and Shares shall be personal, and may not be transferred, assigned, pledged or mortgaged, other than by will or laws of descent and distribution. |
15.3. | Without derogating from the inherent power of the shareholders of the Company to alter or modify the rights of the Company’s shares, the Administrator may impose on any Participant such additional restrictions on the transfer of Shares as the Administrator may determine at the time that Options are granted to the Participant or as may be agreed to by the Administrator and the Participant following purchase of said Shares upon exercise of such Options under this Plan or upon termination of the Participant’s employment or service with the Company. Such additional restrictions shall be included in the Award Agreement entered into between the Company and the Participant, or, upon agreement of the Participants, or in this Plan. |
16. | Rights and Restrictions Attaching to the Shares |
16.1. | Equal Rights. Unless the Administrator determines otherwise at any time and subject to Applicable Laws, the Shares shall have equal rights for all intents and purposes as the rights attached to Shares of the Company according to the Articles, subject also to the provisions of this Plan and the Award Agreement. Any change to Articles which modify rights attaching to the Company’s shares shall also apply to the Awards and the Shares. The provisions of the Plan shall remain applicable, with the necessary modifications arising from any such amendment. The grant of Awards or the issuance of Shares under this Plan shall not entitle any Participant to receive any compensation in the event of any change to the Company’s capital. |
16.2. | Dividend Rights. Unless the Administrator determines otherwise at any time and subject to Applicable Laws, all Shares issued upon the exercise of Options granted under the Plan, shall entitle the Participant thereof, or the Trustee for the benefit of Participant, subject to any applicable taxation on distribution of dividends and, when applicable, subject to the provisions of Section 102, to receive dividends with respect thereto in accordance with the Articles, provided, however, that Participant, or the Trustee for the benefit of Participant, shall have no right to dividends or distribution or other right, including without limitation in connection with rights offering, with respect to Shares for which the record date is prior to the date on which the Participant shall have become the holder of record. |
16.3. | Transfer of Shares. Without derogating from the provisions of the Plan and the terms and conditions set forth in the Award Agreement or the Articles, until the consummation of an IPO and unless the Administrator determines otherwise at any time, prior to any transfer of any Shares acquired upon the exercise of Options to a transferee (the “Transferred Shares”) and as a condition to the transfer of the Transferred Shares (if and to the extent the Transferred Share were subject to a Proxy), such transferee shall execute an irrevocable proxy substantially in the form of the Proxy, appointing the chairman of the Board, or any other person designated for such purpose by the Board, as such transferee’s proxy with respect to the Transferred Shares. |
17. | Termination of Relationship as an Employee or as a Consultant |
17.1. | Subject to the provisions of Sections 17.4 and 17.5 below, if a Participant ceases to be an Employee or a Consultant, such Participant may exercise his or her Option within such additional period of time beyond the date of such termination as is specified in the applicable Award Agreement (solely to the extent that the Option is vested on the date of such termination), but in no event later than the Expiration Date of such Option (for the purpose of this Section 17.1 the “Extended Period”). In the absence of a specified Extended Period in the Award Agreement and unless the Administrator determines otherwise at any time, the Option (solely to the extent that the Option is vested on the date of such termination) shall remain exercisable for, and the Extended Period shall be deemed to be, three (3) months following the Participant’s termination (but in no event later than the Expiration Date of such Option). If, on the date of termination, the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option shall automatically revert to the Plan and shall no longer be exercisable. If, after termination of engagement with the Company, the Participant does not exercise the vested portion of his or her Option within the Extended Period, the Option shall forthwith terminate, and the Shares covered by such Option shall automatically revert to the Plan. For the avoidance of doubt, Awards granted hereunder shall not continue to vest during the Extended Period thereof. |
17.2. | At any time, including following the date on which an Award is granted the Administrator, at its sole and absolute discretion and without such act constituting a precedent in respect of any other Participant, shall be entitled to extend the period during which the Participant shall be entitled to exercise his\her vested Options, by a period to be fixed by the Administrator. |
17.3. | Anything in this Plan to the contrary notwithstanding, but subject to the provisions of section 102 of the Ordinance and the tax regulations thereto, if a Participant ceases to be an Employee or a Consultant of the Company or any Parent or Subsidiary thereof, but continues to be employed or provide services to the Company or any other Parent or Subsidiary thereof, such Participant will be deemed for the purpose of this Section 17 to have continuously remained an Employee or a Consultant of the Company (as applicable) during such term, and his/her Awards shall vest pursuant to their original terms. Notwithstanding anything to the contrary hereinabove, unless the Administrator determines otherwise at any time and subject to Applicable Laws, if termination of Participant is for Cause, the entire unexercised Option (whether vested or not) shall ipso facto terminate and the Shares covered by such Option shall automatically revert to the Plan. |
17.4. | Retirement. If a Participant should retire, he/she may, subject to the approval of the Administrator (at its sole discretion), continue to enjoy such rights, if any, with respect to his/her Awards under the Plan and on such terms and conditions, with such limitations and subject to such requirements as the Administrator, at its sole discretion, may determine at the time of such retirement or at any time theretofore. |
17.5. | Death or Disability of Participant. If Participant’s engagement with the Company as an Employee or a Consultant is terminated as a result of the Participant’s death or inability to substantially perform the ordinary functions of his/her position in the Company by reason of any medically diagnosed physical or mental impairment, permanent disability or chronic illness, which last for a continuous period of nine (9) months or more (“Disability”), the Participant (or, if the Participant died, the Participant’s estate or any person who acquired the right to exercise the Option by bequest or inheritance) may exercise his or her Option within such additional period of time thereafter as is specified in the Award Agreement (which period shall be of at least six (6) months) (and with respect to Options, to the extent the Option is vested on the date of such termination), but in no event later than the Expiration Date of the such Option (for the purpose of this Section 17.5 the “Extended Period”). A determination of any Disability will be made by a physician reasonably acceptable to the Company. In the absence of a specified Extended Period in the Award Agreement, the Option, to the extent it is vested on the date of such termination, shall remain exercisable for, and the Extended Period shall be deemed to be, twelve (12) months following the Participant’s termination, or any longer period determined by the Administrator (but in no event later than the Expiration Date of such Option). If, on the date of termination, the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option shall automatically revert to the Plan and shall no longer be exercisable. If, after termination, the vested portion of the Participant’s Option are not exercised within the applicable Extended Period, the Option shall forthwith terminate, and the Shares covered by such Option shall automatically revert to the Plan. For the avoidance of doubt, the Awards granted hereunder shall not continue to vest during the Extended Period. |
18. | Restricted Stock |
18.1. | Awards of Restricted Stock may be issued either alone or in addition to other Awards granted under the Plan (including, without limitation, under Section 102). The Administrator shall determine, at its sole discretion, the Eligible Recipients to whom, and the time or times at which, Awards of Restricted Stock shall be made, the number of Shares to be awarded, the Exercise Price, if any, to be paid by the Participant for the acquisition of Restricted Stock, the Restricted Period (as defined in Section 18.3(i) below) and all other conditions of the Awards of Restricted Stock. The Administrator may also condition the grant of the Award of Restricted Stock upon the exercise of Options, or upon such other criteria as the Administrator may determine, at its sole discretion. The provisions of the Awards of Restricted Stock need not be the same with respect to each Participant. |
18.2. | Awards and Certificates |
(i) | The prospective recipient of Awards of Restricted Stock shall not have any rights with respect to any such Award, unless and until such recipient has executed an Award Agreement evidencing the Award (a “Restricted Stock Award Agreement”) and delivered a fully executed copy thereof to the Company, within a period of sixty (60) days (or such other period as the Administrator may specify at any time) after the Award date and has otherwise complied with the applicable terms and conditions of such Award. |
(ii) | Except as otherwise provided below in Section (iii), (a) each Participant who is granted an Award of Restricted Stock shall be issued a share certificate in respect of such Shares of Restricted Stock, and (b) such certificate shall be registered in the name of the Participant (or, if so determined by the Administrator or required under any Applicable Law – such certificate shall be registered in the name of the Trustee), and shall bear an appropriate legend referring to the terms, conditions, and restrictions applicable to any such Award. |
(iii) | The Company may require that the share certificates evidencing Restricted Stock granted hereunder be held in the custody of the Company until the restrictions thereon shall have lapsed, and that, as a condition of any Award of Restricted Stock, the Participant shall have delivered a stock power, endorsed in blank, relating to the Shares covered by such Award. |
18.3. | Restrictions and Conditions |
Unless the Administrator determines otherwise at any time and subject to Applicable Laws, the Awards of Restricted Stock granted pursuant to this Section 18 shall be subject to the following restrictions and conditions:
(i) | Subject to the provisions of the Plan and the Restricted Stock Award Agreement governing any such Award, during such period as may be set by the Administrator commencing on the date of grant (the “Restricted Period”), the Participant shall not be permitted to sell, transfer, pledge, assign or otherwise dispose Shares of Restricted Stock awarded under the Plan; provided, however, that the Administrator may at any time and at its sole discretion, provide for the lapse of such restrictions in installments and may accelerate or waive such restrictions in whole or in part based on such factors and such circumstances as the Administrator may determine, at its sole discretion, including, but not limited to, the attainment of certain performance related goals, the Participant’s termination of employment or service as a director, consultant or advisor to the Company, any Subsidiary or Affiliate, the Participant’s death or Disability or the occurrence of a Transaction. |
(ii) | Subject to the provisions of the applicable Award Agreement or as otherwise determined by the Administrator at any time, once the Participant has been issued a certificate or certificates for Restricted Stock or the Restricted Stock has been issued in the Participant’s name by book-entry registration, the Participant will have, with respect to the Restricted Stock, the right to vote the Shares, but will not have the right to receive any cash distributions or dividends prior to the lapse of the Restriction Period. If any cash distributions or dividends are payable with respect to the Restricted Stock, the Administrator, in its sole discretion, may require the cash distributions or dividends to be subjected to the same Restriction Period as is applicable to the Restricted Stock with respect to which such amounts are paid, or, if the Administrator so determines, to allocate such cash distributions or dividends among all other eligible shareholders, or to reinvest such cash distributions or dividends in additional Restricted Stock to the extent Shares are available under Section 3 of the Plan. If the Administrator determines that cash distributions or dividends shall be payable with respect to the Restricted Stock, such dividends shall be paid or distributed at the end of the Restriction Period and a Participant shall not be entitled to interest with respect to any such dividends or distributions subjected to the Restriction Period. Unless otherwise determined by the Administrator at any time subject to Applicable Laws, any distributions or dividends paid in the form of securities with respect to Restricted Stock will be subject to the same terms and conditions as the Restricted Stock with respect to which they were paid, including, without limitation, the same Restriction Period. |
(iii) | Subject to the provisions of the applicable Award Agreement or as otherwise determined by the Administrator at any time, if a Participant’s service or employment with the Company, its Subsidiary or Parent terminates prior to the expiration of the applicable Restriction Period, the Participant’s Restricted Stock and any associated dividends, if any, that then remain subject to forfeiture will then be forfeited automatically. Upon forfeiture of Restricted Stock, the Participant shall have no further rights with respect to such Restricted Stock. |
(iv) | In the event that Awards of Restricted Stock are granted to Israeli Employees, such grant shall be subject to the provisions of Section 102 and the provisions of Sections 8, 9, 10, 11, 12, and 14 hereof shall apply to such Award, mutatis mutandis. |
19. | Restricted Stock Units |
Subject to the other terms of the Plan, the Administrator may grant Restricted Stock Units to Eligible Recipients, either alone or in addition to other Awards granted under the Plan, (including under Section 102) and may at any time, in its sole and absolute discretion, impose conditions on such units as it may deem appropriate, including, without limitation, continued employment or service of the Participant or the attainment of specified individual or corporate performance goals. Each Restricted Stock Unit shall be evidenced by an Award Agreement in the form that is approved by the Administrator.
Unless the Administrator determines otherwise at any time and subject to Applicable Laws, each Restricted Stock Unit will represent a right to receive from the Company, upon fulfillment of any applicable conditions, one Share. All other terms governing Restricted Stock Units, such as vesting, time and form of payment and termination of units shall be set forth in the applicable Award Agreement. The terms governing the Restricted Stock Units need not be the same with respect to each Participant. Unless the Administrator determines otherwise at any time and subject to Applicable Laws, the Participant shall not have any shareholder rights with respect to the Shares subject to a Restricted Stock Unit Award until that Award vests and any Shares are actually issued thereunder. Unless the Administrator determines otherwise at any time and subject to Applicable Laws, a Participant will not be permitted to sell, transfer, pledge, assign or otherwise encumber Restricted Stock Units awarded under the Plan. Subject to the provisions of the applicable Award Agreement or as otherwise determined by the Administrator at any time, if a Participant’s service with the Company, its Subsidiary or Parent terminates prior to the Restricted Stock Unit Award vesting, the Participant’s Restricted Stock Units that then remain subject to forfeiture will then be forfeited automatically. Upon forfeiture of Restricted Stock Units, the Participant shall have no further rights with respect to such Restricted Stock Units.
20. | [Reserved] |
21. | Adjustments |
21.1. | Changes in Capitalization. Subject to any required action by the shareholders of the Company, the number of Shares covered by each outstanding Award, and the number of Shares which have been authorized for issuance under the Plan but as to which no Awards have yet been granted or which have been returned to the Plan upon cancellation or expiration of an Award, as well as the Exercise Price of Shares covered by each such outstanding Award, may be proportionately adjusted upon any increase or decrease in the number of issued Shares resulting from a stock split, reverse stock split, stock dividend (if so determined by the Board upon the issuance of such stock dividend), combination or reclassification of the Shares, or any other increase or decrease in the number of issued Shares effected without receipt of consideration by the Company. The conversion of any convertible securities of the Company shall not be deemed to have been effected without receipt of consideration. Such adjustment shall be made by the Board, whose determination in that respect shall be final, binding and conclusive. Except as expressly provided herein, no issuance by the Company of shares of any class, or securities convertible into shares of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of Shares subject to an Award. |
21.2. | Dissolution or Liquidation. In the event of the proposed dissolution or liquidation of the Company, any or all outstanding Awards will terminate immediately prior to the consummation of such proposed action. The Administrator may, in the exercise of its sole discretion in such instances, declare that any Award shall terminate as of such other date fixed by the Administrator and give each Participant the right to exercise his\her Award as to all or any part of the Shares, including Shares as to which the Award would not otherwise be exercisable. |
21.3. | Changes to Plan. The Administrator shall be entitled, from time to time, to update and/or change the terms of this Plan, in whole or in part, at its sole discretion, provided that in the Board’s opinion such a change shall not materially derogate from the terms of vested Awards or Shares issued under this Plan. The Board shall be entitled to terminate this Plan at any time provided such termination does not materially affect the rights of any Participant with respect to vested Awards. |
21.4. | Transaction. Without derogating from the Administrator’s general authority and power under this Plan, in the event of a Transaction the following shall occur, without the Participant’s consent and action and without any prior notice requirement: |
21.4.1 | Unless otherwise determined by the Administrator in its sole and absolute discretion, any Award then outstanding shall be assumed or be substituted by the Company, or by a Successor Company, under terms as determined by the Administrator or the terms of this Plan applied by the Successor Company to such assumed or substituted Awards; |
For the purposes of this Section 21.4.1, the Award shall be considered assumed or substituted if, following a Transaction, the Award confers on the holder thereof the right to purchase or receive, for each Share underlying an Award immediately prior to the Transaction, either (i) the consideration (whether stock, cash, or other securities or property, or any combination thereof) distributed to or received by holders of Shares in the Transaction for each Share held on the effective date of the Transaction (and if holders were offered a choice or several types of consideration, the type of consideration as determined by the Administrator), or (ii) regardless of the consideration received by the holders of Shares in the Transaction, solely shares or any type of Awards (or their equivalent) of the Successor Company at a value to be determined by the Administrator in its discretion, or a certain type of consideration (whether stock, cash, or other securities or property, or any combination thereof) as determined by the Administrator. Any of the above consideration referred to clauses (i) and (ii) may be subject to vesting, expiration and other terms as determined by the Administrator in its discretion and may differ from the vesting, expiration and other terms applying on the Awards immediately prior to the Transaction. The foregoing shall not limit the Administrator’s authority to determine, in its sole discretion and in compliance with all Applicable Laws, that in lieu of such assumption or substitution of Awards for Awards of the Successor Company, such Award will be substituted for any other type of asset or property, including as set forth in Section 21.4.2 hereunder.
21.4.2 | Regardless of whether or not Awards are assumed or substituted, the Administrator may (but shall not be obligated to), in its sole discretion: |
(a) | provide for any Participant to have the right to exercise the Award in respect of Shares covered by the Award which would otherwise be exercisable or vested, under such terms and conditions as the Administrator shall determine, and the cancellation of all unexercised and unvested Awards upon or immediately prior to the closing of the Transaction, unless the Administrator provides for the Participant to have the right to exercise the Award; and/or |
(b) | provide for the acceleration of vesting of such Award, as to all or part of the Shares covered by the Award which would not otherwise be exercisable or vested, under such terms and conditions as the Administrator shall determine; and/or |
(c) | provide for the cancellation of each outstanding Award at or immediately prior to the closing of such Transaction, and payment to the Participant of an amount in cash, shares of the Company, the acquirer or of a corporation or other business entity which is a party to the Transaction or other property, as determined by the Administrator to be fair in the circumstances, and subject to such terms and conditions as determined by the Administrator. The Administrator shall have full authority to select the method for determining the payment (being the Black-Scholes model or any other method). The Administrator’s determination may further provide that payment shall be set to zero if the value of the Shares is determined to be less than the Exercise Price or in respect of Shares covered by the Award which would not otherwise be exercisable or vested, or that payment may be made only in excess of the Exercise Price. |
21.4.3 | The Administrator may determine that any payments made in respect of Awards shall be (i) subject to vesting terms substantially identical to those that applied to the canceled Award immediately prior to the Transaction; and/or (ii) made or delayed to the same extent that payment of consideration to the holders of the Shares in connection with the Transaction is made or delayed as a result of escrows, indemnification, earn outs, holdbacks or any other contingencies; and the terms and conditions applying to the payment made to the Participants, including participation in escrow, indemnification, releases, earn-outs, holdbacks or any other contingencies. |
21.4.4 | Notwithstanding the foregoing, in the event of a Transaction, the Administrator may determine, in its sole discretion that upon completion of such Transaction the terms of any Award be otherwise amended, modified or terminated, as the Administrator shall deem in good faith to be appropriate and without any liability to the Company or any Affiliate, Parent or Subsidiary thereof, and to their respective its officers, directors, employees and representatives and the respective successors and assigns of any of the foregoing in connection with the method of treatment or chosen course of action permitted hereunder. |
21.4.5 | Neither the authorities and powers of the Administrator under this Section 21.4, nor the exercise or implementation thereof, shall (i) be restricted or limited in any way by any adverse consequences (tax or otherwise) that may result to any holder of an Award, and (ii) as, inter alia, being a feature of the Award upon its grant, be deemed to constitute a change or an amendment of the rights of such holder under this Plan, nor shall any such adverse consequences (as well as any adverse tax consequences that may result from any tax ruling or other approval or determination of any relevant tax authority) be deemed to constitute a change or an amendment of the rights of such holder under this Plan, and may be effected without consent of any Participant and without any liability to the Company or its Affiliates and to their respective its officers, directors, employees and representatives and the respective successors and assigns of any of the foregoing. The Administrator needs not take the same action with respect to all Awards or with respect to all Eligible Recipients. The Administrator may take different actions with respect to the vested and unvested portions of an Award. The Administrator may determine an amount or type of consideration to be received or distributed in a Transaction which may differ as among the Participants, and as between the Participants and any other holders of shares of the Company. |
21.4.6 | The Administrator’s determinations pursuant to this Section 21.4 shall be conclusive and binding on all Participants. |
21.4.7 | If determined by the Administrator, the Participants shall be subject to the definitive agreement(s) in connection with the Transaction as applying to holders of Shares including, such terms, conditions, representations, undertakings, liabilities, limitations, releases, indemnities, participating in transaction expenses and escrow arrangement, in each case as determined by the Administrator. Each Participant shall execute such separate agreement(s) or instruments as may be requested by the Company, the Successor Company or the acquirer in connection with such in such Transaction and in the form required by them. The execution of such separate agreement(s) may be a condition to the receipt of assumed or substituted Awards, payment in lieu of the Award or the exercise of any Award. |
21.5. | Anything herein to the contrary notwithstanding and unless otherwise determined by the Administrator, in its sole and absolute discretion, if prior to the completion of the IPO, all or substantially all of the shares of the Company (determined without taking into account the shares issued or issuable under this Plan) are to be sold (whether under the Articles or any other contract by which the shareholders of the Company are bound or pursuant to any applicable law) to any third party, whether or not related to or affiliated with the Company or its shareholders, each Participant shall be obliged to sell the Shares such Participant purchased under the Plan, in accordance with the instructions then issued by the Administrator whose determination shall be final. |
22. | Time of Granting Awards |
Unless explicitly determined otherwise by the Administrator, the date of grant of an Award shall be, for all purposes, the later of (i) the date on which the Administrator makes the determination granting such Award, or (ii) the commencement date of the Participant’s engagement with the Company or any Parent or Subsidiary thereof (whether as an Employee, Consultant or Director). Notice of the determination shall be given to each Participant to whom an Award is so granted within a reasonable time after the date of such grant.
23. | Amendment and Termination of the Plan |
23.1. | Amendment and Termination. The Board may at any time amend, alter, suspend or terminate the Plan. |
23.2. | Shareholders Approval. The Board shall obtain shareholders approval of any Plan amendment to the extent necessary and desirable to comply with Applicable Laws. |
23.3. | Effect of Amendment or Termination. No amendment, alteration, suspension or termination of the Plan shall impair the rights of any Participant, unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be in writing and signed by the Participant and the Company. Termination of the Plan shall not affect the Administrator’s ability to exercise the powers granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination. |
24. | Conditions Upon Issuance of Shares |
24.1. | Legal Compliance. Shares shall not be issued pursuant to the exercise of an Award granted hereunder unless the exercise of such Award and the issuance and delivery of such Shares shall comply with Applicable Laws and shall be further subject to the approval of counsel for the Company with respect to such compliance. |
24.2. | Investment Representations. The Administrator may require each Participant acquiring Shares to represent and warrant that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such representation is required. |
24.3. | Market Stand-Off. In connection with any public offering of the Company’s equity securities, pursuant to an effective registration statement, for such period as the Company or its underwriters may request (such period not to exceed one hundred and eighty (180) days following the date of the applicable offering), the Participant shall not, directly or indirectly, sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer, or agree to engage in any of the foregoing transactions with respect to, any Shares acquired under this Plan without the prior written consent of the Company or its underwriters. |
25. | Rights as a Shareholder; Voting and Dividends |
25.1. | Without derogating from other provisions of the Plan, including Section 18.3(ii) above and unless otherwise determined by the Administrator at any time, subject to Applicable Laws, a Participant shall have no rights as a shareholder of the Company with respect to any Shares covered by the Award until the date of the issuance of a share certificate to the Participant for such Shares. In the case of 102 Option or 3(i) Option (if such Options are being held by a Trustee), the Trustee shall have no rights as a shareholder of the Company with respect to any Shares covered by such Award until the date of the issuance of a share certificate to the Trustee for such Shares for the Participant’s benefit, and the Participant shall have no rights as a shareholder of the Company with respect to any Shares covered by the Award until the date of the release of such Shares from the Trustee to the Participant and the issuance of a share certificate to the Participant for such Shares. Unless otherwise determined by the Administrator at any time and subject to Applicable Laws, no adjustment shall be made for dividends (ordinary or extraordinary, whether in cash, securities or other property) or distribution of other rights, including without limitation in connection with any rights offering, for which the record date is prior to the date such share certificate is issued. |
25.2. | The Company may, but shall not be obligated to, register or qualify the sale of Shares under any applicable securities law or any other Applicable Law. |
26. | No Right for Continuing Relationship |
Neither the Plan nor any Award shall confer upon any Participant any right with respect to continuing the Participant’s relationship as an Employee or as a Consultant with the Company, nor shall it interfere in any way with his or her right or the Company’s right to terminate such relationship at any time, with or without Cause.
27. | Inability to Obtain Authority |
The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.
28. | Default |
A Participant shall be deemed to be in default under this Plan, including the Award Agreement, in the event that the Participant fails to pay any sum or perform any obligation provided for in the Plan, in a timely fashion or in a manner required. Any default under this Plan not cured within ten (10) days after the Company gives written notice of such default to Participant shall entitle the Company to exercise any and all remedies and rights against the defaulting Participant contained in any and all of the documents comprising this Plan or provided under Applicable Law.
29. | Notices |
All notices and elections sent to the Company by a Participant shall be in writing and delivered in person or by certified mail to the CEO of the Company at the principal office of the Company. All notices given by the Company to a Participant under the Plan shall be in writing and delivered in person or by certified mail to the Participant’s address as reflected in the Company’s records. All notices will be deemed delivered within seven (7) days of their dispatch by certified mail, postage prepaid.
30. | Reservation of Shares |
At all time during the term of this Plan, the Company shall reserve and keep available such number of Shares as shall be sufficient to satisfy the requirements of the Plan.
31. | Miscellaneous |
31.1. | Any tax consequences arising from the grant or exercise of any Awards or from the payment for, or the sale of or other disposition of, Shares covered thereby or from any other event or act (whether of the Participant, the Trustee, or the Company or its Subsidiaries) hereunder, shall be borne solely by the Participant. The Company, its Parents, subsidiaries and the Trustee shall be entitled to withhold taxes according to the requirements of any Applicable Laws, rules and regulations, including withholding taxes at source and particularly regulation 7(b) of the Income Tax Regulations (tax benefits on the issuance of shares to employees) 2003. Furthermore, the Participant shall agree to indemnify the Company or Subsidiary that employs the Participant and the Trustee, if applicable, and hold them harmless against and from any and all liability for any such tax or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to the Participant. The Company may exercise such indemnification by deducting the Tax subject to indemnification from Participant’s salaries or remunerations. Except as otherwise required by law, the Company and the Trustee shall not be obligated to exercise any Awards on behalf of a Participant, or to release any share certificate, until all tax consequences arising from the exercise of such Awards are resolved in a manner reasonably acceptable to the Company and the Trustee, and all required payments in connection with the exercise of the Award, or the sale of the Shares, have been fully paid by the Employee. |
31.2. | The ramifications of any future modification of any Applicable Law regarding the taxation of Awards and/or Shares granted to Participants shall apply to the Participants accordingly and such Participants shall bear the full cost thereof, unless such modified laws expressly provide otherwise. For the avoidance of doubt, should the applicability of such taxing arrangements to this Plan or to securities issued in the framework thereof be stipulated by an application by the Company or by the Trustee that same shall apply, the Company shall be entitled to decide, at its absolute discretion, whether to apply such taxing arrangements and to instruct the Trustee to act accordingly. |
31.3. | Governing Law and Jurisdiction. This Plan shall be governed by and construed and enforced in accordance with the laws of the State of Israel, without giving effect to the principles of conflict of laws. The competent courts of Tel-Aviv, Israel shall have exclusive jurisdiction in any matters pertaining to the Plan. |
31.4. | Conflicts. This Plan (together with the Award Agreements signed by the Company and the Participant) supersedes all of the agreements and/or understandings existing prior to the date of the grant of Awards to an Participant between the Company, or any of its Affiliates, and such Participant in connection with issuance of capital shares of the Company or options for capital shares of the Company to such Participant, other than any written option agreement entered into pursuant to a different stock option plan approved by the Board. Any representation and/or promise and/or undertaking made and/or given by the Company and/or by any of its Affiliates or by any person on their behalf, which have not been expressed herein, shall have no force and effect. For the removal of doubt, it is hereby clarified that in the event of any contradiction between the terms set forth in this Plan and the terms of any Award Agreement, or in a Participant’s employment or services agreement, the terms of this Plan shall prevail, unless explicitly provided otherwise in the Award Agreement. |
32. | Multiple Agreements |
The terms of each Award may differ from other Awards granted, whether concurrent with, prior to or following its grant under this Plan . No Participant or other person shall have any claim to be granted Awards and there is no obligation for uniformity of treatment of Participants, or holders or beneficiaries of Awards. The terms and conditions of Awards and the Administrator’s determinations and interpretations with respect to them need not be the same with respect to each Participant (whether or not such Participants are similarly situated and whether or not the Awards are granted at the same time or at any other time).
Schedule A
PROXY
I, the undersigned, as record holder of the securities of Pagaya Technologies Ltd. (the “Company”) described below, hereby irrevocably appoint the chairman of the Company’s Board of Directors, or any other person designated for such purpose by the Company’s Board of Directors (the “Proxy Holder”), as my proxy instead of myself and on my behalf, with respect to any and all aspects of my shareholdings in the Company in virtue of the shares granted to me pursuant to the Company’s 2016 Equity Incentive Plan (including, without limitation and for the sake of clarification, any shares issued to me upon exercise of any option granted to me under the Company’s 2016 Equity Incentive Plan) (the “Shares”), including, without limiting the foregoing generality: (i) receiving any notices that the Company may deliver to its shareholders, pursuant to the Articles of Association of the Company (as amended from time to time), any shareholders agreement, applicable law or otherwise, (ii) attending all meetings of the shareholders of the Company and voting such Shares at any meeting of the shareholders of the Company (and at any postponements or adjournments thereof) and waiving all minimum notice requirements for such meetings of shareholders, (iii) executing any consents or dissents in writing without a meeting of the shareholders of the Company to any corporate action thereof, (iv) waiving any preemptive right, right of first refusal, right of first offer, co-sale right or any other similar right or restriction to which I will be entitled by virtue of the Shares, (v) giving or withholding consent or agreement to any matter which requires my consent or agreement in my capacity as a shareholder of the Company (whether such is required under the Articles of Association of the Company (as amended from time to time), any agreement to which I am a party as a shareholder or otherwise), and/or (vi) joining in making a request to convene a general meeting or class meeting of the shareholders of the Company or to otherwise exercise any and all powers and authorities vested within me in my capacity as a shareholder of the Company (in each of the foregoing cases, to the fullest extent that I will be entitled to act so, and in the same manner and with the same effect as if the undersigned were personally present at any such meeting or voting such Shares or personally acting on any matters submitted to shareholders for approval or consent).
The Shares shall be voted by the Proxy Holder in the same proportion as the votes of the other shareholders of the Company.
This proxy is irrevocable to the maximum extent allowed by applicable laws and it will remain in full force and effect until the consummation of an IPO (as defined in the Company’s 2016 Equity Incentive Plan), upon which it will automatically terminate.
The Proxy Holder will have the full power of substitution and revocation. All authority herein conferred shall survive the death or incapacity of the undersigned and any obligation of the undersigned hereunder shall be binding upon the heirs, personal representatives, successors and assigns of the undersigned.
Name
|
Date
|
|
Signature |
27
Exhibit 10.10
PAGAYA TECHNOLOGIES LTD.
2016 EQUITY INCENTIVE PLAN
STOCK OPTION SUB-PLAN FOR UNITED STATES PERSONS
1. | Introduction |
1.1 Pursuant to Section 4.2(xii) of the PAGAYA TECHNOLOGIES LTD. 2016 EQUITY INCENTIVE PLAN (the “Plan”), which Plan was adopted by the Board on May 10, 2016, the provisions set forth herein are made applicable to Options granted under this sub-plan (this “U.S. Sub-Plan”) of the Plan to Eligible Persons residing in the United States of America or whose primary place of performing services for the Company is located in the United States of America (“U.S. Eligible Persons”).
1.2 Except as expressly set forth herein to the contrary, all of the terms and conditions of the Plan shall apply to Options granted under the Plan to U.S. Eligible Persons.
1.3 The Company intends that securities issued under the Plan to U.S. Eligible Persons be exempt from requirements of registration and qualification of such securities pursuant the exemptions afforded by Rule 701 promulgated under the Securities Act and any applicable exemptions under applicable United States state securities laws, and the Plan shall be so construed. Further, the Company intends that Options granted under the Plan to U.S. Eligible Persons be exempt from or comply with Section 409A of the U.S. Code (including any amendments or replacements of such section), and the Plan shall be so construed.
2. | Definitions |
2.1 Except as set forth in Section 2.2, capitalized terms used in this U.S. Sub-Plan but not defined herein shall have the meanings set forth in the Plan.
2.2 Whenever used herein, the following terms shall have their respective meanings set forth below:
(a) “Consultant” has the meaning as defined in the Plan, provided that the identity of such person, the nature of such services or the entity to which such services are provided would not preclude the Company from offering or selling securities to such person pursuant to the Plan in reliance on either the exemption from registration provided by Rule 701 under the Securities Act or, if the Company is required to file reports pursuant to Section 13 or 15(d) of the Exchange Act, registration on a Form S-8 Registration Statement under the Securities Act.
(b) “Employee” has the meaning as defined in the Plan, provided that, with respect to any Incentive Stock Option granted to such an individual, the individual is considered an employee for purposes of Section 422 of the U.S. Code.
(c) “Fair Market Value” has the meaning as defined in the Plan, provided that any good faith determination by the Administrator in the absence of an established market for the Shares shall be made without regard to any restriction other than a restriction which, by its terms, will never lapse, and in a manner consistent with the requirements of Section 409A of the Code.
(d) “Insider” means an Officer, a Director or other person whose transactions in Shares are subject to Section 16 of the Exchange Act.
(e) “Rule 16b-3” means Rule 16b-3 under the Exchange Act, as amended from time to time, or any successor rule or regulation.
(f) “Securities Act” means the United States Securities Act of 1933, as amended.
(g) “Ten Percent Shareholder” means a person who, at the time an Option is granted to such person, owns stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company within the meaning of Section 422(b)(6) of the Code.
3. | Option Terms. |
3.1 Options may be granted under the U.S. Sub-Plan only to Employees, Consultants and Directors.
3.2 The exercise price per Share for each Option granted under the U.S. Sub-Plan shall be not less than the Fair Market Value of a Share on the date of grant of the Option.
3.3 Incentive Stock Options shall be subject to the following additional limitations:
(a) The maximum aggregate number of Shares that may be issued under the U.S. Sub-Plan pursuant to the exercise of Incentive Stock Options is one hundred eleven thousand one hundred eleven (111,111) Shares (the “ISO Share Limit”).
(b) An Incentive Stock Option may be granted only to an individual who, on the date of grant, is an Employee.
(c) To the extent that Options designated as Incentive Stock Options (granted under all stock plans of the Company, including the Plan) become exercisable by a Participant for the first time during any calendar year for Shares having a Fair Market Value greater than One Hundred Thousand Dollars ($100,000), the portions of such Options that exceed such amount shall be treated as Nonstatutory Stock Options in accordance with Section 7.2 of the Plan. If an Option is treated as an Incentive Stock Option in part and as a Nonstatutory Stock Option in part by reason of the limitation set forth in this Section, the Participant may designate which portion of such Option the Participant is exercising. In the absence of such designation, the Participant shall be deemed to have exercised the Incentive Stock Option portion of the Option first. Upon exercise of the Option, Shares issued pursuant to each such portion shall be separately identified.
(d) The exercise price per Share for an Incentive Stock Option granted to a Ten Percent Shareholder shall be not less than one hundred ten percent (110%) of the Fair Market Value of a Share on the date of grant of the Option.
(e) No Incentive Stock Option may be granted more than ten (10) years after the date the Plan was adopted by the Board.
(f) No Incentive Stock Option shall be exercisable more than ten (10) years after the date of grant of such Option. No Incentive Stock Option granted to a Ten Percent Shareholder shall be exercisable more than five (5) years after the date of grant of such Option.
(g) During the lifetime of the Participant, an Incentive Stock Option shall be exercisable only by the Participant or the Participant’s guardian or legal representative. An Incentive Stock Option shall not be subject in any manner to anticipation, alienation, sale, exchange, transfer, assignment, pledge, encumbrance, or garnishment by creditors of the Participant or the Participant’s beneficiary, except transfer by will or by the laws of descent and distribution.
4. | Tax Withholding. |
4.1 The Company may require a Participant, through payroll withholding, cash payment or otherwise, to make adequate provision for, United States federal, state, local and non-U.S. taxes (including any social insurance), if any, required by law to be withheld by the Company with respect to an Option or the Shares acquired pursuant thereto. The Company shall have no obligation to deliver Shares until the Company’s tax withholding obligations have been satisfied by the Participant.
4.2 The Company shall have the right, but not the obligation, to deduct from the Shares issuable to a Participant upon the exercise of an Option, or to accept from the Participant the tender of, a number of whole Shares having a Fair Market Value, as determined by the Company, equal to all or any part of the tax withholding obligations of the Company. After and IPO and subject to compliance with all applicable requirements of applicable securities laws, the Company may require a Participant to direct a broker, upon the exercise of an Option, to sell a portion of the Shares subject to the Option determined by the Board in its discretion to be sufficient to cover the tax withholding obligations of the Company and to remit an amount equal to such tax withholding obligations to the Company in cash.
5. | Compliance With U.S. Securities And Other Applicable Law. |
5.1 The grant of Options and the issuance of Shares upon exercise of Options shall be subject to compliance with all applicable requirements of United States federal and state law with respect to such securities and the requirements of any stock exchange or market system upon which the Shares may then be listed. In addition, no Option may be exercised or Shares issued pursuant to an Option unless (a) a registration statement under the Securities Act shall at the time of such exercise or issuance be in effect with respect to the Shares issuable pursuant to the Option or (b) in the opinion of legal counsel to the Company, the Shares issuable pursuant to the Option may be issued in accordance with the terms of an applicable exemption from the registration requirements of the Securities Act. The inability of the Company to obtain from any regulatory body having jurisdiction the authority, if any, deemed by the Company’s legal counsel to be necessary to the lawful issuance and sale of any shares hereunder shall relieve the Company of any liability in respect of the failure to issue or sell such shares as to which such requisite authority shall not have been obtained. As a condition to issuance of any Share, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate, to evidence compliance with any applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company.
5.2 With respect to participation by Insiders in the Plan, at any time that any class of equity security of the Company is registered pursuant to Section 12 of the Exchange Act, the Plan shall be administered in compliance with the requirements, if any, of Rule 16b-3.
5.3 No Option granted to an Employee who is a non-exempt employee for purposes of the United States Fair Labor Standards Act of 1938, as amended, shall become exercisable until at least six (6) months following the date of grant of such Option (except in the event of such Employee’s death or Disability, or as otherwise permitted by the United States Worker Economic Opportunity Act).
5.4 To the extent permitted by the Board, in its discretion, and set forth in the Award Agreement evidencing such Option, a Nonstatutory Stock Option may be assignable or transferable only in compliance with the applicable limitations, if any, described in Rule 701 under the Securities Act and the General Instructions to Form S-8 Registration Statement under the Securities Act.
5.5 At least annually, copies of the Company’s balance sheet and income statement for the just completed fiscal year shall be made available to each U.S. Eligible Person holding Options or Shares acquired upon the exercise of an Option; provided, however, that this requirement shall not apply if all offers and sales of securities pursuant to the U.S. Sub-Plan comply with all applicable conditions of Rule 701 under the Securities Act. The Company shall not be required to provide such information to persons whose duties in connection with the Company assure them access to equivalent information. The Company shall deliver to each Participant such disclosures as are required in accordance with Rule 701 under the Securities Act.
6. | Amendment Of U.S. Sub-plan. |
6.1 The Board may amend the U.S. Sub-Plan at any time. However, without the approval of the Company’s shareholders, no such amendment shall (a) increase the ISO Share Limit, (b) change the class of persons eligible to receive Incentive Stock Options, or (c) make any other change that would require approval of the Shareholders under any Applicable Law, including the rules of any stock exchange or quotation system upon which the Shares may then be listed or quoted.
7. | Shareholder Approval |
7.1 The U.S. Sub-Plan shall be submitted for approval by the Company’s shareholders during the period beginning twelve (12) months before and ending twelve (12) months after the date of adoption thereof by the Board. Incentive Stock Options granted prior to Shareholder approval of the U.S. Sub-Plan shall become exercisable no earlier than the date of Shareholder approval of the U.S. Sub-Plan, and such Options shall become Nonstatutory Stock Options if such Shareholder approval is not received in the manner described in the preceding sentence.
IN WITNESS WHEREOF, the undersigned Secretary of the Company certifies that the foregoing sets forth the additional provisions of the Pagaya Technologies Ltd. 2016 Equity Incentive Plan applicable to grants to U.S. Eligible Persons, as duly adopted by the Board on May 9th, 2018.
/s/ Gal Krubiner |
|
Secretary | |
Gal Krubiner |
5
Exhibit 10.11
PAGAYA TECHNOLOGIES LTD.
2021 EQUITY INCENTIVE PLAN
1. | Purposes of the Plan |
The purposes of this Equity Incentive Plan are to attract and retain the best available personnel, to provide additional incentive to Employees, Directors and Consultants and to promote the success of the business of the Company and its Subsidiaries. Awards granted under this Plan may be 102 Options, 3(i) Options, Awards of Restricted Stock, Awards of Restricted Stock Units, Incentive Stock Options, Nonstatutory Stock Options or any combination of the foregoing, as determined by the Administrator at the time of grant.
2. | Definitions |
As used herein, the following definitions shall apply:
2.1. | “Affiliate” means any “employing company” within the meaning of Section 102(a) of the Ordinance. |
2.2. | “Administrator” means the Board or any of its Committees as shall be administrating the Plan in accordance with Section 4 hereof. |
2.3. | “Applicable Laws” means the requirements relating to the administration of stock option plans under Israeli and U.S. state corporate laws, Israeli and U.S. federal and state securities laws, the Code, the Ordinance, any stock exchange or quotation system on which the Shares are listed or quoted and the applicable laws of any other country or jurisdiction that may apply to Awards which are granted under the Plan. |
2.4. | “Articles” means the Articles of Association of the Company, as amended or restated from time to time. |
2.5. | “Award” means any 102 Options, 3(i) Options, awards of Restricted Stock, awards of Restricted Stock Units, Incentive Stock Options, Nonstatutory Stock Options or any combination of the foregoing, which are granted under the Plan. |
2.6. | “Award Agreement” means, with respect to each Award, the applicable signed written agreement between the Company and the Participant setting forth the terms and conditions of an individual Award granted under the plan. |
2.7. | “Board” means the Board of Directors of the Company. |
2.8. | “Code” means the Internal Revenue Code of 1986, as amended from time to time. |
2.9. | “Cause” shall have the meaning ascribed to it in the applicable employment or consulting agreement of Participant. In the absence of such definition, “Cause” shall mean any of the following: (i) the Participant’s theft, dishonesty, or falsification of any Company documents or records; (ii) the Participant’s improper use or disclosure of the Company’s confidential or proprietary information; (iii) any action by the Participant which has a detrimental effect on the Company’s reputation or business; (iv) the Participant’s failure or inability to perform any reasonable assigned duties after written notice from the Company of, and a reasonable opportunity to cure, such failure or inability; (v) any material breach of the Participant of any employment agreement between the Participant and the Company, which breach is not cured within thirty (30) days pursuant to the terms of such agreement; or (vi) the Participant’s conviction (including any plea of guilty) of any criminal act which impairs the Participant’s ability to perform his or her duties with the Company. For purposes of the definition of Cause, with respect to a Participant employed by or providing services to a Parent or Subsidiary of the Company, the term “Company” shall also include the Parent or Subsidiary employing or engaging the services of the Participant. |
2.10. | “Committee” means a committee of Directors appointed by the Board in accordance with Section 4 hereof. |
2.11. | “Company” means Pagaya Technologies Ltd., an Israeli company. |
2.12. | “Consultant” means any person who is engaged by the Company or any Parent or Subsidiary to render consulting or advisory services to such entity, including any employees of such person and including a non-Employee Director of the Company or any Parent or Subsidiary thereof. A Participant shall not cease to be a Consultant in case of any temporary interruption in such person’s availability to provide services to the Company, its Parent, any Subsidiary, or any successor, which has been authorized in writing by the engaging company (or by the Parent or Subsidiary) prior to its commencement. |
2.13. | “Controlling Shareholder” shall have the meaning ascribed to it in Section 32(i) of the Ordinance. |
2.14. | “Director” means a member of the Board of Directors of the Company or any Parent or Subsidiary. |
2.15. | “Eligible Recipient” means an Employee or Consultant. |
2.16. | “Employee” means any person, including Officers and Directors, employed by the Company, or any Parent or Subsidiary of the Company, with or without payment. Subject to the provisions of any Applicable Law, a Participant shall not cease to be an Employee in the case of (i) any leave of absence approved by the Company (or by the Parent or Subsidiary that employs the person) or (ii) transfers between locations of the Company (or the Parent or Subsidiary that employs the person) or between the Company, its Parent, any Subsidiary, or any successor. |
2.17. | “Exchange Act” means the Securities Exchange Act of 1934, as amended. |
2.18. | “Employing Company” shall have the meaning ascribed to it in Section 102(a) of the Ordinance. |
2.19. | “Exercise Price” means the per share price at which a holder of an Award may purchase Shares issuable upon exercise of the Award. |
2.20. | “Fair Market Value” means, as of any date, the value of Shares determined as follows: |
(i) | If the Shares are listed on any established stock exchange or a national market system, including without limitation the Nasdaq National Market or The Nasdaq SmallCap Market of The Nasdaq Stock Market, its Fair Market Value shall be the closing sales price for such shares (or the closing bid, if no sales were reported) as quoted on such exchange or system for the last market trading day prior to the time of determination, as reported in The Wall Street Journal or such other source as the Administrator deems reliable (if the Shares are listed or quoted on more than one established stock exchange or national market system, the Administrator shall determine the appropriate exchange or system); |
(ii) | If the Shares are regularly quoted by a recognized securities dealer but selling prices are not reported, its Fair Market Value shall be the mean between the high bid and low asked prices for the Shares on the last market trading day prior to the day of determination; or |
(iii) | In the absence of an established market for the Shares, the Fair Market Value thereof shall be determined in good faith by the Administrator. |
2.21. | “Incentive Stock Option” means an Option intended to qualify as an incentive stock option within the meaning of Section 422 of the Code. |
2.22. | “IPO” means the consummation of the initial public offering of the Company’s Ordinary Shares. |
2.23. | “Israeli Employee” means a person who is a resident of the state of Israel or who is deemed to be a resident of the state of Israel for tax purposes, and who is an Employee or an Office Holder (“Nose Missra”) of the Company, or any Parent or Subsidiary of the Company, in each case excluding a person who is a Controlling Shareholder prior to the issuance of the relevant Award or as a result thereof. |
2.24. | “Israeli Non-Employee” means a person who is a resident of the state of Israel or who is deemed to be a resident of the state of Israel for tax purposes, and who is (i) a Consultant, who is not an Employee, or (ii) a Controlling shareholder (whether or not an employee of the Company or any Parent or Subsidiary thereof) prior to the issuance of the relevant Option or as a result thereof. |
2.25. | “ITA” means the Israeli Income Tax Authorities. |
2.26. | “Nonstatutory Stock Option” means an Option not intended to qualify as an Incentive Stock Option. |
2.27. | “Officer” or “Office Holder” shall have the meaning ascribed to it in the Israeli Companies Law, 5759-1999, as amended from time to time. |
2.28. | “Non-Trustee 102 Option” means an Option granted to an Employee pursuant to Section 102(c) of the Ordinance, which is not required to be held in trust by a Trustee. |
2.29. | “Option” means a stock option granted pursuant to the Plan (including 102 Options, 3(i) Options, Incentive Stock Options and Nonstatutory Stock Options). |
2.30. | “Option Exchange Program” means a program whereby outstanding Options are exchanged for Options with a lower Exercise Price. |
2.31. | “Ordinance” means the Israeli Income Tax Ordinance (New Version), 1961, as amended, the rules promulgated thereunder, or any law or regulations which shall replace the Ordinance or Sections 3(i) or 102 promulgated thereunder. |
2.32. | “Parent” means a company, whether now or hereafter existing, to which the Company is a Subsidiary. |
2.33. | “Participant” means any Eligible Recipient selected by the Administrator, pursuant to the Administrator’s authority in Section 4 below, to receive grants of Options, Restricted Stock, Restricted Stock Units or any combination of the foregoing. |
2.34. | “Plan” means this 2021 Equity Incentive Plan. |
2.35. | “Restricted Stock” means Shares subject to certain restrictions granted pursuant to Section 18 below. |
2.36. | “Restricted Stock Unit” means a right granted under and subject to restrictions pursuant to Section 19 below. |
2.37. | “Share” means an Ordinary Share of the Company, having a nominal value of NIS 0. 01, as may be adjusted in accordance with Section 21 below. |
2.38. | “Section 102” means section 102 of the Ordinance and any regulations, rules, orders or procedures promulgated thereunder as now in effect or as amended or replaced from time to time. |
2.39. | “Subsidiary” means any company, whether now or hereafter existing, other than the first company, in an unbroken chain of companies, if each of the companies (other than the last company) in the unbroken chain, owns shares possessing more than fifty percent (50%) of the total combined voting power of all classes of shares in one of the other companies in such chain. |
2.40. | “Successor Company” means a successor corporation in a Transaction or any parent or Affiliate thereof, as determined by the Administrator in its discretion. |
2.41. | “Transaction” means: (i) a sale of all or substantially all of the assets of the Company, or a sale (including an exchange) of all or substantially all of the shares of the Company, to any person, or a purchase by a shareholder of the Company or by an Affiliate of such shareholder, of all or substantially all the shares of the Company held by all or substantially all other shareholders or by other shareholders who are not Affiliated with such acquiring party; (ii) a merger (including, a reverse merger and a reverse triangular merger), consolidation, amalgamation or like transaction of the Company with or into another corporation; (iii) a scheme of arrangement for the purpose of effecting such sale, merger, consolidation, amalgamation or other transaction; or (iv) such other transaction or set of circumstances that is determined by the Administrator, in its discretion, to be a Transaction subject to the provisions of Section 21.4 below; excluding (a) any of the above transactions in clauses (i) through (iv) with a wholly-owned subsidiary (directly or indirectly) of the Company for the purpose of reincorporating the Company in another jurisdiction, (b) any of the above transactions in clauses (i) through (iii) if the Administrator determines that such transaction should be excluded from the definition hereof and the applicability of Section 21.4 below, (c) any of the above transactions in clauses (i) through (iv) in which shareholders of the Company prior to the transaction will maintain more than fifty percent (50%) of the voting power of the resulting or surviving entity after the transaction (provided, however, that shares of the resulting or surviving entity held by shareholders of the Company acquired by means other than the exchange or conversion of the shares of the Company shall not be used in determining if the shareholders of the Company own more than fifty percent (50%) of the voting power of the resulting or surviving entity (or its parent), but shall be used for determining the total outstanding voting power of the resulting or surviving entity); (d) any of the above transactions in clauses (i) through (iv) in connection with an issuance of securities by the Company as part of a transaction financing. |
2.42. | “Trustee” means any person or entity appointed by the Company, any of its Parents or any of its Subsidiaries, as applicable, and approved by the ITA, to serve as a trustee, all in accordance with the provisions of Section 102(a) of the Ordinance. |
2.43. | “Trustee 102 Option” means an Option granted pursuant to the rules set in Section 102(b) of the Ordinance and held in trust by a Trustee for the benefit of the Participant. |
2.44. | “102 Option” means an Option granted under the rules of Section 102 of the Ordinance, as amended, or any law or regulations, which shall replace Section 102. |
2.45. | “102 Capital Gain Options (102 CGO)” means a Trustee 102 Option elected and designated by the Employing Company to qualify for capital gain tax treatment in accordance with the provisions of Section 102(b)(2) of the Ordinance. |
2.46. | “102 Ordinary Income Option (102 OIO)” means a Trustee 102 Option elected and designated by the Employing Company to qualify for ordinary income tax treatment in accordance with the provisions of Section 102(b)(1) of the Ordinance. |
2.47. | “3(i) Option” means an Option granted under the rules of Section 3(i) of the Ordinance, as amended, or any law or regulations, which shall replace Section 3(i). |
3. | Shares Subject to the Plan |
Subject to the provisions of Section 21 of the Plan, the aggregate number of Shares reserved and available for grant of Awards under the Plan is 111,111 or such other number of Shares as the Board shall determine from time to time. The Shares may be authorized but unissued, or reacquired Shares. Such Shares may consist, in whole or in part, of authorized and unissued shares or treasury shares.
If and to the extent that an Option expires, terminates or is canceled or forfeited for any reason without having been exercised in full, the Shares associated with that portion of that Option which was not exercised will again become available for grant under the Plan. Similarly, if and to the extent an Award of Restricted Stock or Restricted Stock Units is canceled or forfeited for any reason, the Shares subject to that Award will again become available for grant under the Plan. Shares withheld in settlement of a tax withholding obligation associated with an Award, or in satisfaction of the Exercise Price payable upon exercise of an Award, will again become available for grant under the Plan. If any Award or portion thereof is settled for cash, the Shares attributable for such cash settlement will again become available for grant.
4. | Administration of the Plan |
4.1. | Administrator. The Plan shall be administered by the Board or a Committee appointed by the Board, which Committee shall be constituted to comply with Applicable Laws. Notwithstanding the above, the Board shall automatically have residual authority if no Committee shall be constituted or if such Committee shall cease to operate for any reason. |
4.2. | Powers of the Administrator. Subject to the provisions of the Plan and, in the case of a Committee, the specific duties delegated by the Board to such Committee, and subject to the approval of any relevant authorities and compliance with all Applicable Laws, the Administrator shall have the full power and authority at its sole discretion, from time to time and at any time: |
(i) | To determine whether and to what extent Awards are to be granted hereunder to Participants; |
(ii) | To determine and/or amend the Exercise Price of the Awards; |
(iii) | To determine and/or amend the vesting schedule of the Awards; |
(iv) | To determine and/or amend the terms of payment for the Shares; |
(v) | To select the Eligible Recipients to whom Awards may from time to time be granted hereunder; |
(vi) | To determine the number of Shares to be covered by each Award granted hereunder; |
(vii) | To approve forms of agreement for use under the Plan; |
(viii) | To determine the terms and conditions of any Award granted hereunder. Such terms and conditions shall include, but shall not be limited to, the Exercise Price, the time or times and the extent to which the Awards may be exercised (which may be based on performance criteria), any vesting acceleration (whether or not in connection with a Transaction) or waiver of forfeiture restrictions, and any restriction or limitation regarding any Award or the Shares relating thereto, based in each case on such factors as the Administrator, at its sole discretion, shall determine; |
(ix) | To determine the Fair Market Value of the shares covered by each Award; |
(x) | To make an election as to the type of 102 Option; |
(xi) | To establish, add, cancel, amend or otherwise alter any restrictions, terms or conditions of any Award or Shares subject to any Award (including, without limitation, change the vesting terms, or accelerate the vesting periods, or add acceleration provisions with respect to, any Award granted hereunder); |
(xii) | To prescribe, amend and rescind rules and regulations relating to the Plan, including rules and regulations relating to sub-plans established for the purpose of qualifying for preferred tax treatment under foreign tax laws; |
(xiii) | To authorize conversion or substitution under the Plan of any or all Awards and to cancel or suspend Awards, as necessary, provided the material interests of the Participants are not harmed; |
(xiv) | To construe and interpret the terms of the Plan and Awards granted pursuant to the Plan; |
(xv) | To alter, revise or otherwise adjust the terms of the Plan and the Award Agreement, as may be required pursuant to any applicable laws of local or foreign jurisdictions; |
All the abovementioned powers and actions may be taken by the Administrator at the date of grant of the Award and/or at any time thereafter.
4.3. | In the event of a tie vote with respect to any matter brought before the Administrator, such matter shall be presented to the Board and the decision of the Board shall be final with respect to such matter. |
4.4. | Neither the Trustee nor any member of the Board or the Committee shall be liable to the Company or to any Participant, for any action or determination taken or made in good faith as a Committee member in the course of administrating the Plan. Each member of the Board or the Committee shall be indemnified and held harmless by the Company or by any Participant against any cost or expense (including counsel fees) reasonably incurred by him, or any liability (including any sum paid in settlement of a claim with the approval of the Company) arising out of any act or omission to act in connection with the Plan unless arising out of such member’s own fraud or bad faith, all to the extent permitted by applicable law. Such indemnification shall be in addition to any rights of indemnification the member may have as a director or otherwise under the Company’s charter documents, any agreement, any vote of shareholders or disinterested directors, insurance policy or otherwise. |
4.5. | Effect of Administrator’s Decision. All decisions, determinations and interpretations of the Administrator shall be final and binding on all Participants. |
5. | Term of Plan |
5.1. | The Plan shall become effective upon its adoption by the Board. It shall continue in effect for a term of ten (10) years unless sooner terminated under Section 23 below. |
5.2. | Termination of the Plan shall not affect the Administrator’s ability to exercise the powers granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination. |
6. | Eligibility |
Awards may be granted to Participants and to persons to whom offers of employment or engagement as Employees or Consultants have been extended.
7. | Options to Non Israeli Participants |
7.1. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, Nonstatutory Stock Options may be granted to non-Israeli Employees and non-Israeli Consultants and Incentive Stock Options may be granted only to non-Israeli Employees. |
7.2. | Each Option granted to non Israeli Participants shall be designated in the Award Agreement as either an Incentive Stock Option or a Nonstatutory Stock Option, unless the Administrator determines otherwise at any time and subject to Applicable Laws. However, notwithstanding such designation, to the extent that the aggregate Fair Market Value of the Shares with respect to which Incentive Stock Options are exercisable for the first time by the Participant during any calendar year (under all plans of the Company and any Parent or Subsidiary) exceeds $100,000, then unless the Administrator determines otherwise at any time and subject to the requirements of any applicable law, such options shall be treated as Nonstatutory Stock Options. For purposes of this Section, Incentive Stock Options shall be taken into account in the order in which they were granted. The Fair Market Value of the Shares shall be determined as of the time the option with respect to such Shares is granted. |
8. | Options to Israeli Participants |
8.1. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, Israeli Employees may be granted only 102 Options and Israeli Non-Employees may be granted only 3(i) Options. In each case, such options shall be subject to the terms and conditions of the Ordinance. |
8.2. | The Employing Company may designate 102 Options granted to Israeli Employees pursuant to Section 102 as Non-Trustee 102 Options or as Trustee 102 Options. |
9. | Trustee 102 Options |
9.1. | Options granted pursuant to this Section 9 are intended to constitute Trustee 102 Options and are subject to the provisions of Section 102 and the general terms and conditions specified in the Plan, except for such provisions of the Plan applying to options under a different tax law or regulation. |
9.2. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, Trustee 102 Options may be granted only to Israeli Employees. |
9.3. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, Trustee 102 Options shall be classified as either 102 CGO or 102 OIO, subject to the terms and conditions of Section 102 and the provisions of the Plan. |
9.4. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, no Trustee 102 Options may be granted under this Plan, unless the Employing Company’s election of the type of Trustee 102 Options granted to Israeli Employees, 102 CGO or 102 OIO (the “Election”), is appropriately filed with the ITA. |
9.5. | After making an Election, unless the Administrator determines otherwise at any time and subject to Applicable Laws, the Company may grant only the type of Trustee 102 Options it has elected (i.e. 102 CGO or 102 OIO), and the Election shall apply to all grants to Participants of Trustee 102 Options until such Election is changed pursuant to the provisions of Section 102(g) of the Ordinance. Unless the Administrator determines otherwise at any time and subject to Applicable Laws, the Employing Company may change such Election only after the passage of at least one year following the end of the year during which the applicable Employing Company first granted Trustee 102 Options in accordance with the previous Election. |
9.6. | For the avoidance of doubt, such Election shall not prevent the Company from granting Non-Trustee 102 Options or 3(i) Options simultaneously with the grant of Trustee 102 Options. |
9.7. | The grant of Trustee 102 Options shall be conditioned upon the approval (or the deemed approval pursuant to the provisions of section 102(a) of the Ordinance) of the Plan and the Trustee by the ITA. |
9.8. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, Trustee 102 Options may be granted only after the passage of thirty (30) days (or a shorter period as and if approved by the ITA) following the delivery by the appropriate Employing Company to the ITA of a request for approval of the Plan and the Trustee according to Section 102, as mentioned in section 9.4 above. |
9.9. | Notwithstanding the foregoing paragraph, if within ninety (90) days of delivery of the abovementioned request, the appropriate ITA officer notifies the Employing Company of his or her decision not to approve the Plan or the Trustee, the Options that were intended to be granted as a Trustee 102 Options shall be deemed to be Non-Trustee 102 Options, unless otherwise determined by the ITA officer. |
9.10. | Anything herein to the contrary notwithstanding, all Trustee 102 Options granted under this Plan shall be granted or issued to a Trustee. The Trustee shall hold each such Trustee 102 Option, all Shares issued upon exercise thereof, and all other securities received following any exercise or realization of rights, including bonus shares, in trust for the benefit of the Participant in respect of whom such Option was granted. All certificates representing Options or Shares issued to the Trustee under the Plan shall be deposited with the Trustee, and shall be held by the Trustee until such time that such Options or Shares are released from the trust. |
9.11. | With respect to 102 CGO and 102 OIO, the Options or Shares issued upon the exercise thereof and all rights related to them, including bonus shares, will be held by the Trustee for such period of time as required under Section 102 (currently, at least 24 months (in case of a 102 CGO) and 12 months (in case of a 102 OIO), from the date on which such Option was issued and deposited with the Trustee) or a shorter period as approved by the ITA (hereinafter, the “Holding Period”), under the terms set forth in Section 102. |
9.12. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, in accordance with Section 102, the Participant shall not sell, cause the release from trust, or otherwise dispose of, any Trustee 102 Option, any Share issued upon the exercise thereof, or any rights related to them, including bonus shares, until the end of the applicable Holding Period. Notwithstanding the foregoing but without derogating from the provisions of the Plan and the terms and conditions set forth in the Award Agreement, if any such sale, release, or disposition occurs during the Holding Period, then the provision of Section 102, relating to non-compliance with the Holding Period, will apply and all sanctions under Section 102 shall be borne by the Participant. |
9.13. | Anything herein to the contrary notwithstanding, the Trustee shall not release any Options which were not already exercised into Shares by the Participant, nor release any Shares issued upon exercise of the Trustee 102 Options or rights related thereto, including bonus shares, prior to the full payment of the Exercise Price and Participant’s tax liability arising from the Trustee 102 Options which were granted to him or her. |
9.14. | In the event that a stock split shall be effected or bonus shares shall be issued on account of the Shares which have been issued for the Participant’s benefit, such new split or bonus shares shall be transferred by the Company to the Trustee to hold for such Participant’s benefit. |
9.15. | The validity of any order given to the Trustee by a Participant shall be subject to the approval of the Company. The Company shall render its decision regarding orders given by any Participant to the Trustee within a reasonable period of time. The Company shall not be required to approve any order which is incomplete, is not in accordance with the provisions of this Plan and the relevant Award Agreement or which the Company believes should not be executed for any reasonable reason. The Company shall notify the Participant of the reason for not approving his/her order. Approval by the Company of any order given to the Trustee by a Participant shall not constitute proof of the Company’s recognition of any right of such Participant. |
9.16. | Without derogating from the aforementioned, the Administrator shall have the authority to determine the specific procedures and conditions of the trusteeship with the Trustee in a separate agreement between the Company and the Trustee. |
9.17. | In the event that the requirements for the Trustee 102 Options are not met, then the Trustee 102 Options shall be regarded as Non-Trustee 102 Options. |
9.18. | Upon receipt of a Trustee 102 Option, the Participant will sign an Award Agreement under which such Participant will agree to be subject to the trust agreement between the Company and/or its Subsidiaries and the Trustee, stating, inter alia, that the Trustee will be released from any liability in respect of any action or decision duly taken and executed in good faith in relation to this Appendix, or any Trustee 102 Option or Share issued to him or her thereunder. |
10. | Fair Market Value For Israeli Tax Purposes |
Without derogating from Section 2.20 and solely for the purpose of determining the tax liability pursuant to Section 102(b)(3) of the Ordinance, if at the date of grant of a 102 CGO the Company’s shares are listed on any established stock exchange or a national market system, or if the Company’s shares are registered for trading within ninety (90) days following the date of grant of the 102 CGO, the fair market value of the Shares at the date of grant shall be determined in accordance with the average value of the Company’s shares on the thirty (30) trading days preceding the date of grant or on the thirty (30) trading days following the date of registration for trading, as applicable, unless the Administrator determines otherwise at any time and subject to Applicable Laws.
11. | Integration of Section 102 and Tax Assessing Officer’s Permit |
Unless the Administrator determines otherwise at any time and subject to Applicable Laws, with respect to Trustee 102 Options, the provisions of the Plan and the Award Agreement shall be subject to the provisions of Section 102 and the Tax Assessing Officer’s permit (to the extent that such permit is issued) (the “Permit”), and said provisions and Permit shall be deemed an integral part of the Plan and the Award Agreement.
12. | Non-Trustee 102 Options |
12.1. | Options granted pursuant to this Section 12 are intended to constitute Non-Trustee 102 Options and are subject to the provisions of Section 102 and the general terms and conditions specified in the Plan, except for such provisions of the Plan applying to Options granted under a different tax law or regulations. |
12.2. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, Non-Trustee 102 Options may be granted only to Israeli Employees. |
12.3. | Non-Trustee 102 Options shall be granted pursuant to the Plan may be issued directly to the Israeli Employee or to a trustee appointed by the Administrator in his\its sole discretion. In the event that the Administrator determines that Non-Trustee 102 Options, and Shares issued upon the exercise thereof, shall be deposited with a trustee, the provisions of Sections 9.10, 9.13, and 9.17 hereof shall apply, mutatis mutandis. |
12.4. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, in the event that an Israeli Employee who was granted a Non-Trustee 102 Option is an employee of the Company, or any Parent or Subsidiary thereof, such employee will be obligated to provide his employer, upon the termination of his employment for any reason, with a security or guarantee to cover any future tax obligation resulting from the grant, exercise or disposition of the Option or the Shares issuable upon the exercise thereof, in the form satisfactory to such employer in the latter’s sole discretion. |
13. | 3(i) Options |
13.1. | Options granted pursuant to this Section 13 are intended to constitute 3(i) Options and are subject to the provisions of Section 3(i) of the Ordinance and the general terms and conditions specified in the Plan, except for provisions of the Plan applying to Options granted under a different tax law or regulations. |
13.2. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, 3(i) Options may be granted only to Israeli or foreigners Non-Employees. |
13.3. | 3(i) Options that shall be granted pursuant to the Plan may be issued directly to the Israeli and foreigners Non-Employee or to a trustee appointed by the Administrator in his\its sole discretion. In the event that the Administrator determines that 3(i) Options, and Shares issued upon the exercise thereof, shall be deposited with a trustee, the provisions of Sections 9.10, 9.13, and 9.17 hereof shall apply, mutatis mutandis. |
14. | General Provisions |
14.1. | Term of Option. The expiration date of the term of each Option shall be stated in the Award Agreement (the “Expiration Date”); provided, however, that in no event the term of any Option shall be more than ten (10) years from the date of grant thereof. Each unexercised Option shall automatically expire and shall no longer be exercisable immediately upon the earlier of: (i) the Expiration Date of such Option (as set forth in the applicable Award Agreement), or (ii) at the time at which such Option otherwise expires pursuant to the terms of the Plan. |
14.2. | Option Exercise Price and Consideration |
(i) | The per share Exercise Price for the Shares to be issued upon exercise of an Option shall be such price as is determined by the Administrator at any time at its sole and absolute discretion, subject to any Applicable Laws. |
(ii) | The consideration to be paid for the Shares to be issued upon exercise of an Option, including the method of payment, shall be determined by the Administrator at the time of grant and/or at any time thereafter, subject to any Applicable Law. Such consideration may consist of (1) cash; (2) check; (3) previously acquired Shares based on the Fair Market Value of the Shares on the date the Option is exercised; (4) a cashless exercise method, whereby the Option’s Exercise Price will not be due in cash and where the number of Shares issued upon such exercise will be equal to: (A) the product of (i) the number of Shares as to which the Option is then being exercised, and (ii) the excess, if any, of (a) the then current Fair Market Value per Share over (b) the Option Exercise Price, divided by (B) the then current Fair Market Value per Share; (5) any combination of the foregoing methods of payment; or (6) any other method as shall be determined by the Administrator at its sole discretion. |
14.3. | Manner of Exercising the Option |
(i) | Procedure for Exercise; Rights as a Shareholder. Any Option granted hereunder shall be exercisable according to the terms hereof, at such times and under such conditions as determined by the Administrator and set forth in the Award Agreement and in accordance with the requirements of Section 102 of the Ordinance, if applicable. |
(ii) | In the event of any conflict between the terms and conditions of an Award Agreement and the terms hereof, the terms hereof shall control, unless explicitly provided otherwise in the Award Agreement. |
(iii) | Unless the Administrator provides otherwise at any time, vesting of Options granted hereunder shall be ceased during any unpaid leave of absence. |
(iv) | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, an Option shall be deemed exercised when the Company receives: (i) written notice of exercise (in accordance with the Award Agreement) from the person entitled to exercise the Option and (ii) full payment for the Shares with respect to which the Option is exercised. Full payment may consist of any consideration and method of payment authorized by the Administrator and permitted by the Award Agreement and the Plan. Unless the Administrator determines otherwise at any time and subject to Applicable Laws, Shares issued upon exercise of an Option (excluding Shares underlying a 102 Option, which Shares shall be issued in the name of the Trustee) shall be issued in the name of the Participant or, if requested by the Participant, in the name of the Participant and his or her spouse. |
(v) | Until the applicable Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a shareholder shall exist with respect to such Shares, notwithstanding the exercise of the Option, nor shall the Participants be deemed to be a class of shareholders or creditors of the Company for the purpose of the operation of sections 350 and 351 of the Israeli Companies Law, 5759-1999 or any successor to such sections. |
(vi) | The Company shall issue (or cause to be issued) such Shares promptly after the Option is exercised. No adjustment will be made for a dividend or other right, including without limitation, in connection with rights offering, for which the record date is prior to the date the Shares are issued, except as provided in Section 21 hereof. |
(vii) | Exercise of an Option in any manner shall result in a decrease in the number of Shares thereafter available, both for purposes of the Plan and for sale under the Option, by the number of Shares as to which the Option is exercised. |
(viii) | An Option may not be exercised for fractional shares. |
(ix) | Until the consummation of an IPO, and unless explicitly provided otherwise in the Award Agreement, any Shares acquired upon the exercise of Options shall be voted by an irrevocable proxy, substantially in the form attached hereto as Schedule A (or any other form approved by the Board) (the “Proxy”), according to which, the Participant irrevocably appoints the chairman of the Board, or any other person designated for such purpose by the Board, as his/her proxy with respect to the Shares acquired upon the exercise of Options (the “Proxy Holder”). The Proxy will be signed and delivered to the Company by the Participant concurrently with the execution of the Participant’s Award Agreement. |
(x) | The Proxy Holder shall be indemnified and held harmless by the Company against any cost or expense (including counsel fees) reasonably incurred by him/her, or any liability (including any sum paid in settlement of a claim with the approval of the Company) arising out of any act or omission to act in connection with the voting of such Proxy, unless arising out of such Proxy Holder’s own fraud or willful misconduct, to the extent permitted by Applicable Law. Such indemnification shall be in addition to any rights of indemnification the Proxy Holder may have (if any) as a director or otherwise under the Articles, any agreement, any vote of shareholders or disinterested directors, insurance policy or otherwise. Without derogating from the above, with respect to 102 Options, such shares shall be voted in accordance with the provisions of Section 102 and any rules, regulations or orders promulgated thereunder. |
15. | Non-Transferability of Options |
15.1. | Unless the Administrator determines otherwise at any time and subject to Applicable Laws, Options may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime of the Participant, only by the Participant. |
15.2. | Without derogating from the foregoing and unless the Administrator determines otherwise at any time and subject to Applicable Laws, for as long as Options or Shares purchased upon the exercise thereof are held by the Trustee on behalf of the Participant, all rights of the Participant with respect to such Options and Shares shall be personal, and may not be transferred, assigned, pledged or mortgaged, other than by will or laws of descent and distribution. |
15.3. | Without derogating from the inherent power of the shareholders of the Company to alter or modify the rights of the Company’s shares, the Administrator may impose on any Participant such additional restrictions on the transfer of Shares as the Administrator may determine at the time that Options are granted to the Participant or as may be agreed to by the Administrator and the Participant following purchase of said Shares upon exercise of such Options under this Plan or upon termination of the Participant’s employment or service with the Company. Such additional restrictions shall be included in the Award Agreement entered into between the Company and the Participant, or, upon agreement of the Participants, or in this Plan. |
16. | Rights and Restrictions Attaching to the Shares |
16.1. | Equal Rights. Unless the Administrator determines otherwise at any time and subject to Applicable Laws, the Shares shall have equal rights for all intents and purposes as the rights attached to Shares of the Company according to the Articles, subject also to the provisions of this Plan and the Award Agreement. Any change to Articles which modify rights attaching to the Company’s shares shall also apply to the Awards and the Shares. The provisions of the Plan shall remain applicable, with the necessary modifications arising from any such amendment. The grant of Awards or the issuance of Shares under this Plan shall not entitle any Participant to receive any compensation in the event of any change to the Company’s capital. |
16.2. | Dividend Rights. Unless the Administrator determines otherwise at any time and subject to Applicable Laws, all Shares issued upon the exercise of Options granted under the Plan, shall entitle the Participant thereof, or the Trustee for the benefit of Participant, subject to any applicable taxation on distribution of dividends and, when applicable, subject to the provisions of Section 102, to receive dividends with respect thereto in accordance with the Articles, provided, however, that Participant, or the Trustee for the benefit of Participant, shall have no right to dividends or distribution or other right, including without limitation in connection with rights offering, with respect to Shares for which the record date is prior to the date on which the Participant shall have become the holder of record. |
16.3. | Transfer of Shares. Without derogating from the provisions of the Plan and the terms and conditions set forth in the Award Agreement or the Articles, until the consummation of an IPO and unless the Administrator determines otherwise at any time, prior to any transfer of any Shares acquired upon the exercise of Options to a transferee (the “Transferred Shares”) and as a condition to the transfer of the Transferred Shares (if and to the extent the Transferred Share were subject to a Proxy), such transferee shall execute an irrevocable proxy substantially in the form of the Proxy, appointing the chairman of the Board, or any other person designated for such purpose by the Board, as such transferee’s proxy with respect to the Transferred Shares. |
17. | Termination of Relationship as an Employee or as a Consultant |
17.1. | Subject to the provisions of Sections 17.4 and 17.5 below, if a Participant ceases to be an Employee or a Consultant, such Participant may exercise his or her Option within such additional period of time beyond the date of such termination as is specified in the applicable Award Agreement (solely to the extent that the Option is vested on the date of such termination), but in no event later than the Expiration Date of such Option (for the purpose of this Section 17.1 the “Extended Period”). In the absence of a specified Extended Period in the Award Agreement and unless the Administrator determines otherwise at any time, the Option (solely to the extent that the Option is vested on the date of such termination) shall remain exercisable for, and the Extended Period shall be deemed to be, three (3) months following the Participant’s termination (but in no event later than the Expiration Date of such Option). If, on the date of termination, the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option shall automatically revert to the Plan and shall no longer be exercisable. If, after termination of engagement with the Company, the Participant does not exercise the vested portion of his or her Option within the Extended Period, the Option shall forthwith terminate, and the Shares covered by such Option shall automatically revert to the Plan. For the avoidance of doubt, Awards granted hereunder shall not continue to vest during the Extended Period thereof. |
17.2. | At any time, including following the date on which an Award is granted the Administrator, at its sole and absolute discretion and without such act constituting a precedent in respect of any other Participant, shall be entitled to extend the period during which the Participant shall be entitled to exercise his\her vested Options, by a period to be fixed by the Administrator. |
17.3. | Anything in this Plan to the contrary notwithstanding, but subject to the provisions of section 102 of the Ordinance and the tax regulations thereto, if a Participant ceases to be an Employee or a Consultant of the Company or any Parent or Subsidiary thereof, but continues to be employed or provide services to the Company or any other Parent or Subsidiary thereof, such Participant will be deemed for the purpose of this Section 17 to have continuously remained an Employee or a Consultant of the Company (as applicable) during such term, and his/her Awards shall vest pursuant to their original terms. Notwithstanding anything to the contrary hereinabove, unless the Administrator determines otherwise at any time and subject to Applicable Laws, if termination of Participant is for Cause, the entire unexercised Option (whether vested or not) shall ipso facto terminate and the Shares covered by such Option shall automatically revert to the Plan. |
17.4. | Retirement. If a Participant should retire, he/she may, subject to the approval of the Administrator (at its sole discretion), continue to enjoy such rights, if any, with respect to his/her Awards under the Plan and on such terms and conditions, with such limitations and subject to such requirements as the Administrator, at its sole discretion, may determine at the time of such retirement or at any time theretofore. |
17.5. | Death or Disability of Participant. If Participant’s engagement with the Company as an Employee or a Consultant is terminated as a result of the Participant’s death or inability to substantially perform the ordinary functions of his/her position in the Company by reason of any medically diagnosed physical or mental impairment, permanent disability or chronic illness, which last for a continuous period of nine (9) months or more (“Disability”), the Participant (or, if the Participant died, the Participant’s estate or any person who acquired the right to exercise the Option by bequest or inheritance) may exercise his or her Option within such additional period of time thereafter as is specified in the Award Agreement (which period shall be of at least six (6) months) (and with respect to Options, to the extent the Option is vested on the date of such termination), but in no event later than the Expiration Date of the such Option (for the purpose of this Section 17.5 the “Extended Period”). A determination of any Disability will be made by a physician reasonably acceptable to the Company. In the absence of a specified Extended Period in the Award Agreement, the Option, to the extent it is vested on the date of such termination, shall remain exercisable for, and the Extended Period shall be deemed to be, twelve (12) months following the Participant’s termination, or any longer period determined by the Administrator (but in no event later than the Expiration Date of such Option). If, on the date of termination, the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option shall automatically revert to the Plan and shall no longer be exercisable. If, after termination, the vested portion of the Participant’s Option are not exercised within the applicable Extended Period, the Option shall forthwith terminate, and the Shares covered by such Option shall automatically revert to the Plan. For the avoidance of doubt, the Awards granted hereunder shall not continue to vest during the Extended Period. |
18. | Restricted Stock |
18.1. | Awards of Restricted Stock may be issued either alone or in addition to other Awards granted under the Plan (including, without limitation, under Section 102). The Administrator shall determine, at its sole discretion, the Eligible Recipients to whom, and the time or times at which, Awards of Restricted Stock shall be made, the number of Shares to be awarded, the Exercise Price, if any, to be paid by the Participant for the acquisition of Restricted Stock, the Restricted Period (as defined in Section 18.3(i) below) and all other conditions of the Awards of Restricted Stock. The Administrator may also condition the grant of the Award of Restricted Stock upon the exercise of Options, or upon such other criteria as the Administrator may determine, at its sole discretion. The provisions of the Awards of Restricted Stock need not be the same with respect to each Participant. |
18.2. | Awards and Certificates |
(i) | The prospective recipient of Awards of Restricted Stock shall not have any rights with respect to any such Award, unless and until such recipient has executed an Award Agreement evidencing the Award (a “Restricted Stock Award Agreement”) and delivered a fully executed copy thereof to the Company, within a period of sixty (60) days (or such other period as the Administrator may specify at any time) after the Award date and has otherwise complied with the applicable terms and conditions of such Award. |
(ii) | Except as otherwise provided below in Section (iii), (a) each Participant who is granted an Award of Restricted Stock shall be issued a share certificate in respect of such Shares of Restricted Stock, and (b) such certificate shall be registered in the name of the Participant (or, if so determined by the Administrator or required under any Applicable Law – such certificate shall be registered in the name of the Trustee), and shall bear an appropriate legend referring to the terms, conditions, and restrictions applicable to any such Award. |
(iii) | The Company may require that the share certificates evidencing Restricted Stock granted hereunder be held in the custody of the Company until the restrictions thereon shall have lapsed, and that, as a condition of any Award of Restricted Stock, the Participant shall have delivered a stock power, endorsed in blank, relating to the Shares covered by such Award. |
18.3. | Restrictions and Conditions |
Unless the Administrator determines otherwise at any time and subject to Applicable Laws, the Awards of Restricted Stock granted pursuant to this Section 18 shall be subject to the following restrictions and conditions:
(i) | Subject to the provisions of the Plan and the Restricted Stock Award Agreement governing any such Award, during such period as may be set by the Administrator commencing on the date of grant (the “Restricted Period”), the Participant shall not be permitted to sell, transfer, pledge, assign or otherwise dispose Shares of Restricted Stock awarded under the Plan; provided, however, that the Administrator may at any time and at its sole discretion, provide for the lapse of such restrictions in installments and may accelerate or waive such restrictions in whole or in part based on such factors and such circumstances as the Administrator may determine, at its sole discretion, including, but not limited to, the attainment of certain performance related goals, the Participant’s termination of employment or service as a director, consultant or advisor to the Company, any Subsidiary or Affiliate, the Participant’s death or Disability or the occurrence of a Transaction. |
(ii) | Subject to the provisions of the applicable Award Agreement or as otherwise determined by the Administrator at any time, once the Participant has been issued a certificate or certificates for Restricted Stock or the Restricted Stock has been issued in the Participant’s name by book-entry registration, the Participant will have, with respect to the Restricted Stock, the right to vote the Shares, but will not have the right to receive any cash distributions or dividends prior to the lapse of the Restriction Period. If any cash distributions or dividends are payable with respect to the Restricted Stock, the Administrator, in its sole discretion, may require the cash distributions or dividends to be subjected to the same Restriction Period as is applicable to the Restricted Stock with respect to which such amounts are paid, or, if the Administrator so determines, to allocate such cash distributions or dividends among all other eligible shareholders, or to reinvest such cash distributions or dividends in additional Restricted Stock to the extent Shares are available under Section 3 of the Plan. If the Administrator determines that cash distributions or dividends shall be payable with respect to the Restricted Stock, such dividends shall be paid or distributed at the end of the Restriction Period and a Participant shall not be entitled to interest with respect to any such dividends or distributions subjected to the Restriction Period. Unless otherwise determined by the Administrator at any time subject to Applicable Laws, any distributions or dividends paid in the form of securities with respect to Restricted Stock will be subject to the same terms and conditions as the Restricted Stock with respect to which they were paid, including, without limitation, the same Restriction Period. |
(iii) | Subject to the provisions of the applicable Award Agreement or as otherwise determined by the Administrator at any time, if a Participant’s service or employment with the Company, its Subsidiary or Parent terminates prior to the expiration of the applicable Restriction Period, the Participant’s Restricted Stock and any associated dividends, if any, that then remain subject to forfeiture will then be forfeited automatically. Upon forfeiture of Restricted Stock, the Participant shall have no further rights with respect to such Restricted Stock. |
(iv) | In the event that Awards of Restricted Stock are granted to Israeli Employees, such grant shall be subject to the provisions of Section 102 and the provisions of Sections 8, 9, 10, 11, 12, and 14 hereof shall apply to such Award, mutatis mutandis. |
19. | Restricted Stock Units |
Subject to the other terms of the Plan, the Administrator may grant Restricted Stock Units to Eligible Recipients, either alone or in addition to other Awards granted under the Plan, (including under Section 102) and may at any time, in its sole and absolute discretion, impose conditions on such units as it may deem appropriate, including, without limitation, continued employment or service of the Participant or the attainment of specified individual or corporate performance goals. Each Restricted Stock Unit shall be evidenced by an Award Agreement in the form that is approved by the Administrator.
Unless the Administrator determines otherwise at any time and subject to Applicable Laws, each Restricted Stock Unit will represent a right to receive from the Company, upon fulfillment of any applicable conditions, one Share. All other terms governing Restricted Stock Units, such as vesting, time and form of payment and termination of units shall be set forth in the applicable Award Agreement. The terms governing the Restricted Stock Units need not be the same with respect to each Participant. Unless the Administrator determines otherwise at any time and subject to Applicable Laws, the Participant shall not have any shareholder rights with respect to the Shares subject to a Restricted Stock Unit Award until that Award vests and any Shares are actually issued thereunder. Unless the Administrator determines otherwise at any time and subject to Applicable Laws, a Participant will not be permitted to sell, transfer, pledge, assign or otherwise encumber Restricted Stock Units awarded under the Plan. Subject to the provisions of the applicable Award Agreement or as otherwise determined by the Administrator at any time, if a Participant’s service with the Company, its Subsidiary or Parent terminates prior to the Restricted Stock Unit Award vesting, the Participant’s Restricted Stock Units that then remain subject to forfeiture will then be forfeited automatically. Upon forfeiture of Restricted Stock Units, the Participant shall have no further rights with respect to such Restricted Stock Units.
20. | [Reserved] |
21. | Adjustments |
21.1. | Changes in Capitalization. Subject to any required action by the shareholders of the Company, the number of Shares covered by each outstanding Award, and the number of Shares which have been authorized for issuance under the Plan but as to which no Awards have yet been granted or which have been returned to the Plan upon cancellation or expiration of an Award, as well as the Exercise Price of Shares covered by each such outstanding Award, may be proportionately adjusted upon any increase or decrease in the number of issued Shares resulting from a stock split, reverse stock split, stock dividend (if so determined by the Board upon the issuance of such stock dividend), combination or reclassification of the Shares, or any other increase or decrease in the number of issued Shares effected without receipt of consideration by the Company. The conversion of any convertible securities of the Company shall not be deemed to have been effected without receipt of consideration. Such adjustment shall be made by the Board, whose determination in that respect shall be final, binding and conclusive. Except as expressly provided herein, no issuance by the Company of shares of any class, or securities convertible into shares of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of Shares subject to an Award. |
21.2. | Dissolution or Liquidation. In the event of the proposed dissolution or liquidation of the Company, any or all outstanding Awards will terminate immediately prior to the consummation of such proposed action. The Administrator may, in the exercise of its sole discretion in such instances, declare that any Award shall terminate as of such other date fixed by the Administrator and give each Participant the right to exercise his\her Award as to all or any part of the Shares, including Shares as to which the Award would not otherwise be exercisable. |
21.3. | Changes to Plan. The Administrator shall be entitled, from time to time, to update and/or change the terms of this Plan, in whole or in part, at its sole discretion, provided that in the Board’s opinion such a change shall not materially derogate from the terms of vested Awards or Shares issued under this Plan. The Board shall be entitled to terminate this Plan at any time provided such termination does not materially affect the rights of any Participant with respect to vested Awards. |
21.4. | Transaction. Without derogating from the Administrator’s general authority and power under this Plan, in the event of a Transaction the following shall occur, without the Participant’s consent and action and without any prior notice requirement: |
21.4.1 | Unless otherwise determined by the Administrator in its sole and absolute discretion, any Award then outstanding shall be assumed or be substituted by the Company, or by a Successor Company, under terms as determined by the Administrator or the terms of this Plan applied by the Successor Company to such assumed or substituted Awards; |
For the purposes of this Section 21.4.1, the Award shall be considered assumed or substituted if, following a Transaction, the Award confers on the holder thereof the right to purchase or receive, for each Share underlying an Award immediately prior to the Transaction, either (i) the consideration (whether stock, cash, or other securities or property, or any combination thereof) distributed to or received by holders of Shares in the Transaction for each Share held on the effective date of the Transaction (and if holders were offered a choice or several types of consideration, the type of consideration as determined by the Administrator), or (ii) regardless of the consideration received by the holders of Shares in the Transaction, solely shares or any type of Awards (or their equivalent) of the Successor Company at a value to be determined by the Administrator in its discretion, or a certain type of consideration (whether stock, cash, or other securities or property, or any combination thereof) as determined by the Administrator. Any of the above consideration referred to clauses (i) and (ii) may be subject to vesting, expiration and other terms as determined by the Administrator in its discretion and may differ from the vesting, expiration and other terms applying on the Awards immediately prior to the Transaction. The foregoing shall not limit the Administrator’s authority to determine, in its sole discretion and in compliance with all Applicable Laws, that in lieu of such assumption or substitution of Awards for Awards of the Successor Company, such Award will be substituted for any other type of asset or property, including as set forth in Section 21.4.2 hereunder.
21.4.2 | Regardless of whether or not Awards are assumed or substituted, the Administrator may (but shall not be obligated to), in its sole discretion: |
(a) | provide for any Participant to have the right to exercise the Award in respect of Shares covered by the Award which would otherwise be exercisable or vested, under such terms and conditions as the Administrator shall determine, and the cancellation of all unexercised and unvested Awards upon or immediately prior to the closing of the Transaction, unless the Administrator provides for the Participant to have the right to exercise the Award; and/or |
(b) | provide for the acceleration of vesting of such Award, as to all or part of the Shares covered by the Award which would not otherwise be exercisable or vested, under such terms and conditions as the Administrator shall determine; and/or |
(c) | provide for the cancellation of each outstanding Award at or immediately prior to the closing of such Transaction, and payment to the Participant of an amount in cash, shares of the Company, the acquirer or of a corporation or other business entity which is a party to the Transaction or other property, as determined by the Administrator to be fair in the circumstances, and subject to such terms and conditions as determined by the Administrator. The Administrator shall have full authority to select the method for determining the payment (being the Black-Scholes model or any other method). The Administrator’s determination may further provide that payment shall be set to zero if the value of the Shares is determined to be less than the Exercise Price or in respect of Shares covered by the Award which would not otherwise be exercisable or vested, or that payment may be made only in excess of the Exercise Price. |
21.4.3 | The Administrator may determine that any payments made in respect of Awards shall be (i) subject to vesting terms substantially identical to those that applied to the canceled Award immediately prior to the Transaction; and/or (ii) made or delayed to the same extent that payment of consideration to the holders of the Shares in connection with the Transaction is made or delayed as a result of escrows, indemnification, earn outs, holdbacks or any other contingencies; and the terms and conditions applying to the payment made to the Participants, including participation in escrow, indemnification, releases, earn-outs, holdbacks or any other contingencies. |
21.4.4 | Notwithstanding the foregoing, in the event of a Transaction, the Administrator may determine, in its sole discretion that upon completion of such Transaction the terms of any Award be otherwise amended, modified or terminated, as the Administrator shall deem in good faith to be appropriate and without any liability to the Company or any Affiliate, Parent or Subsidiary thereof, and to their respective its officers, directors, employees and representatives and the respective successors and assigns of any of the foregoing in connection with the method of treatment or chosen course of action permitted hereunder. |
21.4.5 | Neither the authorities and powers of the Administrator under this Section 21.4, nor the exercise or implementation thereof, shall (i) be restricted or limited in any way by any adverse consequences (tax or otherwise) that may result to any holder of an Award, and (ii) as, inter alia, being a feature of the Award upon its grant, be deemed to constitute a change or an amendment of the rights of such holder under this Plan, nor shall any such adverse consequences (as well as any adverse tax consequences that may result from any tax ruling or other approval or determination of any relevant tax authority) be deemed to constitute a change or an amendment of the rights of such holder under this Plan, and may be effected without consent of any Participant and without any liability to the Company or its Affiliates and to their respective its officers, directors, employees and representatives and the respective successors and assigns of any of the foregoing. The Administrator needs not take the same action with respect to all Awards or with respect to all Eligible Recipients. The Administrator may take different actions with respect to the vested and unvested portions of an Award. The Administrator may determine an amount or type of consideration to be received or distributed in a Transaction which may differ as among the Participants, and as between the Participants and any other holders of shares of the Company. |
21.4.6 | The Administrator’s determinations pursuant to this Section 21.4 shall be conclusive and binding on all Participants. |
21.4.7 | If determined by the Administrator, the Participants shall be subject to the definitive agreement(s) in connection with the Transaction as applying to holders of Shares including, such terms, conditions, representations, undertakings, liabilities, limitations, releases, indemnities, participating in transaction expenses and escrow arrangement, in each case as determined by the Administrator. Each Participant shall execute such separate agreement(s) or instruments as may be requested by the Company, the Successor Company or the acquirer in connection with such in such Transaction and in the form required by them. The execution of such separate agreement(s) may be a condition to the receipt of assumed or substituted Awards, payment in lieu of the Award or the exercise of any Award. |
21.5. | Anything herein to the contrary notwithstanding and unless otherwise determined by the Administrator, in its sole and absolute discretion, if prior to the completion of the IPO, all or substantially all of the shares of the Company (determined without taking into account the shares issued or issuable under this Plan) are to be sold (whether under the Articles or any other contract by which the shareholders of the Company are bound or pursuant to any applicable law) to any third party, whether or not related to or affiliated with the Company or its shareholders, each Participant shall be obliged to sell the Shares such Participant purchased under the Plan, in accordance with the instructions then issued by the Administrator whose determination shall be final. |
22. | Time of Granting Awards |
Unless explicitly determined otherwise by the Administrator, the date of grant of an Award shall be, for all purposes, the later of (i) the date on which the Administrator makes the determination granting such Award, or (ii) the commencement date of the Participant’s engagement with the Company or any Parent or Subsidiary thereof (whether as an Employee, Consultant or Director). Notice of the determination shall be given to each Participant to whom an Award is so granted within a reasonable time after the date of such grant.
23. | Amendment and Termination of the Plan |
23.1. | Amendment and Termination. The Board may at any time amend, alter, suspend or terminate the Plan. |
23.2. | Shareholders Approval. The Board shall obtain shareholders approval of any Plan amendment to the extent necessary and desirable to comply with Applicable Laws. |
23.3. | Effect of Amendment or Termination. No amendment, alteration, suspension or termination of the Plan shall impair the rights of any Participant, unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be in writing and signed by the Participant and the Company. Termination of the Plan shall not affect the Administrator’s ability to exercise the powers granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination. |
24. | Conditions Upon Issuance of Shares |
24.1. | Legal Compliance. Shares shall not be issued pursuant to the exercise of an Award granted hereunder unless the exercise of such Award and the issuance and delivery of such Shares shall comply with Applicable Laws and shall be further subject to the approval of counsel for the Company with respect to such compliance. |
24.2. | Investment Representations. The Administrator may require each Participant acquiring Shares to represent and warrant that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such representation is required. |
24.3. | Market Stand-Off. In connection with any public offering of the Company’s equity securities, pursuant to an effective registration statement, for such period as the Company or its underwriters may request (such period not to exceed one hundred and eighty (180) days following the date of the applicable offering), the Participant shall not, directly or indirectly, sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer, or agree to engage in any of the foregoing transactions with respect to, any Shares acquired under this Plan without the prior written consent of the Company or its underwriters. |
25. | Rights as a Shareholder; Voting and Dividends |
25.1. | Without derogating from other provisions of the Plan, including Section 18.3(ii) above and unless otherwise determined by the Administrator at any time, subject to Applicable Laws, a Participant shall have no rights as a shareholder of the Company with respect to any Shares covered by the Award until the date of the issuance of a share certificate to the Participant for such Shares. In the case of 102 Option or 3(i) Option (if such Options are being held by a Trustee), the Trustee shall have no rights as a shareholder of the Company with respect to any Shares covered by such Award until the date of the issuance of a share certificate to the Trustee for such Shares for the Participant’s benefit, and the Participant shall have no rights as a shareholder of the Company with respect to any Shares covered by the Award until the date of the release of such Shares from the Trustee to the Participant and the issuance of a share certificate to the Participant for such Shares. Unless otherwise determined by the Administrator at any time and subject to Applicable Laws, no adjustment shall be made for dividends (ordinary or extraordinary, whether in cash, securities or other property) or distribution of other rights, including without limitation in connection with any rights offering, for which the record date is prior to the date such share certificate is issued. |
25.2. | The Company may, but shall not be obligated to, register or qualify the sale of Shares under any applicable securities law or any other Applicable Law. |
26. | No Right for Continuing Relationship |
Neither the Plan nor any Award shall confer upon any Participant any right with respect to continuing the Participant’s relationship as an Employee or as a Consultant with the Company, nor shall it interfere in any way with his or her right or the Company’s right to terminate such relationship at any time, with or without Cause.
27. | Inability to Obtain Authority |
The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.
28. | Default |
A Participant shall be deemed to be in default under this Plan, including the Award Agreement, in the event that the Participant fails to pay any sum or perform any obligation provided for in the Plan, in a timely fashion or in a manner required. Any default under this Plan not cured within ten (10) days after the Company gives written notice of such default to Participant shall entitle the Company to exercise any and all remedies and rights against the defaulting Participant contained in any and all of the documents comprising this Plan or provided under Applicable Law.
29. | Notices |
All notices and elections sent to the Company by a Participant shall be in writing and delivered in person or by certified mail to the CEO of the Company at the principal office of the Company. All notices given by the Company to a Participant under the Plan shall be in writing and delivered in person or by certified mail to the Participant’s address as reflected in the Company’s records. All notices will be deemed delivered within seven (7) days of their dispatch by certified mail, postage prepaid.
30. | Reservation of Shares |
At all time during the term of this Plan, the Company shall reserve and keep available such number of Shares as shall be sufficient to satisfy the requirements of the Plan.
31. | Miscellaneous |
31.1. | Any tax consequences arising from the grant or exercise of any Awards or from the payment for, or the sale of or other disposition of, Shares covered thereby or from any other event or act (whether of the Participant, the Trustee, or the Company or its Subsidiaries) hereunder, shall be borne solely by the Participant. The Company, its Parents, subsidiaries and the Trustee shall be entitled to withhold taxes according to the requirements of any Applicable Laws, rules and regulations, including withholding taxes at source and particularly regulation 7(b) of the Income Tax Regulations (tax benefits on the issuance of shares to employees) 2003. Furthermore, the Participant shall agree to indemnify the Company or Subsidiary that employs the Participant and the Trustee, if applicable, and hold them harmless against and from any and all liability for any such tax or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to the Participant. The Company may exercise such indemnification by deducting the Tax subject to indemnification from Participant’s salaries or remunerations. Except as otherwise required by law, the Company and the Trustee shall not be obligated to exercise any Awards on behalf of a Participant, or to release any share certificate, until all tax consequences arising from the exercise of such Awards are resolved in a manner reasonably acceptable to the Company and the Trustee, and all required payments in connection with the exercise of the Award, or the sale of the Shares, have been fully paid by the Employee. |
31.2. | The ramifications of any future modification of any Applicable Law regarding the taxation of Awards and/or Shares granted to Participants shall apply to the Participants accordingly and such Participants shall bear the full cost thereof, unless such modified laws expressly provide otherwise. For the avoidance of doubt, should the applicability of such taxing arrangements to this Plan or to securities issued in the framework thereof be stipulated by an application by the Company or by the Trustee that same shall apply, the Company shall be entitled to decide, at its absolute discretion, whether to apply such taxing arrangements and to instruct the Trustee to act accordingly. |
31.3. | Governing Law and Jurisdiction. This Plan shall be governed by and construed and enforced in accordance with the laws of the State of Israel, without giving effect to the principles of conflict of laws. The competent courts of Tel-Aviv, Israel shall have exclusive jurisdiction in any matters pertaining to the Plan. |
31.4. | Conflicts. This Plan (together with the Award Agreements signed by the Company and the Participant) supersedes all of the agreements and/or understandings existing prior to the date of the grant of Awards to an Participant between the Company, or any of its Affiliates, and such Participant in connection with issuance of capital shares of the Company or options for capital shares of the Company to such Participant, other than any written option agreement entered into pursuant to a different stock option plan approved by the Board. Any representation and/or promise and/or undertaking made and/or given by the Company and/or by any of its Affiliates or by any person on their behalf, which have not been expressed herein, shall have no force and effect. For the removal of doubt, it is hereby clarified that in the event of any contradiction between the terms set forth in this Plan and the terms of any Award Agreement, or in a Participant’s employment or services agreement, the terms of this Plan shall prevail, unless explicitly provided otherwise in the Award Agreement. |
32. | Multiple Agreements |
The terms of each Award may differ from other Awards granted, whether concurrent with, prior to or following its grant under this Plan . No Participant or other person shall have any claim to be granted Awards and there is no obligation for uniformity of treatment of Participants, or holders or beneficiaries of Awards. The terms and conditions of Awards and the Administrator’s determinations and interpretations with respect to them need not be the same with respect to each Participant (whether or not such Participants are similarly situated and whether or not the Awards are granted at the same time or at any other time).
Schedule A
PROXY
I, the undersigned, as record holder of the securities of Pagaya Technologies Ltd. (the “Company”) described below, hereby irrevocably appoint the chairman of the Company’s Board of Directors, or any other person designated for such purpose by the Company’s Board of Directors (the “Proxy Holder”), as my proxy instead of myself and on my behalf, with respect to any and all aspects of my shareholdings in the Company in virtue of the shares granted to me pursuant to the Company’s 2021 Equity Incentive Plan (including, without limitation and for the sake of clarification, any shares issued to me upon exercise of any option granted to me under the Company’s 2021 Equity Incentive Plan) (the “Shares”), including, without limiting the foregoing generality: (i) receiving any notices that the Company may deliver to its shareholders, pursuant to the Articles of Association of the Company (as amended from time to time), any shareholders agreement, applicable law or otherwise, (ii) attending all meetings of the shareholders of the Company and voting such Shares at any meeting of the shareholders of the Company (and at any postponements or adjournments thereof) and waiving all minimum notice requirements for such meetings of shareholders, (iii) executing any consents or dissents in writing without a meeting of the shareholders of the Company to any corporate action thereof, (iv) waiving any preemptive right, right of first refusal, right of first offer, co-sale right or any other similar right or restriction to which I will be entitled by virtue of the Shares, (v) giving or withholding consent or agreement to any matter which requires my consent or agreement in my capacity as a shareholder of the Company (whether such is required under the Articles of Association of the Company (as amended from time to time), any agreement to which I am a party as a shareholder or otherwise), and/or (vi) joining in making a request to convene a general meeting or class meeting of the shareholders of the Company or to otherwise exercise any and all powers and authorities vested within me in my capacity as a shareholder of the Company (in each of the foregoing cases, to the fullest extent that I will be entitled to act so, and in the same manner and with the same effect as if the undersigned were personally present at any such meeting or voting such Shares or personally acting on any matters submitted to shareholders for approval or consent).
The Shares shall be voted by the Proxy Holder in the same proportion as the votes of the other shareholders of the Company.
This proxy is irrevocable to the maximum extent allowed by applicable laws and it will remain in full force and effect until the consummation of an IPO (as defined in the Company’s 2021 Equity Incentive Plan), upon which it will automatically terminate.
The Proxy Holder will have the full power of substitution and revocation. All authority herein conferred shall survive the death or incapacity of the undersigned and any obligation of the undersigned hereunder shall be binding upon the heirs, personal representatives, successors and assigns of the undersigned.
Name | Date | |
Signature |
26
Exhibit 10.12
PAGAYA TECHNOLOGIES LTD.
2021 EQUITY INCENTIVE PLAN
STOCK OPTION SUB-PLAN FOR UNITED STATES PERSONS
1. | Introduction |
1.1 Pursuant to Section 4.2(xii) of the PAGAYA TECHNOLOGIES LTD. 2021 EQUITY INCENTIVE PLAN (the “Plan”), which Plan was adopted by the Board on March [_], 2021, the provisions set forth herein are made applicable to Options granted under this sub-plan (this “U.S. Sub-Plan”) of the Plan to Eligible Persons residing in the United States of America or whose primary place of performing services for the Company is located in the United States of America (“U.S. Eligible Persons”).
1.2 Except as expressly set forth herein to the contrary, all of the terms and conditions of the Plan shall apply to Options granted under the Plan to U.S. Eligible Persons.
1.3 The Company intends that securities issued under the Plan to U.S. Eligible Persons be exempt from requirements of registration and qualification of such securities pursuant the exemptions afforded by Rule 701 promulgated under the Securities Act and any applicable exemptions under applicable United States state securities laws, and the Plan shall be so construed. Further, the Company intends that Options granted under the Plan to U.S. Eligible Persons be exempt from or comply with Section 409A of the U.S. Code (including any amendments or replacements of such section), and the Plan shall be so construed.
2. | Definitions |
2.1 Except as set forth in Section 2.2, capitalized terms used in this U.S. Sub-Plan but not defined herein shall have the meanings set forth in the Plan.
2.2 Whenever used herein, the following terms shall have their respective meanings set forth below:
(a) “Consultant” has the meaning as defined in the Plan, provided that the identity of such person, the nature of such services or the entity to which such services are provided would not preclude the Company from offering or selling securities to such person pursuant to the Plan in reliance on either the exemption from registration provided by Rule 701 under the Securities Act or, if the Company is required to file reports pursuant to Section 13 or 15(d) of the Exchange Act, registration on a Form S-8 Registration Statement under the Securities Act.
(b) “Employee” has the meaning as defined in the Plan, provided that, with respect to any Incentive Stock Option granted to such an individual, the individual is considered an employee for purposes of Section 422 of the U.S. Code.
(c) “Fair Market Value” has the meaning as defined in the Plan, provided that any good faith determination by the Administrator in the absence of an established market for the Shares shall be made without regard to any restriction other than a restriction which, by its terms, will never lapse, and in a manner consistent with the requirements of Section 409A of the Code.
(d) “Insider” means an Officer, a Director or other person whose transactions in Shares are subject to Section 16 of the Exchange Act.
(e) “Rule I6b-3” means Rule 16b-3 under the Exchange Act, as amended from time to time, or any successor rule or regulation.
(f) “Securities Act” means the United States Securities Act of 1933, as amended.
(g) “Ten Percent Shareholder” means a person who, at the time an Option is granted to such person, owns stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company within the meaning of Section 422(b)(6) of the Code.
3. | Option Terms. |
3.1 Options may be granted under the U.S. Sub-Plan only to Employees, Consultants and Directors.
3.2 The exercise price per Share for each Option granted under the U.S. Sub-Plan shall be not less than the Fair Market Value of a Share on the date of grant of the Option.
3.3 Incentive Stock Options shall be subject to the following additional limitations:
(a) The maximum aggregate number of Shares that may be issued under the U.S. Sub-Plan pursuant to the exercise of Incentive Stock Options is one hundred eleven thousand one hundred eleven (111,111) Shares (the “ISO Share Limit”).
(b) An Incentive Stock Option may be granted only to an individual who, on the date of grant, is an Employee.
(c) To the extent that Options designated as Incentive Stock Options (granted under all stock plans of the Company, including the Plan) become exercisable by a Participant for the first time during any calendar year for Shares having a Fair Market Value greater than One Hundred Thousand Dollars ($100,000), the portions of such Options that exceed such amount shall be treated as Nonstatutory Stock Options in accordance with Section 7.2 of the Plan. If an Option is treated as an Incentive Stock Option in part and as a Nonstatutory Stock Option in part by reason of the limitation set forth in this Section, the Participant may designate which portion of such Option the Participant is exercising. In the absence of such designation, the Participant shall be deemed to have exercised the Incentive Stock Option portion of the Option first. Upon exercise of the Option, Shares issued pursuant to each such portion shall be separately identified.
(d) The exercise price per Share for an Incentive Stock Option granted to a Ten Percent Shareholder shall be not less than one hundred ten percent (110%) of the Fair Market Value of a Share on the date of grant of the Option.
(e) No Incentive Stock Option may be granted more than ten (10) years after the date the Plan was adopted by the Board.
(f) No Incentive Stock Option shall be exercisable more than ten (10) years after the date of grant of such Option. No Incentive Stock Option granted to a Ten Percent Shareholder shall be exercisable more than five (5) years after the date of grant of such Option.
(g) During the lifetime of the Participant, an Incentive Stock Option shall be exercisable only by the Participant or the Participant’s guardian or legal representative. An Incentive Stock Option shall not be subject in any manner to anticipation, alienation, sale, exchange, transfer, assignment, pledge, encumbrance, or garnishment by creditors of the Participant or the Participant’s beneficiary, except transfer by will or by the laws of descent and distribution.
4. | Tax Withholding. |
4.1 The Company may require a Participant, through payroll withholding, cash payment or otherwise, to make adequate provision for, United States federal, state, local and non-U.S. taxes (including any social insurance), if any, required by law to be withheld by the Company with respect to an Option or the Shares acquired pursuant thereto. The Company shall have no obligation to deliver Shares until the Company’s tax withholding obligations have been satisfied by the Participant.
4.2 The Company shall have the right, but not the obligation, to deduct from the Shares issuable to a Participant upon the exercise of an Option, or to accept from the Participant the tender of, a number of whole Shares having a Fair Market Value, as determined by the Company, equal to all or any part of the tax withholding obligations of the Company. After and IPO and subject to compliance with all applicable requirements of applicable securities laws, the Company may require a Participant to direct a broker, upon the exercise of an Option, to sell a portion of the Shares subject to the Option determined by the Board in its discretion to be sufficient to cover the tax withholding obligations of the Company and to remit an amount equal to such tax withholding obligations to the Company in cash.
5. | Compliance with U.S. Securities and Other Applicable Law. |
5.1 The grant of Options and the issuance of Shares upon exercise of Options shall be subject to compliance with all applicable requirements of United States federal and state law’ with respect to such securities and the requirements of any stock exchange or market system upon which the Shares may then be listed. In addition, no Option may be exercised or Shares issued pursuant to an Option unless (a) a registration statement under the Securities Act shall at the time of such exercise or issuance be in effect with respect to the Shares issuable pursuant to the Option or (b) in the opinion of legal counsel to the Company, the Shares issuable pursuant to the Option may be issued in accordance with the terms of an applicable exemption from the registration requirements of the Securities Act. The inability of the Company to obtain from any regulatory body having jurisdiction the authority, if any, deemed by the Company’s legal counsel to be necessary to the lawful issuance and sale of any shares hereunder shall relieve the Company of any liability in respect of the failure to issue or sell such shares as to which such requisite authority shall not have been obtained. As a condition to issuance of any Share, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate, to evidence compliance with any applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company.
5.2 With respect to participation by Insiders in the Plan, at any time that any class of equity security of the Company is registered pursuant to Section 12 of the Exchange Act, the Plan shall be administered in compliance with the requirements, if any, of Rule 16b-3.
5.3 No Option granted to an Employee who is a non-exempt employee for purposes of the United States Fair Labor Standards Act of 1938, as amended, shall become exercisable until at least six (6) months following the date of grant of such Option (except in the event of such Employee’s death or Disability, or as otherwise permitted by the United States Worker Economic Opportunity Act).
5.4 To the extent permitted by the Board, in its discretion, and set forth in the Award Agreement evidencing such Option, a Nonstatutory Stock Option may be assignable or transferable only in compliance with the applicable limitations, if any, described in Rule 701 under the Securities Act and the General Instructions to Form S-8 Registration Statement under the Securities Act.
5.5 At least annually, copies of the Company’s balance sheet and income statement for the just completed fiscal year shall be made available to each U.S. Eligible Person holding Options or Shares acquired upon the exercise of an Option; provided, however, that this requirement shall not apply if all offers and sales of securities pursuant to the U.S. Sub-Plan comply with all applicable conditions of Rule 701 under the Securities Act. The Company shall not be required to provide such information to persons whose duties in connection with the Company assure them access to equivalent information. The Company shall deliver to each Participant such disclosures as are required in accordance with Rule 701 under the Securities Act.
6. | Amendment of U.S. Sub-Plan. |
6.1 The Board may amend the U.S. Sub-Plan at any time. However, without the approval of the Company’s shareholders, no such amendment shall (a) increase the ISO Share Limit, (b) change the class of persons eligible to receive Incentive Stock Options, or (c) make any other change that would require approval of the Shareholders under any Applicable Law, including the rules of any stock exchange or quotation system upon which the Shares may then be listed or quoted.
7. | Shareholder Approval |
7.1 The U.S. Sub-Plan shall be submitted for approval by the Company’s shareholders during the period beginning twelve (12) months before and ending twelve (12) months after the date of adoption thereof by the Board. Incentive Stock Options granted prior to Shareholder approval of the U.S. Sub-Plan shall become exercisable no earlier than the date of Shareholder approval of the U.S. Sub-Plan, and such Options shall become Nonstatutory Stock Options if such Shareholder approval is not received in the manner described in the preceding sentence.
IN WITNESS WHEREOF, the undersigned Secretary of the Company certifies that the foregoing sets forth the additional provisions of the Pagaya Technologies Ltd. 2021 Equity Incentive Plan applicable to grants to U.S. Eligible Persons, as du)y adopted by the Board on March [__], 2021
Secretary
4
Page
|
||
ARTICLE I DEFINITIONS
|
1
|
|
SECTION 1.01.
|
Defined Terms
|
1
|
SECTION 1.02.
|
Classification of Loans and Borrowings
|
28
|
SECTION 1.03.
|
Terms Generally
|
29
|
SECTION 1.04.
|
Accounting Terms; GAAP; Pro Forma Calculations
|
29
|
SECTION 1.05.
|
Interest Rates; Benchmark Notification
|
30
|
SECTION 1.06.
|
[Reserved]
|
30
|
SECTION 1.07.
|
Divisions
|
30
|
ARTICLE II THE CREDITS
|
30
|
|
SECTION 2.01.
|
Commitments
|
30
|
SECTION 2.02.
|
Loans and Borrowings
|
31
|
SECTION 2.03.
|
Requests for Revolving Borrowings
|
31
|
SECTION 2.04.
|
[Reserved]
|
32
|
SECTION 2.05.
|
[Reserved]
|
32
|
SECTION 2.06.
|
[Reserved]
|
32
|
SECTION 2.07.
|
Funding of Borrowings
|
32
|
SECTION 2.08.
|
Interest Elections
|
32
|
SECTION 2.09.
|
Termination and Reduction of Commitments
|
33
|
SECTION 2.10.
|
Repayment of Loans; Evidence of Debt
|
34
|
SECTION 2.11.
|
Prepayment of Loans
|
34
|
SECTION 2.12.
|
Fees
|
35
|
SECTION 2.13.
|
Interest
|
35
|
SECTION 2.14.
|
Alternate Rate of Interest
|
36
|
SECTION 2.15.
|
Increased Costs
|
38
|
SECTION 2.16.
|
Break Funding Payments
|
40
|
SECTION 2.17.
|
Taxes
|
40
|
SECTION 2.18.
|
Payments Generally; Allocations of Proceeds; Pro Rata Treatment; Sharing of Setoffs
|
44 |
SECTION 2.19.
|
Mitigation Obligations; Replacement of Lenders
|
46
|
SECTION 2.20.
|
[Reserved]
|
46
|
SECTION 2.21.
|
Defaulting Lenders
|
47
|
ARTICLE III REPRESENTATIONS AND WARRANTIES
|
47
|
|
SECTION 3.01.
|
Organization; Powers; Subsidiaries
|
47
|
SECTION 3.02.
|
Authorization; Enforceability
|
48
|
SECTION 3.03.
|
Governmental Approvals; No Conflicts
|
48
|
SECTION 3.04.
|
Financial Condition; No Material Adverse Change
|
48
|
SECTION 3.05.
|
Properties
|
48
|
SECTION 3.06.
|
Litigation and Environmental Matters
|
49
|
SECTION 3.07.
|
Compliance with Laws and Agreements
|
49
|
SECTION 3.08.
|
Investment Company Status
|
49
|
SECTION 3.09.
|
Taxes
|
49
|
SECTION 3.10.
|
ERISA
|
49
|
SECTION 3.11.
|
Disclosure
|
49
|
SECTION 3.12.
|
Liens
|
50
|
SECTION 3.13.
|
No Default
|
50
|
Page
|
||
SECTION 3.14.
|
Solvency
|
50
|
SECTION 3.15.
|
Insurance
|
50
|
SECTION 3.16.
|
[Reserved]
|
50
|
SECTION 3.17.
|
Anti-Corruption Laws and Sanctions
|
50
|
SECTION 3.18.
|
Affected Financial Institutions
|
50
|
SECTION 3.19.
|
Plan Assets; Prohibited Transactions
|
50
|
SECTION 3.20.
|
Margin Regulations
|
51
|
SECTION 3.21.
|
Breaching Company
|
51
|
SECTION 3.22.
|
IIA and Investment Center
|
51
|
ARTICLE IV CONDITIONS
|
51
|
|
SECTION 4.01.
|
Effective Date
|
51
|
SECTION 4.02.
|
Each Credit Event
|
52
|
ARTICLE V AFFIRMATIVE COVENANTS
|
53
|
|
SECTION 5.01.
|
Financial Statements and Other Information
|
53
|
SECTION 5.02.
|
Notices of Material Events
|
55
|
SECTION 5.03.
|
Existence; Conduct of Business
|
55
|
SECTION 5.04.
|
Payment of Taxes
|
55
|
SECTION 5.05.
|
Maintenance of Properties; Insurance
|
56
|
SECTION 5.06.
|
Books and Records; Inspection Rights
|
56
|
SECTION 5.07.
|
Compliance with Laws
|
56
|
SECTION 5.08.
|
Use of Proceeds
|
57
|
SECTION 5.09.
|
Maintenance of Collateral Account
|
57
|
SECTION 5.10.
|
Post-Closing Obligations
|
57
|
SECTION 5.11.
|
Grants
|
57
|
ARTICLE VI NEGATIVE COVENANTS
|
57
|
|
SECTION 6.01.
|
Indebtedness
|
57
|
SECTION 6.02.
|
Liens
|
59
|
SECTION 6.03.
|
Fundamental Changes
|
62
|
SECTION 6.04.
|
Dispositions
|
63
|
SECTION 6.05.
|
Investments, Loans, Advances, Guarantees and Acquisitions
|
64
|
SECTION 6.06.
|
Swap Agreements
|
66
|
SECTION 6.07.
|
Transactions with Affiliates
|
66
|
SECTION 6.08.
|
Restricted Payments
|
67
|
SECTION 6.09.
|
Restrictive Agreements
|
68
|
SECTION 6.10.
|
Subordinated Indebtedness and Amendments to Subordinated Indebtedness Documents
|
68
|
SECTION 6.11.
|
Sale and Leaseback Transactions
|
69
|
SECTION 6.12.
|
Financial Covenants
|
69
|
ARTICLE VII EVENTS OF DEFAULT
|
69
|
|
SECTION 7.01.
|
Events of Default
|
69
|
SECTION 7.02.
|
Remedies Upon an Event of Default
|
71
|
SECTION 7.03.
|
Application of Payments
|
73
|
Page
|
||
ARTICLE VIII THE ADMINISTRATIVE AGENT
|
73
|
|
SECTION 8.01.
|
Authorization and Action
|
73
|
SECTION 8.02.
|
Administrative Agent’s Reliance, Limitation of Liability, Etc
|
76
|
SECTION 8.03.
|
Posting of Communications
|
77
|
SECTION 8.04.
|
The Administrative Agent Individually
|
78
|
SECTION 8.05.
|
Successor Administrative Agent
|
78
|
SECTION 8.06.
|
Acknowledgements of Lenders
|
79
|
SECTION 8.07.
|
Collateral Matters.
|
81
|
SECTION 8.08.
|
Credit Bidding
|
83
|
SECTION 8.09.
|
Certain ERISA Matters
|
83
|
ARTICLE IX MISCELLANEOUS
|
84
|
|
SECTION 9.01.
|
Notices
|
84
|
SECTION 9.02.
|
Waivers; Amendments
|
85
|
SECTION 9.03.
|
Expenses; Limitation of Liability; Indemnity, Etc
|
88
|
SECTION 9.04.
|
Successors and Assigns
|
90
|
SECTION 9.05.
|
Survival
|
93
|
SECTION 9.06.
|
Counterparts; Integration; Effectiveness; Electronic Execution
|
94
|
SECTION 9.07.
|
Severability
|
94
|
SECTION 9.08.
|
Right of Setoff
|
94
|
SECTION 9.09.
|
Governing Law; Jurisdiction; Consent to Service of Process
|
95
|
SECTION 9.10.
|
WAIVER OF JURY TRIAL
|
95
|
SECTION 9.11.
|
Headings
|
96
|
SECTION 9.12.
|
Confidentiality
|
96
|
SECTION 9.13.
|
USA PATRIOT Act
|
97
|
SECTION 9.14.
|
[Reserved]
|
97
|
SECTION 9.15.
|
Appointment for Perfection
|
97
|
SECTION 9.16.
|
Interest Rate Limitation
|
97
|
SECTION 9.17.
|
No Fiduciary Duty, etc
|
97
|
SECTION 9.18.
|
Acknowledgement and Consent to Bail-In of Affected Financial Institutions
|
98
|
SECTION 9.19.
|
Acknowledgement Regarding Any Supported QFCs
|
99
|
SECTION 9.20.
|
Judgment Currency
|
99
|
ARTICLE X CONSENT TO DE-SPAC TRANSACTION AND THE RESTRUCTURING
|
100
|
|
Page |
SCHEDULES:
|
|
Schedule 2.01 – Commitments
|
|
Schedule 6.01 – Existing Indebtedness
|
|
Schedule 6.02 – Existing Liens
|
|
Schedule 6.05 – Existing Investments
|
|
Schedule 6.07 – Transaction with Affiliates
|
|
Schedule 6.09 – Restrictive Agreements
|
|
EXHIBITS:
|
|
Exhibit A – Assignment and Assumption
|
|
Exhibit B – Form of Monthly Compliance Certificate
|
|
Exhibit C – Compliance Certificate
|
|
Exhibit D – [Reserved]
|
|
Exhibit E – List of Closing Documents
|
|
Exhibit F – Form of Prepayment Notice
|
|
Exhibit G-1 – Form of Borrowing Request
|
|
Exhibit G-2 – Form of Interest Election Request
|
|
Exhibit H – Form of Note
|
PAGAYA TECHNOLOGIES LTD.,
as the Borrower
|
||
By
|
/s/ Gal Krubiner
|
|
Name: Gal Krubiner
|
||
Title: Chief Executive Officer
|
By
|
/s/ Michael Kurlander
|
|
Name: Michael Kurlander
|
||
Title: Chief Financial Officer
|
JPMORGAN CHASE BANK, N.A., individually as a Lender and as Administrative Agent
|
||
By
|
/s/ Stephanie Lis
|
|
Name: Stephanie Lis
|
||
Title: Authorized Officer
|
Bank Leumi Le-Israel B.M., as a Lender
|
||
By
|
/s/ Delia Pekelman
|
|
Name: Delia Pekelman
|
||
Title: Deputy Head
|
By
|
/s/ Moran Aizikovich
|
|
Name: Moran Aizikovich
|
||
Title: Relationship Manager
|
Bank Leumi USA, as a Lender
|
||
By
|
/s/ Daniel Lorberbaum
|
|
Name: Daniel Lorberbaum
|
||
Title: AVP
|
By
|
/s/ Tal Shpaizer
|
|
Name: Tal Shpaizer
|
||
Title: SVP
|
Barclays Bank PLC, as a Lender
|
||
By
|
/s/ Evan Moriarty
|
|
Name: Evan Moriarty
|
||
Title: Vice President
|
HSBC Bank USA, National Association, as a Lender
|
||
By
|
/s/ Kyle O’Reilly
|
|
Name: Kyle O’Reilly
|
||
Title: Vice President #23203
|
Exhibit 21.1
SUBSIDIARIES OF PAGAYA TECHNOLOGIES LTD.
Name of Subsidiary |
Jurisdiction of Organization |
|
Pagaya Auto Loans Manager Ltd. | Cayman Islands | |
Pagaya Auto Loans Manager, LP | Cayman Islands | |
Pagaya Auto Loans Fund, LP | Cayman Islands | |
Pagaya Auto Loans Sub Ltd. | Cayman Islands | |
Pagaya Auto Loan Trust | U.S. (Delaware) | |
Pagaya Auto Loan Trust II | U.S. (Delaware) | |
Pagaya Structured Holdings II LLC | Cayman Islands | |
Pagaya Structured Holdings III LLC | Cayman Islands | |
Pagaya US Holding Company LLC | U.S. (Delaware) | |
Pagaya Investments US LLC | U.S. (Delaware) | |
Pagaya RE Management GP LLC | U.S. (Delaware) | |
Pagaya Smartresi F1 Feeder 1 LP | U.S. (Delaware) | |
Pagaya Smartresi F1 Feeder 2 LP | U.S. (Delaware) | |
Pagaya Smartresi F1 Feeder 3 LP | U.S. (Delaware) | |
Pagaya Smartresi F1 IL Feeder 2 Ltd. | Israel | |
Pagaya Smartresi F1 Feeder 3 Holdings LP | U.S. (Delaware) | |
Pagaya Smartresi F1 Feeder 3 RH LP | U.S. (Delaware) | |
Pagaya Smartresi F1 Feeder 2 Holdings LP | U.S. (Delaware) | |
Pagaya Smartresi F1 Feeder 2 BL LLC | U.S. (Delaware) | |
Pagaya Smartresi F1 REIT Holdings, LP | U.S. (Delaware) | |
Pagaya Smartresi F1 REIT LLC | U.S. (Delaware) | |
Pagaya Smartresi F1 Fund, LP | U.S. (Delaware) | |
Pagaya Smartresi F1 Fund Equity Owner II LLC | U.S. (Delaware) | |
Pagaya Smartresi F1 Fund Property Owner II LLC | U.S. (Delaware) | |
Pagaya Smartresi F1 Fund Equity Owner LLC | U.S. (Delaware) | |
Pagaya Smartresi F1 Fund Property Owner LLC | U.S. (Delaware) | |
PATH 2021-1 REIT LLC | U.S. (Delaware) | |
Pagaya SFR Depositor LLC | U.S. (Delaware) | |
Pagaya Smartresi F1 Fund Equity Owner III LLC | U.S. (Delaware) | |
Pagaya Smartresi F1 Fund Property Owner III LLC | U.S. (Delaware) | |
Pagaya Structured Holdings III LLC | Cayman Islands | |
Pagaya Opportunity Manager Ltd. | Cayman Islands | |
Pagaya Opportunity Offshore Feeder Fund I, LP | Cayman Islands | |
Pagaya Opportunity Master Fund Ltd. | Cayman Islands | |
Pagaya Funding Trust | U.S. (Delaware) | |
Pagaya Funding Trust II | U.S. (Delaware) |
Name of Subsidiary |
Jurisdiction of Organization |
|
Pagaya Funding Trust III | U.S. (Delaware) | |
Pagaya Structured Holdings LLC | Cayman Islands | |
Pagaya Credit Opportunity Ltd | Cayman Islands | |
Pagaya Opportunity Onshore Feeder Fund 1, LP | U.S. (Delaware) | |
Pagaya Credit Opportunity LLC | U.S. (Delaware) | |
Pagaya Credit Opportunity Trust | U.S. (Delaware) | |
Pagaya Securities Holdings LLC | U.S. (Delaware) | |
Pagaya Securities Holdings Trust | U.S. (Delaware) | |
PREF 2019 LLC | U.S. (Delaware) | |
Pagaya Technologies US LLC | U.S. (Delaware) | |
Pagaya Motor Receivables Trust | U.S. (Delaware) | |
Pagaya Acquisition Trust | U.S. (Delaware) | |
Pagaya Acquisition Trust II | U.S. (Delaware) | |
Pagaya Acquisition Trust III | U.S. (Delaware) | |
Asset Acquisition Capital LLC | U.S. (Delaware) | |
Citrus Tree Finance LLC | U.S. (Delaware) | |
Pagaya US Holdings LLC | U.S. (Delaware) | |
PAPA Owner LLC | U.S. (Delaware) | |
Park Avenue Property Advisors LLC | U.S. (Delaware) | |
TISCo 1, LLC | U.S. (Delaware) | |
TISCO 2, LLC | U.S. (Delaware) | |
Tangent Insurance Services LLC | U.S. (Delaware) | |
Tangent Captive Insurance IC | U.S. (Delaware) | |
PLG 1 LLC | U.S. (Delaware) | |
PLGA LP | U.S. (Delaware) | |
PLG 2 LLC | U.S. (Delaware) | |
Rigel Merger Sub Inc. | Cayman Islands |